Mitch Report
Antony Kaspi & Mark Ziemann
date generated: 2024-08-16
Background
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Input profiles
Here is the first few lines of the input profile.
| x | |
|---|---|
| HIST1H1C | -10.93778 |
| TNFRSF9 | 10.76330 |
| LAYN | 10.64524 |
| GPR183 | 10.62632 |
| NDRG2 | -10.35576 |
| IL6R-AS1 | 10.13508 |
Here are some metrics about the input data profile:
| Profile metrics | |
|---|---|
| num_genesets | 10461 |
| num_genes_in_profile | 16735 |
| duplicated_genes_present | 0 |
| num_profile_genes_in_sets | 12129 |
| num_profile_genes_not_in_sets | 4606 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Input genesets
Here are some metrics about the gene sets used:
GMT file of genesets:| Gene sets metrics | |
|---|---|
| num_genesets | 10461 |
| num_genesets_excluded | 4322 |
| num_genesets_included | 6139 |
Differential pathway expression
Interactive enrichment scatterplot
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
Results table
Top N= 50 gene sets| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOBP THREONINE METABOLIC PROCESS | 5 | 0.000713 | 0.874 | 0.01720 |
| GOBP RESPONSE TO MOLECULE OF FUNGAL ORIGIN | 5 | 0.001150 | -0.839 | 0.02430 |
| GOBP REGULATION OF CDC42 PROTEIN SIGNAL TRANSDUCTION | 6 | 0.000383 | -0.837 | 0.01070 |
| GOCC MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TRANSPORTER COMPLEX | 6 | 0.000499 | 0.821 | 0.01310 |
| GOBP INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY | 6 | 0.000515 | -0.819 | 0.01340 |
| GOMF ANGIOTENSIN RECEPTOR BINDING | 5 | 0.001550 | -0.817 | 0.02980 |
| GOBP NEGATIVE REGULATION OF MONOCYTE DIFFERENTIATION | 5 | 0.001710 | -0.810 | 0.03180 |
| GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS | 5 | 0.002040 | 0.797 | 0.03630 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 8 | 0.000107 | -0.791 | 0.00403 |
| GOBP REGULATION OF ADIPONECTIN SECRETION | 7 | 0.000328 | 0.784 | 0.00951 |
| GOBP BRANCHED CHAIN AMINO ACID BIOSYNTHETIC PROCESS | 5 | 0.002470 | 0.782 | 0.04220 |
| GOBP REGULATION OF DNA TOPOISOMERASE ATP HYDROLYZING ACTIVITY | 5 | 0.002740 | -0.774 | 0.04510 |
| GOMF HISTONE DEACETYLASE REGULATOR ACTIVITY | 6 | 0.001330 | -0.756 | 0.02660 |
| GOCC PROTEASE INHIBITOR COMPLEX | 5 | 0.003950 | 0.744 | 0.05780 |
| GOBP RESOLUTION OF RECOMBINATION INTERMEDIATES | 6 | 0.001740 | -0.738 | 0.03220 |
| GOBP MIRNA MEDIATED GENE SILENCING BY MRNA DESTABILIZATION | 5 | 0.004520 | -0.733 | 0.06290 |
| GOBP HISTONE H3 K9 METHYLATION | 5 | 0.004630 | -0.731 | 0.06410 |
| GOBP ADP METABOLIC PROCESS | 7 | 0.000810 | 0.731 | 0.01880 |
| GOBP ASTROCYTE CELL MIGRATION | 6 | 0.002140 | 0.724 | 0.03760 |
| GOMF CD4 RECEPTOR BINDING | 6 | 0.002220 | -0.721 | 0.03880 |
| GOBP VITAMIN B6 METABOLIC PROCESS | 5 | 0.005260 | 0.721 | 0.07000 |
| GOMF SUPERCOILED DNA BINDING | 6 | 0.002380 | -0.716 | 0.04080 |
| GOMF HISTONE H3K9ME2 METHYLTRANSFERASE ACTIVITY | 6 | 0.002500 | -0.713 | 0.04230 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 0.005850 | -0.712 | 0.07580 |
| GOBP RESPONSE TO FUNGICIDE | 6 | 0.002710 | -0.707 | 0.04490 |
| GOBP PURINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 0.002720 | 0.707 | 0.04510 |
| GOBP CATECHOLAMINE UPTAKE | 6 | 0.002780 | 0.705 | 0.04550 |
| GOMF PROTEIN SERINE THREONINE KINASE BINDING | 7 | 0.001360 | -0.699 | 0.02700 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 6 | 0.003070 | -0.698 | 0.04870 |
| GOCC EKC KEOPS COMPLEX | 5 | 0.007470 | 0.691 | 0.08590 |
| GOCC RISC LOADING COMPLEX | 8 | 0.000786 | -0.686 | 0.01840 |
| GOMF HISTONE H3K9 MONOMETHYLTRANSFERASE ACTIVITY | 5 | 0.008160 | -0.683 | 0.09130 |
| GOMF AMINOACYL TRNA HYDROLASE ACTIVITY | 5 | 0.009260 | 0.672 | 0.09950 |
| GOBP MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 5 | 0.009440 | -0.670 | 0.10000 |
| GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING | 7 | 0.002200 | -0.668 | 0.03860 |
| GOBP FATTY ACID ELONGATION SATURATED FATTY ACID | 5 | 0.009920 | 0.666 | 0.10400 |
| GOMF FATTY ACID ELONGASE ACTIVITY | 5 | 0.009920 | 0.666 | 0.10400 |
| GOBP CORTICOSPINAL TRACT MORPHOGENESIS | 5 | 0.009950 | -0.666 | 0.10400 |
| GOMF IGG BINDING | 6 | 0.004760 | -0.665 | 0.06520 |
| GOBP NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS | 5 | 0.010000 | 0.665 | 0.10400 |
| GOCC ACTIVIN RECEPTOR COMPLEX | 5 | 0.010300 | -0.663 | 0.10600 |
| GOBP NEGATIVE REGULATION OF CATECHOLAMINE SECRETION | 5 | 0.010400 | -0.662 | 0.10600 |
| GOBP ADP BIOSYNTHETIC PROCESS | 5 | 0.010400 | 0.662 | 0.10600 |
| GOMF HISTONE H3K9 METHYLTRANSFERASE ACTIVITY | 10 | 0.000294 | -0.661 | 0.00874 |
| GOBP NEGATIVE REGULATION OF T CELL MIGRATION | 5 | 0.010800 | -0.658 | 0.10900 |
| GOMF TRANSLATION TERMINATION FACTOR ACTIVITY | 6 | 0.005240 | 0.658 | 0.07000 |
| GOMF HISTONE H4K16 ACETYLTRANSFERASE ACTIVITY | 9 | 0.000638 | -0.657 | 0.01580 |
| GOBP REGULATION OF FC GAMMA RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 5 | 0.011000 | -0.657 | 0.11000 |
| GOBP REGULATION OF ISOMERASE ACTIVITY | 8 | 0.001290 | -0.657 | 0.02630 |
| GOBP PROTEIN TRANSPORT WITHIN LIPID BILAYER | 5 | 0.011300 | 0.654 | 0.11200 |
Results (complete table)
Click HERE to show results for all gene sets
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOBP THREONINE METABOLIC PROCESS | 5 | 7.13e-04 | 8.74e-01 | 1.72e-02 |
| GOBP RESPONSE TO MOLECULE OF FUNGAL ORIGIN | 5 | 1.15e-03 | -8.39e-01 | 2.43e-02 |
| GOBP REGULATION OF CDC42 PROTEIN SIGNAL TRANSDUCTION | 6 | 3.83e-04 | -8.37e-01 | 1.07e-02 |
| GOCC MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TRANSPORTER COMPLEX | 6 | 4.99e-04 | 8.21e-01 | 1.31e-02 |
| GOBP INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY | 6 | 5.15e-04 | -8.19e-01 | 1.34e-02 |
| GOMF ANGIOTENSIN RECEPTOR BINDING | 5 | 1.55e-03 | -8.17e-01 | 2.98e-02 |
| GOBP NEGATIVE REGULATION OF MONOCYTE DIFFERENTIATION | 5 | 1.71e-03 | -8.10e-01 | 3.18e-02 |
| GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS | 5 | 2.04e-03 | 7.97e-01 | 3.63e-02 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 8 | 1.07e-04 | -7.91e-01 | 4.03e-03 |
| GOBP REGULATION OF ADIPONECTIN SECRETION | 7 | 3.28e-04 | 7.84e-01 | 9.51e-03 |
| GOBP BRANCHED CHAIN AMINO ACID BIOSYNTHETIC PROCESS | 5 | 2.47e-03 | 7.82e-01 | 4.22e-02 |
| GOBP REGULATION OF DNA TOPOISOMERASE ATP HYDROLYZING ACTIVITY | 5 | 2.74e-03 | -7.74e-01 | 4.51e-02 |
| GOMF HISTONE DEACETYLASE REGULATOR ACTIVITY | 6 | 1.33e-03 | -7.56e-01 | 2.66e-02 |
| GOCC PROTEASE INHIBITOR COMPLEX | 5 | 3.95e-03 | 7.44e-01 | 5.78e-02 |
| GOBP RESOLUTION OF RECOMBINATION INTERMEDIATES | 6 | 1.74e-03 | -7.38e-01 | 3.22e-02 |
| GOBP MIRNA MEDIATED GENE SILENCING BY MRNA DESTABILIZATION | 5 | 4.52e-03 | -7.33e-01 | 6.29e-02 |
| GOBP HISTONE H3 K9 METHYLATION | 5 | 4.63e-03 | -7.31e-01 | 6.41e-02 |
| GOBP ADP METABOLIC PROCESS | 7 | 8.10e-04 | 7.31e-01 | 1.88e-02 |
| GOBP ASTROCYTE CELL MIGRATION | 6 | 2.14e-03 | 7.24e-01 | 3.76e-02 |
| GOMF CD4 RECEPTOR BINDING | 6 | 2.22e-03 | -7.21e-01 | 3.88e-02 |
| GOBP VITAMIN B6 METABOLIC PROCESS | 5 | 5.26e-03 | 7.21e-01 | 7.00e-02 |
| GOMF SUPERCOILED DNA BINDING | 6 | 2.38e-03 | -7.16e-01 | 4.08e-02 |
| GOMF HISTONE H3K9ME2 METHYLTRANSFERASE ACTIVITY | 6 | 2.50e-03 | -7.13e-01 | 4.23e-02 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 5.85e-03 | -7.12e-01 | 7.58e-02 |
| GOBP RESPONSE TO FUNGICIDE | 6 | 2.71e-03 | -7.07e-01 | 4.49e-02 |
| GOBP PURINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 2.72e-03 | 7.07e-01 | 4.51e-02 |
| GOBP CATECHOLAMINE UPTAKE | 6 | 2.78e-03 | 7.05e-01 | 4.55e-02 |
| GOMF PROTEIN SERINE THREONINE KINASE BINDING | 7 | 1.36e-03 | -6.99e-01 | 2.70e-02 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 6 | 3.07e-03 | -6.98e-01 | 4.87e-02 |
| GOCC EKC KEOPS COMPLEX | 5 | 7.47e-03 | 6.91e-01 | 8.59e-02 |
| GOCC RISC LOADING COMPLEX | 8 | 7.86e-04 | -6.86e-01 | 1.84e-02 |
| GOMF HISTONE H3K9 MONOMETHYLTRANSFERASE ACTIVITY | 5 | 8.16e-03 | -6.83e-01 | 9.13e-02 |
| GOMF AMINOACYL TRNA HYDROLASE ACTIVITY | 5 | 9.26e-03 | 6.72e-01 | 9.95e-02 |
| GOBP MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 5 | 9.44e-03 | -6.70e-01 | 1.00e-01 |
| GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING | 7 | 2.20e-03 | -6.68e-01 | 3.86e-02 |
| GOBP FATTY ACID ELONGATION SATURATED FATTY ACID | 5 | 9.92e-03 | 6.66e-01 | 1.04e-01 |
| GOMF FATTY ACID ELONGASE ACTIVITY | 5 | 9.92e-03 | 6.66e-01 | 1.04e-01 |
| GOBP CORTICOSPINAL TRACT MORPHOGENESIS | 5 | 9.95e-03 | -6.66e-01 | 1.04e-01 |
| GOMF IGG BINDING | 6 | 4.76e-03 | -6.65e-01 | 6.52e-02 |
| GOBP NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS | 5 | 1.00e-02 | 6.65e-01 | 1.04e-01 |
| GOCC ACTIVIN RECEPTOR COMPLEX | 5 | 1.03e-02 | -6.63e-01 | 1.06e-01 |
| GOBP NEGATIVE REGULATION OF CATECHOLAMINE SECRETION | 5 | 1.04e-02 | -6.62e-01 | 1.06e-01 |
| GOBP ADP BIOSYNTHETIC PROCESS | 5 | 1.04e-02 | 6.62e-01 | 1.06e-01 |
| GOMF HISTONE H3K9 METHYLTRANSFERASE ACTIVITY | 10 | 2.94e-04 | -6.61e-01 | 8.74e-03 |
| GOBP NEGATIVE REGULATION OF T CELL MIGRATION | 5 | 1.08e-02 | -6.58e-01 | 1.09e-01 |
| GOMF TRANSLATION TERMINATION FACTOR ACTIVITY | 6 | 5.24e-03 | 6.58e-01 | 7.00e-02 |
| GOMF HISTONE H4K16 ACETYLTRANSFERASE ACTIVITY | 9 | 6.38e-04 | -6.57e-01 | 1.58e-02 |
| GOBP REGULATION OF FC GAMMA RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 5 | 1.10e-02 | -6.57e-01 | 1.10e-01 |
| GOBP REGULATION OF ISOMERASE ACTIVITY | 8 | 1.29e-03 | -6.57e-01 | 2.63e-02 |
| GOBP PROTEIN TRANSPORT WITHIN LIPID BILAYER | 5 | 1.13e-02 | 6.54e-01 | 1.12e-01 |
| GOCC SPECTRIN ASSOCIATED CYTOSKELETON | 5 | 1.13e-02 | 6.54e-01 | 1.12e-01 |
| GOBP DERMATAN SULFATE BIOSYNTHETIC PROCESS | 5 | 1.15e-02 | 6.52e-01 | 1.14e-01 |
| GOCC IRON SULFUR CLUSTER ASSEMBLY COMPLEX | 12 | 9.65e-05 | 6.50e-01 | 3.74e-03 |
| GOCC MSL COMPLEX | 5 | 1.19e-02 | -6.50e-01 | 1.16e-01 |
| GOBP POSITIVE REGULATION OF RIG I SIGNALING PATHWAY | 8 | 1.66e-03 | -6.42e-01 | 3.14e-02 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 5 | 1.29e-02 | -6.42e-01 | 1.22e-01 |
| GOBP ORNITHINE METABOLIC PROCESS | 6 | 6.49e-03 | 6.42e-01 | 7.96e-02 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE MODIFICATION | 5 | 1.30e-02 | 6.41e-01 | 1.22e-01 |
| GOBP PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY | 6 | 6.63e-03 | 6.40e-01 | 8.00e-02 |
| GOBP VIRAL TRANSLATIONAL TERMINATION REINITIATION | 5 | 1.33e-02 | -6.39e-01 | 1.25e-01 |
| GOBP REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 6 | 7.13e-03 | -6.34e-01 | 8.39e-02 |
| GOBP IMMATURE T CELL PROLIFERATION | 7 | 3.71e-03 | 6.33e-01 | 5.51e-02 |
| GOBP UTERINE SMOOTH MUSCLE CONTRACTION | 5 | 1.49e-02 | -6.29e-01 | 1.34e-01 |
| GOBP REGULATION OF PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS | 5 | 1.50e-02 | 6.28e-01 | 1.35e-01 |
| GOMF AZOLE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 4.06e-03 | 6.27e-01 | 5.89e-02 |
| GOBP THYROID HORMONE MEDIATED SIGNALING PATHWAY | 6 | 7.83e-03 | -6.27e-01 | 8.89e-02 |
| GOBP POSITIVE REGULATION OF GLOMERULAR MESANGIAL CELL PROLIFERATION | 5 | 1.57e-02 | 6.24e-01 | 1.39e-01 |
| GOBP REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 6 | 8.18e-03 | -6.23e-01 | 9.13e-02 |
| GOMF HISTONE H4K5 ACETYLTRANSFERASE ACTIVITY | 11 | 3.54e-04 | -6.22e-01 | 1.00e-02 |
| GOBP REGULATION OF ODONTOGENESIS | 5 | 1.61e-02 | 6.22e-01 | 1.41e-01 |
| GOBP REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 9 | 1.26e-03 | -6.21e-01 | 2.57e-02 |
| GOBP REGULATION OF SPONTANEOUS SYNAPTIC TRANSMISSION | 6 | 8.57e-03 | 6.20e-01 | 9.42e-02 |
| GOCC U2AF COMPLEX | 5 | 1.68e-02 | -6.18e-01 | 1.45e-01 |
| GOMF INSULIN BINDING | 5 | 1.68e-02 | -6.18e-01 | 1.45e-01 |
| GOBP REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS | 6 | 9.29e-03 | 6.13e-01 | 9.98e-02 |
| GOBP RISC COMPLEX ASSEMBLY | 10 | 7.86e-04 | -6.13e-01 | 1.84e-02 |
| GOMF HISTONE H3K9 DEMETHYLASE ACTIVITY | 11 | 4.45e-04 | -6.12e-01 | 1.21e-02 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION | 10 | 8.14e-04 | -6.11e-01 | 1.89e-02 |
| GOBP INTERLEUKIN 23 PRODUCTION | 6 | 9.66e-03 | -6.10e-01 | 1.02e-01 |
| GOBP DETECTION OF LIPOPOLYSACCHARIDE | 5 | 1.82e-02 | 6.10e-01 | 1.49e-01 |
| GOCC TRAMP COMPLEX | 5 | 1.84e-02 | -6.09e-01 | 1.50e-01 |
| GOMF HISTONE H3K14 ACETYLTRANSFERASE ACTIVITY | 9 | 1.57e-03 | -6.09e-01 | 3.00e-02 |
| GOBP CHORIONIC TROPHOBLAST CELL DIFFERENTIATION | 5 | 1.89e-02 | -6.06e-01 | 1.52e-01 |
| GOMF MHC CLASS II PROTEIN BINDING | 5 | 1.90e-02 | -6.06e-01 | 1.53e-01 |
| GOBP 2FE 2S CLUSTER ASSEMBLY | 11 | 5.11e-04 | 6.05e-01 | 1.33e-02 |
| GOBP NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 9 | 1.67e-03 | -6.05e-01 | 3.14e-02 |
| GOCC DENDRITIC SPINE HEAD | 5 | 1.92e-02 | -6.05e-01 | 1.53e-01 |
| GOMF AXON GUIDANCE RECEPTOR ACTIVITY | 5 | 1.92e-02 | -6.05e-01 | 1.53e-01 |
| GOCC POSTSYNAPTIC CYTOSKELETON | 5 | 1.95e-02 | 6.03e-01 | 1.54e-01 |
| GOBP INTERLEUKIN 4 MEDIATED SIGNALING PATHWAY | 9 | 1.74e-03 | -6.03e-01 | 3.22e-02 |
| GOBP NEGATIVE REGULATION OF MIRNA PROCESSING | 6 | 1.07e-02 | -6.02e-01 | 1.09e-01 |
| GOMF HISTONE H3 ACETYLTRANSFERASE ACTIVITY | 14 | 9.97e-05 | -6.01e-01 | 3.82e-03 |
| GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY | 7 | 5.97e-03 | -6.00e-01 | 7.64e-02 |
| GOMF HISTONE H3K27ME2 H3K27ME3 DEMETHYLASE ACTIVITY | 5 | 2.06e-02 | -5.98e-01 | 1.59e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 5 | 2.07e-02 | -5.97e-01 | 1.59e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 5 | 2.07e-02 | -5.97e-01 | 1.59e-01 |
| GOBP CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 7 | 6.61e-03 | -5.93e-01 | 7.99e-02 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE | 13 | 2.15e-04 | 5.93e-01 | 6.90e-03 |
| GOBP VASCULAR WOUND HEALING | 11 | 6.71e-04 | 5.92e-01 | 1.64e-02 |
| GOMF ADP RIBOSE DIPHOSPHATASE ACTIVITY | 6 | 1.21e-02 | 5.91e-01 | 1.17e-01 |
| GOBP PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER | 17 | 2.47e-05 | 5.91e-01 | 1.27e-03 |
| GOBP REGULATION OF LENS FIBER CELL DIFFERENTIATION | 6 | 1.23e-02 | -5.90e-01 | 1.18e-01 |
| GOMF CARBOXYLESTERASE ACTIVITY | 5 | 2.24e-02 | -5.90e-01 | 1.66e-01 |
| GOMF CALCIUM INDEPENDENT PHOSPHOLIPASE A2 ACTIVITY | 8 | 4.01e-03 | 5.87e-01 | 5.85e-02 |
| GOBP REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY | 7 | 7.11e-03 | -5.87e-01 | 8.39e-02 |
| GOBP REGULATION OF NEUTROPHIL DEGRANULATION | 7 | 7.20e-03 | -5.87e-01 | 8.42e-02 |
| GOBP CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 8 | 4.07e-03 | -5.87e-01 | 5.89e-02 |
| GOBP NEGATIVE REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 5 | 2.33e-02 | -5.86e-01 | 1.71e-01 |
| GOBP GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 10 | 1.36e-03 | -5.85e-01 | 2.70e-02 |
| GOBP CARNITINE TRANSMEMBRANE TRANSPORT | 5 | 2.38e-02 | 5.84e-01 | 1.73e-01 |
| GOCC TIM22 MITOCHONDRIAL IMPORT INNER MEMBRANE INSERTION COMPLEX | 7 | 7.60e-03 | 5.83e-01 | 8.72e-02 |
| GOBP DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 10 | 1.43e-03 | -5.82e-01 | 2.79e-02 |
| GOMF ADP PHOSPHATASE ACTIVITY | 5 | 2.42e-02 | 5.82e-01 | 1.74e-01 |
| GOMF HISTONE H3K27 METHYLTRANSFERASE ACTIVITY | 6 | 1.37e-02 | -5.81e-01 | 1.27e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 9 | 2.57e-03 | -5.80e-01 | 4.33e-02 |
| GOBP RESPONSE TO INTERLEUKIN 15 | 11 | 9.77e-04 | -5.74e-01 | 2.19e-02 |
| GOBP HIPPOCAMPAL NEURON APOPTOTIC PROCESS | 5 | 2.65e-02 | 5.73e-01 | 1.84e-01 |
| GOMF CYTIDYLYLTRANSFERASE ACTIVITY | 9 | 2.93e-03 | 5.73e-01 | 4.74e-02 |
| GOBP NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING | 8 | 5.13e-03 | -5.71e-01 | 6.91e-02 |
| GOCC MHC CLASS II PROTEIN COMPLEX | 14 | 2.16e-04 | -5.71e-01 | 6.92e-03 |
| GOBP ACTIN MYOSIN FILAMENT SLIDING | 5 | 2.71e-02 | 5.71e-01 | 1.87e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET | 7 | 9.09e-03 | -5.69e-01 | 9.85e-02 |
| GOCC PEPTIDASE INHIBITOR COMPLEX | 7 | 9.38e-03 | 5.67e-01 | 1.00e-01 |
| GOBP ATRIAL SEPTUM MORPHOGENESIS | 8 | 5.56e-03 | -5.66e-01 | 7.31e-02 |
| GOBP DEOXYRIBONUCLEOSIDE CATABOLIC PROCESS | 6 | 1.70e-02 | 5.63e-01 | 1.45e-01 |
| GOMF ADENYLATE KINASE ACTIVITY | 8 | 5.88e-03 | 5.62e-01 | 7.58e-02 |
| GOBP CELLULAR RESPONSE TO WATER STIMULUS | 5 | 2.95e-02 | -5.62e-01 | 1.97e-01 |
| GOCC SODIUM POTASSIUM EXCHANGING ATPASE COMPLEX | 5 | 3.00e-02 | 5.61e-01 | 1.97e-01 |
| GOBP RESPONSE TO INTERLEUKIN 2 | 7 | 1.04e-02 | -5.59e-01 | 1.06e-01 |
| GOBP PROTEIN POLYUFMYLATION | 5 | 3.04e-02 | 5.59e-01 | 1.99e-01 |
| GOBP AMPA GLUTAMATE RECEPTOR CLUSTERING | 6 | 1.78e-02 | -5.59e-01 | 1.48e-01 |
| GOBP DISACCHARIDE METABOLIC PROCESS | 6 | 1.79e-02 | -5.58e-01 | 1.48e-01 |
| GOMF DEOXYNUCLEOSIDE KINASE ACTIVITY | 5 | 3.08e-02 | -5.58e-01 | 2.00e-01 |
| GOMF ANKYRIN REPEAT BINDING | 6 | 1.83e-02 | 5.56e-01 | 1.50e-01 |
| GOCC MCM COMPLEX | 8 | 6.54e-03 | -5.55e-01 | 7.96e-02 |
| GOBP RNA GUANINE N7 METHYLATION | 7 | 1.10e-02 | 5.55e-01 | 1.10e-01 |
| GOBP NEGATIVE REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 6 | 1.85e-02 | 5.55e-01 | 1.50e-01 |
| GOBP REGULATION OF MUCUS SECRETION | 6 | 1.86e-02 | 5.55e-01 | 1.51e-01 |
| GOBP PROTEIN MATURATION BY 4FE 4S CLUSTER TRANSFER | 7 | 1.11e-02 | 5.54e-01 | 1.11e-01 |
| GOBP INTERLEUKIN 2 MEDIATED SIGNALING PATHWAY | 6 | 1.87e-02 | -5.54e-01 | 1.51e-01 |
| GOMF ASPARTIC ENDOPEPTIDASE ACTIVITY INTRAMEMBRANE CLEAVING | 7 | 1.13e-02 | -5.53e-01 | 1.13e-01 |
| GOMF SPHINGOSINE N ACYLTRANSFERASE ACTIVITY | 6 | 1.94e-02 | -5.51e-01 | 1.54e-01 |
| GOMF SIRNA BINDING | 9 | 4.25e-03 | -5.50e-01 | 6.05e-02 |
| GOCC CALCINEURIN COMPLEX | 5 | 3.32e-02 | -5.50e-01 | 2.11e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 8 | 7.14e-03 | -5.49e-01 | 8.39e-02 |
| GOBP REGULATION OF REGULATORY NCRNA PROCESSING | 12 | 9.92e-04 | -5.49e-01 | 2.20e-02 |
| GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 6 | 2.04e-02 | -5.47e-01 | 1.58e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION | 8 | 7.41e-03 | 5.47e-01 | 8.56e-02 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL PROLIFERATION | 8 | 7.41e-03 | -5.47e-01 | 8.56e-02 |
| GOBP ERBB2 ERBB4 SIGNALING PATHWAY | 5 | 3.44e-02 | 5.46e-01 | 2.16e-01 |
| GOMF INTERLEUKIN 1 RECEPTOR ACTIVITY | 5 | 3.49e-02 | -5.45e-01 | 2.17e-01 |
| GOMF HISTONE H3K4 TRIMETHYLTRANSFERASE ACTIVITY | 8 | 7.63e-03 | -5.45e-01 | 8.74e-02 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX | 13 | 6.90e-04 | -5.44e-01 | 1.68e-02 |
| GOBP MAMMALIAN OOGENESIS STAGE | 7 | 1.28e-02 | -5.43e-01 | 1.21e-01 |
| GOBP RESPONSE TO VITAMIN A | 6 | 2.14e-02 | -5.42e-01 | 1.61e-01 |
| GOBP CADMIUM ION TRANSMEMBRANE TRANSPORT | 5 | 3.61e-02 | 5.41e-01 | 2.20e-01 |
| GOMF TRAIL BINDING | 5 | 3.61e-02 | 5.41e-01 | 2.20e-01 |
| GOBP RIG I SIGNALING PATHWAY | 24 | 5.13e-06 | -5.38e-01 | 3.62e-04 |
| GOBP NEGATIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 9 | 5.26e-03 | -5.37e-01 | 7.00e-02 |
| GOBP PHOSPHATIDYLSERINE ACYL CHAIN REMODELING | 8 | 8.52e-03 | -5.37e-01 | 9.40e-02 |
| GOBP ISOLEUCINE METABOLIC PROCESS | 7 | 1.39e-02 | 5.37e-01 | 1.28e-01 |
| GOMF C X C CHEMOKINE RECEPTOR ACTIVITY | 5 | 3.78e-02 | 5.36e-01 | 2.25e-01 |
| GOMF HISTONE H3K4 MONOMETHYLTRANSFERASE ACTIVITY | 8 | 8.67e-03 | -5.36e-01 | 9.49e-02 |
| GOBP CELL CYCLE DNA REPLICATION INITIATION | 5 | 3.84e-02 | -5.35e-01 | 2.27e-01 |
| GOBP REGULATION OF CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 5 | 3.88e-02 | -5.34e-01 | 2.28e-01 |
| GOBP ISG15 PROTEIN CONJUGATION | 6 | 2.37e-02 | -5.33e-01 | 1.72e-01 |
| GOBP MITOCHONDRIAL TRANSLATIONAL ELONGATION | 5 | 3.95e-02 | 5.32e-01 | 2.30e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL PROLIFERATION | 9 | 5.86e-03 | -5.30e-01 | 7.58e-02 |
| GOMF DNA TRANSLOCASE ACTIVITY | 5 | 4.02e-02 | -5.30e-01 | 2.31e-01 |
| GOCC PAM COMPLEX TIM23 ASSOCIATED IMPORT MOTOR | 5 | 4.04e-02 | 5.29e-01 | 2.32e-01 |
| GOBP CORONARY ARTERY MORPHOGENESIS | 7 | 1.54e-02 | -5.29e-01 | 1.38e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH OXIDATION OF A PAIR OF DONORS RESULTING IN THE REDUCTION OF MOLECULAR OXYGEN TO TWO MOLECULES OF WATER | 8 | 9.65e-03 | 5.28e-01 | 1.02e-01 |
| GOMF 7SK SNRNA BINDING | 8 | 9.82e-03 | -5.27e-01 | 1.03e-01 |
| GOBP REGULATION OF TERMINATION OF DNA TEMPLATED TRANSCRIPTION | 5 | 4.23e-02 | -5.24e-01 | 2.39e-01 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 9 | 6.44e-03 | -5.24e-01 | 7.93e-02 |
| GOMF ACTIVIN RECEPTOR ACTIVITY | 8 | 1.02e-02 | -5.24e-01 | 1.06e-01 |
| GOCC ALPHA DNA POLYMERASE PRIMASE COMPLEX | 5 | 4.24e-02 | -5.24e-01 | 2.39e-01 |
| GOBP DIAPEDESIS | 6 | 2.64e-02 | -5.24e-01 | 1.84e-01 |
| GOBP INTRACELLULAR SPHINGOLIPID HOMEOSTASIS | 5 | 4.27e-02 | 5.23e-01 | 2.40e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 9 | 6.57e-03 | -5.23e-01 | 7.96e-02 |
| GOBP HISTONE H4 K16 ACETYLATION | 7 | 1.67e-02 | -5.23e-01 | 1.45e-01 |
| GOBP REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 9 | 6.75e-03 | -5.21e-01 | 8.13e-02 |
| GOBP REGULATION OF DENDRITIC CELL CHEMOTAXIS | 7 | 1.70e-02 | -5.21e-01 | 1.45e-01 |
| GOBP RESPONSE TO VITAMIN E | 6 | 2.75e-02 | -5.20e-01 | 1.88e-01 |
| GOBP NEGATIVE REGULATION OF PLASMINOGEN ACTIVATION | 5 | 4.53e-02 | 5.17e-01 | 2.48e-01 |
| GOBP REGULATION OF GENE EXPRESSION BY GENOMIC IMPRINTING | 8 | 1.14e-02 | -5.17e-01 | 1.13e-01 |
| GOMF COPPER CHAPERONE ACTIVITY | 7 | 1.80e-02 | 5.16e-01 | 1.49e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT PHOSPHATASE ACTIVITY | 7 | 1.82e-02 | -5.16e-01 | 1.49e-01 |
| GOCC TRNA METHYLTRANSFERASE COMPLEX | 7 | 1.86e-02 | 5.14e-01 | 1.51e-01 |
| GOBP MAINTENANCE OF DNA REPEAT ELEMENTS | 6 | 2.98e-02 | -5.12e-01 | 1.97e-01 |
| GOMF MYOSIN LIGHT CHAIN BINDING | 5 | 4.77e-02 | 5.11e-01 | 2.54e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION | 5 | 4.77e-02 | 5.11e-01 | 2.54e-01 |
| GOBP INTRACELLULAR MONOATOMIC ANION HOMEOSTASIS | 7 | 1.92e-02 | -5.11e-01 | 1.53e-01 |
| GOBP SCARNA LOCALIZATION TO CAJAL BODY | 5 | 4.78e-02 | 5.11e-01 | 2.54e-01 |
| GOMF OPSONIN RECEPTOR ACTIVITY | 5 | 4.80e-02 | -5.11e-01 | 2.55e-01 |
| GOBP NATURAL KILLER CELL CHEMOTAXIS | 7 | 1.94e-02 | 5.10e-01 | 1.54e-01 |
| GOMF TORC2 COMPLEX BINDING | 5 | 4.82e-02 | -5.10e-01 | 2.55e-01 |
| GOMF CCR1 CHEMOKINE RECEPTOR BINDING | 5 | 4.88e-02 | 5.09e-01 | 2.57e-01 |
| GOBP REGULATION OF MICROVILLUS ASSEMBLY | 6 | 3.12e-02 | -5.08e-01 | 2.02e-01 |
| GOBP MAMMARY GLAND BRANCHING INVOLVED IN PREGNANCY | 5 | 4.93e-02 | -5.08e-01 | 2.58e-01 |
| GOBP RENAL SYSTEM VASCULATURE MORPHOGENESIS | 6 | 3.14e-02 | -5.07e-01 | 2.03e-01 |
| GOBP CERAMIDE 1 PHOSPHATE TRANSPORT | 5 | 4.96e-02 | 5.07e-01 | 2.59e-01 |
| GOMF CERAMIDE 1 PHOSPHATE TRANSFER ACTIVITY | 5 | 4.96e-02 | 5.07e-01 | 2.59e-01 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC VESICLE MEMBRANE | 7 | 2.02e-02 | 5.07e-01 | 1.57e-01 |
| GOMF SODIUM ION BINDING | 5 | 5.00e-02 | 5.06e-01 | 2.60e-01 |
| GOBP EPITHELIAL CELL FATE COMMITMENT | 7 | 2.05e-02 | -5.06e-01 | 1.58e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 7 | 2.06e-02 | -5.06e-01 | 1.58e-01 |
| GOBP REGULATION OF PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 10 | 5.78e-03 | 5.04e-01 | 7.51e-02 |
| GOBP RESPONSE TO ZINC ION STARVATION | 7 | 2.09e-02 | -5.04e-01 | 1.59e-01 |
| GOCC T CELL RECEPTOR COMPLEX | 7 | 2.09e-02 | -5.04e-01 | 1.59e-01 |
| GOBP REGULATION OF MONOCYTE DIFFERENTIATION | 17 | 3.24e-04 | -5.04e-01 | 9.44e-03 |
| GOBP 3 UTR MEDIATED MRNA DESTABILIZATION | 16 | 4.93e-04 | -5.03e-01 | 1.31e-02 |
| GOBP POSITIVE REGULATION OF HISTONE DEACETYLATION | 5 | 5.15e-02 | -5.03e-01 | 2.62e-01 |
| GOBP REGULATION OF HISTONE DEACETYLATION | 5 | 5.15e-02 | -5.03e-01 | 2.62e-01 |
| GOBP DIET INDUCED THERMOGENESIS | 6 | 3.30e-02 | -5.03e-01 | 2.10e-01 |
| GOMF ATP DEPENDENT CHROMATIN REMODELER ACTIVITY | 34 | 3.91e-07 | -5.03e-01 | 4.51e-05 |
| GOBP MICROGLIA DIFFERENTIATION | 10 | 5.98e-03 | -5.02e-01 | 7.64e-02 |
| GOBP FATTY ACID ALPHA OXIDATION | 5 | 5.20e-02 | 5.02e-01 | 2.64e-01 |
| GOBP SODIUM ION EXPORT ACROSS PLASMA MEMBRANE | 6 | 3.33e-02 | 5.02e-01 | 2.11e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE LID SUBCOMPLEX | 7 | 2.17e-02 | 5.01e-01 | 1.63e-01 |
| GOCC HOST CELLULAR COMPONENT | 8 | 1.41e-02 | -5.01e-01 | 1.29e-01 |
| GOBP FARNESYL DIPHOSPHATE METABOLIC PROCESS | 5 | 5.28e-02 | 5.00e-01 | 2.65e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 6 | 3.42e-02 | -4.99e-01 | 2.15e-01 |
| GOCC TIM23 MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE COMPLEX | 16 | 5.47e-04 | 4.99e-01 | 1.40e-02 |
| GOBP REGULATION OF VASCULAR WOUND HEALING | 7 | 2.24e-02 | 4.99e-01 | 1.66e-01 |
| GOMF SUPEROXIDE GENERATING NAD P H OXIDASE ACTIVITY | 6 | 3.45e-02 | -4.98e-01 | 2.16e-01 |
| GOBP POSITIVE REGULATION OF NUCLEASE ACTIVITY | 7 | 2.26e-02 | -4.98e-01 | 1.67e-01 |
| GOMF CYSTEINE TYPE EXOPEPTIDASE ACTIVITY | 6 | 3.49e-02 | 4.97e-01 | 2.17e-01 |
| GOBP 4FE 4S CLUSTER ASSEMBLY | 5 | 5.41e-02 | 4.97e-01 | 2.67e-01 |
| GOMF UBIQUITIN LIGASE INHIBITOR ACTIVITY | 8 | 1.49e-02 | -4.97e-01 | 1.34e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 12 | 2.92e-03 | -4.96e-01 | 4.73e-02 |
| GOBP POSITIVE REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 6 | 3.54e-02 | 4.96e-01 | 2.18e-01 |
| GOBP PRE MIRNA PROCESSING | 14 | 1.32e-03 | -4.96e-01 | 2.65e-02 |
| GOBP CARDIAC LEFT VENTRICLE MORPHOGENESIS | 8 | 1.52e-02 | -4.95e-01 | 1.37e-01 |
| GOBP REGULATION OF RIBONUCLEASE ACTIVITY | 8 | 1.53e-02 | -4.95e-01 | 1.38e-01 |
| GOBP NEGATIVE REGULATION OF CYCLASE ACTIVITY | 5 | 5.55e-02 | -4.95e-01 | 2.71e-01 |
| GOMF FIBROBLAST GROWTH FACTOR RECEPTOR BINDING | 5 | 5.55e-02 | -4.94e-01 | 2.71e-01 |
| GOBP REGULATION OF RELAXATION OF MUSCLE | 6 | 3.60e-02 | -4.94e-01 | 2.20e-01 |
| GOBP ALPHA LINOLENIC ACID METABOLIC PROCESS | 9 | 1.03e-02 | 4.94e-01 | 1.06e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 6 | 3.63e-02 | -4.93e-01 | 2.20e-01 |
| GOMF MHC CLASS II RECEPTOR ACTIVITY | 8 | 1.57e-02 | -4.93e-01 | 1.39e-01 |
| GOMF HISTONE DECROTONYLASE ACTIVITY | 5 | 5.64e-02 | -4.93e-01 | 2.74e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL MIGRATION | 5 | 5.66e-02 | -4.92e-01 | 2.74e-01 |
| GOMF HISTONE H4 DEMETHYLASE ACTIVITY | 5 | 5.67e-02 | -4.92e-01 | 2.74e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR BINDING | 5 | 5.68e-02 | -4.92e-01 | 2.74e-01 |
| GOCC H3 HISTONE ACETYLTRANSFERASE COMPLEX | 8 | 1.61e-02 | -4.91e-01 | 1.41e-01 |
| GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 6 | 3.77e-02 | -4.90e-01 | 2.25e-01 |
| GOMF 1 4 ALPHA OLIGOGLUCAN PHOSPHORYLASE ACTIVITY | 5 | 5.84e-02 | -4.89e-01 | 2.79e-01 |
| GOBP SPERMINE METABOLIC PROCESS | 5 | 5.84e-02 | 4.89e-01 | 2.79e-01 |
| GOBP NEGATIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 7 | 2.54e-02 | -4.88e-01 | 1.80e-01 |
| GOBP POSITIVE THYMIC T CELL SELECTION | 8 | 1.70e-02 | -4.87e-01 | 1.45e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION VIA CPG ISLAND METHYLATION | 7 | 2.59e-02 | -4.86e-01 | 1.82e-01 |
| GOBP CELL ADHESION INVOLVED IN HEART MORPHOGENESIS | 5 | 5.98e-02 | -4.86e-01 | 2.82e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 8 | 1.77e-02 | 4.84e-01 | 1.48e-01 |
| GOBP ETHANOL CATABOLIC PROCESS | 6 | 4.01e-02 | -4.84e-01 | 2.31e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 9 | 1.19e-02 | 4.84e-01 | 1.16e-01 |
| GOMF OXYGEN CARRIER ACTIVITY | 5 | 6.09e-02 | -4.84e-01 | 2.85e-01 |
| GOBP REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 7 | 2.68e-02 | -4.83e-01 | 1.86e-01 |
| GOBP POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 9 | 1.21e-02 | 4.83e-01 | 1.17e-01 |
| GOBP RESPONSE TO PHORBOL 13 ACETATE 12 MYRISTATE | 5 | 6.17e-02 | -4.82e-01 | 2.87e-01 |
| GOMF FOLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.23e-02 | 4.81e-01 | 2.88e-01 |
| GOMF CALCIUM SODIUM ANTIPORTER ACTIVITY | 6 | 4.12e-02 | -4.81e-01 | 2.35e-01 |
| GOBP KIDNEY MESENCHYME DEVELOPMENT | 7 | 2.74e-02 | -4.81e-01 | 1.88e-01 |
| GOMF DELTA CATENIN BINDING | 7 | 2.74e-02 | -4.81e-01 | 1.88e-01 |
| GOMF PROTEIN TYROSINE KINASE INHIBITOR ACTIVITY | 5 | 6.26e-02 | -4.81e-01 | 2.89e-01 |
| GOMF NEUROPEPTIDE RECEPTOR ACTIVITY | 5 | 6.30e-02 | 4.80e-01 | 2.89e-01 |
| GOBP POSITIVE REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 5 | 6.31e-02 | -4.80e-01 | 2.89e-01 |
| GOBP METANEPHRIC MESENCHYME DEVELOPMENT | 6 | 4.18e-02 | -4.80e-01 | 2.37e-01 |
| GOBP CHORION DEVELOPMENT | 8 | 1.89e-02 | -4.79e-01 | 1.52e-01 |
| GOBP NATURAL KILLER CELL DIFFERENTIATION | 20 | 2.07e-04 | -4.79e-01 | 6.79e-03 |
| GOBP WATER SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 9 | 1.28e-02 | 4.79e-01 | 1.21e-01 |
| GOBP REGULATION OF RIG I SIGNALING PATHWAY | 18 | 4.46e-04 | -4.78e-01 | 1.21e-02 |
| GOCC MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT | 32 | 2.87e-06 | 4.78e-01 | 2.16e-04 |
| GOMF SIALIC ACID BINDING | 12 | 4.16e-03 | -4.78e-01 | 5.94e-02 |
| GOCC TETRASPANIN ENRICHED MICRODOMAIN | 10 | 8.90e-03 | -4.78e-01 | 9.71e-02 |
| GOMF CUPROUS ION BINDING | 6 | 4.33e-02 | 4.76e-01 | 2.41e-01 |
| GOMF THIOL OXIDASE ACTIVITY | 6 | 4.35e-02 | 4.76e-01 | 2.42e-01 |
| GOBP G2 MI TRANSITION OF MEIOTIC CELL CYCLE | 6 | 4.35e-02 | -4.76e-01 | 2.42e-01 |
| GOCC CMG COMPLEX | 11 | 6.34e-03 | -4.75e-01 | 7.85e-02 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 9 | 1.38e-02 | 4.74e-01 | 1.28e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 8 | 2.04e-02 | -4.73e-01 | 1.58e-01 |
| GOBP POSITIVE REGULATION OF NEUTROPHIL ACTIVATION | 5 | 6.71e-02 | -4.73e-01 | 2.99e-01 |
| GOMF INHIBITORY MHC CLASS I RECEPTOR ACTIVITY | 7 | 3.05e-02 | 4.72e-01 | 1.99e-01 |
| GOMF CERAMIDE 1 PHOSPHATE BINDING | 6 | 4.52e-02 | 4.72e-01 | 2.48e-01 |
| GOBP TERMINATION OF RNA POLYMERASE II TRANSCRIPTION | 10 | 9.95e-03 | -4.71e-01 | 1.04e-01 |
| GOMF UNMETHYLATED CPG BINDING | 9 | 1.48e-02 | -4.69e-01 | 1.34e-01 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 5 | 6.94e-02 | -4.69e-01 | 3.05e-01 |
| GOMF NUCLEAR VITAMIN D RECEPTOR BINDING | 15 | 1.67e-03 | -4.69e-01 | 3.14e-02 |
| GOBP DEVELOPMENT OF SECONDARY FEMALE SEXUAL CHARACTERISTICS | 5 | 6.95e-02 | -4.69e-01 | 3.05e-01 |
| GOBP NEUTROPHIL EXTRAVASATION | 12 | 5.05e-03 | -4.67e-01 | 6.82e-02 |
| GOMF TRANSCRIPTION ELONGATION FACTOR ACTIVITY | 6 | 4.77e-02 | 4.67e-01 | 2.54e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE SIGNAL SEQUENCE RECOGNITION | 5 | 7.14e-02 | 4.66e-01 | 3.11e-01 |
| GOMF PHOSPHATIDATE PHOSPHATASE ACTIVITY | 8 | 2.29e-02 | 4.65e-01 | 1.69e-01 |
| GOBP MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY | 23 | 1.17e-04 | 4.64e-01 | 4.30e-03 |
| GOBP INOSINE METABOLIC PROCESS | 5 | 7.24e-02 | 4.64e-01 | 3.14e-01 |
| GOMF ACID PHOSPHATASE ACTIVITY | 6 | 4.93e-02 | 4.63e-01 | 2.58e-01 |
| GOMF AMIDINE LYASE ACTIVITY | 7 | 3.38e-02 | 4.63e-01 | 2.13e-01 |
| GOBP REPLICATION BORN DOUBLE STRAND BREAK REPAIR VIA SISTER CHROMATID EXCHANGE | 6 | 4.94e-02 | -4.63e-01 | 2.59e-01 |
| GOBP AMP SALVAGE | 5 | 7.30e-02 | 4.63e-01 | 3.16e-01 |
| GOMF POLYAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 3.39e-02 | 4.63e-01 | 2.14e-01 |
| GOMF INOSITOL 1 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 4.97e-02 | -4.63e-01 | 2.59e-01 |
| GOCC GID COMPLEX | 5 | 7.32e-02 | -4.63e-01 | 3.16e-01 |
| GOCC PLATELET DENSE TUBULAR NETWORK | 7 | 3.42e-02 | -4.62e-01 | 2.15e-01 |
| GOMF PROTEIN PRENYLTRANSFERASE ACTIVITY | 7 | 3.46e-02 | -4.61e-01 | 2.16e-01 |
| GOMF P TYPE CALCIUM TRANSPORTER ACTIVITY | 8 | 2.39e-02 | -4.61e-01 | 1.74e-01 |
| GOBP REGULATION OF SYNAPSE STRUCTURAL PLASTICITY | 5 | 7.43e-02 | -4.61e-01 | 3.19e-01 |
| GOMF ARYL HYDROCARBON RECEPTOR BINDING | 6 | 5.07e-02 | -4.61e-01 | 2.61e-01 |
| GOBP ARGININE CATABOLIC PROCESS | 6 | 5.12e-02 | 4.60e-01 | 2.62e-01 |
| GOBP PURINE RIBONUCLEOSIDE CATABOLIC PROCESS | 6 | 5.13e-02 | 4.59e-01 | 2.62e-01 |
| GOMF CALMODULIN DEPENDENT PROTEIN PHOSPHATASE ACTIVITY | 5 | 7.60e-02 | -4.58e-01 | 3.23e-01 |
| GOBP IRON SULFUR CLUSTER ASSEMBLY | 30 | 1.42e-05 | 4.58e-01 | 8.33e-04 |
| GOCC ISWI TYPE COMPLEX | 13 | 4.30e-03 | -4.57e-01 | 6.09e-02 |
| GOMF L LACTATE DEHYDROGENASE ACTIVITY | 5 | 7.66e-02 | 4.57e-01 | 3.25e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX EIF3M | 7 | 3.63e-02 | -4.57e-01 | 2.20e-01 |
| GOBP MONOCYTE EXTRAVASATION | 6 | 5.27e-02 | -4.57e-01 | 2.65e-01 |
| GOBP DNA METHYLATION ON CYTOSINE | 5 | 7.69e-02 | -4.57e-01 | 3.25e-01 |
| GOBP NEGATIVE REGULATION OF FIBRINOLYSIS | 6 | 5.27e-02 | 4.57e-01 | 2.65e-01 |
| GOBP BLEB ASSEMBLY | 10 | 1.24e-02 | -4.57e-01 | 1.19e-01 |
| GOBP POSITIVE REGULATION OF PLASMINOGEN ACTIVATION | 6 | 5.32e-02 | 4.56e-01 | 2.66e-01 |
| GOCC PLATELET DENSE TUBULAR NETWORK MEMBRANE | 6 | 5.37e-02 | -4.55e-01 | 2.66e-01 |
| GOBP METHYLGLYOXAL METABOLIC PROCESS | 6 | 5.37e-02 | 4.55e-01 | 2.66e-01 |
| GOMF PROTEIN ARGININE OMEGA N MONOMETHYLTRANSFERASE ACTIVITY | 5 | 7.85e-02 | -4.54e-01 | 3.30e-01 |
| GOBP PROTEIN DNA COVALENT CROSS LINKING REPAIR | 7 | 3.74e-02 | -4.54e-01 | 2.24e-01 |
| GOMF MAGNESIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 3.26e-03 | 4.54e-01 | 5.05e-02 |
| GOBP SEX DETERMINATION | 6 | 5.43e-02 | -4.54e-01 | 2.67e-01 |
| GOBP NEGATIVE REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION | 5 | 7.91e-02 | -4.54e-01 | 3.31e-01 |
| GOBP MAST CELL PROLIFERATION | 5 | 7.92e-02 | -4.53e-01 | 3.31e-01 |
| GOBP NEGATIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 7 | 3.79e-02 | -4.53e-01 | 2.25e-01 |
| GOBP CORONARY VASCULATURE MORPHOGENESIS | 12 | 6.57e-03 | -4.53e-01 | 7.96e-02 |
| GOBP PROTEIN O LINKED GLYCOSYLATION VIA THREONINE | 8 | 2.66e-02 | 4.53e-01 | 1.85e-01 |
| GOBP CYTOSOLIC RIBOSOME ASSEMBLY | 5 | 7.96e-02 | 4.53e-01 | 3.32e-01 |
| GOBP VESICLE FUSION WITH GOLGI APPARATUS | 9 | 1.89e-02 | 4.52e-01 | 1.52e-01 |
| GOBP REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 7 | 3.84e-02 | -4.52e-01 | 2.27e-01 |
| GOBP CHOLESTEROL IMPORT | 7 | 3.84e-02 | 4.52e-01 | 2.27e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION | 10 | 1.34e-02 | -4.52e-01 | 1.25e-01 |
| GOMF METALLOCHAPERONE ACTIVITY | 13 | 4.83e-03 | 4.51e-01 | 6.59e-02 |
| GOMF POLY A RNA POLYMERASE ACTIVITY | 8 | 2.72e-02 | -4.51e-01 | 1.87e-01 |
| GOBP LUTEOLYSIS | 6 | 5.58e-02 | -4.51e-01 | 2.72e-01 |
| GOBP REGULATION OF RNA EXPORT FROM NUCLEUS | 13 | 4.89e-03 | -4.51e-01 | 6.66e-02 |
| GOBP POSITIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 9 | 1.93e-02 | -4.50e-01 | 1.54e-01 |
| GOBP URATE METABOLIC PROCESS | 5 | 8.14e-02 | 4.50e-01 | 3.36e-01 |
| GOMF OXIDIZED DNA BINDING | 11 | 9.79e-03 | -4.50e-01 | 1.03e-01 |
| GOBP ENDOCARDIUM DEVELOPMENT | 8 | 2.76e-02 | -4.50e-01 | 1.88e-01 |
| GOBP RESPONSE TO FOLIC ACID | 6 | 5.65e-02 | -4.50e-01 | 2.74e-01 |
| GOBP CELLULAR HYPOTONIC RESPONSE | 9 | 1.96e-02 | -4.49e-01 | 1.55e-01 |
| GOCC POLYSOMAL RIBOSOME | 30 | 2.10e-05 | -4.49e-01 | 1.15e-03 |
| GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 7 | 4.00e-02 | -4.48e-01 | 2.31e-01 |
| GOBP MUSCLE HYPERTROPHY IN RESPONSE TO STRESS | 13 | 5.20e-03 | -4.48e-01 | 6.96e-02 |
| GOMF HISTONE H4K12 ACETYLTRANSFERASE ACTIVITY | 12 | 7.35e-03 | -4.47e-01 | 8.53e-02 |
| GOBP KETONE BODY METABOLIC PROCESS | 5 | 8.36e-02 | 4.47e-01 | 3.40e-01 |
| GOBP NEGATIVE REGULATION OF CHROMATIN ORGANIZATION | 5 | 8.37e-02 | -4.47e-01 | 3.40e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 5 | 8.38e-02 | -4.47e-01 | 3.40e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATIONAL ELONGATION | 5 | 8.42e-02 | -4.46e-01 | 3.41e-01 |
| GOMF TESTOSTERONE 17 BETA DEHYDROGENASE NADPPLUS ACTIVITY | 6 | 5.86e-02 | 4.46e-01 | 2.79e-01 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX | 17 | 1.46e-03 | -4.46e-01 | 2.85e-02 |
| GOBP LINOLEIC ACID METABOLIC PROCESS | 11 | 1.05e-02 | 4.45e-01 | 1.07e-01 |
| GOMF LEUCINE BINDING | 6 | 5.88e-02 | -4.45e-01 | 2.79e-01 |
| GOCC RIBBON SYNAPSE | 9 | 2.07e-02 | -4.45e-01 | 1.59e-01 |
| GOBP PURINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 18 | 1.08e-03 | 4.45e-01 | 2.32e-02 |
| GOBP GDP MANNOSE METABOLIC PROCESS | 6 | 5.90e-02 | 4.45e-01 | 2.80e-01 |
| GOBP REGULATION OF POLYAMINE TRANSMEMBRANE TRANSPORT | 5 | 8.51e-02 | 4.45e-01 | 3.43e-01 |
| GOMF ORNITHINE DECARBOXYLASE REGULATOR ACTIVITY | 5 | 8.51e-02 | 4.45e-01 | 3.43e-01 |
| GOBP REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 23 | 2.29e-04 | -4.44e-01 | 7.20e-03 |
| GOMF PEPTIDE ALPHA N ACETYLTRANSFERASE ACTIVITY | 7 | 4.22e-02 | 4.43e-01 | 2.39e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL CHEMOTAXIS | 6 | 6.06e-02 | -4.42e-01 | 2.84e-01 |
| GOBP REGULATION OF GENE SILENCING BY REGULATORY NCRNA | 23 | 2.44e-04 | -4.42e-01 | 7.51e-03 |
| GOBP GAMMA DELTA T CELL DIFFERENTIATION | 8 | 3.08e-02 | -4.41e-01 | 2.00e-01 |
| GOMF ARRESTIN FAMILY PROTEIN BINDING | 5 | 8.78e-02 | -4.41e-01 | 3.46e-01 |
| GOBP POSITIVE REGULATION OF RNA EXPORT FROM NUCLEUS | 5 | 8.79e-02 | -4.41e-01 | 3.46e-01 |
| GOMF GLUTATHIONE DISULFIDE OXIDOREDUCTASE ACTIVITY | 5 | 8.80e-02 | 4.41e-01 | 3.46e-01 |
| GOCC UNIPLEX COMPLEX | 6 | 6.19e-02 | 4.40e-01 | 2.88e-01 |
| GOBP MAINTENANCE OF LENS TRANSPARENCY | 6 | 6.23e-02 | -4.39e-01 | 2.88e-01 |
| GOMF HISTONE H3 METHYLTRANSFERASE ACTIVITY | 38 | 2.76e-06 | -4.39e-01 | 2.10e-04 |
| GOBP REGULATION OF SKELETAL MUSCLE ADAPTATION | 6 | 6.27e-02 | -4.39e-01 | 2.89e-01 |
| GOBP REGULATION OF RAB PROTEIN SIGNAL TRANSDUCTION | 7 | 4.48e-02 | -4.38e-01 | 2.46e-01 |
| GOCC ORGANELLAR RIBOSOME | 89 | 1.10e-12 | 4.36e-01 | 4.08e-10 |
| GOBP NATURAL KILLER CELL PROLIFERATION | 12 | 8.87e-03 | -4.36e-01 | 9.69e-02 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE | 9 | 2.34e-02 | -4.36e-01 | 1.72e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 6 | 6.45e-02 | 4.36e-01 | 2.93e-01 |
| GOCC DNA REPLICATION PREINITIATION COMPLEX | 12 | 9.00e-03 | -4.36e-01 | 9.76e-02 |
| GOMF HYALURONONGLUCOSAMINIDASE ACTIVITY | 6 | 6.48e-02 | -4.35e-01 | 2.93e-01 |
| GOBP REGULATION OF MRNA EXPORT FROM NUCLEUS | 7 | 4.62e-02 | -4.35e-01 | 2.50e-01 |
| GOMF HISTONE H3K36 METHYLTRANSFERASE ACTIVITY | 11 | 1.25e-02 | -4.35e-01 | 1.19e-01 |
| GOBP POSITIVE REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 5 | 9.20e-02 | -4.35e-01 | 3.56e-01 |
| GOMF STRUCTURAL CONSTITUENT OF MYELIN SHEATH | 6 | 6.50e-02 | 4.35e-01 | 2.94e-01 |
| GOBP POLYAMINE TRANSPORT | 13 | 6.79e-03 | 4.34e-01 | 8.17e-02 |
| GOMF PROTEIN DEMETHYLASE ACTIVITY | 28 | 7.24e-05 | -4.33e-01 | 3.07e-03 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 7 | 4.72e-02 | 4.33e-01 | 2.54e-01 |
| GOBP BONE TRABECULA FORMATION | 6 | 6.64e-02 | -4.33e-01 | 2.98e-01 |
| GOBP AMINOACYL TRNA METABOLISM INVOLVED IN TRANSLATIONAL FIDELITY | 8 | 3.40e-02 | 4.33e-01 | 2.14e-01 |
| GOMF AMINOACYL TRNA EDITING ACTIVITY | 8 | 3.40e-02 | 4.33e-01 | 2.14e-01 |
| GOBP NEGATIVE REGULATION OF MONOCYTE CHEMOTAXIS | 5 | 9.38e-02 | -4.33e-01 | 3.61e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS | 5 | 9.39e-02 | -4.33e-01 | 3.61e-01 |
| GOBP REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 10 | 1.80e-02 | -4.32e-01 | 1.49e-01 |
| GOMF DNA DNA ANNEALING ACTIVITY | 7 | 4.78e-02 | -4.32e-01 | 2.54e-01 |
| GOMF LYSINE ACETYLATED HISTONE BINDING | 22 | 4.57e-04 | -4.32e-01 | 1.23e-02 |
| GOBP SPONTANEOUS SYNAPTIC TRANSMISSION | 8 | 3.47e-02 | 4.31e-01 | 2.16e-01 |
| GOMF ARMADILLO REPEAT DOMAIN BINDING | 7 | 4.84e-02 | -4.31e-01 | 2.56e-01 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 19 | 1.16e-03 | -4.30e-01 | 2.43e-02 |
| GOMF COMPLEMENT RECEPTOR ACTIVITY | 7 | 4.87e-02 | -4.30e-01 | 2.57e-01 |
| GOCC MITOCHONDRIAL LARGE RIBOSOMAL SUBUNIT | 56 | 2.58e-08 | 4.30e-01 | 4.32e-06 |
| GOBP MAGNESIUM ION TRANSPORT | 16 | 2.90e-03 | 4.30e-01 | 4.71e-02 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ADAPTOR ACTIVITY | 14 | 5.35e-03 | -4.30e-01 | 7.09e-02 |
| GOMF RIBOSOMAL PROTEIN S6 KINASE ACTIVITY | 6 | 6.82e-02 | -4.30e-01 | 3.02e-01 |
| GOMF MALATE DEHYDROGENASE ACTIVITY | 6 | 6.83e-02 | 4.30e-01 | 3.02e-01 |
| GOBP DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 25 | 2.00e-04 | -4.30e-01 | 6.63e-03 |
| GOBP REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY | 6 | 6.84e-02 | 4.30e-01 | 3.02e-01 |
| GOBP NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 8 | 3.54e-02 | -4.30e-01 | 2.18e-01 |
| GOBP ANTIFUNGAL INNATE IMMUNE RESPONSE | 11 | 1.37e-02 | -4.29e-01 | 1.27e-01 |
| GOBP REGULATION OF RIBOSOME BIOGENESIS | 9 | 2.57e-02 | 4.29e-01 | 1.81e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 7 | 4.93e-02 | 4.29e-01 | 2.58e-01 |
| GOBP CDC42 PROTEIN SIGNAL TRANSDUCTION | 13 | 7.41e-03 | -4.29e-01 | 8.56e-02 |
| GOBP POSITIVE REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION | 5 | 9.68e-02 | -4.29e-01 | 3.66e-01 |
| GOBP VITAMIN TRANSMEMBRANE TRANSPORT | 12 | 1.01e-02 | 4.29e-01 | 1.05e-01 |
| GOBP AZOLE TRANSMEMBRANE TRANSPORT | 8 | 3.59e-02 | 4.28e-01 | 2.20e-01 |
| GOBP RESPONSE TO LECTIN | 16 | 3.02e-03 | -4.28e-01 | 4.81e-02 |
| GOBP ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE | 10 | 1.91e-02 | 4.28e-01 | 1.53e-01 |
| GOMF RNA POLYMERASE II C TERMINAL DOMAIN BINDING | 10 | 1.91e-02 | -4.28e-01 | 1.53e-01 |
| GOCC CYCLIN CDK POSITIVE TRANSCRIPTION ELONGATION FACTOR COMPLEX | 6 | 6.96e-02 | -4.28e-01 | 3.06e-01 |
| GOBP TETRAHYDROBIOPTERIN METABOLIC PROCESS | 7 | 5.01e-02 | 4.28e-01 | 2.60e-01 |
| GOBP MESENCHYMAL STEM CELL PROLIFERATION | 5 | 9.78e-02 | -4.27e-01 | 3.66e-01 |
| GOBP POSITIVE REGULATION OF MESENCHYMAL STEM CELL PROLIFERATION | 5 | 9.78e-02 | -4.27e-01 | 3.66e-01 |
| GOBP NEGATIVE REGULATION OF CELL DIVISION | 12 | 1.04e-02 | -4.27e-01 | 1.06e-01 |
| GOBP MAINTENANCE OF APICAL BASAL CELL POLARITY | 7 | 5.02e-02 | 4.27e-01 | 2.60e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 5 | 9.80e-02 | 4.27e-01 | 3.66e-01 |
| GOBP LEFT RIGHT AXIS SPECIFICATION | 11 | 1.42e-02 | -4.27e-01 | 1.29e-01 |
| GOCC SUPER ELONGATION COMPLEX | 5 | 9.81e-02 | 4.27e-01 | 3.67e-01 |
| GOBP REGULATION OF HEXOKINASE ACTIVITY | 5 | 9.84e-02 | 4.27e-01 | 3.67e-01 |
| GOBP REGULATION OF CELLULAR EXTRAVASATION | 25 | 2.22e-04 | -4.27e-01 | 7.04e-03 |
| GOBP GANGLIOSIDE CATABOLIC PROCESS | 5 | 9.86e-02 | 4.27e-01 | 3.67e-01 |
| GOBP REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 10 | 1.96e-02 | -4.26e-01 | 1.55e-01 |
| GOBP RESPONSE TO DIETARY EXCESS | 16 | 3.16e-03 | -4.26e-01 | 4.97e-02 |
| GOBP REGULATION OF NEUROTRANSMITTER UPTAKE | 8 | 3.69e-02 | 4.26e-01 | 2.23e-01 |
| GOCC MITOTIC COHESIN COMPLEX | 6 | 7.08e-02 | -4.26e-01 | 3.09e-01 |
| GOBP ANGIOGENESIS INVOLVED IN WOUND HEALING | 17 | 2.38e-03 | 4.26e-01 | 4.08e-02 |
| GOMF REGULATORY RNA BINDING | 42 | 1.91e-06 | -4.25e-01 | 1.56e-04 |
| GOCC PHOTORECEPTOR RIBBON SYNAPSE | 7 | 5.19e-02 | -4.24e-01 | 2.64e-01 |
| GOBP REGULATION OF TRANSLATIONAL FIDELITY | 13 | 8.12e-03 | 4.24e-01 | 9.11e-02 |
| GOBP PROTEIN K27 LINKED UBIQUITINATION | 7 | 5.22e-02 | 4.24e-01 | 2.64e-01 |
| GOBP COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY | 8 | 3.80e-02 | -4.24e-01 | 2.26e-01 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE SLEEP | 8 | 3.81e-02 | -4.23e-01 | 2.26e-01 |
| GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX | 7 | 5.26e-02 | 4.23e-01 | 2.65e-01 |
| GOBP ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION | 20 | 1.07e-03 | 4.23e-01 | 2.31e-02 |
| GOMF POTASSIUM ION BINDING | 7 | 5.29e-02 | 4.22e-01 | 2.66e-01 |
| GOMF 7S RNA BINDING | 7 | 5.30e-02 | 4.22e-01 | 2.66e-01 |
| GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION | 7 | 5.31e-02 | -4.22e-01 | 2.66e-01 |
| GOMF HISTONE H4 ACETYLTRANSFERASE ACTIVITY | 22 | 6.11e-04 | -4.22e-01 | 1.53e-02 |
| GOCC GLYCOGEN GRANULE | 7 | 5.33e-02 | 4.22e-01 | 2.66e-01 |
| GOBP PROTEIN REPAIR | 6 | 7.43e-02 | 4.21e-01 | 3.19e-01 |
| GOBP TYPE I PNEUMOCYTE DIFFERENTIATION | 6 | 7.49e-02 | -4.20e-01 | 3.21e-01 |
| GOBP ODONTOBLAST DIFFERENTIATION | 9 | 2.93e-02 | -4.20e-01 | 1.95e-01 |
| GOMF HEPARAN SULFATE PROTEOGLYCAN BINDING | 10 | 2.16e-02 | -4.19e-01 | 1.63e-01 |
| GOBP PROTEIN LOCALIZATION TO ADHERENS JUNCTION | 6 | 7.53e-02 | 4.19e-01 | 3.21e-01 |
| GOBP UTERUS DEVELOPMENT | 12 | 1.19e-02 | -4.19e-01 | 1.16e-01 |
| GOBP T FOLLICULAR HELPER CELL DIFFERENTIATION | 5 | 1.05e-01 | -4.19e-01 | 3.79e-01 |
| GOBP GLUCOSAMINE CONTAINING COMPOUND CATABOLIC PROCESS | 8 | 4.01e-02 | 4.19e-01 | 2.31e-01 |
| GOMF IMMUNOGLOBULIN RECEPTOR ACTIVITY | 7 | 5.53e-02 | -4.18e-01 | 2.71e-01 |
| GOBP SEBACEOUS GLAND DEVELOPMENT | 6 | 7.61e-02 | -4.18e-01 | 3.23e-01 |
| GOMF NADPLUS PROTEIN CYSTEINE ADP RIBOSYLTRANSFERASE ACTIVITY | 6 | 7.62e-02 | -4.18e-01 | 3.23e-01 |
| GOBP FIBROBLAST GROWTH FACTOR PRODUCTION | 5 | 1.06e-01 | 4.18e-01 | 3.81e-01 |
| GOBP RNA SECONDARY STRUCTURE UNWINDING | 9 | 3.00e-02 | -4.18e-01 | 1.97e-01 |
| GOMF PHOSPHATIDYLETHANOLAMINE BINDING | 12 | 1.23e-02 | 4.17e-01 | 1.18e-01 |
| GOCC GRANULAR COMPONENT | 6 | 7.68e-02 | -4.17e-01 | 3.25e-01 |
| GOMF MRF BINDING | 5 | 1.06e-01 | -4.17e-01 | 3.82e-01 |
| GOBP PROTEIN LOCALIZATION TO PHOTORECEPTOR OUTER SEGMENT | 5 | 1.06e-01 | 4.17e-01 | 3.82e-01 |
| GOBP EMBRYONIC BODY MORPHOGENESIS | 7 | 5.65e-02 | -4.16e-01 | 2.74e-01 |
| GOMF RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 14 | 7.02e-03 | -4.16e-01 | 8.34e-02 |
| GOBP PROTEIN DENEDDYLATION | 11 | 1.69e-02 | 4.16e-01 | 1.45e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT MODIFYING ACTIVITY | 17 | 3.00e-03 | -4.16e-01 | 4.80e-02 |
| GOBP INTRACELLULAR TRIGLYCERIDE HOMEOSTASIS | 7 | 5.69e-02 | 4.16e-01 | 2.74e-01 |
| GOBP RESPONSE TO VASOPRESSIN | 5 | 1.08e-01 | -4.15e-01 | 3.84e-01 |
| GOBP RESPONSE TO YEAST | 6 | 7.82e-02 | -4.15e-01 | 3.29e-01 |
| GOBP NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING | 6 | 7.82e-02 | -4.15e-01 | 3.29e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 15 | 5.47e-03 | -4.14e-01 | 7.21e-02 |
| GOBP DNA REPLICATION DEPENDENT CHROMATIN ASSEMBLY | 6 | 7.90e-02 | -4.14e-01 | 3.31e-01 |
| GOBP TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY | 11 | 1.74e-02 | 4.14e-01 | 1.47e-01 |
| GOMF RS DOMAIN BINDING | 5 | 1.09e-01 | -4.14e-01 | 3.87e-01 |
| GOBP TYPE II INTERFERON MEDIATED SIGNALING PATHWAY | 21 | 1.03e-03 | -4.14e-01 | 2.25e-02 |
| GOBP ERBB2 EGFR SIGNALING PATHWAY | 5 | 1.09e-01 | 4.13e-01 | 3.88e-01 |
| GOBP CITRATE METABOLIC PROCESS | 5 | 1.09e-01 | -4.13e-01 | 3.88e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE V1 DOMAIN | 10 | 2.36e-02 | 4.13e-01 | 1.72e-01 |
| GOBP FATTY ACID ELONGATION | 11 | 1.79e-02 | 4.12e-01 | 1.48e-01 |
| GOBP POSITIVE REGULATION OF SYNAPSE MATURATION | 7 | 5.89e-02 | -4.12e-01 | 2.79e-01 |
| GOBP CELLULAR RESPONSE TO ALDOSTERONE | 5 | 1.11e-01 | -4.12e-01 | 3.90e-01 |
| GOBP FC EPSILON RECEPTOR SIGNALING PATHWAY | 23 | 6.31e-04 | -4.12e-01 | 1.57e-02 |
| GOBP NEGATIVE REGULATION OF RIBOSOME BIOGENESIS | 7 | 5.93e-02 | 4.12e-01 | 2.81e-01 |
| GOBP SPHINGOLIPID TRANSLOCATION | 5 | 1.11e-01 | -4.12e-01 | 3.90e-01 |
| GOBP SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION | 5 | 1.11e-01 | 4.11e-01 | 3.91e-01 |
| GOMF LAMIN BINDING | 14 | 7.77e-03 | -4.11e-01 | 8.84e-02 |
| GOBP PROTEIN TRIMERIZATION | 12 | 1.37e-02 | -4.11e-01 | 1.27e-01 |
| GOCC MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 11 | 1.83e-02 | 4.11e-01 | 1.49e-01 |
| GOCC NUCLEOLAR RIBONUCLEASE P COMPLEX | 7 | 5.99e-02 | 4.11e-01 | 2.83e-01 |
| GOBP REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS | 10 | 2.46e-02 | -4.10e-01 | 1.76e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 10 | 2.49e-02 | -4.09e-01 | 1.78e-01 |
| GOBP LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS | 5 | 1.13e-01 | -4.09e-01 | 3.95e-01 |
| GOMF NEDD8 TRANSFERASE ACTIVITY | 7 | 6.10e-02 | 4.09e-01 | 2.85e-01 |
| GOBP MEIOTIC CELL CYCLE PHASE TRANSITION | 10 | 2.52e-02 | -4.09e-01 | 1.79e-01 |
| GOMF COMPLEMENT BINDING | 10 | 2.52e-02 | -4.09e-01 | 1.79e-01 |
| GOBP REGULATION OF DOSAGE COMPENSATION BY INACTIVATION OF X CHROMOSOME | 13 | 1.07e-02 | -4.09e-01 | 1.09e-01 |
| GOBP MIRNA PROCESSING | 40 | 7.88e-06 | -4.08e-01 | 4.90e-04 |
| GOBP POSITIVE REGULATION OF SUPEROXIDE ANION GENERATION | 12 | 1.44e-02 | -4.08e-01 | 1.31e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC CELL APOPTOTIC PROCESS | 5 | 1.14e-01 | 4.08e-01 | 3.97e-01 |
| GOMF U1 SNRNP BINDING | 6 | 8.39e-02 | -4.08e-01 | 3.40e-01 |
| GOBP SEROTONIN UPTAKE | 6 | 8.40e-02 | 4.07e-01 | 3.40e-01 |
| GOCC PRESPLICEOSOME | 16 | 4.81e-03 | -4.07e-01 | 6.57e-02 |
| GOCC SPERM ANNULUS | 5 | 1.15e-01 | -4.07e-01 | 3.99e-01 |
| GOBP DNA TOPOLOGICAL CHANGE | 9 | 3.47e-02 | -4.06e-01 | 2.16e-01 |
| GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 9 | 3.49e-02 | -4.06e-01 | 2.17e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION | 7 | 6.31e-02 | -4.06e-01 | 2.89e-01 |
| GOBP POLYAMINE BIOSYNTHETIC PROCESS | 14 | 8.63e-03 | 4.05e-01 | 9.46e-02 |
| GOMF HISTONE H3K4 METHYLTRANSFERASE ACTIVITY | 16 | 5.04e-03 | -4.05e-01 | 6.82e-02 |
| GOBP RESPONSE TO HYDROSTATIC PRESSURE | 6 | 8.63e-02 | -4.04e-01 | 3.45e-01 |
| GOBP PIGMENT GRANULE LOCALIZATION | 22 | 1.03e-03 | 4.04e-01 | 2.25e-02 |
| GOCC NUCLEAR PORE CENTRAL TRANSPORT CHANNEL | 6 | 8.65e-02 | 4.04e-01 | 3.45e-01 |
| GOBP L SERINE METABOLIC PROCESS | 10 | 2.70e-02 | 4.04e-01 | 1.86e-01 |
| GOMF ALDITOL NADPPLUS 1 OXIDOREDUCTASE ACTIVITY | 7 | 6.42e-02 | 4.04e-01 | 2.93e-01 |
| GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY | 5 | 1.18e-01 | -4.04e-01 | 4.02e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 11 | 2.04e-02 | 4.04e-01 | 1.58e-01 |
| GOMF DENEDDYLASE ACTIVITY | 6 | 8.68e-02 | 4.04e-01 | 3.45e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 6 | 8.69e-02 | -4.04e-01 | 3.45e-01 |
| GOMF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 5 | 1.18e-01 | 4.03e-01 | 4.02e-01 |
| GOBP DETECTION OF MOLECULE OF BACTERIAL ORIGIN | 9 | 3.62e-02 | 4.03e-01 | 2.20e-01 |
| GOBP REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION | 5 | 1.18e-01 | -4.03e-01 | 4.02e-01 |
| GOCC PARANODAL JUNCTION | 5 | 1.18e-01 | 4.03e-01 | 4.02e-01 |
| GOBP REGULATION OF RECEPTOR CLUSTERING | 9 | 3.63e-02 | -4.03e-01 | 2.20e-01 |
| GOBP REGULATION OF MITOCHONDRIAL ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 6 | 8.74e-02 | 4.03e-01 | 3.45e-01 |
| GOMF 2 IRON 2 SULFUR CLUSTER BINDING | 23 | 8.24e-04 | 4.03e-01 | 1.90e-02 |
| GOBP HYPOTONIC RESPONSE | 11 | 2.10e-02 | -4.02e-01 | 1.60e-01 |
| GOBP REGULATION OF NEUTROPHIL EXTRAVASATION | 7 | 6.57e-02 | -4.02e-01 | 2.96e-01 |
| GOBP CELLULAR RESPONSE TO PROGESTERONE STIMULUS | 5 | 1.21e-01 | -4.01e-01 | 4.06e-01 |
| GOCC COPI COATED VESICLE MEMBRANE | 18 | 3.23e-03 | 4.01e-01 | 5.04e-02 |
| GOBP ASYMMETRIC NEUROBLAST DIVISION | 6 | 8.91e-02 | 4.01e-01 | 3.49e-01 |
| GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 5 | 1.21e-01 | -4.01e-01 | 4.06e-01 |
| GOBP NEUTROPHIL DEGRANULATION | 12 | 1.63e-02 | -4.00e-01 | 1.42e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 8 | 5.00e-02 | -4.00e-01 | 2.60e-01 |
| GOMF LIGAND GATED SODIUM CHANNEL ACTIVITY | 5 | 1.21e-01 | -4.00e-01 | 4.08e-01 |
| GOBP DERMATAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 8 | 5.02e-02 | 4.00e-01 | 2.60e-01 |
| GOBP POSITIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 5 | 1.22e-01 | -4.00e-01 | 4.08e-01 |
| GOBP MITOCHONDRIAL PROTEIN CATABOLIC PROCESS | 6 | 9.02e-02 | 3.99e-01 | 3.52e-01 |
| GOCC NBAF COMPLEX | 14 | 9.70e-03 | -3.99e-01 | 1.02e-01 |
| GOBP T CELL ANTIGEN PROCESSING AND PRESENTATION | 5 | 1.22e-01 | -3.99e-01 | 4.10e-01 |
| GOBP REGULATION OF BRANCHING MORPHOGENESIS OF A NERVE | 6 | 9.06e-02 | 3.99e-01 | 3.52e-01 |
| GOBP NEGATIVE REGULATION OF RUFFLE ASSEMBLY | 7 | 6.79e-02 | -3.98e-01 | 3.02e-01 |
| GOCC GTPASE ACTIVATOR COMPLEX | 11 | 2.21e-02 | 3.98e-01 | 1.65e-01 |
| GOBP FACULTATIVE HETEROCHROMATIN FORMATION | 38 | 2.20e-05 | -3.98e-01 | 1.18e-03 |
| GOMF INTERLEUKIN 1 RECEPTOR BINDING | 10 | 2.95e-02 | 3.98e-01 | 1.96e-01 |
| GOBP REGULATION OF CELL MATURATION | 13 | 1.31e-02 | 3.98e-01 | 1.22e-01 |
| GOMF HISTONE H4K20 METHYLTRANSFERASE ACTIVITY | 9 | 3.90e-02 | -3.97e-01 | 2.28e-01 |
| GOBP REGULATION OF ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 43 | 6.73e-06 | -3.97e-01 | 4.36e-04 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE I PROMOTER | 10 | 2.98e-02 | -3.97e-01 | 1.97e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 12 | 1.74e-02 | -3.96e-01 | 1.47e-01 |
| GOMF PSEUDOURIDINE SYNTHASE ACTIVITY | 13 | 1.34e-02 | 3.96e-01 | 1.25e-01 |
| GOBP NEGATIVE REGULATION OF RIG I SIGNALING PATHWAY | 8 | 5.25e-02 | -3.96e-01 | 2.65e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 5 | 1.25e-01 | -3.96e-01 | 4.16e-01 |
| GOBP CELLULAR RESPONSE TO NITROGEN STARVATION | 9 | 3.99e-02 | 3.96e-01 | 2.31e-01 |
| GOBP NEURAL PLATE DEVELOPMENT | 6 | 9.38e-02 | 3.95e-01 | 3.61e-01 |
| GOMF PRE MRNA 3 SPLICE SITE BINDING | 5 | 1.26e-01 | -3.95e-01 | 4.17e-01 |
| GOBP TYPE II HYPERSENSITIVITY | 5 | 1.26e-01 | -3.95e-01 | 4.17e-01 |
| GOBP EOSINOPHIL ACTIVATION | 6 | 9.41e-02 | 3.95e-01 | 3.62e-01 |
| GOBP MUCUS SECRETION | 11 | 2.35e-02 | 3.94e-01 | 1.72e-01 |
| GOBP RECEPTOR GUANYLYL CYCLASE SIGNALING PATHWAY | 6 | 9.44e-02 | 3.94e-01 | 3.62e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS | 10 | 3.09e-02 | -3.94e-01 | 2.01e-01 |
| GOBP POSITIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 9 | 4.08e-02 | -3.94e-01 | 2.34e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE BINDING | 18 | 3.85e-03 | -3.93e-01 | 5.65e-02 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST MIGRATION | 7 | 7.16e-02 | -3.93e-01 | 3.12e-01 |
| GOMF ATPASE COUPLED ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 21 | 1.82e-03 | 3.93e-01 | 3.33e-02 |
| GOMF FERRIC IRON BINDING | 6 | 9.55e-02 | 3.93e-01 | 3.65e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 8 | 5.45e-02 | -3.93e-01 | 2.68e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS | 5 | 1.28e-01 | 3.93e-01 | 4.20e-01 |
| GOMF PEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 4.16e-02 | 3.92e-01 | 2.37e-01 |
| GOCC PROTEASOME ACCESSORY COMPLEX | 23 | 1.14e-03 | 3.92e-01 | 2.41e-02 |
| GOBP REGULATION OF CHRONIC INFLAMMATORY RESPONSE | 7 | 7.25e-02 | 3.92e-01 | 3.15e-01 |
| GOCC MHC PROTEIN COMPLEX | 22 | 1.48e-03 | -3.92e-01 | 2.87e-02 |
| GOBP RESPONSE TO ALDOSTERONE | 14 | 1.12e-02 | -3.91e-01 | 1.12e-01 |
| GOMF CHROMO SHADOW DOMAIN BINDING | 6 | 9.69e-02 | -3.91e-01 | 3.66e-01 |
| GOCC CHITOSOME | 14 | 1.14e-02 | 3.91e-01 | 1.13e-01 |
| GOBP INTESTINAL LIPID ABSORPTION | 9 | 4.25e-02 | 3.90e-01 | 2.40e-01 |
| GOBP REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS | 5 | 1.31e-01 | 3.90e-01 | 4.24e-01 |
| GOCC LAMININ COMPLEX | 6 | 9.81e-02 | 3.90e-01 | 3.67e-01 |
| GOBP NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION | 9 | 4.29e-02 | -3.90e-01 | 2.40e-01 |
| GOBP GLOMERULAR MESANGIAL CELL PROLIFERATION | 8 | 5.64e-02 | 3.90e-01 | 2.74e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 14 | 1.16e-02 | -3.90e-01 | 1.14e-01 |
| GOMF ANNEALING ACTIVITY | 10 | 3.30e-02 | -3.89e-01 | 2.10e-01 |
| GOBP PLASMINOGEN ACTIVATION | 16 | 7.00e-03 | 3.89e-01 | 8.33e-02 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION | 9 | 4.32e-02 | -3.89e-01 | 2.41e-01 |
| GOBP PROTEIN DESUMOYLATION | 8 | 5.71e-02 | -3.88e-01 | 2.75e-01 |
| GOCC SIGNAL RECOGNITION PARTICLE | 7 | 7.53e-02 | 3.88e-01 | 3.21e-01 |
| GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT | 55 | 6.41e-07 | -3.88e-01 | 6.40e-05 |
| GOBP HEXOSE PHOSPHATE TRANSPORT | 5 | 1.33e-01 | 3.88e-01 | 4.27e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE | 19 | 3.41e-03 | 3.88e-01 | 5.21e-02 |
| GOBP REGULATION OF NEURON MATURATION | 7 | 7.57e-02 | 3.88e-01 | 3.22e-01 |
| GOBP PROTEIN MATURATION BY PROTEIN FOLDING | 8 | 5.77e-02 | 3.88e-01 | 2.77e-01 |
| GOBP RESPONSE TO INTERLEUKIN 3 | 7 | 7.58e-02 | -3.87e-01 | 3.23e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR EXTRAVASATION | 11 | 2.61e-02 | -3.87e-01 | 1.83e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 5 | 1.34e-01 | 3.87e-01 | 4.29e-01 |
| GOBP NK T CELL DIFFERENTIATION | 9 | 4.47e-02 | -3.86e-01 | 2.46e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 28 | 4.05e-04 | 3.86e-01 | 1.11e-02 |
| GOBP NEGATIVE REGULATION OF VITAMIN METABOLIC PROCESS | 6 | 1.02e-01 | 3.86e-01 | 3.73e-01 |
| GOMF PROTEIN SERINE THREONINE PHOSPHATASE INHIBITOR ACTIVITY | 9 | 4.51e-02 | 3.86e-01 | 2.47e-01 |
| GOBP NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 9 | 4.53e-02 | 3.85e-01 | 2.48e-01 |
| GOBP FATTY ACYL COA CATABOLIC PROCESS | 6 | 1.02e-01 | 3.85e-01 | 3.74e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 11 | 2.69e-02 | 3.85e-01 | 1.86e-01 |
| GOBP SYNAPTIC TRANSMISSION DOPAMINERGIC | 11 | 2.70e-02 | 3.85e-01 | 1.86e-01 |
| GOBP MICROGLIAL CELL MIGRATION | 6 | 1.03e-01 | 3.85e-01 | 3.75e-01 |
| GOBP REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 15 | 9.94e-03 | -3.84e-01 | 1.04e-01 |
| GOBP POSITIVE REGULATION OF HISTONE ACETYLATION | 9 | 4.59e-02 | -3.84e-01 | 2.49e-01 |
| GOMF FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 1.03e-01 | 3.84e-01 | 3.76e-01 |
| GOBP ADRENERGIC RECEPTOR SIGNALING PATHWAY | 17 | 6.09e-03 | -3.84e-01 | 7.68e-02 |
| GOMF RRNA ADENINE METHYLTRANSFERASE ACTIVITY | 7 | 7.85e-02 | 3.84e-01 | 3.30e-01 |
| GOCC RIPOPTOSOME | 6 | 1.03e-01 | -3.84e-01 | 3.77e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 9 | 4.61e-02 | 3.84e-01 | 2.50e-01 |
| GOBP REGULATION OF HELICASE ACTIVITY | 11 | 2.76e-02 | -3.84e-01 | 1.88e-01 |
| GOBP TRIPARTITE REGIONAL SUBDIVISION | 9 | 4.63e-02 | -3.84e-01 | 2.50e-01 |
| GOCC UBIQUITIN CONJUGATING ENZYME COMPLEX | 8 | 6.04e-02 | 3.83e-01 | 2.84e-01 |
| GOBP RENAL SODIUM ION ABSORPTION | 6 | 1.04e-01 | -3.83e-01 | 3.78e-01 |
| GOBP RENAL SODIUM ION TRANSPORT | 6 | 1.04e-01 | -3.83e-01 | 3.78e-01 |
| GOBP BONE TRABECULA MORPHOGENESIS | 8 | 6.06e-02 | -3.83e-01 | 2.84e-01 |
| GOMF LYSOPHOSPHATIDIC ACID BINDING | 6 | 1.04e-01 | -3.83e-01 | 3.78e-01 |
| GOBP REGULATION OF GLUTAMATE SECRETION NEUROTRANSMISSION | 5 | 1.38e-01 | -3.83e-01 | 4.36e-01 |
| GOBP POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 14 | 1.31e-02 | -3.83e-01 | 1.23e-01 |
| GOBP PEPTIDYL ARGININE METHYLATION | 5 | 1.38e-01 | -3.83e-01 | 4.36e-01 |
| GOBP INNERVATION | 13 | 1.69e-02 | -3.83e-01 | 1.45e-01 |
| GOBP MITOCHONDRIAL TRANSLATION | 128 | 7.73e-14 | 3.83e-01 | 3.44e-11 |
| GOBP NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION | 8 | 6.11e-02 | 3.82e-01 | 2.85e-01 |
| GOBP PRIMARY ALCOHOL CATABOLIC PROCESS | 7 | 7.99e-02 | -3.82e-01 | 3.32e-01 |
| GOBP CYCLIC GMP AMP TRANSMEMBRANE IMPORT ACROSS PLASMA MEMBRANE | 5 | 1.39e-01 | -3.82e-01 | 4.38e-01 |
| GOBP KERATINOCYTE APOPTOTIC PROCESS | 6 | 1.05e-01 | -3.82e-01 | 3.80e-01 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE C END DEGRON RULE PATHWAY | 12 | 2.20e-02 | -3.82e-01 | 1.64e-01 |
| GOBP POSITIVE REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 6 | 1.05e-01 | -3.82e-01 | 3.81e-01 |
| GOBP ESTROUS CYCLE | 11 | 2.84e-02 | -3.82e-01 | 1.91e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 6 | 1.06e-01 | -3.82e-01 | 3.81e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS III | 6 | 1.06e-01 | -3.81e-01 | 3.81e-01 |
| GOMF D LOOP DNA BINDING | 5 | 1.40e-01 | -3.81e-01 | 4.39e-01 |
| GOBP CLUSTERING OF VOLTAGE GATED SODIUM CHANNELS | 5 | 1.40e-01 | -3.81e-01 | 4.39e-01 |
| GOBP VITAMIN D RECEPTOR SIGNALING PATHWAY | 10 | 3.70e-02 | -3.81e-01 | 2.23e-01 |
| GOBP RESPONSE TO TYPE III INTERFERON | 7 | 8.09e-02 | -3.81e-01 | 3.35e-01 |
| GOMF POLY A SPECIFIC RIBONUCLEASE ACTIVITY | 12 | 2.24e-02 | -3.81e-01 | 1.66e-01 |
| GOCC CATION TRANSPORTING ATPASE COMPLEX | 7 | 8.11e-02 | 3.81e-01 | 3.35e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR I BINDING | 8 | 6.22e-02 | -3.81e-01 | 2.88e-01 |
| GOBP NEGATIVE REGULATION OF INTERFERON ALPHA PRODUCTION | 5 | 1.41e-01 | 3.80e-01 | 4.40e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION | 12 | 2.26e-02 | -3.80e-01 | 1.67e-01 |
| GOMF PHOSPHATIDYLSERINE FLIPPASE ACTIVITY | 5 | 1.41e-01 | -3.80e-01 | 4.41e-01 |
| GOBP NEGATIVE REGULATION OF BEHAVIOR | 6 | 1.07e-01 | -3.80e-01 | 3.83e-01 |
| GOBP SPERMIDINE METABOLIC PROCESS | 8 | 6.29e-02 | 3.80e-01 | 2.89e-01 |
| GOCC COP9 SIGNALOSOME | 15 | 1.09e-02 | 3.80e-01 | 1.10e-01 |
| GOBP ERBB4 SIGNALING PATHWAY | 7 | 8.21e-02 | 3.79e-01 | 3.37e-01 |
| GOBP EMBRYONIC SKELETAL JOINT DEVELOPMENT | 5 | 1.42e-01 | 3.79e-01 | 4.42e-01 |
| GOMF PROTEIN GERANYLGERANYLTRANSFERASE ACTIVITY | 5 | 1.42e-01 | -3.79e-01 | 4.42e-01 |
| GOBP APOPTOTIC CHROMOSOME CONDENSATION | 5 | 1.42e-01 | -3.79e-01 | 4.42e-01 |
| GOBP IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION | 11 | 2.96e-02 | -3.79e-01 | 1.97e-01 |
| GOBP REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM | 5 | 1.43e-01 | -3.79e-01 | 4.43e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE INHIBITOR ACTIVITY | 11 | 2.97e-02 | -3.78e-01 | 1.97e-01 |
| GOMF MIRNA BINDING | 35 | 1.10e-04 | -3.78e-01 | 4.09e-03 |
| GOMF 1 ACYLGLYCEROPHOSPHOCHOLINE O ACYLTRANSFERASE ACTIVITY | 7 | 8.35e-02 | -3.78e-01 | 3.40e-01 |
| GOCC EARLY PHAGOSOME | 10 | 3.88e-02 | -3.77e-01 | 2.28e-01 |
| GOBP BRANCH ELONGATION OF AN EPITHELIUM | 6 | 1.10e-01 | -3.77e-01 | 3.88e-01 |
| GOBP ARGININE METABOLIC PROCESS | 12 | 2.37e-02 | 3.77e-01 | 1.73e-01 |
| GOCC NURF COMPLEX | 6 | 1.10e-01 | -3.77e-01 | 3.88e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 9 | 5.02e-02 | 3.77e-01 | 2.60e-01 |
| GOMF IMPORTIN ALPHA FAMILY PROTEIN BINDING | 9 | 5.02e-02 | 3.77e-01 | 2.60e-01 |
| GOMF HISTONE H3K36 DEMETHYLASE ACTIVITY | 10 | 3.93e-02 | -3.76e-01 | 2.29e-01 |
| GOBP REGULATION OF TRANSFORMING GROWTH FACTOR BETA ACTIVATION | 5 | 1.45e-01 | 3.76e-01 | 4.45e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 11 | 3.07e-02 | -3.76e-01 | 2.00e-01 |
| GOBP ENDOTHELIAL CELL FATE COMMITMENT | 5 | 1.45e-01 | -3.76e-01 | 4.45e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX | 9 | 5.08e-02 | 3.76e-01 | 2.61e-01 |
| GOBP EOSINOPHIL MIGRATION | 17 | 7.29e-03 | 3.76e-01 | 8.49e-02 |
| GOBP NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 12 | 2.43e-02 | 3.76e-01 | 1.75e-01 |
| GOBP NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 6 | 1.11e-01 | 3.76e-01 | 3.91e-01 |
| GOBP TELOMERASE HOLOENZYME COMPLEX ASSEMBLY | 6 | 1.12e-01 | -3.75e-01 | 3.92e-01 |
| GOCC IMMUNOGLOBULIN COMPLEX | 7 | 8.59e-02 | 3.75e-01 | 3.44e-01 |
| GOMF BUBBLE DNA BINDING | 8 | 6.66e-02 | -3.75e-01 | 2.98e-01 |
| GOBP BOX C D SNORNP ASSEMBLY | 9 | 5.17e-02 | 3.74e-01 | 2.63e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 15 | 1.20e-02 | -3.74e-01 | 1.17e-01 |
| GOBP INTERFERON MEDIATED SIGNALING PATHWAY | 73 | 3.24e-08 | -3.74e-01 | 5.05e-06 |
| GOMF PROCOLLAGEN PROLINE 4 DIOXYGENASE ACTIVITY | 5 | 1.47e-01 | 3.74e-01 | 4.49e-01 |
| GOCC LAMIN FILAMENT | 5 | 1.47e-01 | 3.74e-01 | 4.49e-01 |
| GOMF OXO ACID LYASE ACTIVITY | 5 | 1.47e-01 | -3.74e-01 | 4.49e-01 |
| GOCC BBAF COMPLEX | 9 | 5.20e-02 | -3.74e-01 | 2.64e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN RADICAL | 16 | 9.60e-03 | 3.74e-01 | 1.02e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID SECRETION | 6 | 1.13e-01 | -3.74e-01 | 3.94e-01 |
| GOBP PROTEIN RETENTION IN GOLGI APPARATUS | 5 | 1.48e-01 | -3.74e-01 | 4.49e-01 |
| GOBP PROTEIN DEMETHYLATION | 12 | 2.51e-02 | -3.73e-01 | 1.79e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 10 | 4.10e-02 | -3.73e-01 | 2.35e-01 |
| GOBP REGULATION OF GRANULOCYTE DIFFERENTIATION | 12 | 2.53e-02 | -3.73e-01 | 1.79e-01 |
| GOBP COMPLEMENT DEPENDENT CYTOTOXICITY | 8 | 6.78e-02 | 3.73e-01 | 3.01e-01 |
| GOBP IMMUNOLOGICAL MEMORY FORMATION PROCESS | 10 | 4.13e-02 | -3.73e-01 | 2.35e-01 |
| GOBP RADIAL GLIAL CELL DIFFERENTIATION | 7 | 8.78e-02 | 3.73e-01 | 3.46e-01 |
| GOBP RESPONSE TO TYPE I INTERFERON | 64 | 2.55e-07 | -3.73e-01 | 3.19e-05 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGA ISOTYPES | 6 | 1.14e-01 | -3.72e-01 | 3.97e-01 |
| GOMF INSULIN RECEPTOR SUBSTRATE BINDING | 12 | 2.57e-02 | -3.72e-01 | 1.81e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE PHOSPHORYLATION | 6 | 1.15e-01 | 3.72e-01 | 3.98e-01 |
| GOBP POSITIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 12 | 2.59e-02 | -3.71e-01 | 1.82e-01 |
| GOBP MANCHETTE ASSEMBLY | 5 | 1.50e-01 | 3.71e-01 | 4.53e-01 |
| GOCC CALYX OF HELD | 11 | 3.31e-02 | 3.71e-01 | 2.10e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 3 KINASE ACTIVITY | 7 | 8.91e-02 | -3.71e-01 | 3.49e-01 |
| GOMF SERINE TYPE EXOPEPTIDASE ACTIVITY | 9 | 5.40e-02 | -3.71e-01 | 2.67e-01 |
| GOMF INORGANIC DIPHOSPHATE PHOSPHATASE ACTIVITY | 5 | 1.51e-01 | 3.71e-01 | 4.54e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II | 27 | 8.52e-04 | -3.71e-01 | 1.95e-02 |
| GOMF SMALL PROTEIN ACTIVATING ENZYME BINDING | 5 | 1.51e-01 | 3.71e-01 | 4.54e-01 |
| GOMF NUCLEOSIDE MONOPHOSPHATE KINASE ACTIVITY | 20 | 4.12e-03 | 3.71e-01 | 5.93e-02 |
| GOBP VAGINA DEVELOPMENT | 7 | 8.98e-02 | -3.70e-01 | 3.51e-01 |
| GOCC BLOC 1 COMPLEX | 9 | 5.45e-02 | 3.70e-01 | 2.68e-01 |
| GOBP TONGUE DEVELOPMENT | 7 | 9.02e-02 | -3.70e-01 | 3.52e-01 |
| GOBP POSITIVE REGULATION OF RRNA PROCESSING | 10 | 4.32e-02 | 3.69e-01 | 2.41e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS | 12 | 2.69e-02 | 3.69e-01 | 1.86e-01 |
| GOMF DNA TOPOISOMERASE ACTIVITY | 6 | 1.18e-01 | -3.69e-01 | 4.02e-01 |
| GOBP NEGATIVE REGULATION OF CELL FATE COMMITMENT | 5 | 1.53e-01 | 3.69e-01 | 4.58e-01 |
| GOBP REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 5 | 1.53e-01 | 3.69e-01 | 4.58e-01 |
| GOMF AP 1 ADAPTOR COMPLEX BINDING | 5 | 1.53e-01 | 3.69e-01 | 4.58e-01 |
| GOMF PROTEASOME ACTIVATING ACTIVITY | 6 | 1.18e-01 | 3.69e-01 | 4.02e-01 |
| GOCC SCHMIDT LANTERMAN INCISURE | 7 | 9.14e-02 | 3.68e-01 | 3.54e-01 |
| GOCC HEMIDESMOSOME | 6 | 1.18e-01 | -3.68e-01 | 4.02e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 10 | 4.37e-02 | -3.68e-01 | 2.43e-01 |
| GOBP EOSINOPHIL MEDIATED IMMUNITY | 6 | 1.18e-01 | 3.68e-01 | 4.02e-01 |
| GOBP PHOSPHATIDYLINOSITOL MEDIATED SIGNALING | 20 | 4.41e-03 | -3.68e-01 | 6.19e-02 |
| GOBP PROTEIN HEXAMERIZATION | 9 | 5.65e-02 | -3.67e-01 | 2.74e-01 |
| GOMF NUCLEAR THYROID HORMONE RECEPTOR BINDING | 28 | 7.73e-04 | -3.67e-01 | 1.83e-02 |
| GOBP HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 9 | 5.66e-02 | -3.67e-01 | 2.74e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 12 | 2.78e-02 | 3.67e-01 | 1.89e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH | 14 | 1.75e-02 | -3.67e-01 | 1.48e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 14 | 1.76e-02 | 3.66e-01 | 1.48e-01 |
| GOBP CRANIAL NERVE STRUCTURAL ORGANIZATION | 5 | 1.56e-01 | -3.66e-01 | 4.62e-01 |
| GOBP MONOATOMIC ANION HOMEOSTASIS | 12 | 2.81e-02 | -3.66e-01 | 1.90e-01 |
| GOCC MKS COMPLEX | 13 | 2.23e-02 | 3.66e-01 | 1.66e-01 |
| GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK FORMATION | 5 | 1.56e-01 | -3.66e-01 | 4.62e-01 |
| GOCC LUMENAL SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 24 | 1.94e-03 | -3.66e-01 | 3.48e-02 |
| GOCC INTRACILIARY TRANSPORT PARTICLE B | 17 | 9.14e-03 | 3.65e-01 | 9.88e-02 |
| GOBP CARDIAC NEURAL CREST CELL DEVELOPMENT INVOLVED IN OUTFLOW TRACT MORPHOGENESIS | 7 | 9.49e-02 | 3.64e-01 | 3.63e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE COMPLEX | 24 | 2.00e-03 | 3.64e-01 | 3.57e-02 |
| GOBP MONOACYLGLYCEROL METABOLIC PROCESS | 9 | 5.86e-02 | 3.64e-01 | 2.79e-01 |
| GOMF NADPLUS PROTEIN LYSINE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 1.59e-01 | -3.64e-01 | 4.65e-01 |
| GOBP PROTEIN AUTO ADP RIBOSYLATION | 11 | 3.66e-02 | -3.64e-01 | 2.22e-01 |
| GOBP UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 5 | 1.59e-01 | 3.64e-01 | 4.65e-01 |
| GOBP REGULATION OF VIRAL TRANSCRIPTION | 19 | 6.07e-03 | -3.64e-01 | 7.67e-02 |
| GOBP 3 UTR MEDIATED MRNA STABILIZATION | 18 | 7.65e-03 | -3.63e-01 | 8.75e-02 |
| GOBP RESPONSE TO OXYGEN RADICAL | 20 | 4.96e-03 | 3.63e-01 | 6.73e-02 |
| GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 12 | 2.96e-02 | -3.63e-01 | 1.97e-01 |
| GOBP ERBB2 SIGNALING PATHWAY | 13 | 2.35e-02 | 3.63e-01 | 1.72e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 6 | 1.24e-01 | -3.63e-01 | 4.13e-01 |
| GOBP RESPIRATORY CHAIN COMPLEX IV ASSEMBLY | 28 | 8.96e-04 | 3.63e-01 | 2.04e-02 |
| GOBP PEPTIDYL LYSINE DIMETHYLATION | 10 | 4.72e-02 | -3.63e-01 | 2.53e-01 |
| GOCC ASTROCYTE PROJECTION | 7 | 9.69e-02 | -3.62e-01 | 3.66e-01 |
| GOCC CYTOPLASMIC SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 14 | 1.90e-02 | -3.62e-01 | 1.52e-01 |
| GOBP REGULATION OF MACROPHAGE PROLIFERATION | 5 | 1.62e-01 | -3.61e-01 | 4.70e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING | 9 | 6.05e-02 | -3.61e-01 | 2.84e-01 |
| GOBP TRANSCRIPTION ELONGATION COUPLED CHROMATIN REMODELING | 7 | 9.78e-02 | -3.61e-01 | 3.66e-01 |
| GOCC U7 SNRNP | 7 | 9.79e-02 | 3.61e-01 | 3.66e-01 |
| GOCC PROXIMAL DENDRITE | 5 | 1.62e-01 | 3.61e-01 | 4.71e-01 |
| GOBP AUTOPHAGOSOME LYSOSOME FUSION | 9 | 6.10e-02 | 3.61e-01 | 2.85e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN NAD P H AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 18 | 8.16e-03 | 3.60e-01 | 9.13e-02 |
| GOBP NEURON FATE SPECIFICATION | 7 | 9.90e-02 | -3.60e-01 | 3.68e-01 |
| GOCC RSC TYPE COMPLEX | 14 | 1.98e-02 | -3.60e-01 | 1.56e-01 |
| GOCC COPI VESICLE COAT | 13 | 2.48e-02 | 3.60e-01 | 1.78e-01 |
| GOBP RESPONSE TO INTERLEUKIN 9 | 7 | 9.95e-02 | -3.60e-01 | 3.69e-01 |
| GOBP ETHANOL METABOLIC PROCESS | 9 | 6.20e-02 | -3.59e-01 | 2.88e-01 |
| GOBP MULTI PASS TRANSMEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 9 | 6.20e-02 | 3.59e-01 | 2.88e-01 |
| GOCC MULTI PASS TRANSLOCON COMPLEX | 9 | 6.20e-02 | 3.59e-01 | 2.88e-01 |
| GOBP T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 10 | 4.92e-02 | -3.59e-01 | 2.58e-01 |
| GOBP ZINC ION TRANSPORT | 21 | 4.40e-03 | 3.59e-01 | 6.19e-02 |
| GOBP POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 6 | 1.28e-01 | -3.59e-01 | 4.20e-01 |
| GOCC FASCIA ADHERENS | 6 | 1.29e-01 | 3.58e-01 | 4.20e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY TRANSPOSING C C BONDS | 11 | 3.98e-02 | 3.58e-01 | 2.31e-01 |
| GOBP ISOTYPE SWITCHING TO IGA ISOTYPES | 7 | 1.01e-01 | -3.58e-01 | 3.73e-01 |
| GOBP ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 59 | 2.00e-06 | -3.58e-01 | 1.62e-04 |
| GOBP REGULATION OF MONOATOMIC ANION TRANSPORT | 10 | 5.04e-02 | -3.57e-01 | 2.60e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION TERMINATION | 23 | 3.01e-03 | -3.57e-01 | 4.81e-02 |
| GOCC RPAP3 R2TP PREFOLDIN LIKE COMPLEX | 10 | 5.05e-02 | 3.57e-01 | 2.61e-01 |
| GOBP BIOLOGICAL PHASE | 6 | 1.30e-01 | 3.57e-01 | 4.23e-01 |
| GOBP TAURINE TRANSPORT | 7 | 1.02e-01 | -3.57e-01 | 3.74e-01 |
| GOMF NUCLEOSIDE DIPHOSPHATE PHOSPHATASE ACTIVITY | 15 | 1.68e-02 | 3.57e-01 | 1.45e-01 |
| GOMF RNA POLYMERASE I TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 8.09e-02 | -3.56e-01 | 3.35e-01 |
| GOMF JUN KINASE BINDING | 10 | 5.13e-02 | 3.56e-01 | 2.62e-01 |
| GOBP POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 6 | 1.31e-01 | 3.56e-01 | 4.25e-01 |
| GOBP REGULATION OF MONOATOMIC ANION TRANSMEMBRANE TRANSPORT | 5 | 1.69e-01 | -3.56e-01 | 4.81e-01 |
| GOMF NEUROTROPHIN RECEPTOR BINDING | 6 | 1.32e-01 | -3.55e-01 | 4.25e-01 |
| GOBP REGULATION OF RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 7 | 1.04e-01 | 3.55e-01 | 3.78e-01 |
| GOBP MDA 5 SIGNALING PATHWAY | 10 | 5.20e-02 | -3.55e-01 | 2.64e-01 |
| GOMF LNCRNA BINDING | 11 | 4.18e-02 | -3.54e-01 | 2.37e-01 |
| GOBP ADRENAL GLAND DEVELOPMENT | 16 | 1.41e-02 | -3.54e-01 | 1.29e-01 |
| GOBP T HELPER 17 TYPE IMMUNE RESPONSE | 34 | 3.51e-04 | -3.54e-01 | 9.99e-03 |
| GOBP REGULATION OF HETEROCHROMATIN ORGANIZATION | 22 | 4.04e-03 | -3.54e-01 | 5.87e-02 |
| GOBP NOSE DEVELOPMENT | 7 | 1.05e-01 | -3.54e-01 | 3.80e-01 |
| GOBP NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS | 18 | 9.44e-03 | 3.53e-01 | 1.00e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 8 | 8.37e-02 | -3.53e-01 | 3.40e-01 |
| GOBP NEGATIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 8 | 8.40e-02 | 3.53e-01 | 3.40e-01 |
| GOMF ASPARTIC TYPE PEPTIDASE ACTIVITY | 17 | 1.18e-02 | -3.53e-01 | 1.15e-01 |
| GOBP T TUBULE ORGANIZATION | 5 | 1.72e-01 | 3.53e-01 | 4.86e-01 |
| GOBP MITOCHONDRIAL DNA REPAIR | 5 | 1.72e-01 | -3.53e-01 | 4.86e-01 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 12 | 3.50e-02 | 3.52e-01 | 2.17e-01 |
| GOBP HISTONE METHYLATION | 34 | 3.90e-04 | -3.51e-01 | 1.08e-02 |
| GOBP IMMUNOLOGICAL MEMORY PROCESS | 13 | 2.83e-02 | -3.51e-01 | 1.91e-01 |
| GOBP RESPONSE TO DEXAMETHASONE | 24 | 2.90e-03 | -3.51e-01 | 4.71e-02 |
| GOMF CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 35 | 3.26e-04 | -3.51e-01 | 9.47e-03 |
| GOMF CONNEXIN BINDING | 5 | 1.74e-01 | 3.51e-01 | 4.89e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL GENOME REPLICATION | 46 | 3.87e-05 | -3.51e-01 | 1.84e-03 |
| GOBP HISTONE DEACETYLATION | 22 | 4.41e-03 | -3.51e-01 | 6.19e-02 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 9 | 6.88e-02 | -3.50e-01 | 3.03e-01 |
| GOBP REGULATION OF MRNA SPLICING VIA SPLICEOSOME | 87 | 1.63e-08 | -3.50e-01 | 2.83e-06 |
| GOBP BERGMANN GLIAL CELL DIFFERENTIATION | 8 | 8.63e-02 | -3.50e-01 | 3.45e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID TRANSPORT | 12 | 3.57e-02 | 3.50e-01 | 2.20e-01 |
| GOMF TRANSCRIPTION COACTIVATOR BINDING | 35 | 3.39e-04 | -3.50e-01 | 9.74e-03 |
| GOBP REGULATION OF BILE ACID METABOLIC PROCESS | 8 | 8.69e-02 | -3.50e-01 | 3.45e-01 |
| GOBP WNT PROTEIN SECRETION | 6 | 1.39e-01 | 3.49e-01 | 4.37e-01 |
| GOBP NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 5 | 1.77e-01 | -3.49e-01 | 4.92e-01 |
| GOBP REGULATION OF ACROSOME REACTION | 5 | 1.77e-01 | 3.49e-01 | 4.92e-01 |
| GOCC APICAL CORTEX | 5 | 1.77e-01 | 3.48e-01 | 4.92e-01 |
| GOBP NEGATIVE REGULATION OF MICROGLIAL CELL ACTIVATION | 7 | 1.11e-01 | -3.48e-01 | 3.90e-01 |
| GOBP INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 1.40e-01 | -3.48e-01 | 4.39e-01 |
| GOMF MUTLALPHA COMPLEX BINDING | 6 | 1.40e-01 | -3.48e-01 | 4.39e-01 |
| GOBP POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION | 20 | 7.07e-03 | -3.48e-01 | 8.36e-02 |
| GOMF INSULIN RECEPTOR BINDING | 16 | 1.60e-02 | -3.48e-01 | 1.40e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX PROTON TRANSPORTING DOMAIN | 25 | 2.62e-03 | 3.48e-01 | 4.37e-02 |
| GOBP MONOCYTE DIFFERENTIATION | 29 | 1.20e-03 | -3.48e-01 | 2.47e-02 |
| GOMF HEXOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 16 | 1.63e-02 | 3.47e-01 | 1.42e-01 |
| GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPSE | 12 | 3.74e-02 | 3.47e-01 | 2.24e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION INDEPENDENT DECAY | 7 | 1.12e-01 | -3.47e-01 | 3.93e-01 |
| GOBP NEGATIVE T CELL SELECTION | 5 | 1.79e-01 | -3.47e-01 | 4.95e-01 |
| GOMF PROTEIN ANTIGEN BINDING | 5 | 1.80e-01 | -3.47e-01 | 4.95e-01 |
| GOBP PROTEIN TO MEMBRANE DOCKING | 5 | 1.80e-01 | 3.47e-01 | 4.95e-01 |
| GOMF MONOATOMIC CATION BICARBONATE SYMPORTER ACTIVITY | 9 | 7.18e-02 | 3.47e-01 | 3.13e-01 |
| GOBP RESPONSE TO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR | 7 | 1.12e-01 | -3.46e-01 | 3.93e-01 |
| GOMF CYTOSKELETON NUCLEAR MEMBRANE ANCHOR ACTIVITY | 5 | 1.80e-01 | -3.46e-01 | 4.95e-01 |
| GOMF C2H2 ZINC FINGER DOMAIN BINDING | 9 | 7.20e-02 | -3.46e-01 | 3.13e-01 |
| GOBP REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 21 | 6.01e-03 | 3.46e-01 | 7.66e-02 |
| GOBP B CELL LINEAGE COMMITMENT | 5 | 1.80e-01 | -3.46e-01 | 4.96e-01 |
| GOBP REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 15 | 2.04e-02 | -3.46e-01 | 1.58e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT KINASE ACTIVITY | 10 | 5.85e-02 | -3.46e-01 | 2.79e-01 |
| GOBP PROTEIN OXIDATION | 8 | 9.05e-02 | -3.46e-01 | 3.52e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS INVOLVED IN CHOLESTEROL TRANSPORT | 5 | 1.81e-01 | 3.46e-01 | 4.97e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MATURATION | 17 | 1.37e-02 | 3.46e-01 | 1.27e-01 |
| GOBP SNRNA CATABOLIC PROCESS | 5 | 1.82e-01 | -3.45e-01 | 4.98e-01 |
| GOBP DELAMINATION | 5 | 1.82e-01 | -3.45e-01 | 4.98e-01 |
| GOBP REGULATION OF WNT PROTEIN SECRETION | 5 | 1.82e-01 | 3.45e-01 | 4.98e-01 |
| GOBP PROTEIN DNA COMPLEX DISASSEMBLY | 17 | 1.38e-02 | -3.45e-01 | 1.28e-01 |
| GOBP REGULATION OF MITOCHONDRIAL FUSION | 11 | 4.77e-02 | 3.45e-01 | 2.54e-01 |
| GOBP CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 16 | 1.70e-02 | -3.45e-01 | 1.45e-01 |
| GOCC FLOTILLIN COMPLEX | 8 | 9.15e-02 | 3.45e-01 | 3.55e-01 |
| GOBP INTRACELLULAR TRANSPORT OF VIRUS | 9 | 7.38e-02 | -3.44e-01 | 3.18e-01 |
| GOBP OLFACTORY BEHAVIOR | 7 | 1.15e-01 | 3.44e-01 | 3.98e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEASE ACTIVITY | 6 | 1.45e-01 | 3.44e-01 | 4.45e-01 |
| GOBP REGULATION OF TETRAPYRROLE METABOLIC PROCESS | 7 | 1.15e-01 | 3.44e-01 | 3.99e-01 |
| GOBP NUCLEAR MIGRATION ALONG MICROTUBULE | 5 | 1.83e-01 | -3.44e-01 | 5.00e-01 |
| GOMF ACTIVIN BINDING | 11 | 4.83e-02 | -3.44e-01 | 2.56e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPIRATION | 8 | 9.22e-02 | 3.44e-01 | 3.56e-01 |
| GOMF TOXIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 1.83e-01 | 3.44e-01 | 5.00e-01 |
| GOMF CARBON SULFUR LYASE ACTIVITY | 13 | 3.19e-02 | 3.44e-01 | 2.05e-01 |
| GOBP CALCIUM IMPORT INTO THE MITOCHONDRION | 12 | 3.95e-02 | 3.43e-01 | 2.30e-01 |
| GOBP HEART TRABECULA FORMATION | 10 | 6.05e-02 | 3.43e-01 | 2.84e-01 |
| GOBP REGULATION OF B CELL DIFFERENTIATION | 25 | 3.01e-03 | -3.43e-01 | 4.81e-02 |
| GOMF ADENOSINE 3 5 BISPHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 1.84e-01 | 3.43e-01 | 5.01e-01 |
| GOBP REGULATION OF OXIDATIVE PHOSPHORYLATION | 20 | 7.99e-03 | 3.43e-01 | 9.02e-02 |
| GOBP MOTOR NEURON MIGRATION | 6 | 1.46e-01 | 3.43e-01 | 4.47e-01 |
| GOBP FC GAMMA RECEPTOR SIGNALING PATHWAY | 29 | 1.41e-03 | -3.42e-01 | 2.77e-02 |
| GOMF PEPTIDE LYSINE N ACETYLTRANSFERASE ACTIVITY | 44 | 8.48e-05 | -3.42e-01 | 3.44e-03 |
| GOMF PRERIBOSOME BINDING | 8 | 9.39e-02 | 3.42e-01 | 3.61e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 15 | 2.18e-02 | -3.42e-01 | 1.64e-01 |
| GOBP MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY | 97 | 6.10e-09 | 3.42e-01 | 1.27e-06 |
| GOBP CARBOHYDRATE MEDIATED SIGNALING | 9 | 7.61e-02 | -3.41e-01 | 3.23e-01 |
| GOBP EMBRYONIC VISCEROCRANIUM MORPHOGENESIS | 7 | 1.18e-01 | -3.41e-01 | 4.02e-01 |
| GOBP SEGMENT SPECIFICATION | 7 | 1.18e-01 | -3.41e-01 | 4.02e-01 |
| GOCC INO80 COMPLEX | 15 | 2.22e-02 | 3.41e-01 | 1.65e-01 |
| GOMF POLY A BINDING | 20 | 8.29e-03 | -3.41e-01 | 9.24e-02 |
| GOMF PEROXIREDOXIN ACTIVITY | 8 | 9.49e-02 | 3.41e-01 | 3.63e-01 |
| GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 5 | 1.87e-01 | -3.41e-01 | 5.05e-01 |
| GOCC RIBONUCLEASE P COMPLEX | 13 | 3.36e-02 | 3.40e-01 | 2.13e-01 |
| GOCC ORGANELLE ENVELOPE LUMEN | 81 | 1.20e-07 | 3.40e-01 | 1.70e-05 |
| GOMF GUANYLATE KINASE ACTIVITY | 9 | 7.72e-02 | 3.40e-01 | 3.26e-01 |
| GOMF FOUR WAY JUNCTION DNA BINDING | 18 | 1.25e-02 | -3.40e-01 | 1.19e-01 |
| GOBP REGULATION OF CHROMATIN ORGANIZATION | 46 | 6.64e-05 | -3.40e-01 | 2.85e-03 |
| GOCC MATRIX SIDE OF MITOCHONDRIAL INNER MEMBRANE | 6 | 1.50e-01 | 3.39e-01 | 4.53e-01 |
| GOMF MHC CLASS I RECEPTOR ACTIVITY | 10 | 6.33e-02 | 3.39e-01 | 2.90e-01 |
| GOBP POSITIVE REGULATION OF SISTER CHROMATID COHESION | 8 | 9.68e-02 | -3.39e-01 | 3.66e-01 |
| GOBP GLOMERULAR MESANGIUM DEVELOPMENT | 10 | 6.34e-02 | 3.39e-01 | 2.90e-01 |
| GOBP LYSINE METABOLIC PROCESS | 5 | 1.89e-01 | -3.39e-01 | 5.09e-01 |
| GOBP ANTEROGRADE NEURONAL DENSE CORE VESICLE TRANSPORT | 5 | 1.89e-01 | 3.39e-01 | 5.09e-01 |
| GOBP OUTER EAR MORPHOGENESIS | 5 | 1.89e-01 | -3.39e-01 | 5.09e-01 |
| GOBP REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 17 | 1.56e-02 | -3.39e-01 | 1.39e-01 |
| GOMF NEUROPEPTIDE RECEPTOR BINDING | 11 | 5.18e-02 | 3.39e-01 | 2.63e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC | 101 | 4.13e-09 | -3.39e-01 | 9.18e-07 |
| GOBP LIPOPROTEIN LOCALIZATION | 14 | 2.84e-02 | 3.38e-01 | 1.91e-01 |
| GOBP POSITIVE REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 11 | 5.21e-02 | -3.38e-01 | 2.64e-01 |
| GOBP SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR | 6 | 1.51e-01 | -3.38e-01 | 4.55e-01 |
| GOBP POSITIVE REGULATION OF CELL MATURATION | 6 | 1.52e-01 | 3.38e-01 | 4.55e-01 |
| GOBP SLEEP | 11 | 5.26e-02 | -3.37e-01 | 2.65e-01 |
| GOBP ENDOSOMAL LUMEN ACIDIFICATION | 13 | 3.52e-02 | 3.37e-01 | 2.17e-01 |
| GOBP REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 9 | 7.99e-02 | 3.37e-01 | 3.32e-01 |
| GOMF BIOTIN BINDING | 5 | 1.92e-01 | 3.37e-01 | 5.11e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS | 9 | 8.00e-02 | 3.37e-01 | 3.32e-01 |
| GOBP SEMINIFEROUS TUBULE DEVELOPMENT | 13 | 3.54e-02 | -3.37e-01 | 2.18e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN ACETYLATION | 20 | 9.10e-03 | -3.37e-01 | 9.85e-02 |
| GOBP REGULATION OF NEUTROPHIL ACTIVATION | 12 | 4.33e-02 | -3.37e-01 | 2.41e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION | 10 | 6.53e-02 | 3.37e-01 | 2.95e-01 |
| GOBP KERATINOCYTE DEVELOPMENT | 5 | 1.93e-01 | 3.36e-01 | 5.11e-01 |
| GOBP COBALT ION TRANSPORT | 6 | 1.54e-01 | 3.36e-01 | 4.58e-01 |
| GOMF KINETOCHORE BINDING | 6 | 1.54e-01 | -3.36e-01 | 4.59e-01 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 16 | 2.00e-02 | -3.36e-01 | 1.56e-01 |
| GOBP TETRAHYDROFOLATE BIOSYNTHETIC PROCESS | 5 | 1.93e-01 | -3.36e-01 | 5.12e-01 |
| GOMF SERINE TYPE CARBOXYPEPTIDASE ACTIVITY | 5 | 1.94e-01 | -3.36e-01 | 5.12e-01 |
| GOBP MITOTIC DNA REPLICATION | 16 | 2.01e-02 | -3.36e-01 | 1.57e-01 |
| GOBP FLOOR PLATE DEVELOPMENT | 7 | 1.24e-01 | -3.35e-01 | 4.14e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 2 COMPLEX | 5 | 1.94e-01 | 3.35e-01 | 5.13e-01 |
| GOBP INOSITOL TRISPHOSPHATE METABOLIC PROCESS | 10 | 6.64e-02 | -3.35e-01 | 2.98e-01 |
| GOBP RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION | 14 | 2.98e-02 | 3.35e-01 | 1.97e-01 |
| GOBP NUCLEOSOME ORGANIZATION | 59 | 8.49e-06 | -3.35e-01 | 5.24e-04 |
| GOBP U4 SNRNA 3 END PROCESSING | 8 | 1.01e-01 | 3.35e-01 | 3.72e-01 |
| GOBP POSITIVE REGULATION OF PODOSOME ASSEMBLY | 9 | 8.20e-02 | 3.35e-01 | 3.37e-01 |
| GOCC NUCLEAR INCLUSION BODY | 12 | 4.48e-02 | -3.35e-01 | 2.46e-01 |
| GOBP HETEROCHROMATIN ORGANIZATION | 83 | 1.38e-07 | -3.35e-01 | 1.92e-05 |
| GOBP MITOCHONDRIAL GENE EXPRESSION | 161 | 2.55e-13 | 3.34e-01 | 1.03e-10 |
| GOMF MHC CLASS II PROTEIN COMPLEX BINDING | 23 | 5.53e-03 | -3.34e-01 | 7.28e-02 |
| GOBP PROSTATE GLANDULAR ACINUS DEVELOPMENT | 5 | 1.96e-01 | -3.34e-01 | 5.15e-01 |
| GOBP REGULATION OF PLASMINOGEN ACTIVATION | 13 | 3.70e-02 | 3.34e-01 | 2.23e-01 |
| GOBP SUPPRESSION OF VIRAL RELEASE BY HOST | 14 | 3.05e-02 | -3.34e-01 | 1.99e-01 |
| GOBP UBIQUITIN DEPENDENT ENDOCYTOSIS | 6 | 1.57e-01 | -3.34e-01 | 4.62e-01 |
| GOBP ANDROGEN CATABOLIC PROCESS | 5 | 1.96e-01 | -3.34e-01 | 5.15e-01 |
| GOCC ENDOPLASMIC RETICULUM QUALITY CONTROL COMPARTMENT | 13 | 3.71e-02 | 3.34e-01 | 2.23e-01 |
| GOBP CELL MIGRATION INVOLVED IN GASTRULATION | 5 | 1.96e-01 | 3.34e-01 | 5.15e-01 |
| GOMF OPSONIN BINDING | 8 | 1.02e-01 | -3.34e-01 | 3.74e-01 |
| GOCC MULTIMERIC RIBONUCLEASE P COMPLEX | 10 | 6.75e-02 | 3.34e-01 | 3.01e-01 |
| GOMF RIBONUCLEASE P RNA BINDING | 10 | 6.75e-02 | 3.34e-01 | 3.01e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION | 13 | 3.73e-02 | -3.34e-01 | 2.24e-01 |
| GOBP PSEUDOURIDINE SYNTHESIS | 18 | 1.43e-02 | 3.34e-01 | 1.30e-01 |
| GOBP TRANSLATIONAL TERMINATION | 16 | 2.10e-02 | 3.33e-01 | 1.60e-01 |
| GOBP NEGATIVE REGULATION OF CENTRIOLE REPLICATION | 7 | 1.27e-01 | -3.33e-01 | 4.18e-01 |
| GOCC ESC E Z COMPLEX | 10 | 6.81e-02 | -3.33e-01 | 3.02e-01 |
| GOBP REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 8 | 1.03e-01 | -3.33e-01 | 3.76e-01 |
| GOBP EMBRYONIC PROCESS INVOLVED IN FEMALE PREGNANCY | 6 | 1.58e-01 | -3.33e-01 | 4.64e-01 |
| GOBP ECTODERMAL PLACODE DEVELOPMENT | 6 | 1.58e-01 | -3.33e-01 | 4.65e-01 |
| GOBP NEGATIVE ADAPTATION OF SIGNALING PATHWAY | 11 | 5.62e-02 | -3.33e-01 | 2.73e-01 |
| GOBP POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST | 13 | 3.80e-02 | -3.32e-01 | 2.26e-01 |
| GOBP REGULATION OF MACROPHAGE FUSION | 5 | 1.98e-01 | 3.32e-01 | 5.19e-01 |
| GOMF PHOSPHATIDYLCHOLINE FLOPPASE ACTIVITY | 7 | 1.28e-01 | -3.32e-01 | 4.20e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 8 | 1.04e-01 | 3.32e-01 | 3.78e-01 |
| GOBP REGULATION OF BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS | 5 | 1.99e-01 | -3.31e-01 | 5.20e-01 |
| GOMF PROTEIN KINASE B BINDING | 10 | 6.96e-02 | -3.31e-01 | 3.06e-01 |
| GOBP MYOFIBROBLAST DIFFERENTIATION | 9 | 8.52e-02 | -3.31e-01 | 3.43e-01 |
| GOBP NADH DEHYDROGENASE COMPLEX ASSEMBLY | 59 | 1.08e-05 | 3.31e-01 | 6.55e-04 |
| GOBP URETER DEVELOPMENT | 6 | 1.60e-01 | -3.31e-01 | 4.67e-01 |
| GOMF LIPOPROTEIN LIPASE ACTIVITY | 6 | 1.61e-01 | -3.31e-01 | 4.69e-01 |
| GOMF MYOSIN II BINDING | 8 | 1.05e-01 | 3.31e-01 | 3.81e-01 |
| GOCC NUCLEAR STRESS GRANULE | 6 | 1.61e-01 | -3.31e-01 | 4.69e-01 |
| GOBP AXONAL FASCICULATION | 12 | 4.74e-02 | -3.31e-01 | 2.54e-01 |
| GOBP ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY | 15 | 2.68e-02 | 3.30e-01 | 1.86e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 8 | 1.06e-01 | 3.30e-01 | 3.81e-01 |
| GOBP REGULATION OF MITOPHAGY | 15 | 2.69e-02 | -3.30e-01 | 1.86e-01 |
| GOBP MYELOID PROGENITOR CELL DIFFERENTIATION | 5 | 2.02e-01 | -3.30e-01 | 5.24e-01 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 31 | 1.48e-03 | 3.30e-01 | 2.87e-02 |
| GOBP TRANSLOCATION OF MOLECULES INTO HOST | 8 | 1.06e-01 | -3.30e-01 | 3.82e-01 |
| GOBP QUINOLINATE METABOLIC PROCESS | 5 | 2.02e-01 | -3.30e-01 | 5.24e-01 |
| GOBP NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 11 | 5.85e-02 | -3.29e-01 | 2.79e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 18 | 1.56e-02 | -3.29e-01 | 1.39e-01 |
| GOBP OXALOACETATE METABOLIC PROCESS | 7 | 1.32e-01 | 3.29e-01 | 4.25e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 13 | 4.00e-02 | -3.29e-01 | 2.31e-01 |
| GOBP SERINE TRANSPORT | 8 | 1.07e-01 | -3.29e-01 | 3.83e-01 |
| GOMF SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 1.07e-01 | -3.29e-01 | 3.83e-01 |
| GOBP REGULATION OF MYOBLAST FUSION | 15 | 2.76e-02 | 3.29e-01 | 1.88e-01 |
| GOCC R2TP COMPLEX | 5 | 2.03e-01 | 3.28e-01 | 5.26e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL MIGRATION | 8 | 1.08e-01 | 3.28e-01 | 3.84e-01 |
| GOBP POSITIVE REGULATION OF GLUTAMATE SECRETION | 6 | 1.64e-01 | -3.28e-01 | 4.74e-01 |
| GOBP AORTA DEVELOPMENT | 38 | 4.63e-04 | -3.28e-01 | 1.25e-02 |
| GOBP REGULATION OF SUPEROXIDE ANION GENERATION | 14 | 3.35e-02 | -3.28e-01 | 2.12e-01 |
| GOBP BEHAVIORAL RESPONSE TO ETHANOL | 5 | 2.04e-01 | -3.28e-01 | 5.27e-01 |
| GOMF CARBONYL REDUCTASE NADPH ACTIVITY | 7 | 1.33e-01 | -3.28e-01 | 4.28e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX | 44 | 1.69e-04 | 3.28e-01 | 5.72e-03 |
| GOBP POSITIVE REGULATION OF URINE VOLUME | 5 | 2.05e-01 | -3.28e-01 | 5.27e-01 |
| GOMF NUCLEOSOMAL DNA BINDING | 23 | 6.54e-03 | -3.28e-01 | 7.96e-02 |
| GOMF SINGLE STRANDED DNA HELICASE ACTIVITY | 23 | 6.57e-03 | -3.27e-01 | 7.96e-02 |
| GOMF TRNA GUANINE METHYLTRANSFERASE ACTIVITY | 12 | 4.96e-02 | 3.27e-01 | 2.59e-01 |
| GOCC COHESIN COMPLEX | 8 | 1.09e-01 | -3.27e-01 | 3.87e-01 |
| GOBP PROTEIN PROCESSING INVOLVED IN PROTEIN TARGETING TO MITOCHONDRION | 7 | 1.34e-01 | 3.27e-01 | 4.29e-01 |
| GOBP MRNA SPLICE SITE RECOGNITION | 30 | 1.94e-03 | -3.27e-01 | 3.48e-02 |
| GOMF MYOSIN HEAVY CHAIN BINDING | 8 | 1.09e-01 | 3.27e-01 | 3.88e-01 |
| GOCC TRANSCRIPTION EXPORT COMPLEX | 10 | 7.36e-02 | -3.27e-01 | 3.17e-01 |
| GOBP PSEUDOPODIUM ORGANIZATION | 11 | 6.07e-02 | -3.27e-01 | 2.85e-01 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS | 17 | 1.98e-02 | 3.26e-01 | 1.56e-01 |
| GOMF FATTY ACID DERIVATIVE BINDING | 14 | 3.45e-02 | 3.26e-01 | 2.16e-01 |
| GOBP IRON ION TRANSMEMBRANE TRANSPORT | 22 | 8.10e-03 | 3.26e-01 | 9.11e-02 |
| GOBP NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 32 | 1.43e-03 | -3.26e-01 | 2.80e-02 |
| GOBP CONSTITUTIVE SECRETORY PATHWAY | 7 | 1.36e-01 | 3.25e-01 | 4.33e-01 |
| GOMF POLYSACCHARIDE BINDING | 14 | 3.52e-02 | -3.25e-01 | 2.17e-01 |
| GOMF LARGE RIBOSOMAL SUBUNIT RRNA BINDING | 5 | 2.08e-01 | -3.25e-01 | 5.32e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 13 | 4.27e-02 | -3.25e-01 | 2.40e-01 |
| GOBP REGULATION OF CALCIDIOL 1 MONOOXYGENASE ACTIVITY | 6 | 1.69e-01 | 3.25e-01 | 4.81e-01 |
| GOCC MULTIVESICULAR BODY INTERNAL VESICLE | 5 | 2.09e-01 | 3.24e-01 | 5.33e-01 |
| GOBP SIGNAL COMPLEX ASSEMBLY | 6 | 1.69e-01 | 3.24e-01 | 4.82e-01 |
| GOBP PLASMA MEMBRANE TO ENDOSOME TRANSPORT | 8 | 1.12e-01 | 3.24e-01 | 3.93e-01 |
| GOBP CELLULAR RESPONSE TO TESTOSTERONE STIMULUS | 12 | 5.18e-02 | -3.24e-01 | 2.63e-01 |
| GOBP CELLULAR RESPONSE TO MINERALOCORTICOID STIMULUS | 7 | 1.38e-01 | -3.24e-01 | 4.36e-01 |
| GOBP PYROPTOSIS | 28 | 3.03e-03 | -3.24e-01 | 4.82e-02 |
| GOBP DNA REPLICATION SYNTHESIS OF RNA PRIMER | 7 | 1.38e-01 | -3.24e-01 | 4.36e-01 |
| GOCC IKAPPAB KINASE COMPLEX | 6 | 1.70e-01 | -3.24e-01 | 4.82e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 5 | 2.10e-01 | 3.24e-01 | 5.34e-01 |
| GOBP RESPONSE TO IRON II ION | 5 | 2.10e-01 | 3.24e-01 | 5.34e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN | 36 | 7.88e-04 | -3.23e-01 | 1.84e-02 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 11 | 6.34e-02 | 3.23e-01 | 2.90e-01 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 11 | 6.34e-02 | -3.23e-01 | 2.90e-01 |
| GOMF ZINC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 1.48e-02 | 3.23e-01 | 1.34e-01 |
| GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION | 8 | 1.14e-01 | -3.23e-01 | 3.96e-01 |
| GOCC N TERMINAL PROTEIN ACETYLTRANSFERASE COMPLEX | 9 | 9.37e-02 | 3.23e-01 | 3.61e-01 |
| GOMF ADENYLATE CYCLASE BINDING | 7 | 1.39e-01 | -3.23e-01 | 4.38e-01 |
| GOBP POSITIVE REGULATION OF CHROMATIN ORGANIZATION | 13 | 4.41e-02 | -3.23e-01 | 2.44e-01 |
| GOMF GROWTH HORMONE RECEPTOR BINDING | 5 | 2.12e-01 | -3.23e-01 | 5.36e-01 |
| GOBP REGULATION OF MDA 5 SIGNALING PATHWAY | 6 | 1.72e-01 | -3.22e-01 | 4.86e-01 |
| GOBP HYALURONAN CATABOLIC PROCESS | 11 | 6.43e-02 | -3.22e-01 | 2.93e-01 |
| GOBP RESPONSE TO GLUCAGON | 12 | 5.33e-02 | -3.22e-01 | 2.66e-01 |
| GOBP HEMATOPOIETIC STEM CELL PROLIFERATION | 25 | 5.35e-03 | -3.22e-01 | 7.09e-02 |
| GOBP DEVELOPMENT OF SECONDARY SEXUAL CHARACTERISTICS | 7 | 1.40e-01 | -3.22e-01 | 4.39e-01 |
| GOBP THIAMINE TRANSPORT | 5 | 2.13e-01 | 3.22e-01 | 5.38e-01 |
| GOBP INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 34 | 1.18e-03 | -3.21e-01 | 2.45e-02 |
| GOBP MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT | 16 | 2.61e-02 | 3.21e-01 | 1.83e-01 |
| GOBP PROTEIN UFMYLATION | 6 | 1.73e-01 | 3.21e-01 | 4.87e-01 |
| GOBP L LYSINE TRANSPORT | 5 | 2.14e-01 | 3.21e-01 | 5.38e-01 |
| GOMF L LYSINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 2.14e-01 | 3.21e-01 | 5.38e-01 |
| GOBP FEMALE GENITALIA DEVELOPMENT | 11 | 6.52e-02 | -3.21e-01 | 2.94e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 6 | 1.73e-01 | -3.21e-01 | 4.88e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II | 30 | 2.34e-03 | -3.21e-01 | 4.06e-02 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING NITROGENOUS GROUPS | 19 | 1.54e-02 | 3.21e-01 | 1.38e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 5 | 2.14e-01 | 3.21e-01 | 5.39e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 5 | 2.14e-01 | -3.21e-01 | 5.39e-01 |
| GOMF ALKALI METAL ION BINDING | 11 | 6.54e-02 | 3.21e-01 | 2.95e-01 |
| GOCC DENDRITIC SPINE MEMBRANE | 8 | 1.16e-01 | -3.21e-01 | 4.01e-01 |
| GOBP UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS | 9 | 9.58e-02 | 3.21e-01 | 3.65e-01 |
| GOBP BONE MARROW DEVELOPMENT | 8 | 1.16e-01 | -3.20e-01 | 4.01e-01 |
| GOCC B WICH COMPLEX | 7 | 1.42e-01 | -3.20e-01 | 4.42e-01 |
| GOBP IODIDE TRANSPORT | 6 | 1.74e-01 | 3.20e-01 | 4.89e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 7 | 1.42e-01 | -3.20e-01 | 4.42e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA CLASSICAL NONHOMOLOGOUS END JOINING | 6 | 1.74e-01 | -3.20e-01 | 4.89e-01 |
| GOMF RIBONUCLEASE P ACTIVITY | 11 | 6.60e-02 | 3.20e-01 | 2.97e-01 |
| GOCC BRAHMA COMPLEX | 13 | 4.57e-02 | -3.20e-01 | 2.49e-01 |
| GOMF FK506 BINDING | 9 | 9.65e-02 | 3.20e-01 | 3.66e-01 |
| GOMF MACROLIDE BINDING | 9 | 9.65e-02 | 3.20e-01 | 3.66e-01 |
| GOMF CHROMATIN DNA BINDING | 82 | 5.66e-07 | -3.20e-01 | 5.86e-05 |
| GOMF CALCIUM CHANNEL INHIBITOR ACTIVITY | 11 | 6.65e-02 | 3.20e-01 | 2.98e-01 |
| GOBP INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY | 7 | 1.43e-01 | 3.20e-01 | 4.44e-01 |
| GOCC PRESYNAPTIC CYTOSKELETON | 6 | 1.75e-01 | 3.20e-01 | 4.90e-01 |
| GOBP INTRACELLULAR AMINO ACID HOMEOSTASIS | 5 | 2.16e-01 | -3.19e-01 | 5.42e-01 |
| GOBP REGULATION OF GLUCOCORTICOID SECRETION | 7 | 1.44e-01 | 3.19e-01 | 4.45e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION | 13 | 4.63e-02 | -3.19e-01 | 2.50e-01 |
| GOBP NEGATIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 17 | 2.27e-02 | -3.19e-01 | 1.68e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS I | 9 | 9.74e-02 | -3.19e-01 | 3.66e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF T CELL POLARITY | 6 | 1.76e-01 | -3.19e-01 | 4.91e-01 |
| GOMF LIGASE ACTIVITY FORMING PHOSPHORIC ESTER BONDS | 6 | 1.76e-01 | 3.19e-01 | 4.91e-01 |
| GOBP AMINOGLYCOSIDE ANTIBIOTIC METABOLIC PROCESS | 6 | 1.76e-01 | 3.19e-01 | 4.91e-01 |
| GOBP POLYKETIDE METABOLIC PROCESS | 6 | 1.76e-01 | 3.19e-01 | 4.91e-01 |
| GOBP CHROMOSOME CONDENSATION | 29 | 2.98e-03 | -3.19e-01 | 4.80e-02 |
| GOBP PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX ASSEMBLY | 14 | 3.90e-02 | 3.19e-01 | 2.28e-01 |
| GOBP 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS | 10 | 8.13e-02 | -3.18e-01 | 3.35e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX CATALYTIC DOMAIN | 17 | 2.33e-02 | 3.18e-01 | 1.71e-01 |
| GOCC ER MEMBRANE INSERTION COMPLEX | 14 | 3.97e-02 | 3.18e-01 | 2.30e-01 |
| GOCC PROCENTRIOLE REPLICATION COMPLEX | 6 | 1.78e-01 | -3.17e-01 | 4.93e-01 |
| GOBP DETECTION OF OTHER ORGANISM | 14 | 3.97e-02 | -3.17e-01 | 2.30e-01 |
| GOBP CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS | 18 | 1.99e-02 | -3.17e-01 | 1.56e-01 |
| GOMF INTRACILIARY TRANSPORT PARTICLE B BINDING | 5 | 2.20e-01 | 3.17e-01 | 5.48e-01 |
| GOMF ABC TYPE GLUTATHIONE S CONJUGATE TRANSPORTER ACTIVITY | 8 | 1.21e-01 | -3.17e-01 | 4.06e-01 |
| GOBP REGULATION OF PENTOSE PHOSPHATE SHUNT | 6 | 1.79e-01 | -3.17e-01 | 4.94e-01 |
| GOCC APICAL DENDRITE | 12 | 5.74e-02 | 3.17e-01 | 2.76e-01 |
| GOBP RESPONSE TO CORTISOL | 6 | 1.79e-01 | -3.17e-01 | 4.94e-01 |
| GOBP LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL | 5 | 2.20e-01 | 3.17e-01 | 5.48e-01 |
| GOBP BLASTODERM SEGMENTATION | 11 | 6.91e-02 | -3.17e-01 | 3.04e-01 |
| GOBP FC RECEPTOR SIGNALING PATHWAY | 48 | 1.49e-04 | -3.16e-01 | 5.21e-03 |
| GOBP PURINE NUCLEOBASE BIOSYNTHETIC PROCESS | 10 | 8.33e-02 | 3.16e-01 | 3.40e-01 |
| GOBP POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 6 | 1.80e-01 | 3.16e-01 | 4.95e-01 |
| GOBP INNER MITOCHONDRIAL MEMBRANE ORGANIZATION | 38 | 7.45e-04 | 3.16e-01 | 1.77e-02 |
| GOBP CLATHRIN COAT ASSEMBLY | 12 | 5.82e-02 | -3.16e-01 | 2.78e-01 |
| GOBP NEGATIVE REGULATION OF CELL VOLUME | 5 | 2.22e-01 | -3.16e-01 | 5.50e-01 |
| GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY | 25 | 6.31e-03 | 3.16e-01 | 7.83e-02 |
| GOBP NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 8 | 1.22e-01 | -3.16e-01 | 4.09e-01 |
| GOCC MEIOTIC COHESIN COMPLEX | 5 | 2.22e-01 | -3.15e-01 | 5.50e-01 |
| GOBP G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY | 6 | 1.81e-01 | 3.15e-01 | 4.97e-01 |
| GOBP UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 13 | 4.91e-02 | 3.15e-01 | 2.58e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 22 | 1.05e-02 | -3.15e-01 | 1.07e-01 |
| GOBP SODIUM INDEPENDENT ORGANIC ANION TRANSPORT | 5 | 2.23e-01 | -3.15e-01 | 5.51e-01 |
| GOMF AP 2 ADAPTOR COMPLEX BINDING | 10 | 8.47e-02 | -3.15e-01 | 3.41e-01 |
| GOMF LACTATE DEHYDROGENASE ACTIVITY | 6 | 1.82e-01 | 3.15e-01 | 4.98e-01 |
| GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE CLEARANCE | 5 | 2.23e-01 | -3.15e-01 | 5.52e-01 |
| GOCC NEURONAL DENSE CORE VESICLE | 8 | 1.24e-01 | -3.14e-01 | 4.12e-01 |
| GOBP CYTOCHROME COMPLEX ASSEMBLY | 37 | 9.36e-04 | 3.14e-01 | 2.11e-02 |
| GOBP REGULATION OF ERYTHROCYTE DIFFERENTIATION | 39 | 6.88e-04 | -3.14e-01 | 1.68e-02 |
| GOBP CELLULAR RESPONSE TO PEPTIDOGLYCAN | 6 | 1.83e-01 | 3.14e-01 | 5.00e-01 |
| GOBP REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY | 9 | 1.03e-01 | -3.14e-01 | 3.76e-01 |
| GOBP ELASTIN METABOLIC PROCESS | 7 | 1.50e-01 | 3.14e-01 | 4.53e-01 |
| GOCC NUCLEOLAR EXOSOME RNASE COMPLEX | 10 | 8.60e-02 | 3.14e-01 | 3.44e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 10 | 8.62e-02 | 3.13e-01 | 3.45e-01 |
| GOCC EARLY ENDOSOME LUMEN | 5 | 2.25e-01 | 3.13e-01 | 5.53e-01 |
| GOBP TRANSCRIPTION DEPENDENT TETHERING OF RNA POLYMERASE II GENE DNA AT NUCLEAR PERIPHERY | 7 | 1.51e-01 | -3.13e-01 | 4.54e-01 |
| GOMF RNA POLYMERASE III ACTIVITY | 10 | 8.63e-02 | 3.13e-01 | 3.45e-01 |
| GOBP DETECTION OF BACTERIUM | 11 | 7.22e-02 | -3.13e-01 | 3.13e-01 |
| GOBP PENTOSE METABOLIC PROCESS | 10 | 8.65e-02 | 3.13e-01 | 3.45e-01 |
| GOMF ARYLSULFATASE ACTIVITY | 8 | 1.25e-01 | 3.13e-01 | 4.15e-01 |
| GOBP NEGATIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 6 | 1.84e-01 | 3.13e-01 | 5.01e-01 |
| GOBP REGULATION OF TRANSLATIONAL TERMINATION | 9 | 1.04e-01 | 3.13e-01 | 3.78e-01 |
| GOBP PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX | 19 | 1.83e-02 | 3.13e-01 | 1.49e-01 |
| GOBP POSITIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 7 | 1.52e-01 | -3.13e-01 | 4.56e-01 |
| GOMF PROMOTER SPECIFIC CHROMATIN BINDING | 54 | 7.07e-05 | -3.13e-01 | 3.01e-03 |
| GOBP REGULATORY T CELL DIFFERENTIATION | 31 | 2.60e-03 | -3.13e-01 | 4.35e-02 |
| GOBP POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION | 10 | 8.71e-02 | -3.12e-01 | 3.45e-01 |
| GOBP NUCLEOBASE CATABOLIC PROCESS | 8 | 1.26e-01 | 3.12e-01 | 4.17e-01 |
| GOBP MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 14 | 4.31e-02 | -3.12e-01 | 2.41e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL TRANSCRIPTION | 15 | 3.63e-02 | -3.12e-01 | 2.20e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 7 | 1.53e-01 | -3.12e-01 | 4.57e-01 |
| GOMF HISTONE METHYLTRANSFERASE ACTIVITY | 60 | 2.92e-05 | -3.12e-01 | 1.46e-03 |
| GOCC MITOCHONDRIAL PROTEIN CONTAINING COMPLEX | 285 | 1.37e-19 | 3.12e-01 | 9.39e-17 |
| GOCC BLOC COMPLEX | 14 | 4.34e-02 | 3.12e-01 | 2.42e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 20 | 1.58e-02 | 3.12e-01 | 1.40e-01 |
| GOBP DNA INTEGRATION | 6 | 1.86e-01 | -3.12e-01 | 5.04e-01 |
| GOBP NEGATIVE REGULATION OF FILOPODIUM ASSEMBLY | 5 | 2.28e-01 | -3.11e-01 | 5.57e-01 |
| GOBP REGULATION OF MITOCHONDRIAL TRANSCRIPTION | 5 | 2.28e-01 | 3.11e-01 | 5.57e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE | 37 | 1.05e-03 | 3.11e-01 | 2.29e-02 |
| GOBP FATTY ACID DERIVATIVE CATABOLIC PROCESS | 12 | 6.19e-02 | 3.11e-01 | 2.88e-01 |
| GOBP GERM CELL PROLIFERATION | 9 | 1.06e-01 | 3.11e-01 | 3.82e-01 |
| GOMF AMP ACTIVATED PROTEIN KINASE ACTIVITY | 6 | 1.87e-01 | 3.11e-01 | 5.05e-01 |
| GOCC BRISC COMPLEX | 6 | 1.87e-01 | 3.11e-01 | 5.05e-01 |
| GOMF PHOSPHATE ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 1.06e-01 | 3.11e-01 | 3.82e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATORY SUBUNIT BINDING | 7 | 1.54e-01 | -3.11e-01 | 4.59e-01 |
| GOBP RIBONUCLEOPROTEIN COMPLEX LOCALIZATION | 9 | 1.06e-01 | -3.11e-01 | 3.82e-01 |
| GOBP RESPONSE TO HEPATOCYTE GROWTH FACTOR | 15 | 3.72e-02 | -3.11e-01 | 2.24e-01 |
| GOMF DYNEIN HEAVY CHAIN BINDING | 9 | 1.06e-01 | 3.11e-01 | 3.82e-01 |
| GOMF ACYL COA BINDING | 17 | 2.67e-02 | 3.10e-01 | 1.85e-01 |
| GOMF SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 1.92e-02 | 3.10e-01 | 1.53e-01 |
| GOBP DNA UNWINDING INVOLVED IN DNA REPLICATION | 21 | 1.39e-02 | -3.10e-01 | 1.28e-01 |
| GOBP CELLULAR RESPONSE TO NUTRIENT | 36 | 1.28e-03 | -3.10e-01 | 2.61e-02 |
| GOMF MUSCLE ALPHA ACTININ BINDING | 11 | 7.50e-02 | 3.10e-01 | 3.21e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 33 | 2.06e-03 | -3.10e-01 | 3.64e-02 |
| GOBP TRICARBOXYLIC ACID METABOLIC PROCESS | 12 | 6.30e-02 | -3.10e-01 | 2.89e-01 |
| GOBP REGULATION OF RECEPTOR BINDING | 10 | 8.99e-02 | -3.10e-01 | 3.51e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR SENESCENCE | 10 | 9.01e-02 | -3.10e-01 | 3.51e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL DEVELOPMENT | 15 | 3.80e-02 | -3.10e-01 | 2.26e-01 |
| GOBP SUPEROXIDE ANION GENERATION | 26 | 6.31e-03 | -3.09e-01 | 7.83e-02 |
| GOMF EPHRIN RECEPTOR ACTIVITY | 6 | 1.90e-01 | -3.09e-01 | 5.09e-01 |
| GOMF TRANSMEMBRANE EPHRIN RECEPTOR ACTIVITY | 6 | 1.90e-01 | -3.09e-01 | 5.09e-01 |
| GOBP PHAGOCYTOSIS RECOGNITION | 13 | 5.38e-02 | -3.09e-01 | 2.67e-01 |
| GOBP REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 9 | 1.09e-01 | -3.09e-01 | 3.86e-01 |
| GOMF CALCIUM ACTIVATED POTASSIUM CHANNEL ACTIVITY | 8 | 1.30e-01 | 3.09e-01 | 4.23e-01 |
| GOBP REGULATION OF I KAPPAB PHOSPHORYLATION | 5 | 2.32e-01 | -3.09e-01 | 5.63e-01 |
| GOBP GLYCOSIDE METABOLIC PROCESS | 13 | 5.41e-02 | 3.09e-01 | 2.67e-01 |
| GOBP PLATELET DEGRANULATION | 6 | 1.91e-01 | -3.08e-01 | 5.10e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 5 | 2.32e-01 | -3.08e-01 | 5.63e-01 |
| GOMF INTERMEDIATE FILAMENT BINDING | 6 | 1.91e-01 | -3.08e-01 | 5.10e-01 |
| GOBP MACROPHAGE COLONY STIMULATING FACTOR SIGNALING PATHWAY | 6 | 1.91e-01 | -3.08e-01 | 5.10e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 6 | 1.92e-01 | 3.08e-01 | 5.10e-01 |
| GOMF DEMETHYLASE ACTIVITY | 36 | 1.39e-03 | -3.08e-01 | 2.74e-02 |
| GOBP REGULATION OF HISTONE METHYLATION | 17 | 2.80e-02 | -3.08e-01 | 1.90e-01 |
| GOBP MANGANESE ION TRANSPORT | 9 | 1.10e-01 | 3.08e-01 | 3.88e-01 |
| GOBP PULMONARY VALVE DEVELOPMENT | 15 | 3.91e-02 | -3.08e-01 | 2.28e-01 |
| GOBP BRANCHING MORPHOGENESIS OF A NERVE | 8 | 1.32e-01 | 3.08e-01 | 4.25e-01 |
| GOBP CELLULAR RESPONSE TO UV A | 7 | 1.59e-01 | -3.07e-01 | 4.65e-01 |
| GOBP DNA PROTECTION | 5 | 2.34e-01 | 3.07e-01 | 5.65e-01 |
| GOBP RENAL ABSORPTION | 14 | 4.65e-02 | -3.07e-01 | 2.51e-01 |
| GOBP CELLULAR RESPONSE TO IRON ION | 6 | 1.92e-01 | -3.07e-01 | 5.11e-01 |
| GOMF TRNA SPECIFIC RIBONUCLEASE ACTIVITY | 15 | 3.94e-02 | 3.07e-01 | 2.29e-01 |
| GOBP PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE | 8 | 1.33e-01 | -3.07e-01 | 4.27e-01 |
| GOBP POSITIVE REGULATION OF B CELL DIFFERENTIATION | 14 | 4.70e-02 | -3.07e-01 | 2.53e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE ACTIVATION | 12 | 6.59e-02 | -3.07e-01 | 2.96e-01 |
| GOBP PEPTIDE CATABOLIC PROCESS | 18 | 2.43e-02 | -3.07e-01 | 1.75e-01 |
| GOBP REGULATION OF MRNA PROCESSING | 108 | 3.83e-08 | -3.06e-01 | 5.77e-06 |
| GOBP CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE | 8 | 1.34e-01 | -3.06e-01 | 4.29e-01 |
| GOCC NADPH OXIDASE COMPLEX | 11 | 7.91e-02 | -3.06e-01 | 3.31e-01 |
| GOMF DNA SECONDARY STRUCTURE BINDING | 34 | 2.04e-03 | -3.06e-01 | 3.63e-02 |
| GOBP RESPONSE TO HYDROXYUREA | 10 | 9.43e-02 | -3.06e-01 | 3.62e-01 |
| GOMF CYTOCHROME B5 REDUCTASE ACTIVITY ACTING ON NAD P H | 6 | 1.95e-01 | 3.05e-01 | 5.15e-01 |
| GOBP VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS | 10 | 9.47e-02 | -3.05e-01 | 3.63e-01 |
| GOBP MITOTIC CHROMOSOME CONDENSATION | 19 | 2.14e-02 | -3.05e-01 | 1.61e-01 |
| GOBP TETRAPYRROLE BIOSYNTHETIC PROCESS | 30 | 3.84e-03 | 3.05e-01 | 5.65e-02 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 8 | 1.36e-01 | -3.04e-01 | 4.33e-01 |
| GOBP MONOUBIQUITINATED PROTEIN DEUBIQUITINATION | 8 | 1.36e-01 | -3.04e-01 | 4.33e-01 |
| GOBP LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS | 15 | 4.13e-02 | 3.04e-01 | 2.36e-01 |
| GOBP CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY | 20 | 1.86e-02 | 3.04e-01 | 1.51e-01 |
| GOCC INNER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 146 | 2.31e-10 | 3.04e-01 | 5.71e-08 |
| GOBP RRNA 3 END PROCESSING | 10 | 9.65e-02 | 3.04e-01 | 3.66e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 19 | 2.20e-02 | -3.04e-01 | 1.64e-01 |
| GOBP URONIC ACID METABOLIC PROCESS | 7 | 1.64e-01 | 3.03e-01 | 4.75e-01 |
| GOBP BASOLATERAL PROTEIN SECRETION | 5 | 2.40e-01 | 3.03e-01 | 5.74e-01 |
| GOBP ZINC ION IMPORT ACROSS PLASMA MEMBRANE | 8 | 1.38e-01 | 3.03e-01 | 4.36e-01 |
| GOMF AROMATIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 1.65e-01 | 3.03e-01 | 4.76e-01 |
| GOBP CAMP CATABOLIC PROCESS | 8 | 1.38e-01 | -3.03e-01 | 4.36e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 10 | 9.71e-02 | 3.03e-01 | 3.66e-01 |
| GOBP STEROL BIOSYNTHETIC PROCESS | 52 | 1.57e-04 | 3.03e-01 | 5.40e-03 |
| GOBP NEGATIVE REGULATION OF LYASE ACTIVITY | 7 | 1.65e-01 | -3.03e-01 | 4.76e-01 |
| GOCC ARP2 3 PROTEIN COMPLEX | 9 | 1.16e-01 | 3.03e-01 | 3.99e-01 |
| GOBP CELLULAR RESPONSE TO COCAINE | 6 | 1.99e-01 | -3.03e-01 | 5.20e-01 |
| GOBP MAINTENANCE OF CELL POLARITY | 14 | 4.99e-02 | 3.03e-01 | 2.60e-01 |
| GOBP REGULATION OF NUCLEASE ACTIVITY | 20 | 1.92e-02 | -3.03e-01 | 1.53e-01 |
| GOBP PROTEIN K6 LINKED UBIQUITINATION | 11 | 8.23e-02 | 3.03e-01 | 3.38e-01 |
| GOBP REGULATION OF RRNA PROCESSING | 16 | 3.62e-02 | 3.03e-01 | 2.20e-01 |
| GOMF UBIQUITIN LIGASE ACTIVATOR ACTIVITY | 5 | 2.42e-01 | -3.02e-01 | 5.75e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 10 | 9.79e-02 | -3.02e-01 | 3.66e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 9 | 1.17e-01 | 3.02e-01 | 4.01e-01 |
| GOMF NEUROTRANSMITTER BINDING | 5 | 2.42e-01 | -3.02e-01 | 5.75e-01 |
| GOMF PHOSPHATIDYLSERINE FLOPPASE ACTIVITY | 9 | 1.17e-01 | -3.02e-01 | 4.01e-01 |
| GOMF LIPID PHOSPHATASE ACTIVITY | 11 | 8.31e-02 | 3.02e-01 | 3.40e-01 |
| GOBP CALMODULIN DEPENDENT KINASE SIGNALING PATHWAY | 7 | 1.67e-01 | 3.02e-01 | 4.79e-01 |
| GOBP UREA TRANSMEMBRANE TRANSPORT | 5 | 2.43e-01 | -3.02e-01 | 5.76e-01 |
| GOMF UREA TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 2.43e-01 | -3.02e-01 | 5.76e-01 |
| GOBP PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 46 | 4.02e-04 | 3.02e-01 | 1.11e-02 |
| GOBP POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 11 | 8.34e-02 | 3.01e-01 | 3.40e-01 |
| GOBP DNA REPLICATION INITIATION | 36 | 1.75e-03 | -3.01e-01 | 3.24e-02 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE BINDING | 8 | 1.40e-01 | -3.01e-01 | 4.39e-01 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 14 | 5.11e-02 | 3.01e-01 | 2.62e-01 |
| GOMF D GLUCOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 2.02e-01 | 3.01e-01 | 5.24e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY GLUCOSE | 9 | 1.18e-01 | -3.01e-01 | 4.02e-01 |
| GOBP VITAMIN K METABOLIC PROCESS | 7 | 1.68e-01 | 3.01e-01 | 4.81e-01 |
| GOMF PROTEIN BINDING INVOLVED IN HETEROTYPIC CELL CELL ADHESION | 8 | 1.41e-01 | -3.01e-01 | 4.40e-01 |
| GOBP ENTRAINMENT OF CIRCADIAN CLOCK | 24 | 1.08e-02 | -3.01e-01 | 1.09e-01 |
| GOCC PROTEIN FOLDING CHAPERONE COMPLEX | 39 | 1.17e-03 | 3.00e-01 | 2.43e-02 |
| GOBP POLYAMINE METABOLIC PROCESS | 18 | 2.74e-02 | 3.00e-01 | 1.88e-01 |
| GOBP EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS | 7 | 1.69e-01 | 3.00e-01 | 4.82e-01 |
| GOBP CARBON CATABOLITE REGULATION OF TRANSCRIPTION | 7 | 1.69e-01 | -3.00e-01 | 4.82e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL FUSION | 8 | 1.42e-01 | 3.00e-01 | 4.42e-01 |
| GOBP POSITIVE REGULATION OF MEMORY T CELL DIFFERENTIATION | 6 | 2.04e-01 | -3.00e-01 | 5.26e-01 |
| GOBP PRIMARY MIRNA PROCESSING | 17 | 3.24e-02 | -3.00e-01 | 2.07e-01 |
| GOBP ATRIOVENTRICULAR CANAL DEVELOPMENT | 6 | 2.04e-01 | -2.99e-01 | 5.27e-01 |
| GOMF CERAMIDE BINDING | 18 | 2.79e-02 | 2.99e-01 | 1.90e-01 |
| GOBP GLYCOSIDE CATABOLIC PROCESS | 7 | 1.70e-01 | 2.99e-01 | 4.84e-01 |
| GOBP BRADYKININ CATABOLIC PROCESS | 6 | 2.04e-01 | -2.99e-01 | 5.27e-01 |
| GOCC CHROMATOID BODY | 6 | 2.04e-01 | -2.99e-01 | 5.27e-01 |
| GOMF MEMBRANE INSERTASE ACTIVITY | 17 | 3.29e-02 | 2.99e-01 | 2.10e-01 |
| GOBP FATTY ACYL COA BIOSYNTHETIC PROCESS | 21 | 1.78e-02 | 2.99e-01 | 1.48e-01 |
| GOBP PIGMENT BIOSYNTHETIC PROCESS | 43 | 6.99e-04 | 2.99e-01 | 1.69e-02 |
| GOBP NEGATIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 10 | 1.02e-01 | -2.99e-01 | 3.74e-01 |
| GOBP OXYGEN TRANSPORT | 6 | 2.05e-01 | -2.99e-01 | 5.28e-01 |
| GOMF CARBON NITROGEN LYASE ACTIVITY | 12 | 7.32e-02 | 2.99e-01 | 3.16e-01 |
| GOBP CAMP BIOSYNTHETIC PROCESS | 8 | 1.44e-01 | -2.99e-01 | 4.45e-01 |
| GOBP WHITE FAT CELL DIFFERENTIATION | 13 | 6.26e-02 | -2.98e-01 | 2.89e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE CHECKPOINT | 5 | 2.48e-01 | -2.98e-01 | 5.82e-01 |
| GOBP NEGATIVE REGULATION OF NEUTROPHIL MIGRATION | 5 | 2.48e-01 | -2.98e-01 | 5.82e-01 |
| GOBP FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE | 11 | 8.68e-02 | 2.98e-01 | 3.45e-01 |
| GOBP REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 37 | 1.70e-03 | -2.98e-01 | 3.18e-02 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 7 | 1.72e-01 | 2.98e-01 | 4.86e-01 |
| GOBP POSITIVE REGULATION OF PINOCYTOSIS | 7 | 1.72e-01 | -2.98e-01 | 4.87e-01 |
| GOMF INTERLEUKIN 17 RECEPTOR ACTIVITY | 5 | 2.49e-01 | -2.98e-01 | 5.84e-01 |
| GOMF TRANSCRIPTION COREGULATOR BINDING | 93 | 7.14e-07 | -2.98e-01 | 6.97e-05 |
| GOBP RESPONSE TO DISACCHARIDE | 5 | 2.50e-01 | -2.97e-01 | 5.84e-01 |
| GOCC NPBAF COMPLEX | 14 | 5.43e-02 | -2.97e-01 | 2.67e-01 |
| GOMF HISTONE MODIFYING ACTIVITY | 187 | 2.51e-12 | -2.97e-01 | 8.58e-10 |
| GOBP POSITIVE REGULATION OF AMYLOID BETA CLEARANCE | 6 | 2.08e-01 | -2.97e-01 | 5.32e-01 |
| GOBP RHYTHMIC BEHAVIOR | 28 | 6.57e-03 | -2.97e-01 | 7.96e-02 |
| GOMF PRE MRNA INTRONIC BINDING | 11 | 8.85e-02 | -2.97e-01 | 3.48e-01 |
| GOMF CHROMATIN PROTEIN ADAPTOR ACTIVITY | 14 | 5.49e-02 | -2.96e-01 | 2.69e-01 |
| GOBP REGULATION OF DNA METHYLATION | 13 | 6.44e-02 | -2.96e-01 | 2.93e-01 |
| GOBP POST EMBRYONIC ANIMAL ORGAN MORPHOGENESIS | 7 | 1.75e-01 | -2.96e-01 | 4.90e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE CATABOLIC PROCESS | 7 | 1.75e-01 | 2.96e-01 | 4.90e-01 |
| GOBP MITOCHONDRIAL PROTEIN PROCESSING | 13 | 6.45e-02 | 2.96e-01 | 2.93e-01 |
| GOBP LATE NUCLEOPHAGY | 8 | 1.47e-01 | -2.96e-01 | 4.49e-01 |
| GOBP REGULATION OF TRANSLATION INITIATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 8 | 1.47e-01 | 2.96e-01 | 4.49e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 34 | 2.84e-03 | 2.96e-01 | 4.64e-02 |
| GOBP ONCOGENE INDUCED CELL SENESCENCE | 5 | 2.52e-01 | 2.96e-01 | 5.87e-01 |
| GOMF G QUADRUPLEX RNA BINDING | 5 | 2.53e-01 | -2.95e-01 | 5.87e-01 |
| GOBP REGULATION OF RNA SPLICING | 154 | 2.54e-10 | -2.95e-01 | 6.10e-08 |
| GOBP INTESTINAL CHOLESTEROL ABSORPTION | 7 | 1.76e-01 | 2.95e-01 | 4.91e-01 |
| GOBP LIPID DIGESTION | 7 | 1.76e-01 | 2.95e-01 | 4.91e-01 |
| GOBP URINARY BLADDER SMOOTH MUSCLE CONTRACTION | 5 | 2.53e-01 | -2.95e-01 | 5.88e-01 |
| GOBP URINARY TRACT SMOOTH MUSCLE CONTRACTION | 5 | 2.53e-01 | -2.95e-01 | 5.88e-01 |
| GOBP L SERINE BIOSYNTHETIC PROCESS | 5 | 2.53e-01 | 2.95e-01 | 5.88e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5 | 9 | 1.25e-01 | 2.95e-01 | 4.16e-01 |
| GOBP MRNA ALTERNATIVE POLYADENYLATION | 5 | 2.53e-01 | -2.95e-01 | 5.88e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX | 19 | 2.61e-02 | 2.95e-01 | 1.83e-01 |
| GOBP NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 7 | 1.77e-01 | 2.95e-01 | 4.92e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 7 | 1.77e-01 | 2.95e-01 | 4.92e-01 |
| GOMF MANGANESE ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 1.77e-01 | 2.95e-01 | 4.92e-01 |
| GOMF MOLECULAR CONDENSATE SCAFFOLD ACTIVITY | 26 | 9.31e-03 | -2.95e-01 | 9.98e-02 |
| GOBP RNA POLYMERASE I PREINITIATION COMPLEX ASSEMBLY | 8 | 1.49e-01 | -2.95e-01 | 4.52e-01 |
| GOBP POSITIVE REGULATION OF PHAGOCYTOSIS | 49 | 3.63e-04 | -2.94e-01 | 1.03e-02 |
| GOBP GLUTAMATE SECRETION NEUROTRANSMISSION | 6 | 2.12e-01 | -2.94e-01 | 5.36e-01 |
| GOBP SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY | 11 | 9.09e-02 | 2.94e-01 | 3.53e-01 |
| GOBP PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT | 15 | 4.84e-02 | 2.94e-01 | 2.56e-01 |
| GOBP RESPONSE TO MINERALOCORTICOID | 22 | 1.69e-02 | -2.94e-01 | 1.45e-01 |
| GOBP L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 11 | 9.12e-02 | -2.94e-01 | 3.54e-01 |
| GOBP MAMMARY GLAND DUCT MORPHOGENESIS | 19 | 2.65e-02 | -2.94e-01 | 1.84e-01 |
| GOMF HISTONE ACETYLTRANSFERASE BINDING | 20 | 2.29e-02 | -2.94e-01 | 1.69e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT | 12 | 7.81e-02 | -2.94e-01 | 3.29e-01 |
| GOBP RESPONSE TO MANGANESE ION | 15 | 4.95e-02 | 2.93e-01 | 2.59e-01 |
| GOBP BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS | 14 | 5.79e-02 | -2.93e-01 | 2.77e-01 |
| GOBP PURINE NUCLEOSIDE CATABOLIC PROCESS | 8 | 1.52e-01 | 2.93e-01 | 4.55e-01 |
| GOBP NEGATIVE REGULATION OF CILIUM ASSEMBLY | 18 | 3.16e-02 | -2.93e-01 | 2.03e-01 |
| GOBP PEPTIDYL SERINE AUTOPHOSPHORYLATION | 8 | 1.52e-01 | -2.93e-01 | 4.55e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 9 | 1.28e-01 | 2.93e-01 | 4.20e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 36 | 2.39e-03 | -2.93e-01 | 4.08e-02 |
| GOBP TAURINE METABOLIC PROCESS | 5 | 2.57e-01 | -2.92e-01 | 5.93e-01 |
| GOMF METHYL CPG BINDING | 21 | 2.04e-02 | -2.92e-01 | 1.58e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 29 | 6.52e-03 | 2.92e-01 | 7.96e-02 |
| GOBP REGULATION OF DENDRITIC SPINE MAINTENANCE | 10 | 1.10e-01 | -2.92e-01 | 3.90e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO TUMOR CELL | 10 | 1.11e-01 | 2.91e-01 | 3.90e-01 |
| GOCC LATERAL PLASMA MEMBRANE | 48 | 4.78e-04 | 2.91e-01 | 1.28e-02 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 8 | 1.54e-01 | 2.91e-01 | 4.59e-01 |
| GOCC GLYCOSYLPHOSPHATIDYLINOSITOL N ACETYLGLUCOSAMINYLTRANSFERASE GPI GNT COMPLEX | 6 | 2.17e-01 | 2.91e-01 | 5.44e-01 |
| GOCC SMAD PROTEIN COMPLEX | 8 | 1.54e-01 | -2.91e-01 | 4.59e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 7 | 1.83e-01 | 2.91e-01 | 5.00e-01 |
| GOBP POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 26 | 1.04e-02 | -2.90e-01 | 1.06e-01 |
| GOMF HISTONE H2A UBIQUITIN LIGASE ACTIVITY | 5 | 2.61e-01 | 2.90e-01 | 5.97e-01 |
| GOBP RESPONSE TO UV A | 9 | 1.32e-01 | -2.90e-01 | 4.25e-01 |
| GOMF DNA REPLICATION ORIGIN BINDING | 16 | 4.44e-02 | -2.90e-01 | 2.45e-01 |
| GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY | 9 | 1.32e-01 | -2.90e-01 | 4.25e-01 |
| GOBP PROTEIN LOCALIZATION TO CONDENSED CHROMOSOME | 15 | 5.17e-02 | -2.90e-01 | 2.63e-01 |
| GOBP CELL FATE SPECIFICATION | 41 | 1.32e-03 | -2.90e-01 | 2.65e-02 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I | 8 | 1.56e-01 | -2.90e-01 | 4.61e-01 |
| GOMF 3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY | 12 | 8.23e-02 | -2.90e-01 | 3.38e-01 |
| GOBP TRNA SURVEILLANCE | 8 | 1.56e-01 | 2.90e-01 | 4.62e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 9 | 1.33e-01 | -2.89e-01 | 4.27e-01 |
| GOBP REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 7 | 1.85e-01 | 2.89e-01 | 5.02e-01 |
| GOCC MANCHETTE | 15 | 5.26e-02 | 2.89e-01 | 2.65e-01 |
| GOBP REGULATION OF CHROMATIN BINDING | 11 | 9.70e-02 | -2.89e-01 | 3.66e-01 |
| GOBP POSITIVE REGULATION OF MRNA 3 END PROCESSING | 6 | 2.20e-01 | 2.89e-01 | 5.48e-01 |
| GOBP CYCLIC NUCLEOTIDE CATABOLIC PROCESS | 12 | 8.34e-02 | -2.89e-01 | 3.40e-01 |
| GOBP TONGUE MORPHOGENESIS | 6 | 2.21e-01 | -2.88e-01 | 5.49e-01 |
| GOCC BBSOME | 8 | 1.58e-01 | 2.88e-01 | 4.64e-01 |
| GOCC SORTING ENDOSOME | 5 | 2.64e-01 | -2.88e-01 | 6.01e-01 |
| GOBP NEUROTRANSMITTER REUPTAKE | 15 | 5.33e-02 | 2.88e-01 | 2.66e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL PROCESS | 75 | 1.61e-05 | -2.88e-01 | 9.22e-04 |
| GOBP CAMP METABOLIC PROCESS | 17 | 3.98e-02 | -2.88e-01 | 2.30e-01 |
| GOMF 14 3 3 PROTEIN BINDING | 30 | 6.33e-03 | -2.88e-01 | 7.85e-02 |
| GOBP RESPONSE TO PROGESTERONE | 27 | 9.61e-03 | -2.88e-01 | 1.02e-01 |
| GOBP FIBROBLAST APOPTOTIC PROCESS | 23 | 1.68e-02 | -2.88e-01 | 1.45e-01 |
| GOCC PLATELET DENSE GRANULE LUMEN | 8 | 1.59e-01 | -2.88e-01 | 4.65e-01 |
| GOBP POSITIVE REGULATION OF CHROMATIN BINDING | 9 | 1.35e-01 | -2.88e-01 | 4.31e-01 |
| GOBP NEGATIVE REGULATION OF PHAGOCYTOSIS | 19 | 2.99e-02 | -2.88e-01 | 1.97e-01 |
| GOBP RESPONSE TO L ASCORBIC ACID | 5 | 2.65e-01 | 2.88e-01 | 6.02e-01 |
| GOCC EXOCYST | 12 | 8.44e-02 | -2.88e-01 | 3.41e-01 |
| GOCC DNA REPLICATION FACTOR C COMPLEX | 5 | 2.66e-01 | -2.87e-01 | 6.03e-01 |
| GOBP RETINAL BIPOLAR NEURON DIFFERENTIATION | 5 | 2.66e-01 | -2.87e-01 | 6.03e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 28 | 8.56e-03 | -2.87e-01 | 9.42e-02 |
| GOBP KERATINIZATION | 12 | 8.52e-02 | 2.87e-01 | 3.43e-01 |
| GOBP PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING | 6 | 2.24e-01 | 2.87e-01 | 5.52e-01 |
| GOBP C4 DICARBOXYLATE TRANSPORT | 19 | 3.05e-02 | -2.87e-01 | 1.99e-01 |
| GOBP CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION | 13 | 7.38e-02 | -2.86e-01 | 3.18e-01 |
| GOMF IMMUNOGLOBULIN BINDING | 14 | 6.37e-02 | -2.86e-01 | 2.91e-01 |
| GOCC ZONA PELLUCIDA RECEPTOR COMPLEX | 6 | 2.25e-01 | 2.86e-01 | 5.53e-01 |
| GOBP REGULATION OF STEM CELL PROLIFERATION | 43 | 1.17e-03 | -2.86e-01 | 2.44e-02 |
| GOBP PURINE RIBONUCLEOTIDE SALVAGE | 7 | 1.90e-01 | 2.86e-01 | 5.09e-01 |
| GOBP RETINAL GANGLION CELL AXON GUIDANCE | 14 | 6.42e-02 | -2.86e-01 | 2.93e-01 |
| GOBP MRNA EXPORT FROM NUCLEUS | 64 | 7.76e-05 | -2.86e-01 | 3.24e-03 |
| GOBP PRENYLATION | 11 | 1.01e-01 | -2.86e-01 | 3.72e-01 |
| GOMF PHOSPHORYLATION DEPENDENT PROTEIN BINDING | 6 | 2.26e-01 | -2.86e-01 | 5.54e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA2 PRODUCTION | 6 | 2.26e-01 | -2.85e-01 | 5.54e-01 |
| GOBP POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 7 | 1.91e-01 | -2.85e-01 | 5.10e-01 |
| GOBP HORMONE CATABOLIC PROCESS | 9 | 1.38e-01 | -2.85e-01 | 4.36e-01 |
| GOBP MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 7 | 1.91e-01 | -2.85e-01 | 5.10e-01 |
| GOCC MLL3 4 COMPLEX | 12 | 8.70e-02 | -2.85e-01 | 3.45e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 8 | 1.62e-01 | -2.85e-01 | 4.71e-01 |
| GOCC MITOTIC SPINDLE ASTRAL MICROTUBULE | 6 | 2.26e-01 | 2.85e-01 | 5.55e-01 |
| GOBP TRANSEPITHELIAL CHLORIDE TRANSPORT | 5 | 2.69e-01 | 2.85e-01 | 6.06e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 10 | 1.19e-01 | -2.85e-01 | 4.02e-01 |
| GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL ACTIVATION | 8 | 1.63e-01 | -2.85e-01 | 4.73e-01 |
| GOMF POLY PURINE TRACT BINDING | 26 | 1.20e-02 | -2.85e-01 | 1.16e-01 |
| GOBP TRANSCRIPTION INITIATION COUPLED CHROMATIN REMODELING | 35 | 3.56e-03 | -2.85e-01 | 5.38e-02 |
| GOBP CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS | 20 | 2.76e-02 | -2.85e-01 | 1.88e-01 |
| GOBP BICARBONATE TRANSPORT | 24 | 1.58e-02 | 2.85e-01 | 1.40e-01 |
| GOBP DETECTION OF CELL DENSITY | 7 | 1.92e-01 | -2.85e-01 | 5.11e-01 |
| GOBP STRIATED MUSCLE ADAPTATION | 22 | 2.09e-02 | -2.85e-01 | 1.59e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION | 16 | 4.90e-02 | 2.84e-01 | 2.58e-01 |
| GOBP DNA METHYLATION | 40 | 1.87e-03 | -2.84e-01 | 3.39e-02 |
| GOBP REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT | 6 | 2.28e-01 | 2.84e-01 | 5.57e-01 |
| GOBP CELL ADHESION MOLECULE PRODUCTION | 9 | 1.40e-01 | -2.84e-01 | 4.39e-01 |
| GOBP VIRAL TRANSCRIPTION | 47 | 7.63e-04 | -2.84e-01 | 1.81e-02 |
| GOBP MITOTIC SISTER CHROMATID COHESION | 29 | 8.18e-03 | -2.84e-01 | 9.13e-02 |
| GOBP REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 6 | 2.29e-01 | -2.84e-01 | 5.58e-01 |
| GOBP REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 20 | 2.81e-02 | -2.84e-01 | 1.90e-01 |
| GOBP REGULATION OF FIBRINOLYSIS | 10 | 1.20e-01 | 2.84e-01 | 4.06e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN | 19 | 3.24e-02 | 2.84e-01 | 2.07e-01 |
| GOMF ANDROGEN BINDING | 5 | 2.72e-01 | -2.84e-01 | 6.09e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 7 | 1.94e-01 | -2.83e-01 | 5.13e-01 |
| GOBP ACTIN FILAMENT NETWORK FORMATION | 8 | 1.65e-01 | 2.83e-01 | 4.77e-01 |
| GOBP NEGATIVE REGULATION OF SCHWANN CELL PROLIFERATION | 7 | 1.95e-01 | -2.83e-01 | 5.14e-01 |
| GOBP SCHWANN CELL PROLIFERATION | 7 | 1.95e-01 | -2.83e-01 | 5.14e-01 |
| GOMF ESTROGEN RESPONSE ELEMENT BINDING | 8 | 1.66e-01 | -2.83e-01 | 4.77e-01 |
| GOBP BLOOD COAGULATION INTRINSIC PATHWAY | 5 | 2.73e-01 | -2.83e-01 | 6.09e-01 |
| GOBP POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE | 8 | 1.66e-01 | -2.83e-01 | 4.77e-01 |
| GOCC PARASPECKLES | 8 | 1.66e-01 | -2.83e-01 | 4.77e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 6 | 2.30e-01 | 2.83e-01 | 5.61e-01 |
| GOMF HYALURONIC ACID BINDING | 10 | 1.22e-01 | -2.82e-01 | 4.09e-01 |
| GOCC PAR POLARITY COMPLEX | 5 | 2.74e-01 | 2.82e-01 | 6.11e-01 |
| GOBP HISTONE H3 K4 METHYLATION | 19 | 3.33e-02 | -2.82e-01 | 2.11e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 19 | 3.33e-02 | -2.82e-01 | 2.11e-01 |
| GOBP NEGATIVE REGULATION OF G0 TO G1 TRANSITION | 5 | 2.75e-01 | 2.82e-01 | 6.11e-01 |
| GOBP OOCYTE CONSTRUCTION | 5 | 2.75e-01 | -2.82e-01 | 6.11e-01 |
| GOBP INTRACELLULAR ZINC ION HOMEOSTASIS | 26 | 1.28e-02 | 2.82e-01 | 1.21e-01 |
| GOBP CELLULAR RESPONSE TO ETHER | 6 | 2.32e-01 | -2.82e-01 | 5.63e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 27 | 1.14e-02 | -2.81e-01 | 1.13e-01 |
| GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 16 | 5.14e-02 | 2.81e-01 | 2.62e-01 |
| GOBP TROPHOBLAST GIANT CELL DIFFERENTIATION | 6 | 2.33e-01 | 2.81e-01 | 5.63e-01 |
| GOBP NEURONAL STEM CELL POPULATION MAINTENANCE | 17 | 4.50e-02 | -2.81e-01 | 2.47e-01 |
| GOBP PROTEIN TARGETING TO MITOCHONDRION | 102 | 9.65e-07 | 2.81e-01 | 9.13e-05 |
| GOBP REGULATION OF CAVEOLIN MEDIATED ENDOCYTOSIS | 5 | 2.77e-01 | 2.81e-01 | 6.15e-01 |
| GOBP FRUCTOSE TRANSMEMBRANE TRANSPORT | 8 | 1.69e-01 | 2.81e-01 | 4.82e-01 |
| GOBP PHOSPHOLIPID EFFLUX | 9 | 1.45e-01 | -2.80e-01 | 4.45e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME MATURATION | 6 | 2.35e-01 | -2.80e-01 | 5.66e-01 |
| GOCC ARYL HYDROCARBON RECEPTOR COMPLEX | 5 | 2.79e-01 | -2.80e-01 | 6.16e-01 |
| GOBP ECTODERMAL CELL DIFFERENTIATION | 6 | 2.36e-01 | 2.80e-01 | 5.67e-01 |
| GOBP CDP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 13 | 8.10e-02 | 2.79e-01 | 3.35e-01 |
| GOBP PROSTAGLANDIN SECRETION | 11 | 1.09e-01 | 2.79e-01 | 3.86e-01 |
| GOBP SYNAPTIC VESICLE LUMEN ACIDIFICATION | 14 | 7.03e-02 | 2.79e-01 | 3.08e-01 |
| GOBP NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT | 13 | 8.11e-02 | -2.79e-01 | 3.35e-01 |
| GOBP NUCLEOLAR CHROMATIN ORGANIZATION | 10 | 1.26e-01 | -2.79e-01 | 4.17e-01 |
| GOCC NADH DEHYDROGENASE COMPLEX | 48 | 8.25e-04 | 2.79e-01 | 1.90e-02 |
| GOMF PHOSPHATE ION BINDING | 6 | 2.37e-01 | 2.79e-01 | 5.68e-01 |
| GOBP RESPONSE TO LEUCINE | 13 | 8.20e-02 | -2.79e-01 | 3.37e-01 |
| GOBP ASPARTATE TRANSMEMBRANE TRANSPORT | 13 | 8.23e-02 | -2.78e-01 | 3.38e-01 |
| GOCC DERLIN 1 RETROTRANSLOCATION COMPLEX | 8 | 1.73e-01 | 2.78e-01 | 4.88e-01 |
| GOBP FOLIC ACID TRANSPORT | 9 | 1.49e-01 | 2.78e-01 | 4.51e-01 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 BINDING | 8 | 1.73e-01 | 2.78e-01 | 4.88e-01 |
| GOBP REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL | 5 | 2.82e-01 | 2.78e-01 | 6.20e-01 |
| GOMF FATTY ACID BINDING | 31 | 7.40e-03 | 2.78e-01 | 8.56e-02 |
| GOBP POSITIVE REGULATION OF BONE MINERALIZATION | 26 | 1.43e-02 | -2.78e-01 | 1.30e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL PROLIFERATION | 20 | 3.17e-02 | -2.78e-01 | 2.04e-01 |
| GOMF BETA GALACTOSIDE CMP ALPHA 2 3 SIALYLTRANSFERASE ACTIVITY | 6 | 2.39e-01 | -2.77e-01 | 5.73e-01 |
| GOMF PROTEIN ARGININE N METHYLTRANSFERASE ACTIVITY | 11 | 1.11e-01 | -2.77e-01 | 3.91e-01 |
| GOBP REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 18 | 4.18e-02 | -2.77e-01 | 2.37e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 10 | 1.29e-01 | -2.77e-01 | 4.21e-01 |
| GOCC ACTIN FILAMENT BUNDLE | 64 | 1.27e-04 | 2.77e-01 | 4.56e-03 |
| GOBP REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 8 | 1.75e-01 | -2.77e-01 | 4.90e-01 |
| GOCC ATPASE DEPENDENT TRANSMEMBRANE TRANSPORT COMPLEX | 11 | 1.12e-01 | 2.77e-01 | 3.92e-01 |
| GOBP OVULATION CYCLE | 42 | 1.91e-03 | -2.77e-01 | 3.45e-02 |
| GOBP VITAMIN BIOSYNTHETIC PROCESS | 18 | 4.21e-02 | 2.77e-01 | 2.38e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 9 | 1.51e-01 | -2.77e-01 | 4.54e-01 |
| GOCC DOPAMINERGIC SYNAPSE | 6 | 2.41e-01 | 2.76e-01 | 5.75e-01 |
| GOMF STAT FAMILY PROTEIN BINDING | 8 | 1.76e-01 | -2.76e-01 | 4.91e-01 |
| GOBP LOCOMOTOR RHYTHM | 12 | 9.76e-02 | -2.76e-01 | 3.66e-01 |
| GOBP SISTER CHROMATID COHESION | 50 | 7.32e-04 | -2.76e-01 | 1.75e-02 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION | 16 | 5.59e-02 | -2.76e-01 | 2.72e-01 |
| GOBP COMMON MYELOID PROGENITOR CELL PROLIFERATION | 7 | 2.06e-01 | 2.76e-01 | 5.29e-01 |
| GOBP REGULATION OF MICROVILLUS ORGANIZATION | 11 | 1.13e-01 | -2.76e-01 | 3.95e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 6 | 2.42e-01 | -2.76e-01 | 5.75e-01 |
| GOBP REGULATION OF LYSOSOME SIZE | 8 | 1.77e-01 | 2.76e-01 | 4.92e-01 |
| GOCC BORC COMPLEX | 8 | 1.77e-01 | 2.76e-01 | 4.92e-01 |
| GOBP CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS | 32 | 6.93e-03 | -2.76e-01 | 8.29e-02 |
| GOMF PRE MRNA BINDING | 33 | 6.12e-03 | -2.76e-01 | 7.68e-02 |
| GOBP POSITIVE REGULATION OF CELL CYCLE CHECKPOINT | 17 | 4.90e-02 | -2.76e-01 | 2.58e-01 |
| GOMF PROTON TRANSPORTING ATP SYNTHASE ACTIVITY ROTATIONAL MECHANISM | 17 | 4.90e-02 | 2.76e-01 | 2.58e-01 |
| GOBP POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 25 | 1.70e-02 | -2.76e-01 | 1.45e-01 |
| GOCC TRANSCRIPTION REPRESSOR COMPLEX | 61 | 1.97e-04 | -2.76e-01 | 6.58e-03 |
| GOCC SIN3 TYPE COMPLEX | 22 | 2.52e-02 | -2.76e-01 | 1.79e-01 |
| GOMF MITOCHONDRIAL RIBOSOME BINDING | 8 | 1.77e-01 | 2.76e-01 | 4.92e-01 |
| GOBP REGULATION OF VIRAL GENOME REPLICATION | 73 | 4.73e-05 | -2.75e-01 | 2.20e-03 |
| GOBP FORMATION OF TRANSLATION PREINITIATION COMPLEX | 9 | 1.52e-01 | 2.75e-01 | 4.57e-01 |
| GOMF PH DOMAIN BINDING | 7 | 2.07e-01 | 2.75e-01 | 5.31e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS NAD P AS ACCEPTOR | 11 | 1.14e-01 | 2.75e-01 | 3.97e-01 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ASSEMBLY | 44 | 1.59e-03 | -2.75e-01 | 3.04e-02 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION REGENERATION | 8 | 1.78e-01 | -2.75e-01 | 4.93e-01 |
| GOMF ICOSANOID RECEPTOR ACTIVITY | 7 | 2.08e-01 | -2.75e-01 | 5.32e-01 |
| GOBP POSITIVE REGULATION OF HELICASE ACTIVITY | 7 | 2.08e-01 | -2.75e-01 | 5.32e-01 |
| GOBP GALACTOSE CATABOLIC PROCESS | 5 | 2.87e-01 | -2.75e-01 | 6.26e-01 |
| GOBP LEUCINE TRANSPORT | 8 | 1.79e-01 | 2.74e-01 | 4.94e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR CLUSTERING | 5 | 2.88e-01 | -2.74e-01 | 6.27e-01 |
| GOBP ATRIAL SEPTUM DEVELOPMENT | 13 | 8.72e-02 | -2.74e-01 | 3.45e-01 |
| GOMF CALCIUM ACTIVATED CATION CHANNEL ACTIVITY | 17 | 5.06e-02 | 2.74e-01 | 2.61e-01 |
| GOBP POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 13 | 8.73e-02 | 2.74e-01 | 3.45e-01 |
| GOBP POSITIVE REGULATION OF VIRAL LIFE CYCLE | 22 | 2.62e-02 | -2.74e-01 | 1.83e-01 |
| GOCC CRD MEDIATED MRNA STABILITY COMPLEX | 5 | 2.89e-01 | -2.74e-01 | 6.28e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE HYPERTROPHY | 21 | 3.00e-02 | -2.74e-01 | 1.97e-01 |
| GOBP INTRACILIARY ANTEROGRADE TRANSPORT | 17 | 5.09e-02 | 2.73e-01 | 2.62e-01 |
| GOBP POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 12 | 1.01e-01 | -2.73e-01 | 3.73e-01 |
| GOCC COMPACT MYELIN | 10 | 1.35e-01 | 2.73e-01 | 4.31e-01 |
| GOMF ALDEHYDE LYASE ACTIVITY | 6 | 2.47e-01 | 2.73e-01 | 5.81e-01 |
| GOMF FLAP ENDONUCLEASE ACTIVITY | 7 | 2.11e-01 | -2.73e-01 | 5.35e-01 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION | 11 | 1.17e-01 | 2.73e-01 | 4.01e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON DIPHENOLS AND RELATED SUBSTANCES AS DONORS | 8 | 1.81e-01 | 2.73e-01 | 4.98e-01 |
| GOBP RESPONSE TO FUNGUS | 31 | 8.58e-03 | -2.73e-01 | 9.42e-02 |
| GOCC ENZYME ACTIVATOR COMPLEX | 16 | 5.89e-02 | 2.73e-01 | 2.79e-01 |
| GOBP THERMOCEPTION | 6 | 2.48e-01 | -2.73e-01 | 5.82e-01 |
| GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 24 | 2.08e-02 | -2.73e-01 | 1.59e-01 |
| GOBP REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 11 | 1.18e-01 | -2.72e-01 | 4.02e-01 |
| GOMF ADENYLYLTRANSFERASE ACTIVITY | 25 | 1.84e-02 | -2.72e-01 | 1.50e-01 |
| GOBP CELLULAR EXTRAVASATION | 50 | 8.68e-04 | -2.72e-01 | 1.98e-02 |
| GOBP REGULATORY NCRNA PROCESSING | 64 | 1.69e-04 | -2.72e-01 | 5.72e-03 |
| GOBP TRANSFORMING GROWTH FACTOR BETA ACTIVATION | 7 | 2.13e-01 | 2.72e-01 | 5.38e-01 |
| GOBP POST CHAPERONIN TUBULIN FOLDING PATHWAY | 7 | 2.13e-01 | -2.72e-01 | 5.38e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 17 | 5.24e-02 | 2.72e-01 | 2.65e-01 |
| GOMF FAD BINDING | 34 | 6.16e-03 | 2.72e-01 | 7.72e-02 |
| GOMF CALCIUM DEPENDENT PHOSPHOLIPASE A2 ACTIVITY | 5 | 2.93e-01 | 2.71e-01 | 6.31e-01 |
| GOMF LONG CHAIN FATTY ACID BINDING | 12 | 1.04e-01 | 2.71e-01 | 3.77e-01 |
| GOBP REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 8 | 1.84e-01 | -2.71e-01 | 5.01e-01 |
| GOMF CYCLOHYDROLASE ACTIVITY | 5 | 2.94e-01 | -2.71e-01 | 6.32e-01 |
| GOBP POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 15 | 6.90e-02 | -2.71e-01 | 3.04e-01 |
| GOMF VITAMIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 21 | 3.16e-02 | 2.71e-01 | 2.03e-01 |
| GOMF NUCLEOSOME BINDING | 52 | 7.27e-04 | -2.71e-01 | 1.74e-02 |
| GOMF PHOSPHATIDIC ACID BINDING | 16 | 6.06e-02 | -2.71e-01 | 2.84e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 17 | 5.32e-02 | 2.71e-01 | 2.66e-01 |
| GOCC CYTOCHROME COMPLEX | 32 | 8.02e-03 | 2.71e-01 | 9.03e-02 |
| GOBP SEQUESTERING OF IRON ION | 5 | 2.94e-01 | 2.71e-01 | 6.32e-01 |
| GOBP CELLULAR RESPONSE TO VITAMIN | 20 | 3.61e-02 | -2.71e-01 | 2.20e-01 |
| GOBP PHOSPHATIDYLCHOLINE CATABOLIC PROCESS | 13 | 9.11e-02 | 2.71e-01 | 3.53e-01 |
| GOBP POSITIVE REGULATION OF INTEGRIN ACTIVATION | 9 | 1.60e-01 | 2.71e-01 | 4.67e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION | 22 | 2.80e-02 | -2.71e-01 | 1.90e-01 |
| GOBP FATTY ACYL COA METABOLIC PROCESS | 32 | 8.12e-03 | 2.70e-01 | 9.11e-02 |
| GOBP T HELPER 17 CELL DIFFERENTIATION | 23 | 2.48e-02 | -2.70e-01 | 1.78e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 8 | 1.86e-01 | 2.70e-01 | 5.03e-01 |
| GOBP LYMPHOCYTE ANERGY | 5 | 2.95e-01 | -2.70e-01 | 6.33e-01 |
| GOMF SUMO POLYMER BINDING | 6 | 2.52e-01 | -2.70e-01 | 5.87e-01 |
| GOBP NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 5 | 2.96e-01 | -2.70e-01 | 6.33e-01 |
| GOMF POLY G BINDING | 8 | 1.86e-01 | -2.70e-01 | 5.03e-01 |
| GOCC HISTONE DEACETYLASE COMPLEX | 76 | 4.73e-05 | -2.70e-01 | 2.20e-03 |
| GOMF SINGLE STRANDED RNA BINDING | 69 | 1.06e-04 | -2.70e-01 | 4.02e-03 |
| GOBP MYOTUBE DIFFERENTIATION INVOLVED IN SKELETAL MUSCLE REGENERATION | 6 | 2.53e-01 | 2.70e-01 | 5.87e-01 |
| GOMF FRUCTOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 2.17e-01 | 2.70e-01 | 5.43e-01 |
| GOBP SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY | 9 | 1.61e-01 | -2.70e-01 | 4.70e-01 |
| GOBP NEUTROPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 18 | 4.78e-02 | -2.70e-01 | 2.54e-01 |
| GOBP PROTEIN INSERTION INTO MEMBRANE | 69 | 1.09e-04 | 2.69e-01 | 4.08e-03 |
| GOBP POSITIVE REGULATION OF VASOCONSTRICTION | 16 | 6.22e-02 | -2.69e-01 | 2.88e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMATIN | 36 | 5.18e-03 | -2.69e-01 | 6.96e-02 |
| GOBP REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS | 8 | 1.88e-01 | 2.69e-01 | 5.06e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION | 17 | 5.49e-02 | -2.69e-01 | 2.69e-01 |
| GOBP POSITIVE REGULATION OF INTERFERON BETA PRODUCTION | 36 | 5.26e-03 | -2.69e-01 | 7.00e-02 |
| GOBP POSITIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 6 | 2.54e-01 | -2.69e-01 | 5.89e-01 |
| GOBP T CELL EXTRAVASATION | 11 | 1.23e-01 | -2.69e-01 | 4.11e-01 |
| GOBP REGULATION OF MICROTUBULE DEPOLYMERIZATION | 25 | 2.01e-02 | -2.69e-01 | 1.57e-01 |
| GOBP TRYPTOPHAN CATABOLIC PROCESS | 8 | 1.88e-01 | -2.69e-01 | 5.07e-01 |
| GOBP IMMUNE RESPONSE INHIBITING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 6 | 2.55e-01 | 2.69e-01 | 5.90e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C | 13 | 9.37e-02 | 2.69e-01 | 3.61e-01 |
| GOCC RESPIRATORY CHAIN COMPLEX IV | 20 | 3.77e-02 | 2.68e-01 | 2.25e-01 |
| GOBP REGULATION OF HISTONE MODIFICATION | 35 | 6.00e-03 | -2.68e-01 | 7.65e-02 |
| GOBP REGULATION OF RESPIRATORY SYSTEM PROCESS | 9 | 1.63e-01 | -2.68e-01 | 4.73e-01 |
| GOBP GLYCOSAMINOGLYCAN CATABOLIC PROCESS | 19 | 4.29e-02 | -2.68e-01 | 2.40e-01 |
| GOMF MANNOSE BINDING | 13 | 9.43e-02 | -2.68e-01 | 3.62e-01 |
| GOBP NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 46 | 1.67e-03 | -2.68e-01 | 3.14e-02 |
| GOBP POSITIVE REGULATION OF SYNAPTIC PLASTICITY | 8 | 1.90e-01 | -2.68e-01 | 5.09e-01 |
| GOMF LYSINE N METHYLTRANSFERASE ACTIVITY | 55 | 5.95e-04 | -2.68e-01 | 1.50e-02 |
| GOCC HIGH DENSITY LIPOPROTEIN PARTICLE | 15 | 7.27e-02 | -2.68e-01 | 3.15e-01 |
| GOCC CIS GOLGI NETWORK MEMBRANE | 8 | 1.90e-01 | 2.68e-01 | 5.09e-01 |
| GOMF HISTONE H4 METHYLTRANSFERASE ACTIVITY | 15 | 7.30e-02 | -2.67e-01 | 3.16e-01 |
| GOBP MICROGLIAL CELL PROLIFERATION | 5 | 3.01e-01 | 2.67e-01 | 6.39e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 46 | 1.72e-03 | -2.67e-01 | 3.19e-02 |
| GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 83 | 2.60e-05 | -2.67e-01 | 1.32e-03 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 8 | 1.91e-01 | 2.67e-01 | 5.10e-01 |
| GOBP POSITIVE REGULATION OF OSSIFICATION | 32 | 8.97e-03 | -2.67e-01 | 9.75e-02 |
| GOBP REGULATION OF MUSCLE ORGAN DEVELOPMENT | 9 | 1.66e-01 | -2.67e-01 | 4.77e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 12 | 1.09e-01 | -2.67e-01 | 3.88e-01 |
| GOCC MULTIVESICULAR BODY MEMBRANE | 24 | 2.36e-02 | 2.67e-01 | 1.72e-01 |
| GOBP PROTEIN LOCALIZATION TO SITE OF DOUBLE STRAND BREAK | 6 | 2.58e-01 | -2.67e-01 | 5.93e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID TRANSPORT | 10 | 1.44e-01 | -2.67e-01 | 4.45e-01 |
| GOCC CYTOSOLIC RIBOSOME | 110 | 1.35e-06 | -2.67e-01 | 1.19e-04 |
| GOCC PROTEIN PHOSPHATASE TYPE 2A COMPLEX | 16 | 6.49e-02 | 2.67e-01 | 2.94e-01 |
| GOBP POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS | 40 | 3.54e-03 | -2.67e-01 | 5.36e-02 |
| GOCC CCR4 NOT CORE COMPLEX | 6 | 2.58e-01 | -2.66e-01 | 5.94e-01 |
| GOBP PHOSPHATE ION TRANSMEMBRANE TRANSPORT | 14 | 8.45e-02 | 2.66e-01 | 3.41e-01 |
| GOBP RESPONSE TO TESTOSTERONE | 30 | 1.16e-02 | -2.66e-01 | 1.14e-01 |
| GOBP CELLULAR RESPONSE TO MANGANESE ION | 8 | 1.92e-01 | 2.66e-01 | 5.11e-01 |
| GOBP NEURON FATE COMMITMENT | 18 | 5.05e-02 | -2.66e-01 | 2.61e-01 |
| GOMF HISTONE BINDING | 219 | 1.18e-11 | -2.66e-01 | 3.49e-09 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 9 | 1.67e-01 | 2.66e-01 | 4.79e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 BISPHOSPHATE BINDING | 22 | 3.09e-02 | -2.66e-01 | 2.01e-01 |
| GOBP REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 10 | 1.46e-01 | -2.66e-01 | 4.46e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN | 43 | 2.57e-03 | -2.66e-01 | 4.33e-02 |
| GOBP PLUS END DIRECTED ORGANELLE TRANSPORT ALONG MICROTUBULE | 7 | 2.24e-01 | 2.66e-01 | 5.52e-01 |
| GOBP IRIS MORPHOGENESIS | 5 | 3.04e-01 | -2.65e-01 | 6.43e-01 |
| GOBP SUCCINATE METABOLIC PROCESS | 5 | 3.04e-01 | -2.65e-01 | 6.43e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 23 | 2.77e-02 | -2.65e-01 | 1.89e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR BINDING | 11 | 1.28e-01 | -2.65e-01 | 4.20e-01 |
| GOBP NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 19 | 4.55e-02 | -2.65e-01 | 2.48e-01 |
| GOBP REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 33 | 8.46e-03 | -2.65e-01 | 9.36e-02 |
| GOBP REGULATION OF NATURAL KILLER CELL ACTIVATION | 31 | 1.08e-02 | -2.65e-01 | 1.09e-01 |
| GOBP REGULATION OF DNA STRAND ELONGATION | 17 | 5.89e-02 | 2.65e-01 | 2.79e-01 |
| GOCC RESPIRASOME | 91 | 1.30e-05 | 2.65e-01 | 7.68e-04 |
| GOBP REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT | 10 | 1.48e-01 | 2.64e-01 | 4.49e-01 |
| GOBP CHROMATIN LOOPING | 11 | 1.29e-01 | -2.64e-01 | 4.21e-01 |
| GOBP REGULATION OF PROSTAGLANDIN SECRETION | 9 | 1.70e-01 | 2.64e-01 | 4.82e-01 |
| GOBP MYOBLAST FUSION | 31 | 1.09e-02 | 2.64e-01 | 1.09e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 18 | 5.22e-02 | -2.64e-01 | 2.64e-01 |
| GOBP SYNAPTIC VESICLE BUDDING | 8 | 1.96e-01 | -2.64e-01 | 5.15e-01 |
| GOBP ANTRAL OVARIAN FOLLICLE GROWTH | 7 | 2.26e-01 | -2.64e-01 | 5.55e-01 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION INITIATION | 14 | 8.72e-02 | -2.64e-01 | 3.45e-01 |
| GOBP PIGMENT ACCUMULATION | 10 | 1.48e-01 | 2.64e-01 | 4.50e-01 |
| GOBP PIGMENT GRANULE MATURATION | 10 | 1.48e-01 | 2.64e-01 | 4.50e-01 |
| GOMF MYRISTOYLTRANSFERASE ACTIVITY | 11 | 1.30e-01 | -2.64e-01 | 4.22e-01 |
| GOBP PEPTIDYL PROLINE HYDROXYLATION TO 4 HYDROXY L PROLINE | 8 | 1.96e-01 | 2.64e-01 | 5.16e-01 |
| GOMF PEPTIDYL PROLINE 4 DIOXYGENASE ACTIVITY | 8 | 1.96e-01 | 2.64e-01 | 5.16e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN WOUND HEALING | 5 | 3.07e-01 | 2.64e-01 | 6.46e-01 |
| GOBP REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 24 | 2.54e-02 | -2.64e-01 | 1.80e-01 |
| GOMF IMMUNOGLOBULIN RECEPTOR BINDING | 5 | 3.08e-01 | 2.63e-01 | 6.48e-01 |
| GOMF METHYLATION DEPENDENT PROTEIN BINDING | 75 | 8.27e-05 | -2.63e-01 | 3.40e-03 |
| GOBP POSITIVE REGULATION OF FEEDING BEHAVIOR | 5 | 3.09e-01 | 2.63e-01 | 6.48e-01 |
| GOBP RESPONSE TO WATER | 10 | 1.50e-01 | -2.63e-01 | 4.53e-01 |
| GOBP GDP METABOLIC PROCESS | 11 | 1.31e-01 | 2.63e-01 | 4.25e-01 |
| GOMF STRUCTURAL CONSTITUENT OF SYNAPSE | 15 | 7.81e-02 | 2.63e-01 | 3.29e-01 |
| GOBP FILOPODIUM ASSEMBLY | 54 | 8.41e-04 | -2.63e-01 | 1.94e-02 |
| GOBP CRD MEDIATED MRNA STABILIZATION | 10 | 1.50e-01 | -2.63e-01 | 4.53e-01 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR BINDING | 11 | 1.32e-01 | 2.62e-01 | 4.25e-01 |
| GOCC EUCHROMATIN | 44 | 2.60e-03 | -2.62e-01 | 4.35e-02 |
| GOBP RESPONSE TO GROWTH HORMONE | 25 | 2.33e-02 | -2.62e-01 | 1.71e-01 |
| GOBP POSITIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 6 | 2.66e-01 | -2.62e-01 | 6.03e-01 |
| GOMF CASPASE BINDING | 8 | 1.99e-01 | 2.62e-01 | 5.20e-01 |
| GOBP ARTERY DEVELOPMENT | 60 | 4.50e-04 | -2.62e-01 | 1.22e-02 |
| GOMF G PROTEIN ACTIVITY | 36 | 6.54e-03 | 2.62e-01 | 7.96e-02 |
| GOCC CCR4 NOT COMPLEX | 14 | 8.98e-02 | -2.62e-01 | 3.51e-01 |
| GOMF PEPTIDE N ACETYLTRANSFERASE ACTIVITY | 48 | 1.70e-03 | -2.62e-01 | 3.18e-02 |
| GOBP REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION | 7 | 2.30e-01 | -2.62e-01 | 5.61e-01 |
| GOMF PHOSPHATASE INHIBITOR ACTIVITY | 32 | 1.04e-02 | 2.62e-01 | 1.06e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION | 10 | 1.52e-01 | -2.62e-01 | 4.55e-01 |
| GOBP AMP METABOLIC PROCESS | 18 | 5.47e-02 | 2.62e-01 | 2.69e-01 |
| GOCC SIGNAL PEPTIDASE COMPLEX | 5 | 3.11e-01 | 2.62e-01 | 6.50e-01 |
| GOMF UBIQUINOL CYTOCHROME C REDUCTASE ACTIVITY | 6 | 2.67e-01 | 2.62e-01 | 6.04e-01 |
| GOBP HISTONE H4 ACETYLATION | 12 | 1.17e-01 | -2.62e-01 | 4.01e-01 |
| GOMF TRANSCRIPTION REGULATOR ACTIVATOR ACTIVITY | 5 | 3.11e-01 | -2.61e-01 | 6.50e-01 |
| GOBP SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION | 6 | 2.67e-01 | 2.61e-01 | 6.05e-01 |
| GOBP POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 18 | 5.49e-02 | -2.61e-01 | 2.69e-01 |
| GOBP OUTER MITOCHONDRIAL MEMBRANE ORGANIZATION | 15 | 7.97e-02 | 2.61e-01 | 3.32e-01 |
| GOBP RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 23 | 3.01e-02 | -2.61e-01 | 1.97e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 49 | 1.58e-03 | 2.61e-01 | 3.01e-02 |
| GOMF POLY PYRIMIDINE TRACT BINDING | 22 | 3.41e-02 | -2.61e-01 | 2.15e-01 |
| GOBP POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 80 | 5.50e-05 | -2.61e-01 | 2.49e-03 |
| GOMF ADENOSINE DEAMINASE ACTIVITY | 9 | 1.75e-01 | 2.61e-01 | 4.91e-01 |
| GOBP SYNAPTIC MEMBRANE ADHESION | 12 | 1.18e-01 | 2.61e-01 | 4.02e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 6 | 2.69e-01 | -2.61e-01 | 6.06e-01 |
| GOBP REGULATION OF CILIUM BEAT FREQUENCY INVOLVED IN CILIARY MOTILITY | 6 | 2.69e-01 | 2.60e-01 | 6.06e-01 |
| GOBP CARDIAC MUSCLE CELL CARDIAC MUSCLE CELL ADHESION | 5 | 3.13e-01 | -2.60e-01 | 6.52e-01 |
| GOBP PROTEIN LOCALIZATION TO AXON | 5 | 3.13e-01 | 2.60e-01 | 6.52e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOLYTIC PROCESS | 16 | 7.15e-02 | -2.60e-01 | 3.11e-01 |
| GOBP INTERLEUKIN 4 PRODUCTION | 22 | 3.47e-02 | -2.60e-01 | 2.16e-01 |
| GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY | 5 | 3.14e-01 | 2.60e-01 | 6.53e-01 |
| GOMF BICARBONATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 21 | 3.92e-02 | 2.60e-01 | 2.29e-01 |
| GOMF UBIQUITIN MODIFICATION DEPENDENT HISTONE BINDING | 6 | 2.70e-01 | -2.60e-01 | 6.07e-01 |
| GOCC SEX CHROMATIN | 5 | 3.15e-01 | 2.60e-01 | 6.54e-01 |
| GOBP REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 8 | 2.04e-01 | -2.60e-01 | 5.26e-01 |
| GOBP EPIGENETIC REGULATION OF GENE EXPRESSION | 186 | 1.08e-09 | -2.59e-01 | 2.52e-07 |
| GOBP NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 11 | 1.37e-01 | -2.59e-01 | 4.34e-01 |
| GOMF COPPER ION BINDING | 39 | 5.09e-03 | 2.59e-01 | 6.86e-02 |
| GOBP CELLULAR PIGMENTATION | 58 | 6.42e-04 | 2.59e-01 | 1.59e-02 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL PROLIFERATION | 8 | 2.04e-01 | -2.59e-01 | 5.27e-01 |
| GOMF HISTONE CHAPERONE ACTIVITY | 11 | 1.37e-01 | -2.59e-01 | 4.34e-01 |
| GOMF HISTONE METHYLTRANSFERASE BINDING | 14 | 9.35e-02 | -2.59e-01 | 3.61e-01 |
| GOMF MODIFIED AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 29 | 1.58e-02 | 2.59e-01 | 1.40e-01 |
| GOCC NUCLEAR EXOSOME RNASE COMPLEX | 12 | 1.21e-01 | 2.59e-01 | 4.06e-01 |
| GOBP LEUKOTRIENE TRANSPORT | 7 | 2.36e-01 | -2.59e-01 | 5.68e-01 |
| GOBP TRNA PSEUDOURIDINE SYNTHESIS | 6 | 2.73e-01 | 2.59e-01 | 6.09e-01 |
| GOBP VENTRICULAR SEPTUM MORPHOGENESIS | 26 | 2.25e-02 | -2.59e-01 | 1.67e-01 |
| GOBP MYOBLAST PROLIFERATION | 15 | 8.30e-02 | -2.59e-01 | 3.39e-01 |
| GOBP INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY | 16 | 7.34e-02 | -2.59e-01 | 3.17e-01 |
| GOBP MAMMARY GLAND MORPHOGENESIS | 24 | 2.84e-02 | -2.58e-01 | 1.91e-01 |
| GOBP L SERINE TRANSPORT | 6 | 2.73e-01 | -2.58e-01 | 6.09e-01 |
| GOMF L SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 2.73e-01 | -2.58e-01 | 6.09e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 11 | 1.38e-01 | 2.58e-01 | 4.36e-01 |
| GOBP POSITIVE REGULATION OF NECROPTOTIC PROCESS | 5 | 3.17e-01 | -2.58e-01 | 6.56e-01 |
| GOBP NEGATIVE REGULATION OF NEUROBLAST PROLIFERATION | 5 | 3.17e-01 | -2.58e-01 | 6.56e-01 |
| GOBP REGULATION OF GLYCOGEN CATABOLIC PROCESS | 6 | 2.73e-01 | 2.58e-01 | 6.09e-01 |
| GOBP REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 22 | 3.60e-02 | 2.58e-01 | 2.20e-01 |
| GOMF HEXOSAMINIDASE ACTIVITY | 13 | 1.07e-01 | -2.58e-01 | 3.83e-01 |
| GOMF ADENYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 15 | 8.35e-02 | 2.58e-01 | 3.40e-01 |
| GOMF 3 HYDROXYACYL COA DEHYDROGENASE ACTIVITY | 7 | 2.37e-01 | 2.58e-01 | 5.69e-01 |
| GOMF MHC PROTEIN COMPLEX BINDING | 28 | 1.82e-02 | -2.58e-01 | 1.49e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 8 | 2.07e-01 | -2.58e-01 | 5.30e-01 |
| GOBP REGULATION OF EXOSOMAL SECRETION | 17 | 6.58e-02 | 2.58e-01 | 2.96e-01 |
| GOBP NEUTROPHIL MEDIATED IMMUNITY | 25 | 2.58e-02 | -2.58e-01 | 1.81e-01 |
| GOBP PROLINE METABOLIC PROCESS | 6 | 2.75e-01 | 2.58e-01 | 6.11e-01 |
| GOBP CAMKK AMPK SIGNALING CASCADE | 6 | 2.75e-01 | 2.57e-01 | 6.11e-01 |
| GOCC MRNA EDITING COMPLEX | 13 | 1.09e-01 | -2.57e-01 | 3.86e-01 |
| GOBP POSITIVE REGULATION OF RNA SPLICING | 35 | 8.51e-03 | -2.57e-01 | 9.40e-02 |
| GOBP 7 METHYLGUANOSINE CAP HYPERMETHYLATION | 8 | 2.08e-01 | 2.57e-01 | 5.32e-01 |
| GOBP MEGAKARYOCYTE DIFFERENTIATION | 38 | 6.17e-03 | -2.57e-01 | 7.73e-02 |
| GOBP RAC PROTEIN SIGNAL TRANSDUCTION | 41 | 4.46e-03 | -2.57e-01 | 6.23e-02 |
| GOBP RESPONSE TO REDOX STATE | 11 | 1.41e-01 | 2.57e-01 | 4.40e-01 |
| GOBP OXIDATIVE PHOSPHORYLATION | 134 | 2.98e-07 | 2.57e-01 | 3.59e-05 |
| GOMF TRNA SPECIFIC ADENOSINE DEAMINASE ACTIVITY | 5 | 3.21e-01 | 2.57e-01 | 6.60e-01 |
| GOBP VIRAL TRANSLATION | 20 | 4.72e-02 | -2.56e-01 | 2.53e-01 |
| GOBP LYSOSOMAL MEMBRANE ORGANIZATION | 14 | 9.68e-02 | 2.56e-01 | 3.66e-01 |
| GOBP GLUCOCORTICOID SECRETION | 9 | 1.83e-01 | 2.56e-01 | 5.00e-01 |
| GOMF RETROMER COMPLEX BINDING | 9 | 1.83e-01 | 2.56e-01 | 5.00e-01 |
| GOBP NEGATIVE REGULATION OF CHROMOSOME SEGREGATION | 46 | 2.65e-03 | -2.56e-01 | 4.41e-02 |
| GOBP NEGATIVE REGULATION OF ERAD PATHWAY | 6 | 2.77e-01 | 2.56e-01 | 6.15e-01 |
| GOBP ESTABLISHMENT OF SISTER CHROMATID COHESION | 10 | 1.61e-01 | -2.56e-01 | 4.69e-01 |
| GOMF SOLUTE INORGANIC ANION ANTIPORTER ACTIVITY | 20 | 4.75e-02 | 2.56e-01 | 2.54e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX | 14 | 9.73e-02 | -2.56e-01 | 3.66e-01 |
| GOBP PML BODY ORGANIZATION | 6 | 2.78e-01 | 2.56e-01 | 6.15e-01 |
| GOMF CYCLASE ACTIVATOR ACTIVITY | 7 | 2.41e-01 | 2.56e-01 | 5.75e-01 |
| GOBP REGULATION OF METALLOENDOPEPTIDASE ACTIVITY | 6 | 2.78e-01 | -2.56e-01 | 6.15e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT | 9 | 1.84e-01 | 2.56e-01 | 5.01e-01 |
| GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY | 5 | 3.22e-01 | -2.56e-01 | 6.61e-01 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY | 36 | 7.94e-03 | -2.56e-01 | 8.99e-02 |
| GOBP ANTIVIRAL INNATE IMMUNE RESPONSE | 40 | 5.14e-03 | -2.56e-01 | 6.92e-02 |
| GOMF CLATHRIN HEAVY CHAIN BINDING | 9 | 1.84e-01 | -2.56e-01 | 5.01e-01 |
| GOBP SERINE FAMILY AMINO ACID CATABOLIC PROCESS | 9 | 1.84e-01 | 2.56e-01 | 5.01e-01 |
| GOBP POSITIVE REGULATION OF SYNAPSE ASSEMBLY | 29 | 1.72e-02 | -2.56e-01 | 1.46e-01 |
| GOCC SMOOTH ENDOPLASMIC RETICULUM MEMBRANE | 5 | 3.22e-01 | 2.56e-01 | 6.62e-01 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 12 | 1.26e-01 | -2.55e-01 | 4.16e-01 |
| GOBP REGULATION OF NUCLEOTIDE EXCISION REPAIR | 26 | 2.42e-02 | -2.55e-01 | 1.75e-01 |
| GOBP SIRNA PROCESSING | 8 | 2.11e-01 | -2.55e-01 | 5.35e-01 |
| GOCC COPI COATED VESICLE | 23 | 3.42e-02 | 2.55e-01 | 2.15e-01 |
| GOCC M BAND | 18 | 6.10e-02 | 2.55e-01 | 2.85e-01 |
| GOBP PIGMENT METABOLIC PROCESS | 55 | 1.07e-03 | 2.55e-01 | 2.31e-02 |
| GOBP METANEPHRIC EPITHELIUM DEVELOPMENT | 13 | 1.11e-01 | 2.55e-01 | 3.91e-01 |
| GOBP CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS | 39 | 5.87e-03 | -2.55e-01 | 7.58e-02 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 6 | 2.80e-01 | -2.55e-01 | 6.17e-01 |
| GOBP MONOACYLGLYCEROL CATABOLIC PROCESS | 6 | 2.80e-01 | 2.55e-01 | 6.17e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE REGULATOR ACTIVITY | 43 | 3.85e-03 | -2.55e-01 | 5.65e-02 |
| GOBP REGULATION OF CONNECTIVE TISSUE REPLACEMENT | 5 | 3.24e-01 | -2.55e-01 | 6.62e-01 |
| GOBP SOMATIC STEM CELL DIVISION | 7 | 2.43e-01 | 2.55e-01 | 5.77e-01 |
| GOBP CHAPERONE MEDIATED AUTOPHAGY | 13 | 1.12e-01 | 2.55e-01 | 3.92e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 18 | 6.14e-02 | -2.55e-01 | 2.87e-01 |
| GOBP FATTY ACID DERIVATIVE METABOLIC PROCESS | 48 | 2.29e-03 | 2.54e-01 | 3.98e-02 |
| GOBP REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 13 | 1.12e-01 | 2.54e-01 | 3.93e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE P38 BINDING | 7 | 2.44e-01 | -2.54e-01 | 5.77e-01 |
| GOBP OVULATION CYCLE PROCESS | 28 | 1.99e-02 | -2.54e-01 | 1.56e-01 |
| GOBP COPPER ION TRANSPORT | 14 | 9.97e-02 | 2.54e-01 | 3.69e-01 |
| GOBP COCHLEA MORPHOGENESIS | 6 | 2.81e-01 | 2.54e-01 | 6.19e-01 |
| GOBP REGULATION OF ASTROCYTE DIFFERENTIATION | 17 | 6.98e-02 | 2.54e-01 | 3.06e-01 |
| GOBP SULFUR AMINO ACID CATABOLIC PROCESS | 6 | 2.81e-01 | -2.54e-01 | 6.19e-01 |
| GOCC NSL COMPLEX | 11 | 1.45e-01 | -2.54e-01 | 4.45e-01 |
| GOBP OSTEOCLAST PROLIFERATION | 7 | 2.45e-01 | 2.54e-01 | 5.79e-01 |
| GOBP DEHYDROASCORBIC ACID TRANSPORT | 5 | 3.26e-01 | 2.54e-01 | 6.63e-01 |
| GOMF DEHYDROASCORBIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 3.26e-01 | 2.54e-01 | 6.63e-01 |
| GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN | 9 | 1.88e-01 | 2.54e-01 | 5.06e-01 |
| GOBP RESPONSE TO KETONE | 129 | 6.63e-07 | -2.54e-01 | 6.55e-05 |
| GOBP SYNAPTIC VESICLE DOCKING | 7 | 2.45e-01 | 2.54e-01 | 5.79e-01 |
| GOMF PHOSPHATIDYLINOSITOL KINASE ACTIVITY | 24 | 3.16e-02 | -2.54e-01 | 2.03e-01 |
| GOBP POSITIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 5 | 3.26e-01 | 2.53e-01 | 6.63e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 7 | 2.46e-01 | 2.53e-01 | 5.79e-01 |
| GOBP CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS | 17 | 7.05e-02 | -2.53e-01 | 3.08e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR INTERNALIZATION | 7 | 2.46e-01 | -2.53e-01 | 5.79e-01 |
| GOMF PHOSPHATIDYLCHOLINE TRANSPORTER ACTIVITY | 16 | 7.93e-02 | -2.53e-01 | 3.32e-01 |
| GOBP ACTIVATED T CELL PROLIFERATION | 34 | 1.06e-02 | -2.53e-01 | 1.07e-01 |
| GOCC CIA COMPLEX | 5 | 3.27e-01 | 2.53e-01 | 6.63e-01 |
| GOBP REGULATION OF RESPIRATORY BURST | 13 | 1.14e-01 | -2.53e-01 | 3.97e-01 |
| GOBP EXTRACELLULAR VESICLE BIOGENESIS | 22 | 3.99e-02 | 2.53e-01 | 2.31e-01 |
| GOCC NURD COMPLEX | 15 | 8.98e-02 | -2.53e-01 | 3.51e-01 |
| GOBP REGULATION OF T HELPER CELL DIFFERENTIATION | 33 | 1.20e-02 | -2.53e-01 | 1.16e-01 |
| GOBP POSITIVE REGULATION OF EXOSOMAL SECRETION | 13 | 1.15e-01 | 2.53e-01 | 3.98e-01 |
| GOBP DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION | 15 | 9.05e-02 | -2.52e-01 | 3.52e-01 |
| GOBP INTESTINAL ABSORPTION | 23 | 3.61e-02 | 2.52e-01 | 2.20e-01 |
| GOBP SYNAPTIC VESICLE CLUSTERING | 9 | 1.90e-01 | 2.52e-01 | 5.09e-01 |
| GOCC PERICENTRIC HETEROCHROMATIN | 29 | 1.86e-02 | -2.52e-01 | 1.51e-01 |
| GOMF SH2 DOMAIN BINDING | 33 | 1.21e-02 | -2.52e-01 | 1.17e-01 |
| GOBP REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 12 | 1.30e-01 | -2.52e-01 | 4.23e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 7 | 2.48e-01 | -2.52e-01 | 5.82e-01 |
| GOMF NITRIC OXIDE SYNTHASE REGULATOR ACTIVITY | 5 | 3.29e-01 | -2.52e-01 | 6.66e-01 |
| GOBP REGULATION OF PRESYNAPSE ORGANIZATION | 16 | 8.09e-02 | 2.52e-01 | 3.35e-01 |
| GOCC MCRD MEDIATED MRNA STABILITY COMPLEX | 5 | 3.29e-01 | -2.52e-01 | 6.66e-01 |
| GOBP AMINE CATABOLIC PROCESS | 12 | 1.31e-01 | 2.52e-01 | 4.24e-01 |
| GOBP PYRIMIDINE NUCLEOBASE CATABOLIC PROCESS | 6 | 2.85e-01 | 2.52e-01 | 6.23e-01 |
| GOCC CANONICAL INFLAMMASOME COMPLEX | 14 | 1.03e-01 | -2.52e-01 | 3.76e-01 |
| GOBP PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE | 36 | 8.99e-03 | 2.52e-01 | 9.76e-02 |
| GOBP MUSCLE HYPERTROPHY | 56 | 1.13e-03 | -2.52e-01 | 2.41e-02 |
| GOBP IRON IMPORT INTO CELL | 5 | 3.30e-01 | 2.51e-01 | 6.67e-01 |
| GOMF SEQUENCE SPECIFIC MRNA BINDING | 8 | 2.18e-01 | -2.51e-01 | 5.46e-01 |
| GOBP REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 22 | 4.13e-02 | -2.51e-01 | 2.35e-01 |
| GOBP MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER | 13 | 1.17e-01 | -2.51e-01 | 4.01e-01 |
| GOBP CARDIAC ATRIUM MORPHOGENESIS | 15 | 9.22e-02 | -2.51e-01 | 3.56e-01 |
| GOBP PROTON MOTIVE FORCE DRIVEN ATP SYNTHESIS | 73 | 2.08e-04 | 2.51e-01 | 6.79e-03 |
| GOBP REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 13 | 1.17e-01 | -2.51e-01 | 4.01e-01 |
| GOBP REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION | 51 | 1.93e-03 | -2.51e-01 | 3.47e-02 |
| GOMF MHC CLASS IB PROTEIN BINDING | 5 | 3.31e-01 | 2.51e-01 | 6.67e-01 |
| GOBP CELLULAR RESPONSE TO KETONE | 69 | 3.13e-04 | -2.51e-01 | 9.14e-03 |
| GOMF HISTONE H3K4ME H3K4ME2 H3K4ME3 DEMETHYLASE ACTIVITY | 5 | 3.31e-01 | -2.51e-01 | 6.67e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION | 13 | 1.17e-01 | 2.51e-01 | 4.01e-01 |
| GOBP PROTEIN RETENTION IN ER LUMEN | 7 | 2.51e-01 | 2.51e-01 | 5.85e-01 |
| GOBP SECONDARY PALATE DEVELOPMENT | 13 | 1.18e-01 | -2.51e-01 | 4.02e-01 |
| GOBP NEGATIVE REGULATION OF GLUCONEOGENESIS | 12 | 1.33e-01 | -2.51e-01 | 4.27e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 25 | 3.01e-02 | -2.51e-01 | 1.97e-01 |
| GOMF HELICASE ACTIVITY | 143 | 2.32e-07 | -2.51e-01 | 2.99e-05 |
| GOBP CHOLESTEROL STORAGE | 21 | 4.69e-02 | 2.51e-01 | 2.52e-01 |
| GOBP REGULATION OF BILE ACID SECRETION | 5 | 3.32e-01 | -2.50e-01 | 6.67e-01 |
| GOBP BRANCHED CHAIN AMINO ACID TRANSPORT | 10 | 1.70e-01 | 2.50e-01 | 4.84e-01 |
| GOBP DENSE CORE GRANULE LOCALIZATION | 6 | 2.88e-01 | 2.50e-01 | 6.27e-01 |
| GOBP GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT | 8 | 2.20e-01 | 2.50e-01 | 5.48e-01 |
| GOCC DYNEIN AXONEMAL PARTICLE | 10 | 1.71e-01 | 2.50e-01 | 4.84e-01 |
| GOBP RESPONSE TO INTERFERON ALPHA | 16 | 8.32e-02 | -2.50e-01 | 3.40e-01 |
| GOBP UTP METABOLIC PROCESS | 11 | 1.51e-01 | 2.50e-01 | 4.54e-01 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 14 | 1.05e-01 | -2.50e-01 | 3.81e-01 |
| GOBP NUCLEOBASE BIOSYNTHETIC PROCESS | 17 | 7.44e-02 | 2.50e-01 | 3.19e-01 |
| GOBP NEGATIVE REGULATION OF MRNA METABOLIC PROCESS | 78 | 1.37e-04 | -2.50e-01 | 4.86e-03 |
| GOBP CARDIAC MUSCLE CELL PROLIFERATION | 27 | 2.47e-02 | -2.50e-01 | 1.77e-01 |
| GOMF MRNA 3 UTR BINDING | 86 | 6.30e-05 | -2.50e-01 | 2.77e-03 |
| GOBP EXPLORATION BEHAVIOR | 13 | 1.19e-01 | -2.50e-01 | 4.03e-01 |
| GOBP REGULATION OF MRNA METABOLIC PROCESS | 252 | 9.35e-12 | -2.50e-01 | 2.87e-09 |
| GOMF PHOSPHOLIPID SCRAMBLASE ACTIVITY | 10 | 1.72e-01 | -2.50e-01 | 4.86e-01 |
| GOBP RNA EXPORT FROM NUCLEUS | 83 | 8.51e-05 | -2.50e-01 | 3.44e-03 |
| GOMF ATP GATED ION CHANNEL ACTIVITY | 6 | 2.90e-01 | 2.49e-01 | 6.29e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 10 | 1.72e-01 | -2.49e-01 | 4.86e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 6 | 2.90e-01 | 2.49e-01 | 6.29e-01 |
| GOBP REGULATION OF ACYL COA BIOSYNTHETIC PROCESS | 5 | 3.35e-01 | 2.49e-01 | 6.70e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION | 11 | 1.52e-01 | 2.49e-01 | 4.57e-01 |
| GOMF CHEMOKINE BINDING | 19 | 6.01e-02 | 2.49e-01 | 2.84e-01 |
| GOCC EMC COMPLEX | 10 | 1.73e-01 | 2.49e-01 | 4.87e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 9 | 1.96e-01 | -2.49e-01 | 5.15e-01 |
| GOMF CO RECEPTOR BINDING | 5 | 3.35e-01 | 2.49e-01 | 6.70e-01 |
| GOBP LYSOSOMAL PROTEIN CATABOLIC PROCESS | 17 | 7.55e-02 | 2.49e-01 | 3.22e-01 |
| GOMF PROTEIN LYSINE DEACETYLASE ACTIVITY | 23 | 3.88e-02 | -2.49e-01 | 2.28e-01 |
| GOMF MICROTUBULE SEVERING ATPASE ACTIVITY | 5 | 3.35e-01 | -2.49e-01 | 6.70e-01 |
| GOBP CELLULAR RESPONSE TO PARATHYROID HORMONE STIMULUS | 6 | 2.91e-01 | -2.49e-01 | 6.30e-01 |
| GOBP REGULATION OF OVARIAN FOLLICLE DEVELOPMENT | 5 | 3.36e-01 | 2.49e-01 | 6.70e-01 |
| GOBP CRANIAL NERVE MORPHOGENESIS | 14 | 1.07e-01 | -2.48e-01 | 3.84e-01 |
| GOMF MISMATCH REPAIR COMPLEX BINDING | 10 | 1.74e-01 | -2.48e-01 | 4.89e-01 |
| GOBP MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 72 | 2.69e-04 | -2.48e-01 | 8.22e-03 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS | 14 | 1.08e-01 | 2.48e-01 | 3.84e-01 |
| GOBP VESICLE TETHERING TO GOLGI | 5 | 3.36e-01 | -2.48e-01 | 6.71e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 28 | 2.30e-02 | -2.48e-01 | 1.70e-01 |
| GOBP SERINE PHOSPHORYLATION OF STAT PROTEIN | 6 | 2.93e-01 | 2.48e-01 | 6.31e-01 |
| GOMF ESTRADIOL 17 BETA DEHYDROGENASE NAD P ACTIVITY | 13 | 1.22e-01 | 2.48e-01 | 4.09e-01 |
| GOBP REGULATION OF CHROMOSOME CONDENSATION | 11 | 1.55e-01 | -2.48e-01 | 4.60e-01 |
| GOCC H4 HISTONE ACETYLTRANSFERASE COMPLEX | 36 | 1.01e-02 | -2.48e-01 | 1.05e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE ADAPTATION | 6 | 2.94e-01 | -2.48e-01 | 6.32e-01 |
| GOMF LONG CHAIN FATTY ACID TRANSPORTER ACTIVITY | 13 | 1.23e-01 | 2.47e-01 | 4.11e-01 |
| GOBP RHODOPSIN MEDIATED SIGNALING PATHWAY | 9 | 1.99e-01 | 2.47e-01 | 5.20e-01 |
| GOCC AXON HILLOCK | 7 | 2.58e-01 | 2.47e-01 | 5.94e-01 |
| GOBP PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS | 41 | 6.27e-03 | 2.47e-01 | 7.83e-02 |
| GOBP REGULATION OF SISTER CHROMATID COHESION | 14 | 1.10e-01 | -2.47e-01 | 3.89e-01 |
| GOBP RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 12 | 1.39e-01 | -2.47e-01 | 4.37e-01 |
| GOCC ASTER | 9 | 2.00e-01 | 2.47e-01 | 5.22e-01 |
| GOBP TRNA 3 END PROCESSING | 7 | 2.59e-01 | 2.47e-01 | 5.94e-01 |
| GOBP INOSITOL PHOSPHATE METABOLIC PROCESS | 28 | 2.40e-02 | -2.46e-01 | 1.74e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 11 | 1.57e-01 | -2.46e-01 | 4.63e-01 |
| GOMF D1 DOPAMINE RECEPTOR BINDING | 5 | 3.40e-01 | -2.46e-01 | 6.76e-01 |
| GOMF BHLH TRANSCRIPTION FACTOR BINDING | 23 | 4.08e-02 | -2.46e-01 | 2.34e-01 |
| GOMF CCR CHEMOKINE RECEPTOR BINDING | 18 | 7.03e-02 | 2.46e-01 | 3.08e-01 |
| GOBP RESPONSE TO COBALT ION | 10 | 1.77e-01 | -2.46e-01 | 4.92e-01 |
| GOMF PEPTIDE ANTIGEN BINDING | 31 | 1.77e-02 | -2.46e-01 | 1.48e-01 |
| GOBP NEGATIVE REGULATION OF BMP SIGNALING PATHWAY | 34 | 1.30e-02 | -2.46e-01 | 1.22e-01 |
| GOBP REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 39 | 7.81e-03 | 2.46e-01 | 8.88e-02 |
| GOBP INTRA GOLGI VESICLE MEDIATED TRANSPORT | 30 | 1.97e-02 | 2.46e-01 | 1.55e-01 |
| GOCC ORGANELLE INNER MEMBRANE | 491 | 1.21e-20 | 2.46e-01 | 8.93e-18 |
| GOMF MECHANOSENSITIVE MONOATOMIC ION CHANNEL ACTIVITY | 10 | 1.78e-01 | 2.46e-01 | 4.93e-01 |
| GOBP VIRAL GENOME REPLICATION | 114 | 5.99e-06 | -2.46e-01 | 4.06e-04 |
| GOMF SINGLE STRANDED DNA BINDING | 113 | 6.60e-06 | -2.46e-01 | 4.31e-04 |
| GOBP CHROMATIN REMODELING | 500 | 7.46e-21 | -2.45e-01 | 6.63e-18 |
| GOMF PHOSPHATIDYLGLYCEROL BINDING | 11 | 1.59e-01 | -2.45e-01 | 4.65e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION | 11 | 1.59e-01 | -2.45e-01 | 4.65e-01 |
| GOBP THYMIC T CELL SELECTION | 11 | 1.59e-01 | -2.45e-01 | 4.65e-01 |
| GOBP RESPONSE TO L PHENYLALANINE DERIVATIVE | 5 | 3.43e-01 | -2.45e-01 | 6.79e-01 |
| GOBP AXIS ELONGATION | 12 | 1.42e-01 | -2.45e-01 | 4.42e-01 |
| GOBP REGULATION OF RHODOPSIN MEDIATED SIGNALING PATHWAY | 7 | 2.62e-01 | 2.45e-01 | 5.98e-01 |
| GOBP MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION | 7 | 2.62e-01 | -2.45e-01 | 5.98e-01 |
| GOMF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 19 | 6.48e-02 | -2.45e-01 | 2.93e-01 |
| GOCC PML BODY | 100 | 2.37e-05 | -2.45e-01 | 1.24e-03 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON DNA | 112 | 7.77e-06 | -2.45e-01 | 4.88e-04 |
| GOBP POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT | 13 | 1.27e-01 | -2.45e-01 | 4.18e-01 |
| GOBP TAIL ANCHORED MEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 17 | 8.08e-02 | 2.45e-01 | 3.35e-01 |
| GOMF RACEMASE AND EPIMERASE ACTIVITY ACTING ON CARBOHYDRATES AND DERIVATIVES | 9 | 2.04e-01 | 2.45e-01 | 5.26e-01 |
| GOBP POSITIVE T CELL SELECTION | 26 | 3.09e-02 | -2.45e-01 | 2.01e-01 |
| GOMF LAMININ BINDING | 16 | 9.06e-02 | 2.44e-01 | 3.52e-01 |
| GOBP INTERFERON BETA PRODUCTION | 53 | 2.09e-03 | -2.44e-01 | 3.69e-02 |
| GOMF FERROUS IRON TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 3.00e-01 | 2.44e-01 | 6.39e-01 |
| GOBP NEGATIVE REGULATION OF DNA BINDING | 25 | 3.46e-02 | -2.44e-01 | 2.16e-01 |
| GOBP IRON ION TRANSPORT | 42 | 6.19e-03 | 2.44e-01 | 7.73e-02 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 21 | 5.27e-02 | -2.44e-01 | 2.65e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIARY MEMBRANE | 10 | 1.82e-01 | 2.44e-01 | 4.98e-01 |
| GOBP REGULATION OF HEART GROWTH | 32 | 1.72e-02 | -2.43e-01 | 1.46e-01 |
| GOBP ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 92 | 5.51e-05 | 2.43e-01 | 2.49e-03 |
| GOMF MUTSALPHA COMPLEX BINDING | 6 | 3.02e-01 | -2.43e-01 | 6.41e-01 |
| GOBP PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION | 9 | 2.06e-01 | 2.43e-01 | 5.30e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 6 | 3.02e-01 | -2.43e-01 | 6.41e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO LYSOSOME | 5 | 3.46e-01 | -2.43e-01 | 6.82e-01 |
| GOCC APICOLATERAL PLASMA MEMBRANE | 12 | 1.45e-01 | 2.43e-01 | 4.45e-01 |
| GOBP NEGATIVE REGULATION OF ORGAN GROWTH | 21 | 5.39e-02 | -2.43e-01 | 2.67e-01 |
| GOBP HISTONE MRNA CATABOLIC PROCESS | 15 | 1.03e-01 | -2.43e-01 | 3.76e-01 |
| GOBP BINDING OF SPERM TO ZONA PELLUCIDA | 20 | 6.00e-02 | 2.43e-01 | 2.83e-01 |
| GOBP ENGULFMENT OF APOPTOTIC CELL | 9 | 2.07e-01 | 2.43e-01 | 5.31e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 65 | 7.10e-04 | 2.43e-01 | 1.71e-02 |
| GOBP NEGATIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 41 | 7.17e-03 | -2.43e-01 | 8.40e-02 |
| GOMF FOUR WAY JUNCTION HELICASE ACTIVITY | 6 | 3.03e-01 | -2.43e-01 | 6.43e-01 |
| GOBP GONADOTROPIN SECRETION | 5 | 3.48e-01 | -2.43e-01 | 6.83e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 17 | 8.37e-02 | -2.42e-01 | 3.40e-01 |
| GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 11 | 1.64e-01 | 2.42e-01 | 4.74e-01 |
| GOBP ADAPTATION OF SIGNALING PATHWAY | 13 | 1.30e-01 | -2.42e-01 | 4.23e-01 |
| GOMF MRNA 5 UTR BINDING | 23 | 4.43e-02 | -2.42e-01 | 2.45e-01 |
| GOBP CELL CELL ADHESION MEDIATED BY INTEGRIN | 14 | 1.17e-01 | 2.42e-01 | 4.01e-01 |
| GOMF ALPHA ACTININ BINDING | 17 | 8.41e-02 | 2.42e-01 | 3.40e-01 |
| GOBP PROTEIN POLY ADP RIBOSYLATION | 10 | 1.85e-01 | -2.42e-01 | 5.02e-01 |
| GOCC HISTONE METHYLTRANSFERASE COMPLEX | 61 | 1.09e-03 | -2.42e-01 | 2.33e-02 |
| GOBP GLUCOCORTICOID BIOSYNTHETIC PROCESS | 6 | 3.05e-01 | -2.42e-01 | 6.44e-01 |
| GOBP REGULATION OF GLUCOCORTICOID BIOSYNTHETIC PROCESS | 6 | 3.05e-01 | -2.42e-01 | 6.44e-01 |
| GOBP NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 10 | 1.86e-01 | -2.42e-01 | 5.03e-01 |
| GOBP CLEARANCE OF FOREIGN INTRACELLULAR NUCLEIC ACIDS | 5 | 3.50e-01 | 2.41e-01 | 6.85e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 11 | 1.66e-01 | 2.41e-01 | 4.77e-01 |
| GOBP MITOCHONDRIAL FUSION | 32 | 1.82e-02 | 2.41e-01 | 1.49e-01 |
| GOMF FERROUS IRON BINDING | 21 | 5.58e-02 | 2.41e-01 | 2.72e-01 |
| GOCC TRNA SPLICING LIGASE COMPLEX | 8 | 2.38e-01 | 2.41e-01 | 5.70e-01 |
| GOBP REGULATION OF CHROMOSOME SEGREGATION | 118 | 6.17e-06 | -2.41e-01 | 4.07e-04 |
| GOBP FOREGUT MORPHOGENESIS | 6 | 3.07e-01 | -2.41e-01 | 6.46e-01 |
| GOBP MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON | 7 | 2.70e-01 | 2.41e-01 | 6.07e-01 |
| GOBP REGULATION OF ENDOSOME SIZE | 13 | 1.33e-01 | 2.41e-01 | 4.27e-01 |
| GOBP TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 133 | 1.69e-06 | -2.41e-01 | 1.42e-04 |
| GOBP THYROID GLAND DEVELOPMENT | 17 | 8.60e-02 | -2.41e-01 | 3.44e-01 |
| GOBP LACTATE METABOLIC PROCESS | 16 | 9.58e-02 | 2.41e-01 | 3.65e-01 |
| GOBP SYNAPTIC VESICLE RECYCLING VIA ENDOSOME | 5 | 3.52e-01 | -2.40e-01 | 6.87e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 23 | 4.59e-02 | 2.40e-01 | 2.49e-01 |
| GOCC PROTEASOME COMPLEX | 58 | 1.54e-03 | 2.40e-01 | 2.97e-02 |
| GOBP REGULATION OF AEROBIC RESPIRATION | 29 | 2.51e-02 | 2.40e-01 | 1.79e-01 |
| GOBP TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 16 | 9.62e-02 | 2.40e-01 | 3.66e-01 |
| GOBP REGULATION OF GAMMA DELTA T CELL ACTIVATION | 9 | 2.12e-01 | -2.40e-01 | 5.37e-01 |
| GOBP SEROTONIN METABOLIC PROCESS | 7 | 2.71e-01 | -2.40e-01 | 6.08e-01 |
| GOBP POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 7 | 2.71e-01 | -2.40e-01 | 6.08e-01 |
| GOCC CCAAT BINDING FACTOR COMPLEX | 5 | 3.52e-01 | -2.40e-01 | 6.87e-01 |
| GOMF I SMAD BINDING | 14 | 1.20e-01 | -2.40e-01 | 4.05e-01 |
| GOCC RAGULATOR COMPLEX | 5 | 3.53e-01 | 2.40e-01 | 6.87e-01 |
| GOMF METALLOENDOPEPTIDASE INHIBITOR ACTIVITY | 11 | 1.68e-01 | 2.40e-01 | 4.81e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID BETA CLEARANCE | 6 | 3.09e-01 | 2.40e-01 | 6.49e-01 |
| GOBP CYCLIC NUCLEOTIDE TRANSPORT | 8 | 2.40e-01 | -2.40e-01 | 5.74e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA | 5 | 3.53e-01 | -2.40e-01 | 6.87e-01 |
| GOBP ACROSOME REACTION | 16 | 9.71e-02 | 2.40e-01 | 3.66e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT ENDOSOME TO POSTSYNAPTIC MEMBRANE | 9 | 2.13e-01 | 2.40e-01 | 5.38e-01 |
| GOBP POSITIVE REGULATION OF SPROUTING ANGIOGENESIS | 14 | 1.21e-01 | 2.40e-01 | 4.06e-01 |
| GOBP SECRETION BY TISSUE | 21 | 5.75e-02 | 2.39e-01 | 2.76e-01 |
| GOBP MRNA PSEUDOURIDINE SYNTHESIS | 9 | 2.14e-01 | 2.39e-01 | 5.38e-01 |
| GOBP COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY | 10 | 1.90e-01 | -2.39e-01 | 5.09e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 6 | 3.10e-01 | -2.39e-01 | 6.49e-01 |
| GOMF CYCLIN BINDING | 33 | 1.74e-02 | -2.39e-01 | 1.47e-01 |
| GOBP NOREPINEPHRINE METABOLIC PROCESS | 5 | 3.54e-01 | 2.39e-01 | 6.87e-01 |
| GOBP INTRACELLULAR MRNA LOCALIZATION | 11 | 1.70e-01 | -2.39e-01 | 4.82e-01 |
| GOBP REGULATION OF TRANSLATION AT SYNAPSE | 6 | 3.11e-01 | -2.39e-01 | 6.50e-01 |
| GOCC SPINDLE MIDZONE | 34 | 1.59e-02 | 2.39e-01 | 1.40e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 16 | 9.79e-02 | 2.39e-01 | 3.66e-01 |
| GOBP LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT | 14 | 1.22e-01 | -2.39e-01 | 4.08e-01 |
| GOCC DENDRITIC SHAFT | 26 | 3.50e-02 | -2.39e-01 | 2.17e-01 |
| GOBP CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER | 14 | 1.22e-01 | 2.39e-01 | 4.09e-01 |
| GOBP ARACHIDONIC ACID SECRETION | 10 | 1.91e-01 | 2.39e-01 | 5.10e-01 |
| GOMF PHOSPHATIDYLINOSITOL TRANSFER ACTIVITY | 10 | 1.91e-01 | -2.39e-01 | 5.10e-01 |
| GOBP TRACHEA FORMATION | 6 | 3.11e-01 | -2.39e-01 | 6.50e-01 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE NON REM SLEEP | 5 | 3.56e-01 | -2.39e-01 | 6.89e-01 |
| GOBP REGULATION OF TORC2 SIGNALING | 8 | 2.43e-01 | -2.39e-01 | 5.76e-01 |
| GOMF TRANSCRIPTION COREPRESSOR BINDING | 43 | 6.84e-03 | -2.38e-01 | 8.20e-02 |
| GOMF NADP RETINOL DEHYDROGENASE ACTIVITY | 10 | 1.92e-01 | 2.38e-01 | 5.11e-01 |
| GOMF TFIID CLASS TRANSCRIPTION FACTOR COMPLEX BINDING | 10 | 1.92e-01 | -2.38e-01 | 5.11e-01 |
| GOBP POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 30 | 2.40e-02 | -2.38e-01 | 1.74e-01 |
| GOMF MAP KINASE PHOSPHATASE ACTIVITY | 12 | 1.53e-01 | 2.38e-01 | 4.58e-01 |
| GOBP NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 18 | 8.05e-02 | 2.38e-01 | 3.34e-01 |
| GOBP REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT | 8 | 2.44e-01 | -2.38e-01 | 5.77e-01 |
| GOCC SET1C COMPASS COMPLEX | 13 | 1.38e-01 | -2.38e-01 | 4.36e-01 |
| GOMF PLUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 11 | 1.72e-01 | 2.38e-01 | 4.87e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID METABOLIC PROCESS | 6 | 3.14e-01 | -2.37e-01 | 6.53e-01 |
| GOCC MYOSIN II COMPLEX | 13 | 1.38e-01 | 2.37e-01 | 4.36e-01 |
| GOBP LATE ENDOSOME TO LYSOSOME TRANSPORT | 21 | 5.97e-02 | 2.37e-01 | 2.82e-01 |
| GOBP RESPIRATORY ELECTRON TRANSPORT CHAIN | 112 | 1.45e-05 | 2.37e-01 | 8.42e-04 |
| GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION INVOLVED IN INACTIVATION OF PROTEIN KINASE ACTIVITY | 5 | 3.58e-01 | 2.37e-01 | 6.91e-01 |
| GOBP REGULATION OF HISTONE ACETYLATION | 16 | 1.01e-01 | -2.37e-01 | 3.72e-01 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 16 | 1.01e-01 | -2.37e-01 | 3.72e-01 |
| GOMF 5 3 EXONUCLEASE ACTIVITY | 19 | 7.37e-02 | -2.37e-01 | 3.17e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 6 | 3.15e-01 | 2.37e-01 | 6.54e-01 |
| GOBP POSITIVE REGULATION OF SULFUR METABOLIC PROCESS | 5 | 3.59e-01 | -2.37e-01 | 6.91e-01 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 1 SIGNALING PATHWAY | 8 | 2.46e-01 | 2.37e-01 | 5.80e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE ACTIVITY | 6 | 3.15e-01 | -2.37e-01 | 6.54e-01 |
| GOBP RESPONSE TO INTERLEUKIN 4 | 30 | 2.49e-02 | -2.37e-01 | 1.78e-01 |
| GOMF PEPTIDE HORMONE BINDING | 20 | 6.71e-02 | -2.37e-01 | 2.99e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT TO PLASMA MEMBRANE | 12 | 1.56e-01 | 2.36e-01 | 4.62e-01 |
| GOBP ORGAN INDUCTION | 9 | 2.20e-01 | -2.36e-01 | 5.48e-01 |
| GOBP ENDODERMAL CELL FATE COMMITMENT | 7 | 2.79e-01 | 2.36e-01 | 6.16e-01 |
| GOBP DEFINITIVE HEMOPOIESIS | 13 | 1.40e-01 | -2.36e-01 | 4.39e-01 |
| GOBP ROSTROCAUDAL NEURAL TUBE PATTERNING | 5 | 3.60e-01 | -2.36e-01 | 6.93e-01 |
| GOBP PROTEIN LOCALIZATION TO MITOCHONDRION | 124 | 5.64e-06 | 2.36e-01 | 3.91e-04 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL EFFLUX | 20 | 6.76e-02 | -2.36e-01 | 3.01e-01 |
| GOMF OUTWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 7 | 2.79e-01 | -2.36e-01 | 6.17e-01 |
| GOBP T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 62 | 1.31e-03 | -2.36e-01 | 2.65e-02 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEGREGATION | 26 | 3.72e-02 | -2.36e-01 | 2.24e-01 |
| GOBP EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION | 8 | 2.48e-01 | -2.36e-01 | 5.82e-01 |
| GOMF CHLORIDE ION BINDING | 5 | 3.61e-01 | -2.36e-01 | 6.93e-01 |
| GOBP REGULATION OF PEPTIDYL LYSINE ACETYLATION | 24 | 4.55e-02 | -2.36e-01 | 2.48e-01 |
| GOBP BODY MORPHOGENESIS | 35 | 1.58e-02 | -2.36e-01 | 1.40e-01 |
| GOBP POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 16 | 1.02e-01 | -2.36e-01 | 3.75e-01 |
| GOBP POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 19 | 7.53e-02 | -2.36e-01 | 3.21e-01 |
| GOBP HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 98 | 5.61e-05 | -2.36e-01 | 2.52e-03 |
| GOBP REGULATION OF MUSCLE ADAPTATION | 51 | 3.62e-03 | -2.36e-01 | 5.45e-02 |
| GOCC HFE TRANSFERRIN RECEPTOR COMPLEX | 6 | 3.18e-01 | 2.36e-01 | 6.57e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE PRODUCTION | 52 | 3.33e-03 | -2.35e-01 | 5.10e-02 |
| GOBP FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 30 | 2.57e-02 | -2.35e-01 | 1.81e-01 |
| GOBP DEFENSE RESPONSE TO FUNGUS | 21 | 6.19e-02 | -2.35e-01 | 2.88e-01 |
| GOBP REGULATION OF COMPLEMENT ACTIVATION CLASSICAL PATHWAY | 6 | 3.18e-01 | 2.35e-01 | 6.57e-01 |
| GOCC THO COMPLEX | 6 | 3.18e-01 | -2.35e-01 | 6.57e-01 |
| GOMF NUCLEOSIDE KINASE ACTIVITY | 9 | 2.22e-01 | -2.35e-01 | 5.50e-01 |
| GOBP NEGATIVE REGULATION OF CHOLESTEROL STORAGE | 10 | 1.98e-01 | 2.35e-01 | 5.19e-01 |
| GOMF NADPLUS PROTEIN ADP RIBOSYLTRANSFERASE ACTIVITY | 24 | 4.62e-02 | -2.35e-01 | 2.50e-01 |
| GOBP REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 23 | 5.10e-02 | 2.35e-01 | 2.62e-01 |
| GOMF GTPASE INHIBITOR ACTIVITY | 11 | 1.77e-01 | 2.35e-01 | 4.92e-01 |
| GOMF GAMMA CATENIN BINDING | 5 | 3.63e-01 | -2.35e-01 | 6.95e-01 |
| GOBP CYSTEINE METABOLIC PROCESS | 7 | 2.82e-01 | -2.35e-01 | 6.20e-01 |
| GOBP REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 7 | 2.82e-01 | -2.35e-01 | 6.20e-01 |
| GOBP SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 18 | 8.47e-02 | -2.35e-01 | 3.41e-01 |
| GOBP POSITIVE REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY | 6 | 3.20e-01 | -2.35e-01 | 6.59e-01 |
| GOBP POSITIVE REGULATION OF ERBB SIGNALING PATHWAY | 21 | 6.28e-02 | -2.35e-01 | 2.89e-01 |
| GOMF POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 13 | 1.43e-01 | 2.35e-01 | 4.44e-01 |
| GOBP CELLULAR RESPONSE TO X RAY | 7 | 2.83e-01 | -2.35e-01 | 6.20e-01 |
| GOBP MACROPHAGE DIFFERENTIATION | 47 | 5.43e-03 | -2.34e-01 | 7.17e-02 |
| GOBP OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS | 21 | 6.30e-02 | 2.34e-01 | 2.89e-01 |
| GOBP MEDIUM CHAIN FATTY ACYL COA METABOLIC PROCESS | 5 | 3.64e-01 | 2.34e-01 | 6.97e-01 |
| GOBP CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 25 | 4.26e-02 | -2.34e-01 | 2.40e-01 |
| GOCC SODIUM CHANNEL COMPLEX | 9 | 2.24e-01 | -2.34e-01 | 5.52e-01 |
| GOBP REGULATION OF MIRNA CATABOLIC PROCESS | 8 | 2.51e-01 | -2.34e-01 | 5.86e-01 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 14 | 1.30e-01 | 2.34e-01 | 4.22e-01 |
| GOBP SECRETION OF LYSOSOMAL ENZYMES | 7 | 2.84e-01 | 2.34e-01 | 6.21e-01 |
| GOBP REGULATION OF L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 6 | 3.21e-01 | -2.34e-01 | 6.60e-01 |
| GOBP MITOCHONDRIAL TRANSMEMBRANE TRANSPORT | 57 | 2.26e-03 | 2.34e-01 | 3.93e-02 |
| GOMF CHROMATIN BINDING | 465 | 6.55e-18 | -2.34e-01 | 3.64e-15 |
| GOCC GATOR2 COMPLEX | 5 | 3.65e-01 | 2.34e-01 | 6.97e-01 |
| GOBP NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 14 | 1.30e-01 | -2.34e-01 | 4.23e-01 |
| GOMF SUMO TRANSFERASE ACTIVITY | 24 | 4.77e-02 | -2.34e-01 | 2.54e-01 |
| GOMF SNAP RECEPTOR ACTIVITY | 35 | 1.69e-02 | 2.33e-01 | 1.45e-01 |
| GOBP HEAD MORPHOGENESIS | 27 | 3.58e-02 | -2.33e-01 | 2.20e-01 |
| GOBP I KAPPAB PHOSPHORYLATION | 13 | 1.45e-01 | -2.33e-01 | 4.45e-01 |
| GOMF VITAMIN B6 BINDING | 37 | 1.41e-02 | 2.33e-01 | 1.29e-01 |
| GOMF PROTEIN METHYLTRANSFERASE ACTIVITY | 83 | 2.40e-04 | -2.33e-01 | 7.44e-03 |
| GOBP HISTONE UBIQUITINATION | 9 | 2.26e-01 | 2.33e-01 | 5.54e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 3.23e-01 | -2.33e-01 | 6.62e-01 |
| GOBP PROGESTERONE RECEPTOR SIGNALING PATHWAY | 8 | 2.54e-01 | -2.33e-01 | 5.88e-01 |
| GOMF NEUROTROPHIN TRK RECEPTOR BINDING | 5 | 3.67e-01 | -2.33e-01 | 6.98e-01 |
| GOMF ALDO KETO REDUCTASE NADP ACTIVITY | 21 | 6.47e-02 | 2.33e-01 | 2.93e-01 |
| GOMF METALLODIPEPTIDASE ACTIVITY | 6 | 3.23e-01 | -2.33e-01 | 6.62e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR | 33 | 2.07e-02 | 2.33e-01 | 1.59e-01 |
| GOBP RESPONSE TO INACTIVITY | 6 | 3.24e-01 | -2.33e-01 | 6.62e-01 |
| GOBP FACE MORPHOGENESIS | 23 | 5.35e-02 | -2.33e-01 | 2.66e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH | 7 | 2.87e-01 | -2.33e-01 | 6.25e-01 |
| GOBP INTERLEUKIN 13 PRODUCTION | 12 | 1.63e-01 | -2.33e-01 | 4.73e-01 |
| GOBP PARKIN MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 6 | 3.24e-01 | 2.33e-01 | 6.62e-01 |
| GOBP MUSCLE CELL CELLULAR HOMEOSTASIS | 17 | 9.69e-02 | 2.33e-01 | 3.66e-01 |
| GOBP ZYMOGEN ACTIVATION | 37 | 1.44e-02 | 2.32e-01 | 1.31e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE CHECKPOINT | 5 | 3.68e-01 | -2.32e-01 | 7.00e-01 |
| GOBP REGULATION OF SISTER CHROMATID SEGREGATION | 95 | 9.13e-05 | -2.32e-01 | 3.59e-03 |
| GOBP MAINTENANCE OF CENTROSOME LOCATION | 6 | 3.25e-01 | 2.32e-01 | 6.63e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 21 | 6.57e-02 | -2.32e-01 | 2.96e-01 |
| GOBP LENS FIBER CELL DIFFERENTIATION | 24 | 4.92e-02 | -2.32e-01 | 2.58e-01 |
| GOMF THIOREDOXIN DEPENDENT PEROXIREDOXIN ACTIVITY | 6 | 3.25e-01 | 2.32e-01 | 6.63e-01 |
| GOBP PHOSPHATIDYLGLYCEROL METABOLIC PROCESS | 25 | 4.48e-02 | 2.32e-01 | 2.46e-01 |
| GOBP REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 45 | 7.15e-03 | -2.32e-01 | 8.39e-02 |
| GOBP POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 18 | 8.87e-02 | -2.32e-01 | 3.48e-01 |
| GOCC PERICHROMATIN FIBRILS | 5 | 3.70e-01 | -2.32e-01 | 7.00e-01 |
| GOBP PEPTIDYL PROLINE MODIFICATION | 31 | 2.57e-02 | 2.32e-01 | 1.81e-01 |
| GOBP SECONDARY METABOLIC PROCESS | 32 | 2.34e-02 | 2.32e-01 | 1.72e-01 |
| GOBP DIRECT OSSIFICATION | 5 | 3.70e-01 | -2.32e-01 | 7.00e-01 |
| GOBP PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS | 21 | 6.63e-02 | -2.31e-01 | 2.98e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE BINDING | 32 | 2.35e-02 | -2.31e-01 | 1.72e-01 |
| GOBP CELL CYCLE DNA REPLICATION | 42 | 9.54e-03 | -2.31e-01 | 1.01e-01 |
| GOCC POST MRNA RELEASE SPLICEOSOMAL COMPLEX | 9 | 2.30e-01 | -2.31e-01 | 5.60e-01 |
| GOMF GLYCINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 3.71e-01 | 2.31e-01 | 7.00e-01 |
| GOBP MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 17 | 9.94e-02 | -2.31e-01 | 3.69e-01 |
| GOBP RESPONSE TO ANGIOTENSIN | 25 | 4.58e-02 | -2.31e-01 | 2.49e-01 |
| GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT MEMBRANE | 70 | 8.43e-04 | 2.31e-01 | 1.94e-02 |
| GOBP NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 14 | 1.35e-01 | -2.31e-01 | 4.31e-01 |
| GOCC PRERIBOSOME LARGE SUBUNIT PRECURSOR | 19 | 8.18e-02 | 2.31e-01 | 3.37e-01 |
| GOBP CYTOPLASMIC TRANSLATION | 147 | 1.41e-06 | -2.31e-01 | 1.23e-04 |
| GOBP NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 8 | 2.59e-01 | 2.31e-01 | 5.94e-01 |
| GOCC CHLORIDE CHANNEL COMPLEX | 21 | 6.76e-02 | 2.30e-01 | 3.01e-01 |
| GOBP DOSAGE COMPENSATION | 30 | 2.90e-02 | -2.30e-01 | 1.94e-01 |
| GOBP EXTRAEMBRYONIC MEMBRANE DEVELOPMENT | 10 | 2.07e-01 | -2.30e-01 | 5.31e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 6 | 3.29e-01 | 2.30e-01 | 6.66e-01 |
| GOCC MMXD COMPLEX | 5 | 3.72e-01 | 2.30e-01 | 7.01e-01 |
| GOBP DEOXYRIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 5 | 3.73e-01 | 2.30e-01 | 7.01e-01 |
| GOCC PLATELET ALPHA GRANULE MEMBRANE | 14 | 1.36e-01 | 2.30e-01 | 4.33e-01 |
| GOMF SUMO LIGASE ACTIVITY | 13 | 1.51e-01 | -2.30e-01 | 4.54e-01 |
| GOBP REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 5 | 3.73e-01 | -2.30e-01 | 7.02e-01 |
| GOBP ICOSANOID SECRETION | 18 | 9.11e-02 | 2.30e-01 | 3.53e-01 |
| GOMF VIRION BINDING | 9 | 2.32e-01 | -2.30e-01 | 5.63e-01 |
| GOBP INHIBITORY POSTSYNAPTIC POTENTIAL | 7 | 2.92e-01 | -2.30e-01 | 6.31e-01 |
| GOCC OUTER KINETOCHORE | 18 | 9.17e-02 | -2.30e-01 | 3.55e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 10 | 2.09e-01 | -2.30e-01 | 5.33e-01 |
| GOBP REGULATION OF NADP METABOLIC PROCESS | 8 | 2.61e-01 | -2.30e-01 | 5.97e-01 |
| GOBP MONOCYTE ACTIVATION | 12 | 1.69e-01 | -2.29e-01 | 4.82e-01 |
| GOCC MITOCHONDRIAL ENVELOPE | 710 | 3.47e-25 | 2.29e-01 | 7.82e-22 |
| GOBP NEGATIVE REGULATION OF DNA RECOMBINATION | 36 | 1.74e-02 | -2.29e-01 | 1.47e-01 |
| GOBP ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT | 28 | 3.60e-02 | 2.29e-01 | 2.20e-01 |
| GOBP PHOTOPERIODISM | 24 | 5.22e-02 | -2.29e-01 | 2.64e-01 |
| GOBP AROMATIC AMINO ACID TRANSPORT | 8 | 2.62e-01 | 2.29e-01 | 5.98e-01 |
| GOCC MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX III | 13 | 1.53e-01 | 2.29e-01 | 4.58e-01 |
| GOBP UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 36 | 1.76e-02 | 2.29e-01 | 1.48e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 8 | 2.63e-01 | -2.29e-01 | 5.99e-01 |
| GOBP TRANSITION METAL ION TRANSPORT | 73 | 7.38e-04 | 2.29e-01 | 1.76e-02 |
| GOMF DOLICHYL PHOSPHATE MANNOSE PROTEIN MANNOSYLTRANSFERASE ACTIVITY | 8 | 2.63e-01 | -2.28e-01 | 5.99e-01 |
| GOMF CAMP RESPONSE ELEMENT BINDING | 10 | 2.11e-01 | -2.28e-01 | 5.35e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SECRETION | 42 | 1.05e-02 | 2.28e-01 | 1.07e-01 |
| GOBP REGULATION OF CELL FATE SPECIFICATION | 17 | 1.04e-01 | -2.28e-01 | 3.77e-01 |
| GOBP REGULATION OF GLUCONEOGENESIS | 40 | 1.26e-02 | -2.28e-01 | 1.19e-01 |
| GOBP GLUTAMATERGIC NEURON DIFFERENTIATION | 8 | 2.64e-01 | -2.28e-01 | 6.01e-01 |
| GOBP SIALYLATION | 5 | 3.77e-01 | -2.28e-01 | 7.05e-01 |
| GOBP GLUCURONATE CATABOLIC PROCESS TO XYLULOSE 5 PHOSPHATE | 5 | 3.78e-01 | 2.28e-01 | 7.05e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL | 17 | 1.04e-01 | -2.28e-01 | 3.78e-01 |
| GOCC DENDRITIC FILOPODIUM | 5 | 3.78e-01 | 2.28e-01 | 7.05e-01 |
| GOCC ZYMOGEN GRANULE | 7 | 2.97e-01 | -2.28e-01 | 6.35e-01 |
| GOBP POLY A PLUS MRNA EXPORT FROM NUCLEUS | 19 | 8.58e-02 | -2.28e-01 | 3.44e-01 |
| GOCC REPLISOME | 15 | 1.27e-01 | -2.28e-01 | 4.18e-01 |
| GOBP MICROTUBULE DEPOLYMERIZATION | 36 | 1.82e-02 | -2.28e-01 | 1.49e-01 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE | 30 | 3.10e-02 | 2.28e-01 | 2.01e-01 |
| GOMF GLUTATHIONE TRANSFERASE ACTIVITY | 20 | 7.82e-02 | 2.28e-01 | 3.29e-01 |
| GOBP CHITIN METABOLIC PROCESS | 5 | 3.78e-01 | 2.27e-01 | 7.06e-01 |
| GOMF CHITINASE ACTIVITY | 5 | 3.78e-01 | 2.27e-01 | 7.06e-01 |
| GOBP CELLULAR RESPONSE TO VITAMIN D | 14 | 1.41e-01 | -2.27e-01 | 4.40e-01 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 14 | 1.41e-01 | 2.27e-01 | 4.40e-01 |
| GOMF COA HYDROLASE ACTIVITY | 19 | 8.64e-02 | 2.27e-01 | 3.45e-01 |
| GOMF PHOSPHOLIPASE D ACTIVITY | 5 | 3.79e-01 | -2.27e-01 | 7.06e-01 |
| GOBP MEIOTIC CELL CYCLE CHECKPOINT SIGNALING | 7 | 2.98e-01 | -2.27e-01 | 6.36e-01 |
| GOBP REGULATION OF GONAD DEVELOPMENT | 5 | 3.79e-01 | -2.27e-01 | 7.07e-01 |
| GOBP REGULATION OF TAU PROTEIN KINASE ACTIVITY | 8 | 2.66e-01 | 2.27e-01 | 6.03e-01 |
| GOBP L GLUTAMATE IMPORT | 28 | 3.77e-02 | -2.27e-01 | 2.25e-01 |
| GOBP REGULATION OF LEUKOCYTE DEGRANULATION | 36 | 1.85e-02 | -2.27e-01 | 1.50e-01 |
| GOBP KETONE CATABOLIC PROCESS | 11 | 1.93e-01 | 2.27e-01 | 5.11e-01 |
| GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT | 38 | 1.56e-02 | -2.27e-01 | 1.39e-01 |
| GOBP REGULATION OF CHOLESTEROL STORAGE | 16 | 1.16e-01 | 2.27e-01 | 4.01e-01 |
| GOMF MAP KINASE ACTIVITY | 13 | 1.57e-01 | -2.27e-01 | 4.63e-01 |
| GOBP OSMOSENSORY SIGNALING PATHWAY | 5 | 3.80e-01 | -2.27e-01 | 7.07e-01 |
| GOBP HEMATOPOIETIC STEM CELL MIGRATION | 5 | 3.80e-01 | -2.27e-01 | 7.07e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM | 10 | 2.15e-01 | 2.27e-01 | 5.40e-01 |
| GOBP UNSATURATED FATTY ACID METABOLIC PROCESS | 66 | 1.46e-03 | 2.27e-01 | 2.85e-02 |
| GOMF ENDODEOXYRIBONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 12 | 1.74e-01 | -2.27e-01 | 4.89e-01 |
| GOBP T HELPER CELL LINEAGE COMMITMENT | 15 | 1.29e-01 | -2.26e-01 | 4.21e-01 |
| GOBP REGULATION OF CIRCADIAN RHYTHM | 83 | 3.66e-04 | -2.26e-01 | 1.03e-02 |
| GOBP POSITIVE REGULATION OF ENDOCYTIC RECYCLING | 6 | 3.37e-01 | -2.26e-01 | 6.72e-01 |
| GOCC ELONGATOR HOLOENZYME COMPLEX | 6 | 3.37e-01 | 2.26e-01 | 6.72e-01 |
| GOBP REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 16 | 1.17e-01 | 2.26e-01 | 4.01e-01 |
| GOBP SKELETAL MUSCLE TISSUE REGENERATION | 27 | 4.20e-02 | 2.26e-01 | 2.38e-01 |
| GOBP STRAND INVASION | 5 | 3.81e-01 | -2.26e-01 | 7.09e-01 |
| GOMF INORGANIC PHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 2.69e-01 | 2.26e-01 | 6.06e-01 |
| GOBP REGULATION OF SYNAPSE MATURATION | 13 | 1.59e-01 | -2.26e-01 | 4.65e-01 |
| GOBP MAINTENANCE OF BLOOD BRAIN BARRIER | 26 | 4.65e-02 | 2.26e-01 | 2.51e-01 |
| GOBP RELAXATION OF CARDIAC MUSCLE | 14 | 1.44e-01 | -2.26e-01 | 4.45e-01 |
| GOBP VIRAL RNA GENOME REPLICATION | 27 | 4.25e-02 | -2.26e-01 | 2.40e-01 |
| GOBP RHYTHMIC PROCESS | 203 | 3.14e-08 | -2.26e-01 | 4.98e-06 |
| GOBP RESPONSE TO GLYCOPROTEIN | 8 | 2.70e-01 | 2.25e-01 | 6.06e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 19 | 8.91e-02 | 2.25e-01 | 3.49e-01 |
| GOBP ALCOHOL CATABOLIC PROCESS | 21 | 7.39e-02 | -2.25e-01 | 3.18e-01 |
| GOBP REGULATION OF MITOTIC CYTOKINESIS | 10 | 2.17e-01 | 2.25e-01 | 5.44e-01 |
| GOBP TOXIN TRANSPORT | 7 | 3.02e-01 | 2.25e-01 | 6.42e-01 |
| GOBP MITOCHONDRIAL FRAGMENTATION INVOLVED IN APOPTOTIC PROCESS | 9 | 2.42e-01 | 2.25e-01 | 5.76e-01 |
| GOBP REGULATION OF LIPOPROTEIN METABOLIC PROCESS | 13 | 1.60e-01 | 2.25e-01 | 4.67e-01 |
| GOBP DERMATAN SULFATE METABOLIC PROCESS | 9 | 2.43e-01 | 2.25e-01 | 5.76e-01 |
| GOMF PHOSPHOLIPASE INHIBITOR ACTIVITY | 8 | 2.71e-01 | 2.25e-01 | 6.08e-01 |
| GOCC PALMITOYLTRANSFERASE COMPLEX | 10 | 2.18e-01 | 2.25e-01 | 5.45e-01 |
| GOMF K48 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 10 | 2.18e-01 | 2.25e-01 | 5.45e-01 |
| GOBP ENERGY HOMEOSTASIS | 49 | 6.48e-03 | -2.25e-01 | 7.96e-02 |
| GOBP SODIUM ION HOMEOSTASIS | 15 | 1.32e-01 | 2.25e-01 | 4.25e-01 |
| GOBP POST EMBRYONIC ANIMAL MORPHOGENESIS | 12 | 1.78e-01 | -2.25e-01 | 4.93e-01 |
| GOBP EYELID DEVELOPMENT IN CAMERA TYPE EYE | 6 | 3.41e-01 | -2.25e-01 | 6.77e-01 |
| GOCC CYTOPLASMIC DYNEIN COMPLEX | 17 | 1.09e-01 | 2.25e-01 | 3.87e-01 |
| GOCC TUBULAR ENDOSOME | 5 | 3.85e-01 | -2.24e-01 | 7.12e-01 |
| GOMF PHOSPHATIDYL PHOSPHOLIPASE B ACTIVITY | 10 | 2.19e-01 | 2.24e-01 | 5.48e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION | 13 | 1.62e-01 | -2.24e-01 | 4.70e-01 |
| GOBP AUTOPHAGOSOME MEMBRANE DOCKING | 7 | 3.05e-01 | -2.24e-01 | 6.43e-01 |
| GOCC TRANSCRIPTION FACTOR AP 1 COMPLEX | 5 | 3.86e-01 | -2.24e-01 | 7.12e-01 |
| GOBP RNA STABILIZATION | 56 | 3.75e-03 | -2.24e-01 | 5.55e-02 |
| GOCC TRAPPII PROTEIN COMPLEX | 11 | 1.98e-01 | 2.24e-01 | 5.19e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEACETYLATION | 10 | 2.20e-01 | -2.24e-01 | 5.48e-01 |
| GOMF TOXIC SUBSTANCE BINDING | 5 | 3.86e-01 | 2.24e-01 | 7.12e-01 |
| GOBP NEUROMUSCULAR SYNAPTIC TRANSMISSION | 15 | 1.33e-01 | -2.24e-01 | 4.28e-01 |
| GOBP CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION | 5 | 3.86e-01 | 2.24e-01 | 7.12e-01 |
| GOBP SEROTONIN TRANSPORT | 10 | 2.20e-01 | 2.24e-01 | 5.48e-01 |
| GOBP NODAL SIGNALING PATHWAY | 8 | 2.73e-01 | -2.24e-01 | 6.09e-01 |
| GOBP ANATOMICAL STRUCTURE REGRESSION | 5 | 3.87e-01 | -2.24e-01 | 7.13e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 14 | 1.48e-01 | 2.23e-01 | 4.49e-01 |
| GOBP TRANSFERRIN TRANSPORT | 8 | 2.74e-01 | 2.23e-01 | 6.10e-01 |
| GOCC POLYSOME | 62 | 2.35e-03 | -2.23e-01 | 4.06e-02 |
| GOBP PROTEIN DNA COMPLEX ORGANIZATION | 699 | 1.14e-23 | -2.23e-01 | 1.45e-20 |
| GOBP INOSITOL METABOLIC PROCESS | 7 | 3.06e-01 | -2.23e-01 | 6.45e-01 |
| GOBP NOREPINEPHRINE TRANSPORT | 9 | 2.46e-01 | 2.23e-01 | 5.80e-01 |
| GOCC PHOSPHORYLASE KINASE COMPLEX | 5 | 3.87e-01 | -2.23e-01 | 7.13e-01 |
| GOBP REGULATION OF FAT CELL PROLIFERATION | 7 | 3.06e-01 | -2.23e-01 | 6.45e-01 |
| GOMF PALMITOYL COA HYDROLASE ACTIVITY | 13 | 1.64e-01 | 2.23e-01 | 4.74e-01 |
| GOBP SUCKLING BEHAVIOR | 6 | 3.44e-01 | 2.23e-01 | 6.81e-01 |
| GOBP T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 8 | 2.75e-01 | -2.23e-01 | 6.11e-01 |
| GOBP PROTEIN LOCALIZATION TO NON MOTILE CILIUM | 9 | 2.47e-01 | 2.23e-01 | 5.82e-01 |
| GOMF RECEPTOR SERINE THREONINE KINASE BINDING | 12 | 1.81e-01 | 2.23e-01 | 4.98e-01 |
| GOMF PROTEOGLYCAN BINDING | 23 | 6.45e-02 | -2.23e-01 | 2.93e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 10 | 2.23e-01 | -2.23e-01 | 5.51e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 6 | 3.45e-01 | -2.23e-01 | 6.81e-01 |
| GOBP POSITIVE REGULATION OF DNA LIGATION | 5 | 3.89e-01 | -2.22e-01 | 7.15e-01 |
| GOBP RNA DESTABILIZATION | 98 | 1.43e-04 | -2.22e-01 | 5.03e-03 |
| GOBP CENP A CONTAINING CHROMATIN ASSEMBLY | 9 | 2.48e-01 | -2.22e-01 | 5.82e-01 |
| GOCC KATANIN COMPLEX | 5 | 3.89e-01 | -2.22e-01 | 7.15e-01 |
| GOBP LUNG CELL DIFFERENTIATION | 14 | 1.50e-01 | -2.22e-01 | 4.53e-01 |
| GOBP REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 12 | 1.82e-01 | -2.22e-01 | 4.99e-01 |
| GOMF DISULFIDE OXIDOREDUCTASE ACTIVITY | 32 | 2.96e-02 | 2.22e-01 | 1.97e-01 |
| GOBP REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 92 | 2.33e-04 | -2.22e-01 | 7.32e-03 |
| GOBP DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 26 | 5.00e-02 | 2.22e-01 | 2.60e-01 |
| GOBP PROTEIN NEDDYLATION | 27 | 4.59e-02 | 2.22e-01 | 2.49e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY | 14 | 1.50e-01 | -2.22e-01 | 4.53e-01 |
| GOBP INTERLEUKIN 17 PRODUCTION | 28 | 4.22e-02 | -2.22e-01 | 2.39e-01 |
| GOBP CELLULAR RESPONSE TO ATP | 15 | 1.37e-01 | -2.22e-01 | 4.35e-01 |
| GOMF HISTONE READER ACTIVITY | 11 | 2.03e-01 | -2.22e-01 | 5.26e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 33 | 2.76e-02 | -2.22e-01 | 1.88e-01 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 13 | 1.67e-01 | 2.21e-01 | 4.79e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 10 | 2.25e-01 | -2.21e-01 | 5.54e-01 |
| GOBP GUANINE NUCLEOTIDE TRANSPORT | 8 | 2.78e-01 | -2.21e-01 | 6.16e-01 |
| GOBP REGULATION OF PODOSOME ASSEMBLY | 12 | 1.85e-01 | 2.21e-01 | 5.01e-01 |
| GOCC CELL POLE | 5 | 3.92e-01 | 2.21e-01 | 7.18e-01 |
| GOBP POLYPRENOL METABOLIC PROCESS | 23 | 6.66e-02 | 2.21e-01 | 2.98e-01 |
| GOBP HISTONE MODIFICATION | 110 | 6.30e-05 | -2.21e-01 | 2.77e-03 |
| GOBP RESPONSE TO EPIDERMAL GROWTH FACTOR | 38 | 1.85e-02 | -2.21e-01 | 1.50e-01 |
| GOBP MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 25 | 5.60e-02 | 2.21e-01 | 2.72e-01 |
| GOMF NUCLEOSIDE DIPHOSPHATE KINASE ACTIVITY | 16 | 1.26e-01 | 2.21e-01 | 4.17e-01 |
| GOBP DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS | 138 | 7.67e-06 | -2.21e-01 | 4.87e-04 |
| GOBP POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 11 | 2.05e-01 | -2.21e-01 | 5.28e-01 |
| GOBP METANEPHRIC TUBULE MORPHOGENESIS | 6 | 3.49e-01 | 2.21e-01 | 6.85e-01 |
| GOCC LUMENAL SIDE OF MEMBRANE | 33 | 2.83e-02 | -2.21e-01 | 1.91e-01 |
| GOBP T CELL SELECTION | 33 | 2.83e-02 | -2.21e-01 | 1.91e-01 |
| GOBP FEMALE SEX DIFFERENTIATION | 72 | 1.22e-03 | -2.20e-01 | 2.51e-02 |
| GOBP POSITIVE REGULATION OF MYOBLAST FUSION | 11 | 2.06e-01 | 2.20e-01 | 5.28e-01 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 45 | 1.05e-02 | -2.20e-01 | 1.07e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 9 | 2.52e-01 | 2.20e-01 | 5.87e-01 |
| GOBP ENDOCARDIAL CUSHION FORMATION | 17 | 1.16e-01 | -2.20e-01 | 3.99e-01 |
| GOCC MIB COMPLEX | 13 | 1.69e-01 | 2.20e-01 | 4.82e-01 |
| GOBP REGULATION OF PROTEIN ACETYLATION | 33 | 2.86e-02 | -2.20e-01 | 1.92e-01 |
| GOBP REGULATION OF PHAGOCYTOSIS | 74 | 1.07e-03 | -2.20e-01 | 2.31e-02 |
| GOBP POSITIVE REGULATION OF HISTONE METHYLATION | 14 | 1.54e-01 | -2.20e-01 | 4.59e-01 |
| GOBP VOCALIZATION BEHAVIOR | 12 | 1.87e-01 | 2.20e-01 | 5.05e-01 |
| GOCC INTERCELLULAR CANALICULUS | 6 | 3.51e-01 | 2.20e-01 | 6.86e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 10 | 2.29e-01 | 2.20e-01 | 5.58e-01 |
| GOBP POSITIVE REGULATION OF MRNA METABOLIC PROCESS | 124 | 2.37e-05 | -2.20e-01 | 1.24e-03 |
| GOBP REGULATION OF MUSCLE HYPERTROPHY | 39 | 1.75e-02 | -2.20e-01 | 1.48e-01 |
| GOBP PHOSPHATIDYLINOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 57 | 4.10e-03 | -2.20e-01 | 5.92e-02 |
| GOBP ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 47 | 9.19e-03 | -2.20e-01 | 9.90e-02 |
| GOCC MITOCHONDRIAL ALPHA KETOGLUTARATE DEHYDROGENASE COMPLEX | 6 | 3.52e-01 | 2.20e-01 | 6.87e-01 |
| GOBP NEGATIVE REGULATION OF MRNA PROCESSING | 24 | 6.26e-02 | -2.20e-01 | 2.89e-01 |
| GOBP MOTOR NEURON AXON GUIDANCE | 16 | 1.28e-01 | -2.20e-01 | 4.20e-01 |
| GOBP SKELETAL MUSCLE ADAPTATION | 10 | 2.29e-01 | -2.20e-01 | 5.59e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 17 | 1.17e-01 | -2.19e-01 | 4.01e-01 |
| GOBP CELLULAR RESPONSE TO AMYLOID BETA | 29 | 4.09e-02 | -2.19e-01 | 2.35e-01 |
| GOBP G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 8 | 2.83e-01 | -2.19e-01 | 6.21e-01 |
| GOMF G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR ACTIVITY | 8 | 2.83e-01 | -2.19e-01 | 6.21e-01 |
| GOBP REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 13 | 1.72e-01 | 2.19e-01 | 4.86e-01 |
| GOMF SULFURIC ESTER HYDROLASE ACTIVITY | 11 | 2.09e-01 | 2.19e-01 | 5.33e-01 |
| GOBP NEGATIVE REGULATION OF MAP KINASE ACTIVITY | 40 | 1.67e-02 | -2.19e-01 | 1.45e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS | 19 | 9.94e-02 | -2.18e-01 | 3.69e-01 |
| GOBP SPHINGOLIPID MEDIATED SIGNALING PATHWAY | 10 | 2.32e-01 | -2.18e-01 | 5.63e-01 |
| GOMF ISOCITRATE DEHYDROGENASE NAD P PLUS ACTIVITY | 5 | 3.98e-01 | -2.18e-01 | 7.21e-01 |
| GOBP OUTER DYNEIN ARM ASSEMBLY | 8 | 2.85e-01 | 2.18e-01 | 6.23e-01 |
| GOBP PROTEIN K29 LINKED UBIQUITINATION | 6 | 3.55e-01 | 2.18e-01 | 6.88e-01 |
| GOBP MITOCHONDRIAL MEMBRANE ORGANIZATION | 108 | 8.97e-05 | 2.18e-01 | 3.56e-03 |
| GOBP NATURAL KILLER CELL ACTIVATION | 56 | 4.75e-03 | -2.18e-01 | 6.52e-02 |
| GOBP REGULATION OF MRNA CATABOLIC PROCESS | 162 | 1.69e-06 | -2.18e-01 | 1.42e-04 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE REGULATOR ACTIVITY | 24 | 6.44e-02 | -2.18e-01 | 2.93e-01 |
| GOMF HORMONE ACTIVITY | 30 | 3.87e-02 | 2.18e-01 | 2.28e-01 |
| GOBP POINTED END ACTIN FILAMENT CAPPING | 5 | 3.98e-01 | -2.18e-01 | 7.22e-01 |
| GOBP REGULATION OF CELLULAR SENESCENCE | 34 | 2.79e-02 | -2.18e-01 | 1.89e-01 |
| GOBP G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 15 | 1.44e-01 | -2.18e-01 | 4.45e-01 |
| GOBP NEGATIVE REGULATION OF B CELL PROLIFERATION | 13 | 1.74e-01 | -2.18e-01 | 4.89e-01 |
| GOBP AORTA MORPHOGENESIS | 19 | 1.00e-01 | -2.18e-01 | 3.71e-01 |
| GOBP CENTRAL NERVOUS SYSTEM MYELIN FORMATION | 6 | 3.56e-01 | 2.18e-01 | 6.89e-01 |
| GOBP PROTEIN LINEAR POLYUBIQUITINATION | 5 | 4.00e-01 | 2.18e-01 | 7.22e-01 |
| GOBP POSITIVE REGULATION OF RUFFLE ASSEMBLY | 12 | 1.92e-01 | 2.18e-01 | 5.11e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS | 14 | 1.59e-01 | -2.18e-01 | 4.65e-01 |
| GOBP MRNA TRANSPORT | 113 | 6.57e-05 | -2.17e-01 | 2.84e-03 |
| GOBP REGULATION OF DNA DUPLEX UNWINDING | 5 | 4.00e-01 | 2.17e-01 | 7.22e-01 |
| GOCC AP 3 ADAPTOR COMPLEX | 9 | 2.59e-01 | -2.17e-01 | 5.94e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 34 | 2.85e-02 | -2.17e-01 | 1.91e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 6 | 3.57e-01 | 2.17e-01 | 6.90e-01 |
| GOBP RESPONSE TO ETHANOL | 73 | 1.35e-03 | -2.17e-01 | 2.70e-02 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON OTHER NITROGENOUS COMPOUNDS AS DONORS | 7 | 3.20e-01 | -2.17e-01 | 6.60e-01 |
| GOCC HETEROCHROMATIN | 69 | 1.86e-03 | -2.17e-01 | 3.37e-02 |
| GOBP CORTISOL METABOLIC PROCESS | 5 | 4.01e-01 | -2.17e-01 | 7.23e-01 |
| GOBP DETECTION OF VIRUS | 5 | 4.01e-01 | -2.17e-01 | 7.23e-01 |
| GOBP REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS | 7 | 3.21e-01 | -2.17e-01 | 6.60e-01 |
| GOBP SEGMENTATION | 53 | 6.39e-03 | -2.17e-01 | 7.89e-02 |
| GOBP MICROTUBULE ANCHORING | 21 | 8.58e-02 | -2.17e-01 | 3.44e-01 |
| GOCC CYTOPLASMIC SIDE OF ENDOSOME MEMBRANE | 6 | 3.59e-01 | 2.16e-01 | 6.91e-01 |
| GOBP REGULATION OF ENDOCRINE PROCESS | 18 | 1.12e-01 | -2.16e-01 | 3.92e-01 |
| GOBP MELANIN METABOLIC PROCESS | 17 | 1.23e-01 | 2.16e-01 | 4.11e-01 |
| GOMF GDP DISSOCIATION INHIBITOR ACTIVITY | 14 | 1.62e-01 | 2.16e-01 | 4.70e-01 |
| GOBP N GLYCAN PROCESSING | 13 | 1.78e-01 | -2.16e-01 | 4.93e-01 |
| GOMF GLUCURONOSYLTRANSFERASE ACTIVITY | 13 | 1.78e-01 | 2.16e-01 | 4.93e-01 |
| GOMF GDP BINDING | 61 | 3.58e-03 | 2.16e-01 | 5.40e-02 |
| GOBP NADH METABOLIC PROCESS | 10 | 2.38e-01 | 2.16e-01 | 5.70e-01 |
| GOBP WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 6 | 3.60e-01 | -2.16e-01 | 6.93e-01 |
| GOBP ENDOTHELIAL CELL ACTIVATION | 7 | 3.23e-01 | -2.16e-01 | 6.62e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 13 | 1.79e-01 | -2.16e-01 | 4.94e-01 |
| GOBP T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 83 | 6.93e-04 | -2.15e-01 | 1.68e-02 |
| GOBP REGULATION OF MESENCHYMAL CELL PROLIFERATION | 18 | 1.14e-01 | -2.15e-01 | 3.96e-01 |
| GOBP PRIMARY ALCOHOL BIOSYNTHETIC PROCESS | 7 | 3.24e-01 | -2.15e-01 | 6.62e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX | 26 | 5.74e-02 | -2.15e-01 | 2.76e-01 |
| GOMF ALCOHOL DEHYDROGENASE NADPPLUS ACTIVITY | 17 | 1.24e-01 | 2.15e-01 | 4.14e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 45 | 1.25e-02 | -2.15e-01 | 1.19e-01 |
| GOBP RESPONSE TO ACETYLCHOLINE | 21 | 8.77e-02 | -2.15e-01 | 3.46e-01 |
| GOMF THIOREDOXIN DISULFIDE REDUCTASE NADP ACTIVITY | 6 | 3.61e-01 | 2.15e-01 | 6.94e-01 |
| GOBP REGULATION OF BILE ACID BIOSYNTHETIC PROCESS | 6 | 3.61e-01 | -2.15e-01 | 6.94e-01 |
| GOMF PROTEIN KINASE A CATALYTIC SUBUNIT BINDING | 12 | 1.97e-01 | -2.15e-01 | 5.17e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME CONDENSATION | 8 | 2.92e-01 | -2.15e-01 | 6.31e-01 |
| GOCC CONDENSIN COMPLEX | 8 | 2.92e-01 | -2.15e-01 | 6.31e-01 |
| GOBP MITOCHONDRIAL TRANSCRIPTION | 19 | 1.05e-01 | 2.15e-01 | 3.79e-01 |
| GOCC FILAMENTOUS ACTIN | 22 | 8.09e-02 | 2.15e-01 | 3.35e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 17 | 1.25e-01 | -2.15e-01 | 4.15e-01 |
| GOBP LEYDIG CELL DIFFERENTIATION | 6 | 3.62e-01 | -2.15e-01 | 6.94e-01 |
| GOMF CADHERIN BINDING INVOLVED IN CELL CELL ADHESION | 13 | 1.80e-01 | 2.15e-01 | 4.95e-01 |
| GOBP LONG CHAIN FATTY ACYL COA METABOLIC PROCESS | 20 | 9.64e-02 | 2.15e-01 | 3.66e-01 |
| GOBP REGULATION OF BEHAVIOR | 38 | 2.20e-02 | -2.15e-01 | 1.64e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 12 | 1.98e-01 | 2.15e-01 | 5.19e-01 |
| GOBP PRESYNAPSE ORGANIZATION | 27 | 5.36e-02 | 2.15e-01 | 2.66e-01 |
| GOBP SPERM EGG RECOGNITION | 27 | 5.36e-02 | 2.15e-01 | 2.66e-01 |
| GOMF HISTONE H3K4 DEMETHYLASE ACTIVITY | 8 | 2.93e-01 | -2.15e-01 | 6.31e-01 |
| GOBP REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 27 | 5.37e-02 | -2.15e-01 | 2.66e-01 |
| GOBP REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 8 | 2.94e-01 | -2.14e-01 | 6.32e-01 |
| GOMF MONOCARBOXYLIC ACID BINDING | 46 | 1.19e-02 | 2.14e-01 | 1.16e-01 |
| GOBP REGULATION OF AMINO ACID TRANSMEMBRANE TRANSPORT | 11 | 2.18e-01 | -2.14e-01 | 5.46e-01 |
| GOMF GANGLIOSIDE BINDING | 5 | 4.07e-01 | 2.14e-01 | 7.27e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 10 | 2.41e-01 | 2.14e-01 | 5.75e-01 |
| GOBP T HELPER 17 CELL LINEAGE COMMITMENT | 11 | 2.19e-01 | -2.14e-01 | 5.47e-01 |
| GOMF PROTON TRANSMEMBRANE TRANSPORTER ACTIVITY | 113 | 8.60e-05 | 2.14e-01 | 3.44e-03 |
| GOMF BICARBONATE MONOATOMIC ANION ANTIPORTER ACTIVITY | 8 | 2.95e-01 | 2.14e-01 | 6.32e-01 |
| GOBP SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING | 8 | 2.95e-01 | 2.14e-01 | 6.32e-01 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 35 | 2.86e-02 | 2.14e-01 | 1.92e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 1 CELL DIFFERENTIATION | 5 | 4.08e-01 | 2.14e-01 | 7.27e-01 |
| GOBP ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE | 18 | 1.16e-01 | -2.14e-01 | 4.01e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 17 | 1.27e-01 | 2.14e-01 | 4.18e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION ARBORIZATION | 7 | 3.27e-01 | 2.14e-01 | 6.64e-01 |
| GOBP STRIATED MUSCLE CELL PROLIFERATION | 43 | 1.53e-02 | -2.14e-01 | 1.38e-01 |
| GOBP REGULATION OF MITOCHONDRIAL GENE EXPRESSION | 30 | 4.28e-02 | 2.14e-01 | 2.40e-01 |
| GOBP POSITIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 6 | 3.65e-01 | -2.14e-01 | 6.97e-01 |
| GOBP DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS | 64 | 3.13e-03 | -2.14e-01 | 4.94e-02 |
| GOMF DOUBLE STRANDED TELOMERIC DNA BINDING | 9 | 2.67e-01 | -2.14e-01 | 6.05e-01 |
| GOBP LYSOSOMAL LUMEN ACIDIFICATION | 22 | 8.31e-02 | 2.13e-01 | 3.40e-01 |
| GOBP MITOCHONDRIAL TRANSPORT | 173 | 1.31e-06 | 2.13e-01 | 1.17e-04 |
| GOBP REGULATION OF NON MOTILE CILIUM ASSEMBLY | 9 | 2.68e-01 | -2.13e-01 | 6.05e-01 |
| GOMF C C CHEMOKINE BINDING | 11 | 2.20e-01 | 2.13e-01 | 5.48e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 7 | 3.28e-01 | -2.13e-01 | 6.65e-01 |
| GOMF INOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 17 | 1.28e-01 | -2.13e-01 | 4.20e-01 |
| GOBP T CELL LINEAGE COMMITMENT | 23 | 7.66e-02 | -2.13e-01 | 3.25e-01 |
| GOBP DETOXIFICATION OF COPPER ION | 10 | 2.43e-01 | 2.13e-01 | 5.76e-01 |
| GOBP REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 11 | 2.21e-01 | -2.13e-01 | 5.49e-01 |
| GOBP AMINO SUGAR BIOSYNTHETIC PROCESS | 11 | 2.21e-01 | 2.13e-01 | 5.49e-01 |
| GOBP FACE DEVELOPMENT | 37 | 2.49e-02 | -2.13e-01 | 1.78e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION | 17 | 1.29e-01 | -2.13e-01 | 4.20e-01 |
| GOBP RETINOIC ACID METABOLIC PROCESS | 12 | 2.02e-01 | -2.13e-01 | 5.24e-01 |
| GOCC ACTOMYOSIN | 62 | 3.74e-03 | 2.13e-01 | 5.55e-02 |
| GOBP COPII COATED VESICLE CARGO LOADING | 15 | 1.53e-01 | 2.13e-01 | 4.58e-01 |
| GOMF PHOSPHOLIPASE A2 ACTIVITY | 18 | 1.18e-01 | 2.13e-01 | 4.02e-01 |
| GOMF SUPEROXIDE GENERATING NADPH OXIDASE ACTIVATOR ACTIVITY | 7 | 3.29e-01 | -2.13e-01 | 6.66e-01 |
| GOBP PROTEASOME ASSEMBLY | 12 | 2.02e-01 | 2.13e-01 | 5.24e-01 |
| GOBP L KYNURENINE METABOLIC PROCESS | 6 | 3.67e-01 | 2.13e-01 | 6.98e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 9 | 2.69e-01 | -2.13e-01 | 6.06e-01 |
| GOBP STEM CELL PROLIFERATION | 63 | 3.52e-03 | -2.13e-01 | 5.35e-02 |
| GOBP NEGATIVE REGULATION OF CELLULAR EXTRAVASATION | 5 | 4.10e-01 | -2.13e-01 | 7.29e-01 |
| GOMF RNA STEM LOOP BINDING | 14 | 1.69e-01 | -2.13e-01 | 4.81e-01 |
| GOMF AMINO ACID BINDING | 26 | 6.08e-02 | -2.12e-01 | 2.85e-01 |
| GOBP LIPOPHAGY | 7 | 3.30e-01 | 2.12e-01 | 6.67e-01 |
| GOCC X CHROMOSOME | 8 | 2.98e-01 | 2.12e-01 | 6.36e-01 |
| GOBP MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 21 | 9.20e-02 | -2.12e-01 | 3.56e-01 |
| GOBP REGULATION OF THE FORCE OF HEART CONTRACTION | 12 | 2.03e-01 | -2.12e-01 | 5.25e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL STORAGE | 6 | 3.68e-01 | 2.12e-01 | 6.99e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE POTENTIAL | 11 | 2.23e-01 | 2.12e-01 | 5.51e-01 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 16 | 1.42e-01 | 2.12e-01 | 4.42e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 61 | 4.19e-03 | -2.12e-01 | 5.98e-02 |
| GOCC CHYLOMICRON | 6 | 3.69e-01 | -2.12e-01 | 7.00e-01 |
| GOMF MONOATOMIC ANION SODIUM SYMPORTER ACTIVITY | 7 | 3.32e-01 | 2.12e-01 | 6.67e-01 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS | 11 | 2.24e-01 | -2.12e-01 | 5.52e-01 |
| GOBP THYROID HORMONE TRANSPORT | 7 | 3.32e-01 | 2.12e-01 | 6.67e-01 |
| GOBP SARCOMERE ORGANIZATION | 25 | 6.69e-02 | 2.12e-01 | 2.99e-01 |
| GOBP REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY | 9 | 2.71e-01 | -2.12e-01 | 6.08e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 11 | 2.24e-01 | -2.12e-01 | 5.52e-01 |
| GOBP REGULATION OF VOLTAGE GATED SODIUM CHANNEL ACTIVITY | 6 | 3.69e-01 | -2.12e-01 | 7.00e-01 |
| GOBP G QUADRUPLEX DNA UNWINDING | 7 | 3.33e-01 | -2.12e-01 | 6.67e-01 |
| GOBP CARDIAC NEURAL CREST CELL MIGRATION INVOLVED IN OUTFLOW TRACT MORPHOGENESIS | 5 | 4.13e-01 | 2.11e-01 | 7.31e-01 |
| GOMF PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY | 42 | 1.78e-02 | -2.11e-01 | 1.48e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 15 | 1.56e-01 | -2.11e-01 | 4.62e-01 |
| GOMF CELL MATRIX ADHESION MEDIATOR ACTIVITY | 5 | 4.13e-01 | 2.11e-01 | 7.31e-01 |
| GOBP REGULATION OF RECEPTOR CATABOLIC PROCESS | 10 | 2.47e-01 | -2.11e-01 | 5.82e-01 |
| GOBP SNORNA LOCALIZATION | 6 | 3.70e-01 | -2.11e-01 | 7.00e-01 |
| GOBP MITOCHONDRIAL FISSION | 36 | 2.83e-02 | 2.11e-01 | 1.91e-01 |
| GOBP REGULATION OF VIRAL PROCESS | 138 | 1.89e-05 | -2.11e-01 | 1.04e-03 |
| GOBP NEGATIVE REGULATION OF PLATELET AGGREGATION | 6 | 3.71e-01 | 2.11e-01 | 7.00e-01 |
| GOMF ICOSANOID TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 3.71e-01 | -2.11e-01 | 7.00e-01 |
| GOBP REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS | 5 | 4.14e-01 | -2.11e-01 | 7.32e-01 |
| GOMF CHLORIDE CHANNEL INHIBITOR ACTIVITY | 5 | 4.14e-01 | 2.11e-01 | 7.32e-01 |
| GOBP L ASCORBIC ACID METABOLIC PROCESS | 8 | 3.02e-01 | 2.11e-01 | 6.41e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CELL CHEMOTAXIS | 5 | 4.14e-01 | -2.11e-01 | 7.33e-01 |
| GOBP AMINE BIOSYNTHETIC PROCESS | 25 | 6.82e-02 | 2.11e-01 | 3.02e-01 |
| GOCC LATERAL ELEMENT | 10 | 2.49e-01 | -2.11e-01 | 5.83e-01 |
| GOBP INTERLEUKIN 10 PRODUCTION | 43 | 1.69e-02 | -2.11e-01 | 1.45e-01 |
| GOMF SOLUTE POTASSIUM ANTIPORTER ACTIVITY | 12 | 2.07e-01 | -2.10e-01 | 5.31e-01 |
| GOBP REGULATION OF MAST CELL ACTIVATION | 31 | 4.26e-02 | -2.10e-01 | 2.40e-01 |
| GOBP CELL PROLIFERATION IN HINDBRAIN | 5 | 4.15e-01 | 2.10e-01 | 7.33e-01 |
| GOMF CO SMAD BINDING | 8 | 3.03e-01 | -2.10e-01 | 6.42e-01 |
| GOBP REGULATION OF NEUTROPHIL CHEMOTAXIS | 26 | 6.34e-02 | -2.10e-01 | 2.90e-01 |
| GOCC NUCLEOTIDE EXCISION REPAIR COMPLEX | 11 | 2.27e-01 | -2.10e-01 | 5.56e-01 |
| GOBP PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS | 9 | 2.75e-01 | 2.10e-01 | 6.11e-01 |
| GOBP RECOMBINATIONAL REPAIR | 169 | 2.46e-06 | -2.10e-01 | 1.90e-04 |
| GOBP MITOTIC RECOMBINATION | 22 | 8.79e-02 | -2.10e-01 | 3.46e-01 |
| GOBP POSITIVE REGULATION OF MITOPHAGY | 7 | 3.36e-01 | -2.10e-01 | 6.70e-01 |
| GOBP MAST CELL MEDIATED IMMUNITY | 44 | 1.59e-02 | -2.10e-01 | 1.40e-01 |
| GOMF CHEMOKINE ACTIVITY | 23 | 8.13e-02 | 2.10e-01 | 3.35e-01 |
| GOMF OXALATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 3.04e-01 | 2.10e-01 | 6.43e-01 |
| GOMF ADENYLATE CYCLASE REGULATOR ACTIVITY | 6 | 3.74e-01 | -2.10e-01 | 7.02e-01 |
| GOMF 1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE ACTIVITY | 7 | 3.37e-01 | 2.10e-01 | 6.71e-01 |
| GOBP GLIAL CELL ACTIVATION | 41 | 2.03e-02 | -2.10e-01 | 1.58e-01 |
| GOBP AMYLOID BETA METABOLIC PROCESS | 44 | 1.64e-02 | -2.09e-01 | 1.43e-01 |
| GOBP POSITIVE REGULATION OF HEMOPOIESIS | 152 | 8.78e-06 | -2.09e-01 | 5.38e-04 |
| GOMF VERY LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 7 | 3.38e-01 | -2.09e-01 | 6.73e-01 |
| GOBP TETRAPYRROLE METABOLIC PROCESS | 49 | 1.14e-02 | 2.09e-01 | 1.13e-01 |
| GOBP CELLULAR RESPONSE TO POTASSIUM ION | 8 | 3.06e-01 | -2.09e-01 | 6.45e-01 |
| GOBP VITAMIN D METABOLIC PROCESS | 9 | 2.78e-01 | 2.09e-01 | 6.15e-01 |
| GOBP FOAM CELL DIFFERENTIATION | 27 | 6.06e-02 | 2.09e-01 | 2.84e-01 |
| GOBP HEAT GENERATION | 10 | 2.53e-01 | -2.09e-01 | 5.88e-01 |
| GOBP DEVELOPMENTAL INDUCTION | 14 | 1.77e-01 | -2.09e-01 | 4.92e-01 |
| GOMF TYPE II TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 10 | 2.54e-01 | -2.08e-01 | 5.88e-01 |
| GOBP ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 21 | 9.84e-02 | -2.08e-01 | 3.67e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 16 | 1.49e-01 | -2.08e-01 | 4.52e-01 |
| GOBP CANNABINOID SIGNALING PATHWAY | 5 | 4.20e-01 | 2.08e-01 | 7.38e-01 |
| GOBP PHOSPHATIDYLSERINE METABOLIC PROCESS | 20 | 1.07e-01 | -2.08e-01 | 3.82e-01 |
| GOBP FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS | 31 | 4.49e-02 | 2.08e-01 | 2.46e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET ACTIVATION | 11 | 2.32e-01 | 2.08e-01 | 5.63e-01 |
| GOCC MYELIN SHEATH ABAXONAL REGION | 6 | 3.77e-01 | 2.08e-01 | 7.05e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 36 | 3.08e-02 | -2.08e-01 | 2.00e-01 |
| GOBP POSITIVE REGULATION OF CELL KILLING | 44 | 1.70e-02 | -2.08e-01 | 1.45e-01 |
| GOCC PROTEASOME CORE COMPLEX | 18 | 1.27e-01 | 2.08e-01 | 4.18e-01 |
| GOCC SWI SNF COMPLEX | 27 | 6.16e-02 | -2.08e-01 | 2.87e-01 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE | 7 | 3.41e-01 | -2.08e-01 | 6.77e-01 |
| GOBP REGULATORY NCRNA MEDIATED GENE SILENCING | 124 | 6.46e-05 | -2.08e-01 | 2.82e-03 |
| GOBP REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 10 | 2.55e-01 | -2.08e-01 | 5.90e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS | 13 | 1.95e-01 | 2.08e-01 | 5.14e-01 |
| GOMF VOLTAGE GATED MONOATOMIC ANION CHANNEL ACTIVITY | 12 | 2.13e-01 | 2.08e-01 | 5.38e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE CAPPING | 14 | 1.79e-01 | -2.08e-01 | 4.94e-01 |
| GOBP RESPONSE TO NICOTINE | 24 | 7.85e-02 | -2.07e-01 | 3.30e-01 |
| GOBP CELLULAR RESPONSE TO ALKALOID | 29 | 5.32e-02 | -2.07e-01 | 2.66e-01 |
| GOBP MUSCLE ADAPTATION | 64 | 4.13e-03 | -2.07e-01 | 5.93e-02 |
| GOBP PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE | 8 | 3.10e-01 | -2.07e-01 | 6.50e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR ACTIVITY | 8 | 3.10e-01 | -2.07e-01 | 6.50e-01 |
| GOMF STRUCTURAL CONSTITUENT OF MUSCLE | 27 | 6.24e-02 | 2.07e-01 | 2.88e-01 |
| GOMF TITIN BINDING | 9 | 2.82e-01 | 2.07e-01 | 6.20e-01 |
| GOMF MAP KINASE KINASE KINASE ACTIVITY | 24 | 7.90e-02 | -2.07e-01 | 3.31e-01 |
| GOBP RESPONSE TO ALCOHOL | 164 | 4.84e-06 | -2.07e-01 | 3.47e-04 |
| GOCC SYNAPTIC CLEFT | 7 | 3.43e-01 | -2.07e-01 | 6.80e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 11 | 2.35e-01 | -2.07e-01 | 5.66e-01 |
| GOBP REGULATION OF MYOTUBE DIFFERENTIATION | 27 | 6.29e-02 | -2.07e-01 | 2.89e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 24 | 7.95e-02 | -2.07e-01 | 3.32e-01 |
| GOMF SULFURTRANSFERASE ACTIVITY | 11 | 2.35e-01 | 2.07e-01 | 5.66e-01 |
| GOBP RRNA PSEUDOURIDINE SYNTHESIS | 8 | 3.11e-01 | 2.07e-01 | 6.50e-01 |
| GOCC U5 SNRNP | 19 | 1.19e-01 | 2.07e-01 | 4.03e-01 |
| GOMF N ACETYLTRANSFERASE ACTIVITY | 60 | 5.65e-03 | -2.07e-01 | 7.39e-02 |
| GOBP POSITIVE REGULATION OF RECEPTOR CATABOLIC PROCESS | 6 | 3.81e-01 | -2.07e-01 | 7.08e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 26 | 6.83e-02 | -2.07e-01 | 3.02e-01 |
| GOBP POSTSYNAPTIC CYTOSKELETON ORGANIZATION | 10 | 2.58e-01 | 2.07e-01 | 5.94e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME | 93 | 5.82e-04 | -2.06e-01 | 1.47e-02 |
| GOCC ROUGH ENDOPLASMIC RETICULUM MEMBRANE | 23 | 8.66e-02 | 2.06e-01 | 3.45e-01 |
| GOBP RESPONSE TO SORBITOL | 6 | 3.81e-01 | -2.06e-01 | 7.09e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT | 6 | 3.82e-01 | 2.06e-01 | 7.09e-01 |
| GOBP CORTICOSTEROID RECEPTOR SIGNALING PATHWAY | 12 | 2.16e-01 | -2.06e-01 | 5.42e-01 |
| GOBP ACTIVIN RECEPTOR SIGNALING PATHWAY | 29 | 5.47e-02 | -2.06e-01 | 2.69e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 14 | 1.82e-01 | -2.06e-01 | 4.98e-01 |
| GOCC CHROMAFFIN GRANULE MEMBRANE | 7 | 3.45e-01 | -2.06e-01 | 6.81e-01 |
| GOMF LYSOPHOSPHOLIPASE ACTIVITY | 21 | 1.02e-01 | 2.06e-01 | 3.74e-01 |
| GOBP CELLULAR RESPONSE TO THYROID HORMONE STIMULUS | 13 | 1.98e-01 | -2.06e-01 | 5.19e-01 |
| GOBP REGULATION OF TOLERANCE INDUCTION | 13 | 1.98e-01 | -2.06e-01 | 5.19e-01 |
| GOBP REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 20 | 1.11e-01 | -2.06e-01 | 3.90e-01 |
| GOBP L PHENYLALANINE METABOLIC PROCESS | 7 | 3.45e-01 | 2.06e-01 | 6.82e-01 |
| GOBP REGULATION OF COMPLEMENT ACTIVATION | 15 | 1.67e-01 | 2.06e-01 | 4.80e-01 |
| GOBP REGULATION OF COMPLEMENT DEPENDENT CYTOTOXICITY | 6 | 3.83e-01 | 2.06e-01 | 7.10e-01 |
| GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 23 | 8.77e-02 | -2.06e-01 | 3.46e-01 |
| GOBP DETOXIFICATION OF INORGANIC COMPOUND | 16 | 1.54e-01 | 2.06e-01 | 4.59e-01 |
| GOBP MEGAKARYOCYTE DEVELOPMENT | 16 | 1.54e-01 | -2.06e-01 | 4.59e-01 |
| GOMF SULFATIDE BINDING | 6 | 3.83e-01 | -2.06e-01 | 7.10e-01 |
| GOBP VITAMIN D BIOSYNTHETIC PROCESS | 7 | 3.47e-01 | 2.05e-01 | 6.82e-01 |
| GOBP CARDIAC SEPTUM DEVELOPMENT | 71 | 2.77e-03 | -2.05e-01 | 4.55e-02 |
| GOBP POSITIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS | 11 | 2.38e-01 | -2.05e-01 | 5.71e-01 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 5 | 4.27e-01 | -2.05e-01 | 7.44e-01 |
| GOCC MICROTUBULE PLUS END | 22 | 9.58e-02 | 2.05e-01 | 3.65e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 12 | 2.19e-01 | 2.05e-01 | 5.46e-01 |
| GOBP OLIGOPEPTIDE TRANSMEMBRANE TRANSPORT | 8 | 3.15e-01 | -2.05e-01 | 6.54e-01 |
| GOBP REGULATION OF FATTY ACID BETA OXIDATION | 15 | 1.69e-01 | -2.05e-01 | 4.82e-01 |
| GOCC NODE OF RANVIER | 9 | 2.87e-01 | 2.05e-01 | 6.25e-01 |
| GOBP SUGAR MEDIATED SIGNALING PATHWAY | 7 | 3.47e-01 | -2.05e-01 | 6.83e-01 |
| GOMF SINGLE STRANDED DNA 5 3 DNA EXONUCLEASE ACTIVITY | 5 | 4.27e-01 | -2.05e-01 | 7.44e-01 |
| GOMF BMP BINDING | 7 | 3.48e-01 | -2.05e-01 | 6.83e-01 |
| GOBP DEPYRIMIDINATION | 8 | 3.15e-01 | 2.05e-01 | 6.54e-01 |
| GOCC NUCLEAR CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 15 | 1.69e-01 | -2.05e-01 | 4.82e-01 |
| GOMF CYTOKINE RECEPTOR ACTIVITY | 55 | 8.59e-03 | -2.05e-01 | 9.42e-02 |
| GOCC CTF18 RFC LIKE COMPLEX | 7 | 3.48e-01 | -2.05e-01 | 6.83e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 20 | 1.13e-01 | 2.04e-01 | 3.96e-01 |
| GOBP VIRAL GENE EXPRESSION | 95 | 5.76e-04 | -2.04e-01 | 1.47e-02 |
| GOMF NAD P H DEHYDROGENASE QUINONE ACTIVITY | 45 | 1.78e-02 | 2.04e-01 | 1.48e-01 |
| GOBP RESPONSE TO LIPOTEICHOIC ACID | 9 | 2.89e-01 | 2.04e-01 | 6.27e-01 |
| GOBP PROTEIN LOCALIZATION TO MEMBRANE RAFT | 6 | 3.86e-01 | 2.04e-01 | 7.13e-01 |
| GOBP REGULATION OF MYELOID CELL DIFFERENTIATION | 151 | 1.50e-05 | -2.04e-01 | 8.65e-04 |
| GOBP RESPONSE TO BACTERIAL LIPOPROTEIN | 7 | 3.50e-01 | 2.04e-01 | 6.85e-01 |
| GOBP INDOLE CONTAINING COMPOUND METABOLIC PROCESS | 17 | 1.45e-01 | -2.04e-01 | 4.45e-01 |
| GOBP MITOCHONDRION MORPHOGENESIS | 20 | 1.14e-01 | 2.04e-01 | 3.97e-01 |
| GOBP REGULATION OF TRANSMISSION OF NERVE IMPULSE | 7 | 3.50e-01 | -2.04e-01 | 6.86e-01 |
| GOBP EPITHELIAL CELL CELL ADHESION | 12 | 2.22e-01 | 2.04e-01 | 5.50e-01 |
| GOMF NF KAPPAB INDUCING KINASE ACTIVITY | 6 | 3.87e-01 | 2.04e-01 | 7.14e-01 |
| GOBP REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 19 | 1.24e-01 | -2.04e-01 | 4.14e-01 |
| GOBP CELLULAR RESPONSE TO ACIDIC PH | 9 | 2.90e-01 | 2.04e-01 | 6.29e-01 |
| GOMF ACTININ BINDING | 22 | 9.82e-02 | 2.04e-01 | 3.67e-01 |
| GOCC MALE PRONUCLEUS | 7 | 3.51e-01 | -2.04e-01 | 6.86e-01 |
| GOBP GANGLION DEVELOPMENT | 9 | 2.90e-01 | 2.04e-01 | 6.29e-01 |
| GOBP TRYPTOPHAN TRANSPORT | 5 | 4.30e-01 | 2.04e-01 | 7.48e-01 |
| GOBP REGULATION OF VASOCONSTRICTION | 31 | 4.98e-02 | -2.04e-01 | 2.60e-01 |
| GOMF ATPASE COUPLED MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 37 | 3.22e-02 | 2.04e-01 | 2.06e-01 |
| GOMF G PROTEIN COUPLED CHEMOATTRACTANT RECEPTOR ACTIVITY | 12 | 2.22e-01 | 2.03e-01 | 5.51e-01 |
| GOBP EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT | 6 | 3.88e-01 | 2.03e-01 | 7.14e-01 |
| GOBP RESPONSE TO ANTIBIOTIC | 34 | 4.01e-02 | -2.03e-01 | 2.31e-01 |
| GOBP REGULATION OF GRANULOCYTE CHEMOTAXIS | 37 | 3.23e-02 | -2.03e-01 | 2.07e-01 |
| GOBP MYOBLAST MIGRATION | 9 | 2.91e-01 | 2.03e-01 | 6.30e-01 |
| GOBP REGULATION OF RESPONSE TO OSMOTIC STRESS | 11 | 2.43e-01 | 2.03e-01 | 5.76e-01 |
| GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 6 | 3.89e-01 | -2.03e-01 | 7.15e-01 |
| GOMF INTERLEUKIN 6 RECEPTOR BINDING | 5 | 4.31e-01 | 2.03e-01 | 7.48e-01 |
| GOBP NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 6 | 3.89e-01 | 2.03e-01 | 7.15e-01 |
| GOBP NEGATIVE REGULATION OF SODIUM ION TRANSPORT | 6 | 3.89e-01 | 2.03e-01 | 7.15e-01 |
| GOBP REGULATION OF INTRACELLULAR LIPID TRANSPORT | 6 | 3.89e-01 | 2.03e-01 | 7.15e-01 |
| GOBP REGULATION OF SENSORY PERCEPTION | 10 | 2.66e-01 | 2.03e-01 | 6.03e-01 |
| GOCC PRESYNAPTIC ENDOCYTIC ZONE | 7 | 3.52e-01 | -2.03e-01 | 6.87e-01 |
| GOBP ATP BIOSYNTHETIC PROCESS | 93 | 7.14e-04 | 2.03e-01 | 1.72e-02 |
| GOMF BETA N ACETYLHEXOSAMINIDASE ACTIVITY | 5 | 4.32e-01 | -2.03e-01 | 7.49e-01 |
| GOBP REGULATION OF CHAPERONE MEDIATED AUTOPHAGY | 6 | 3.89e-01 | 2.03e-01 | 7.15e-01 |
| GOBP DENDRITE EXTENSION | 24 | 8.52e-02 | 2.03e-01 | 3.43e-01 |
| GOMF NOTCH BINDING | 18 | 1.36e-01 | -2.03e-01 | 4.33e-01 |
| GOBP PROTEIN GERANYLGERANYLATION | 7 | 3.53e-01 | -2.03e-01 | 6.87e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID BETA FORMATION | 14 | 1.89e-01 | -2.03e-01 | 5.08e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM EXIT SITE | 7 | 3.53e-01 | 2.03e-01 | 6.87e-01 |
| GOMF FLOPPASE ACTIVITY | 15 | 1.75e-01 | -2.03e-01 | 4.90e-01 |
| GOBP POSTSYNAPTIC MEMBRANE ORGANIZATION | 25 | 7.98e-02 | -2.02e-01 | 3.32e-01 |
| GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 8 | 3.22e-01 | -2.02e-01 | 6.61e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY | 10 | 2.68e-01 | 2.02e-01 | 6.05e-01 |
| GOBP CELLULAR RESPONSE TO RETINOIC ACID | 32 | 4.76e-02 | -2.02e-01 | 2.54e-01 |
| GOCC VACUOLAR PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 9 | 2.93e-01 | 2.02e-01 | 6.31e-01 |
| GOMF PHOSPHOTYROSINE RESIDUE BINDING | 40 | 2.69e-02 | -2.02e-01 | 1.86e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX CATALYTIC CORE F 1 | 6 | 3.91e-01 | 2.02e-01 | 7.17e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL FISSION | 18 | 1.38e-01 | 2.02e-01 | 4.36e-01 |
| GOBP TOLL SIGNALING PATHWAY | 10 | 2.69e-01 | -2.02e-01 | 6.06e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 105 | 3.58e-04 | -2.02e-01 | 1.01e-02 |
| GOCC SNARE COMPLEX | 41 | 2.54e-02 | 2.02e-01 | 1.80e-01 |
| GOMF ATPASE REGULATOR ACTIVITY | 46 | 1.80e-02 | 2.02e-01 | 1.49e-01 |
| GOBP T CELL TOLERANCE INDUCTION | 9 | 2.95e-01 | -2.02e-01 | 6.32e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 40 | 2.73e-02 | 2.02e-01 | 1.88e-01 |
| GOMF COBALAMIN BINDING | 8 | 3.24e-01 | 2.02e-01 | 6.62e-01 |
| GOBP DE NOVO NAD BIOSYNTHETIC PROCESS | 7 | 3.56e-01 | -2.02e-01 | 6.89e-01 |
| GOMF MRNA BINDING | 271 | 1.18e-08 | -2.02e-01 | 2.29e-06 |
| GOBP REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 9 | 2.95e-01 | 2.02e-01 | 6.33e-01 |
| GOBP CRANIOFACIAL SUTURE MORPHOGENESIS | 8 | 3.24e-01 | 2.01e-01 | 6.62e-01 |
| GOBP REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 13 | 2.08e-01 | -2.01e-01 | 5.32e-01 |
| GOBP ECTOPIC GERM CELL PROGRAMMED CELL DEATH | 13 | 2.09e-01 | 2.01e-01 | 5.32e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 11 | 2.47e-01 | -2.01e-01 | 5.82e-01 |
| GOBP L ARGININE TRANSMEMBRANE TRANSPORT | 11 | 2.47e-01 | 2.01e-01 | 5.82e-01 |
| GOBP G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY | 7 | 3.56e-01 | 2.01e-01 | 6.89e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR | 82 | 1.63e-03 | -2.01e-01 | 3.10e-02 |
| GOBP REGULATION OF NK T CELL PROLIFERATION | 6 | 3.93e-01 | -2.01e-01 | 7.18e-01 |
| GOBP DETERMINATION OF DORSAL VENTRAL ASYMMETRY | 6 | 3.94e-01 | -2.01e-01 | 7.18e-01 |
| GOBP POSITIVE REGULATION OF BEHAVIOR | 10 | 2.71e-01 | 2.01e-01 | 6.08e-01 |
| GOCC RNA POLYMERASE I COMPLEX | 10 | 2.71e-01 | 2.01e-01 | 6.08e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION | 208 | 5.91e-07 | -2.01e-01 | 6.04e-05 |
| GOBP LIPID DROPLET DISASSEMBLY | 5 | 4.36e-01 | -2.01e-01 | 7.51e-01 |
| GOMF HISTONE H4K20 MONOMETHYLTRANSFERASE ACTIVITY | 5 | 4.37e-01 | -2.01e-01 | 7.51e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS | 32 | 4.93e-02 | -2.01e-01 | 2.58e-01 |
| GOBP CYCLOOXYGENASE PATHWAY | 8 | 3.26e-01 | -2.01e-01 | 6.63e-01 |
| GOBP EMBRYONIC PLACENTA MORPHOGENESIS | 17 | 1.52e-01 | -2.01e-01 | 4.56e-01 |
| GOBP ALPHA BETA T CELL PROLIFERATION | 33 | 4.62e-02 | -2.01e-01 | 2.50e-01 |
| GOBP B CELL DIFFERENTIATION | 105 | 3.86e-04 | -2.01e-01 | 1.07e-02 |
| GOBP HOMOCYSTEINE METABOLIC PROCESS | 8 | 3.26e-01 | 2.01e-01 | 6.63e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 59 | 7.75e-03 | -2.00e-01 | 8.84e-02 |
| GOBP CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 9 | 2.98e-01 | 2.00e-01 | 6.36e-01 |
| GOCC FILTRATION DIAPHRAGM | 5 | 4.38e-01 | 2.00e-01 | 7.51e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 16 | 1.65e-01 | 2.00e-01 | 4.76e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY | 10 | 2.73e-01 | -2.00e-01 | 6.09e-01 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE | 30 | 5.76e-02 | 2.00e-01 | 2.76e-01 |
| GOBP RELAXATION OF SMOOTH MUSCLE | 7 | 3.59e-01 | -2.00e-01 | 6.91e-01 |
| GOMF IMMUNE RECEPTOR ACTIVITY | 87 | 1.26e-03 | -2.00e-01 | 2.57e-02 |
| GOCC CYTOPLASMIC STRESS GRANULE | 78 | 2.26e-03 | -2.00e-01 | 3.93e-02 |
| GOMF INOSITOL TETRAKISPHOSPHATE PHOSPHATASE ACTIVITY | 7 | 3.59e-01 | -2.00e-01 | 6.91e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY | 11 | 2.51e-01 | 2.00e-01 | 5.85e-01 |
| GOBP PROTEIN PEPTIDYL PROLYL ISOMERIZATION | 19 | 1.31e-01 | 2.00e-01 | 4.25e-01 |
| GOCC CONE PHOTORECEPTOR OUTER SEGMENT | 5 | 4.39e-01 | 2.00e-01 | 7.52e-01 |
| GOMF L ASCORBIC ACID BINDING | 16 | 1.67e-01 | 2.00e-01 | 4.79e-01 |
| GOBP NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 12 | 2.31e-01 | 2.00e-01 | 5.62e-01 |
| GOBP METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT | 12 | 2.31e-01 | 2.00e-01 | 5.62e-01 |
| GOBP REGULATION OF TELOMERE CAPPING | 23 | 9.76e-02 | -2.00e-01 | 3.66e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 14 | 1.96e-01 | 1.99e-01 | 5.16e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE SECRETION | 38 | 3.34e-02 | 1.99e-01 | 2.11e-01 |
| GOMF PATTERN RECOGNITION RECEPTOR ACTIVITY | 24 | 9.08e-02 | -1.99e-01 | 3.53e-01 |
| GOBP BASE EXCISION REPAIR | 42 | 2.54e-02 | -1.99e-01 | 1.80e-01 |
| GOBP CLATHRIN COATED VESICLE CARGO LOADING | 7 | 3.61e-01 | -1.99e-01 | 6.94e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 78 | 2.36e-03 | -1.99e-01 | 4.06e-02 |
| GOBP VACUOLAR ACIDIFICATION | 32 | 5.12e-02 | 1.99e-01 | 2.62e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGG ISOTYPES | 8 | 3.29e-01 | -1.99e-01 | 6.66e-01 |
| GOBP RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR | 16 | 1.68e-01 | -1.99e-01 | 4.81e-01 |
| GOBP NUCLEAR PORE COMPLEX ASSEMBLY | 11 | 2.53e-01 | -1.99e-01 | 5.88e-01 |
| GOMF SYNTAXIN 1 BINDING | 12 | 2.33e-01 | -1.99e-01 | 5.63e-01 |
| GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 6 | 3.99e-01 | 1.99e-01 | 7.22e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE CAPPING | 8 | 3.30e-01 | -1.99e-01 | 6.67e-01 |
| GOCC MITOCHONDRIAL MATRIX | 445 | 7.72e-13 | 1.99e-01 | 2.99e-10 |
| GOMF DYNEIN INTERMEDIATE CHAIN BINDING | 28 | 6.92e-02 | 1.98e-01 | 3.05e-01 |
| GOBP TRNA 5 LEADER REMOVAL | 13 | 2.16e-01 | 1.98e-01 | 5.42e-01 |
| GOBP POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 75 | 3.00e-03 | -1.98e-01 | 4.80e-02 |
| GOMF TELOMERIC DNA BINDING | 38 | 3.45e-02 | -1.98e-01 | 2.16e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL | 9 | 3.03e-01 | -1.98e-01 | 6.42e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY | 7 | 3.64e-01 | 1.98e-01 | 6.96e-01 |
| GOBP MODIFICATION OF POSTSYNAPTIC STRUCTURE | 14 | 1.99e-01 | 1.98e-01 | 5.20e-01 |
| GOBP NEGATIVE REGULATION OF ATP DEPENDENT ACTIVITY | 12 | 2.35e-01 | -1.98e-01 | 5.66e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 8 | 3.32e-01 | 1.98e-01 | 6.67e-01 |
| GOBP CELLULAR RESPONSE TO LEUCINE | 11 | 2.55e-01 | -1.98e-01 | 5.91e-01 |
| GOBP REGULATION OF HEAT GENERATION | 7 | 3.64e-01 | -1.98e-01 | 6.97e-01 |
| GOBP NK T CELL PROLIFERATION | 8 | 3.32e-01 | -1.98e-01 | 6.67e-01 |
| GOBP HISTAMINE SECRETION | 11 | 2.56e-01 | -1.98e-01 | 5.91e-01 |
| GOBP HISTAMINE TRANSPORT | 11 | 2.56e-01 | -1.98e-01 | 5.91e-01 |
| GOBP DEFENSE RESPONSE TO TUMOR CELL | 11 | 2.56e-01 | 1.98e-01 | 5.91e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 9 | 3.04e-01 | -1.98e-01 | 6.43e-01 |
| GOBP MEIOTIC CHROMOSOME SEPARATION | 5 | 4.44e-01 | -1.98e-01 | 7.55e-01 |
| GOBP SYNCYTIUM FORMATION | 45 | 2.18e-02 | 1.98e-01 | 1.63e-01 |
| GOBP CHONDROCYTE HYPERTROPHY | 5 | 4.44e-01 | -1.98e-01 | 7.55e-01 |
| GOBP WATER SOLUBLE VITAMIN METABOLIC PROCESS | 50 | 1.57e-02 | 1.98e-01 | 1.39e-01 |
| GOBP CARNITINE TRANSPORT | 7 | 3.65e-01 | 1.98e-01 | 6.97e-01 |
| GOBP PROXIMAL TUBULE DEVELOPMENT | 7 | 3.66e-01 | 1.97e-01 | 6.98e-01 |
| GOBP TOLERANCE INDUCTION | 18 | 1.47e-01 | -1.97e-01 | 4.49e-01 |
| GOCC PARALLEL FIBER TO PURKINJE CELL SYNAPSE | 12 | 2.37e-01 | -1.97e-01 | 5.68e-01 |
| GOCC NUCLEOSOME | 33 | 5.00e-02 | -1.97e-01 | 2.60e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC | 5 | 4.45e-01 | 1.97e-01 | 7.56e-01 |
| GOCC RNA POLYMERASE III COMPLEX | 18 | 1.48e-01 | 1.97e-01 | 4.50e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 73 | 3.64e-03 | -1.97e-01 | 5.45e-02 |
| GOBP FRUCTOSE METABOLIC PROCESS | 12 | 2.38e-01 | 1.97e-01 | 5.70e-01 |
| GOMF CHANNEL INHIBITOR ACTIVITY | 27 | 7.67e-02 | 1.97e-01 | 3.25e-01 |
| GOBP REGULATION OF NEURON MIGRATION | 28 | 7.15e-02 | -1.97e-01 | 3.11e-01 |
| GOCC ENDOPEPTIDASE COMPLEX | 75 | 3.23e-03 | 1.97e-01 | 5.04e-02 |
| GOBP NEGATIVE REGULATION OF RNA SPLICING | 27 | 7.69e-02 | -1.97e-01 | 3.25e-01 |
| GOBP OLIGOPEPTIDE IMPORT ACROSS PLASMA MEMBRANE | 5 | 4.46e-01 | 1.97e-01 | 7.57e-01 |
| GOBP LEUKOCYTE DEGRANULATION | 60 | 8.46e-03 | -1.97e-01 | 9.36e-02 |
| GOBP POSITIVE REGULATION OF TISSUE REMODELING | 7 | 3.68e-01 | -1.96e-01 | 7.00e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION | 49 | 1.74e-02 | -1.96e-01 | 1.47e-01 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 6 | 4.05e-01 | -1.96e-01 | 7.26e-01 |
| GOBP VITAMIN TRANSPORT | 31 | 5.87e-02 | 1.96e-01 | 2.79e-01 |
| GOMF DNA BINDING TRANSCRIPTION REPRESSOR ACTIVITY | 237 | 2.04e-07 | -1.96e-01 | 2.72e-05 |
| GOMF 5 3 DNA EXONUCLEASE ACTIVITY | 9 | 3.08e-01 | -1.96e-01 | 6.48e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS | 49 | 1.76e-02 | 1.96e-01 | 1.48e-01 |
| GOBP PEPTIDYL PROLINE HYDROXYLATION | 10 | 2.83e-01 | 1.96e-01 | 6.21e-01 |
| GOBP RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION | 6 | 4.06e-01 | -1.96e-01 | 7.27e-01 |
| GOBP STEROL METABOLIC PROCESS | 106 | 4.96e-04 | 1.96e-01 | 1.31e-02 |
| GOBP POSITIVE REGULATION OF TAU PROTEIN KINASE ACTIVITY | 5 | 4.48e-01 | 1.96e-01 | 7.58e-01 |
| GOMF PROTEIN PHOSPHATASE ACTIVATOR ACTIVITY | 14 | 2.05e-01 | 1.96e-01 | 5.27e-01 |
| GOBP PROSTAGLANDIN TRANSPORT | 15 | 1.89e-01 | 1.96e-01 | 5.09e-01 |
| GOBP MAINTENANCE OF POSTSYNAPTIC SPECIALIZATION STRUCTURE | 8 | 3.38e-01 | 1.96e-01 | 6.72e-01 |
| GOBP ANGIOTENSIN ACTIVATED SIGNALING PATHWAY | 10 | 2.84e-01 | -1.96e-01 | 6.22e-01 |
| GOBP METENCEPHALON DEVELOPMENT | 75 | 3.41e-03 | -1.96e-01 | 5.21e-02 |
| GOCC RNA POLYMERASE II CORE COMPLEX | 15 | 1.90e-01 | 1.96e-01 | 5.09e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 699 | 1.67e-18 | -1.96e-01 | 9.92e-16 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING POSTURE | 13 | 2.22e-01 | 1.96e-01 | 5.51e-01 |
| GOMF OXIDOREDUCTION DRIVEN ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 65 | 6.42e-03 | 1.96e-01 | 7.91e-02 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 10 | 2.84e-01 | -1.96e-01 | 6.22e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING | 9 | 3.10e-01 | -1.96e-01 | 6.49e-01 |
| GOBP MAST CELL ACTIVATION | 50 | 1.68e-02 | -1.96e-01 | 1.45e-01 |
| GOBP CONVERGENT EXTENSION INVOLVED IN GASTRULATION | 6 | 4.07e-01 | 1.95e-01 | 7.27e-01 |
| GOMF ORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 20 | 1.30e-01 | 1.95e-01 | 4.23e-01 |
| GOBP POSITIVE REGULATION OF AMINE METABOLIC PROCESS | 5 | 4.50e-01 | 1.95e-01 | 7.59e-01 |
| GOBP PROTEIN HETEROTETRAMERIZATION | 12 | 2.42e-01 | -1.95e-01 | 5.75e-01 |
| GOBP MODULATION OF PROCESS OF ANOTHER ORGANISM | 9 | 3.11e-01 | -1.95e-01 | 6.50e-01 |
| GOMF RECEPTOR TYROSINE KINASE BINDING | 63 | 7.50e-03 | -1.95e-01 | 8.61e-02 |
| GOMF NITRIC OXIDE SYNTHASE BINDING | 8 | 3.40e-01 | -1.95e-01 | 6.76e-01 |
| GOBP RESPONSE TO MURAMYL DIPEPTIDE | 19 | 1.42e-01 | -1.95e-01 | 4.42e-01 |
| GOBP CD40 SIGNALING PATHWAY | 14 | 2.07e-01 | 1.95e-01 | 5.31e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 17 | 1.65e-01 | -1.95e-01 | 4.76e-01 |
| GOBP REGULATION OF HYALURONAN BIOSYNTHETIC PROCESS | 5 | 4.51e-01 | 1.95e-01 | 7.60e-01 |
| GOBP HEART GROWTH | 48 | 1.97e-02 | -1.95e-01 | 1.56e-01 |
| GOBP PROTON TRANSMEMBRANE TRANSPORT | 127 | 1.55e-04 | 1.94e-01 | 5.35e-03 |
| GOBP SECRETORY GRANULE LOCALIZATION | 9 | 3.12e-01 | 1.94e-01 | 6.51e-01 |
| GOMF SPHINGOLIPID BINDING | 21 | 1.23e-01 | 1.94e-01 | 4.11e-01 |
| GOBP ALLANTOIN METABOLIC PROCESS | 6 | 4.10e-01 | 1.94e-01 | 7.29e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 4.52e-01 | -1.94e-01 | 7.61e-01 |
| GOBP ACTIN CROSSLINK FORMATION | 11 | 2.65e-01 | 1.94e-01 | 6.02e-01 |
| GOBP MITOCHONDRIAL RESPIRASOME ASSEMBLY | 9 | 3.13e-01 | 1.94e-01 | 6.52e-01 |
| GOBP CELLULAR DETOXIFICATION OF ALDEHYDE | 7 | 3.74e-01 | 1.94e-01 | 7.02e-01 |
| GOBP REGULATION OF MITOCHONDRIAL TRANSLATION | 25 | 9.32e-02 | 1.94e-01 | 3.60e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 7 | 3.74e-01 | 1.94e-01 | 7.02e-01 |
| GOMF N ACYLTRANSFERASE ACTIVITY | 76 | 3.47e-03 | -1.94e-01 | 5.28e-02 |
| GOBP NEGATIVE REGULATION OF FAT CELL PROLIFERATION | 5 | 4.53e-01 | -1.94e-01 | 7.61e-01 |
| GOBP POSITIVE REGULATION OF MRNA PROCESSING | 26 | 8.70e-02 | -1.94e-01 | 3.45e-01 |
| GOBP ESTABLISHMENT OF RNA LOCALIZATION | 144 | 6.05e-05 | -1.94e-01 | 2.70e-03 |
| GOMF TRANSCRIPTION COREPRESSOR ACTIVITY | 166 | 1.70e-05 | -1.94e-01 | 9.65e-04 |
| GOMF TAT PROTEIN BINDING | 10 | 2.89e-01 | -1.94e-01 | 6.28e-01 |
| GOCC SARCOPLASMIC RETICULUM MEMBRANE | 30 | 6.66e-02 | -1.94e-01 | 2.98e-01 |
| GOBP PARAXIAL MESODERM DEVELOPMENT | 10 | 2.90e-01 | -1.93e-01 | 6.29e-01 |
| GOBP GTP METABOLIC PROCESS | 23 | 1.08e-01 | 1.93e-01 | 3.86e-01 |
| GOMF PROTEIN TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 36 | 4.47e-02 | 1.93e-01 | 2.46e-01 |
| GOMF RAGE RECEPTOR BINDING | 8 | 3.44e-01 | -1.93e-01 | 6.80e-01 |
| GOBP R LOOP PROCESSING | 6 | 4.12e-01 | -1.93e-01 | 7.31e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS | 34 | 5.13e-02 | 1.93e-01 | 2.62e-01 |
| GOCC INHIBITORY SYNAPSE | 6 | 4.13e-01 | -1.93e-01 | 7.31e-01 |
| GOBP LIPOXYGENASE PATHWAY | 5 | 4.55e-01 | 1.93e-01 | 7.62e-01 |
| GOBP BONE MATURATION | 17 | 1.68e-01 | 1.93e-01 | 4.81e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS | 1150 | 5.92e-28 | -1.93e-01 | 5.26e-24 |
| GOBP POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT | 13 | 2.28e-01 | 1.93e-01 | 5.58e-01 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 65 | 7.14e-03 | -1.93e-01 | 8.39e-02 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN | 8 | 3.45e-01 | -1.93e-01 | 6.81e-01 |
| GOBP EMBRYONIC HEMOPOIESIS | 15 | 1.96e-01 | -1.93e-01 | 5.15e-01 |
| GOMF DNA DIRECTED DNA POLYMERASE ACTIVITY | 23 | 1.09e-01 | -1.93e-01 | 3.88e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF NF KAPPAB | 8 | 3.45e-01 | 1.93e-01 | 6.81e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 8 | 3.45e-01 | 1.93e-01 | 6.81e-01 |
| GOCC RNA POLYMERASE I TRANSCRIPTION REGULATOR COMPLEX | 5 | 4.55e-01 | -1.93e-01 | 7.62e-01 |
| GOCC RNA POLYMERASE TRANSCRIPTION FACTOR SL1 COMPLEX | 5 | 4.55e-01 | -1.93e-01 | 7.62e-01 |
| GOMF GLUTATHIONE PEROXIDASE ACTIVITY | 14 | 2.12e-01 | 1.93e-01 | 5.37e-01 |
| GOCC MRNA CLEAVAGE FACTOR COMPLEX | 19 | 1.46e-01 | -1.93e-01 | 4.47e-01 |
| GOMF DOUBLE STRANDED RNA BINDING | 65 | 7.27e-03 | -1.93e-01 | 8.48e-02 |
| GOBP NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS | 964 | 7.74e-24 | -1.93e-01 | 1.15e-20 |
| GOBP REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 10 | 2.92e-01 | -1.93e-01 | 6.31e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS | 12 | 2.48e-01 | 1.93e-01 | 5.82e-01 |
| GOBP POSITIVE REGULATION OF PSEUDOPODIUM ASSEMBLY | 8 | 3.46e-01 | -1.92e-01 | 6.82e-01 |
| GOCC CILIARY ROOTLET | 11 | 2.69e-01 | -1.92e-01 | 6.06e-01 |
| GOMF L ARGININE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 3.18e-01 | 1.92e-01 | 6.57e-01 |
| GOCC SPERM HEAD | 7 | 3.78e-01 | 1.92e-01 | 7.06e-01 |
| GOBP REGULATION OF STEM CELL POPULATION MAINTENANCE | 62 | 8.83e-03 | -1.92e-01 | 9.66e-02 |
| GOMF CYCLIC NUCLEOTIDE DEPENDENT PROTEIN KINASE ACTIVITY | 6 | 4.15e-01 | 1.92e-01 | 7.33e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 8 | 3.46e-01 | 1.92e-01 | 6.82e-01 |
| GOBP MARGINAL ZONE B CELL DIFFERENTIATION | 8 | 3.46e-01 | -1.92e-01 | 6.82e-01 |
| GOBP CARDIAC CHAMBER FORMATION | 5 | 4.57e-01 | 1.92e-01 | 7.62e-01 |
| GOBP RESPONSE TO GRAM POSITIVE BACTERIUM | 5 | 4.57e-01 | 1.92e-01 | 7.62e-01 |
| GOBP RESPONSE TO MITOCHONDRIAL DEPOLARISATION | 20 | 1.37e-01 | 1.92e-01 | 4.34e-01 |
| GOBP MAGNESIUM ION HOMEOSTASIS | 7 | 3.79e-01 | 1.92e-01 | 7.06e-01 |
| GOBP CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE | 13 | 2.30e-01 | -1.92e-01 | 5.61e-01 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 57 | 1.21e-02 | -1.92e-01 | 1.17e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR KINASE ACTIVITY | 6 | 4.15e-01 | -1.92e-01 | 7.33e-01 |
| GOMF ISOPRENOID BINDING | 14 | 2.13e-01 | -1.92e-01 | 5.38e-01 |
| GOBP PROTEIN FOLDING IN ENDOPLASMIC RETICULUM | 11 | 2.70e-01 | -1.92e-01 | 6.07e-01 |
| GOBP LEUKOCYTE TETHERING OR ROLLING | 21 | 1.28e-01 | -1.92e-01 | 4.20e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS | 21 | 1.28e-01 | 1.92e-01 | 4.20e-01 |
| GOBP V D J RECOMBINATION | 16 | 1.84e-01 | -1.92e-01 | 5.01e-01 |
| GOBP RESPONSE TO THYROID HORMONE | 21 | 1.28e-01 | -1.92e-01 | 4.20e-01 |
| GOBP POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 8 | 3.48e-01 | 1.92e-01 | 6.83e-01 |
| GOBP RESPONSE TO UV | 130 | 1.62e-04 | -1.92e-01 | 5.51e-03 |
| GOCC CILIARY TRANSITION FIBER | 7 | 3.80e-01 | -1.92e-01 | 7.07e-01 |
| GOBP INTERLEUKIN 6 PRODUCTION | 116 | 3.67e-04 | -1.92e-01 | 1.03e-02 |
| GOBP SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 14 | 2.15e-01 | 1.92e-01 | 5.40e-01 |
| GOBP CELLULAR RESPONSE TO EXOGENOUS DSRNA | 13 | 2.32e-01 | -1.92e-01 | 5.63e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE BINDING | 28 | 7.94e-02 | -1.92e-01 | 3.32e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 22 | 1.20e-01 | -1.92e-01 | 4.05e-01 |
| GOBP ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT | 125 | 2.20e-04 | 1.92e-01 | 7.00e-03 |
| GOBP TRIF DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 11 | 2.72e-01 | -1.91e-01 | 6.09e-01 |
| GOBP POSITIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 8 | 3.49e-01 | -1.91e-01 | 6.84e-01 |
| GOMF INOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 2.72e-01 | -1.91e-01 | 6.09e-01 |
| GOBP REGULATION OF NEUTROPHIL MIGRATION | 37 | 4.42e-02 | -1.91e-01 | 2.44e-01 |
| GOBP REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 40 | 3.66e-02 | -1.91e-01 | 2.22e-01 |
| GOBP GAS TRANSPORT | 9 | 3.21e-01 | -1.91e-01 | 6.61e-01 |
| GOMF DAMAGED DNA BINDING | 70 | 5.75e-03 | -1.91e-01 | 7.50e-02 |
| GOMF TRANSCRIPTION COREGULATOR ACTIVITY | 440 | 7.52e-12 | -1.91e-01 | 2.39e-09 |
| GOMF PROTEIN DISULFIDE REDUCTASE ACTIVITY | 25 | 9.86e-02 | 1.91e-01 | 3.67e-01 |
| GOBP TRNA 5 END PROCESSING | 16 | 1.86e-01 | 1.91e-01 | 5.04e-01 |
| GOBP POSITIVE REGULATION OF STEROID HORMONE SECRETION | 5 | 4.60e-01 | -1.91e-01 | 7.64e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYPOXIA | 9 | 3.22e-01 | -1.91e-01 | 6.61e-01 |
| GOBP ELECTRON TRANSPORT CHAIN | 154 | 4.54e-05 | 1.91e-01 | 2.14e-03 |
| GOCC ALVEOLAR LAMELLAR BODY | 5 | 4.61e-01 | 1.90e-01 | 7.64e-01 |
| GOBP ADIPOSE TISSUE DEVELOPMENT | 49 | 2.12e-02 | -1.90e-01 | 1.61e-01 |
| GOMF GLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY | 5 | 4.61e-01 | 1.90e-01 | 7.64e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 40 | 3.74e-02 | 1.90e-01 | 2.24e-01 |
| GOBP SENSORY PERCEPTION OF TEMPERATURE STIMULUS | 17 | 1.75e-01 | -1.90e-01 | 4.90e-01 |
| GOBP NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE | 76 | 4.16e-03 | -1.90e-01 | 5.94e-02 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 50 | 2.00e-02 | -1.90e-01 | 1.57e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE C SIGNALING | 5 | 4.62e-01 | 1.90e-01 | 7.64e-01 |
| GOBP MEMBRANE HYPERPOLARIZATION | 8 | 3.52e-01 | 1.90e-01 | 6.87e-01 |
| GOMF RNA DNA HYBRID RIBONUCLEASE ACTIVITY | 5 | 4.62e-01 | -1.90e-01 | 7.64e-01 |
| GOBP MATURATION OF 5 8S RRNA | 36 | 4.86e-02 | 1.90e-01 | 2.57e-01 |
| GOBP NEGATIVE REGULATION OF HEMOPOIESIS | 78 | 3.75e-03 | -1.90e-01 | 5.55e-02 |
| GOBP RESPONSE TO AMPHETAMINE | 16 | 1.89e-01 | -1.90e-01 | 5.08e-01 |
| GOBP CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS | 12 | 2.56e-01 | -1.90e-01 | 5.91e-01 |
| GOMF TUMOR NECROSIS FACTOR BINDING | 7 | 3.86e-01 | -1.89e-01 | 7.12e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A RRNA | 22 | 1.24e-01 | 1.89e-01 | 4.14e-01 |
| GOCC PROTEIN DNA COMPLEX | 899 | 1.00e-21 | -1.89e-01 | 9.91e-19 |
| GOBP INORGANIC ANION TRANSMEMBRANE TRANSPORT | 71 | 5.84e-03 | 1.89e-01 | 7.58e-02 |
| GOBP INTESTINAL EPITHELIAL CELL DEVELOPMENT | 12 | 2.56e-01 | 1.89e-01 | 5.91e-01 |
| GOBP CORONARY VASCULATURE DEVELOPMENT | 34 | 5.63e-02 | -1.89e-01 | 2.74e-01 |
| GOBP UV PROTECTION | 9 | 3.26e-01 | -1.89e-01 | 6.63e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL JUNCTION | 77 | 4.15e-03 | 1.89e-01 | 5.94e-02 |
| GOBP POSITIVE REGULATION OF BONE RESORPTION | 15 | 2.05e-01 | 1.89e-01 | 5.28e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN BINDING | 50 | 2.09e-02 | 1.89e-01 | 1.59e-01 |
| GOMF TRANSCRIPTION COACTIVATOR ACTIVITY | 244 | 3.87e-07 | -1.89e-01 | 4.51e-05 |
| GOCC NUCLEAR REPLICATION FORK | 33 | 6.05e-02 | -1.89e-01 | 2.84e-01 |
| GOBP ADHESION OF SYMBIONT TO HOST CELL | 6 | 4.23e-01 | -1.89e-01 | 7.42e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS | 12 | 2.58e-01 | 1.89e-01 | 5.93e-01 |
| GOBP MICROVILLUS ASSEMBLY | 20 | 1.44e-01 | -1.89e-01 | 4.45e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 7 | 3.88e-01 | -1.89e-01 | 7.14e-01 |
| GOBP RESPIRATORY CHAIN COMPLEX III ASSEMBLY | 9 | 3.28e-01 | 1.88e-01 | 6.64e-01 |
| GOBP DNA TEMPLATED DNA REPLICATION MAINTENANCE OF FIDELITY | 55 | 1.57e-02 | -1.88e-01 | 1.39e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE | 24 | 1.10e-01 | 1.88e-01 | 3.90e-01 |
| GOBP ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS | 12 | 2.59e-01 | 1.88e-01 | 5.94e-01 |
| GOBP POSITIVE REGULATION OF CELL MORPHOGENESIS | 31 | 6.97e-02 | -1.88e-01 | 3.06e-01 |
| GOBP PROTEIN DEACETYLATION | 52 | 1.89e-02 | -1.88e-01 | 1.52e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 9 | 3.28e-01 | 1.88e-01 | 6.65e-01 |
| GOBP RESPONSE TO FRUCTOSE | 6 | 4.25e-01 | 1.88e-01 | 7.43e-01 |
| GOBP DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION | 12 | 2.59e-01 | 1.88e-01 | 5.94e-01 |
| GOBP AMINO ACID IMPORT ACROSS PLASMA MEMBRANE | 30 | 7.47e-02 | -1.88e-01 | 3.20e-01 |
| GOBP COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 22 | 1.27e-01 | 1.88e-01 | 4.18e-01 |
| GOBP FEVER GENERATION | 6 | 4.25e-01 | 1.88e-01 | 7.43e-01 |
| GOBP ANDROGEN RECEPTOR SIGNALING PATHWAY | 38 | 4.50e-02 | -1.88e-01 | 2.47e-01 |
| GOCC CHROMOSOME TELOMERIC REGION | 140 | 1.25e-04 | -1.88e-01 | 4.52e-03 |
| GOBP MACROPHAGE ACTIVATION | 80 | 3.70e-03 | -1.88e-01 | 5.50e-02 |
| GOBP NUCLEOTIDE EXCISION REPAIR | 82 | 3.31e-03 | -1.88e-01 | 5.10e-02 |
| GOBP NEGATIVE REGULATION OF RNA CATABOLIC PROCESS | 66 | 8.39e-03 | -1.88e-01 | 9.31e-02 |
| GOCC DYNACTIN COMPLEX | 8 | 3.58e-01 | 1.88e-01 | 6.91e-01 |
| GOCC PERINUCLEAR ENDOPLASMIC RETICULUM | 17 | 1.80e-01 | -1.88e-01 | 4.96e-01 |
| GOBP REGULATION OF ORGAN GROWTH | 51 | 2.05e-02 | -1.88e-01 | 1.58e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H OXYGEN AS ACCEPTOR | 12 | 2.61e-01 | -1.88e-01 | 5.97e-01 |
| GOMF EXTRACELLULARLY ATP GATED MONOATOMIC CATION CHANNEL ACTIVITY | 5 | 4.68e-01 | 1.88e-01 | 7.67e-01 |
| GOMF PHOSPHATIDIC ACID TRANSFER ACTIVITY | 7 | 3.90e-01 | 1.88e-01 | 7.16e-01 |
| GOCC MICOS COMPLEX | 8 | 3.59e-01 | 1.87e-01 | 6.91e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY GLUCOSE | 6 | 4.27e-01 | -1.87e-01 | 7.44e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 5 | 4.68e-01 | 1.87e-01 | 7.68e-01 |
| GOCC CYTOPLASMIC SIDE OF LYSOSOMAL MEMBRANE | 11 | 2.82e-01 | 1.87e-01 | 6.20e-01 |
| GOBP ARTERY MORPHOGENESIS | 39 | 4.33e-02 | -1.87e-01 | 2.41e-01 |
| GOBP ISOCITRATE METABOLIC PROCESS | 6 | 4.27e-01 | -1.87e-01 | 7.44e-01 |
| GOBP RESPONSE TO ESTRADIOL | 72 | 6.10e-03 | -1.87e-01 | 7.68e-02 |
| GOBP POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 17 | 1.82e-01 | -1.87e-01 | 4.98e-01 |
| GOBP RESPONSE TO INTERFERON BETA | 26 | 9.91e-02 | -1.87e-01 | 3.68e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 15 | 2.10e-01 | -1.87e-01 | 5.34e-01 |
| GOBP POSITIVE REGULATION OF NEURON DIFFERENTIATION | 41 | 3.85e-02 | -1.87e-01 | 2.27e-01 |
| GOBP REGULATION OF MACROPHAGE CHEMOTAXIS | 22 | 1.29e-01 | -1.87e-01 | 4.22e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION | 10 | 3.07e-01 | 1.87e-01 | 6.46e-01 |
| GOMF ANTIGEN BINDING | 51 | 2.12e-02 | -1.87e-01 | 1.61e-01 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM | 9 | 3.33e-01 | -1.87e-01 | 6.67e-01 |
| GOCC TRIGLYCERIDE RICH PLASMA LIPOPROTEIN PARTICLE | 13 | 2.45e-01 | -1.86e-01 | 5.79e-01 |
| GOBP EMBRYONIC CLEAVAGE | 7 | 3.94e-01 | -1.86e-01 | 7.18e-01 |
| GOMF MODIFICATION DEPENDENT PROTEIN BINDING | 169 | 3.03e-05 | -1.86e-01 | 1.50e-03 |
| GOMF PROTON CHANNEL ACTIVITY | 21 | 1.40e-01 | 1.86e-01 | 4.39e-01 |
| GOBP REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 11 | 2.85e-01 | 1.86e-01 | 6.23e-01 |
| GOBP REGULATION OF MESENCHYMAL STEM CELL DIFFERENTIATION | 7 | 3.94e-01 | 1.86e-01 | 7.19e-01 |
| GOBP REGULATION OF METAPHASE PLATE CONGRESSION | 13 | 2.46e-01 | -1.86e-01 | 5.79e-01 |
| GOBP CELL REDOX HOMEOSTASIS | 35 | 5.70e-02 | 1.86e-01 | 2.75e-01 |
| GOBP REGULATION OF LYMPHOCYTE DIFFERENTIATION | 156 | 6.25e-05 | -1.86e-01 | 2.77e-03 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR | 125 | 3.35e-04 | -1.86e-01 | 9.68e-03 |
| GOBP REGULATION OF MITOCHONDRIAL MRNA STABILITY | 7 | 3.95e-01 | 1.86e-01 | 7.19e-01 |
| GOBP FRUCTOSE 1 6 BISPHOSPHATE METABOLIC PROCESS | 6 | 4.31e-01 | 1.86e-01 | 7.48e-01 |
| GOBP POSITIVE REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 9 | 3.35e-01 | 1.86e-01 | 6.70e-01 |
| GOBP PIGMENT GRANULE ORGANIZATION | 37 | 5.07e-02 | 1.86e-01 | 2.61e-01 |
| GOBP CELLULAR SENESCENCE | 80 | 4.12e-03 | -1.86e-01 | 5.93e-02 |
| GOBP CELLULAR RESPONSE TO INTERFERON ALPHA | 7 | 3.95e-01 | -1.86e-01 | 7.20e-01 |
| GOBP ADHERENS JUNCTION MAINTENANCE | 6 | 4.31e-01 | 1.86e-01 | 7.48e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 55 | 1.74e-02 | 1.85e-01 | 1.47e-01 |
| GOBP DENDRITE SELF AVOIDANCE | 6 | 4.31e-01 | 1.85e-01 | 7.49e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MICROTUBULE | 5 | 4.73e-01 | -1.85e-01 | 7.72e-01 |
| GOBP EXIT FROM MITOSIS | 29 | 8.44e-02 | -1.85e-01 | 3.41e-01 |
| GOBP CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES | 13 | 2.48e-01 | -1.85e-01 | 5.82e-01 |
| GOBP CIRCADIAN RHYTHM | 142 | 1.41e-04 | -1.85e-01 | 5.01e-03 |
| GOBP CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 220 | 2.34e-06 | -1.85e-01 | 1.83e-04 |
| GOMF RNA POLYMERASE I ACTIVITY | 9 | 3.37e-01 | 1.85e-01 | 6.71e-01 |
| GOBP RESPONSE TO SODIUM PHOSPHATE | 6 | 4.33e-01 | 1.85e-01 | 7.49e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 19 | 1.63e-01 | -1.85e-01 | 4.73e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 47 | 2.85e-02 | -1.85e-01 | 1.91e-01 |
| GOBP NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY | 10 | 3.12e-01 | 1.85e-01 | 6.51e-01 |
| GOBP VITAMIN METABOLIC PROCESS | 74 | 6.06e-03 | 1.85e-01 | 7.67e-02 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 7 | 3.98e-01 | -1.84e-01 | 7.21e-01 |
| GOBP INTERLEUKIN 12 PRODUCTION | 49 | 2.55e-02 | -1.84e-01 | 1.80e-01 |
| GOBP INTRACELLULAR IRON ION HOMEOSTASIS | 56 | 1.70e-02 | 1.84e-01 | 1.45e-01 |
| GOBP NEGATIVE REGULATION OF MACROAUTOPHAGY | 31 | 7.57e-02 | -1.84e-01 | 3.22e-01 |
| GOBP ISOPRENOID BIOSYNTHETIC PROCESS | 23 | 1.26e-01 | 1.84e-01 | 4.17e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 42 | 3.90e-02 | -1.84e-01 | 2.28e-01 |
| GOBP SPHINGOMYELIN CATABOLIC PROCESS | 5 | 4.76e-01 | -1.84e-01 | 7.75e-01 |
| GOBP NUCLEAR BODY ORGANIZATION | 13 | 2.51e-01 | 1.84e-01 | 5.86e-01 |
| GOBP REGULATION OF DNA LIGATION | 6 | 4.36e-01 | -1.84e-01 | 7.51e-01 |
| GOBP MACROPHAGE FUSION | 6 | 4.36e-01 | 1.84e-01 | 7.51e-01 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 49 | 2.62e-02 | -1.84e-01 | 1.83e-01 |
| GOMF FIBROBLAST GROWTH FACTOR BINDING | 14 | 2.34e-01 | 1.84e-01 | 5.66e-01 |
| GOBP NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS | 5 | 4.77e-01 | 1.84e-01 | 7.75e-01 |
| GOBP PENTOSE PHOSPHATE SHUNT NON OXIDATIVE BRANCH | 5 | 4.77e-01 | -1.84e-01 | 7.75e-01 |
| GOCC DENSE CORE GRANULE | 15 | 2.19e-01 | -1.84e-01 | 5.46e-01 |
| GOMF CIS REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 802 | 1.47e-18 | -1.84e-01 | 9.32e-16 |
| GOBP ANATOMICAL STRUCTURE ARRANGEMENT | 10 | 3.15e-01 | -1.83e-01 | 6.54e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION IMPORT | 5 | 4.77e-01 | -1.83e-01 | 7.75e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR | 284 | 1.09e-07 | -1.83e-01 | 1.56e-05 |
| GOBP CHROMOSOME SEPARATION | 74 | 6.38e-03 | -1.83e-01 | 7.89e-02 |
| GOBP REGULATION OF PROTEIN GLYCOSYLATION | 11 | 2.92e-01 | 1.83e-01 | 6.31e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H QUINONE OR SIMILAR COMPOUND AS ACCEPTOR | 54 | 1.98e-02 | 1.83e-01 | 1.56e-01 |
| GOBP POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 5 | 4.78e-01 | -1.83e-01 | 7.75e-01 |
| GOBP MITOCHONDRIAL CALCIUM ION HOMEOSTASIS | 24 | 1.20e-01 | 1.83e-01 | 4.06e-01 |
| GOBP INTRACELLULAR OXYGEN HOMEOSTASIS | 6 | 4.37e-01 | 1.83e-01 | 7.51e-01 |
| GOBP LAYER FORMATION IN CEREBRAL CORTEX | 8 | 3.70e-01 | 1.83e-01 | 7.00e-01 |
| GOMF PROTEIN PHOSPHATASE 2B BINDING | 5 | 4.79e-01 | -1.83e-01 | 7.76e-01 |
| GOCC REPLICATION FORK | 65 | 1.08e-02 | -1.83e-01 | 1.09e-01 |
| GOBP SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 11 | 2.93e-01 | -1.83e-01 | 6.32e-01 |
| GOBP MYELOID LEUKOCYTE MEDIATED IMMUNITY | 80 | 4.69e-03 | -1.83e-01 | 6.46e-02 |
| GOBP PORE COMPLEX ASSEMBLY | 20 | 1.57e-01 | -1.83e-01 | 4.62e-01 |
| GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS | 6 | 4.38e-01 | -1.83e-01 | 7.52e-01 |
| GOMF ACTIVIN RECEPTOR BINDING | 6 | 4.38e-01 | 1.83e-01 | 7.52e-01 |
| GOBP MIRNA METABOLIC PROCESS | 79 | 4.99e-03 | -1.83e-01 | 6.76e-02 |
| GOBP NADPH REGENERATION | 20 | 1.57e-01 | -1.83e-01 | 4.63e-01 |
| GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 10 | 3.17e-01 | 1.83e-01 | 6.56e-01 |
| GOBP ATP METABOLIC PROCESS | 119 | 5.80e-04 | 1.83e-01 | 1.47e-02 |
| GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE | 11 | 2.94e-01 | -1.83e-01 | 6.32e-01 |
| GOBP RETROGRADE AXONAL TRANSPORT | 14 | 2.37e-01 | 1.83e-01 | 5.68e-01 |
| GOBP REGULATION OF RNA BINDING | 8 | 3.71e-01 | -1.83e-01 | 7.00e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 2.37e-01 | 1.83e-01 | 5.68e-01 |
| GOBP MITOTIC SISTER CHROMATID COHESION CENTROMERIC | 5 | 4.79e-01 | 1.83e-01 | 7.77e-01 |
| GOBP UBIQUITIN DEPENDENT GLYCOPROTEIN ERAD PATHWAY | 7 | 4.03e-01 | 1.83e-01 | 7.24e-01 |
| GOMF MANNOSYL OLIGOSACCHARIDE 1 2 ALPHA MANNOSIDASE ACTIVITY | 7 | 4.03e-01 | 1.83e-01 | 7.24e-01 |
| GOBP POSITIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS | 8 | 3.71e-01 | 1.83e-01 | 7.00e-01 |
| GOMF NUCLEAR RECEPTOR BINDING | 117 | 6.49e-04 | -1.83e-01 | 1.60e-02 |
| GOMF TYPE I TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 11 | 2.94e-01 | -1.83e-01 | 6.32e-01 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION | 6 | 4.39e-01 | -1.83e-01 | 7.52e-01 |
| GOBP MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA PRODUCTION | 5 | 4.80e-01 | 1.82e-01 | 7.77e-01 |
| GOBP PUTRESCINE METABOLIC PROCESS | 8 | 3.72e-01 | 1.82e-01 | 7.00e-01 |
| GOBP REGULATION OF NEUROINFLAMMATORY RESPONSE | 26 | 1.08e-01 | -1.82e-01 | 3.84e-01 |
| GOBP INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT | 51 | 2.45e-02 | 1.82e-01 | 1.76e-01 |
| GOBP FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX | 15 | 2.22e-01 | -1.82e-01 | 5.51e-01 |
| GOBP RIBOSOME DISASSEMBLY | 13 | 2.56e-01 | 1.82e-01 | 5.91e-01 |
| GOBP LIPOPROTEIN CATABOLIC PROCESS | 13 | 2.56e-01 | -1.82e-01 | 5.91e-01 |
| GOBP MALATE METABOLIC PROCESS | 7 | 4.05e-01 | 1.82e-01 | 7.26e-01 |
| GOBP XENOBIOTIC TRANSPORT ACROSS BLOOD BRAIN BARRIER | 5 | 4.81e-01 | 1.82e-01 | 7.78e-01 |
| GOBP SULFUR AMINO ACID TRANSPORT | 9 | 3.45e-01 | -1.82e-01 | 6.81e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY INTERCONVERTING ALDOSES AND KETOSES | 6 | 4.41e-01 | 1.82e-01 | 7.52e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER | 15 | 2.23e-01 | 1.82e-01 | 5.51e-01 |
| GOCC TRANSCRIPTION FACTOR TFIID COMPLEX | 32 | 7.52e-02 | 1.82e-01 | 3.21e-01 |
| GOBP LABYRINTHINE LAYER DEVELOPMENT | 30 | 8.50e-02 | -1.82e-01 | 3.42e-01 |
| GOMF MICROTUBULE PLUS END BINDING | 21 | 1.50e-01 | 1.82e-01 | 4.53e-01 |
| GOBP RESPONSE TO AMYLOID BETA | 33 | 7.10e-02 | -1.82e-01 | 3.10e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 38 | 5.27e-02 | -1.82e-01 | 2.65e-01 |
| GOBP AXO DENDRITIC PROTEIN TRANSPORT | 5 | 4.82e-01 | -1.81e-01 | 7.79e-01 |
| GOBP REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 21 | 1.50e-01 | -1.81e-01 | 4.53e-01 |
| GOBP REGULATION OF RENAL SYSTEM PROCESS | 9 | 3.46e-01 | 1.81e-01 | 6.82e-01 |
| GOBP NEUROTRANSMITTER UPTAKE | 21 | 1.50e-01 | 1.81e-01 | 4.53e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEVELOPMENT | 7 | 4.06e-01 | 1.81e-01 | 7.27e-01 |
| GOBP REGULATION OF FILOPODIUM ASSEMBLY | 39 | 5.02e-02 | -1.81e-01 | 2.60e-01 |
| GOBP L GLUTAMATE TRANSMEMBRANE TRANSPORT | 21 | 1.51e-01 | -1.81e-01 | 4.54e-01 |
| GOCC HOPS COMPLEX | 9 | 3.47e-01 | -1.81e-01 | 6.82e-01 |
| GOBP ECTODERM DEVELOPMENT | 16 | 2.10e-01 | 1.81e-01 | 5.34e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 159 | 8.30e-05 | -1.81e-01 | 3.40e-03 |
| GOBP CO TRANSCRIPTIONAL RNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 6 | 4.43e-01 | -1.81e-01 | 7.54e-01 |
| GOMF N6 METHYLADENOSINE CONTAINING RNA BINDING | 10 | 3.22e-01 | -1.81e-01 | 6.61e-01 |
| GOBP REGULATION OF LEUKOCYTE DIFFERENTIATION | 243 | 1.22e-06 | -1.81e-01 | 1.11e-04 |
| GOMF ELECTRON TRANSFER ACTIVITY | 105 | 1.37e-03 | 1.81e-01 | 2.70e-02 |
| GOMF CARBOXY LYASE ACTIVITY | 25 | 1.18e-01 | 1.81e-01 | 4.02e-01 |
| GOBP POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION | 7 | 4.08e-01 | 1.81e-01 | 7.27e-01 |
| GOBP NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION | 9 | 3.48e-01 | -1.81e-01 | 6.83e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 6 | 4.44e-01 | -1.81e-01 | 7.55e-01 |
| GOBP MRNA CATABOLIC PROCESS | 216 | 5.00e-06 | -1.80e-01 | 3.55e-04 |
| GOBP PARTURITION | 6 | 4.44e-01 | 1.80e-01 | 7.55e-01 |
| GOBP POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 17 | 1.98e-01 | 1.80e-01 | 5.19e-01 |
| GOCC CHROMOSOMAL REGION | 354 | 6.15e-09 | -1.80e-01 | 1.27e-06 |
| GOBP DEDIFFERENTIATION | 6 | 4.45e-01 | 1.80e-01 | 7.55e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 5 | 4.85e-01 | -1.80e-01 | 7.81e-01 |
| GOBP NEGATIVE REGULATION OF MIRNA METABOLIC PROCESS | 19 | 1.74e-01 | -1.80e-01 | 4.89e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 101 | 1.78e-03 | -1.80e-01 | 3.27e-02 |
| GOBP PROLINE TRANSPORT | 7 | 4.09e-01 | -1.80e-01 | 7.29e-01 |
| GOMF ATPASE ACTIVATOR ACTIVITY | 24 | 1.27e-01 | 1.80e-01 | 4.18e-01 |
| GOBP SEX DIFFERENTIATION | 162 | 7.87e-05 | -1.80e-01 | 3.27e-03 |
| GOBP AEROBIC RESPIRATION | 179 | 3.36e-05 | 1.80e-01 | 1.64e-03 |
| GOBP POSITIVE REGULATION OF FAT CELL DIFFERENTIATION | 48 | 3.12e-02 | -1.80e-01 | 2.02e-01 |
| GOCC CONTRACTILE RING | 10 | 3.25e-01 | -1.80e-01 | 6.63e-01 |
| GOBP PODOCYTE CELL MIGRATION | 6 | 4.46e-01 | -1.80e-01 | 7.57e-01 |
| GOBP GLYOXYLATE METABOLIC PROCESS | 5 | 4.87e-01 | -1.80e-01 | 7.81e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 5 | 4.87e-01 | -1.79e-01 | 7.81e-01 |
| GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 6 | 4.47e-01 | -1.79e-01 | 7.57e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 11 | 3.03e-01 | -1.79e-01 | 6.42e-01 |
| GOBP FATTY ACID TRANSPORT | 62 | 1.47e-02 | 1.79e-01 | 1.33e-01 |
| GOBP REFLEX | 8 | 3.80e-01 | 1.79e-01 | 7.07e-01 |
| GOBP MRNA 3 SPLICE SITE RECOGNITION | 6 | 4.47e-01 | -1.79e-01 | 7.57e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 13 | 2.63e-01 | -1.79e-01 | 5.99e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 113 | 1.01e-03 | -1.79e-01 | 2.22e-02 |
| GOBP REGULATION OF HISTONE H3 K4 METHYLATION | 12 | 2.83e-01 | -1.79e-01 | 6.20e-01 |
| GOBP DEFENSE RESPONSE TO SYMBIONT | 264 | 5.67e-07 | -1.79e-01 | 5.86e-05 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 29 | 9.52e-02 | -1.79e-01 | 3.64e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 61 | 1.57e-02 | -1.79e-01 | 1.39e-01 |
| GOBP REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL | 11 | 3.04e-01 | -1.79e-01 | 6.43e-01 |
| GOCC RNA N6 METHYLADENOSINE METHYLTRANSFERASE COMPLEX | 9 | 3.53e-01 | -1.79e-01 | 6.87e-01 |
| GOCC NUCLEAR ENVELOPE LUMEN | 7 | 4.13e-01 | 1.79e-01 | 7.31e-01 |
| GOBP POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION | 9 | 3.53e-01 | -1.79e-01 | 6.87e-01 |
| GOBP INNER CELL MASS CELL PROLIFERATION | 13 | 2.64e-01 | 1.79e-01 | 6.01e-01 |
| GOBP REGULATION OF HEMOPOIESIS | 305 | 8.31e-08 | -1.79e-01 | 1.21e-05 |
| GOBP POSITIVE REGULATION OF AMINO ACID TRANSPORT | 13 | 2.65e-01 | -1.79e-01 | 6.02e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 17 | 2.02e-01 | 1.79e-01 | 5.25e-01 |
| GOBP PEPTIDYL LYSINE METHYLATION | 47 | 3.44e-02 | -1.78e-01 | 2.15e-01 |
| GOBP REGULATION OF MITOCHONDRIAL FISSION | 26 | 1.15e-01 | 1.78e-01 | 3.99e-01 |
| GOBP DE NOVO PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 5 | 4.90e-01 | 1.78e-01 | 7.83e-01 |
| GOBP PHOTORECEPTOR CELL DEVELOPMENT | 25 | 1.23e-01 | 1.78e-01 | 4.11e-01 |
| GOBP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 13 | 2.66e-01 | -1.78e-01 | 6.03e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS | 5 | 4.90e-01 | 1.78e-01 | 7.83e-01 |
| GOMF SEQUENCE SPECIFIC DNA BINDING | 1151 | 4.82e-24 | -1.78e-01 | 8.57e-21 |
| GOCC CILIARY TIP | 37 | 6.09e-02 | 1.78e-01 | 2.85e-01 |
| GOCC BETA CATENIN TCF COMPLEX | 12 | 2.86e-01 | -1.78e-01 | 6.23e-01 |
| GOBP CHEMOSENSORY BEHAVIOR | 10 | 3.30e-01 | 1.78e-01 | 6.66e-01 |
| GOBP POSITIVE REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 5 | 4.91e-01 | -1.78e-01 | 7.83e-01 |
| GOBP EMBRYONIC FORELIMB MORPHOGENESIS | 15 | 2.33e-01 | 1.78e-01 | 5.63e-01 |
| GOBP AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM | 14 | 2.49e-01 | 1.78e-01 | 5.84e-01 |
| GOBP MAINTENANCE OF GASTROINTESTINAL EPITHELIUM | 8 | 3.84e-01 | -1.78e-01 | 7.12e-01 |
| GOMF PHOSPHATASE ACTIVATOR ACTIVITY | 17 | 2.05e-01 | 1.78e-01 | 5.27e-01 |
| GOBP CELLULAR RESPONSE TO MURAMYL DIPEPTIDE | 8 | 3.84e-01 | -1.78e-01 | 7.12e-01 |
| GOBP CARDIAC ATRIUM DEVELOPMENT | 21 | 1.59e-01 | -1.78e-01 | 4.65e-01 |
| GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY | 102 | 1.96e-03 | -1.78e-01 | 3.51e-02 |
| GOCC BETA CATENIN DESTRUCTION COMPLEX | 9 | 3.57e-01 | -1.78e-01 | 6.90e-01 |
| GOBP ENDOPLASMIC RETICULUM LOCALIZATION | 9 | 3.57e-01 | 1.77e-01 | 6.90e-01 |
| GOBP CELLULAR RESPONSE TO UV B | 10 | 3.32e-01 | -1.77e-01 | 6.67e-01 |
| GOBP PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 20 | 1.70e-01 | 1.77e-01 | 4.83e-01 |
| GOCC DENDRITE MEMBRANE | 18 | 1.93e-01 | -1.77e-01 | 5.12e-01 |
| GOBP NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY | 8 | 3.85e-01 | 1.77e-01 | 7.12e-01 |
| GOBP CLATHRIN DEPENDENT ENDOCYTOSIS | 42 | 4.73e-02 | -1.77e-01 | 2.54e-01 |
| GOCC PHAGOCYTIC CUP | 25 | 1.26e-01 | -1.77e-01 | 4.16e-01 |
| GOBP CELLULAR RESPONSE TO INSULIN LIKE GROWTH FACTOR STIMULUS | 7 | 4.18e-01 | 1.77e-01 | 7.36e-01 |
| GOBP VENTRICULAR SEPTUM DEVELOPMENT | 46 | 3.81e-02 | -1.77e-01 | 2.26e-01 |
| GOBP REGULATION OF MITOTIC RECOMBINATION | 5 | 4.94e-01 | 1.77e-01 | 7.84e-01 |
| GOBP NEGATIVE REGULATION OF STEROID METABOLIC PROCESS | 18 | 1.94e-01 | 1.77e-01 | 5.13e-01 |
| GOBP ENDOPLASMIC RETICULUM PLASMA MEMBRANE TETHERING | 6 | 4.53e-01 | 1.77e-01 | 7.62e-01 |
| GOBP DE NOVO PROTEIN FOLDING | 40 | 5.32e-02 | 1.77e-01 | 2.66e-01 |
| GOBP SHORT TERM MEMORY | 5 | 4.94e-01 | -1.77e-01 | 7.84e-01 |
| GOMF SUMO BINDING | 17 | 2.07e-01 | -1.77e-01 | 5.31e-01 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 12 | 2.89e-01 | -1.77e-01 | 6.28e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 9 | 3.59e-01 | -1.77e-01 | 6.91e-01 |
| GOCC NUCLEAR SPECK | 372 | 5.30e-09 | -1.77e-01 | 1.15e-06 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 5 | 4.94e-01 | 1.77e-01 | 7.84e-01 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE BY STOP TRANSFER MEMBRANE ANCHOR SEQUENCE | 11 | 3.11e-01 | 1.77e-01 | 6.50e-01 |
| GOBP POSITIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 18 | 1.95e-01 | 1.76e-01 | 5.15e-01 |
| GOMF OLIGOPEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 4.95e-01 | 1.76e-01 | 7.85e-01 |
| GOBP CYCLIC NUCLEOTIDE METABOLIC PROCESS | 30 | 9.48e-02 | -1.76e-01 | 3.63e-01 |
| GOMF OXYSTEROL BINDING | 7 | 4.19e-01 | 1.76e-01 | 7.37e-01 |
| GOMF DOUBLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 6 | 4.55e-01 | -1.76e-01 | 7.62e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 3 PHOSPHATASE ACTIVITY | 11 | 3.12e-01 | -1.76e-01 | 6.51e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 6 | 4.55e-01 | -1.76e-01 | 7.62e-01 |
| GOBP MITOCHONDRION ORGANIZATION | 502 | 1.69e-11 | 1.76e-01 | 4.83e-09 |
| GOMF RNA POLYMERASE BINDING | 55 | 2.40e-02 | -1.76e-01 | 1.74e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 41 | 5.13e-02 | -1.76e-01 | 2.62e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 19 | 1.84e-01 | 1.76e-01 | 5.01e-01 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON RNA | 68 | 1.22e-02 | -1.76e-01 | 1.17e-01 |
| GOBP NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 6 | 4.56e-01 | 1.76e-01 | 7.62e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 44 | 4.38e-02 | -1.76e-01 | 2.43e-01 |
| GOBP POSITIVE REGULATION OF VIRAL PROCESS | 59 | 1.96e-02 | -1.76e-01 | 1.55e-01 |
| GOMF PROTEIN PHOSPHORYLATED AMINO ACID BINDING | 52 | 2.84e-02 | -1.76e-01 | 1.91e-01 |
| GOBP REGULATION OF LAMELLIPODIUM ASSEMBLY | 30 | 9.58e-02 | -1.76e-01 | 3.65e-01 |
| GOBP POSITIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 8 | 3.90e-01 | -1.76e-01 | 7.15e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE TRANSPORT | 5 | 4.96e-01 | 1.76e-01 | 7.85e-01 |
| GOMF PROTEIN CYSTEINE S STEAROYLTRANSFERASE ACTIVITY | 7 | 4.21e-01 | -1.76e-01 | 7.39e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO HEAT | 16 | 2.24e-01 | -1.76e-01 | 5.52e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 14 | 2.56e-01 | -1.75e-01 | 5.91e-01 |
| GOBP PLACENTA BLOOD VESSEL DEVELOPMENT | 23 | 1.46e-01 | -1.75e-01 | 4.46e-01 |
| GOMF NUCLEOTIDASE ACTIVITY | 10 | 3.37e-01 | -1.75e-01 | 6.72e-01 |
| GOBP LIPID HOMEOSTASIS | 114 | 1.24e-03 | 1.75e-01 | 2.53e-02 |
| GOBP INTESTINAL EPITHELIAL CELL MATURATION | 5 | 4.98e-01 | 1.75e-01 | 7.86e-01 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS | 12 | 2.93e-01 | -1.75e-01 | 6.31e-01 |
| GOBP NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 5 | 4.98e-01 | 1.75e-01 | 7.86e-01 |
| GOMF SNRNP BINDING | 9 | 3.63e-01 | -1.75e-01 | 6.95e-01 |
| GOBP CELLULAR RESPIRATION | 216 | 9.47e-06 | 1.75e-01 | 5.77e-04 |
| GOBP REGULATION OF LYSOSOMAL LUMEN PH | 27 | 1.16e-01 | 1.75e-01 | 3.99e-01 |
| GOBP DESMOSOME ORGANIZATION | 6 | 4.58e-01 | 1.75e-01 | 7.64e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 48 | 3.62e-02 | -1.75e-01 | 2.20e-01 |
| GOMF GALACTOSYLTRANSFERASE ACTIVITY | 21 | 1.66e-01 | 1.75e-01 | 4.77e-01 |
| GOMF DNA HELICASE ACTIVITY | 58 | 2.14e-02 | -1.75e-01 | 1.61e-01 |
| GOBP MALE SEX DIFFERENTIATION | 100 | 2.57e-03 | -1.75e-01 | 4.33e-02 |
| GOBP B CELL RECEPTOR SIGNALING PATHWAY | 50 | 3.28e-02 | -1.75e-01 | 2.09e-01 |
| GOMF RNA POLYMERASE II INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 7 | 4.24e-01 | 1.75e-01 | 7.42e-01 |
| GOBP REGULATION OF DENDRITE EXTENSION | 16 | 2.27e-01 | 1.75e-01 | 5.56e-01 |
| GOBP REGULATION OF INCLUSION BODY ASSEMBLY | 15 | 2.42e-01 | 1.74e-01 | 5.75e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL DEPOLARIZATION | 6 | 4.59e-01 | -1.74e-01 | 7.64e-01 |
| GOBP NUCLEAR PORE LOCALIZATION | 5 | 4.99e-01 | -1.74e-01 | 7.87e-01 |
| GOMF PRE MIRNA BINDING | 8 | 3.93e-01 | -1.74e-01 | 7.18e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE RESPONSE | 153 | 2.04e-04 | -1.74e-01 | 6.73e-03 |
| GOMF T CELL RECEPTOR BINDING | 8 | 3.94e-01 | -1.74e-01 | 7.19e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 28 | 1.11e-01 | -1.74e-01 | 3.90e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO TUMOR CELL | 5 | 5.00e-01 | -1.74e-01 | 7.88e-01 |
| GOBP INTRACELLULAR GLUCOSE HOMEOSTASIS | 98 | 2.92e-03 | -1.74e-01 | 4.73e-02 |
| GOBP RECEPTOR LOCALIZATION TO SYNAPSE | 42 | 5.11e-02 | 1.74e-01 | 2.62e-01 |
| GOMF C3HC4 TYPE RING FINGER DOMAIN BINDING | 5 | 5.01e-01 | -1.74e-01 | 7.88e-01 |
| GOBP PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 12 | 2.97e-01 | 1.74e-01 | 6.35e-01 |
| GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 6 | 4.61e-01 | 1.74e-01 | 7.64e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 12 | 2.97e-01 | 1.74e-01 | 6.35e-01 |
| GOBP NEGATIVE REGULATION OF DNA REPLICATION | 21 | 1.68e-01 | -1.74e-01 | 4.81e-01 |
| GOBP REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL | 13 | 2.78e-01 | 1.74e-01 | 6.15e-01 |
| GOBP CELLULAR RESPONSE TO SALT | 135 | 4.99e-04 | -1.74e-01 | 1.31e-02 |
| GOBP NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 117 | 1.19e-03 | 1.74e-01 | 2.45e-02 |
| GOBP RESPONSE TO NERVE GROWTH FACTOR | 34 | 7.99e-02 | -1.74e-01 | 3.32e-01 |
| GOBP CELL MIGRATION INVOLVED IN HEART DEVELOPMENT | 9 | 3.67e-01 | 1.74e-01 | 6.99e-01 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 23 | 1.50e-01 | -1.74e-01 | 4.53e-01 |
| GOBP PEPTIDYL THREONINE MODIFICATION | 90 | 4.46e-03 | -1.74e-01 | 6.23e-02 |
| GOBP CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 18 | 2.03e-01 | 1.73e-01 | 5.25e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 110 | 1.69e-03 | -1.73e-01 | 3.16e-02 |
| GOBP PHOTOTRANSDUCTION VISIBLE LIGHT | 12 | 2.98e-01 | 1.73e-01 | 6.37e-01 |
| GOMF EPOXIDE HYDROLASE ACTIVITY | 5 | 5.02e-01 | -1.73e-01 | 7.88e-01 |
| GOMF TRANSCRIPTION FACTOR BINDING | 487 | 6.65e-11 | -1.73e-01 | 1.79e-08 |
| GOCC NEUROFILAMENT | 5 | 5.02e-01 | 1.73e-01 | 7.88e-01 |
| GOMF PROTEASOME BINDING | 16 | 2.30e-01 | 1.73e-01 | 5.61e-01 |
| GOCC CILIARY BASE | 29 | 1.07e-01 | 1.73e-01 | 3.82e-01 |
| GOBP ISOTYPE SWITCHING TO IGG ISOTYPES | 12 | 2.99e-01 | -1.73e-01 | 6.37e-01 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 12 | 2.99e-01 | 1.73e-01 | 6.37e-01 |
| GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 90 | 4.58e-03 | 1.73e-01 | 6.35e-02 |
| GOBP REGULATION OF PROTEIN ADP RIBOSYLATION | 8 | 3.97e-01 | -1.73e-01 | 7.21e-01 |
| GOBP POLYADENYLATION DEPENDENT RNA CATABOLIC PROCESS | 8 | 3.97e-01 | 1.73e-01 | 7.21e-01 |
| GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC DEPRESSION | 6 | 4.63e-01 | -1.73e-01 | 7.65e-01 |
| GOMF EUKARYOTIC TRANSLATION INITIATION FACTOR 2ALPHA KINASE ACTIVITY | 6 | 4.63e-01 | 1.73e-01 | 7.65e-01 |
| GOBP REGULATION OF CELLULAR PH REDUCTION | 5 | 5.03e-01 | -1.73e-01 | 7.88e-01 |
| GOBP NEURONAL ACTION POTENTIAL PROPAGATION | 5 | 5.04e-01 | -1.73e-01 | 7.88e-01 |
| GOBP CELLULAR RESPONSE TO ALCOHOL | 68 | 1.39e-02 | -1.73e-01 | 1.28e-01 |
| GOCC MEDIATOR COMPLEX | 37 | 6.93e-02 | -1.73e-01 | 3.05e-01 |
| GOBP GMP METABOLIC PROCESS | 26 | 1.28e-01 | 1.73e-01 | 4.20e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS | 70 | 1.26e-02 | -1.73e-01 | 1.19e-01 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 9 | 3.70e-01 | 1.73e-01 | 7.00e-01 |
| GOBP NEGATIVE REGULATION OF HIPPO SIGNALING | 12 | 3.01e-01 | 1.72e-01 | 6.40e-01 |
| GOBP POSTSYNAPTIC SIGNAL TRANSDUCTION | 24 | 1.44e-01 | -1.72e-01 | 4.45e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 25 | 1.36e-01 | 1.72e-01 | 4.33e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 22 | 1.62e-01 | -1.72e-01 | 4.70e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 9 | 3.71e-01 | -1.72e-01 | 7.00e-01 |
| GOMF TAU PROTEIN KINASE ACTIVITY | 20 | 1.83e-01 | -1.72e-01 | 4.99e-01 |
| GOBP REGULATION OF SUPEROXIDE METABOLIC PROCESS | 21 | 1.72e-01 | -1.72e-01 | 4.86e-01 |
| GOBP LYMPHATIC ENDOTHELIAL CELL DIFFERENTIATION | 5 | 5.05e-01 | 1.72e-01 | 7.89e-01 |
| GOBP POSITIVE REGULATION OF AMINE TRANSPORT | 17 | 2.19e-01 | -1.72e-01 | 5.48e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS | 30 | 1.03e-01 | 1.72e-01 | 3.76e-01 |
| GOBP NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION | 87 | 5.60e-03 | -1.72e-01 | 7.35e-02 |
| GOBP L ALANINE TRANSPORT | 8 | 4.00e-01 | 1.72e-01 | 7.22e-01 |
| GOCC CUL3 RING UBIQUITIN LIGASE COMPLEX | 34 | 8.29e-02 | -1.72e-01 | 3.39e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 52 | 3.21e-02 | 1.72e-01 | 2.06e-01 |
| GOBP VESICLE TETHERING INVOLVED IN EXOCYTOSIS | 9 | 3.72e-01 | -1.72e-01 | 7.01e-01 |
| GOCC NUCLEAR LAMINA | 12 | 3.03e-01 | 1.72e-01 | 6.42e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS | 5 | 5.06e-01 | 1.72e-01 | 7.90e-01 |
| GOBP REPLICATIVE SENESCENCE | 13 | 2.84e-01 | -1.71e-01 | 6.22e-01 |
| GOBP REGULATION OF GOLGI ORGANIZATION | 17 | 2.21e-01 | 1.71e-01 | 5.49e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL CHEMOTAXIS | 5 | 5.07e-01 | 1.71e-01 | 7.90e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 9 | 3.73e-01 | 1.71e-01 | 7.02e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 55 | 2.80e-02 | -1.71e-01 | 1.90e-01 |
| GOBP CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT | 19 | 1.96e-01 | -1.71e-01 | 5.16e-01 |
| GOCC RETROMER COMPLEX | 12 | 3.04e-01 | -1.71e-01 | 6.43e-01 |
| GOMF TELOMERASE INHIBITOR ACTIVITY | 5 | 5.07e-01 | 1.71e-01 | 7.90e-01 |
| GOBP ZINC ION IMPORT INTO ORGANELLE | 6 | 4.68e-01 | 1.71e-01 | 7.67e-01 |
| GOBP DOPAMINERGIC NEURON DIFFERENTIATION | 16 | 2.36e-01 | -1.71e-01 | 5.67e-01 |
| GOBP REGULATION OF PLASMA MEMBRANE ORGANIZATION | 16 | 2.36e-01 | -1.71e-01 | 5.67e-01 |
| GOMF CARDIOLIPIN BINDING | 8 | 4.02e-01 | -1.71e-01 | 7.24e-01 |
| GOBP MITOCHONDRIAL RNA CATABOLIC PROCESS | 6 | 4.68e-01 | -1.71e-01 | 7.68e-01 |
| GOBP T HELPER 2 CELL DIFFERENTIATION | 16 | 2.36e-01 | -1.71e-01 | 5.68e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY | 20 | 1.86e-01 | 1.71e-01 | 5.03e-01 |
| GOMF MRNA 5 PHOSPHATASE ACTIVITY | 11 | 3.26e-01 | -1.71e-01 | 6.63e-01 |
| GOBP CELL PROLIFERATION IN FOREBRAIN | 11 | 3.27e-01 | -1.71e-01 | 6.63e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 53 | 3.16e-02 | -1.71e-01 | 2.03e-01 |
| GOBP LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE | 38 | 6.87e-02 | -1.71e-01 | 3.03e-01 |
| GOMF NEUROPEPTIDE ACTIVITY | 10 | 3.50e-01 | 1.71e-01 | 6.85e-01 |
| GOCC OUTER DYNEIN ARM | 5 | 5.09e-01 | -1.71e-01 | 7.91e-01 |
| GOBP CAP DEPENDENT TRANSLATIONAL INITIATION | 7 | 4.34e-01 | -1.71e-01 | 7.50e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 16 | 2.37e-01 | -1.71e-01 | 5.69e-01 |
| GOBP DNA TEMPLATED DNA REPLICATION | 157 | 2.28e-04 | -1.71e-01 | 7.20e-03 |
| GOMF DISORDERED DOMAIN SPECIFIC BINDING | 25 | 1.40e-01 | 1.71e-01 | 4.39e-01 |
| GOMF CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 27 | 1.25e-01 | 1.71e-01 | 4.15e-01 |
| GOBP PROTEIN DNA COMPLEX ASSEMBLY | 144 | 4.16e-04 | -1.71e-01 | 1.14e-02 |
| GOBP TANGENTIAL MIGRATION FROM THE SUBVENTRICULAR ZONE TO THE OLFACTORY BULB | 7 | 4.35e-01 | 1.71e-01 | 7.50e-01 |
| GOBP CELLULAR RESPONSE TO GLUCOSE STARVATION | 43 | 5.31e-02 | -1.71e-01 | 2.66e-01 |
| GOMF FILAMIN BINDING | 10 | 3.51e-01 | 1.70e-01 | 6.86e-01 |
| GOBP CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT | 10 | 3.51e-01 | 1.70e-01 | 6.86e-01 |
| GOBP EPIBOLY | 28 | 1.19e-01 | 1.70e-01 | 4.02e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL CELL JUNCTION | 19 | 1.99e-01 | 1.70e-01 | 5.19e-01 |
| GOBP ISOPRENOID METABOLIC PROCESS | 83 | 7.35e-03 | 1.70e-01 | 8.53e-02 |
| GOBP IMMUNE SYSTEM DEVELOPMENT | 152 | 2.95e-04 | -1.70e-01 | 8.74e-03 |
| GOBP MYELOID CELL DEVELOPMENT | 65 | 1.77e-02 | -1.70e-01 | 1.48e-01 |
| GOBP REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 8 | 4.05e-01 | 1.70e-01 | 7.26e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 38 | 6.95e-02 | -1.70e-01 | 3.06e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 9 | 3.77e-01 | 1.70e-01 | 7.05e-01 |
| GOBP REGULATION OF GERM CELL PROLIFERATION | 7 | 4.36e-01 | 1.70e-01 | 7.51e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS | 8 | 4.05e-01 | -1.70e-01 | 7.26e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 44 | 5.12e-02 | -1.70e-01 | 2.62e-01 |
| GOCC CATSPER COMPLEX | 8 | 4.05e-01 | 1.70e-01 | 7.26e-01 |
| GOBP HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT | 68 | 1.54e-02 | -1.70e-01 | 1.38e-01 |
| GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR BINDING | 6 | 4.71e-01 | -1.70e-01 | 7.71e-01 |
| GOCC CHROMOSOME | 1376 | 1.12e-25 | -1.70e-01 | 4.99e-22 |
| GOBP REGULATION OF HYPERSENSITIVITY | 9 | 3.77e-01 | -1.70e-01 | 7.05e-01 |
| GOCC PINOSOME | 6 | 4.71e-01 | -1.70e-01 | 7.71e-01 |
| GOBP FAT SOLUBLE VITAMIN METABOLIC PROCESS | 20 | 1.89e-01 | 1.70e-01 | 5.08e-01 |
| GOBP PURINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 5 | 5.11e-01 | 1.70e-01 | 7.93e-01 |
| GOBP DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE | 8 | 4.06e-01 | -1.70e-01 | 7.27e-01 |
| GOBP POSITIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 6 | 4.72e-01 | -1.70e-01 | 7.71e-01 |
| GOMF THIOLESTER HYDROLASE ACTIVITY | 34 | 8.71e-02 | 1.70e-01 | 3.45e-01 |
| GOBP REGULATION OF ISOTYPE SWITCHING TO IGE ISOTYPES | 5 | 5.11e-01 | -1.70e-01 | 7.93e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST PROLIFERATION | 7 | 4.37e-01 | -1.70e-01 | 7.51e-01 |
| GOBP CHEMOKINE PRODUCTION | 69 | 1.50e-02 | -1.69e-01 | 1.35e-01 |
| GOBP XENOBIOTIC TRANSMEMBRANE TRANSPORT | 15 | 2.56e-01 | -1.69e-01 | 5.91e-01 |
| GOBP PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES | 11 | 3.31e-01 | -1.69e-01 | 6.67e-01 |
| GOBP GAMMA DELTA T CELL ACTIVATION | 16 | 2.41e-01 | -1.69e-01 | 5.75e-01 |
| GOBP REGULATION OF GLYCOLYTIC PROCESS | 43 | 5.48e-02 | -1.69e-01 | 2.69e-01 |
| GOCC INTERSTITIAL MATRIX | 5 | 5.12e-01 | -1.69e-01 | 7.93e-01 |
| GOMF CCR5 CHEMOKINE RECEPTOR BINDING | 7 | 4.38e-01 | 1.69e-01 | 7.52e-01 |
| GOBP VENTRICULAR SYSTEM DEVELOPMENT | 27 | 1.28e-01 | 1.69e-01 | 4.20e-01 |
| GOCC MON1 CCZ1 COMPLEX | 5 | 5.12e-01 | 1.69e-01 | 7.93e-01 |
| GOMF RNA POLYMERASE II SPECIFIC DNA BINDING TRANSCRIPTION FACTOR BINDING | 271 | 1.70e-06 | -1.69e-01 | 1.42e-04 |
| GOBP FATTY ACID HOMEOSTASIS | 12 | 3.10e-01 | 1.69e-01 | 6.50e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 15 | 2.57e-01 | 1.69e-01 | 5.92e-01 |
| GOBP INTERSTRAND CROSS LINK REPAIR | 39 | 6.78e-02 | -1.69e-01 | 3.01e-01 |
| GOCC CHROMOSOME CENTROMERIC REGION | 227 | 1.17e-05 | -1.69e-01 | 6.98e-04 |
| GOBP AMINOPHOSPHOLIPID TRANSLOCATION | 6 | 4.74e-01 | -1.69e-01 | 7.73e-01 |
| GOMF AMINOPHOSPHOLIPID FLIPPASE ACTIVITY | 6 | 4.74e-01 | -1.69e-01 | 7.73e-01 |
| GOBP GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 35 | 8.42e-02 | 1.69e-01 | 3.40e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 8 | 4.09e-01 | -1.69e-01 | 7.28e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSPORT | 32 | 9.88e-02 | 1.69e-01 | 3.68e-01 |
| GOBP REGULATION OF CELL FATE COMMITMENT | 22 | 1.71e-01 | -1.69e-01 | 4.85e-01 |
| GOBP CONNECTIVE TISSUE REPLACEMENT | 10 | 3.56e-01 | -1.69e-01 | 6.89e-01 |
| GOBP EMBRYONIC NEUROCRANIUM MORPHOGENESIS | 7 | 4.40e-01 | 1.69e-01 | 7.52e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 5 | 5.14e-01 | -1.69e-01 | 7.94e-01 |
| GOBP OLFACTORY BULB INTERNEURON DIFFERENTIATION | 7 | 4.40e-01 | 1.69e-01 | 7.52e-01 |
| GOBP REGULATION OF CD40 SIGNALING PATHWAY | 6 | 4.75e-01 | 1.69e-01 | 7.74e-01 |
| GOMF CYTOSKELETAL ANCHOR ACTIVITY | 20 | 1.92e-01 | -1.68e-01 | 5.11e-01 |
| GOBP REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 34 | 8.92e-02 | -1.68e-01 | 3.49e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 15 | 2.59e-01 | 1.68e-01 | 5.94e-01 |
| GOBP THYMUS DEVELOPMENT | 34 | 8.96e-02 | -1.68e-01 | 3.50e-01 |
| GOBP POST TRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE | 15 | 2.59e-01 | 1.68e-01 | 5.94e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 54 | 3.25e-02 | -1.68e-01 | 2.08e-01 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE | 25 | 1.46e-01 | -1.68e-01 | 4.47e-01 |
| GOBP ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL COMMUNICATION | 11 | 3.35e-01 | 1.68e-01 | 6.70e-01 |
| GOMF TRANSCRIPTION REGULATOR ACTIVITY | 1381 | 3.52e-25 | -1.68e-01 | 7.82e-22 |
| GOMF ORGANOPHOSPHATE ESTER TRANSMEMBRANE TRANSPORTER ACTIVITY | 34 | 9.04e-02 | 1.68e-01 | 3.52e-01 |
| GOBP INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 44 | 5.42e-02 | -1.68e-01 | 2.67e-01 |
| GOBP GRANULOCYTE DIFFERENTIATION | 32 | 1.01e-01 | -1.68e-01 | 3.72e-01 |
| GOBP POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 23 | 1.64e-01 | -1.68e-01 | 4.74e-01 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR BINDING | 383 | 1.90e-08 | -1.68e-01 | 3.25e-06 |
| GOBP L PROLINE BIOSYNTHETIC PROCESS | 5 | 5.16e-01 | 1.68e-01 | 7.95e-01 |
| GOBP INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 17 | 2.31e-01 | -1.68e-01 | 5.63e-01 |
| GOBP NUCLEAR PORE ORGANIZATION | 15 | 2.61e-01 | -1.68e-01 | 5.97e-01 |
| GOBP REGULATION OF FEEDING BEHAVIOR | 11 | 3.36e-01 | -1.68e-01 | 6.70e-01 |
| GOBP DITERPENOID BIOSYNTHETIC PROCESS | 7 | 4.43e-01 | -1.68e-01 | 7.54e-01 |
| GOBP MHC CLASS II BIOSYNTHETIC PROCESS | 16 | 2.46e-01 | -1.68e-01 | 5.80e-01 |
| GOBP GLUCOSE 6 PHOSPHATE METABOLIC PROCESS | 23 | 1.64e-01 | -1.68e-01 | 4.75e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT | 15 | 2.61e-01 | 1.68e-01 | 5.97e-01 |
| GOBP POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 13 | 2.96e-01 | -1.67e-01 | 6.34e-01 |
| GOBP DICARBOXYLIC ACID CATABOLIC PROCESS | 14 | 2.78e-01 | 1.67e-01 | 6.15e-01 |
| GOMF METAL CATION PROTON ANTIPORTER ACTIVITY | 17 | 2.32e-01 | 1.67e-01 | 5.63e-01 |
| GOBP LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 154 | 3.45e-04 | -1.67e-01 | 9.85e-03 |
| GOBP REGULATION OF CELLULAR RESPIRATION | 39 | 7.08e-02 | 1.67e-01 | 3.09e-01 |
| GOCC AUTOLYSOSOME | 12 | 3.16e-01 | 1.67e-01 | 6.55e-01 |
| GOBP DEMETHYLATION | 41 | 6.41e-02 | -1.67e-01 | 2.92e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM CALCIUM ION CONCENTRATION | 8 | 4.13e-01 | -1.67e-01 | 7.31e-01 |
| GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME | 8 | 4.13e-01 | 1.67e-01 | 7.32e-01 |
| GOBP PROTEIN AUTOPHOSPHORYLATION | 159 | 2.85e-04 | -1.67e-01 | 8.54e-03 |
| GOBP SPERM CAPACITATION | 12 | 3.17e-01 | 1.67e-01 | 6.56e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 14 | 2.80e-01 | -1.67e-01 | 6.17e-01 |
| GOBP REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 243 | 7.80e-06 | -1.67e-01 | 4.88e-04 |
| GOBP RNA SPLICING VIA TRANSESTERIFICATION REACTIONS | 275 | 2.03e-06 | -1.67e-01 | 1.62e-04 |
| GOBP CARBOHYDRATE HOMEOSTASIS | 159 | 2.91e-04 | -1.67e-01 | 8.67e-03 |
| GOMF INOSITOL POLYPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 4.80e-01 | -1.67e-01 | 7.77e-01 |
| GOBP HEMATOPOIETIC STEM CELL DIFFERENTIATION | 30 | 1.14e-01 | -1.67e-01 | 3.97e-01 |
| GOCC STEREOCILIA COUPLING LINK | 5 | 5.19e-01 | 1.67e-01 | 7.97e-01 |
| GOBP REGULATION OF HEPATIC STELLATE CELL ACTIVATION | 5 | 5.19e-01 | -1.67e-01 | 7.97e-01 |
| GOBP REGULATION OF HEPATOCYTE PROLIFERATION | 11 | 3.39e-01 | 1.66e-01 | 6.75e-01 |
| GOBP REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 175 | 1.49e-04 | -1.66e-01 | 5.21e-03 |
| GOBP CARDIAC SEPTUM MORPHOGENESIS | 43 | 5.92e-02 | -1.66e-01 | 2.80e-01 |
| GOMF GABA RECEPTOR ACTIVITY | 5 | 5.20e-01 | -1.66e-01 | 7.98e-01 |
| GOBP NUCLEOTIDE SUGAR METABOLIC PROCESS | 34 | 9.33e-02 | 1.66e-01 | 3.60e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 57 | 3.00e-02 | -1.66e-01 | 1.97e-01 |
| GOBP EATING BEHAVIOR | 18 | 2.22e-01 | -1.66e-01 | 5.51e-01 |
| GOBP MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 33 | 9.88e-02 | 1.66e-01 | 3.68e-01 |
| GOBP POSITIVE REGULATION OF ORGAN GROWTH | 22 | 1.78e-01 | -1.66e-01 | 4.93e-01 |
| GOMF ATPASE COUPLED INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 4.16e-01 | -1.66e-01 | 7.34e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF LIPID ANTIGEN VIA MHC CLASS IB | 5 | 5.21e-01 | -1.66e-01 | 7.98e-01 |
| GOBP MYELOID LEUKOCYTE DIFFERENTIATION | 181 | 1.22e-04 | -1.66e-01 | 4.44e-03 |
| GOBP REPRODUCTIVE SYSTEM DEVELOPMENT | 181 | 1.22e-04 | -1.66e-01 | 4.44e-03 |
| GOBP ACTIVATION OF PHOSPHOLIPASE C ACTIVITY | 18 | 2.23e-01 | -1.66e-01 | 5.52e-01 |
| GOBP MACROMOLECULE DEACYLATION | 63 | 2.31e-02 | -1.66e-01 | 1.70e-01 |
| GOMF DEACETYLASE ACTIVITY | 34 | 9.48e-02 | -1.66e-01 | 3.63e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS OXYGEN AS ACCEPTOR | 10 | 3.65e-01 | 1.66e-01 | 6.97e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 5 PRODUCTION | 5 | 5.22e-01 | -1.65e-01 | 7.99e-01 |
| GOCC BLEB | 9 | 3.90e-01 | -1.65e-01 | 7.16e-01 |
| GOBP BASIC AMINO ACID TRANSPORT | 15 | 2.68e-01 | 1.65e-01 | 6.05e-01 |
| GOCC ENDOPLASMIC RETICULUM PLASMA MEMBRANE CONTACT SITE | 10 | 3.65e-01 | 1.65e-01 | 6.97e-01 |
| GOMF PROTEIN TYROSINE KINASE BINDING | 89 | 7.06e-03 | -1.65e-01 | 8.36e-02 |
| GOBP MATURE B CELL DIFFERENTIATION | 28 | 1.30e-01 | -1.65e-01 | 4.23e-01 |
| GOBP TRNA PROCESSING | 130 | 1.16e-03 | 1.65e-01 | 2.43e-02 |
| GOMF MRNA 3 UTR AU RICH REGION BINDING | 25 | 1.53e-01 | -1.65e-01 | 4.58e-01 |
| GOBP VIRION ASSEMBLY | 33 | 1.01e-01 | 1.65e-01 | 3.72e-01 |
| GOBP REGULATION OF CHROMOSOME ORGANIZATION | 229 | 1.72e-05 | -1.65e-01 | 9.68e-04 |
| GOMF PHOSPHOLIPASE BINDING | 18 | 2.25e-01 | -1.65e-01 | 5.54e-01 |
| GOCC PTW PP1 PHOSPHATASE COMPLEX | 7 | 4.50e-01 | -1.65e-01 | 7.59e-01 |
| GOBP AMINOGLYCAN CATABOLIC PROCESS | 24 | 1.62e-01 | -1.65e-01 | 4.70e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 20 | 2.01e-01 | 1.65e-01 | 5.24e-01 |
| GOBP REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 25 | 1.53e-01 | -1.65e-01 | 4.58e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 2B COMPLEX | 5 | 5.23e-01 | -1.65e-01 | 7.99e-01 |
| GOBP MUCOSA ASSOCIATED LYMPHOID TISSUE DEVELOPMENT | 5 | 5.23e-01 | -1.65e-01 | 7.99e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE | 240 | 1.12e-05 | 1.65e-01 | 6.71e-04 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 6 | 4.84e-01 | -1.65e-01 | 7.81e-01 |
| GOBP BILE ACID AND BILE SALT TRANSPORT | 17 | 2.40e-01 | 1.65e-01 | 5.73e-01 |
| GOBP POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 32 | 1.07e-01 | 1.65e-01 | 3.82e-01 |
| GOBP MIRNA MEDIATED GENE SILENCING BY INHIBITION OF TRANSLATION | 16 | 2.54e-01 | -1.65e-01 | 5.89e-01 |
| GOBP POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY | 15 | 2.70e-01 | 1.65e-01 | 6.06e-01 |
| GOBP REGULATION OF RECEPTOR RECYCLING | 18 | 2.27e-01 | 1.65e-01 | 5.55e-01 |
| GOBP TYPE I INTERFERON PRODUCTION | 109 | 3.00e-03 | -1.65e-01 | 4.80e-02 |
| GOBP PARALLEL ACTIN FILAMENT BUNDLE ASSEMBLY | 5 | 5.24e-01 | -1.65e-01 | 8.00e-01 |
| GOBP REGULATION OF PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 6 | 4.85e-01 | -1.65e-01 | 7.81e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT ASSEMBLY | 24 | 1.63e-01 | -1.65e-01 | 4.73e-01 |
| GOCC PROTEIN KINASE COMPLEX | 128 | 1.31e-03 | -1.65e-01 | 2.65e-02 |
| GOBP NEUROINFLAMMATORY RESPONSE | 58 | 3.02e-02 | -1.65e-01 | 1.98e-01 |
| GOBP CELLULAR RESPONSE TO PEPTIDE | 265 | 4.15e-06 | -1.65e-01 | 3.03e-04 |
| GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 12 | 3.24e-01 | 1.65e-01 | 6.62e-01 |
| GOBP RIBONUCLEOSIDE CATABOLIC PROCESS | 18 | 2.27e-01 | 1.65e-01 | 5.56e-01 |
| GOCC H4 H2A HISTONE ACETYLTRANSFERASE COMPLEX | 22 | 1.82e-01 | -1.64e-01 | 4.98e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 12 | 3.24e-01 | 1.64e-01 | 6.63e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE | 34 | 9.73e-02 | -1.64e-01 | 3.66e-01 |
| GOBP ESTABLISHMENT OF GOLGI LOCALIZATION | 7 | 4.52e-01 | 1.64e-01 | 7.61e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 6 | 4.86e-01 | -1.64e-01 | 7.81e-01 |
| GOBP RESPONSE TO UV C | 12 | 3.25e-01 | -1.64e-01 | 6.63e-01 |
| GOBP TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR | 10 | 3.69e-01 | -1.64e-01 | 7.00e-01 |
| GOBP ALPHA BETA T CELL DIFFERENTIATION | 95 | 5.77e-03 | -1.64e-01 | 7.51e-02 |
| GOBP INHIBITORY SYNAPSE ASSEMBLY | 6 | 4.87e-01 | -1.64e-01 | 7.81e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION VIA SERINE | 6 | 4.87e-01 | 1.64e-01 | 7.81e-01 |
| GOBP PROTEIN N LINKED GLYCOSYLATION | 60 | 2.83e-02 | 1.64e-01 | 1.91e-01 |
| GOBP MONOCARBOXYLIC ACID TRANSPORT | 100 | 4.69e-03 | 1.64e-01 | 6.46e-02 |
| GOMF ALPHA CATENIN BINDING | 5 | 5.26e-01 | 1.64e-01 | 8.01e-01 |
| GOBP RESPONSE TO CADMIUM ION | 46 | 5.49e-02 | -1.64e-01 | 2.69e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL SHEET | 40 | 7.34e-02 | 1.64e-01 | 3.17e-01 |
| GOMF PROCOLLAGEN PROLINE DIOXYGENASE ACTIVITY | 6 | 4.88e-01 | 1.64e-01 | 7.81e-01 |
| GOMF ACID AMINO ACID LIGASE ACTIVITY | 16 | 2.57e-01 | -1.64e-01 | 5.93e-01 |
| GOBP NEGATIVE REGULATION OF T CELL PROLIFERATION | 48 | 5.00e-02 | -1.64e-01 | 2.60e-01 |
| GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 7 | 4.54e-01 | -1.64e-01 | 7.62e-01 |
| GOBP DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 12 | 3.27e-01 | 1.64e-01 | 6.63e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H HEME PROTEIN AS ACCEPTOR | 10 | 3.71e-01 | 1.63e-01 | 7.00e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 101 | 4.56e-03 | -1.63e-01 | 6.34e-02 |
| GOBP PROTEIN LOCALIZATION TO SYNAPSE | 53 | 3.98e-02 | 1.63e-01 | 2.31e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN MATURATION | 21 | 1.95e-01 | 1.63e-01 | 5.15e-01 |
| GOBP REGULATION OF VITAMIN METABOLIC PROCESS | 10 | 3.72e-01 | 1.63e-01 | 7.00e-01 |
| GOBP TYPE II INTERFERON PRODUCTION | 76 | 1.40e-02 | -1.63e-01 | 1.28e-01 |
| GOBP RELAXATION OF MUSCLE | 23 | 1.76e-01 | -1.63e-01 | 4.91e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS | 7 | 4.55e-01 | 1.63e-01 | 7.62e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 38 | 8.20e-02 | -1.63e-01 | 3.37e-01 |
| GOBP KERATAN SULFATE METABOLIC PROCESS | 13 | 3.09e-01 | -1.63e-01 | 6.48e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 17 | 2.45e-01 | 1.63e-01 | 5.79e-01 |
| GOCC CHROMATIN SILENCING COMPLEX | 13 | 3.09e-01 | -1.63e-01 | 6.49e-01 |
| GOMF GLUCOSIDASE ACTIVITY | 6 | 4.90e-01 | -1.63e-01 | 7.82e-01 |
| GOCC MICROBODY MEMBRANE | 60 | 2.93e-02 | 1.63e-01 | 1.95e-01 |
| GOBP XENOBIOTIC CATABOLIC PROCESS | 12 | 3.29e-01 | 1.63e-01 | 6.66e-01 |
| GOCC PLATELET DENSE GRANULE | 13 | 3.10e-01 | -1.63e-01 | 6.50e-01 |
| GOBP NEGATIVE REGULATION OF DNA REPAIR | 35 | 9.64e-02 | -1.62e-01 | 3.66e-01 |
| GOBP NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 9 | 3.99e-01 | -1.62e-01 | 7.22e-01 |
| GOCC PRC1 COMPLEX | 16 | 2.61e-01 | 1.62e-01 | 5.97e-01 |
| GOMF EPHRIN RECEPTOR BINDING | 21 | 1.98e-01 | -1.62e-01 | 5.19e-01 |
| GOBP NEUROENDOCRINE CELL DIFFERENTIATION | 6 | 4.92e-01 | 1.62e-01 | 7.83e-01 |
| GOCC SWI SNF SUPERFAMILY TYPE COMPLEX | 86 | 9.40e-03 | -1.62e-01 | 1.00e-01 |
| GOMF BASIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 3.53e-01 | 1.62e-01 | 6.87e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL FOLD | 10 | 3.76e-01 | -1.62e-01 | 7.04e-01 |
| GOBP POSITIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT | 7 | 4.59e-01 | 1.62e-01 | 7.64e-01 |
| GOBP CORNIFIED ENVELOPE ASSEMBLY | 5 | 5.31e-01 | 1.62e-01 | 8.04e-01 |
| GOBP NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 18 | 2.35e-01 | -1.62e-01 | 5.66e-01 |
| GOBP NEGATIVE REGULATION OF BINDING | 92 | 7.43e-03 | -1.62e-01 | 8.56e-02 |
| GOBP INCLUSION BODY ASSEMBLY | 21 | 2.00e-01 | 1.62e-01 | 5.21e-01 |
| GOMF SH3 DOMAIN BINDING | 98 | 5.75e-03 | -1.62e-01 | 7.50e-02 |
| GOBP REGULATION OF PROTEIN LIPIDATION | 9 | 4.02e-01 | 1.61e-01 | 7.23e-01 |
| GOCC SPECIFIC GRANULE MEMBRANE | 78 | 1.37e-02 | -1.61e-01 | 1.27e-01 |
| GOBP ASTROCYTE ACTIVATION | 17 | 2.49e-01 | -1.61e-01 | 5.84e-01 |
| GOBP REGULATION OF CORTICOSTEROID HORMONE SECRETION | 9 | 4.02e-01 | 1.61e-01 | 7.24e-01 |
| GOBP DIGESTIVE TRACT MORPHOGENESIS | 19 | 2.24e-01 | 1.61e-01 | 5.52e-01 |
| GOMF GABA RECEPTOR BINDING | 12 | 3.34e-01 | -1.61e-01 | 6.69e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 36 | 9.43e-02 | -1.61e-01 | 3.62e-01 |
| GOBP NEGATIVE REGULATION OF DNA METABOLIC PROCESS | 112 | 3.24e-03 | -1.61e-01 | 5.04e-02 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 26 | 1.55e-01 | -1.61e-01 | 4.60e-01 |
| GOBP POSITIVE REGULATION OF NEUTROPHIL MIGRATION | 27 | 1.47e-01 | -1.61e-01 | 4.49e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 3.55e-01 | -1.61e-01 | 6.89e-01 |
| GOMF G RICH STRAND TELOMERIC DNA BINDING | 10 | 3.78e-01 | -1.61e-01 | 7.05e-01 |
| GOBP VESICLE TRANSPORT ALONG MICROTUBULE | 41 | 7.45e-02 | 1.61e-01 | 3.19e-01 |
| GOBP RRNA METHYLATION | 22 | 1.91e-01 | 1.61e-01 | 5.10e-01 |
| GOBP POSITIVE REGULATION OF RNA METABOLIC PROCESS | 1363 | 5.47e-23 | -1.61e-01 | 6.08e-20 |
| GOBP TRNA METABOLIC PROCESS | 176 | 2.37e-04 | 1.61e-01 | 7.38e-03 |
| GOBP NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY | 11 | 3.56e-01 | -1.61e-01 | 6.89e-01 |
| GOBP ACTIVATION OF JANUS KINASE ACTIVITY | 8 | 4.31e-01 | 1.61e-01 | 7.48e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSPORT | 20 | 2.13e-01 | 1.61e-01 | 5.38e-01 |
| GOBP MODIFIED AMINO ACID TRANSPORT | 39 | 8.28e-02 | 1.61e-01 | 3.39e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 32 | 1.16e-01 | -1.61e-01 | 4.00e-01 |
| GOCC TRANSLOCON COMPLEX | 6 | 4.96e-01 | 1.60e-01 | 7.85e-01 |
| GOBP VERY LONG CHAIN FATTY ACID METABOLIC PROCESS | 26 | 1.57e-01 | 1.60e-01 | 4.62e-01 |
| GOBP PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY | 15 | 2.82e-01 | -1.60e-01 | 6.20e-01 |
| GOBP SCHWANN CELL DIFFERENTIATION | 31 | 1.22e-01 | -1.60e-01 | 4.10e-01 |
| GOMF DEAMINASE ACTIVITY | 26 | 1.57e-01 | 1.60e-01 | 4.63e-01 |
| GOBP EMBRYONIC EYE MORPHOGENESIS | 16 | 2.67e-01 | -1.60e-01 | 6.04e-01 |
| GOBP NEGATIVE REGULATION OF HYPOXIA INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 6 | 4.97e-01 | -1.60e-01 | 7.86e-01 |
| GOBP REGULATION OF GERMINAL CENTER FORMATION | 7 | 4.63e-01 | 1.60e-01 | 7.65e-01 |
| GOMF PROTEIN SEQUESTERING ACTIVITY | 21 | 2.04e-01 | 1.60e-01 | 5.26e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 76 | 1.58e-02 | -1.60e-01 | 1.40e-01 |
| GOBP PROTEIN K11 LINKED UBIQUITINATION | 29 | 1.36e-01 | 1.60e-01 | 4.33e-01 |
| GOBP THIOESTER METABOLIC PROCESS | 78 | 1.46e-02 | 1.60e-01 | 1.32e-01 |
| GOMF ACIDIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 3.00e-01 | -1.60e-01 | 6.39e-01 |
| GOBP GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION | 5 | 5.36e-01 | -1.60e-01 | 8.09e-01 |
| GOMF MYOSIN BINDING | 48 | 5.56e-02 | 1.60e-01 | 2.72e-01 |
| GOBP REGULATION OF PRO B CELL DIFFERENTIATION | 7 | 4.64e-01 | -1.60e-01 | 7.66e-01 |
| GOBP POSITIVE REGULATION OF VIRAL GENOME REPLICATION | 28 | 1.44e-01 | -1.60e-01 | 4.45e-01 |
| GOBP C TERMINAL PROTEIN AMINO ACID MODIFICATION | 8 | 4.34e-01 | 1.60e-01 | 7.50e-01 |
| GOBP OLIGOSACCHARIDE BIOSYNTHETIC PROCESS | 15 | 2.84e-01 | -1.60e-01 | 6.22e-01 |
| GOBP GTP BIOSYNTHETIC PROCESS | 10 | 3.82e-01 | 1.60e-01 | 7.09e-01 |
| GOBP RENAL FILTRATION | 16 | 2.69e-01 | 1.60e-01 | 6.06e-01 |
| GOBP OBSERVATIONAL LEARNING | 5 | 5.37e-01 | 1.60e-01 | 8.09e-01 |
| GOBP 5S CLASS RRNA TRANSCRIPTION BY RNA POLYMERASE III | 6 | 4.99e-01 | 1.60e-01 | 7.87e-01 |
| GOCC TRANSCRIPTION FACTOR TFIIIC COMPLEX | 6 | 4.99e-01 | 1.60e-01 | 7.87e-01 |
| GOMF NUCLEAR RECEPTOR COACTIVATOR ACTIVITY | 53 | 4.46e-02 | -1.60e-01 | 2.46e-01 |
| GOBP NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY | 22 | 1.95e-01 | -1.60e-01 | 5.15e-01 |
| GOBP NEURON CELL CELL ADHESION | 9 | 4.07e-01 | -1.60e-01 | 7.27e-01 |
| GOMF CHEMOKINE RECEPTOR BINDING | 29 | 1.37e-01 | 1.59e-01 | 4.35e-01 |
| GOMF 5 DEOXYRIBOSE 5 PHOSPHATE LYASE ACTIVITY | 5 | 5.37e-01 | -1.59e-01 | 8.09e-01 |
| GOBP RRNA MODIFICATION | 31 | 1.25e-01 | 1.59e-01 | 4.15e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 5 | 5.37e-01 | 1.59e-01 | 8.09e-01 |
| GOCC AGGRESOME | 28 | 1.45e-01 | -1.59e-01 | 4.45e-01 |
| GOBP INSULIN RECEPTOR SIGNALING PATHWAY | 96 | 7.06e-03 | -1.59e-01 | 8.36e-02 |
| GOMF CHEMOATTRACTANT ACTIVITY | 17 | 2.56e-01 | 1.59e-01 | 5.91e-01 |
| GOBP APOLIPOPROTEIN A I MEDIATED SIGNALING PATHWAY | 5 | 5.38e-01 | 1.59e-01 | 8.10e-01 |
| GOBP REGULATION OF MIRNA TRANSCRIPTION | 50 | 5.17e-02 | -1.59e-01 | 2.63e-01 |
| GOBP RESPONSE TO PARATHYROID HORMONE | 7 | 4.66e-01 | -1.59e-01 | 7.67e-01 |
| GOBP PLATELET ACTIVATING FACTOR METABOLIC PROCESS | 8 | 4.37e-01 | 1.59e-01 | 7.51e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION | 8 | 4.37e-01 | -1.59e-01 | 7.51e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 65 | 2.68e-02 | -1.59e-01 | 1.86e-01 |
| GOMF TRANSITION METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 36 | 9.94e-02 | 1.59e-01 | 3.69e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 14 | 3.04e-01 | -1.59e-01 | 6.43e-01 |
| GOBP AUTOPHAGY OF PEROXISOME | 10 | 3.85e-01 | -1.59e-01 | 7.12e-01 |
| GOMF SMALL RIBOSOMAL SUBUNIT RRNA BINDING | 8 | 4.37e-01 | -1.59e-01 | 7.51e-01 |
| GOBP KINETOCHORE ORGANIZATION | 21 | 2.08e-01 | -1.59e-01 | 5.32e-01 |
| GOBP REGULATION OF REMOVAL OF SUPEROXIDE RADICALS | 6 | 5.01e-01 | 1.59e-01 | 7.88e-01 |
| GOBP REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 19 | 2.32e-01 | -1.58e-01 | 5.63e-01 |
| GOCC AXONEMAL MICROTUBULE | 20 | 2.20e-01 | 1.58e-01 | 5.48e-01 |
| GOBP TROPHECTODERMAL CELL DIFFERENTIATION | 13 | 3.23e-01 | -1.58e-01 | 6.62e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 7 | 4.68e-01 | 1.58e-01 | 7.68e-01 |
| GOBP GLYCINE METABOLIC PROCESS | 10 | 3.86e-01 | 1.58e-01 | 7.12e-01 |
| GOBP REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 57 | 3.88e-02 | -1.58e-01 | 2.28e-01 |
| GOBP RETINA LAYER FORMATION | 13 | 3.23e-01 | 1.58e-01 | 6.62e-01 |
| GOBP PHOSPHATE ION TRANSPORT | 18 | 2.45e-01 | 1.58e-01 | 5.79e-01 |
| GOMF PROTEIN SERINE KINASE ACTIVITY | 311 | 1.69e-06 | -1.58e-01 | 1.42e-04 |
| GOBP ACIDIC AMINO ACID TRANSPORT | 40 | 8.37e-02 | -1.58e-01 | 3.40e-01 |
| GOBP APICAL PROTEIN LOCALIZATION | 9 | 4.12e-01 | 1.58e-01 | 7.31e-01 |
| GOCC EXON EXON JUNCTION COMPLEX | 11 | 3.64e-01 | -1.58e-01 | 6.97e-01 |
| GOBP POSITIVE REGULATION OF FILOPODIUM ASSEMBLY | 23 | 1.90e-01 | -1.58e-01 | 5.09e-01 |
| GOBP INTERLEUKIN 5 PRODUCTION | 8 | 4.39e-01 | -1.58e-01 | 7.52e-01 |
| GOBP REGULATION OF GLUCOSE METABOLIC PROCESS | 76 | 1.73e-02 | -1.58e-01 | 1.47e-01 |
| GOMF VITAMIN BINDING | 97 | 7.20e-03 | 1.58e-01 | 8.42e-02 |
| GOBP REGULATION PROTEIN CATABOLIC PROCESS AT SYNAPSE | 6 | 5.03e-01 | 1.58e-01 | 7.88e-01 |
| GOBP DISTAL TUBULE DEVELOPMENT | 6 | 5.03e-01 | -1.58e-01 | 7.88e-01 |
| GOBP NEGATIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 25 | 1.72e-01 | -1.58e-01 | 4.86e-01 |
| GOBP MRNA TRANSCRIPTION | 48 | 5.86e-02 | -1.58e-01 | 2.79e-01 |
| GOBP AXONEME ASSEMBLY | 50 | 5.36e-02 | 1.58e-01 | 2.66e-01 |
| GOMF C ACETYLTRANSFERASE ACTIVITY | 7 | 4.70e-01 | 1.58e-01 | 7.69e-01 |
| GOBP REGULATION OF GASTRULATION | 9 | 4.13e-01 | -1.58e-01 | 7.31e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID OXIDATION | 9 | 4.13e-01 | -1.58e-01 | 7.31e-01 |
| GOBP HYPERSENSITIVITY | 11 | 3.65e-01 | -1.58e-01 | 6.97e-01 |
| GOBP POSITIVE REGULATION OF WOUND HEALING | 40 | 8.45e-02 | 1.58e-01 | 3.41e-01 |
| GOBP MONONUCLEAR CELL DIFFERENTIATION | 351 | 4.11e-07 | -1.58e-01 | 4.60e-05 |
| GOBP NEGATIVE REGULATION OF AMINE TRANSPORT | 13 | 3.25e-01 | -1.58e-01 | 6.63e-01 |
| GOBP CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS | 221 | 5.52e-05 | -1.58e-01 | 2.49e-03 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 71 | 2.17e-02 | -1.58e-01 | 1.63e-01 |
| GOBP PROGRAMMED NECROTIC CELL DEATH | 45 | 6.76e-02 | -1.58e-01 | 3.01e-01 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 5 | 5.42e-01 | 1.57e-01 | 8.13e-01 |
| GOBP PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS | 29 | 1.42e-01 | 1.57e-01 | 4.42e-01 |
| GOBP ACTIVATION OF INNATE IMMUNE RESPONSE | 222 | 5.45e-05 | -1.57e-01 | 2.49e-03 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 21 | 2.12e-01 | -1.57e-01 | 5.37e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 5 PHOSPHATASE ACTIVITY | 12 | 3.46e-01 | -1.57e-01 | 6.82e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION | 5 | 5.43e-01 | -1.57e-01 | 8.13e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 21 | 2.12e-01 | -1.57e-01 | 5.37e-01 |
| GOBP NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 10 | 3.89e-01 | -1.57e-01 | 7.15e-01 |
| GOMF INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 33 | 1.18e-01 | -1.57e-01 | 4.02e-01 |
| GOBP PROTEIN DEUBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 6 | 5.05e-01 | 1.57e-01 | 7.89e-01 |
| GOBP REGULATION OF PROTEIN AUTOUBIQUITINATION | 5 | 5.43e-01 | -1.57e-01 | 8.14e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 33 | 1.18e-01 | -1.57e-01 | 4.02e-01 |
| GOBP BONE CELL DEVELOPMENT | 15 | 2.92e-01 | -1.57e-01 | 6.31e-01 |
| GOCC OLIGOSACCHARYLTRANSFERASE COMPLEX | 12 | 3.46e-01 | 1.57e-01 | 6.82e-01 |
| GOBP LATE ENDOSOME TO GOLGI TRANSPORT | 5 | 5.43e-01 | 1.57e-01 | 8.14e-01 |
| GOMF NEUROTRANSMITTER TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 4.72e-01 | 1.57e-01 | 7.72e-01 |
| GOCC TRANSPORTER COMPLEX | 246 | 2.30e-05 | 1.57e-01 | 1.23e-03 |
| GOBP NEUTROPHIL APOPTOTIC PROCESS | 7 | 4.72e-01 | -1.57e-01 | 7.72e-01 |
| GOBP CELL FATE DETERMINATION | 15 | 2.93e-01 | 1.57e-01 | 6.31e-01 |
| GOBP GLIAL CELL APOPTOTIC PROCESS | 15 | 2.93e-01 | -1.57e-01 | 6.31e-01 |
| GOBP OUTFLOW TRACT SEPTUM MORPHOGENESIS | 16 | 2.78e-01 | -1.57e-01 | 6.15e-01 |
| GOBP RNA LOCALIZATION | 180 | 2.90e-04 | -1.57e-01 | 8.67e-03 |
| GOBP POSITIVE REGULATION OF MUSCLE HYPERTROPHY | 18 | 2.50e-01 | -1.57e-01 | 5.84e-01 |
| GOBP SISTER CHROMATID SEGREGATION | 212 | 8.53e-05 | -1.57e-01 | 3.44e-03 |
| GOBP GLYCOLIPID TRANSPORT | 8 | 4.43e-01 | 1.57e-01 | 7.54e-01 |
| GOMF OMEGA PEPTIDASE ACTIVITY | 11 | 3.68e-01 | 1.57e-01 | 7.00e-01 |
| GOBP TRACHEA MORPHOGENESIS | 7 | 4.73e-01 | -1.57e-01 | 7.72e-01 |
| GOBP CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 11 | 3.69e-01 | 1.56e-01 | 7.00e-01 |
| GOBP POSITIVE REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 11 | 3.69e-01 | 1.56e-01 | 7.00e-01 |
| GOMF GLUCOSYLTRANSFERASE ACTIVITY | 15 | 2.95e-01 | 1.56e-01 | 6.32e-01 |
| GOBP COENZYME A METABOLIC PROCESS | 19 | 2.39e-01 | 1.56e-01 | 5.71e-01 |
| GOBP CELLULAR RESPONSE TO VIRUS | 47 | 6.42e-02 | -1.56e-01 | 2.93e-01 |
| GOBP LATERAL VENTRICLE DEVELOPMENT | 8 | 4.45e-01 | 1.56e-01 | 7.55e-01 |
| GOCC UBIQUINONE BIOSYNTHESIS COMPLEX | 6 | 5.08e-01 | 1.56e-01 | 7.91e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN UBIQUITINATION | 70 | 2.41e-02 | -1.56e-01 | 1.74e-01 |
| GOMF MONOATOMIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 74 | 2.04e-02 | 1.56e-01 | 1.58e-01 |
| GOMF CLASS I DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 8 | 4.45e-01 | -1.56e-01 | 7.55e-01 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 36 | 1.06e-01 | 1.56e-01 | 3.81e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 11 | 3.71e-01 | -1.56e-01 | 7.00e-01 |
| GOBP ANDROGEN METABOLIC PROCESS | 19 | 2.40e-01 | -1.56e-01 | 5.74e-01 |
| GOMF 3 5 RNA HELICASE ACTIVITY | 5 | 5.47e-01 | -1.56e-01 | 8.17e-01 |
| GOCC OXIDOREDUCTASE COMPLEX | 115 | 4.02e-03 | 1.55e-01 | 5.86e-02 |
| GOBP BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS | 19 | 2.41e-01 | -1.55e-01 | 5.75e-01 |
| GOBP NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 35 | 1.12e-01 | -1.55e-01 | 3.92e-01 |
| GOBP NEGATIVE REGULATION OF VASOCONSTRICTION | 6 | 5.10e-01 | -1.55e-01 | 7.92e-01 |
| GOBP MEMBRANE REPOLARIZATION | 27 | 1.63e-01 | 1.55e-01 | 4.73e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 16 | 2.83e-01 | -1.55e-01 | 6.21e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 9 | 4.21e-01 | 1.55e-01 | 7.39e-01 |
| GOBP DIOL BIOSYNTHETIC PROCESS | 17 | 2.69e-01 | 1.55e-01 | 6.06e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE C ACTIVITY | 28 | 1.56e-01 | -1.55e-01 | 4.62e-01 |
| GOBP PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 7 | 4.78e-01 | 1.55e-01 | 7.75e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 37 | 1.03e-01 | 1.55e-01 | 3.76e-01 |
| GOCC GAMMA SECRETASE COMPLEX | 7 | 4.78e-01 | -1.55e-01 | 7.75e-01 |
| GOMF ENZYME SUBSTRATE ADAPTOR ACTIVITY | 60 | 3.81e-02 | -1.55e-01 | 2.26e-01 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 942 | 1.23e-15 | -1.55e-01 | 6.41e-13 |
| GOMF PROTEIN FOLDING CHAPERONE | 51 | 5.60e-02 | 1.55e-01 | 2.72e-01 |
| GOBP NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 11 | 3.74e-01 | -1.55e-01 | 7.02e-01 |
| GOBP STRESS GRANULE ASSEMBLY | 29 | 1.49e-01 | -1.55e-01 | 4.53e-01 |
| GOBP REGULATION OF KIDNEY DEVELOPMENT | 16 | 2.84e-01 | -1.55e-01 | 6.22e-01 |
| GOBP REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 171 | 4.90e-04 | -1.55e-01 | 1.31e-02 |
| GOBP TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 23 | 1.99e-01 | -1.55e-01 | 5.20e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 5 | 5.49e-01 | -1.55e-01 | 8.19e-01 |
| GOBP RESPONSE TO ETHER | 10 | 3.97e-01 | -1.55e-01 | 7.21e-01 |
| GOBP LEUKOCYTE DIFFERENTIATION | 461 | 1.40e-08 | -1.55e-01 | 2.55e-06 |
| GOBP CELL FATE COMMITMENT | 124 | 2.97e-03 | -1.55e-01 | 4.79e-02 |
| GOMF NUCLEAR ESTROGEN RECEPTOR BINDING | 33 | 1.25e-01 | -1.55e-01 | 4.14e-01 |
| GOMF CARBOHYDRATE PROTON SYMPORTER ACTIVITY | 5 | 5.50e-01 | -1.55e-01 | 8.19e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS OF VIRUS BY HOST CELL | 8 | 4.49e-01 | 1.54e-01 | 7.59e-01 |
| GOBP GLUTATHIONE METABOLIC PROCESS | 38 | 9.96e-02 | 1.54e-01 | 3.69e-01 |
| GOBP REGULATION OF ICOSANOID SECRETION | 10 | 3.98e-01 | 1.54e-01 | 7.21e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 11 | 3.75e-01 | 1.54e-01 | 7.03e-01 |
| GOBP EPITHELIAL CELL APOPTOTIC PROCESS | 88 | 1.24e-02 | -1.54e-01 | 1.18e-01 |
| GOBP REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 8 | 4.50e-01 | 1.54e-01 | 7.59e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 10 | 3.99e-01 | 1.54e-01 | 7.22e-01 |
| GOBP NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION | 6 | 5.13e-01 | -1.54e-01 | 7.94e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 88 | 1.25e-02 | -1.54e-01 | 1.19e-01 |
| GOBP SOMITE DEVELOPMENT | 45 | 7.39e-02 | -1.54e-01 | 3.18e-01 |
| GOBP PROTEIN DELIPIDATION | 5 | 5.51e-01 | 1.54e-01 | 8.19e-01 |
| GOBP SPLICEOSOMAL COMPLEX ASSEMBLY | 72 | 2.40e-02 | -1.54e-01 | 1.74e-01 |
| GOBP CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 9 | 4.24e-01 | 1.54e-01 | 7.42e-01 |
| GOBP NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 5 | 5.51e-01 | 1.54e-01 | 8.19e-01 |
| GOMF PHOSPHATIDYLETHANOLAMINE FLIPPASE ACTIVITY | 5 | 5.51e-01 | -1.54e-01 | 8.19e-01 |
| GOBP RENAL WATER TRANSPORT | 7 | 4.82e-01 | -1.53e-01 | 7.79e-01 |
| GOBP CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS | 99 | 8.35e-03 | -1.53e-01 | 9.29e-02 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS | 7 | 4.82e-01 | -1.53e-01 | 7.79e-01 |
| GOBP INTERLEUKIN 11 MEDIATED SIGNALING PATHWAY | 5 | 5.52e-01 | 1.53e-01 | 8.19e-01 |
| GOMF PROTEIN TYROSINE KINASE ACTIVITY | 101 | 7.76e-03 | -1.53e-01 | 8.84e-02 |
| GOBP IMMUNOGLOBULIN PRODUCTION | 86 | 1.40e-02 | -1.53e-01 | 1.28e-01 |
| GOBP DOPAMINE TRANSPORT | 23 | 2.03e-01 | 1.53e-01 | 5.26e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A TRNA | 108 | 5.96e-03 | 1.53e-01 | 7.64e-02 |
| GOBP NEGATIVE REGULATION OF CELL ACTIVATION | 151 | 1.17e-03 | -1.53e-01 | 2.43e-02 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE BINDING | 10 | 4.01e-01 | 1.53e-01 | 7.23e-01 |
| GOBP MYELOID LEUKOCYTE ACTIVATION | 174 | 4.96e-04 | -1.53e-01 | 1.31e-02 |
| GOBP NEUROPEPTIDE SIGNALING PATHWAY | 26 | 1.77e-01 | -1.53e-01 | 4.92e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 866 | 2.95e-14 | -1.53e-01 | 1.38e-11 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 62 | 3.73e-02 | 1.53e-01 | 2.24e-01 |
| GOBP REGULATION OF MIRNA METABOLIC PROCESS | 63 | 3.58e-02 | -1.53e-01 | 2.20e-01 |
| GOBP REGULATION OF CARDIAC CONDUCTION | 17 | 2.75e-01 | -1.53e-01 | 6.11e-01 |
| GOMF RNA POLYMERASE II ACTIVITY | 11 | 3.80e-01 | 1.53e-01 | 7.07e-01 |
| GOMF PROFILIN BINDING | 10 | 4.02e-01 | 1.53e-01 | 7.24e-01 |
| GOBP DNA SYNTHESIS INVOLVED IN DNA REPAIR | 35 | 1.18e-01 | -1.53e-01 | 4.02e-01 |
| GOBP CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS | 226 | 7.67e-05 | -1.53e-01 | 3.21e-03 |
| GOBP ASTROCYTE DEVELOPMENT | 30 | 1.47e-01 | -1.53e-01 | 4.49e-01 |
| GOBP NEGATIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 10 | 4.03e-01 | 1.53e-01 | 7.24e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE A | 8 | 4.54e-01 | -1.53e-01 | 7.62e-01 |
| GOCC NUCLEAR BODY | 741 | 1.84e-12 | -1.53e-01 | 6.54e-10 |
| GOMF ATP DEPENDENT PEPTIDASE ACTIVITY | 7 | 4.84e-01 | 1.53e-01 | 7.81e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT ASSEMBLY | 15 | 3.06e-01 | 1.53e-01 | 6.45e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 12 | 3.60e-01 | -1.53e-01 | 6.93e-01 |
| GOBP POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 43 | 8.37e-02 | -1.53e-01 | 3.40e-01 |
| GOCC LSM2 8 COMPLEX | 7 | 4.85e-01 | 1.52e-01 | 7.81e-01 |
| GOBP P38MAPK CASCADE | 47 | 7.09e-02 | -1.52e-01 | 3.09e-01 |
| GOBP GROWTH HORMONE SECRETION | 8 | 4.56e-01 | 1.52e-01 | 7.62e-01 |
| GOBP SKELETAL MUSCLE CELL PROLIFERATION | 16 | 2.92e-01 | -1.52e-01 | 6.31e-01 |
| GOMF 2 OXOGLUTARATE DEPENDENT DIOXYGENASE ACTIVITY | 54 | 5.31e-02 | -1.52e-01 | 2.66e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 20 | 2.39e-01 | -1.52e-01 | 5.71e-01 |
| GOBP PEPTIDYL TYROSINE AUTOPHOSPHORYLATION | 10 | 4.05e-01 | -1.52e-01 | 7.26e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION | 839 | 9.69e-14 | -1.52e-01 | 4.10e-11 |
| GOBP JNK CASCADE | 136 | 2.22e-03 | -1.52e-01 | 3.88e-02 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY | 19 | 2.51e-01 | -1.52e-01 | 5.86e-01 |
| GOBP PEPTIDYL SERINE DEPHOSPHORYLATION | 13 | 3.43e-01 | -1.52e-01 | 6.79e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION | 31 | 1.43e-01 | -1.52e-01 | 4.44e-01 |
| GOBP ENDOCARDIAL CUSHION MORPHOGENESIS | 23 | 2.07e-01 | -1.52e-01 | 5.31e-01 |
| GOBP AGGREPHAGY | 8 | 4.57e-01 | 1.52e-01 | 7.62e-01 |
| GOBP RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 197 | 2.41e-04 | -1.52e-01 | 7.45e-03 |
| GOCC MITOCHONDRIAL TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX | 11 | 3.83e-01 | 1.52e-01 | 7.10e-01 |
| GOBP INDOLALKYLAMINE METABOLIC PROCESS | 11 | 3.83e-01 | -1.52e-01 | 7.10e-01 |
| GOMF NUCLEAR RECEPTOR ACTIVITY | 34 | 1.26e-01 | -1.52e-01 | 4.16e-01 |
| GOMF IRON ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 4.31e-01 | 1.52e-01 | 7.48e-01 |
| GOMF INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 84 | 1.63e-02 | 1.52e-01 | 1.42e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 6 | 5.20e-01 | -1.52e-01 | 7.98e-01 |
| GOBP REGULATION OF LIPOPROTEIN LIPASE ACTIVITY | 6 | 5.20e-01 | 1.52e-01 | 7.98e-01 |
| GOBP BONE MINERALIZATION INVOLVED IN BONE MATURATION | 9 | 4.31e-01 | 1.52e-01 | 7.48e-01 |
| GOBP REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION | 10 | 4.07e-01 | -1.52e-01 | 7.27e-01 |
| GOBP NEGATIVE REGULATION OF REPRODUCTIVE PROCESS | 40 | 9.75e-02 | 1.51e-01 | 3.66e-01 |
| GOMF UBIQUINONE BINDING | 6 | 5.21e-01 | 1.51e-01 | 7.98e-01 |
| GOMF ACETYL COA C ACYLTRANSFERASE ACTIVITY | 7 | 4.88e-01 | 1.51e-01 | 7.81e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 12 | 3.64e-01 | 1.51e-01 | 6.96e-01 |
| GOMF CALCIUM CHANNEL REGULATOR ACTIVITY | 26 | 1.82e-01 | 1.51e-01 | 4.98e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS | 121 | 4.07e-03 | -1.51e-01 | 5.89e-02 |
| GOBP NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 11 | 3.85e-01 | -1.51e-01 | 7.12e-01 |
| GOBP REGULATION OF INNATE IMMUNE RESPONSE | 333 | 2.24e-06 | -1.51e-01 | 1.77e-04 |
| GOMF ADP D RIBOSE MODIFICATION DEPENDENT PROTEIN BINDING | 5 | 5.58e-01 | -1.51e-01 | 8.24e-01 |
| GOBP REGULATION OF NCRNA TRANSCRIPTION | 67 | 3.26e-02 | -1.51e-01 | 2.08e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION | 12 | 3.65e-01 | -1.51e-01 | 6.97e-01 |
| GOBP GLOMERULUS DEVELOPMENT | 41 | 9.43e-02 | 1.51e-01 | 3.62e-01 |
| GOBP RNA CATABOLIC PROCESS | 266 | 2.33e-05 | -1.51e-01 | 1.23e-03 |
| GOBP POSITIVE REGULATION OF CELL DEVELOPMENT | 318 | 3.89e-06 | -1.51e-01 | 2.86e-04 |
| GOBP GERMINAL CENTER FORMATION | 12 | 3.66e-01 | 1.51e-01 | 6.97e-01 |
| GOBP REGULATION OF PROTEIN DEACETYLATION | 29 | 1.60e-01 | -1.51e-01 | 4.67e-01 |
| GOMF TASTE RECEPTOR ACTIVITY | 5 | 5.59e-01 | -1.51e-01 | 8.25e-01 |
| GOBP REGULATION OF GLIAL CELL PROLIFERATION | 27 | 1.75e-01 | -1.51e-01 | 4.90e-01 |
| GOBP CMP METABOLIC PROCESS | 7 | 4.90e-01 | 1.51e-01 | 7.82e-01 |
| GOBP TRANSLESION SYNTHESIS | 25 | 1.92e-01 | -1.51e-01 | 5.11e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGY | 81 | 1.91e-02 | -1.51e-01 | 1.53e-01 |
| GOBP RESPONSE TO STARVATION | 172 | 6.62e-04 | -1.51e-01 | 1.62e-02 |
| GOBP PROTEIN TRANSMEMBRANE TRANSPORT | 59 | 4.56e-02 | 1.51e-01 | 2.49e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC CELL CLEARANCE | 6 | 5.23e-01 | 1.50e-01 | 7.99e-01 |
| GOBP POSITIVE REGULATION OF ENDOCYTOSIS | 112 | 5.98e-03 | -1.50e-01 | 7.64e-02 |
| GOBP POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 25 | 1.93e-01 | 1.50e-01 | 5.12e-01 |
| GOBP POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 54 | 5.60e-02 | -1.50e-01 | 2.72e-01 |
| GOCC GOLGI TRANS CISTERNA | 9 | 4.35e-01 | 1.50e-01 | 7.50e-01 |
| GOMF FUCOSYLTRANSFERASE ACTIVITY | 7 | 4.91e-01 | -1.50e-01 | 7.83e-01 |
| GOMF CROSSOVER JUNCTION DNA ENDONUCLEASE ACTIVITY | 8 | 4.62e-01 | -1.50e-01 | 7.64e-01 |
| GOMF DYNEIN COMPLEX BINDING | 21 | 2.33e-01 | 1.50e-01 | 5.63e-01 |
| GOMF MHC CLASS I PROTEIN BINDING | 14 | 3.30e-01 | 1.50e-01 | 6.67e-01 |
| GOMF N ACETYLLACTOSAMINE SYNTHASE ACTIVITY | 5 | 5.61e-01 | 1.50e-01 | 8.26e-01 |
| GOBP NEGATIVE REGULATION OF COMPLEMENT ACTIVATION | 10 | 4.11e-01 | 1.50e-01 | 7.30e-01 |
| GOMF DNA BINDING TRANSCRIPTION ACTIVATOR ACTIVITY | 278 | 1.70e-05 | -1.50e-01 | 9.65e-04 |
| GOMF TRANSFERRIN RECEPTOR BINDING | 10 | 4.11e-01 | -1.50e-01 | 7.30e-01 |
| GOBP DCMP CATABOLIC PROCESS | 5 | 5.61e-01 | 1.50e-01 | 8.26e-01 |
| GOBP POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 41 | 9.65e-02 | -1.50e-01 | 3.66e-01 |
| GOMF BASAL TRANSCRIPTION MACHINERY BINDING | 58 | 4.82e-02 | -1.50e-01 | 2.55e-01 |
| GOBP POSITIVE REGULATION OF CELL SIZE | 9 | 4.36e-01 | -1.50e-01 | 7.51e-01 |
| GOBP INTRACELLULAR RECEPTOR SIGNALING PATHWAY | 276 | 1.89e-05 | -1.50e-01 | 1.04e-03 |
| GOBP NUCLEAR TRANSPORT | 290 | 1.18e-05 | -1.50e-01 | 6.98e-04 |
| GOBP MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY | 39 | 1.06e-01 | -1.50e-01 | 3.81e-01 |
| GOMF L ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 4.93e-01 | 1.50e-01 | 7.84e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 5 | 5.62e-01 | 1.50e-01 | 8.26e-01 |
| GOBP REGULATION OF TELOMERASE ACTIVITY | 44 | 8.57e-02 | -1.50e-01 | 3.44e-01 |
| GOBP RESPONSE TO LEUKEMIA INHIBITORY FACTOR | 80 | 2.07e-02 | -1.50e-01 | 1.59e-01 |
| GOBP SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT | 18 | 2.72e-01 | 1.50e-01 | 6.09e-01 |
| GOBP PEXOPHAGY | 6 | 5.26e-01 | -1.50e-01 | 8.01e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 59 | 4.69e-02 | -1.50e-01 | 2.53e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 34 | 1.31e-01 | -1.50e-01 | 4.25e-01 |
| GOBP MESENCHYME MORPHOGENESIS | 28 | 1.71e-01 | -1.50e-01 | 4.84e-01 |
| GOMF PHOSPHATIDYLSERINE BINDING | 41 | 9.76e-02 | -1.50e-01 | 3.66e-01 |
| GOBP CELLULAR RESPONSE TO ESTROGEN STIMULUS | 16 | 3.00e-01 | -1.50e-01 | 6.39e-01 |
| GOMF PROTEIN GLUTAMIC ACID LIGASE ACTIVITY | 5 | 5.63e-01 | -1.50e-01 | 8.26e-01 |
| GOBP MORPHOGENESIS OF EMBRYONIC EPITHELIUM | 98 | 1.06e-02 | -1.50e-01 | 1.07e-01 |
| GOBP POSITIVE REGULATION OF PYROPTOSIS | 5 | 5.63e-01 | -1.50e-01 | 8.26e-01 |
| GOBP SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 18 | 2.72e-01 | -1.49e-01 | 6.09e-01 |
| GOMF MONOCARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 36 | 1.21e-01 | 1.49e-01 | 4.06e-01 |
| GOMF INTRACELLULAR CHLORIDE CHANNEL ACTIVITY | 10 | 4.13e-01 | 1.49e-01 | 7.32e-01 |
| GOBP DENDRITIC SPINE DEVELOPMENT | 75 | 2.53e-02 | -1.49e-01 | 1.80e-01 |
| GOBP POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION | 9 | 4.38e-01 | 1.49e-01 | 7.51e-01 |
| GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 7 | 4.94e-01 | 1.49e-01 | 7.84e-01 |
| GOBP GOLGI VESICLE BUDDING | 10 | 4.14e-01 | -1.49e-01 | 7.32e-01 |
| GOBP LEPTIN MEDIATED SIGNALING PATHWAY | 8 | 4.65e-01 | -1.49e-01 | 7.66e-01 |
| GOBP DNA DEALKYLATION INVOLVED IN DNA REPAIR | 9 | 4.38e-01 | 1.49e-01 | 7.52e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 15 | 3.17e-01 | -1.49e-01 | 6.56e-01 |
| GOBP GLYCOSYL COMPOUND CATABOLIC PROCESS | 30 | 1.58e-01 | 1.49e-01 | 4.63e-01 |
| GOBP CELL DIFFERENTIATION IN HINDBRAIN | 12 | 3.71e-01 | -1.49e-01 | 7.00e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY | 23 | 2.16e-01 | -1.49e-01 | 5.42e-01 |
| GOCC CIS GOLGI NETWORK | 54 | 5.82e-02 | 1.49e-01 | 2.78e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR BINDING | 7 | 4.95e-01 | -1.49e-01 | 7.85e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 34 | 1.33e-01 | -1.49e-01 | 4.27e-01 |
| GOBP NON LYTIC VIRAL RELEASE | 14 | 3.35e-01 | 1.49e-01 | 6.70e-01 |
| GOBP NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION | 13 | 3.53e-01 | -1.49e-01 | 6.87e-01 |
| GOCC MESSENGER RIBONUCLEOPROTEIN COMPLEX | 10 | 4.15e-01 | 1.49e-01 | 7.33e-01 |
| GOCC POLE PLASM | 14 | 3.35e-01 | -1.49e-01 | 6.70e-01 |
| GOBP TOXIN METABOLIC PROCESS | 7 | 4.95e-01 | 1.49e-01 | 7.85e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 89 | 1.53e-02 | -1.49e-01 | 1.37e-01 |
| GOBP NEGATIVE REGULATION OF CENTROSOME DUPLICATION | 11 | 3.93e-01 | -1.49e-01 | 7.18e-01 |
| GOCC DESMOSOME | 13 | 3.53e-01 | 1.49e-01 | 6.87e-01 |
| GOBP REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 63 | 4.13e-02 | -1.49e-01 | 2.35e-01 |
| GOBP REGULATION OF IMMUNE RESPONSE | 665 | 7.34e-11 | -1.49e-01 | 1.92e-08 |
| GOMF SPECTRIN BINDING | 21 | 2.38e-01 | 1.49e-01 | 5.71e-01 |
| GOCC CONDENSED CHROMOSOME CENTROMERIC REGION | 172 | 7.82e-04 | -1.49e-01 | 1.84e-02 |
| GOBP CARNITINE METABOLIC PROCESS | 9 | 4.40e-01 | -1.49e-01 | 7.52e-01 |
| GOCC LOW DENSITY LIPOPROTEIN PARTICLE | 10 | 4.16e-01 | 1.49e-01 | 7.34e-01 |
| GOCC SPERM MIDPIECE | 34 | 1.34e-01 | 1.48e-01 | 4.30e-01 |
| GOBP REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 98 | 1.12e-02 | -1.48e-01 | 1.12e-01 |
| GOMF URIDYLYLTRANSFERASE ACTIVITY | 7 | 4.97e-01 | -1.48e-01 | 7.86e-01 |
| GOBP ALDITOL PHOSPHATE METABOLIC PROCESS | 11 | 3.94e-01 | 1.48e-01 | 7.19e-01 |
| GOBP ESTABLISHMENT OF SKIN BARRIER | 14 | 3.37e-01 | 1.48e-01 | 6.71e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVITY | 368 | 1.11e-06 | -1.48e-01 | 1.03e-04 |
| GOBP AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 46 | 8.21e-02 | -1.48e-01 | 3.37e-01 |
| GOMF ARP2 3 COMPLEX BINDING | 12 | 3.74e-01 | -1.48e-01 | 7.02e-01 |
| GOBP REGULATION OF TYPE 2 IMMUNE RESPONSE | 24 | 2.09e-01 | -1.48e-01 | 5.33e-01 |
| GOBP RNA CAPPING | 37 | 1.19e-01 | 1.48e-01 | 4.03e-01 |
| GOCC MITOCHONDRION | 1446 | 1.07e-20 | 1.48e-01 | 8.65e-18 |
| GOMF GDP PHOSPHATASE ACTIVITY | 8 | 4.69e-01 | 1.48e-01 | 7.68e-01 |
| GOBP FATTY ACID CATABOLIC PROCESS | 86 | 1.78e-02 | 1.48e-01 | 1.48e-01 |
| GOCC INTERMEDIATE FILAMENT CYTOSKELETON | 76 | 2.58e-02 | -1.48e-01 | 1.81e-01 |
| GOMF N METHYLTRANSFERASE ACTIVITY | 86 | 1.78e-02 | -1.48e-01 | 1.48e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN E | 16 | 3.06e-01 | -1.48e-01 | 6.45e-01 |
| GOBP POSITIVE REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION | 5 | 5.67e-01 | -1.48e-01 | 8.28e-01 |
| GOBP MALONYL COA METABOLIC PROCESS | 6 | 5.31e-01 | -1.48e-01 | 8.04e-01 |
| GOBP PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 24 | 2.10e-01 | 1.48e-01 | 5.34e-01 |
| GOBP BODY FLUID SECRETION | 54 | 6.06e-02 | 1.48e-01 | 2.84e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOTAXIS | 42 | 9.78e-02 | -1.48e-01 | 3.66e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE IMPORT | 25 | 2.01e-01 | -1.48e-01 | 5.24e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIARY TRANSITION ZONE | 7 | 4.99e-01 | 1.47e-01 | 7.87e-01 |
| GOBP MRNA PROCESSING | 434 | 1.49e-07 | -1.47e-01 | 2.04e-05 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR BINDING | 20 | 2.54e-01 | -1.47e-01 | 5.88e-01 |
| GOBP POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY | 9 | 4.44e-01 | -1.47e-01 | 7.55e-01 |
| GOBP CHRONIC INFLAMMATORY RESPONSE | 13 | 3.58e-01 | 1.47e-01 | 6.90e-01 |
| GOBP SNRNA MODIFICATION | 7 | 4.99e-01 | 1.47e-01 | 7.87e-01 |
| GOBP LENS DEVELOPMENT IN CAMERA TYPE EYE | 47 | 8.05e-02 | -1.47e-01 | 3.34e-01 |
| GOMF MICROTUBULE MOTOR ACTIVITY | 52 | 6.62e-02 | 1.47e-01 | 2.97e-01 |
| GOBP IMPORT INTO NUCLEUS | 139 | 2.75e-03 | -1.47e-01 | 4.52e-02 |
| GOBP REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 35 | 1.32e-01 | 1.47e-01 | 4.25e-01 |
| GOBP APOPTOTIC DNA FRAGMENTATION | 15 | 3.24e-01 | 1.47e-01 | 6.62e-01 |
| GOBP DTTP METABOLIC PROCESS | 5 | 5.69e-01 | -1.47e-01 | 8.28e-01 |
| GOMF RNA POLYMERASE CORE ENZYME BINDING | 40 | 1.07e-01 | -1.47e-01 | 3.84e-01 |
| GOBP NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS | 19 | 2.67e-01 | 1.47e-01 | 6.04e-01 |
| GOBP SPINAL CORD PATTERNING | 9 | 4.45e-01 | -1.47e-01 | 7.55e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 26 | 1.94e-01 | 1.47e-01 | 5.14e-01 |
| GOBP RNA SPLICING | 406 | 4.00e-07 | -1.47e-01 | 4.56e-05 |
| GOBP SULFATION | 11 | 3.99e-01 | -1.47e-01 | 7.22e-01 |
| GOMF UDP GALACTOSE BETA N ACETYLGLUCOSAMINE BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 6 | 5.33e-01 | 1.47e-01 | 8.06e-01 |
| GOBP PROSTANOID METABOLIC PROCESS | 34 | 1.38e-01 | 1.47e-01 | 4.36e-01 |
| GOBP REGULATION OF GLOMERULAR FILTRATION | 7 | 5.01e-01 | 1.47e-01 | 7.88e-01 |
| GOMF CENTROMERIC DNA BINDING | 6 | 5.33e-01 | -1.47e-01 | 8.06e-01 |
| GOBP INNER DYNEIN ARM ASSEMBLY | 8 | 4.72e-01 | 1.47e-01 | 7.72e-01 |
| GOBP PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS | 9 | 4.46e-01 | 1.47e-01 | 7.57e-01 |
| GOBP POSITIVE REGULATION OF GLYCOLYTIC PROCESS | 17 | 2.95e-01 | -1.47e-01 | 6.32e-01 |
| GOBP POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 19 | 2.69e-01 | -1.47e-01 | 6.06e-01 |
| GOBP CIRCADIAN REGULATION OF GENE EXPRESSION | 57 | 5.56e-02 | -1.47e-01 | 2.72e-01 |
| GOBP LYMPHOCYTE CHEMOTAXIS | 38 | 1.18e-01 | 1.47e-01 | 4.02e-01 |
| GOBP AUDITORY RECEPTOR CELL MORPHOGENESIS | 15 | 3.26e-01 | 1.47e-01 | 6.63e-01 |
| GOBP RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM | 49 | 7.61e-02 | 1.47e-01 | 3.23e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 11 | 4.00e-01 | -1.47e-01 | 7.22e-01 |
| GOCC F ACTIN CAPPING PROTEIN COMPLEX | 7 | 5.03e-01 | 1.46e-01 | 7.88e-01 |
| GOCC LEWY BODY | 7 | 5.03e-01 | 1.46e-01 | 7.88e-01 |
| GOBP SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION | 11 | 4.01e-01 | 1.46e-01 | 7.23e-01 |
| GOBP REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 17 | 2.97e-01 | -1.46e-01 | 6.35e-01 |
| GOBP PROSTATE GLAND MORPHOGENESIS | 11 | 4.01e-01 | -1.46e-01 | 7.23e-01 |
| GOBP B CELL MEDIATED IMMUNITY | 101 | 1.12e-02 | -1.46e-01 | 1.12e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD PRESSURE | 23 | 2.25e-01 | -1.46e-01 | 5.54e-01 |
| GOBP REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 17 | 2.97e-01 | -1.46e-01 | 6.35e-01 |
| GOMF IONOTROPIC GLUTAMATE RECEPTOR BINDING | 16 | 3.12e-01 | -1.46e-01 | 6.51e-01 |
| GOBP MITOTIC SISTER CHROMATID SEPARATION | 58 | 5.46e-02 | -1.46e-01 | 2.69e-01 |
| GOMF PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 137 | 3.22e-03 | 1.46e-01 | 5.04e-02 |
| GOBP MRNA 5 SPLICE SITE RECOGNITION | 7 | 5.04e-01 | -1.46e-01 | 7.89e-01 |
| GOMF AMIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 36 | 1.30e-01 | 1.46e-01 | 4.23e-01 |
| GOBP REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 37 | 1.25e-01 | 1.46e-01 | 4.15e-01 |
| GOBP SUCCINYL COA METABOLIC PROCESS | 10 | 4.25e-01 | 1.46e-01 | 7.43e-01 |
| GOBP TELOMERE CAPPING | 36 | 1.30e-01 | -1.46e-01 | 4.23e-01 |
| GOBP DEFENSE RESPONSE TO BACTERIUM | 143 | 2.67e-03 | -1.46e-01 | 4.43e-02 |
| GOBP POSITIVE REGULATION OF CELL DIVISION | 62 | 4.75e-02 | 1.46e-01 | 2.54e-01 |
| GOBP SOMITOGENESIS | 35 | 1.36e-01 | -1.46e-01 | 4.33e-01 |
| GOBP LEUCINE CATABOLIC PROCESS | 5 | 5.73e-01 | -1.46e-01 | 8.30e-01 |
| GOBP REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 64 | 4.42e-02 | -1.46e-01 | 2.44e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT | 10 | 4.26e-01 | 1.45e-01 | 7.43e-01 |
| GOCC NONHOMOLOGOUS END JOINING COMPLEX | 9 | 4.50e-01 | -1.45e-01 | 7.59e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS | 54 | 6.46e-02 | 1.45e-01 | 2.93e-01 |
| GOBP PEPTIDYL LYSINE ACETYLATION | 59 | 5.35e-02 | -1.45e-01 | 2.66e-01 |
| GOMF DNA POLYMERASE ACTIVITY | 28 | 1.83e-01 | -1.45e-01 | 5.00e-01 |
| GOBP MAINTENANCE OF CELL NUMBER | 144 | 2.63e-03 | -1.45e-01 | 4.39e-02 |
| GOMF GROWTH FACTOR ACTIVITY | 68 | 3.84e-02 | 1.45e-01 | 2.27e-01 |
| GOBP ESTABLISHMENT OF CENTROSOME LOCALIZATION | 8 | 4.77e-01 | 1.45e-01 | 7.75e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS | 15 | 3.30e-01 | 1.45e-01 | 6.67e-01 |
| GOBP SUBTELOMERIC HETEROCHROMATIN FORMATION | 7 | 5.06e-01 | -1.45e-01 | 7.90e-01 |
| GOBP CHEMOKINE C X C MOTIF LIGAND 12 SIGNALING PATHWAY | 5 | 5.74e-01 | -1.45e-01 | 8.31e-01 |
| GOBP REGULATION OF T CELL MIGRATION | 35 | 1.38e-01 | -1.45e-01 | 4.36e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL MATURATION | 8 | 4.78e-01 | 1.45e-01 | 7.75e-01 |
| GOBP REGULATION OF MICROGLIAL CELL ACTIVATION | 15 | 3.31e-01 | -1.45e-01 | 6.67e-01 |
| GOBP RESPONSE TO VITAMIN | 53 | 6.82e-02 | -1.45e-01 | 3.02e-01 |
| GOBP RETINAL ROD CELL DIFFERENTIATION | 7 | 5.07e-01 | -1.45e-01 | 7.90e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEAR BODY | 12 | 3.85e-01 | 1.45e-01 | 7.12e-01 |
| GOBP NEURON PROJECTION MAINTENANCE | 9 | 4.52e-01 | -1.45e-01 | 7.61e-01 |
| GOBP VASOCONSTRICTION | 40 | 1.13e-01 | -1.45e-01 | 3.96e-01 |
| GOBP CHROMOSOME ORGANIZATION | 531 | 1.34e-08 | -1.45e-01 | 2.48e-06 |
| GOBP POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 12 | 3.86e-01 | -1.45e-01 | 7.12e-01 |
| GOBP REGULATION OF VESICLE SIZE | 18 | 2.89e-01 | 1.44e-01 | 6.27e-01 |
| GOBP MITOCHONDRIAL ATP TRANSMEMBRANE TRANSPORT | 7 | 5.08e-01 | -1.44e-01 | 7.91e-01 |
| GOCC SPLICEOSOMAL COMPLEX | 189 | 6.28e-04 | -1.44e-01 | 1.57e-02 |
| GOBP GOLGI RIBBON FORMATION | 9 | 4.54e-01 | 1.44e-01 | 7.62e-01 |
| GOBP LYMPH NODE DEVELOPMENT | 14 | 3.50e-01 | -1.44e-01 | 6.85e-01 |
| GOBP REGULATION OF IMMUNE EFFECTOR PROCESS | 267 | 5.11e-05 | -1.44e-01 | 2.35e-03 |
| GOBP UREA TRANSPORT | 6 | 5.41e-01 | -1.44e-01 | 8.13e-01 |
| GOBP ONE CARBON COMPOUND TRANSPORT | 36 | 1.34e-01 | 1.44e-01 | 4.30e-01 |
| GOBP RENAL TUBULE DEVELOPMENT | 49 | 8.10e-02 | 1.44e-01 | 3.35e-01 |
| GOBP MYELOID CELL DIFFERENTIATION | 330 | 7.10e-06 | -1.44e-01 | 4.57e-04 |
| GOMF RECEPTOR ANTAGONIST ACTIVITY | 7 | 5.09e-01 | 1.44e-01 | 7.91e-01 |
| GOMF PROTEIN HORMONE RECEPTOR ACTIVITY | 11 | 4.08e-01 | 1.44e-01 | 7.28e-01 |
| GOBP NEGATIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 5 | 5.77e-01 | -1.44e-01 | 8.32e-01 |
| GOBP DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM | 46 | 9.11e-02 | -1.44e-01 | 3.53e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 67 | 4.16e-02 | -1.44e-01 | 2.37e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 168 | 1.30e-03 | -1.44e-01 | 2.63e-02 |
| GOBP ANIMAL ORGAN MATURATION | 19 | 2.78e-01 | 1.44e-01 | 6.15e-01 |
| GOBP RESPONSE TO VIRUS | 339 | 5.55e-06 | -1.44e-01 | 3.89e-04 |
| GOBP STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 195 | 5.43e-04 | -1.44e-01 | 1.40e-02 |
| GOBP CORPUS CALLOSUM MORPHOGENESIS | 5 | 5.78e-01 | 1.44e-01 | 8.32e-01 |
| GOBP RESPONSE TO STEROID HORMONE | 224 | 2.13e-04 | -1.44e-01 | 6.87e-03 |
| GOCC RIBONUCLEOPROTEIN GRANULE | 226 | 2.00e-04 | -1.44e-01 | 6.63e-03 |
| GOMF PROTEIN MEMBRANE ADAPTOR ACTIVITY | 31 | 1.66e-01 | -1.44e-01 | 4.77e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 9 | 4.55e-01 | -1.44e-01 | 7.62e-01 |
| GOMF ASPARTIC TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 5 | 5.78e-01 | 1.44e-01 | 8.32e-01 |
| GOBP STEROID HORMONE MEDIATED SIGNALING PATHWAY | 107 | 1.03e-02 | -1.44e-01 | 1.06e-01 |
| GOBP REGULATION OF VASCULOGENESIS | 10 | 4.32e-01 | 1.44e-01 | 7.49e-01 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 45 | 9.58e-02 | -1.44e-01 | 3.65e-01 |
| GOBP VIRAL RELEASE FROM HOST CELL | 28 | 1.89e-01 | 1.43e-01 | 5.09e-01 |
| GOBP CELLULAR RESPONSE TO NICOTINE | 5 | 5.79e-01 | 1.43e-01 | 8.32e-01 |
| GOBP ACTIVATION OF ADENYLATE CYCLASE ACTIVITY | 12 | 3.90e-01 | 1.43e-01 | 7.16e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS | 21 | 2.56e-01 | -1.43e-01 | 5.91e-01 |
| GOMF TESTOSTERONE DEHYDROGENASE NAD P ACTIVITY | 7 | 5.12e-01 | 1.43e-01 | 7.93e-01 |
| GOMF RIBOSOMAL LARGE SUBUNIT BINDING | 14 | 3.54e-01 | 1.43e-01 | 6.87e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A HEME GROUP OF DONORS | 14 | 3.54e-01 | 1.43e-01 | 6.87e-01 |
| GOBP NEGATIVE REGULATION OF AXON EXTENSION | 31 | 1.68e-01 | 1.43e-01 | 4.81e-01 |
| GOBP ENDOCRINE SYSTEM DEVELOPMENT | 66 | 4.48e-02 | -1.43e-01 | 2.46e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID FIBRIL FORMATION | 11 | 4.12e-01 | 1.43e-01 | 7.31e-01 |
| GOBP NEUTROPHIL DIFFERENTIATION | 9 | 4.58e-01 | -1.43e-01 | 7.64e-01 |
| GOBP POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 39 | 1.23e-01 | -1.43e-01 | 4.11e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION | 23 | 2.36e-01 | -1.43e-01 | 5.68e-01 |
| GOBP GOLGI LUMEN ACIDIFICATION | 13 | 3.73e-01 | 1.43e-01 | 7.02e-01 |
| GOCC BRUSH BORDER | 70 | 3.92e-02 | 1.43e-01 | 2.29e-01 |
| GOBP CELLULAR RESPONSE TO OSMOTIC STRESS | 42 | 1.10e-01 | -1.43e-01 | 3.89e-01 |
| GOBP PLASMA MEMBRANE FUSION | 12 | 3.93e-01 | 1.43e-01 | 7.18e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITE DEVELOPMENT | 5 | 5.81e-01 | 1.43e-01 | 8.32e-01 |
| GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN NEURAL TUBE CLOSURE | 6 | 5.46e-01 | -1.43e-01 | 8.16e-01 |
| GOBP RESPONSE TO X RAY | 24 | 2.27e-01 | -1.42e-01 | 5.56e-01 |
| GOBP SENSORY PERCEPTION OF SMELL | 16 | 3.24e-01 | 1.42e-01 | 6.62e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT | 21 | 2.58e-01 | -1.42e-01 | 5.94e-01 |
| GOBP PROTEIN SUMOYLATION | 61 | 5.45e-02 | -1.42e-01 | 2.68e-01 |
| GOCC CORTICAL CYTOSKELETON | 78 | 2.98e-02 | 1.42e-01 | 1.97e-01 |
| GOMF DESUMOYLASE ACTIVITY | 7 | 5.14e-01 | -1.42e-01 | 7.95e-01 |
| GOBP TRNA THIO MODIFICATION | 5 | 5.81e-01 | -1.42e-01 | 8.32e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINESIS | 6 | 5.46e-01 | -1.42e-01 | 8.17e-01 |
| GOCC UNCONVENTIONAL MYOSIN COMPLEX | 9 | 4.60e-01 | 1.42e-01 | 7.64e-01 |
| GOMF ADENOSINE RECEPTOR BINDING | 5 | 5.82e-01 | -1.42e-01 | 8.33e-01 |
| GOMF ATPASE BINDING | 67 | 4.43e-02 | 1.42e-01 | 2.45e-01 |
| GOMF SOLUTE PROTON SYMPORTER ACTIVITY | 20 | 2.71e-01 | 1.42e-01 | 6.08e-01 |
| GOBP SERINE FAMILY AMINO ACID METABOLIC PROCESS | 28 | 1.93e-01 | 1.42e-01 | 5.12e-01 |
| GOBP GLYCOSYLCERAMIDE METABOLIC PROCESS | 10 | 4.37e-01 | -1.42e-01 | 7.51e-01 |
| GOCC SYNAPTIC VESICLE MEMBRANE | 79 | 2.93e-02 | 1.42e-01 | 1.95e-01 |
| GOBP NEGATIVE REGULATION OF AMINO ACID TRANSPORT | 9 | 4.61e-01 | -1.42e-01 | 7.64e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE | 20 | 2.72e-01 | -1.42e-01 | 6.09e-01 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE | 70 | 4.03e-02 | -1.42e-01 | 2.32e-01 |
| GOBP SOMATIC STEM CELL POPULATION MAINTENANCE | 46 | 9.63e-02 | -1.42e-01 | 3.66e-01 |
| GOBP HEMOPOIESIS | 704 | 1.79e-10 | -1.42e-01 | 4.56e-08 |
| GOMF PROTEIN LIPID COMPLEX BINDING | 21 | 2.61e-01 | -1.42e-01 | 5.97e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 59 | 6.00e-02 | 1.42e-01 | 2.83e-01 |
| GOBP CELLULAR RESPONSE TO DSRNA | 18 | 2.98e-01 | -1.42e-01 | 6.37e-01 |
| GOBP INNER CELL MASS CELL DIFFERENTIATION | 5 | 5.84e-01 | -1.42e-01 | 8.34e-01 |
| GOBP INTERLEUKIN 18 MEDIATED SIGNALING PATHWAY | 6 | 5.48e-01 | -1.41e-01 | 8.18e-01 |
| GOBP MEIOTIC CHROMOSOME CONDENSATION | 6 | 5.48e-01 | -1.41e-01 | 8.18e-01 |
| GOBP REGULATION OF KERATINOCYTE MIGRATION | 10 | 4.39e-01 | 1.41e-01 | 7.52e-01 |
| GOBP PROTEIN LOCALIZATION TO POSTSYNAPSE | 34 | 1.54e-01 | 1.41e-01 | 4.58e-01 |
| GOBP CARTILAGE CONDENSATION | 6 | 5.49e-01 | 1.41e-01 | 8.18e-01 |
| GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 17 | 3.13e-01 | -1.41e-01 | 6.52e-01 |
| GOBP MITOCHONDRIAL RNA 3 END PROCESSING | 6 | 5.49e-01 | 1.41e-01 | 8.18e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS DISULFIDE AS ACCEPTOR | 5 | 5.84e-01 | 1.41e-01 | 8.34e-01 |
| GOBP GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS | 21 | 2.62e-01 | 1.41e-01 | 5.98e-01 |
| GOBP PROTEIN PALMITOYLATION | 29 | 1.88e-01 | 1.41e-01 | 5.06e-01 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 28 | 1.96e-01 | 1.41e-01 | 5.15e-01 |
| GOBP REGULATION OF IMMUNOGLOBULIN PRODUCTION | 58 | 6.28e-02 | -1.41e-01 | 2.89e-01 |
| GOMF DEOXYCYTIDINE DEAMINASE ACTIVITY | 8 | 4.89e-01 | -1.41e-01 | 7.82e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 164 | 1.82e-03 | 1.41e-01 | 3.33e-02 |
| GOBP RESPONSE TO CORTICOSTEROID | 91 | 2.00e-02 | -1.41e-01 | 1.56e-01 |
| GOBP CYTOKINE PRODUCTION | 573 | 8.77e-09 | -1.41e-01 | 1.73e-06 |
| GOBP HEME TRANSPORT | 8 | 4.89e-01 | 1.41e-01 | 7.82e-01 |
| GOMF HEME TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 4.89e-01 | 1.41e-01 | 7.82e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 185 | 9.47e-04 | -1.41e-01 | 2.13e-02 |
| GOCC NUCLEAR CHROMOSOME | 199 | 6.11e-04 | -1.41e-01 | 1.53e-02 |
| GOBP ACROSOMAL VESICLE EXOCYTOSIS | 5 | 5.85e-01 | 1.41e-01 | 8.35e-01 |
| GOBP PRO B CELL DIFFERENTIATION | 10 | 4.40e-01 | -1.41e-01 | 7.52e-01 |
| GOBP LYSOSOMAL MICROAUTOPHAGY | 13 | 3.79e-01 | -1.41e-01 | 7.06e-01 |
| GOBP MESENCHYMAL CELL APOPTOTIC PROCESS | 7 | 5.18e-01 | 1.41e-01 | 7.97e-01 |
| GOCC EUKARYOTIC 48S PREINITIATION COMPLEX | 16 | 3.29e-01 | -1.41e-01 | 6.66e-01 |
| GOBP ENDOCYTOSIS INVOLVED IN VIRAL ENTRY INTO HOST CELL | 10 | 4.41e-01 | 1.41e-01 | 7.52e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 73 | 3.76e-02 | -1.41e-01 | 2.25e-01 |
| GOBP RESPONSE TO CARBOHYDRATE | 154 | 2.59e-03 | -1.41e-01 | 4.35e-02 |
| GOBP ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE | 9 | 4.65e-01 | -1.41e-01 | 7.66e-01 |
| GOBP REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 10 | 4.41e-01 | 1.41e-01 | 7.53e-01 |
| GOBP RESPONSE TO DSRNA | 35 | 1.50e-01 | -1.41e-01 | 4.53e-01 |
| GOCC ENVELOPE | 1105 | 4.59e-15 | 1.41e-01 | 2.26e-12 |
| GOBP AMP BIOSYNTHETIC PROCESS | 11 | 4.19e-01 | 1.41e-01 | 7.37e-01 |
| GOBP REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 35 | 1.50e-01 | 1.41e-01 | 4.53e-01 |
| GOCC MULTIVESICULAR BODY | 46 | 9.92e-02 | 1.41e-01 | 3.68e-01 |
| GOBP PLASMA MEMBRANE RAFT ORGANIZATION | 9 | 4.65e-01 | -1.41e-01 | 7.66e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS | 27 | 2.06e-01 | 1.41e-01 | 5.30e-01 |
| GOMF S METHYLTRANSFERASE ACTIVITY | 6 | 5.51e-01 | 1.40e-01 | 8.19e-01 |
| GOBP KYNURENINE METABOLIC PROCESS | 9 | 4.66e-01 | 1.40e-01 | 7.66e-01 |
| GOMF BILE ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 4.42e-01 | 1.40e-01 | 7.53e-01 |
| GOBP TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 251 | 1.30e-04 | -1.40e-01 | 4.66e-03 |
| GOCC MOTILE CILIUM | 166 | 1.83e-03 | 1.40e-01 | 3.34e-02 |
| GOBP POSITIVE REGULATION OF NON MOTILE CILIUM ASSEMBLY | 6 | 5.52e-01 | -1.40e-01 | 8.19e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS | 61 | 5.84e-02 | -1.40e-01 | 2.79e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 4 PHOSPHATASE ACTIVITY | 9 | 4.67e-01 | -1.40e-01 | 7.67e-01 |
| GOBP MRNA METABOLIC PROCESS | 651 | 1.25e-09 | -1.40e-01 | 2.85e-07 |
| GOBP PURINE RIBONUCLEOSIDE SALVAGE | 6 | 5.53e-01 | 1.40e-01 | 8.19e-01 |
| GOBP SPERM DNA CONDENSATION | 8 | 4.93e-01 | 1.40e-01 | 7.84e-01 |
| GOCC PEPTIDASE COMPLEX | 107 | 1.25e-02 | 1.40e-01 | 1.19e-01 |
| GOBP RESPONSE TO AMINE | 26 | 2.17e-01 | -1.40e-01 | 5.44e-01 |
| GOBP CANONICAL WNT SIGNALING PATHWAY | 203 | 6.04e-04 | -1.40e-01 | 1.52e-02 |
| GOBP COLLAGEN ACTIVATED SIGNALING PATHWAY | 12 | 4.02e-01 | -1.40e-01 | 7.24e-01 |
| GOCC CORTICAL ENDOPLASMIC RETICULUM | 6 | 5.54e-01 | -1.40e-01 | 8.20e-01 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 66 | 5.00e-02 | -1.40e-01 | 2.60e-01 |
| GOBP POST EMBRYONIC DEVELOPMENT | 73 | 3.95e-02 | -1.39e-01 | 2.30e-01 |
| GOBP REGULATION OF URINE VOLUME | 9 | 4.69e-01 | -1.39e-01 | 7.68e-01 |
| GOBP NEURAL TUBE FORMATION | 85 | 2.64e-02 | -1.39e-01 | 1.84e-01 |
| GOBP RESPONSE TO RETINOIC ACID | 58 | 6.65e-02 | -1.39e-01 | 2.98e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 17 | 3.20e-01 | -1.39e-01 | 6.59e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA SYNTHESIS DEPENDENT STRAND ANNEALING | 7 | 5.23e-01 | -1.39e-01 | 7.99e-01 |
| GOBP REGULATION OF MONOCYTE CHEMOTAXIS | 19 | 2.93e-01 | -1.39e-01 | 6.31e-01 |
| GOMF ATP DEPENDENT PROTEIN FOLDING CHAPERONE | 30 | 1.87e-01 | 1.39e-01 | 5.04e-01 |
| GOBP GLYCEROPHOSPHOLIPID CATABOLIC PROCESS | 27 | 2.10e-01 | 1.39e-01 | 5.34e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 13 | 3.85e-01 | 1.39e-01 | 7.12e-01 |
| GOBP PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 17 | 3.21e-01 | -1.39e-01 | 6.60e-01 |
| GOBP REGULATION OF MACROPHAGE DIFFERENTIATION | 18 | 3.07e-01 | -1.39e-01 | 6.46e-01 |
| GOBP 2 OXOGLUTARATE METABOLIC PROCESS | 13 | 3.85e-01 | 1.39e-01 | 7.12e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 97 | 1.80e-02 | -1.39e-01 | 1.49e-01 |
| GOBP SPLEEN DEVELOPMENT | 26 | 2.20e-01 | -1.39e-01 | 5.48e-01 |
| GOCC ATG1 ULK1 KINASE COMPLEX | 6 | 5.56e-01 | 1.39e-01 | 8.21e-01 |
| GOBP SYNAPTIC VESICLE LOCALIZATION | 42 | 1.19e-01 | 1.39e-01 | 4.03e-01 |
| GOBP RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS | 208 | 5.67e-04 | 1.39e-01 | 1.45e-02 |
| GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 10 | 4.48e-01 | -1.39e-01 | 7.57e-01 |
| GOBP T CELL DIFFERENTIATION | 229 | 3.07e-04 | -1.39e-01 | 9.06e-03 |
| GOBP POSITIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 54 | 7.82e-02 | -1.39e-01 | 3.29e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 23 | 2.50e-01 | -1.39e-01 | 5.84e-01 |
| GOBP REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY | 6 | 5.57e-01 | -1.39e-01 | 8.22e-01 |
| GOBP EYE PHOTORECEPTOR CELL DEVELOPMENT | 15 | 3.53e-01 | 1.39e-01 | 6.87e-01 |
| GOMF CARBOHYDRATE DERIVATIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 48 | 9.68e-02 | 1.39e-01 | 3.66e-01 |
| GOBP ZYMOGEN INHIBITION | 7 | 5.26e-01 | 1.39e-01 | 8.00e-01 |
| GOBP CORTICOSTEROID HORMONE SECRETION | 11 | 4.26e-01 | 1.39e-01 | 7.44e-01 |
| GOBP SMOOTH MUSCLE TISSUE DEVELOPMENT | 11 | 4.26e-01 | -1.39e-01 | 7.44e-01 |
| GOCC PREFOLDIN COMPLEX | 7 | 5.26e-01 | 1.38e-01 | 8.01e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 46 | 1.04e-01 | -1.38e-01 | 3.78e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 280 | 6.92e-05 | -1.38e-01 | 2.96e-03 |
| GOBP ERYTHROCYTE MATURATION | 14 | 3.70e-01 | -1.38e-01 | 7.00e-01 |
| GOBP DAMP METABOLIC PROCESS | 6 | 5.57e-01 | 1.38e-01 | 8.23e-01 |
| GOBP NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 13 | 3.88e-01 | 1.38e-01 | 7.14e-01 |
| GOBP RESPONSE TO PEPTIDE | 365 | 6.03e-06 | -1.38e-01 | 4.06e-04 |
| GOBP STEROL HOMEOSTASIS | 59 | 6.64e-02 | 1.38e-01 | 2.98e-01 |
| GOBP REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 12 | 4.07e-01 | -1.38e-01 | 7.27e-01 |
| GOMF ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 157 | 2.84e-03 | 1.38e-01 | 4.64e-02 |
| GOBP PEROXISOME ORGANIZATION | 35 | 1.57e-01 | 1.38e-01 | 4.63e-01 |
| GOMF PROTEIN KINASE ACTIVITY | 470 | 3.16e-07 | -1.38e-01 | 3.74e-05 |
| GOMF U1 SNRNA BINDING | 8 | 4.99e-01 | -1.38e-01 | 7.87e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 35 | 1.58e-01 | -1.38e-01 | 4.64e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE ACTIVATION | 18 | 3.11e-01 | 1.38e-01 | 6.50e-01 |
| GOMF TELOMERASE RNA BINDING | 21 | 2.74e-01 | -1.38e-01 | 6.09e-01 |
| GOMF INOSITOL 1 4 5 TRISPHOSPHATE BINDING | 5 | 5.93e-01 | -1.38e-01 | 8.38e-01 |
| GOBP DNA REPLICATION | 261 | 1.27e-04 | -1.38e-01 | 4.56e-03 |
| GOBP EPITHELIAL CILIUM MOVEMENT INVOLVED IN DETERMINATION OF LEFT RIGHT ASYMMETRY | 7 | 5.28e-01 | -1.38e-01 | 8.02e-01 |
| GOBP EPITHELIAL TUBE FORMATION | 95 | 2.04e-02 | -1.38e-01 | 1.58e-01 |
| GOBP REGULATION OF HEART MORPHOGENESIS | 5 | 5.94e-01 | -1.38e-01 | 8.38e-01 |
| GOCC PERICENTRIOLAR MATERIAL | 20 | 2.87e-01 | -1.38e-01 | 6.25e-01 |
| GOBP REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 153 | 3.32e-03 | -1.38e-01 | 5.10e-02 |
| GOBP NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 9 | 4.75e-01 | 1.38e-01 | 7.74e-01 |
| GOBP RESPONSE TO INCREASED OXYGEN LEVELS | 22 | 2.64e-01 | 1.38e-01 | 6.01e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 37 | 1.48e-01 | 1.38e-01 | 4.49e-01 |
| GOBP RESPONSE TO LITHIUM ION | 9 | 4.75e-01 | -1.38e-01 | 7.74e-01 |
| GOBP CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION | 25 | 2.34e-01 | -1.38e-01 | 5.65e-01 |
| GOBP LUNG SACCULE DEVELOPMENT | 5 | 5.94e-01 | -1.38e-01 | 8.38e-01 |
| GOBP FLUID TRANSPORT | 19 | 3.00e-01 | 1.37e-01 | 6.38e-01 |
| GOBP PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 26 | 2.25e-01 | -1.37e-01 | 5.53e-01 |
| GOBP NECROPTOTIC PROCESS | 35 | 1.60e-01 | -1.37e-01 | 4.66e-01 |
| GOBP CHONDROITIN SULFATE BIOSYNTHETIC PROCESS | 17 | 3.27e-01 | -1.37e-01 | 6.63e-01 |
| GOMF TRANSLATION ACTIVATOR ACTIVITY | 7 | 5.29e-01 | -1.37e-01 | 8.03e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT | 15 | 3.57e-01 | 1.37e-01 | 6.90e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT | 7 | 5.29e-01 | 1.37e-01 | 8.03e-01 |
| GOBP REGULATION OF CARDIOCYTE DIFFERENTIATION | 15 | 3.57e-01 | -1.37e-01 | 6.90e-01 |
| GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 8 | 5.02e-01 | 1.37e-01 | 7.88e-01 |
| GOBP TELOMERE MAINTENANCE VIA RECOMBINATION | 14 | 3.74e-01 | -1.37e-01 | 7.02e-01 |
| GOCC MHC CLASS I PROTEIN COMPLEX | 9 | 4.76e-01 | -1.37e-01 | 7.75e-01 |
| GOBP CARDIOBLAST PROLIFERATION | 5 | 5.95e-01 | -1.37e-01 | 8.39e-01 |
| GOBP REGULATION OF RESPONSE TO TYPE II INTERFERON | 10 | 4.53e-01 | -1.37e-01 | 7.61e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEUBIQUITINATION | 5 | 5.96e-01 | -1.37e-01 | 8.39e-01 |
| GOBP CELLULAR RESPONSE TO ELECTRICAL STIMULUS | 6 | 5.61e-01 | 1.37e-01 | 8.26e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 13 | 3.93e-01 | -1.37e-01 | 7.18e-01 |
| GOMF DNA METHYLTRANSFERASE ACTIVITY | 6 | 5.62e-01 | 1.37e-01 | 8.26e-01 |
| GOBP LAMELLIPODIUM MORPHOGENESIS | 18 | 3.15e-01 | -1.37e-01 | 6.54e-01 |
| GOMF THIAMINE PYROPHOSPHATE BINDING | 5 | 5.96e-01 | 1.37e-01 | 8.39e-01 |
| GOCC KINESIN COMPLEX | 35 | 1.61e-01 | 1.37e-01 | 4.70e-01 |
| GOBP CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 152 | 3.63e-03 | -1.37e-01 | 5.45e-02 |
| GOCC COMMITMENT COMPLEX | 5 | 5.96e-01 | -1.37e-01 | 8.39e-01 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 17 | 3.29e-01 | 1.37e-01 | 6.66e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF CYTOSKELETON POLARITY | 6 | 5.62e-01 | 1.37e-01 | 8.26e-01 |
| GOBP T HELPER 2 CELL CYTOKINE PRODUCTION | 6 | 5.62e-01 | 1.37e-01 | 8.26e-01 |
| GOCC LAMELLAR BODY | 7 | 5.31e-01 | 1.37e-01 | 8.04e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION | 65 | 5.68e-02 | -1.37e-01 | 2.74e-01 |
| GOBP REGULATION OF HISTAMINE SECRETION BY MAST CELL | 6 | 5.62e-01 | -1.37e-01 | 8.26e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY | 11 | 4.33e-01 | -1.37e-01 | 7.49e-01 |
| GOBP SKIN MORPHOGENESIS | 10 | 4.54e-01 | -1.37e-01 | 7.62e-01 |
| GOBP MAST CELL MIGRATION | 11 | 4.33e-01 | -1.37e-01 | 7.49e-01 |
| GOBP DTMP METABOLIC PROCESS | 6 | 5.63e-01 | -1.36e-01 | 8.26e-01 |
| GOBP NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 8 | 5.04e-01 | -1.36e-01 | 7.89e-01 |
| GOCC COMPLEX OF COLLAGEN TRIMERS | 8 | 5.04e-01 | 1.36e-01 | 7.89e-01 |
| GOBP TRNA TRANSCRIPTION | 11 | 4.34e-01 | 1.36e-01 | 7.50e-01 |
| GOBP NEURONAL SIGNAL TRANSDUCTION | 5 | 5.98e-01 | 1.36e-01 | 8.40e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION | 117 | 1.10e-02 | -1.36e-01 | 1.10e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN ACETYLATION | 8 | 5.05e-01 | -1.36e-01 | 7.89e-01 |
| GOBP CELLULAR RESPONSE TO NITROGEN COMPOUND | 470 | 4.58e-07 | -1.36e-01 | 4.96e-05 |
| GOCC AMPHISOME | 13 | 3.95e-01 | 1.36e-01 | 7.20e-01 |
| GOMF PHOSPHOLIPID TRANSFER ACTIVITY | 22 | 2.70e-01 | 1.36e-01 | 6.06e-01 |
| GOBP REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 59 | 7.09e-02 | -1.36e-01 | 3.09e-01 |
| GOBP IMMUNE RESPONSE INHIBITING SIGNAL TRANSDUCTION | 8 | 5.06e-01 | 1.36e-01 | 7.90e-01 |
| GOMF ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 105 | 1.63e-02 | 1.36e-01 | 1.42e-01 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 39 | 1.42e-01 | -1.36e-01 | 4.42e-01 |
| GOMF LRR DOMAIN BINDING | 14 | 3.79e-01 | -1.36e-01 | 7.06e-01 |
| GOBP XENOPHAGY | 13 | 3.97e-01 | -1.36e-01 | 7.21e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION | 31 | 1.91e-01 | -1.36e-01 | 5.10e-01 |
| GOMF MONOATOMIC ANION CHANNEL ACTIVITY | 45 | 1.15e-01 | 1.36e-01 | 3.99e-01 |
| GOCC CONDENSED CHROMOSOME | 252 | 2.13e-04 | -1.36e-01 | 6.87e-03 |
| GOBP REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS | 10 | 4.58e-01 | 1.36e-01 | 7.63e-01 |
| GOBP CELLULAR RESPONSE TO TOXIC SUBSTANCE | 90 | 2.62e-02 | 1.36e-01 | 1.83e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 4F COMPLEX | 11 | 4.36e-01 | -1.36e-01 | 7.51e-01 |
| GOBP REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 21 | 2.82e-01 | 1.36e-01 | 6.20e-01 |
| GOCC HISTONE PRE MRNA 3 END PROCESSING COMPLEX | 6 | 5.65e-01 | 1.36e-01 | 8.28e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION | 6 | 5.66e-01 | -1.35e-01 | 8.28e-01 |
| GOBP MRNA POLYADENYLATION | 23 | 2.61e-01 | -1.35e-01 | 5.97e-01 |
| GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 11 | 4.37e-01 | 1.35e-01 | 7.51e-01 |
| GOBP ENDOTHELIAL CELL MORPHOGENESIS | 5 | 6.00e-01 | 1.35e-01 | 8.40e-01 |
| GOBP PEPTIDYL GLUTAMIC ACID MODIFICATION | 16 | 3.49e-01 | 1.35e-01 | 6.84e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 73 | 4.58e-02 | -1.35e-01 | 2.49e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 57 | 7.74e-02 | -1.35e-01 | 3.27e-01 |
| GOBP HEAT ACCLIMATION | 6 | 5.66e-01 | -1.35e-01 | 8.28e-01 |
| GOBP DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING | 8 | 5.08e-01 | -1.35e-01 | 7.91e-01 |
| GOCC NLRP3 INFLAMMASOME COMPLEX | 8 | 5.08e-01 | -1.35e-01 | 7.91e-01 |
| GOBP TRYPTOPHAN METABOLIC PROCESS | 10 | 4.59e-01 | -1.35e-01 | 7.64e-01 |
| GOBP REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS | 72 | 4.75e-02 | -1.35e-01 | 2.54e-01 |
| GOCC DNA REPAIR COMPLEX | 22 | 2.73e-01 | -1.35e-01 | 6.09e-01 |
| GOBP CALCINEURIN MEDIATED SIGNALING | 35 | 1.67e-01 | -1.35e-01 | 4.79e-01 |
| GOBP FATTY ACID BIOSYNTHETIC PROCESS | 112 | 1.37e-02 | 1.35e-01 | 1.27e-01 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 20 | 2.97e-01 | 1.35e-01 | 6.35e-01 |
| GOBP REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION | 7 | 5.37e-01 | -1.35e-01 | 8.09e-01 |
| GOBP PROTEIN DEPALMITOYLATION | 8 | 5.09e-01 | -1.35e-01 | 7.91e-01 |
| GOMF ADENINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.02e-01 | 1.35e-01 | 8.41e-01 |
| GOBP REGULATION OF RESPONSE TO BIOTIC STIMULUS | 396 | 4.44e-06 | -1.35e-01 | 3.21e-04 |
| GOBP PROTEIN HOMOTETRAMERIZATION | 46 | 1.14e-01 | -1.35e-01 | 3.97e-01 |
| GOMF HIGH DENSITY LIPOPROTEIN PARTICLE BINDING | 9 | 4.84e-01 | 1.35e-01 | 7.81e-01 |
| GOBP INTRACELLULAR SODIUM ION HOMEOSTASIS | 10 | 4.61e-01 | 1.35e-01 | 7.64e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY | 14 | 3.83e-01 | -1.35e-01 | 7.10e-01 |
| GOBP REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 46 | 1.14e-01 | -1.35e-01 | 3.97e-01 |
| GOBP MICROTUBULE BASED PROTEIN TRANSPORT | 9 | 4.85e-01 | 1.35e-01 | 7.81e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 10 | 4.61e-01 | 1.35e-01 | 7.64e-01 |
| GOBP DNA RECOMBINATION | 288 | 8.84e-05 | -1.35e-01 | 3.52e-03 |
| GOBP PLATELET DENSE GRANULE ORGANIZATION | 23 | 2.64e-01 | 1.35e-01 | 6.01e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS | 20 | 2.98e-01 | 1.35e-01 | 6.36e-01 |
| GOBP GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 9 | 4.85e-01 | -1.34e-01 | 7.81e-01 |
| GOBP REGULATION OF LAMELLIPODIUM ORGANIZATION | 42 | 1.32e-01 | -1.34e-01 | 4.25e-01 |
| GOBP POSITIVE REGULATION OF NEURON MIGRATION | 16 | 3.52e-01 | -1.34e-01 | 6.87e-01 |
| GOBP NERVE DEVELOPMENT | 46 | 1.15e-01 | -1.34e-01 | 3.98e-01 |
| GOBP NEPHRON TUBULE FORMATION | 5 | 6.03e-01 | -1.34e-01 | 8.42e-01 |
| GOBP CELLULAR RESPONSE TO INSULIN STIMULUS | 159 | 3.50e-03 | -1.34e-01 | 5.32e-02 |
| GOMF TBP CLASS PROTEIN BINDING | 23 | 2.65e-01 | -1.34e-01 | 6.02e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 23 | 2.65e-01 | 1.34e-01 | 6.02e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 13 | 4.02e-01 | -1.34e-01 | 7.24e-01 |
| GOMF ADENYLATE CYCLASE ACTIVITY | 13 | 4.03e-01 | -1.34e-01 | 7.24e-01 |
| GOCC 90S PRERIBOSOME | 25 | 2.46e-01 | 1.34e-01 | 5.80e-01 |
| GOBP REGULATION OF MEMBRANE TUBULATION | 5 | 6.04e-01 | -1.34e-01 | 8.43e-01 |
| GOBP INTRACELLULAR POTASSIUM ION HOMEOSTASIS | 8 | 5.12e-01 | 1.34e-01 | 7.93e-01 |
| GOBP HINDBRAIN DEVELOPMENT | 96 | 2.35e-02 | -1.34e-01 | 1.72e-01 |
| GOBP PITUITARY GLAND DEVELOPMENT | 12 | 4.22e-01 | -1.34e-01 | 7.41e-01 |
| GOBP PROTEIN COMPLEX OLIGOMERIZATION | 187 | 1.63e-03 | -1.34e-01 | 3.10e-02 |
| GOBP MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 13 | 4.04e-01 | -1.34e-01 | 7.25e-01 |
| GOMF PROTEIN CONTAINING COMPLEX DESTABILIZING ACTIVITY | 11 | 4.43e-01 | -1.34e-01 | 7.54e-01 |
| GOBP MAMMARY GLAND EPITHELIUM DEVELOPMENT | 46 | 1.17e-01 | -1.34e-01 | 4.01e-01 |
| GOBP ALDEHYDE BIOSYNTHETIC PROCESS | 9 | 4.88e-01 | -1.34e-01 | 7.81e-01 |
| GOBP CGMP METABOLIC PROCESS | 11 | 4.43e-01 | 1.33e-01 | 7.54e-01 |
| GOMF NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 29 | 2.14e-01 | 1.33e-01 | 5.39e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 65 | 6.32e-02 | -1.33e-01 | 2.89e-01 |
| GOCC ENDOCYTIC VESICLE LUMEN | 13 | 4.05e-01 | -1.33e-01 | 7.26e-01 |
| GOBP REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 70 | 5.39e-02 | -1.33e-01 | 2.67e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 28 | 2.23e-01 | -1.33e-01 | 5.51e-01 |
| GOCC GAMMA TUBULIN RING COMPLEX | 7 | 5.42e-01 | 1.33e-01 | 8.13e-01 |
| GOBP REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 180 | 2.10e-03 | -1.33e-01 | 3.71e-02 |
| GOBP EMBRYONIC CRANIAL SKELETON MORPHOGENESIS | 24 | 2.59e-01 | -1.33e-01 | 5.94e-01 |
| GOMF KINASE INHIBITOR ACTIVITY | 64 | 6.59e-02 | -1.33e-01 | 2.96e-01 |
| GOMF LIPOPOLYSACCHARIDE IMMUNE RECEPTOR ACTIVITY | 6 | 5.73e-01 | -1.33e-01 | 8.30e-01 |
| GOMF BETA CATENIN BINDING | 61 | 7.27e-02 | -1.33e-01 | 3.15e-01 |
| GOCC ENDOPLASMIC RETICULUM CHAPERONE COMPLEX | 9 | 4.90e-01 | -1.33e-01 | 7.83e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 32 | 1.94e-01 | -1.33e-01 | 5.12e-01 |
| GOBP NUCLEAR EXPORT | 155 | 4.38e-03 | -1.33e-01 | 6.17e-02 |
| GOMF ARACHIDONATE COA LIGASE ACTIVITY | 8 | 5.16e-01 | -1.33e-01 | 7.95e-01 |
| GOBP SEMI LUNAR VALVE DEVELOPMENT | 26 | 2.42e-01 | -1.33e-01 | 5.75e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 13 | 4.08e-01 | -1.33e-01 | 7.27e-01 |
| GOBP TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 9 | 4.91e-01 | -1.32e-01 | 7.83e-01 |
| GOBP WOUND HEALING SPREADING OF EPIDERMAL CELLS | 15 | 3.75e-01 | 1.32e-01 | 7.02e-01 |
| GOMF RIBOSOME BINDING | 103 | 2.03e-02 | 1.32e-01 | 1.58e-01 |
| GOBP DETECTION OF VISIBLE LIGHT | 24 | 2.62e-01 | 1.32e-01 | 5.98e-01 |
| GOBP POSITIVE REGULATION OF DNA REPAIR | 120 | 1.23e-02 | -1.32e-01 | 1.18e-01 |
| GOMF ACTIVE MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 161 | 3.79e-03 | 1.32e-01 | 5.60e-02 |
| GOBP RESPONSE TO ACTINOMYCIN D | 5 | 6.08e-01 | -1.32e-01 | 8.46e-01 |
| GOCC EQUATORIAL MICROTUBULE ORGANIZING CENTER | 5 | 6.08e-01 | -1.32e-01 | 8.46e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 7 | 5.44e-01 | 1.32e-01 | 8.15e-01 |
| GOBP RESPONSE TO INTERLEUKIN 6 | 23 | 2.72e-01 | -1.32e-01 | 6.09e-01 |
| GOBP MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS | 157 | 4.28e-03 | 1.32e-01 | 6.07e-02 |
| GOBP REGULATION OF JNK CASCADE | 109 | 1.71e-02 | -1.32e-01 | 1.46e-01 |
| GOBP ENDOSOME ORGANIZATION | 89 | 3.12e-02 | 1.32e-01 | 2.02e-01 |
| GOBP MEMBRANE FUSION | 140 | 6.97e-03 | 1.32e-01 | 8.30e-02 |
| GOBP ETHER METABOLIC PROCESS | 22 | 2.84e-01 | 1.32e-01 | 6.21e-01 |
| GOCC OUTER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 22 | 2.84e-01 | 1.32e-01 | 6.21e-01 |
| GOMF NUCLEOBASE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 48 | 1.14e-01 | 1.32e-01 | 3.97e-01 |
| GOCC INSULIN RESPONSIVE COMPARTMENT | 6 | 5.76e-01 | 1.32e-01 | 8.31e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 15 | 3.77e-01 | -1.32e-01 | 7.05e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX RECEPTOR RECYCLING | 7 | 5.46e-01 | 1.32e-01 | 8.16e-01 |
| GOBP REGULATION OF PROTEIN NEDDYLATION | 19 | 3.20e-01 | 1.32e-01 | 6.59e-01 |
| GOBP RRNA CATABOLIC PROCESS | 19 | 3.20e-01 | 1.32e-01 | 6.60e-01 |
| GOBP G0 TO G1 TRANSITION | 34 | 1.84e-01 | -1.32e-01 | 5.01e-01 |
| GOBP GLYCEROL ETHER METABOLIC PROCESS | 19 | 3.21e-01 | 1.32e-01 | 6.60e-01 |
| GOBP NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 86 | 3.50e-02 | -1.32e-01 | 2.17e-01 |
| GOBP INTERNAL PROTEIN AMINO ACID ACETYLATION | 51 | 1.04e-01 | -1.32e-01 | 3.78e-01 |
| GOBP REGULATION OF MEMBRANE INVAGINATION | 12 | 4.30e-01 | -1.32e-01 | 7.48e-01 |
| GOBP DE NOVO CENTRIOLE ASSEMBLY | 5 | 6.10e-01 | -1.32e-01 | 8.46e-01 |
| GOBP DE NOVO CENTRIOLE ASSEMBLY INVOLVED IN MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION | 5 | 6.10e-01 | -1.32e-01 | 8.46e-01 |
| GOBP CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS | 31 | 2.05e-01 | -1.32e-01 | 5.28e-01 |
| GOBP NEGATIVE REGULATION OF CELL KILLING | 23 | 2.75e-01 | -1.32e-01 | 6.11e-01 |
| GOBP DNA CONFORMATION CHANGE | 89 | 3.21e-02 | -1.32e-01 | 2.06e-01 |
| GOMF ANTIOXIDANT ACTIVITY | 56 | 8.89e-02 | 1.31e-01 | 3.48e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL IRON ION HOMEOSTASIS | 20 | 3.09e-01 | -1.31e-01 | 6.49e-01 |
| GOBP XENOBIOTIC EXPORT FROM CELL | 13 | 4.12e-01 | -1.31e-01 | 7.31e-01 |
| GOBP CONSTITUTIVE HETEROCHROMATIN FORMATION | 11 | 4.51e-01 | -1.31e-01 | 7.60e-01 |
| GOCC NUCLEAR PORE NUCLEAR BASKET | 12 | 4.31e-01 | -1.31e-01 | 7.48e-01 |
| GOBP REGULATION OF MEMBRANE PERMEABILITY | 60 | 7.87e-02 | 1.31e-01 | 3.30e-01 |
| GOBP ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS | 282 | 1.54e-04 | 1.31e-01 | 5.32e-03 |
| GOBP NUCLEAR MRNA SURVEILLANCE | 10 | 4.73e-01 | 1.31e-01 | 7.72e-01 |
| GOBP RESPONSE TO FORSKOLIN | 8 | 5.21e-01 | 1.31e-01 | 7.98e-01 |
| GOCC PHOTORECEPTOR DISC MEMBRANE | 11 | 4.52e-01 | 1.31e-01 | 7.61e-01 |
| GOBP MRNA 3 END PROCESSING | 48 | 1.16e-01 | -1.31e-01 | 4.01e-01 |
| GOBP DETECTION OF BIOTIC STIMULUS | 27 | 2.39e-01 | -1.31e-01 | 5.71e-01 |
| GOBP POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 11 | 4.52e-01 | -1.31e-01 | 7.61e-01 |
| GOMF EXONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 57 | 8.74e-02 | -1.31e-01 | 3.45e-01 |
| GOBP PROTEIN HOMOOLIGOMERIZATION | 137 | 8.21e-03 | -1.31e-01 | 9.15e-02 |
| GOMF HYDROLASE ACTIVITY ACTING ON ETHER BONDS | 7 | 5.49e-01 | -1.31e-01 | 8.18e-01 |
| GOBP CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 22 | 2.88e-01 | -1.31e-01 | 6.27e-01 |
| GOBP TELENCEPHALON GLIAL CELL MIGRATION | 20 | 3.11e-01 | -1.31e-01 | 6.50e-01 |
| GOCC A BAND | 23 | 2.78e-01 | 1.31e-01 | 6.15e-01 |
| GOBP MITOCHONDRIAL RNA METABOLIC PROCESS | 51 | 1.06e-01 | 1.31e-01 | 3.82e-01 |
| GOBP REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT | 5 | 6.13e-01 | -1.31e-01 | 8.47e-01 |
| GOMF PRENYLTRANSFERASE ACTIVITY | 17 | 3.51e-01 | -1.31e-01 | 6.86e-01 |
| GOBP WATER TRANSPORT | 14 | 3.97e-01 | 1.31e-01 | 7.21e-01 |
| GOBP VIRAL PROCESS | 368 | 1.75e-05 | -1.31e-01 | 9.76e-04 |
| GOBP REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 16 | 3.66e-01 | -1.31e-01 | 6.97e-01 |
| GOBP REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE | 9 | 4.97e-01 | 1.31e-01 | 7.86e-01 |
| GOCC ATG12 ATG5 ATG16 COMPLEX | 5 | 6.13e-01 | 1.31e-01 | 8.47e-01 |
| GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY | 104 | 2.14e-02 | -1.31e-01 | 1.61e-01 |
| GOBP STRESS GRANULE DISASSEMBLY | 5 | 6.13e-01 | 1.31e-01 | 8.47e-01 |
| GOBP STEROID BIOSYNTHETIC PROCESS | 123 | 1.25e-02 | 1.31e-01 | 1.19e-01 |
| GOBP REGULATION OF MACROPHAGE APOPTOTIC PROCESS | 8 | 5.23e-01 | -1.30e-01 | 7.99e-01 |
| GOMF CELL ADHESION MEDIATOR ACTIVITY | 37 | 1.70e-01 | 1.30e-01 | 4.82e-01 |
| GOBP AGGRESOME ASSEMBLY | 5 | 6.13e-01 | 1.30e-01 | 8.47e-01 |
| GOBP RNA SURVEILLANCE | 17 | 3.52e-01 | 1.30e-01 | 6.87e-01 |
| GOMF 2 ACYLGLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY | 9 | 4.98e-01 | -1.30e-01 | 7.87e-01 |
| GOBP CYTOSOLIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 124 | 1.23e-02 | -1.30e-01 | 1.18e-01 |
| GOBP POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 11 | 4.54e-01 | 1.30e-01 | 7.62e-01 |
| GOBP P BODY ASSEMBLY | 21 | 3.02e-01 | -1.30e-01 | 6.41e-01 |
| GOBP LIPID DROPLET FORMATION | 11 | 4.55e-01 | 1.30e-01 | 7.62e-01 |
| GOMF PROTEIN KINASE C BINDING | 40 | 1.54e-01 | 1.30e-01 | 4.59e-01 |
| GOMF QUATERNARY AMMONIUM GROUP TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 4.76e-01 | 1.30e-01 | 7.75e-01 |
| GOBP REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 56 | 9.22e-02 | -1.30e-01 | 3.56e-01 |
| GOCC INCLUSION BODY | 58 | 8.68e-02 | -1.30e-01 | 3.45e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT EXPORT FROM NUCLEUS | 7 | 5.51e-01 | -1.30e-01 | 8.19e-01 |
| GOBP VASCULAR TRANSPORT | 55 | 9.54e-02 | -1.30e-01 | 3.64e-01 |
| GOBP ADENOSINE METABOLIC PROCESS | 5 | 6.15e-01 | 1.30e-01 | 8.48e-01 |
| GOBP INSULIN PROCESSING | 6 | 5.81e-01 | 1.30e-01 | 8.32e-01 |
| GOCC CYTOPLASMIC MICROTUBULE | 72 | 5.69e-02 | 1.30e-01 | 2.74e-01 |
| GOBP VASCULAR ENDOTHELIAL CELL PROLIFERATION | 20 | 3.15e-01 | -1.30e-01 | 6.54e-01 |
| GOBP PHAGOSOME ACIDIFICATION | 7 | 5.52e-01 | -1.30e-01 | 8.19e-01 |
| GOBP REGULATION OF GLUCOCORTICOID RECEPTOR SIGNALING PATHWAY | 5 | 6.15e-01 | -1.30e-01 | 8.48e-01 |
| GOBP 10 FORMYLTETRAHYDROFOLATE METABOLIC PROCESS | 5 | 6.16e-01 | 1.30e-01 | 8.48e-01 |
| GOBP REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 10 | 4.78e-01 | -1.30e-01 | 7.75e-01 |
| GOBP REGULATION OF GLIAL CELL APOPTOTIC PROCESS | 10 | 4.78e-01 | -1.30e-01 | 7.75e-01 |
| GOBP RESPIRATORY SYSTEM PROCESS | 26 | 2.53e-01 | -1.30e-01 | 5.87e-01 |
| GOBP REGULATION OF ADAPTIVE IMMUNE RESPONSE | 163 | 4.35e-03 | -1.30e-01 | 6.13e-02 |
| GOBP EMBRYONIC PLACENTA DEVELOPMENT | 60 | 8.30e-02 | -1.29e-01 | 3.39e-01 |
| GOCC SITE OF DOUBLE STRAND BREAK | 82 | 4.30e-02 | -1.29e-01 | 2.41e-01 |
| GOBP CARBON DIOXIDE TRANSPORT | 6 | 5.84e-01 | -1.29e-01 | 8.34e-01 |
| GOBP ERYTHROCYTE HOMEOSTASIS | 114 | 1.72e-02 | -1.29e-01 | 1.47e-01 |
| GOBP MYELOID CELL APOPTOTIC PROCESS | 31 | 2.13e-01 | -1.29e-01 | 5.38e-01 |
| GOCC ANAPHASE PROMOTING COMPLEX | 20 | 3.17e-01 | 1.29e-01 | 6.57e-01 |
| GOBP RESPONSE TO PEPTIDE HORMONE | 304 | 1.12e-04 | -1.29e-01 | 4.14e-03 |
| GOBP NEGATIVE REGULATION OF VIRAL LIFE CYCLE | 21 | 3.06e-01 | -1.29e-01 | 6.45e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS DISULFIDE AS ACCEPTOR | 7 | 5.55e-01 | 1.29e-01 | 8.20e-01 |
| GOBP ASYMMETRIC CELL DIVISION | 14 | 4.03e-01 | 1.29e-01 | 7.25e-01 |
| GOBP SERTOLI CELL DIFFERENTIATION | 14 | 4.04e-01 | -1.29e-01 | 7.25e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS ENZYMATIC MODIFICATION | 6 | 5.85e-01 | -1.29e-01 | 8.35e-01 |
| GOMF HEPARAN SULFATE SULFOTRANSFERASE ACTIVITY | 6 | 5.85e-01 | -1.29e-01 | 8.35e-01 |
| GOCC CATALYTIC STEP 2 SPLICEOSOME | 88 | 3.71e-02 | -1.29e-01 | 2.23e-01 |
| GOBP ORGANELLE FUSION | 135 | 9.95e-03 | 1.29e-01 | 1.04e-01 |
| GOBP NEUROMUSCULAR JUNCTION DEVELOPMENT | 35 | 1.88e-01 | 1.29e-01 | 5.07e-01 |
| GOBP NEGATIVE REGULATION OF GTPASE ACTIVITY | 16 | 3.73e-01 | 1.29e-01 | 7.02e-01 |
| GOMF CALCIUM MONOATOMIC CATION ANTIPORTER ACTIVITY | 8 | 5.29e-01 | -1.28e-01 | 8.03e-01 |
| GOMF ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 24 | 2.76e-01 | 1.28e-01 | 6.13e-01 |
| GOBP POSITIVE REGULATION OF LYASE ACTIVITY | 21 | 3.08e-01 | 1.28e-01 | 6.48e-01 |
| GOMF RNA POLYMERASE III GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 12 | 4.41e-01 | 1.28e-01 | 7.53e-01 |
| GOBP SYNAPTIC VESICLE COATING | 5 | 6.19e-01 | -1.28e-01 | 8.49e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 32 | 2.09e-01 | -1.28e-01 | 5.33e-01 |
| GOBP REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 154 | 6.05e-03 | -1.28e-01 | 7.67e-02 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 5 | 6.19e-01 | 1.28e-01 | 8.49e-01 |
| GOBP PURINE RIBONUCLEOSIDE METABOLIC PROCESS | 15 | 3.90e-01 | 1.28e-01 | 7.15e-01 |
| GOBP NEGATIVE REGULATION OF JUN KINASE ACTIVITY | 11 | 4.61e-01 | -1.28e-01 | 7.64e-01 |
| GOBP REGULATION OF POSITIVE CHEMOTAXIS | 13 | 4.23e-01 | -1.28e-01 | 7.42e-01 |
| GOCC CHROMOCENTER | 11 | 4.62e-01 | -1.28e-01 | 7.64e-01 |
| GOBP REGULATION OF JUN KINASE ACTIVITY | 35 | 1.89e-01 | -1.28e-01 | 5.09e-01 |
| GOBP REGULATION OF PROTEIN MATURATION | 51 | 1.13e-01 | 1.28e-01 | 3.96e-01 |
| GOBP REGULATION OF CALCINEURIN MEDIATED SIGNALING | 32 | 2.10e-01 | -1.28e-01 | 5.34e-01 |
| GOBP OSTEOBLAST DEVELOPMENT | 9 | 5.06e-01 | -1.28e-01 | 7.90e-01 |
| GOBP NEUROFILAMENT CYTOSKELETON ORGANIZATION | 8 | 5.31e-01 | 1.28e-01 | 8.04e-01 |
| GOBP CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 21 | 3.10e-01 | 1.28e-01 | 6.49e-01 |
| GOBP EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS | 11 | 4.62e-01 | -1.28e-01 | 7.65e-01 |
| GOBP PODOSOME ASSEMBLY | 18 | 3.47e-01 | 1.28e-01 | 6.83e-01 |
| GOMF NUCLEAR GLUCOCORTICOID RECEPTOR BINDING | 11 | 4.63e-01 | 1.28e-01 | 7.65e-01 |
| GOBP DRINKING BEHAVIOR | 5 | 6.20e-01 | -1.28e-01 | 8.50e-01 |
| GOBP NEGATIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 85 | 4.16e-02 | -1.28e-01 | 2.37e-01 |
| GOMF G PROTEIN BETA GAMMA SUBUNIT COMPLEX BINDING | 15 | 3.91e-01 | 1.28e-01 | 7.17e-01 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 10 | 4.84e-01 | -1.28e-01 | 7.81e-01 |
| GOBP CELLULAR RESPONSE TO UV | 78 | 5.10e-02 | -1.28e-01 | 2.62e-01 |
| GOBP IMMUNE RESPONSE REGULATING SIGNALING PATHWAY | 370 | 2.51e-05 | -1.28e-01 | 1.28e-03 |
| GOCC CHAPERONIN CONTAINING T COMPLEX | 9 | 5.07e-01 | 1.28e-01 | 7.90e-01 |
| GOBP REGULATION OF CELL DEVELOPMENT | 570 | 2.05e-07 | -1.28e-01 | 2.72e-05 |
| GOMF DIPEPTIDYL PEPTIDASE ACTIVITY | 10 | 4.84e-01 | -1.28e-01 | 7.81e-01 |
| GOBP REGULATION OF DNA RECOMBINATION | 115 | 1.81e-02 | -1.28e-01 | 1.49e-01 |
| GOBP ENDOPLASMIC RETICULUM ORGANIZATION | 89 | 3.74e-02 | 1.28e-01 | 2.24e-01 |
| GOBP RESPONSE TO PH | 23 | 2.89e-01 | -1.28e-01 | 6.28e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON DNA | 228 | 9.22e-04 | -1.28e-01 | 2.08e-02 |
| GOBP REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT | 20 | 3.24e-01 | -1.27e-01 | 6.62e-01 |
| GOBP COMMISSURAL NEURON AXON GUIDANCE | 10 | 4.85e-01 | -1.27e-01 | 7.81e-01 |
| GOMF MISMATCHED DNA BINDING | 14 | 4.09e-01 | 1.27e-01 | 7.29e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 44 | 1.44e-01 | -1.27e-01 | 4.45e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE RESPONSE | 533 | 5.51e-07 | -1.27e-01 | 5.83e-05 |
| GOMF CARBOHYDRATE PHOSPHATASE ACTIVITY | 7 | 5.60e-01 | -1.27e-01 | 8.26e-01 |
| GOBP MITOTIC SISTER CHROMATID SEGREGATION | 176 | 3.64e-03 | -1.27e-01 | 5.45e-02 |
| GOMF MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 424 | 7.47e-06 | 1.27e-01 | 4.78e-04 |
| GOBP PROTEIN LOCALIZATION TO CELL CORTEX | 10 | 4.86e-01 | 1.27e-01 | 7.81e-01 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 51 | 1.17e-01 | -1.27e-01 | 4.01e-01 |
| GOBP TRANSEPITHELIAL TRANSPORT | 20 | 3.25e-01 | 1.27e-01 | 6.63e-01 |
| GOBP PROTEIN O LINKED MANNOSYLATION | 16 | 3.79e-01 | 1.27e-01 | 7.06e-01 |
| GOBP HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 32 | 2.14e-01 | -1.27e-01 | 5.39e-01 |
| GOMF GLUTAMATE RECEPTOR BINDING | 30 | 2.29e-01 | -1.27e-01 | 5.59e-01 |
| GOBP REGULATION OF APPETITE | 9 | 5.10e-01 | 1.27e-01 | 7.92e-01 |
| GOBP APOPTOTIC CELL CLEARANCE | 36 | 1.88e-01 | 1.27e-01 | 5.07e-01 |
| GOBP NEGATIVE REGULATION OF B CELL ACTIVATION | 25 | 2.72e-01 | -1.27e-01 | 6.09e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST MIGRATION | 10 | 4.88e-01 | 1.27e-01 | 7.81e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY | 22 | 3.04e-01 | -1.27e-01 | 6.43e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY | 222 | 1.16e-03 | -1.27e-01 | 2.43e-02 |
| GOMF THYROID HORMONE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.24e-01 | 1.27e-01 | 8.52e-01 |
| GOBP POSITIVE REGULATION OF CELL DIFFERENTIATION | 576 | 2.28e-07 | -1.27e-01 | 2.99e-05 |
| GOMF CATALYTIC ACTIVITY ACTING ON A GLYCOPROTEIN | 15 | 3.96e-01 | -1.27e-01 | 7.20e-01 |
| GOBP DETOXIFICATION | 102 | 2.72e-02 | 1.27e-01 | 1.87e-01 |
| GOBP POSTSYNAPTIC DENSITY ASSEMBLY | 14 | 4.12e-01 | 1.27e-01 | 7.31e-01 |
| GOBP KERATINOCYTE MIGRATION | 13 | 4.29e-01 | 1.27e-01 | 7.48e-01 |
| GOBP ENDOCARDIAL CUSHION DEVELOPMENT | 27 | 2.55e-01 | -1.26e-01 | 5.91e-01 |
| GOBP ELASTIC FIBER ASSEMBLY | 5 | 6.24e-01 | -1.26e-01 | 8.52e-01 |
| GOBP MEIOSIS I CELL CYCLE PROCESS | 93 | 3.52e-02 | -1.26e-01 | 2.17e-01 |
| GOBP TERPENOID METABOLIC PROCESS | 50 | 1.22e-01 | 1.26e-01 | 4.09e-01 |
| GOBP POSITIVE REGULATION OF MICROTUBULE NUCLEATION | 8 | 5.36e-01 | 1.26e-01 | 8.08e-01 |
| GOBP DENDRITIC SPINE MORPHOGENESIS | 42 | 1.57e-01 | -1.26e-01 | 4.62e-01 |
| GOCC ACETYLTRANSFERASE COMPLEX | 91 | 3.73e-02 | -1.26e-01 | 2.24e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 13 | 4.30e-01 | 1.26e-01 | 7.48e-01 |
| GOBP CLEAVAGE FURROW FORMATION | 7 | 5.63e-01 | -1.26e-01 | 8.26e-01 |
| GOBP PRIMARY AMINO COMPOUND METABOLIC PROCESS | 10 | 4.90e-01 | -1.26e-01 | 7.82e-01 |
| GOBP REGULATION OF APOPTOTIC CELL CLEARANCE | 8 | 5.37e-01 | 1.26e-01 | 8.09e-01 |
| GOMF STEROL TRANSPORTER ACTIVITY | 29 | 2.40e-01 | -1.26e-01 | 5.73e-01 |
| GOBP REGULATION OF DEVELOPMENT HETEROCHRONIC | 6 | 5.93e-01 | -1.26e-01 | 8.38e-01 |
| GOCC NUCLEAR PERIPHERY | 137 | 1.09e-02 | -1.26e-01 | 1.10e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN NEDDYLATION | 5 | 6.26e-01 | -1.26e-01 | 8.52e-01 |
| GOCC CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 49 | 1.27e-01 | -1.26e-01 | 4.18e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 5 | 6.26e-01 | 1.26e-01 | 8.52e-01 |
| GOBP REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 15 | 3.99e-01 | 1.26e-01 | 7.22e-01 |
| GOMF UBIQUITIN LIGASE SUBSTRATE ADAPTOR ACTIVITY | 50 | 1.24e-01 | -1.26e-01 | 4.12e-01 |
| GOMF GTPASE ACTIVATOR ACTIVITY | 229 | 1.05e-03 | -1.26e-01 | 2.29e-02 |
| GOBP MITOCHONDRIAL RIBOSOME ASSEMBLY | 10 | 4.91e-01 | 1.26e-01 | 7.83e-01 |
| GOCC CHROMOSOME PASSENGER COMPLEX | 6 | 5.94e-01 | 1.26e-01 | 8.38e-01 |
| GOCC PSEUDOPODIUM | 15 | 3.99e-01 | 1.26e-01 | 7.22e-01 |
| GOBP CYTIDINE TO URIDINE EDITING | 9 | 5.14e-01 | -1.26e-01 | 7.94e-01 |
| GOBP PROSTHETIC GROUP METABOLIC PROCESS | 5 | 6.26e-01 | 1.26e-01 | 8.53e-01 |
| GOBP ATP TRANSPORT | 17 | 3.69e-01 | -1.26e-01 | 7.00e-01 |
| GOMF ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 326 | 9.87e-05 | 1.26e-01 | 3.81e-03 |
| GOBP HEPOXILIN METABOLIC PROCESS | 5 | 6.26e-01 | 1.26e-01 | 8.53e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 10 | 4.91e-01 | 1.26e-01 | 7.83e-01 |
| GOBP MEDIUM CHAIN FATTY ACID METABOLIC PROCESS | 9 | 5.14e-01 | -1.26e-01 | 7.94e-01 |
| GOBP PIGMENTATION | 83 | 4.80e-02 | 1.26e-01 | 2.55e-01 |
| GOMF PEPTIDYL PROLINE DIOXYGENASE ACTIVITY | 10 | 4.92e-01 | 1.26e-01 | 7.83e-01 |
| GOBP REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 36 | 1.92e-01 | -1.26e-01 | 5.11e-01 |
| GOBP SUPEROXIDE METABOLIC PROCESS | 45 | 1.45e-01 | -1.26e-01 | 4.45e-01 |
| GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION | 25 | 2.77e-01 | -1.26e-01 | 6.15e-01 |
| GOBP TRNA MODIFICATION | 92 | 3.76e-02 | 1.25e-01 | 2.25e-01 |
| GOBP REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 10 | 4.93e-01 | 1.25e-01 | 7.84e-01 |
| GOBP NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS | 13 | 4.34e-01 | 1.25e-01 | 7.50e-01 |
| GOCC NMDA SELECTIVE GLUTAMATE RECEPTOR COMPLEX | 7 | 5.66e-01 | -1.25e-01 | 8.28e-01 |
| GOBP CELLULAR OXIDANT DETOXIFICATION | 67 | 7.65e-02 | 1.25e-01 | 3.25e-01 |
| GOBP INFLAMMATORY RESPONSE | 561 | 4.50e-07 | -1.25e-01 | 4.94e-05 |
| GOCC SITE OF DNA DAMAGE | 109 | 2.42e-02 | -1.25e-01 | 1.74e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT | 48 | 1.34e-01 | 1.25e-01 | 4.29e-01 |
| GOBP RESPONSE TO PEPTIDOGLYCAN | 11 | 4.73e-01 | -1.25e-01 | 7.72e-01 |
| GOBP LACTATE TRANSMEMBRANE TRANSPORT | 5 | 6.28e-01 | -1.25e-01 | 8.54e-01 |
| GOBP MRNA 3 END PROCESSING BY STEM LOOP BINDING AND CLEAVAGE | 6 | 5.96e-01 | 1.25e-01 | 8.39e-01 |
| GOCC CUL4 RING E3 UBIQUITIN LIGASE COMPLEX | 32 | 2.21e-01 | -1.25e-01 | 5.50e-01 |
| GOBP SMOOTH MUSCLE CELL MIGRATION | 52 | 1.19e-01 | 1.25e-01 | 4.03e-01 |
| GOMF TROPOMYOSIN BINDING | 9 | 5.16e-01 | -1.25e-01 | 7.95e-01 |
| GOBP RIBOSE PHOSPHATE METABOLIC PROCESS | 330 | 9.96e-05 | 1.25e-01 | 3.82e-03 |
| GOMF SOLUTE MONOATOMIC CATION SYMPORTER ACTIVITY | 66 | 7.96e-02 | 1.25e-01 | 3.32e-01 |
| GOMF P53 BINDING | 57 | 1.03e-01 | -1.25e-01 | 3.77e-01 |
| GOCC PARANODE REGION OF AXON | 6 | 5.97e-01 | 1.25e-01 | 8.39e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 14 | 4.19e-01 | -1.25e-01 | 7.37e-01 |
| GOBP FAT CELL PROLIFERATION | 9 | 5.17e-01 | -1.25e-01 | 7.96e-01 |
| GOMF ADRENERGIC RECEPTOR BINDING | 11 | 4.74e-01 | -1.25e-01 | 7.73e-01 |
| GOCC LAMELLIPODIUM MEMBRANE | 20 | 3.35e-01 | 1.25e-01 | 6.70e-01 |
| GOBP REGULATION OF IMMUNE SYSTEM PROCESS | 1088 | 5.74e-12 | -1.25e-01 | 1.89e-09 |
| GOBP CEREBROSPINAL FLUID CIRCULATION | 5 | 6.30e-01 | 1.25e-01 | 8.55e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 89 | 4.24e-02 | -1.25e-01 | 2.40e-01 |
| GOBP ROUNDABOUT SIGNALING PATHWAY | 5 | 6.30e-01 | -1.24e-01 | 8.55e-01 |
| GOBP RESPONSE TO EXTRACELLULAR STIMULUS | 374 | 3.75e-05 | -1.24e-01 | 1.79e-03 |
| GOBP CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 383 | 3.04e-05 | -1.24e-01 | 1.50e-03 |
| GOBP MULTINUCLEAR OSTEOCLAST DIFFERENTIATION | 8 | 5.42e-01 | -1.24e-01 | 8.13e-01 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 70 | 7.22e-02 | -1.24e-01 | 3.13e-01 |
| GOCC ENDOPLASMIC RETICULUM PROTEIN CONTAINING COMPLEX | 116 | 2.08e-02 | 1.24e-01 | 1.59e-01 |
| GOBP NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 41 | 1.68e-01 | -1.24e-01 | 4.81e-01 |
| GOBP REGULATION OF OSTEOCLAST DIFFERENTIATION | 51 | 1.25e-01 | -1.24e-01 | 4.15e-01 |
| GOBP VESICLE UNCOATING | 6 | 5.98e-01 | -1.24e-01 | 8.40e-01 |
| GOBP ENDOCRINE PANCREAS DEVELOPMENT | 23 | 3.02e-01 | 1.24e-01 | 6.42e-01 |
| GOMF CIS TRANS ISOMERASE ACTIVITY | 37 | 1.91e-01 | 1.24e-01 | 5.10e-01 |
| GOBP CELL CELL RECOGNITION | 41 | 1.69e-01 | 1.24e-01 | 4.82e-01 |
| GOBP ACTIVATION OF IMMUNE RESPONSE | 395 | 2.41e-05 | -1.24e-01 | 1.25e-03 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 34 | 2.11e-01 | 1.24e-01 | 5.34e-01 |
| GOBP LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 9 | 5.19e-01 | 1.24e-01 | 7.97e-01 |
| GOBP ENTRY OF BACTERIUM INTO HOST CELL | 7 | 5.70e-01 | 1.24e-01 | 8.29e-01 |
| GOBP TYROSINE CATABOLIC PROCESS | 5 | 6.31e-01 | 1.24e-01 | 8.56e-01 |
| GOBP LIPID OXIDATION | 90 | 4.22e-02 | 1.24e-01 | 2.39e-01 |
| GOBP REGULATION OF DIGESTIVE SYSTEM PROCESS | 14 | 4.22e-01 | -1.24e-01 | 7.40e-01 |
| GOBP MELANOSOME ASSEMBLY | 19 | 3.50e-01 | 1.24e-01 | 6.85e-01 |
| GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY PHOSPHOTRANSFERASES | 10 | 4.97e-01 | 1.24e-01 | 7.86e-01 |
| GOMF METALLOENDOPEPTIDASE ACTIVITY | 53 | 1.19e-01 | 1.24e-01 | 4.03e-01 |
| GOBP RESPONSE TO UV B | 16 | 3.92e-01 | -1.24e-01 | 7.17e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR SENESCENCE | 16 | 3.92e-01 | -1.24e-01 | 7.17e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 4.59e-01 | 1.24e-01 | 7.64e-01 |
| GOMF ACYLGLYCEROL LIPASE ACTIVITY | 12 | 4.59e-01 | 1.24e-01 | 7.64e-01 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 47 | 1.43e-01 | 1.24e-01 | 4.44e-01 |
| GOBP RESPONSE TO BMP | 93 | 3.97e-02 | -1.24e-01 | 2.30e-01 |
| GOCC SMC5 SMC6 COMPLEX | 9 | 5.21e-01 | -1.23e-01 | 7.99e-01 |
| GOBP RESPONSE TO INSULIN | 206 | 2.29e-03 | -1.23e-01 | 3.98e-02 |
| GOCC SPECTRIN | 7 | 5.72e-01 | 1.23e-01 | 8.30e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIUM | 59 | 1.01e-01 | 1.23e-01 | 3.73e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 14 | 4.25e-01 | -1.23e-01 | 7.43e-01 |
| GOCC CUL4A RING E3 UBIQUITIN LIGASE COMPLEX | 13 | 4.42e-01 | -1.23e-01 | 7.53e-01 |
| GOBP REGULATION OF SECONDARY METABOLIC PROCESS | 12 | 4.60e-01 | 1.23e-01 | 7.64e-01 |
| GOBP REGULATION OF DENDRITIC SPINE DEVELOPMENT | 45 | 1.53e-01 | -1.23e-01 | 4.57e-01 |
| GOCC CONDENSED NUCLEAR CHROMOSOME | 61 | 9.63e-02 | -1.23e-01 | 3.66e-01 |
| GOMF CAMP BINDING | 16 | 3.94e-01 | -1.23e-01 | 7.19e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 204 | 2.48e-03 | -1.23e-01 | 4.22e-02 |
| GOCC FILOPODIUM TIP | 16 | 3.94e-01 | -1.23e-01 | 7.19e-01 |
| GOCC INO80 TYPE COMPLEX | 26 | 2.78e-01 | 1.23e-01 | 6.15e-01 |
| GOBP FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS | 10 | 5.01e-01 | -1.23e-01 | 7.88e-01 |
| GOBP HEART VALVE DEVELOPMENT | 46 | 1.50e-01 | -1.23e-01 | 4.53e-01 |
| GOMF SULFUR AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 5.24e-01 | -1.23e-01 | 8.00e-01 |
| GOBP MEMBRANE DOCKING | 81 | 5.64e-02 | 1.23e-01 | 2.74e-01 |
| GOBP REGULATION OF BMP SIGNALING PATHWAY | 61 | 9.76e-02 | -1.23e-01 | 3.66e-01 |
| GOMF STEROID DEHYDROGENASE ACTIVITY ACTING ON THE CH OH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 21 | 3.31e-01 | 1.23e-01 | 6.67e-01 |
| GOBP REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL | 7 | 5.75e-01 | -1.23e-01 | 8.31e-01 |
| GOBP DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT | 7 | 5.75e-01 | -1.22e-01 | 8.31e-01 |
| GOMF MONOOXYGENASE ACTIVITY | 40 | 1.80e-01 | 1.22e-01 | 4.96e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 28 | 2.62e-01 | -1.22e-01 | 5.98e-01 |
| GOBP MICROTUBULE SEVERING | 7 | 5.75e-01 | -1.22e-01 | 8.31e-01 |
| GOBP FATTY ACID METABOLIC PROCESS | 277 | 4.73e-04 | 1.22e-01 | 1.27e-02 |
| GOBP L ASPARTATE TRANSMEMBRANE TRANSPORT | 9 | 5.25e-01 | -1.22e-01 | 8.00e-01 |
| GOBP RESPONSE TO MERCURY ION | 5 | 6.36e-01 | -1.22e-01 | 8.58e-01 |
| GOMF HISTONE DEACETYLASE BINDING | 93 | 4.20e-02 | -1.22e-01 | 2.38e-01 |
| GOBP PEPTIDYL L CYSTEINE S PALMITOYLATION | 21 | 3.33e-01 | 1.22e-01 | 6.67e-01 |
| GOBP NEGATIVE REGULATION OF TORC1 SIGNALING | 41 | 1.76e-01 | -1.22e-01 | 4.91e-01 |
| GOCC SPINDLE POLE CENTROSOME | 13 | 4.46e-01 | 1.22e-01 | 7.57e-01 |
| GOBP MITRAL VALVE DEVELOPMENT | 9 | 5.26e-01 | -1.22e-01 | 8.01e-01 |
| GOBP MUSCLE CELL MIGRATION | 62 | 9.71e-02 | 1.22e-01 | 3.66e-01 |
| GOBP REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 59 | 1.06e-01 | -1.22e-01 | 3.81e-01 |
| GOBP B CELL ACTIVATION | 204 | 2.73e-03 | -1.22e-01 | 4.51e-02 |
| GOBP GLYCOSPHINGOLIPID METABOLIC PROCESS | 43 | 1.67e-01 | 1.22e-01 | 4.79e-01 |
| GOBP REGULATION OF DENDRITIC CELL DIFFERENTIATION | 14 | 4.30e-01 | -1.22e-01 | 7.48e-01 |
| GOBP DNA DOUBLE STRAND BREAK PROCESSING | 18 | 3.71e-01 | 1.22e-01 | 7.00e-01 |
| GOCC CONNEXIN COMPLEX | 5 | 6.38e-01 | -1.22e-01 | 8.59e-01 |
| GOCC AMPA GLUTAMATE RECEPTOR COMPLEX | 9 | 5.27e-01 | -1.22e-01 | 8.02e-01 |
| GOBP ORGAN GROWTH | 101 | 3.49e-02 | -1.22e-01 | 2.17e-01 |
| GOMF STRUCTURAL CONSTITUENT OF CYTOSKELETON | 66 | 8.78e-02 | 1.22e-01 | 3.46e-01 |
| GOBP DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 14 | 4.31e-01 | -1.22e-01 | 7.48e-01 |
| GOBP HYALURONAN BIOSYNTHETIC PROCESS | 9 | 5.28e-01 | 1.22e-01 | 8.02e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDE SECRETION | 61 | 1.01e-01 | -1.21e-01 | 3.72e-01 |
| GOBP NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 40 | 1.84e-01 | -1.21e-01 | 5.01e-01 |
| GOBP NUCLEUS LOCALIZATION | 30 | 2.50e-01 | -1.21e-01 | 5.84e-01 |
| GOBP NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 199 | 3.21e-03 | -1.21e-01 | 5.04e-02 |
| GOBP RESPONSE TO POTASSIUM ION | 12 | 4.67e-01 | -1.21e-01 | 7.67e-01 |
| GOBP THIOESTER BIOSYNTHETIC PROCESS | 40 | 1.84e-01 | 1.21e-01 | 5.01e-01 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL | 5 | 6.39e-01 | -1.21e-01 | 8.59e-01 |
| GOMF NUCLEAR EXPORT SIGNAL RECEPTOR ACTIVITY | 12 | 4.67e-01 | -1.21e-01 | 7.67e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 6 | 6.07e-01 | -1.21e-01 | 8.45e-01 |
| GOBP SULFATE TRANSPORT | 14 | 4.32e-01 | 1.21e-01 | 7.49e-01 |
| GOBP NEPHRON MORPHOGENESIS | 36 | 2.08e-01 | 1.21e-01 | 5.32e-01 |
| GOBP REGULATION OF STEM CELL DIVISION | 8 | 5.53e-01 | -1.21e-01 | 8.19e-01 |
| GOBP POSITIVE REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 5 | 6.39e-01 | 1.21e-01 | 8.59e-01 |
| GOBP REGULATION OF LYMPHOCYTE CHEMOTAXIS | 17 | 3.87e-01 | 1.21e-01 | 7.13e-01 |
| GOBP PROTEIN TARGETING | 301 | 3.09e-04 | 1.21e-01 | 9.08e-03 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 22 | 3.25e-01 | -1.21e-01 | 6.63e-01 |
| GOBP REGULATION OF LEUKOCYTE CHEMOTAXIS | 88 | 4.97e-02 | -1.21e-01 | 2.59e-01 |
| GOBP NUCLEAR CHROMOSOME SEGREGATION | 274 | 5.73e-04 | -1.21e-01 | 1.46e-02 |
| GOMF ACETYLCHOLINE RECEPTOR ACTIVITY | 5 | 6.39e-01 | 1.21e-01 | 8.59e-01 |
| GOMF ABC TYPE XENOBIOTIC TRANSPORTER ACTIVITY | 13 | 4.50e-01 | -1.21e-01 | 7.59e-01 |
| GOCC P BODY | 90 | 4.74e-02 | -1.21e-01 | 2.54e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 48 | 1.47e-01 | -1.21e-01 | 4.49e-01 |
| GOBP CELLULAR RESPONSE TO STARVATION | 145 | 1.20e-02 | -1.21e-01 | 1.17e-01 |
| GOBP LIPID PHOSPHORYLATION | 9 | 5.30e-01 | 1.21e-01 | 8.04e-01 |
| GOMF ATP DEPENDENT DIACYLGLYCEROL KINASE ACTIVITY | 9 | 5.30e-01 | 1.21e-01 | 8.04e-01 |
| GOBP SPECIFICATION OF ANIMAL ORGAN IDENTITY | 14 | 4.34e-01 | -1.21e-01 | 7.50e-01 |
| GOBP REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 10 | 5.08e-01 | -1.21e-01 | 7.91e-01 |
| GOMF WATER TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 5.30e-01 | 1.21e-01 | 8.04e-01 |
| GOBP DNA MODIFICATION | 86 | 5.30e-02 | -1.21e-01 | 2.66e-01 |
| GOBP DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 11 | 4.88e-01 | 1.21e-01 | 7.81e-01 |
| GOBP REGULATION OF CARBOHYDRATE CATABOLIC PROCESS | 52 | 1.32e-01 | -1.21e-01 | 4.26e-01 |
| GOBP NEPHRON DEVELOPMENT | 83 | 5.73e-02 | 1.21e-01 | 2.76e-01 |
| GOBP LAMELLIPODIUM ASSEMBLY | 55 | 1.22e-01 | -1.21e-01 | 4.08e-01 |
| GOBP NEURAL CREST FORMATION | 9 | 5.31e-01 | 1.21e-01 | 8.04e-01 |
| GOBP RRNA TRANSPORT | 5 | 6.40e-01 | -1.21e-01 | 8.60e-01 |
| GOBP POSITIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE | 5 | 6.41e-01 | -1.21e-01 | 8.60e-01 |
| GOMF SOLUTE SODIUM SYMPORTER ACTIVITY | 34 | 2.24e-01 | 1.21e-01 | 5.52e-01 |
| GOBP PEPTIDYL CYSTEINE MODIFICATION | 39 | 1.93e-01 | 1.21e-01 | 5.12e-01 |
| GOMF LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY INVOLVED IN REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL | 6 | 6.09e-01 | -1.20e-01 | 8.46e-01 |
| GOBP REGULATION OF LIPID KINASE ACTIVITY | 26 | 2.88e-01 | -1.20e-01 | 6.26e-01 |
| GOCC LSM1 7 PAT1 COMPLEX | 5 | 6.41e-01 | 1.20e-01 | 8.60e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 6 | 6.09e-01 | -1.20e-01 | 8.46e-01 |
| GOBP CELLULAR RESPONSE TO CADMIUM ION | 29 | 2.62e-01 | -1.20e-01 | 5.98e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 6 | 6.10e-01 | -1.20e-01 | 8.46e-01 |
| GOCC CLATHRIN COATED PIT | 62 | 1.01e-01 | -1.20e-01 | 3.73e-01 |
| GOMF SCAVENGER RECEPTOR ACTIVITY | 15 | 4.20e-01 | -1.20e-01 | 7.38e-01 |
| GOCC VESICLE COAT | 57 | 1.16e-01 | 1.20e-01 | 4.01e-01 |
| GOBP CELLULAR RESPONSE TO HORMONE STIMULUS | 421 | 2.44e-05 | -1.20e-01 | 1.26e-03 |
| GOBP PHAGOLYSOSOME ASSEMBLY | 17 | 3.91e-01 | 1.20e-01 | 7.16e-01 |
| GOBP SCHWANN CELL DEVELOPMENT | 24 | 3.08e-01 | -1.20e-01 | 6.48e-01 |
| GOMF LIPASE INHIBITOR ACTIVITY | 10 | 5.11e-01 | 1.20e-01 | 7.92e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE | 348 | 1.23e-04 | -1.20e-01 | 4.47e-03 |
| GOBP 7 METHYLGUANOSINE RNA CAPPING | 9 | 5.33e-01 | 1.20e-01 | 8.06e-01 |
| GOMF NUCLEOBASE CONTAINING COMPOUND KINASE ACTIVITY | 41 | 1.84e-01 | 1.20e-01 | 5.01e-01 |
| GOBP UTP BIOSYNTHETIC PROCESS | 9 | 5.33e-01 | 1.20e-01 | 8.06e-01 |
| GOBP PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 17 | 3.92e-01 | -1.20e-01 | 7.18e-01 |
| GOMF STEROID HYDROXYLASE ACTIVITY | 8 | 5.57e-01 | 1.20e-01 | 8.23e-01 |
| GOMF GLUCOSE BINDING | 9 | 5.34e-01 | -1.20e-01 | 8.06e-01 |
| GOBP MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS | 13 | 4.55e-01 | -1.20e-01 | 7.62e-01 |
| GOBP NEGATIVE REGULATION OF METALLOPEPTIDASE ACTIVITY | 7 | 5.84e-01 | -1.20e-01 | 8.34e-01 |
| GOBP EPITHELIAL STRUCTURE MAINTENANCE | 15 | 4.23e-01 | -1.20e-01 | 7.41e-01 |
| GOCC PRE SNORNP COMPLEX | 7 | 5.84e-01 | 1.20e-01 | 8.34e-01 |
| GOBP POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY | 36 | 2.15e-01 | -1.19e-01 | 5.40e-01 |
| GOMF INORGANIC MOLECULAR ENTITY TRANSMEMBRANE TRANSPORTER ACTIVITY | 410 | 3.50e-05 | 1.19e-01 | 1.69e-03 |
| GOCC BASOLATERAL PLASMA MEMBRANE | 166 | 8.00e-03 | 1.19e-01 | 9.03e-02 |
| GOBP KINETOCHORE ASSEMBLY | 17 | 3.94e-01 | -1.19e-01 | 7.19e-01 |
| GOMF SYNTAXIN BINDING | 47 | 1.57e-01 | -1.19e-01 | 4.63e-01 |
| GOCC MITOTIC SPINDLE MICROTUBULE | 14 | 4.40e-01 | -1.19e-01 | 7.52e-01 |
| GOMF NAD BINDING | 52 | 1.37e-01 | 1.19e-01 | 4.35e-01 |
| GOCC GTPASE COMPLEX | 27 | 2.84e-01 | 1.19e-01 | 6.22e-01 |
| GOCC POLAR MICROTUBULE | 5 | 6.45e-01 | -1.19e-01 | 8.63e-01 |
| GOBP CONVERGENT EXTENSION | 10 | 5.15e-01 | 1.19e-01 | 7.95e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 69 | 8.75e-02 | -1.19e-01 | 3.45e-01 |
| GOBP PROTEIN KINASE C SIGNALING | 20 | 3.57e-01 | 1.19e-01 | 6.90e-01 |
| GOBP ESTROGEN BIOSYNTHETIC PROCESS | 7 | 5.86e-01 | 1.19e-01 | 8.35e-01 |
| GOBP DEFENSE RESPONSE TO OTHER ORGANISM | 801 | 1.30e-08 | -1.19e-01 | 2.47e-06 |
| GOBP TERPENOID BIOSYNTHETIC PROCESS | 11 | 4.95e-01 | 1.19e-01 | 7.85e-01 |
| GOBP PIGMENT CATABOLIC PROCESS | 8 | 5.61e-01 | -1.19e-01 | 8.26e-01 |
| GOBP AMINOPHOSPHOLIPID TRANSPORT | 8 | 5.61e-01 | -1.19e-01 | 8.26e-01 |
| GOMF METAL DEPENDENT DEUBIQUITINASE ACTIVITY | 11 | 4.95e-01 | 1.19e-01 | 7.85e-01 |
| GOBP CILIUM DISASSEMBLY | 5 | 6.46e-01 | -1.19e-01 | 8.64e-01 |
| GOMF ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY | 36 | 2.18e-01 | 1.19e-01 | 5.45e-01 |
| GOBP MONOCARBOXYLIC ACID CATABOLIC PROCESS | 103 | 3.76e-02 | 1.19e-01 | 2.25e-01 |
| GOBP LABYRINTHINE LAYER MORPHOGENESIS | 13 | 4.59e-01 | -1.19e-01 | 7.64e-01 |
| GOCC DNA POLYMERASE COMPLEX | 19 | 3.71e-01 | -1.19e-01 | 7.00e-01 |
| GOBP REGULATION OF DENDRITE MORPHOGENESIS | 46 | 1.64e-01 | -1.19e-01 | 4.75e-01 |
| GOCC PICLN SM PROTEIN COMPLEX | 6 | 6.15e-01 | 1.18e-01 | 8.48e-01 |
| GOCC MITOCHONDRIA ASSOCIATED ENDOPLASMIC RETICULUM MEMBRANE | 19 | 3.72e-01 | 1.18e-01 | 7.00e-01 |
| GOBP SHORT CHAIN FATTY ACID METABOLIC PROCESS | 13 | 4.60e-01 | 1.18e-01 | 7.64e-01 |
| GOBP FOCAL ADHESION ASSEMBLY | 67 | 9.40e-02 | 1.18e-01 | 3.61e-01 |
| GOMF G PROTEIN COUPLED AMINE RECEPTOR ACTIVITY | 9 | 5.39e-01 | -1.18e-01 | 8.11e-01 |
| GOBP LIPID EXPORT FROM CELL | 29 | 2.70e-01 | 1.18e-01 | 6.07e-01 |
| GOBP DEADENYLATION DEPENDENT DECAPPING OF NUCLEAR TRANSCRIBED MRNA | 11 | 4.98e-01 | -1.18e-01 | 7.86e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE CYCLE | 10 | 5.18e-01 | -1.18e-01 | 7.97e-01 |
| GOBP INTERLEUKIN 1 PRODUCTION | 84 | 6.17e-02 | -1.18e-01 | 2.87e-01 |
| GOBP HYPOXIA INDUCIBLE FACTOR 1ALPHA SIGNALING PATHWAY | 6 | 6.17e-01 | 1.18e-01 | 8.49e-01 |
| GOBP PEPTIDYL LYSINE HYDROXYLATION | 6 | 6.17e-01 | 1.18e-01 | 8.49e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION ELONGATION | 128 | 2.13e-02 | -1.18e-01 | 1.61e-01 |
| GOCC GABA ERGIC SYNAPSE | 33 | 2.41e-01 | -1.18e-01 | 5.75e-01 |
| GOMF NUCLEAR LOCALIZATION SEQUENCE BINDING | 20 | 3.62e-01 | -1.18e-01 | 6.94e-01 |
| GOMF CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY | 22 | 3.39e-01 | -1.18e-01 | 6.74e-01 |
| GOBP MICROVILLUS ORGANIZATION | 26 | 2.99e-01 | -1.18e-01 | 6.37e-01 |
| GOBP DNA LIGATION INVOLVED IN DNA REPAIR | 5 | 6.48e-01 | -1.18e-01 | 8.65e-01 |
| GOCC TRANSCRIPTION EXPORT COMPLEX 2 | 5 | 6.48e-01 | 1.18e-01 | 8.65e-01 |
| GOMF POTASSIUM CHLORIDE SYMPORTER ACTIVITY | 7 | 5.90e-01 | -1.18e-01 | 8.36e-01 |
| GOBP RESPONSE TO ELECTRICAL STIMULUS | 28 | 2.81e-01 | -1.18e-01 | 6.19e-01 |
| GOBP CELLULAR RESPONSE TO LEUCINE STARVATION | 12 | 4.81e-01 | 1.18e-01 | 7.78e-01 |
| GOBP VESICLE FUSION TO PLASMA MEMBRANE | 12 | 4.81e-01 | 1.18e-01 | 7.78e-01 |
| GOBP B CELL HOMEOSTASIS | 29 | 2.73e-01 | -1.18e-01 | 6.09e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY | 107 | 3.58e-02 | 1.18e-01 | 2.20e-01 |
| GOBP MITOCHONDRIAL DNA REPLICATION | 14 | 4.47e-01 | 1.17e-01 | 7.57e-01 |
| GOMF UDP GLYCOSYLTRANSFERASE ACTIVITY | 93 | 5.05e-02 | 1.17e-01 | 2.61e-01 |
| GOBP REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 137 | 1.79e-02 | -1.17e-01 | 1.48e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 65 | 1.02e-01 | -1.17e-01 | 3.74e-01 |
| GOBP HINDLIMB MORPHOGENESIS | 15 | 4.32e-01 | 1.17e-01 | 7.49e-01 |
| GOBP INORGANIC ANION TRANSPORT | 91 | 5.34e-02 | 1.17e-01 | 2.66e-01 |
| GOBP REGULATION OF OSTEOCLAST DEVELOPMENT | 8 | 5.66e-01 | -1.17e-01 | 8.28e-01 |
| GOBP RESPONSE TO NUTRIENT | 102 | 4.11e-02 | -1.17e-01 | 2.35e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 105 | 3.84e-02 | -1.17e-01 | 2.27e-01 |
| GOCC TRANSCRIPTION REGULATOR COMPLEX | 376 | 1.02e-04 | -1.17e-01 | 3.89e-03 |
| GOBP DEFENSE RESPONSE | 1169 | 2.36e-11 | -1.17e-01 | 6.55e-09 |
| GOBP MESODERMAL CELL FATE COMMITMENT | 6 | 6.20e-01 | 1.17e-01 | 8.50e-01 |
| GOMF ATPASE COUPLED INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 23 | 3.32e-01 | -1.17e-01 | 6.67e-01 |
| GOBP MEIOTIC SPINDLE ORGANIZATION | 16 | 4.19e-01 | 1.17e-01 | 7.37e-01 |
| GOBP DNA REPAIR | 549 | 3.15e-06 | -1.17e-01 | 2.35e-04 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 5 | 6.51e-01 | 1.17e-01 | 8.66e-01 |
| GOBP REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 16 | 4.19e-01 | 1.17e-01 | 7.37e-01 |
| GOBP TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 74 | 8.27e-02 | -1.17e-01 | 3.39e-01 |
| GOBP MITOTIC G1 S TRANSITION CHECKPOINT SIGNALING | 26 | 3.03e-01 | -1.17e-01 | 6.42e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX | 14 | 4.50e-01 | 1.17e-01 | 7.59e-01 |
| GOBP REGULATION OF PROTON TRANSPORT | 13 | 4.67e-01 | 1.17e-01 | 7.67e-01 |
| GOCC NUCLEOID | 43 | 1.86e-01 | 1.17e-01 | 5.03e-01 |
| GOBP NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 41 | 1.97e-01 | 1.17e-01 | 5.16e-01 |
| GOBP POSITIVE REGULATION OF TORC2 SIGNALING | 5 | 6.52e-01 | -1.17e-01 | 8.67e-01 |
| GOBP RESPONSE TO CELL CYCLE CHECKPOINT SIGNALING | 8 | 5.68e-01 | -1.17e-01 | 8.28e-01 |
| GOBP HISTONE H3 ACETYLATION | 6 | 6.21e-01 | -1.17e-01 | 8.50e-01 |
| GOMF STRUCTURAL CONSTITUENT OF NUCLEAR PORE | 21 | 3.56e-01 | -1.16e-01 | 6.89e-01 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL POLARITY | 28 | 2.87e-01 | -1.16e-01 | 6.25e-01 |
| GOBP RESPONSE TO FOLLICLE STIMULATING HORMONE | 7 | 5.94e-01 | -1.16e-01 | 8.38e-01 |
| GOBP REGULATION OF ALPHA BETA T CELL ACTIVATION | 84 | 6.58e-02 | -1.16e-01 | 2.96e-01 |
| GOMF PROTEIN KINASE C ACTIVITY | 14 | 4.52e-01 | 1.16e-01 | 7.61e-01 |
| GOMF MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 353 | 1.86e-04 | 1.16e-01 | 6.23e-03 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 24 | 3.25e-01 | 1.16e-01 | 6.63e-01 |
| GOBP CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION | 16 | 4.22e-01 | 1.16e-01 | 7.40e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL BUD | 6 | 6.23e-01 | -1.16e-01 | 8.51e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR PERMEABILITY | 10 | 5.25e-01 | 1.16e-01 | 8.00e-01 |
| GOBP POSITIVE REGULATION OF TELOMERASE ACTIVITY | 29 | 2.80e-01 | -1.16e-01 | 6.17e-01 |
| GOBP PEROXISOME FISSION | 9 | 5.47e-01 | 1.16e-01 | 8.17e-01 |
| GOBP RESPONSE TO ORGANIC CYCLIC COMPOUND | 602 | 1.33e-06 | -1.16e-01 | 1.18e-04 |
| GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 8 | 5.71e-01 | 1.16e-01 | 8.29e-01 |
| GOBP CHROMOSOME SEGREGATION | 377 | 1.18e-04 | -1.16e-01 | 4.32e-03 |
| GOBP NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS | 362 | 1.61e-04 | -1.16e-01 | 5.49e-03 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING | 26 | 3.07e-01 | -1.16e-01 | 6.46e-01 |
| GOMF TRANSPORTER ACTIVITY | 793 | 3.60e-08 | 1.16e-01 | 5.51e-06 |
| GOBP ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT | 14 | 4.54e-01 | 1.16e-01 | 7.62e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 2 CELL CYTOKINE PRODUCTION | 5 | 6.54e-01 | 1.16e-01 | 8.68e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 20 | 3.71e-01 | -1.16e-01 | 7.00e-01 |
| GOBP SUCCINYL COA CATABOLIC PROCESS | 6 | 6.24e-01 | 1.16e-01 | 8.52e-01 |
| GOBP ACTOMYOSIN CONTRACTILE RING ORGANIZATION | 10 | 5.27e-01 | -1.15e-01 | 8.02e-01 |
| GOMF FLAVIN ADENINE DINUCLEOTIDE BINDING | 73 | 8.81e-02 | 1.15e-01 | 3.46e-01 |
| GOMF O ACYLTRANSFERASE ACTIVITY | 42 | 1.96e-01 | 1.15e-01 | 5.15e-01 |
| GOBP GRANULOCYTE MIGRATION | 106 | 4.02e-02 | -1.15e-01 | 2.31e-01 |
| GOMF METAL CLUSTER BINDING | 66 | 1.05e-01 | 1.15e-01 | 3.80e-01 |
| GOBP MAMMARY GLAND ALVEOLUS DEVELOPMENT | 14 | 4.55e-01 | 1.15e-01 | 7.62e-01 |
| GOBP REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS | 20 | 3.72e-01 | -1.15e-01 | 7.00e-01 |
| GOBP REGULATION OF BINDING | 203 | 4.67e-03 | -1.15e-01 | 6.44e-02 |
| GOMF SIGNALING RECEPTOR INHIBITOR ACTIVITY | 13 | 4.72e-01 | 1.15e-01 | 7.71e-01 |
| GOBP INNATE IMMUNE RESPONSE | 656 | 5.31e-07 | -1.15e-01 | 5.69e-05 |
| GOBP REGULATION OF DEFENSE RESPONSE | 571 | 2.76e-06 | -1.15e-01 | 2.10e-04 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H | 79 | 7.69e-02 | 1.15e-01 | 3.25e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN BINDING | 50 | 1.59e-01 | -1.15e-01 | 4.65e-01 |
| GOBP POSITIVE REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 7 | 5.98e-01 | 1.15e-01 | 8.40e-01 |
| GOBP INTRACELLULAR STEROL TRANSPORT | 31 | 2.67e-01 | 1.15e-01 | 6.05e-01 |
| GOBP METHYLGUANOSINE CAP DECAPPING | 16 | 4.25e-01 | -1.15e-01 | 7.43e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 285 | 8.46e-04 | -1.15e-01 | 1.94e-02 |
| GOBP REGULATION OF AMPA RECEPTOR ACTIVITY | 8 | 5.73e-01 | -1.15e-01 | 8.30e-01 |
| GOBP TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 65 | 1.09e-01 | -1.15e-01 | 3.87e-01 |
| GOBP GOLGI VESICLE TRANSPORT | 275 | 1.05e-03 | 1.15e-01 | 2.29e-02 |
| GOBP T CELL CHEMOTAXIS | 17 | 4.12e-01 | 1.15e-01 | 7.31e-01 |
| GOBP LYMPHOCYTE MIGRATION INTO LYMPHOID ORGANS | 7 | 5.98e-01 | -1.15e-01 | 8.40e-01 |
| GOBP POSITIVE REGULATION OF CELL MATRIX ADHESION | 40 | 2.09e-01 | 1.15e-01 | 5.33e-01 |
| GOCC 9PLUS2 MOTILE CILIUM | 111 | 3.69e-02 | 1.15e-01 | 2.23e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 99 | 4.87e-02 | -1.15e-01 | 2.57e-01 |
| GOBP REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 34 | 2.47e-01 | -1.15e-01 | 5.82e-01 |
| GOBP REGULATION OF ERBB SIGNALING PATHWAY | 52 | 1.53e-01 | -1.15e-01 | 4.57e-01 |
| GOBP NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY | 19 | 3.87e-01 | -1.15e-01 | 7.13e-01 |
| GOBP NOTOCHORD DEVELOPMENT | 6 | 6.27e-01 | -1.15e-01 | 8.53e-01 |
| GOMF C METHYLTRANSFERASE ACTIVITY | 7 | 5.99e-01 | 1.15e-01 | 8.40e-01 |
| GOBP S ADENOSYLMETHIONINE CYCLE | 7 | 6.00e-01 | 1.15e-01 | 8.40e-01 |
| GOMF THIOESTERASE BINDING | 9 | 5.52e-01 | 1.14e-01 | 8.19e-01 |
| GOBP REGULATION OF OSSIFICATION | 75 | 8.66e-02 | -1.14e-01 | 3.45e-01 |
| GOMF G PROTEIN ALPHA SUBUNIT BINDING | 21 | 3.64e-01 | -1.14e-01 | 6.97e-01 |
| GOMF NUCLEAR RETINOIC ACID RECEPTOR BINDING | 22 | 3.53e-01 | -1.14e-01 | 6.87e-01 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 37 | 2.29e-01 | 1.14e-01 | 5.59e-01 |
| GOBP PROTEIN HYDROXYLATION | 20 | 3.77e-01 | 1.14e-01 | 7.05e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION | 93 | 5.72e-02 | -1.14e-01 | 2.75e-01 |
| GOBP NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS | 252 | 1.84e-03 | 1.14e-01 | 3.34e-02 |
| GOMF K48 LINKED DEUBIQUITINASE ACTIVITY | 16 | 4.30e-01 | -1.14e-01 | 7.48e-01 |
| GOMF CARGO ADAPTOR ACTIVITY | 18 | 4.03e-01 | -1.14e-01 | 7.24e-01 |
| GOCC ENDOLYSOSOME LUMEN | 5 | 6.59e-01 | 1.14e-01 | 8.71e-01 |
| GOBP MOTOR BEHAVIOR | 17 | 4.16e-01 | 1.14e-01 | 7.34e-01 |
| GOCC MITOTIC SPINDLE POLE | 35 | 2.43e-01 | -1.14e-01 | 5.77e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 6 | 6.29e-01 | 1.14e-01 | 8.55e-01 |
| GOBP REGULATION OF FLAGELLATED SPERM MOTILITY | 6 | 6.29e-01 | -1.14e-01 | 8.55e-01 |
| GOBP ALPHA BETA T CELL ACTIVATION | 131 | 2.45e-02 | -1.14e-01 | 1.76e-01 |
| GOBP CELLULAR RESPONSE TO ESTRADIOL STIMULUS | 25 | 3.25e-01 | -1.14e-01 | 6.63e-01 |
| GOCC FEMALE GERM CELL NUCLEUS | 9 | 5.54e-01 | -1.14e-01 | 8.20e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING COMPRESSION RESISTANCE | 7 | 6.02e-01 | -1.14e-01 | 8.42e-01 |
| GOBP NADP METABOLIC PROCESS | 38 | 2.25e-01 | -1.14e-01 | 5.54e-01 |
| GOBP MITOCHONDRIAL RNA PROCESSING | 21 | 3.67e-01 | 1.14e-01 | 6.99e-01 |
| GOMF PROTEIN FOLDING CHAPERONE BINDING | 113 | 3.70e-02 | 1.14e-01 | 2.23e-01 |
| GOBP REGULATION OF MONONUCLEAR CELL MIGRATION | 90 | 6.26e-02 | -1.14e-01 | 2.89e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 61 | 1.25e-01 | 1.14e-01 | 4.15e-01 |
| GOMF PROTEIN CARRIER CHAPERONE | 33 | 2.59e-01 | 1.14e-01 | 5.94e-01 |
| GOBP ANTERIOR POSTERIOR PATTERN SPECIFICATION | 102 | 4.77e-02 | -1.14e-01 | 2.54e-01 |
| GOCC PROTEIN PHOSPHATASE TYPE 1 COMPLEX | 17 | 4.18e-01 | -1.13e-01 | 7.36e-01 |
| GOBP REGULATION OF AMINO ACID TRANSPORT | 23 | 3.47e-01 | -1.13e-01 | 6.83e-01 |
| GOBP CELLULAR RESPONSE TO CALCIUM ION | 57 | 1.40e-01 | -1.13e-01 | 4.38e-01 |
| GOMF UBIQUITIN UBIQUITIN LIGASE ACTIVITY | 14 | 4.64e-01 | -1.13e-01 | 7.65e-01 |
| GOMF PROTEIN HETERODIMERIZATION ACTIVITY | 187 | 7.71e-03 | 1.13e-01 | 8.81e-02 |
| GOBP RNA MODIFICATION | 167 | 1.18e-02 | 1.13e-01 | 1.15e-01 |
| GOCC CILIARY MEMBRANE | 55 | 1.47e-01 | 1.13e-01 | 4.49e-01 |
| GOCC AXOLEMMA | 11 | 5.16e-01 | 1.13e-01 | 7.95e-01 |
| GOBP TRNA METHYLATION | 43 | 2.00e-01 | 1.13e-01 | 5.21e-01 |
| GOBP PEPTIDYL LYSINE MODIFICATION | 190 | 7.32e-03 | -1.13e-01 | 8.51e-02 |
| GOBP DIOL METABOLIC PROCESS | 22 | 3.59e-01 | 1.13e-01 | 6.91e-01 |
| GOBP RRNA BASE METHYLATION | 8 | 5.80e-01 | 1.13e-01 | 8.32e-01 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY | 45 | 1.90e-01 | -1.13e-01 | 5.09e-01 |
| GOBP REGULATION OF CELL KILLING | 71 | 1.00e-01 | -1.13e-01 | 3.71e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 8 | 5.80e-01 | 1.13e-01 | 8.32e-01 |
| GOMF AMP BINDING | 13 | 4.81e-01 | 1.13e-01 | 7.78e-01 |
| GOBP NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 14 | 4.65e-01 | -1.13e-01 | 7.66e-01 |
| GOCC ANNULATE LAMELLAE | 5 | 6.62e-01 | -1.13e-01 | 8.73e-01 |
| GOBP LYMPHOCYTE ACTIVATION | 583 | 3.59e-06 | -1.13e-01 | 2.66e-04 |
| GOMF CARBON CARBON LYASE ACTIVITY | 38 | 2.29e-01 | 1.13e-01 | 5.59e-01 |
| GOBP REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION | 8 | 5.81e-01 | -1.13e-01 | 8.32e-01 |
| GOBP LEUKOCYTE CHEMOTAXIS INVOLVED IN INFLAMMATORY RESPONSE | 6 | 6.33e-01 | 1.13e-01 | 8.57e-01 |
| GOCC GOLGI ASSOCIATED VESICLE MEMBRANE | 48 | 1.78e-01 | 1.12e-01 | 4.93e-01 |
| GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK MEMBRANE | 5 | 6.63e-01 | 1.12e-01 | 8.73e-01 |
| GOBP NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 31 | 2.79e-01 | -1.12e-01 | 6.16e-01 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 166 | 1.25e-02 | -1.12e-01 | 1.19e-01 |
| GOBP IMMUNE EFFECTOR PROCESS | 431 | 6.58e-05 | -1.12e-01 | 2.84e-03 |
| GOBP TUBE FORMATION | 104 | 4.78e-02 | -1.12e-01 | 2.54e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 6 | 6.34e-01 | 1.12e-01 | 8.57e-01 |
| GOMF CHITIN BINDING | 6 | 6.34e-01 | 1.12e-01 | 8.57e-01 |
| GOBP VENOUS BLOOD VESSEL MORPHOGENESIS | 5 | 6.64e-01 | 1.12e-01 | 8.73e-01 |
| GOBP NEGATIVE REGULATION OF JNK CASCADE | 31 | 2.80e-01 | -1.12e-01 | 6.17e-01 |
| GOBP REGULATION OF DNA REPAIR | 200 | 6.29e-03 | -1.12e-01 | 7.83e-02 |
| GOBP REGULATION OF CILIUM BEAT FREQUENCY | 12 | 5.01e-01 | 1.12e-01 | 7.88e-01 |
| GOMF PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 21 | 3.74e-01 | 1.12e-01 | 7.02e-01 |
| GOCC CKM COMPLEX | 5 | 6.64e-01 | -1.12e-01 | 8.73e-01 |
| GOBP RETINOL METABOLIC PROCESS | 25 | 3.32e-01 | 1.12e-01 | 6.67e-01 |
| GOBP CENTROMERE COMPLEX ASSEMBLY | 27 | 3.14e-01 | -1.12e-01 | 6.52e-01 |
| GOBP CILIUM MOVEMENT | 104 | 4.85e-02 | 1.12e-01 | 2.56e-01 |
| GOMF ACETYLTRANSFERASE ACTIVITY | 84 | 7.61e-02 | -1.12e-01 | 3.23e-01 |
| GOMF MISFOLDED PROTEIN BINDING | 19 | 3.99e-01 | 1.12e-01 | 7.22e-01 |
| GOBP REGULATION OF HEART RATE BY CHEMICAL SIGNAL | 5 | 6.65e-01 | -1.12e-01 | 8.74e-01 |
| GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE | 13 | 4.85e-01 | -1.12e-01 | 7.81e-01 |
| GOBP REGULATION OF PIGMENT CELL DIFFERENTIATION | 6 | 6.35e-01 | 1.12e-01 | 8.57e-01 |
| GOBP REGULATION OF AUTOPHAGOSOME ASSEMBLY | 44 | 2.00e-01 | -1.12e-01 | 5.21e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN | 12 | 5.03e-01 | -1.12e-01 | 7.88e-01 |
| GOBP POSITIVE REGULATION OF HEART GROWTH | 15 | 4.54e-01 | -1.12e-01 | 7.62e-01 |
| GOBP MEIOTIC SPINDLE ASSEMBLY | 11 | 5.21e-01 | 1.12e-01 | 7.99e-01 |
| GOCC APICAL PART OF CELL | 280 | 1.33e-03 | 1.12e-01 | 2.66e-02 |
| GOBP GASTRULATION WITH MOUTH FORMING SECOND | 17 | 4.26e-01 | -1.12e-01 | 7.43e-01 |
| GOMF DEAD H BOX RNA HELICASE BINDING | 7 | 6.09e-01 | -1.12e-01 | 8.46e-01 |
| GOCC BRUSH BORDER MEMBRANE | 35 | 2.54e-01 | 1.12e-01 | 5.88e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 15 | 4.55e-01 | 1.12e-01 | 7.62e-01 |
| GOBP PEPTIDYL TYROSINE MODIFICATION | 183 | 9.39e-03 | -1.11e-01 | 1.00e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN | 18 | 4.13e-01 | -1.11e-01 | 7.31e-01 |
| GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 9 | 5.63e-01 | 1.11e-01 | 8.26e-01 |
| GOBP DIENCEPHALON DEVELOPMENT | 29 | 2.99e-01 | -1.11e-01 | 6.37e-01 |
| GOBP REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS | 19 | 4.01e-01 | -1.11e-01 | 7.23e-01 |
| GOCC DENDRITE CYTOPLASM | 22 | 3.66e-01 | -1.11e-01 | 6.98e-01 |
| GOBP B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 72 | 1.03e-01 | -1.11e-01 | 3.75e-01 |
| GOCC MICROTUBULE END | 30 | 2.92e-01 | 1.11e-01 | 6.30e-01 |
| GOBP REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY | 60 | 1.36e-01 | -1.11e-01 | 4.33e-01 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER | 11 | 5.23e-01 | -1.11e-01 | 7.99e-01 |
| GOBP MEIOTIC SISTER CHROMATID COHESION | 13 | 4.87e-01 | -1.11e-01 | 7.81e-01 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE ACTIVITY | 290 | 1.16e-03 | -1.11e-01 | 2.43e-02 |
| GOCC CYTOPLASMIC EXOSOME RNASE COMPLEX | 15 | 4.56e-01 | 1.11e-01 | 7.62e-01 |
| GOBP SPINDLE ASSEMBLY INVOLVED IN FEMALE MEIOSIS | 8 | 5.87e-01 | 1.11e-01 | 8.35e-01 |
| GOBP MATURATION OF SSU RRNA | 50 | 1.75e-01 | 1.11e-01 | 4.90e-01 |
| GOBP REGULATION OF SPROUTING ANGIOGENESIS | 25 | 3.37e-01 | 1.11e-01 | 6.71e-01 |
| GOBP CGMP BIOSYNTHETIC PROCESS | 7 | 6.11e-01 | 1.11e-01 | 8.46e-01 |
| GOMF GUANYLATE CYCLASE ACTIVITY | 7 | 6.11e-01 | 1.11e-01 | 8.46e-01 |
| GOMF RNA METHYLTRANSFERASE ACTIVITY | 62 | 1.31e-01 | 1.11e-01 | 4.24e-01 |
| GOBP CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING | 31 | 2.85e-01 | 1.11e-01 | 6.23e-01 |
| GOBP RESPONSE TO ALKALOID | 63 | 1.28e-01 | -1.11e-01 | 4.20e-01 |
| GOBP GRANULOCYTE CHEMOTAXIS | 86 | 7.57e-02 | -1.11e-01 | 3.22e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 44 | 2.03e-01 | 1.11e-01 | 5.26e-01 |
| GOBP REGULATION OF MYOBLAST DIFFERENTIATION | 53 | 1.64e-01 | -1.11e-01 | 4.74e-01 |
| GOMF C4 DICARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 5.25e-01 | -1.11e-01 | 8.00e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 8 | 5.88e-01 | 1.11e-01 | 8.36e-01 |
| GOCC PHOTORECEPTOR INNER SEGMENT | 37 | 2.45e-01 | 1.10e-01 | 5.79e-01 |
| GOBP NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATION | 8 | 5.89e-01 | -1.10e-01 | 8.36e-01 |
| GOMF ANAPHASE PROMOTING COMPLEX BINDING | 8 | 5.89e-01 | -1.10e-01 | 8.36e-01 |
| GOBP MUSCLE CELL APOPTOTIC PROCESS | 53 | 1.65e-01 | -1.10e-01 | 4.75e-01 |
| GOMF VOLTAGE GATED CHLORIDE CHANNEL ACTIVITY | 7 | 6.13e-01 | 1.10e-01 | 8.47e-01 |
| GOBP OPTIC NERVE DEVELOPMENT | 12 | 5.08e-01 | 1.10e-01 | 7.91e-01 |
| GOBP REGULATION OF PROTEIN BINDING | 115 | 4.12e-02 | -1.10e-01 | 2.35e-01 |
| GOMF SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 188 | 9.19e-03 | 1.10e-01 | 9.90e-02 |
| GOCC PRESYNAPTIC ACTIVE ZONE CYTOPLASMIC COMPONENT | 12 | 5.08e-01 | -1.10e-01 | 7.91e-01 |
| GOMF SYMPORTER ACTIVITY | 90 | 7.07e-02 | 1.10e-01 | 3.09e-01 |
| GOBP CHLORIDE TRANSPORT | 61 | 1.36e-01 | 1.10e-01 | 4.34e-01 |
| GOBP PULMONARY VALVE MORPHOGENESIS | 11 | 5.27e-01 | -1.10e-01 | 8.01e-01 |
| GOCC TERTIARY GRANULE MEMBRANE | 61 | 1.37e-01 | -1.10e-01 | 4.34e-01 |
| GOBP LUTEINIZATION | 8 | 5.89e-01 | -1.10e-01 | 8.36e-01 |
| GOBP IMMATURE B CELL DIFFERENTIATION | 10 | 5.47e-01 | -1.10e-01 | 8.17e-01 |
| GOBP REGULATION OF HEART RATE BY CARDIAC CONDUCTION | 19 | 4.07e-01 | -1.10e-01 | 7.27e-01 |
| GOBP REGULATION OF KETONE BIOSYNTHETIC PROCESS | 15 | 4.61e-01 | -1.10e-01 | 7.64e-01 |
| GOBP CYTOPLASM ORGANIZATION | 12 | 5.10e-01 | -1.10e-01 | 7.92e-01 |
| GOBP DNA METABOLIC PROCESS | 895 | 3.09e-08 | -1.10e-01 | 4.98e-06 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 9 | 5.69e-01 | -1.10e-01 | 8.28e-01 |
| GOBP GMP BIOSYNTHETIC PROCESS | 13 | 4.93e-01 | 1.10e-01 | 7.84e-01 |
| GOBP POSITIVE REGULATION OF DNA RECOMBINATION | 65 | 1.27e-01 | -1.10e-01 | 4.17e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 13 | 4.94e-01 | -1.10e-01 | 7.84e-01 |
| GOBP INTERLEUKIN 8 PRODUCTION | 59 | 1.45e-01 | -1.10e-01 | 4.45e-01 |
| GOBP INSULIN METABOLIC PROCESS | 11 | 5.29e-01 | 1.10e-01 | 8.03e-01 |
| GOBP POSITIVE REGULATION OF FOCAL ADHESION ASSEMBLY | 19 | 4.08e-01 | 1.10e-01 | 7.28e-01 |
| GOMF MINUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 13 | 4.94e-01 | 1.10e-01 | 7.84e-01 |
| GOBP COMPARTMENT PATTERN SPECIFICATION | 5 | 6.71e-01 | 1.10e-01 | 8.77e-01 |
| GOMF PHOSPHATIDYLINOSITOL 5 PHOSPHATE BINDING | 17 | 4.34e-01 | 1.10e-01 | 7.50e-01 |
| GOBP CARDIAC CHAMBER DEVELOPMENT | 104 | 5.38e-02 | -1.10e-01 | 2.67e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS | 100 | 5.86e-02 | 1.09e-01 | 2.79e-01 |
| GOBP CEREBELLAR GRANULAR LAYER DEVELOPMENT | 7 | 6.16e-01 | -1.09e-01 | 8.48e-01 |
| GOBP REGULATION OF CELL CYCLE CHECKPOINT | 44 | 2.09e-01 | -1.09e-01 | 5.33e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 13 | 4.95e-01 | -1.09e-01 | 7.85e-01 |
| GOMF DYSTROGLYCAN BINDING | 9 | 5.70e-01 | -1.09e-01 | 8.29e-01 |
| GOBP DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM | 28 | 3.17e-01 | -1.09e-01 | 6.56e-01 |
| GOMF POLYOL TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 6.17e-01 | 1.09e-01 | 8.49e-01 |
| GOBP ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 16 | 4.49e-01 | 1.09e-01 | 7.59e-01 |
| GOBP TELOMERE MAINTENANCE | 148 | 2.19e-02 | -1.09e-01 | 1.64e-01 |
| GOBP MEMBRANE BIOGENESIS | 54 | 1.65e-01 | 1.09e-01 | 4.76e-01 |
| GOBP NEGATIVE REGULATION OF TOR SIGNALING | 61 | 1.40e-01 | -1.09e-01 | 4.39e-01 |
| GOBP REGULATION OF DNA BIOSYNTHETIC PROCESS | 104 | 5.45e-02 | -1.09e-01 | 2.68e-01 |
| GOBP TYPE B PANCREATIC CELL PROLIFERATION | 16 | 4.50e-01 | -1.09e-01 | 7.59e-01 |
| GOBP POSITIVE REGULATION OF HYPERSENSITIVITY | 5 | 6.73e-01 | -1.09e-01 | 8.78e-01 |
| GOBP INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 67 | 1.23e-01 | -1.09e-01 | 4.11e-01 |
| GOBP NECROPTOTIC SIGNALING PATHWAY | 7 | 6.17e-01 | -1.09e-01 | 8.49e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 133 | 3.00e-02 | -1.09e-01 | 1.97e-01 |
| GOBP MYELOID CELL HOMEOSTASIS | 142 | 2.50e-02 | -1.09e-01 | 1.78e-01 |
| GOBP LEUKOCYTE MEDIATED IMMUNITY | 278 | 1.79e-03 | -1.09e-01 | 3.30e-02 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION | 43 | 2.16e-01 | -1.09e-01 | 5.42e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 773 | 2.92e-07 | -1.09e-01 | 3.56e-05 |
| GOBP RESPONSE TO MAGNESIUM ION | 10 | 5.51e-01 | 1.09e-01 | 8.19e-01 |
| GOBP T CELL PROLIFERATION | 158 | 1.82e-02 | -1.09e-01 | 1.49e-01 |
| GOBP OLIGOSACCHARIDE CATABOLIC PROCESS | 11 | 5.31e-01 | 1.09e-01 | 8.04e-01 |
| GOBP TRNA CATABOLIC PROCESS | 16 | 4.51e-01 | 1.09e-01 | 7.60e-01 |
| GOBP POSITIVE REGULATION OF CILIUM ASSEMBLY | 24 | 3.56e-01 | -1.09e-01 | 6.89e-01 |
| GOBP AMINO ACID BIOSYNTHETIC PROCESS | 56 | 1.59e-01 | 1.09e-01 | 4.65e-01 |
| GOCC CORNIFIED ENVELOPE | 17 | 4.37e-01 | 1.09e-01 | 7.51e-01 |
| GOBP PIGMENT CELL DIFFERENTIATION | 23 | 3.66e-01 | 1.09e-01 | 6.98e-01 |
| GOMF KINESIN BINDING | 35 | 2.65e-01 | 1.09e-01 | 6.02e-01 |
| GOBP POSITIVE REGULATION OF STEROL TRANSPORT | 28 | 3.19e-01 | -1.09e-01 | 6.59e-01 |
| GOBP INTRACILIARY TRANSPORT | 42 | 2.23e-01 | 1.09e-01 | 5.51e-01 |
| GOBP CELL CELL SIGNALING BY WNT | 312 | 9.84e-04 | -1.09e-01 | 2.19e-02 |
| GOBP SKELETAL MYOFIBRIL ASSEMBLY | 5 | 6.74e-01 | -1.09e-01 | 8.78e-01 |
| GOBP NEURONAL ACTION POTENTIAL | 18 | 4.25e-01 | 1.09e-01 | 7.43e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 52 | 1.76e-01 | -1.09e-01 | 4.91e-01 |
| GOMF AMINOACYLTRANSFERASE ACTIVITY | 392 | 2.34e-04 | -1.09e-01 | 7.32e-03 |
| GOBP COBALAMIN TRANSPORT | 5 | 6.74e-01 | -1.09e-01 | 8.78e-01 |
| GOBP NEUTROPHIL MIGRATION | 90 | 7.53e-02 | -1.09e-01 | 3.21e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS | 100 | 6.10e-02 | 1.09e-01 | 2.85e-01 |
| GOBP POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 54 | 1.68e-01 | -1.08e-01 | 4.81e-01 |
| GOBP QUINONE METABOLIC PROCESS | 31 | 2.96e-01 | 1.08e-01 | 6.34e-01 |
| GOMF PROTEIN ARGININE OMEGA N ASYMMETRIC METHYLTRANSFERASE ACTIVITY | 6 | 6.46e-01 | -1.08e-01 | 8.64e-01 |
| GOBP NEGATIVE REGULATION OF CIRCADIAN RHYTHM | 8 | 5.95e-01 | -1.08e-01 | 8.39e-01 |
| GOBP PURINE NUCLEOBASE METABOLIC PROCESS | 17 | 4.39e-01 | 1.08e-01 | 7.52e-01 |
| GOCC TELOMERASE HOLOENZYME COMPLEX | 20 | 4.02e-01 | -1.08e-01 | 7.23e-01 |
| GOBP REGULATION OF PROTEIN SECRETION | 168 | 1.55e-02 | 1.08e-01 | 1.38e-01 |
| GOBP NEGATIVE REGULATION OF CELL CELL ADHESION | 135 | 2.99e-02 | -1.08e-01 | 1.97e-01 |
| GOBP RIBOSOME ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 7 | 6.20e-01 | 1.08e-01 | 8.49e-01 |
| GOMF 3 HYDROXYACYL COA DEHYDRATASE ACTIVITY | 7 | 6.20e-01 | 1.08e-01 | 8.49e-01 |
| GOMF PEPTIDE BINDING | 210 | 6.96e-03 | -1.08e-01 | 8.30e-02 |
| GOBP REGULATION OF B CELL ACTIVATION | 104 | 5.68e-02 | -1.08e-01 | 2.74e-01 |
| GOBP MYOSIN FILAMENT ORGANIZATION | 5 | 6.75e-01 | -1.08e-01 | 8.79e-01 |
| GOCC CILIARY TRANSITION ZONE | 61 | 1.44e-01 | 1.08e-01 | 4.45e-01 |
| GOMF NEUREXIN FAMILY PROTEIN BINDING | 10 | 5.54e-01 | -1.08e-01 | 8.20e-01 |
| GOBP FOLIC ACID CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 7 | 6.20e-01 | -1.08e-01 | 8.50e-01 |
| GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC MEMBRANE | 6 | 6.47e-01 | 1.08e-01 | 8.64e-01 |
| GOBP MULTIVESICULAR BODY SORTING PATHWAY | 44 | 2.15e-01 | 1.08e-01 | 5.41e-01 |
| GOCC MYELIN SHEATH | 33 | 2.83e-01 | 1.08e-01 | 6.21e-01 |
| GOBP NEGATIVE REGULATION OF WOUND HEALING | 40 | 2.37e-01 | 1.08e-01 | 5.69e-01 |
| GOBP EMBRYONIC BRAIN DEVELOPMENT | 13 | 5.00e-01 | -1.08e-01 | 7.88e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 21 | 3.92e-01 | -1.08e-01 | 7.17e-01 |
| GOBP REGULATION OF DNA METABOLIC PROCESS | 449 | 9.28e-05 | -1.08e-01 | 3.63e-03 |
| GOBP DNA REPAIR DEPENDENT CHROMATIN REMODELING | 20 | 4.04e-01 | -1.08e-01 | 7.25e-01 |
| GOMF ATPASE INHIBITOR ACTIVITY | 5 | 6.76e-01 | 1.08e-01 | 8.79e-01 |
| GOCC INTERCALATED DISC | 38 | 2.50e-01 | 1.08e-01 | 5.84e-01 |
| GOCC INTEGRATOR COMPLEX | 16 | 4.55e-01 | -1.08e-01 | 7.62e-01 |
| GOBP SODIUM DEPENDENT PHOSPHATE TRANSPORT | 5 | 6.77e-01 | -1.08e-01 | 8.79e-01 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS | 17 | 4.42e-01 | -1.08e-01 | 7.54e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR DIVISION | 56 | 1.64e-01 | -1.08e-01 | 4.74e-01 |
| GOBP REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 84 | 8.84e-02 | -1.08e-01 | 3.47e-01 |
| GOBP CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS | 15 | 4.71e-01 | -1.07e-01 | 7.71e-01 |
| GOBP DENDRITIC CELL CYTOKINE PRODUCTION | 15 | 4.71e-01 | -1.07e-01 | 7.71e-01 |
| GOBP CELLULAR RESPONSE TO EXTERNAL STIMULUS | 279 | 2.05e-03 | -1.07e-01 | 3.63e-02 |
| GOMF ISOMERASE ACTIVITY | 141 | 2.78e-02 | 1.07e-01 | 1.89e-01 |
| GOCC BOX C D RNP COMPLEX | 5 | 6.77e-01 | -1.07e-01 | 8.79e-01 |
| GOMF PHOSPHATIDYLINOSITOL MONOPHOSPHATE PHOSPHATASE ACTIVITY | 14 | 4.87e-01 | -1.07e-01 | 7.81e-01 |
| GOBP RNA TEMPLATED DNA BIOSYNTHETIC PROCESS | 65 | 1.35e-01 | -1.07e-01 | 4.31e-01 |
| GOBP PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS | 116 | 4.65e-02 | -1.07e-01 | 2.51e-01 |
| GOMF CYTOSKELETAL MOTOR ACTIVITY | 79 | 1.00e-01 | 1.07e-01 | 3.71e-01 |
| GOCC CORE MEDIATOR COMPLEX | 26 | 3.45e-01 | -1.07e-01 | 6.81e-01 |
| GOBP SENSORY PERCEPTION OF BITTER TASTE | 6 | 6.50e-01 | -1.07e-01 | 8.66e-01 |
| GOBP HEPARIN BIOSYNTHETIC PROCESS | 8 | 6.00e-01 | 1.07e-01 | 8.40e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOSE IMPORT | 9 | 5.78e-01 | -1.07e-01 | 8.32e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF PROTEIN | 20 | 4.08e-01 | -1.07e-01 | 7.27e-01 |
| GOBP PYRAMIDAL NEURON DIFFERENTIATION | 9 | 5.79e-01 | -1.07e-01 | 8.32e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CYTOKINESIS | 8 | 6.01e-01 | 1.07e-01 | 8.40e-01 |
| GOBP NEGATIVE REGULATION OF ENDOCYTOSIS | 55 | 1.71e-01 | -1.07e-01 | 4.84e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 13 | 5.05e-01 | 1.07e-01 | 7.89e-01 |
| GOBP ER OVERLOAD RESPONSE | 11 | 5.40e-01 | 1.07e-01 | 8.11e-01 |
| GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 242 | 4.28e-03 | -1.07e-01 | 6.07e-02 |
| GOBP CHONDROCYTE PROLIFERATION | 9 | 5.79e-01 | 1.07e-01 | 8.32e-01 |
| GOBP MESENCHYMAL STEM CELL DIFFERENTIATION | 9 | 5.79e-01 | 1.07e-01 | 8.32e-01 |
| GOBP HOMOLOGOUS RECOMBINATION | 53 | 1.79e-01 | -1.07e-01 | 4.94e-01 |
| GOBP PROTEIN TETRAMERIZATION | 71 | 1.20e-01 | -1.07e-01 | 4.06e-01 |
| GOMF UNFOLDED PROTEIN BINDING | 99 | 6.69e-02 | 1.07e-01 | 2.99e-01 |
| GOMF DYNACTIN BINDING | 12 | 5.22e-01 | -1.07e-01 | 7.99e-01 |
| GOBP RESPONSE TO LIGHT STIMULUS | 236 | 4.85e-03 | -1.07e-01 | 6.61e-02 |
| GOBP ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS | 228 | 5.62e-03 | -1.07e-01 | 7.37e-02 |
| GOBP POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 30 | 3.12e-01 | -1.07e-01 | 6.51e-01 |
| GOBP REGULATION OF PROTEIN POLYUBIQUITINATION | 24 | 3.66e-01 | 1.07e-01 | 6.98e-01 |
| GOBP POSITIVE REGULATION OF VASCULOGENESIS | 8 | 6.02e-01 | 1.06e-01 | 8.41e-01 |
| GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 13 | 5.07e-01 | 1.06e-01 | 7.90e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL PROCESS | 21 | 3.99e-01 | -1.06e-01 | 7.22e-01 |
| GOBP POSITIVE REGULATION OF GLUCONEOGENESIS | 16 | 4.61e-01 | -1.06e-01 | 7.64e-01 |
| GOBP POSITIVE REGULATION OF STEROID METABOLIC PROCESS | 17 | 4.48e-01 | -1.06e-01 | 7.57e-01 |
| GOBP REGULATION OF MAP KINASE ACTIVITY | 103 | 6.23e-02 | -1.06e-01 | 2.88e-01 |
| GOBP PEPTIDYL LYSINE DEACETYLATION | 7 | 6.26e-01 | -1.06e-01 | 8.53e-01 |
| GOBP AMINO ACID NEUROTRANSMITTER REUPTAKE | 5 | 6.81e-01 | 1.06e-01 | 8.81e-01 |
| GOBP CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS | 521 | 3.51e-05 | 1.06e-01 | 1.69e-03 |
| GOBP AMINO ACID SALVAGE | 5 | 6.81e-01 | -1.06e-01 | 8.81e-01 |
| GOBP L METHIONINE SALVAGE FROM METHYLTHIOADENOSINE | 5 | 6.81e-01 | -1.06e-01 | 8.81e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFERASE ACTIVITY | 183 | 1.33e-02 | -1.06e-01 | 1.24e-01 |
| GOBP PEPTIDYL ARGININE MODIFICATION | 8 | 6.03e-01 | -1.06e-01 | 8.42e-01 |
| GOBP PHASIC SMOOTH MUSCLE CONTRACTION | 5 | 6.81e-01 | 1.06e-01 | 8.81e-01 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 16 | 4.62e-01 | -1.06e-01 | 7.65e-01 |
| GOBP NEURON RECOGNITION | 25 | 3.58e-01 | -1.06e-01 | 6.91e-01 |
| GOBP LEUKOTRIENE METABOLIC PROCESS | 16 | 4.62e-01 | -1.06e-01 | 7.65e-01 |
| GOMF TAP BINDING | 7 | 6.27e-01 | 1.06e-01 | 8.53e-01 |
| GOBP REGULATION OF PROTEIN DEUBIQUITINATION | 10 | 5.61e-01 | -1.06e-01 | 8.26e-01 |
| GOMF LIPID KINASE ACTIVITY | 36 | 2.71e-01 | -1.06e-01 | 6.08e-01 |
| GOBP CITRULLINE METABOLIC PROCESS | 5 | 6.81e-01 | 1.06e-01 | 8.82e-01 |
| GOBP MYOBLAST DIFFERENTIATION | 80 | 1.01e-01 | -1.06e-01 | 3.73e-01 |
| GOBP VIRAL LIFE CYCLE | 268 | 2.87e-03 | -1.06e-01 | 4.67e-02 |
| GOBP HEPATOCYTE APOPTOTIC PROCESS | 18 | 4.36e-01 | 1.06e-01 | 7.51e-01 |
| GOBP ALCOHOL BIOSYNTHETIC PROCESS | 99 | 6.86e-02 | 1.06e-01 | 3.03e-01 |
| GOBP GENERATION OF PRECURSOR METABOLITES AND ENERGY | 418 | 2.10e-04 | 1.06e-01 | 6.84e-03 |
| GOBP POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 439 | 1.47e-04 | -1.06e-01 | 5.17e-03 |
| GOBP REGULATION OF P38MAPK CASCADE | 38 | 2.58e-01 | -1.06e-01 | 5.94e-01 |
| GOMF SMAD BINDING | 63 | 1.46e-01 | -1.06e-01 | 4.47e-01 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REGULATOR COMPLEX | 208 | 8.54e-03 | -1.06e-01 | 9.42e-02 |
| GOBP VASCULOGENESIS | 51 | 1.91e-01 | -1.06e-01 | 5.10e-01 |
| GOCC GOLGI MEDIAL CISTERNA | 11 | 5.43e-01 | 1.06e-01 | 8.14e-01 |
| GOMF MANGANESE ION BINDING | 56 | 1.71e-01 | -1.06e-01 | 4.84e-01 |
| GOBP REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 33 | 2.93e-01 | -1.06e-01 | 6.31e-01 |
| GOBP DENDRITIC TRANSPORT | 10 | 5.62e-01 | -1.06e-01 | 8.26e-01 |
| GOCC MRNA CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR COMPLEX | 14 | 4.93e-01 | -1.06e-01 | 7.84e-01 |
| GOBP CELLULAR HYPEROSMOTIC RESPONSE | 15 | 4.78e-01 | -1.06e-01 | 7.75e-01 |
| GOCC EXORIBONUCLEASE COMPLEX | 19 | 4.25e-01 | 1.06e-01 | 7.43e-01 |
| GOBP FOREBRAIN REGIONALIZATION | 6 | 6.54e-01 | -1.06e-01 | 8.68e-01 |
| GOBP MITOTIC CYTOKINETIC PROCESS | 25 | 3.60e-01 | 1.06e-01 | 6.93e-01 |
| GOBP SULFUR COMPOUND METABOLIC PROCESS | 237 | 5.19e-03 | 1.06e-01 | 6.96e-02 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL | 74 | 1.17e-01 | -1.06e-01 | 4.01e-01 |
| GOMF ANTIPORTER ACTIVITY | 99 | 7.00e-02 | 1.05e-01 | 3.07e-01 |
| GOMF PHOSPHORIC DIESTER HYDROLASE ACTIVITY | 61 | 1.55e-01 | -1.05e-01 | 4.59e-01 |
| GOBP NADH OXIDATION | 5 | 6.83e-01 | -1.05e-01 | 8.83e-01 |
| GOBP RESPONSE TO GRAVITY | 5 | 6.83e-01 | -1.05e-01 | 8.83e-01 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 715 | 1.80e-06 | -1.05e-01 | 1.48e-04 |
| GOBP VESICLE CYTOSKELETAL TRAFFICKING | 60 | 1.59e-01 | 1.05e-01 | 4.65e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 5 | 6.84e-01 | 1.05e-01 | 8.83e-01 |
| GOBP NEGATIVE REGULATION OF BONE MINERALIZATION | 12 | 5.28e-01 | 1.05e-01 | 8.02e-01 |
| GOBP REPRODUCTIVE BEHAVIOR | 19 | 4.27e-01 | -1.05e-01 | 7.44e-01 |
| GOBP REGULATION OF GTP BINDING | 8 | 6.07e-01 | -1.05e-01 | 8.45e-01 |
| GOMF GLYCOSPHINGOLIPID BINDING | 6 | 6.56e-01 | 1.05e-01 | 8.70e-01 |
| GOBP IRON COORDINATION ENTITY TRANSPORT | 9 | 5.85e-01 | 1.05e-01 | 8.35e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE | 216 | 7.94e-03 | -1.05e-01 | 8.99e-02 |
| GOMF TRANSMEMBRANE TRANSPORTER BINDING | 97 | 7.43e-02 | 1.05e-01 | 3.19e-01 |
| GOBP RESPONSE TO MONOSACCHARIDE | 134 | 3.62e-02 | -1.05e-01 | 2.20e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN BINDING | 62 | 1.53e-01 | -1.05e-01 | 4.58e-01 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 21 | 4.06e-01 | -1.05e-01 | 7.27e-01 |
| GOBP MITOTIC CELL CYCLE CHECKPOINT SIGNALING | 135 | 3.57e-02 | -1.05e-01 | 2.20e-01 |
| GOBP POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 266 | 3.32e-03 | -1.05e-01 | 5.10e-02 |
| GOBP PROTEIN IMPORT | 6 | 6.57e-01 | -1.05e-01 | 8.70e-01 |
| GOBP HYPOTHALAMUS CELL MIGRATION | 5 | 6.85e-01 | 1.05e-01 | 8.84e-01 |
| GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 13 | 5.14e-01 | 1.05e-01 | 7.94e-01 |
| GOBP MITOTIC METAPHASE CHROMOSOME ALIGNMENT | 57 | 1.72e-01 | -1.05e-01 | 4.86e-01 |
| GOBP NEURAL TUBE DEVELOPMENT | 125 | 4.36e-02 | -1.05e-01 | 2.42e-01 |
| GOMF RNA POLYMERASE III TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 9 | 5.87e-01 | 1.05e-01 | 8.35e-01 |
| GOBP AXIS SPECIFICATION | 50 | 2.01e-01 | -1.05e-01 | 5.23e-01 |
| GOBP ORGANOPHOSPHATE CATABOLIC PROCESS | 118 | 5.01e-02 | 1.05e-01 | 2.60e-01 |
| GOCC SPINDLE POLE | 160 | 2.27e-02 | -1.04e-01 | 1.68e-01 |
| GOBP MACROPINOCYTOSIS | 10 | 5.67e-01 | 1.04e-01 | 8.28e-01 |
| GOMF RNA POLYMERASE ACTIVITY | 31 | 3.14e-01 | 1.04e-01 | 6.53e-01 |
| GOCC RNA POLYMERASE II HOLOENZYME | 69 | 1.34e-01 | 1.04e-01 | 4.29e-01 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REPRESSOR COMPLEX | 13 | 5.15e-01 | -1.04e-01 | 7.95e-01 |
| GOCC SUMO LIGASE COMPLEX | 13 | 5.15e-01 | -1.04e-01 | 7.95e-01 |
| GOBP REGULATION OF FEAR RESPONSE | 7 | 6.33e-01 | -1.04e-01 | 8.57e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 10 | 5.68e-01 | -1.04e-01 | 8.28e-01 |
| GOBP BASEMENT MEMBRANE ORGANIZATION | 26 | 3.58e-01 | 1.04e-01 | 6.90e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 7 | 6.33e-01 | -1.04e-01 | 8.57e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 10 | 5.69e-01 | -1.04e-01 | 8.28e-01 |
| GOBP REGULATION OF FOCAL ADHESION DISASSEMBLY | 6 | 6.59e-01 | 1.04e-01 | 8.71e-01 |
| GOBP REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 13 | 5.16e-01 | -1.04e-01 | 7.95e-01 |
| GOBP DNA DAMAGE RESPONSE | 802 | 6.30e-07 | -1.04e-01 | 6.36e-05 |
| GOCC CALCIUM CHANNEL COMPLEX | 46 | 2.22e-01 | 1.04e-01 | 5.51e-01 |
| GOBP PHAGOSOME LYSOSOME FUSION | 13 | 5.16e-01 | 1.04e-01 | 7.95e-01 |
| GOBP INTERLEUKIN 12 MEDIATED SIGNALING PATHWAY | 7 | 6.34e-01 | -1.04e-01 | 8.57e-01 |
| GOMF PROTEIN KINASE A BINDING | 42 | 2.44e-01 | -1.04e-01 | 5.78e-01 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 57 | 1.75e-01 | -1.04e-01 | 4.90e-01 |
| GOBP NEPHRON EPITHELIUM DEVELOPMENT | 56 | 1.79e-01 | 1.04e-01 | 4.94e-01 |
| GOBP CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 10 | 5.70e-01 | 1.04e-01 | 8.29e-01 |
| GOCC MICROVILLUS MEMBRANE | 21 | 4.10e-01 | 1.04e-01 | 7.29e-01 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 17 | 4.59e-01 | -1.04e-01 | 7.64e-01 |
| GOBP REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 20 | 4.22e-01 | 1.04e-01 | 7.40e-01 |
| GOBP REGULATION OF DNA DIRECTED DNA POLYMERASE ACTIVITY | 9 | 5.90e-01 | -1.04e-01 | 8.36e-01 |
| GOBP SINGLE STRAND BREAK REPAIR | 10 | 5.70e-01 | -1.04e-01 | 8.29e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 123 | 4.72e-02 | -1.04e-01 | 2.53e-01 |
| GOBP PROTOPORPHYRINOGEN IX METABOLIC PROCESS | 10 | 5.70e-01 | 1.04e-01 | 8.29e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS | 35 | 2.89e-01 | -1.04e-01 | 6.28e-01 |
| GOBP EPITHELIAL CELL MATURATION | 15 | 4.88e-01 | 1.04e-01 | 7.81e-01 |
| GOCC ORGANELLE MEMBRANE CONTACT SITE | 46 | 2.25e-01 | 1.03e-01 | 5.53e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 9 | 5.91e-01 | -1.03e-01 | 8.37e-01 |
| GOBP OLEFINIC COMPOUND BIOSYNTHETIC PROCESS | 15 | 4.88e-01 | -1.03e-01 | 7.81e-01 |
| GOBP RESPONSE TO FOOD | 20 | 4.24e-01 | -1.03e-01 | 7.42e-01 |
| GOBP AMINO ACID BETAINE TRANSPORT | 11 | 5.53e-01 | 1.03e-01 | 8.19e-01 |
| GOBP REGULATION OF ISOTYPE SWITCHING | 35 | 2.91e-01 | -1.03e-01 | 6.30e-01 |
| GOBP PHOSPHATIDIC ACID METABOLIC PROCESS | 30 | 3.28e-01 | 1.03e-01 | 6.65e-01 |
| GOCC ORIGIN RECOGNITION COMPLEX | 9 | 5.92e-01 | -1.03e-01 | 8.38e-01 |
| GOBP RIBONUCLEOTIDE CATABOLIC PROCESS | 43 | 2.42e-01 | 1.03e-01 | 5.76e-01 |
| GOBP GLYCOSYLATION | 174 | 1.92e-02 | 1.03e-01 | 1.53e-01 |
| GOCC CARBOXY TERMINAL DOMAIN PROTEIN KINASE COMPLEX | 18 | 4.49e-01 | -1.03e-01 | 7.59e-01 |
| GOBP RESPONSE TO VITAMIN D | 24 | 3.83e-01 | -1.03e-01 | 7.10e-01 |
| GOBP CELLULAR RESPONSE TO ACID CHEMICAL | 67 | 1.45e-01 | -1.03e-01 | 4.45e-01 |
| GOBP REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 15 | 4.90e-01 | -1.03e-01 | 7.83e-01 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 112 | 6.03e-02 | 1.03e-01 | 2.84e-01 |
| GOBP REGULATION OF NEURON PROJECTION REGENERATION | 21 | 4.15e-01 | -1.03e-01 | 7.33e-01 |
| GOBP OXALATE TRANSPORT | 9 | 5.93e-01 | 1.03e-01 | 8.38e-01 |
| GOBP CELL ACTIVATION | 792 | 1.00e-06 | -1.03e-01 | 9.39e-05 |
| GOBP NEGATIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 8 | 6.15e-01 | 1.03e-01 | 8.48e-01 |
| GOMF PROTEIN DOMAIN SPECIFIC BINDING | 512 | 7.32e-05 | -1.03e-01 | 3.08e-03 |
| GOBP METAPHASE CHROMOSOME ALIGNMENT | 92 | 8.88e-02 | -1.03e-01 | 3.48e-01 |
| GOBP DNA BIOSYNTHETIC PROCESS | 164 | 2.34e-02 | -1.03e-01 | 1.72e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 21 | 4.15e-01 | -1.03e-01 | 7.33e-01 |
| GOMF DNA CLAMP LOADER ACTIVITY | 9 | 5.94e-01 | -1.03e-01 | 8.38e-01 |
| GOBP RESPONSE TO HORMONE | 587 | 2.32e-05 | -1.03e-01 | 1.23e-03 |
| GOMF EXTRACELLULAR MATRIX BINDING | 25 | 3.74e-01 | 1.03e-01 | 7.02e-01 |
| GOBP REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 218 | 9.12e-03 | -1.03e-01 | 9.86e-02 |
| GOBP NEGATIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION | 6 | 6.64e-01 | -1.03e-01 | 8.73e-01 |
| GOBP REGULATION OF MUSCLE CELL DIFFERENTIATION | 97 | 8.11e-02 | -1.03e-01 | 3.35e-01 |
| GOBP POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 21 | 4.16e-01 | 1.03e-01 | 7.34e-01 |
| GOBP RESPONSE TO ENDOGENOUS STIMULUS | 1143 | 6.80e-09 | -1.02e-01 | 1.37e-06 |
| GOMF ALDEHYDE DEHYDROGENASE NAD P PLUS ACTIVITY | 13 | 5.22e-01 | 1.02e-01 | 7.99e-01 |
| GOMF NUCLEAR STEROID RECEPTOR ACTIVITY | 17 | 4.65e-01 | -1.02e-01 | 7.66e-01 |
| GOBP MALE GENITALIA DEVELOPMENT | 10 | 5.75e-01 | 1.02e-01 | 8.31e-01 |
| GOBP REGULATION OF IRON ION TRANSPORT | 6 | 6.64e-01 | 1.02e-01 | 8.73e-01 |
| GOBP TELOMERE ORGANIZATION | 153 | 2.90e-02 | -1.02e-01 | 1.94e-01 |
| GOBP REGULATION OF B CELL MEDIATED IMMUNITY | 52 | 2.02e-01 | -1.02e-01 | 5.24e-01 |
| GOBP POSITIVE REGULATION OF MICROGLIAL CELL ACTIVATION | 7 | 6.39e-01 | -1.02e-01 | 8.59e-01 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT | 7 | 6.40e-01 | 1.02e-01 | 8.60e-01 |
| GOBP REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 94 | 8.71e-02 | -1.02e-01 | 3.45e-01 |
| GOBP AXON GUIDANCE | 121 | 5.25e-02 | -1.02e-01 | 2.65e-01 |
| GOBP RETINA MORPHOGENESIS IN CAMERA TYPE EYE | 34 | 3.03e-01 | -1.02e-01 | 6.42e-01 |
| GOMF CYCLOSPORIN A BINDING | 17 | 4.66e-01 | -1.02e-01 | 7.67e-01 |
| GOBP EXCITATORY SYNAPSE ASSEMBLY | 21 | 4.18e-01 | -1.02e-01 | 7.37e-01 |
| GOBP TELOMERASE RNA LOCALIZATION | 19 | 4.42e-01 | 1.02e-01 | 7.53e-01 |
| GOBP REGULATION OF STEM CELL DIFFERENTIATION | 64 | 1.59e-01 | -1.02e-01 | 4.65e-01 |
| GOCC RIBONUCLEASE MRP COMPLEX | 10 | 5.77e-01 | 1.02e-01 | 8.32e-01 |
| GOBP CELL MIGRATION IN HINDBRAIN | 10 | 5.77e-01 | -1.02e-01 | 8.32e-01 |
| GOCC PHOSPHOLIPID TRANSLOCATING ATPASE COMPLEX | 12 | 5.42e-01 | -1.02e-01 | 8.13e-01 |
| GOBP REGULATION OF VACUOLE ORGANIZATION | 53 | 2.00e-01 | -1.02e-01 | 5.22e-01 |
| GOBP STRIATUM DEVELOPMENT | 16 | 4.81e-01 | -1.02e-01 | 7.78e-01 |
| GOBP SUBPALLIUM DEVELOPMENT | 16 | 4.81e-01 | -1.02e-01 | 7.78e-01 |
| GOBP GROOMING BEHAVIOR | 6 | 6.66e-01 | 1.02e-01 | 8.75e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 32 | 3.20e-01 | -1.02e-01 | 6.59e-01 |
| GOBP NEGATIVE REGULATION OF LIPID STORAGE | 18 | 4.56e-01 | 1.02e-01 | 7.62e-01 |
| GOBP REGULATION OF BROWN FAT CELL DIFFERENTIATION | 18 | 4.56e-01 | -1.02e-01 | 7.62e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CONTRACTION | 17 | 4.69e-01 | -1.02e-01 | 7.68e-01 |
| GOCC METHYLTRANSFERASE COMPLEX | 93 | 9.09e-02 | -1.02e-01 | 3.53e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 51 | 2.10e-01 | -1.01e-01 | 5.34e-01 |
| GOBP PROTEIN LOCALIZATION TO BASOLATERAL PLASMA MEMBRANE | 6 | 6.67e-01 | 1.01e-01 | 8.75e-01 |
| GOBP RESPONSE TO GROWTH FACTOR | 469 | 1.75e-04 | -1.01e-01 | 5.90e-03 |
| GOMF HORMONE BINDING | 42 | 2.56e-01 | -1.01e-01 | 5.91e-01 |
| GOMF NAD P H OXIDASE H2O2 FORMING ACTIVITY | 7 | 6.42e-01 | 1.01e-01 | 8.61e-01 |
| GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 25 | 3.80e-01 | 1.01e-01 | 7.07e-01 |
| GOMF METAL CATION MONOATOMIC CATION ANTIPORTER ACTIVITY | 26 | 3.71e-01 | 1.01e-01 | 7.00e-01 |
| GOBP POSITIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 55 | 1.94e-01 | -1.01e-01 | 5.12e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 13 | 5.27e-01 | 1.01e-01 | 8.02e-01 |
| GOMF UDP GLUCOSYLTRANSFERASE ACTIVITY | 8 | 6.20e-01 | 1.01e-01 | 8.49e-01 |
| GOBP CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS | 10 | 5.79e-01 | 1.01e-01 | 8.32e-01 |
| GOCC MRNA CAP BINDING COMPLEX | 12 | 5.43e-01 | 1.01e-01 | 8.14e-01 |
| GOBP AIM2 INFLAMMASOME COMPLEX ASSEMBLY | 5 | 6.95e-01 | 1.01e-01 | 8.88e-01 |
| GOCC LATE ENDOSOME MEMBRANE | 151 | 3.18e-02 | 1.01e-01 | 2.05e-01 |
| GOBP HYPOTHALAMUS CELL DIFFERENTIATION | 6 | 6.67e-01 | 1.01e-01 | 8.75e-01 |
| GOBP HYPOTHALAMUS GONADOTROPHIN RELEASING HORMONE NEURON DIFFERENTIATION | 6 | 6.67e-01 | 1.01e-01 | 8.75e-01 |
| GOBP FATTY ACID BETA OXIDATION | 65 | 1.58e-01 | 1.01e-01 | 4.65e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT | 5 | 6.95e-01 | 1.01e-01 | 8.88e-01 |
| GOMF STEROID DEHYDROGENASE ACTIVITY | 27 | 3.63e-01 | 1.01e-01 | 6.95e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 9 | 5.99e-01 | -1.01e-01 | 8.40e-01 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 9 | 5.99e-01 | -1.01e-01 | 8.40e-01 |
| GOBP SCHWANN CELL MIGRATION | 5 | 6.95e-01 | -1.01e-01 | 8.88e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE | 100 | 8.09e-02 | -1.01e-01 | 3.35e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHORYLATION | 250 | 6.02e-03 | -1.01e-01 | 7.66e-02 |
| GOBP NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 48 | 2.27e-01 | -1.01e-01 | 5.55e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE ADAPTATION | 5 | 6.96e-01 | -1.01e-01 | 8.88e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE ADAPTATION | 5 | 6.96e-01 | -1.01e-01 | 8.88e-01 |
| GOBP T CELL ACTIVATION | 407 | 4.97e-04 | -1.01e-01 | 1.31e-02 |
| GOCC OUTER MEMBRANE | 213 | 1.14e-02 | 1.01e-01 | 1.13e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 10 | 5.81e-01 | -1.01e-01 | 8.32e-01 |
| GOBP TRICARBOXYLIC ACID CYCLE | 29 | 3.48e-01 | -1.01e-01 | 6.83e-01 |
| GOBP SYNAPTIC VESICLE ENDOSOMAL PROCESSING | 9 | 6.01e-01 | 1.01e-01 | 8.40e-01 |
| GOBP REGULATION OF CELL DIFFERENTIATION | 1024 | 6.29e-08 | -1.01e-01 | 9.32e-06 |
| GOMF PHOSPHOLIPASE ACTIVATOR ACTIVITY | 14 | 5.14e-01 | 1.01e-01 | 7.95e-01 |
| GOBP REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 918 | 2.79e-07 | -1.01e-01 | 3.45e-05 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 14 | 5.15e-01 | 1.01e-01 | 7.95e-01 |
| GOMF OLIGOSACCHARYL TRANSFERASE ACTIVITY | 6 | 6.70e-01 | 1.01e-01 | 8.77e-01 |
| GOMF KINASE REGULATOR ACTIVITY | 210 | 1.22e-02 | -1.01e-01 | 1.17e-01 |
| GOBP MUSCLE CELL PROLIFERATION | 133 | 4.56e-02 | -1.00e-01 | 2.49e-01 |
| GOBP CYTOKINE MEDIATED SIGNALING PATHWAY | 340 | 1.50e-03 | -1.00e-01 | 2.90e-02 |
| GOMF NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 5.64e-01 | 1.00e-01 | 8.27e-01 |
| GOBP EMBRYONIC AXIS SPECIFICATION | 22 | 4.15e-01 | -1.00e-01 | 7.33e-01 |
| GOCC CELL CELL CONTACT ZONE | 55 | 1.98e-01 | 1.00e-01 | 5.19e-01 |
| GOBP COLLAGEN METABOLIC PROCESS | 61 | 1.75e-01 | -1.00e-01 | 4.91e-01 |
| GOMF EPIDERMAL GROWTH FACTOR RECEPTOR BINDING | 27 | 3.67e-01 | -1.00e-01 | 6.98e-01 |
| GOBP UDP GLUCOSE METABOLIC PROCESS | 6 | 6.71e-01 | 1.00e-01 | 8.77e-01 |
| GOBP ORGANIC ANION TRANSPORT | 270 | 4.66e-03 | 1.00e-01 | 6.44e-02 |
| GOBP NEUROBLAST DIVISION | 10 | 5.83e-01 | 1.00e-01 | 8.34e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEOPLASM | 14 | 5.16e-01 | 1.00e-01 | 7.95e-01 |
| GOBP VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS | 46 | 2.40e-01 | 1.00e-01 | 5.73e-01 |
| GOBP MODULATION BY HOST OF SYMBIONT PROCESS | 71 | 1.45e-01 | -1.00e-01 | 4.45e-01 |
| GOMF MAP KINASE KINASE ACTIVITY | 16 | 4.88e-01 | -1.00e-01 | 7.82e-01 |
| GOBP ORGANELLE MEMBRANE FUSION | 102 | 8.10e-02 | 1.00e-01 | 3.35e-01 |
| GOMF DIOXYGENASE ACTIVITY | 77 | 1.29e-01 | -1.00e-01 | 4.21e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRANSPORT | 5 | 6.99e-01 | -1.00e-01 | 8.89e-01 |
| GOMF ATPASE COUPLED TRANSMEMBRANE TRANSPORTER ACTIVITY | 72 | 1.43e-01 | 1.00e-01 | 4.43e-01 |
| GOBP CARDIAC CELL FATE COMMITMENT | 5 | 6.99e-01 | 9.99e-02 | 8.89e-01 |
| GOCC EPSILON DNA POLYMERASE COMPLEX | 5 | 6.99e-01 | -9.99e-02 | 8.89e-01 |
| GOMF PROTEIN PHOSPHATASE 1 BINDING | 20 | 4.39e-01 | 9.99e-02 | 7.52e-01 |
| GOCC TRANSCRIPTION PREINITIATION COMPLEX | 13 | 5.33e-01 | -9.98e-02 | 8.06e-01 |
| GOBP PROTEIN KINASE A SIGNALING | 23 | 4.08e-01 | 9.98e-02 | 7.27e-01 |
| GOBP REGULATION OF MYOBLAST PROLIFERATION | 8 | 6.25e-01 | -9.97e-02 | 8.52e-01 |
| GOBP GANGLIOSIDE METABOLIC PROCESS | 20 | 4.40e-01 | 9.97e-02 | 7.52e-01 |
| GOBP SYNAPTIC VESICLE TRANSPORT | 35 | 3.08e-01 | 9.96e-02 | 6.47e-01 |
| GOBP TYROSINE METABOLIC PROCESS | 9 | 6.05e-01 | 9.96e-02 | 8.43e-01 |
| GOBP PROTEIN METHYLATION | 70 | 1.50e-01 | -9.96e-02 | 4.53e-01 |
| GOMF TRNA METHYLTRANSFERASE ACTIVITY | 33 | 3.22e-01 | 9.96e-02 | 6.62e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 12 | 5.50e-01 | -9.96e-02 | 8.19e-01 |
| GOCC SMN SM PROTEIN COMPLEX | 17 | 4.77e-01 | 9.95e-02 | 7.75e-01 |
| GOBP PHOSPHATIDYLINOSITOL METABOLIC PROCESS | 135 | 4.61e-02 | -9.95e-02 | 2.50e-01 |
| GOMF L GLUTAMATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 5.86e-01 | -9.95e-02 | 8.35e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSPORT | 27 | 3.71e-01 | 9.95e-02 | 7.00e-01 |
| GOBP SMOOTH MUSCLE CELL CHEMOTAXIS | 7 | 6.49e-01 | -9.93e-02 | 8.65e-01 |
| GOBP MYOTUBE CELL DEVELOPMENT | 27 | 3.72e-01 | 9.93e-02 | 7.00e-01 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION | 52 | 2.16e-01 | -9.93e-02 | 5.42e-01 |
| GOBP NCRNA TRANSCRIPTION | 106 | 7.75e-02 | -9.93e-02 | 3.27e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 7 | 6.49e-01 | 9.93e-02 | 8.65e-01 |
| GOCC G PROTEIN COUPLED RECEPTOR COMPLEX | 8 | 6.27e-01 | -9.93e-02 | 8.53e-01 |
| GOBP REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 18 | 4.66e-01 | 9.93e-02 | 7.67e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 10 | 5.87e-01 | -9.92e-02 | 8.35e-01 |
| GOBP PROTEIN ACETYLATION | 90 | 1.04e-01 | -9.92e-02 | 3.78e-01 |
| GOCC MITOCHONDRIAL CRISTA | 6 | 6.74e-01 | -9.92e-02 | 8.78e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERSPECIES INTERACTION BETWEEN ORGANISMS | 1165 | 1.52e-08 | -9.92e-02 | 2.70e-06 |
| GOBP BLOOD VESSEL REMODELING | 25 | 3.91e-01 | 9.92e-02 | 7.16e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 874 | 7.60e-07 | -9.92e-02 | 7.26e-05 |
| GOBP REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 11 | 5.69e-01 | -9.91e-02 | 8.28e-01 |
| GOBP CEREBELLAR CORTEX DEVELOPMENT | 36 | 3.04e-01 | -9.91e-02 | 6.43e-01 |
| GOMF MAP KINASE TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 10 | 5.88e-01 | 9.90e-02 | 8.35e-01 |
| GOBP INTRACELLULAR PH REDUCTION | 49 | 2.31e-01 | 9.90e-02 | 5.61e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION | 255 | 6.57e-03 | -9.90e-02 | 7.96e-02 |
| GOBP HEMATOPOIETIC STEM CELL HOMEOSTASIS | 15 | 5.07e-01 | 9.90e-02 | 7.90e-01 |
| GOCC DYNEIN COMPLEX | 36 | 3.04e-01 | 9.90e-02 | 6.43e-01 |
| GOCC ASYMMETRIC GLUTAMATERGIC EXCITATORY SYNAPSE | 9 | 6.08e-01 | 9.89e-02 | 8.46e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY BY REGULATION OF PROTEIN PHOSPHORYLATION | 6 | 6.75e-01 | -9.88e-02 | 8.79e-01 |
| GOMF KINASE ACTIVITY | 614 | 3.14e-05 | -9.88e-02 | 1.54e-03 |
| GOBP NEGATIVE REGULATION OF AMIDE METABOLIC PROCESS | 193 | 1.81e-02 | -9.88e-02 | 1.49e-01 |
| GOBP PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING | 14 | 5.23e-01 | -9.87e-02 | 7.99e-01 |
| GOBP MITOTIC G2 DNA DAMAGE CHECKPOINT SIGNALING | 37 | 2.99e-01 | -9.87e-02 | 6.37e-01 |
| GOBP INTEGRIN MEDIATED SIGNALING PATHWAY | 90 | 1.06e-01 | -9.87e-02 | 3.81e-01 |
| GOBP PURINE NUCLEOBASE TRANSMEMBRANE TRANSPORT | 7 | 6.51e-01 | 9.87e-02 | 8.66e-01 |
| GOCC GEMINI OF COILED BODIES | 12 | 5.54e-01 | 9.86e-02 | 8.20e-01 |
| GOBP PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 8 | 6.29e-01 | 9.86e-02 | 8.55e-01 |
| GOMF MONOSACCHARIDE BINDING | 54 | 2.10e-01 | -9.86e-02 | 5.34e-01 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION | 21 | 4.34e-01 | 9.85e-02 | 7.50e-01 |
| GOCC ESCRT I COMPLEX | 10 | 5.90e-01 | -9.85e-02 | 8.36e-01 |
| GOBP CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION | 8 | 6.29e-01 | -9.85e-02 | 8.55e-01 |
| GOBP POST TRANSLATIONAL PROTEIN MODIFICATION | 932 | 4.14e-07 | -9.85e-02 | 4.60e-05 |
| GOMF E BOX BINDING | 27 | 3.76e-01 | -9.85e-02 | 7.04e-01 |
| GOMF GUANYLYLTRANSFERASE ACTIVITY | 7 | 6.52e-01 | -9.85e-02 | 8.67e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION | 359 | 1.39e-03 | -9.84e-02 | 2.74e-02 |
| GOBP REGULATION OF WOUND HEALING | 79 | 1.31e-01 | 9.84e-02 | 4.23e-01 |
| GOBP IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE | 50 | 2.29e-01 | -9.84e-02 | 5.58e-01 |
| GOBP MITOCHONDRIAL RNA MODIFICATION | 10 | 5.90e-01 | 9.84e-02 | 8.36e-01 |
| GOMF PRIMARY AMINE OXIDASE ACTIVITY | 5 | 7.03e-01 | -9.84e-02 | 8.91e-01 |
| GOBP NEGATIVE REGULATION OF STEROL TRANSPORT | 6 | 6.76e-01 | 9.84e-02 | 8.79e-01 |
| GOBP AXONEMAL DYNEIN COMPLEX ASSEMBLY | 15 | 5.10e-01 | 9.83e-02 | 7.92e-01 |
| GOBP POSITIVE REGULATION OF JNK CASCADE | 71 | 1.52e-01 | -9.83e-02 | 4.57e-01 |
| GOBP REGULATION OF HAIR CYCLE | 16 | 4.96e-01 | -9.83e-02 | 7.85e-01 |
| GOBP NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 74 | 1.44e-01 | -9.82e-02 | 4.45e-01 |
| GOBP TRABECULA MORPHOGENESIS | 32 | 3.37e-01 | -9.82e-02 | 6.71e-01 |
| GOBP CELL CELL ADHESION MEDIATED BY CADHERIN | 19 | 4.59e-01 | 9.82e-02 | 7.64e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR | 37 | 3.02e-01 | 9.81e-02 | 6.41e-01 |
| GOBP POSITIVE REGULATION OF HORMONE METABOLIC PROCESS | 9 | 6.10e-01 | -9.81e-02 | 8.46e-01 |
| GOBP POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 18 | 4.71e-01 | 9.81e-02 | 7.71e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID FIBRIL FORMATION | 5 | 7.04e-01 | -9.81e-02 | 8.92e-01 |
| GOBP REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 7 | 6.53e-01 | 9.80e-02 | 8.68e-01 |
| GOCC MICROTUBULE ORGANIZING CENTER ATTACHMENT SITE | 8 | 6.31e-01 | -9.80e-02 | 8.56e-01 |
| GOBP REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 19 | 4.60e-01 | -9.80e-02 | 7.64e-01 |
| GOBP DOPAMINE METABOLIC PROCESS | 21 | 4.37e-01 | 9.80e-02 | 7.51e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH SYMBIONT | 83 | 1.23e-01 | -9.79e-02 | 4.11e-01 |
| GOBP PROLINE TRANSMEMBRANE TRANSPORT | 7 | 6.54e-01 | -9.79e-02 | 8.68e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 67 | 1.66e-01 | 9.78e-02 | 4.78e-01 |
| GOBP POSITIVE REGULATION OF RESPIRATORY BURST | 5 | 7.05e-01 | -9.78e-02 | 8.93e-01 |
| GOBP HORMONE MEDIATED SIGNALING PATHWAY | 136 | 4.92e-02 | -9.78e-02 | 2.58e-01 |
| GOBP EPHRIN RECEPTOR SIGNALING PATHWAY | 33 | 3.32e-01 | -9.77e-02 | 6.67e-01 |
| GOBP SERTOLI CELL DEVELOPMENT | 11 | 5.75e-01 | -9.77e-02 | 8.31e-01 |
| GOMF GLYCEROPHOSPHOLIPID FLIPPASE ACTIVITY | 11 | 5.75e-01 | -9.77e-02 | 8.31e-01 |
| GOBP REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 48 | 2.42e-01 | -9.76e-02 | 5.75e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 11 | 5.76e-01 | -9.74e-02 | 8.31e-01 |
| GOBP HINDBRAIN MORPHOGENESIS | 31 | 3.48e-01 | -9.74e-02 | 6.83e-01 |
| GOBP TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 30 | 3.56e-01 | 9.73e-02 | 6.89e-01 |
| GOBP PHOSPHOLIPID TRANSLOCATION | 38 | 2.99e-01 | -9.73e-02 | 6.38e-01 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION | 231 | 1.11e-02 | -9.72e-02 | 1.11e-01 |
| GOBP RESPONSE TO NEMATODE | 5 | 7.07e-01 | -9.71e-02 | 8.94e-01 |
| GOBP POSITIVE REGULATION OF TOLERANCE INDUCTION | 9 | 6.14e-01 | -9.71e-02 | 8.48e-01 |
| GOBP FOREBRAIN MORPHOGENESIS | 7 | 6.56e-01 | -9.71e-02 | 8.70e-01 |
| GOBP PEPTIDYL SERINE MODIFICATION | 229 | 1.15e-02 | -9.71e-02 | 1.13e-01 |
| GOBP ENDOTHELIN RECEPTOR SIGNALING PATHWAY | 6 | 6.80e-01 | 9.71e-02 | 8.81e-01 |
| GOBP COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY | 7 | 6.56e-01 | 9.71e-02 | 8.70e-01 |
| GOCC HAUS COMPLEX | 8 | 6.34e-01 | -9.71e-02 | 8.57e-01 |
| GOBP TETRAHYDROFOLATE INTERCONVERSION | 9 | 6.14e-01 | 9.71e-02 | 8.48e-01 |
| GOBP PROTEIN K48 LINKED DEUBIQUITINATION | 25 | 4.01e-01 | -9.70e-02 | 7.23e-01 |
| GOCC GROWTH CONE MEMBRANE | 6 | 6.81e-01 | 9.70e-02 | 8.81e-01 |
| GOBP HEART VALVE FORMATION | 7 | 6.57e-01 | 9.70e-02 | 8.70e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 16 | 5.02e-01 | -9.69e-02 | 7.88e-01 |
| GOCC CILIUM | 502 | 2.12e-04 | 9.69e-02 | 6.87e-03 |
| GOBP NEUTROPHIL CHEMOTAXIS | 72 | 1.56e-01 | -9.69e-02 | 4.61e-01 |
| GOBP PROTEIN TARGETING TO MEMBRANE | 110 | 7.95e-02 | 9.68e-02 | 3.32e-01 |
| GOMF SEMAPHORIN RECEPTOR BINDING | 11 | 5.78e-01 | 9.68e-02 | 8.32e-01 |
| GOMF RACEMASE AND EPIMERASE ACTIVITY | 16 | 5.03e-01 | 9.67e-02 | 7.88e-01 |
| GOBP MITOTIC CELL CYCLE PHASE TRANSITION | 398 | 9.58e-04 | -9.67e-02 | 2.15e-02 |
| GOBP NEGATIVE REGULATION OF PEPTIDASE ACTIVITY | 77 | 1.43e-01 | -9.67e-02 | 4.43e-01 |
| GOBP REGULATION OF LYMPHOCYTE ACTIVATION | 374 | 1.37e-03 | -9.67e-02 | 2.70e-02 |
| GOBP T CELL RECEPTOR SIGNALING PATHWAY | 106 | 8.58e-02 | -9.66e-02 | 3.44e-01 |
| GOBP REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS | 14 | 5.31e-01 | -9.66e-02 | 8.04e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 16 | 5.04e-01 | -9.66e-02 | 7.89e-01 |
| GOBP REGULATION OF CHEMOTAXIS | 146 | 4.42e-02 | -9.66e-02 | 2.44e-01 |
| GOCC AMPHISOME MEMBRANE | 11 | 5.79e-01 | 9.65e-02 | 8.32e-01 |
| GOBP CENTROSOME SEPARATION | 13 | 5.47e-01 | 9.65e-02 | 8.17e-01 |
| GOBP REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 768 | 6.17e-06 | -9.64e-02 | 4.07e-04 |
| GOCC AP 1 ADAPTOR COMPLEX | 11 | 5.80e-01 | 9.63e-02 | 8.32e-01 |
| GOBP REGULATION OF FAT CELL DIFFERENTIATION | 87 | 1.21e-01 | -9.62e-02 | 4.07e-01 |
| GOBP POLYSACCHARIDE CATABOLIC PROCESS | 17 | 4.92e-01 | 9.62e-02 | 7.84e-01 |
| GOCC FLEMMING BODY | 32 | 3.47e-01 | -9.61e-02 | 6.82e-01 |
| GOBP POSITIVE REGULATION OF JUN KINASE ACTIVITY | 25 | 4.06e-01 | -9.61e-02 | 7.27e-01 |
| GOBP OVARIAN FOLLICLE DEVELOPMENT | 36 | 3.19e-01 | -9.60e-02 | 6.58e-01 |
| GOBP MODULATION BY SYMBIONT OF ENTRY INTO HOST | 41 | 2.87e-01 | -9.60e-02 | 6.26e-01 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY | 14 | 5.34e-01 | -9.60e-02 | 8.06e-01 |
| GOBP REGULATION OF CELL PROJECTION ASSEMBLY | 187 | 2.37e-02 | -9.60e-02 | 1.73e-01 |
| GOBP CHROMOSOME LOCALIZATION | 107 | 8.64e-02 | -9.60e-02 | 3.45e-01 |
| GOBP REGULATION OF LEUKOCYTE MIGRATION | 163 | 3.47e-02 | -9.60e-02 | 2.16e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYL OTHER THAN METHYL GROUPS | 52 | 2.31e-01 | 9.60e-02 | 5.63e-01 |
| GOBP GENITALIA DEVELOPMENT | 24 | 4.16e-01 | -9.59e-02 | 7.34e-01 |
| GOBP POSITIVE REGULATION OF PLATELET AGGREGATION | 7 | 6.60e-01 | 9.59e-02 | 8.72e-01 |
| GOCC CASPASE COMPLEX | 9 | 6.18e-01 | 9.59e-02 | 8.49e-01 |
| GOBP PEPTIDE CROSS LINKING | 8 | 6.39e-01 | 9.59e-02 | 8.59e-01 |
| GOBP ROOF OF MOUTH DEVELOPMENT | 52 | 2.32e-01 | -9.59e-02 | 5.63e-01 |
| GOBP REGULATION OF CELLULAR CATABOLIC PROCESS | 565 | 1.04e-04 | -9.59e-02 | 3.95e-03 |
| GOBP DOPAMINE BIOSYNTHETIC PROCESS | 7 | 6.61e-01 | 9.58e-02 | 8.72e-01 |
| GOBP RESPONSE TO CYTOKINE | 665 | 2.75e-05 | -9.58e-02 | 1.38e-03 |
| GOBP AMINO ACID METABOLIC PROCESS | 201 | 1.94e-02 | 9.58e-02 | 1.54e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 23 | 4.27e-01 | 9.58e-02 | 7.44e-01 |
| GOBP LYMPHOCYTE MEDIATED IMMUNITY | 206 | 1.80e-02 | -9.57e-02 | 1.49e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 9 | 6.19e-01 | 9.57e-02 | 8.49e-01 |
| GOMF BMP RECEPTOR ACTIVITY | 5 | 7.11e-01 | 9.57e-02 | 8.96e-01 |
| GOBP DIPEPTIDE TRANSMEMBRANE TRANSPORT | 7 | 6.61e-01 | -9.56e-02 | 8.72e-01 |
| GOBP BRANCHED CHAIN AMINO ACID METABOLIC PROCESS | 26 | 3.99e-01 | 9.56e-02 | 7.22e-01 |
| GOMF SIGNAL RECOGNITION PARTICLE BINDING | 7 | 6.62e-01 | 9.56e-02 | 8.72e-01 |
| GOBP VERY LONG CHAIN FATTY ACID CATABOLIC PROCESS | 6 | 6.85e-01 | 9.56e-02 | 8.84e-01 |
| GOBP REGULATION OF APOPTOTIC DNA FRAGMENTATION | 7 | 6.62e-01 | 9.55e-02 | 8.72e-01 |
| GOBP AMINO ACID ACTIVATION | 26 | 4.00e-01 | 9.54e-02 | 7.22e-01 |
| GOCC U12 TYPE SPLICEOSOMAL COMPLEX | 26 | 4.00e-01 | 9.54e-02 | 7.22e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS | 50 | 2.43e-01 | 9.54e-02 | 5.77e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 41 | 2.91e-01 | -9.53e-02 | 6.30e-01 |
| GOBP NEGATIVE REGULATION OF KINASE ACTIVITY | 152 | 4.28e-02 | -9.53e-02 | 2.40e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 17 | 4.96e-01 | 9.53e-02 | 7.85e-01 |
| GOMF RNA EXONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 38 | 3.10e-01 | -9.53e-02 | 6.49e-01 |
| GOMF LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 10 | 6.02e-01 | -9.52e-02 | 8.41e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME MATURATION | 5 | 7.12e-01 | -9.52e-02 | 8.96e-01 |
| GOBP CELLULAR RESPONSE TO INORGANIC SUBSTANCE | 158 | 3.92e-02 | -9.51e-02 | 2.29e-01 |
| GOBP POSITIVE REGULATION OF DNA METABOLIC PROCESS | 260 | 8.37e-03 | -9.51e-02 | 9.30e-02 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 11 | 5.85e-01 | -9.51e-02 | 8.35e-01 |
| GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK | 26 | 4.01e-01 | -9.51e-02 | 7.23e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 153 | 4.27e-02 | -9.50e-02 | 2.40e-01 |
| GOCC COSTAMERE | 15 | 5.24e-01 | 9.50e-02 | 8.00e-01 |
| GOBP REGULATION OF MITOTIC SPINDLE ASSEMBLY | 22 | 4.41e-01 | -9.50e-02 | 7.52e-01 |
| GOBP PROTEIN AUTOPROCESSING | 19 | 4.74e-01 | 9.50e-02 | 7.73e-01 |
| GOBP REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 133 | 5.89e-02 | -9.49e-02 | 2.79e-01 |
| GOBP CELLULAR LIPID CATABOLIC PROCESS | 166 | 3.51e-02 | 9.49e-02 | 2.17e-01 |
| GOBP GLYCOPROTEIN BIOSYNTHETIC PROCESS | 218 | 1.60e-02 | 9.48e-02 | 1.40e-01 |
| GOBP INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION | 26 | 4.03e-01 | 9.48e-02 | 7.24e-01 |
| GOBP MEMBRANE RAFT ASSEMBLY | 9 | 6.22e-01 | 9.48e-02 | 8.51e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT | 30 | 3.69e-01 | 9.48e-02 | 7.00e-01 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING BALANCE | 28 | 3.85e-01 | -9.48e-02 | 7.12e-01 |
| GOBP REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 12 | 5.70e-01 | -9.48e-02 | 8.29e-01 |
| GOBP REGULATION OF T CELL ACTIVATION | 273 | 7.17e-03 | -9.47e-02 | 8.40e-02 |
| GOCC STEREOCILIUM BUNDLE | 41 | 2.94e-01 | -9.47e-02 | 6.32e-01 |
| GOBP PIRNA PROCESSING | 10 | 6.04e-01 | -9.47e-02 | 8.43e-01 |
| GOMF PROSTANOID RECEPTOR ACTIVITY | 5 | 7.14e-01 | -9.47e-02 | 8.96e-01 |
| GOMF SNRNA BINDING | 45 | 2.72e-01 | -9.46e-02 | 6.09e-01 |
| GOBP CHAPERONE MEDIATED PROTEIN FOLDING | 68 | 1.77e-01 | 9.46e-02 | 4.92e-01 |
| GOBP RESPONSE TO LEPTIN | 12 | 5.71e-01 | -9.46e-02 | 8.29e-01 |
| GOMF NUCLEOCYTOPLASMIC CARRIER ACTIVITY | 31 | 3.62e-01 | -9.46e-02 | 6.95e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE | 259 | 8.96e-03 | -9.45e-02 | 9.75e-02 |
| GOBP REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 117 | 7.78e-02 | -9.45e-02 | 3.28e-01 |
| GOCC POSTSYNAPTIC CYTOSOL | 11 | 5.87e-01 | 9.45e-02 | 8.35e-01 |
| GOMF CAMP RESPONSE ELEMENT BINDING PROTEIN BINDING | 8 | 6.44e-01 | -9.45e-02 | 8.62e-01 |
| GOBP POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 60 | 2.06e-01 | -9.44e-02 | 5.30e-01 |
| GOBP RESPONSE TO COCAINE | 27 | 3.96e-01 | -9.44e-02 | 7.20e-01 |
| GOBP FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE | 11 | 5.88e-01 | 9.43e-02 | 8.36e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 9 | 6.24e-01 | -9.43e-02 | 8.52e-01 |
| GOBP TONIC SMOOTH MUSCLE CONTRACTION | 5 | 7.15e-01 | -9.42e-02 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF PLATELET ACTIVATION | 7 | 6.66e-01 | -9.42e-02 | 8.75e-01 |
| GOBP REGULATION OF DNA DAMAGE CHECKPOINT | 24 | 4.25e-01 | -9.42e-02 | 7.43e-01 |
| GOBP LONG TERM SYNAPTIC POTENTIATION | 48 | 2.59e-01 | 9.41e-02 | 5.94e-01 |
| GOBP PROTEIN PHOSPHORYLATION | 981 | 7.29e-07 | -9.41e-02 | 7.04e-05 |
| GOBP LYMPHOCYTE HOMEOSTASIS | 63 | 1.97e-01 | -9.41e-02 | 5.16e-01 |
| GOCC DEATH INDUCING SIGNALING COMPLEX | 9 | 6.25e-01 | -9.41e-02 | 8.52e-01 |
| GOBP REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 6 | 6.90e-01 | -9.40e-02 | 8.87e-01 |
| GOMF RDNA BINDING | 9 | 6.25e-01 | -9.40e-02 | 8.52e-01 |
| GOBP RESPONSE TO CAMP | 58 | 2.16e-01 | -9.40e-02 | 5.42e-01 |
| GOBP ADAPTIVE IMMUNE RESPONSE | 325 | 3.65e-03 | -9.40e-02 | 5.45e-02 |
| GOMF ACID THIOL LIGASE ACTIVITY | 21 | 4.56e-01 | -9.40e-02 | 7.62e-01 |
| GOBP REGULATION OF T HELPER 1 CELL DIFFERENTIATION | 10 | 6.07e-01 | -9.40e-02 | 8.45e-01 |
| GOBP CILIUM ORGANIZATION | 330 | 3.42e-03 | 9.39e-02 | 5.22e-02 |
| GOBP INTRACELLULAR DISTRIBUTION OF MITOCHONDRIA | 6 | 6.90e-01 | 9.39e-02 | 8.87e-01 |
| GOMF NEUROTRANSMITTER RECEPTOR REGULATOR ACTIVITY | 5 | 7.16e-01 | -9.39e-02 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 17 | 5.03e-01 | -9.39e-02 | 7.88e-01 |
| GOMF PHOSPHATASE REGULATOR ACTIVITY | 82 | 1.42e-01 | 9.39e-02 | 4.42e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION | 161 | 4.01e-02 | 9.38e-02 | 2.31e-01 |
| GOBP RNA METHYLATION | 88 | 1.28e-01 | 9.38e-02 | 4.20e-01 |
| GOBP PROTEIN FOLDING | 186 | 2.75e-02 | 9.38e-02 | 1.88e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS | 501 | 3.42e-04 | 9.38e-02 | 9.81e-03 |
| GOBP REGULATION OF T CELL APOPTOTIC PROCESS | 31 | 3.66e-01 | 9.38e-02 | 6.98e-01 |
| GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY | 63 | 1.99e-01 | 9.37e-02 | 5.19e-01 |
| GOMF SALT TRANSMEMBRANE TRANSPORTER ACTIVITY | 315 | 4.34e-03 | 9.37e-02 | 6.13e-02 |
| GOBP RNA 5 END PROCESSING | 22 | 4.47e-01 | 9.37e-02 | 7.57e-01 |
| GOBP POSITIVE REGULATION OF CIRCADIAN RHYTHM | 8 | 6.47e-01 | 9.36e-02 | 8.64e-01 |
| GOCC RNAI EFFECTOR COMPLEX | 22 | 4.47e-01 | -9.36e-02 | 7.57e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR INVOLVED IN MEIOTIC RECOMBINATION | 5 | 7.17e-01 | 9.36e-02 | 8.97e-01 |
| GOMF SPHINGOLIPID TRANSFER ACTIVITY | 7 | 6.68e-01 | 9.35e-02 | 8.75e-01 |
| GOBP ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS | 165 | 3.84e-02 | 9.35e-02 | 2.27e-01 |
| GOBP GRANULOCYTE ACTIVATION | 36 | 3.32e-01 | -9.35e-02 | 6.67e-01 |
| GOMF FATTY ACID LIGASE ACTIVITY | 13 | 5.60e-01 | -9.34e-02 | 8.26e-01 |
| GOBP POSITIVE REGULATION OF EXOCYTOSIS | 54 | 2.35e-01 | 9.34e-02 | 5.66e-01 |
| GOBP RESPONSE TO IRON ION | 22 | 4.48e-01 | 9.34e-02 | 7.58e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION | 47 | 2.68e-01 | 9.34e-02 | 6.05e-01 |
| GOCC ENDOPLASMIC RETICULUM EXIT SITE | 26 | 4.10e-01 | 9.34e-02 | 7.29e-01 |
| GOBP POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 95 | 1.16e-01 | -9.34e-02 | 4.00e-01 |
| GOMF GLUTATHIONE BINDING | 9 | 6.28e-01 | 9.34e-02 | 8.53e-01 |
| GOBP EMBRYO IMPLANTATION | 36 | 3.32e-01 | -9.34e-02 | 6.67e-01 |
| GOBP REGULATION OF DENDRITE DEVELOPMENT | 71 | 1.74e-01 | -9.34e-02 | 4.89e-01 |
| GOBP REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 104 | 1.00e-01 | -9.33e-02 | 3.71e-01 |
| GOBP NEGATIVE REGULATION OF CATABOLIC PROCESS | 285 | 6.81e-03 | -9.33e-02 | 8.18e-02 |
| GOBP REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 295 | 5.92e-03 | -9.33e-02 | 7.61e-02 |
| GOCC PLASMA MEMBRANE SIGNALING RECEPTOR COMPLEX | 114 | 8.56e-02 | -9.33e-02 | 3.44e-01 |
| GOCC SECONDARY LYSOSOME | 17 | 5.06e-01 | 9.32e-02 | 7.90e-01 |
| GOBP RELAXATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE | 5 | 7.18e-01 | 9.32e-02 | 8.98e-01 |
| GOMF METALLOPEPTIDASE ACTIVITY | 106 | 9.76e-02 | 9.32e-02 | 3.66e-01 |
| GOBP POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE | 34 | 3.47e-01 | 9.32e-02 | 6.83e-01 |
| GOBP CELLULAR RESPONSE TO TYPE II INTERFERON | 86 | 1.36e-01 | -9.31e-02 | 4.33e-01 |
| GOMF CARBOXYLIC ESTER HYDROLASE ACTIVITY | 96 | 1.15e-01 | 9.30e-02 | 3.99e-01 |
| GOBP REELIN MEDIATED SIGNALING PATHWAY | 5 | 7.19e-01 | -9.30e-02 | 8.99e-01 |
| GOMF G QUADRUPLEX DNA BINDING | 11 | 5.93e-01 | 9.30e-02 | 8.38e-01 |
| GOMF PLATELET DERIVED GROWTH FACTOR BINDING | 7 | 6.70e-01 | 9.30e-02 | 8.77e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME ORGANIZATION | 101 | 1.07e-01 | -9.30e-02 | 3.82e-01 |
| GOCC BASAL PART OF CELL | 202 | 2.30e-02 | 9.29e-02 | 1.70e-01 |
| GOBP CDP CHOLINE PATHWAY | 6 | 6.94e-01 | 9.29e-02 | 8.88e-01 |
| GOBP RECEPTOR RECYCLING | 39 | 3.16e-01 | 9.29e-02 | 6.54e-01 |
| GOBP ADIPONECTIN ACTIVATED SIGNALING PATHWAY | 7 | 6.71e-01 | 9.28e-02 | 8.77e-01 |
| GOCC NUCLEAR PROTEIN CONTAINING COMPLEX | 1102 | 2.46e-07 | -9.28e-02 | 3.12e-05 |
| GOBP NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 35 | 3.42e-01 | -9.28e-02 | 6.78e-01 |
| GOBP AROMATIC AMINO ACID METABOLIC PROCESS | 20 | 4.73e-01 | 9.28e-02 | 7.72e-01 |
| GOBP CELLULAR RESPONSE TO LEPTIN STIMULUS | 10 | 6.11e-01 | -9.28e-02 | 8.46e-01 |
| GOMF U4 SNRNA BINDING | 6 | 6.94e-01 | -9.27e-02 | 8.88e-01 |
| GOBP PROTOPORPHYRINOGEN IX BIOSYNTHETIC PROCESS | 8 | 6.50e-01 | 9.27e-02 | 8.66e-01 |
| GOMF RNA POLYMERASE III TYPE 3 PROMOTER SEQUENCE SPECIFIC DNA BINDING | 7 | 6.71e-01 | -9.27e-02 | 8.77e-01 |
| GOBP REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 12 | 5.78e-01 | -9.27e-02 | 8.32e-01 |
| GOCC FANCONI ANAEMIA NUCLEAR COMPLEX | 13 | 5.63e-01 | 9.26e-02 | 8.26e-01 |
| GOMF NAD DEPENDENT HISTONE DEACETYLASE ACTIVITY | 5 | 7.20e-01 | -9.25e-02 | 8.99e-01 |
| GOCC NUCLEAR UBIQUITIN LIGASE COMPLEX | 43 | 2.94e-01 | 9.25e-02 | 6.32e-01 |
| GOMF METALLOCARBOXYPEPTIDASE ACTIVITY | 12 | 5.79e-01 | 9.25e-02 | 8.32e-01 |
| GOBP PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE | 16 | 5.22e-01 | 9.24e-02 | 7.99e-01 |
| GOBP MACROPHAGE CHEMOTAXIS | 31 | 3.73e-01 | -9.24e-02 | 7.02e-01 |
| GOBP CELL CYCLE G1 S PHASE TRANSITION | 216 | 1.94e-02 | -9.24e-02 | 1.54e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 22 | 4.53e-01 | -9.24e-02 | 7.62e-01 |
| GOBP BASE EXCISION REPAIR GAP FILLING | 13 | 5.64e-01 | -9.24e-02 | 8.27e-01 |
| GOBP REGULATION OF TRANSFERASE ACTIVITY | 535 | 2.71e-04 | -9.24e-02 | 8.24e-03 |
| GOBP SPINDLE MIDZONE ASSEMBLY | 13 | 5.64e-01 | 9.24e-02 | 8.27e-01 |
| GOBP RESPONSE TO TYPE II INTERFERON | 103 | 1.06e-01 | -9.23e-02 | 3.81e-01 |
| GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY | 29 | 3.90e-01 | -9.23e-02 | 7.15e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 18 | 4.98e-01 | 9.23e-02 | 7.86e-01 |
| GOMF CHEMOREPELLENT ACTIVITY | 14 | 5.50e-01 | 9.23e-02 | 8.19e-01 |
| GOBP NCRNA EXPORT FROM NUCLEUS | 9 | 6.32e-01 | -9.22e-02 | 8.56e-01 |
| GOBP REGULATION OF T CELL MEDIATED IMMUNITY | 72 | 1.76e-01 | -9.22e-02 | 4.92e-01 |
| GOBP REGULATION OF DNA BINDING | 62 | 2.10e-01 | -9.22e-02 | 5.34e-01 |
| GOCC TRANSLATION PREINITIATION COMPLEX | 18 | 4.99e-01 | -9.21e-02 | 7.87e-01 |
| GOBP CELL SUBSTRATE JUNCTION ORGANIZATION | 83 | 1.47e-01 | 9.21e-02 | 4.49e-01 |
| GOMF MONOCARBOXYLATE SODIUM SYMPORTER ACTIVITY | 7 | 6.73e-01 | 9.21e-02 | 8.78e-01 |
| GOMF CXCR CHEMOKINE RECEPTOR BINDING | 7 | 6.73e-01 | -9.20e-02 | 8.78e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 10 | 6.14e-01 | 9.20e-02 | 8.48e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 13 | 5.66e-01 | -9.20e-02 | 8.28e-01 |
| GOMF NADP BINDING | 44 | 2.91e-01 | -9.20e-02 | 6.30e-01 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 167 | 4.05e-02 | -9.20e-02 | 2.33e-01 |
| GOBP RAB PROTEIN SIGNAL TRANSDUCTION | 20 | 4.76e-01 | -9.20e-02 | 7.75e-01 |
| GOBP LIPID CATABOLIC PROCESS | 228 | 1.69e-02 | 9.20e-02 | 1.45e-01 |
| GOMF TRANSCRIPTION REGULATOR INHIBITOR ACTIVITY | 16 | 5.24e-01 | 9.20e-02 | 8.00e-01 |
| GOBP VESICLE DOCKING | 54 | 2.43e-01 | 9.20e-02 | 5.76e-01 |
| GOCC PCG PROTEIN COMPLEX | 35 | 3.47e-01 | -9.20e-02 | 6.82e-01 |
| GOBP UV DAMAGE EXCISION REPAIR | 12 | 5.81e-01 | -9.19e-02 | 8.32e-01 |
| GOBP ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 635 | 8.28e-05 | -9.19e-02 | 3.40e-03 |
| GOBP RHO PROTEIN SIGNAL TRANSDUCTION | 105 | 1.04e-01 | -9.19e-02 | 3.78e-01 |
| GOBP ORGANIC ACID TRANSPORT | 212 | 2.13e-02 | 9.19e-02 | 1.61e-01 |
| GOBP POSITIVE REGULATION OF NK T CELL ACTIVATION | 6 | 6.97e-01 | 9.19e-02 | 8.89e-01 |
| GOBP CELLULAR RESPONSE TO HYDROPEROXIDE | 6 | 6.97e-01 | -9.19e-02 | 8.89e-01 |
| GOBP MONOCYTE CHEMOTAXIS | 39 | 3.21e-01 | 9.19e-02 | 6.60e-01 |
| GOBP SPERM FLAGELLUM ASSEMBLY | 27 | 4.09e-01 | 9.19e-02 | 7.28e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 7 | 6.74e-01 | -9.19e-02 | 8.78e-01 |
| GOBP ATRIOVENTRICULAR VALVE DEVELOPMENT | 17 | 5.12e-01 | -9.18e-02 | 7.93e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 27 | 4.09e-01 | -9.18e-02 | 7.29e-01 |
| GOBP FOLIC ACID METABOLIC PROCESS | 15 | 5.38e-01 | 9.18e-02 | 8.10e-01 |
| GOBP REGULATION OF CELL PROJECTION SIZE | 7 | 6.74e-01 | 9.18e-02 | 8.78e-01 |
| GOBP MIRNA CATABOLIC PROCESS | 16 | 5.25e-01 | -9.17e-02 | 8.00e-01 |
| GOMF PEPTIDOGLYCAN BINDING | 8 | 6.54e-01 | -9.16e-02 | 8.68e-01 |
| GOBP RESPONSE TO ZINC ION | 33 | 3.63e-01 | -9.16e-02 | 6.95e-01 |
| GOCC TERTIARY GRANULE | 133 | 6.84e-02 | -9.16e-02 | 3.02e-01 |
| GOCC SHELTERIN COMPLEX | 6 | 6.98e-01 | 9.16e-02 | 8.89e-01 |
| GOBP ACYLGLYCEROL HOMEOSTASIS | 24 | 4.38e-01 | 9.16e-02 | 7.51e-01 |
| GOBP RESPONSE TO IONIZING RADIATION | 123 | 7.98e-02 | -9.16e-02 | 3.32e-01 |
| GOCC VESICLE TETHERING COMPLEX | 53 | 2.49e-01 | -9.15e-02 | 5.84e-01 |
| GOBP POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY | 18 | 5.02e-01 | 9.15e-02 | 7.88e-01 |
| GOMF UDP XYLOSYLTRANSFERASE ACTIVITY | 9 | 6.35e-01 | -9.15e-02 | 8.57e-01 |
| GOBP APOPTOTIC MITOCHONDRIAL CHANGES | 94 | 1.26e-01 | 9.15e-02 | 4.16e-01 |
| GOMF SODIUM PROTON ANTIPORTER ACTIVITY | 10 | 6.17e-01 | 9.14e-02 | 8.49e-01 |
| GOBP BLASTOCYST DEVELOPMENT | 90 | 1.35e-01 | -9.13e-02 | 4.31e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS | 13 | 5.69e-01 | 9.13e-02 | 8.28e-01 |
| GOBP NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 31 | 3.79e-01 | -9.13e-02 | 7.06e-01 |
| GOBP POST FERTILIZATION EPIGENETIC REGULATION OF GENE EXPRESSION | 13 | 5.69e-01 | -9.12e-02 | 8.28e-01 |
| GOBP DETECTION OF EXTERNAL BIOTIC STIMULUS | 18 | 5.03e-01 | -9.12e-02 | 7.88e-01 |
| GOMF PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING | 13 | 5.69e-01 | -9.12e-02 | 8.28e-01 |
| GOMF NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 6.36e-01 | 9.12e-02 | 8.57e-01 |
| GOBP MONOCARBOXYLIC ACID METABOLIC PROCESS | 447 | 9.90e-04 | 9.12e-02 | 2.20e-02 |
| GOBP GLYCOPROTEIN METABOLIC PROCESS | 268 | 1.04e-02 | 9.11e-02 | 1.06e-01 |
| GOBP PIECEMEAL MICROAUTOPHAGY OF THE NUCLEUS | 10 | 6.18e-01 | -9.11e-02 | 8.49e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 9 | 6.36e-01 | -9.11e-02 | 8.58e-01 |
| GOBP REGULATION OF RECEPTOR INTERNALIZATION | 42 | 3.07e-01 | -9.11e-02 | 6.46e-01 |
| GOBP POST TRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 7 | 6.77e-01 | 9.10e-02 | 8.79e-01 |
| GOMF RNA CAP BINDING | 19 | 4.92e-01 | -9.10e-02 | 7.84e-01 |
| GOBP IMP BIOSYNTHETIC PROCESS | 10 | 6.18e-01 | 9.10e-02 | 8.49e-01 |
| GOBP DORSAL AORTA DEVELOPMENT | 5 | 7.25e-01 | 9.10e-02 | 9.02e-01 |
| GOBP DORSAL AORTA MORPHOGENESIS | 5 | 7.25e-01 | 9.10e-02 | 9.02e-01 |
| GOMF SODIUM CHANNEL ACTIVITY | 19 | 4.93e-01 | -9.09e-02 | 7.84e-01 |
| GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS VIA LACTOSYLCERAMIDE | 5 | 7.25e-01 | 9.09e-02 | 9.02e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS OXYGEN AS ACCEPTOR | 8 | 6.56e-01 | -9.09e-02 | 8.70e-01 |
| GOBP CELL CYCLE PHASE TRANSITION | 482 | 6.62e-04 | -9.09e-02 | 1.62e-02 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 23 | 4.51e-01 | 9.08e-02 | 7.60e-01 |
| GOCC FEMALE PRONUCLEUS | 9 | 6.37e-01 | -9.08e-02 | 8.58e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 51 | 2.62e-01 | 9.08e-02 | 5.98e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM DEVELOPMENT | 46 | 2.87e-01 | -9.07e-02 | 6.26e-01 |
| GOBP REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 28 | 4.06e-01 | 9.07e-02 | 7.27e-01 |
| GOMF PROTEIN CONTAINING COMPLEX BINDING | 1361 | 2.81e-08 | -9.06e-02 | 4.62e-06 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE BINDING | 13 | 5.72e-01 | -9.06e-02 | 8.29e-01 |
| GOBP SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 411 | 1.67e-03 | -9.06e-02 | 3.14e-02 |
| GOBP SYNAPSE MATURATION | 20 | 4.83e-01 | -9.06e-02 | 7.80e-01 |
| GOBP REGULATION OF ACTIN NUCLEATION | 32 | 3.75e-01 | 9.06e-02 | 7.03e-01 |
| GOBP HEPATOCYTE DIFFERENTIATION | 7 | 6.78e-01 | 9.06e-02 | 8.80e-01 |
| GOBP ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 141 | 6.36e-02 | -9.06e-02 | 2.90e-01 |
| GOMF BH3 DOMAIN BINDING | 5 | 7.26e-01 | 9.06e-02 | 9.02e-01 |
| GOBP GLYCOLIPID BIOSYNTHETIC PROCESS | 54 | 2.50e-01 | 9.06e-02 | 5.84e-01 |
| GOBP REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 16 | 5.31e-01 | 9.05e-02 | 8.04e-01 |
| GOBP REGULATION OF COLLAGEN METABOLIC PROCESS | 24 | 4.43e-01 | -9.05e-02 | 7.54e-01 |
| GOCC TERTIARY GRANULE LUMEN | 42 | 3.11e-01 | -9.04e-02 | 6.50e-01 |
| GOMF CARBOHYDRATE MONOATOMIC CATION SYMPORTER ACTIVITY | 9 | 6.39e-01 | 9.04e-02 | 8.59e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 8 | 6.58e-01 | -9.03e-02 | 8.71e-01 |
| GOBP XMP METABOLIC PROCESS | 7 | 6.79e-01 | 9.03e-02 | 8.80e-01 |
| GOBP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 8 | 6.59e-01 | -9.02e-02 | 8.71e-01 |
| GOBP REGULATION OF ANIMAL ORGAN FORMATION | 11 | 6.05e-01 | -9.02e-02 | 8.43e-01 |
| GOMF GROWTH FACTOR RECEPTOR BINDING | 80 | 1.64e-01 | -9.01e-02 | 4.74e-01 |
| GOBP FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 38 | 3.36e-01 | -9.01e-02 | 6.71e-01 |
| GOBP PROTEIN MONOUBIQUITINATION | 41 | 3.18e-01 | -9.01e-02 | 6.57e-01 |
| GOBP PROTEIN HETEROOLIGOMERIZATION | 20 | 4.86e-01 | -9.01e-02 | 7.81e-01 |
| GOBP AXONAL TRANSPORT | 54 | 2.52e-01 | 9.01e-02 | 5.87e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEPARATION | 26 | 4.27e-01 | -9.00e-02 | 7.44e-01 |
| GOBP POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 88 | 1.45e-01 | -9.00e-02 | 4.45e-01 |
| GOBP ANOIKIS | 27 | 4.19e-01 | -9.00e-02 | 7.37e-01 |
| GOMF SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 13 | 5.75e-01 | 8.99e-02 | 8.31e-01 |
| GOMF PRIMARY MIRNA BINDING | 10 | 6.22e-01 | -8.99e-02 | 8.51e-01 |
| GOBP CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE | 46 | 2.92e-01 | -8.99e-02 | 6.31e-01 |
| GOBP REGULATION OF SYNAPSE ASSEMBLY | 65 | 2.11e-01 | -8.98e-02 | 5.34e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 19 | 4.98e-01 | -8.98e-02 | 7.86e-01 |
| GOBP CYTOLYSIS | 5 | 7.28e-01 | 8.98e-02 | 9.03e-01 |
| GOMF K63 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 26 | 4.28e-01 | -8.98e-02 | 7.45e-01 |
| GOBP TRNA AMINOACYLATION FOR MITOCHONDRIAL PROTEIN TRANSLATION | 7 | 6.81e-01 | 8.98e-02 | 8.81e-01 |
| GOBP ORGANIC ACID BIOSYNTHETIC PROCESS | 233 | 1.85e-02 | 8.97e-02 | 1.50e-01 |
| GOBP CRANIAL NERVE FORMATION | 5 | 7.28e-01 | -8.97e-02 | 9.03e-01 |
| GOBP MECHANOSENSORY BEHAVIOR | 6 | 7.04e-01 | 8.97e-02 | 8.92e-01 |
| GOBP ASTROCYTE DIFFERENTIATION | 56 | 2.46e-01 | -8.96e-02 | 5.80e-01 |
| GOBP GLUCOCORTICOID METABOLIC PROCESS | 14 | 5.62e-01 | -8.96e-02 | 8.26e-01 |
| GOBP NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 12 | 5.91e-01 | -8.96e-02 | 8.37e-01 |
| GOBP MITOCHONDRIAL DNA METABOLIC PROCESS | 21 | 4.78e-01 | 8.95e-02 | 7.75e-01 |
| GOCC RNA POLYMERASE III TRANSCRIPTION REGULATOR COMPLEX | 9 | 6.42e-01 | 8.95e-02 | 8.61e-01 |
| GOBP NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS | 73 | 1.87e-01 | 8.95e-02 | 5.04e-01 |
| GOBP REGULATION OF OSTEOBLAST DIFFERENTIATION | 75 | 1.81e-01 | -8.95e-02 | 4.97e-01 |
| GOCC DIHYDROLIPOYL DEHYDROGENASE COMPLEX | 8 | 6.61e-01 | 8.95e-02 | 8.72e-01 |
| GOMF MOLECULAR SEQUESTERING ACTIVITY | 31 | 3.89e-01 | 8.94e-02 | 7.15e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS | 9 | 6.43e-01 | 8.94e-02 | 8.61e-01 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 31 | 3.89e-01 | 8.94e-02 | 7.15e-01 |
| GOCC BLOOD MICROPARTICLE | 57 | 2.44e-01 | -8.93e-02 | 5.77e-01 |
| GOBP LYTIC VACUOLE ORGANIZATION | 95 | 1.33e-01 | 8.93e-02 | 4.27e-01 |
| GOBP LUNG EPITHELIUM DEVELOPMENT | 23 | 4.59e-01 | -8.93e-02 | 7.64e-01 |
| GOBP CARBOHYDRATE DERIVATIVE METABOLIC PROCESS | 809 | 1.80e-05 | 8.92e-02 | 1.00e-03 |
| GOBP RESPONSE TO GONADOTROPIN | 12 | 5.93e-01 | -8.91e-02 | 8.38e-01 |
| GOMF 3 5 CYCLIC GMP PHOSPHODIESTERASE ACTIVITY | 10 | 6.26e-01 | -8.91e-02 | 8.52e-01 |
| GOBP TRANSPORT OF VIRUS | 19 | 5.02e-01 | -8.90e-02 | 7.88e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE A SIGNALING | 6 | 7.06e-01 | 8.89e-02 | 8.93e-01 |
| GOBP POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 23 | 4.60e-01 | -8.89e-02 | 7.64e-01 |
| GOBP REGULATION OF CELL ACTIVATION | 471 | 9.83e-04 | -8.89e-02 | 2.19e-02 |
| GOMF ATPASE COUPLED LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 6.84e-01 | -8.89e-02 | 8.83e-01 |
| GOMF HYDRO LYASE ACTIVITY | 41 | 3.25e-01 | -8.89e-02 | 6.63e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY | 552 | 3.84e-04 | 8.87e-02 | 1.07e-02 |
| GOBP INFLAMMATORY CELL APOPTOTIC PROCESS | 19 | 5.03e-01 | -8.87e-02 | 7.88e-01 |
| GOMF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 200 | 3.08e-02 | -8.87e-02 | 2.00e-01 |
| GOBP AMIDE CATABOLIC PROCESS | 13 | 5.80e-01 | 8.87e-02 | 8.32e-01 |
| GOBP REGULATION OF RESPONSE TO OXIDATIVE STRESS | 27 | 4.25e-01 | 8.86e-02 | 7.43e-01 |
| GOBP ENUCLEATE ERYTHROCYTE DIFFERENTIATION | 8 | 6.65e-01 | 8.85e-02 | 8.73e-01 |
| GOBP ALPHA AMINO ACID METABOLIC PROCESS | 146 | 6.51e-02 | 8.85e-02 | 2.94e-01 |
| GOBP SEQUESTERING OF METAL ION | 8 | 6.65e-01 | 8.85e-02 | 8.73e-01 |
| GOBP DIGESTION | 51 | 2.74e-01 | 8.85e-02 | 6.11e-01 |
| GOBP CYTOPLASMIC TRANSLATIONAL INITIATION | 38 | 3.45e-01 | -8.85e-02 | 6.82e-01 |
| GOBP POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS | 10 | 6.28e-01 | 8.84e-02 | 8.54e-01 |
| GOBP ACTIN POLYMERIZATION DEPENDENT CELL MOTILITY | 7 | 6.86e-01 | -8.84e-02 | 8.84e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS | 57 | 2.49e-01 | -8.84e-02 | 5.83e-01 |
| GOMF MHC PROTEIN BINDING | 22 | 4.73e-01 | -8.84e-02 | 7.72e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR DIVISION | 36 | 3.59e-01 | 8.84e-02 | 6.91e-01 |
| GOBP ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION | 33 | 3.80e-01 | -8.84e-02 | 7.07e-01 |
| GOBP MANNOSYLATION | 20 | 4.94e-01 | 8.83e-02 | 7.84e-01 |
| GOBP MULTIVESICULAR BODY ORGANIZATION | 31 | 3.95e-01 | 8.83e-02 | 7.20e-01 |
| GOBP POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS | 5 | 7.33e-01 | -8.82e-02 | 9.04e-01 |
| GOBP PLACENTA DEVELOPMENT | 105 | 1.19e-01 | -8.82e-02 | 4.02e-01 |
| GOBP COPPER ION HOMEOSTASIS | 18 | 5.17e-01 | 8.82e-02 | 7.96e-01 |
| GOCC CATALYTIC STEP 1 SPLICEOSOME | 12 | 5.97e-01 | -8.82e-02 | 8.39e-01 |
| GOBP AMYLOID BETA CLEARANCE BY CELLULAR CATABOLIC PROCESS | 7 | 6.86e-01 | 8.81e-02 | 8.85e-01 |
| GOCC ACTIN FILAMENT | 89 | 1.51e-01 | 8.81e-02 | 4.54e-01 |
| GOBP MOTILE CILIUM ASSEMBLY | 43 | 3.18e-01 | 8.80e-02 | 6.57e-01 |
| GOBP RESPONSE TO RADIATION | 330 | 6.10e-03 | -8.80e-02 | 7.68e-02 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 178 | 4.31e-02 | -8.80e-02 | 2.41e-01 |
| GOMF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING | 8 | 6.66e-01 | 8.80e-02 | 8.75e-01 |
| GOBP POSITIVE REGULATION OF GENE EXPRESSION | 816 | 2.17e-05 | -8.80e-02 | 1.18e-03 |
| GOCC NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK | 940 | 5.69e-06 | 8.79e-02 | 3.92e-04 |
| GOBP INTERMEDIATE FILAMENT ORGANIZATION | 13 | 5.83e-01 | -8.79e-02 | 8.34e-01 |
| GOCC KNL1 SPC105 COMPLEX | 5 | 7.34e-01 | -8.79e-02 | 9.04e-01 |
| GOMF SULFOTRANSFERASE ACTIVITY | 24 | 4.57e-01 | -8.78e-02 | 7.62e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 762 | 4.13e-05 | -8.78e-02 | 1.95e-03 |
| GOBP NEURON PROJECTION ORGANIZATION | 71 | 2.01e-01 | -8.77e-02 | 5.24e-01 |
| GOBP POSITIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 9 | 6.49e-01 | -8.77e-02 | 8.65e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 42 | 3.26e-01 | 8.76e-02 | 6.63e-01 |
| GOBP VACUOLE FUSION | 12 | 5.99e-01 | 8.76e-02 | 8.40e-01 |
| GOBP SNRNA 3 END PROCESSING | 21 | 4.88e-01 | 8.75e-02 | 7.81e-01 |
| GOMF MIRNA INHIBITOR ACTIVITY VIA BASE PAIRING | 6 | 7.11e-01 | -8.75e-02 | 8.96e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE PRODUCTION | 16 | 5.45e-01 | -8.74e-02 | 8.15e-01 |
| GOCC APICAL JUNCTION COMPLEX | 98 | 1.35e-01 | 8.73e-02 | 4.32e-01 |
| GOBP NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 10 | 6.33e-01 | -8.73e-02 | 8.57e-01 |
| GOBP HEART DEVELOPMENT | 389 | 3.23e-03 | -8.72e-02 | 5.04e-02 |
| GOBP ENDOTHELIAL CELL APOPTOTIC PROCESS | 35 | 3.72e-01 | -8.72e-02 | 7.00e-01 |
| GOBP MAINTENANCE OF SISTER CHROMATID COHESION | 12 | 6.01e-01 | -8.72e-02 | 8.41e-01 |
| GOBP RESPONSE TO LEAD ION | 17 | 5.34e-01 | -8.72e-02 | 8.06e-01 |
| GOCC CD95 DEATH INDUCING SIGNALING COMPLEX | 6 | 7.12e-01 | 8.72e-02 | 8.96e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED EIF2 ALPHA PHOSPHORYLATION | 5 | 7.36e-01 | 8.71e-02 | 9.05e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SUMOYLATION | 8 | 6.70e-01 | 8.71e-02 | 8.77e-01 |
| GOBP PHAGOCYTOSIS | 184 | 4.21e-02 | -8.70e-02 | 2.38e-01 |
| GOCC SWR1 COMPLEX | 13 | 5.87e-01 | -8.70e-02 | 8.35e-01 |
| GOBP FRUCTOSE 2 6 BISPHOSPHATE METABOLIC PROCESS | 5 | 7.36e-01 | -8.70e-02 | 9.05e-01 |
| GOMF FRUCTOSE 2 6 BISPHOSPHATE 2 PHOSPHATASE ACTIVITY | 5 | 7.36e-01 | -8.70e-02 | 9.05e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 24 | 4.61e-01 | -8.70e-02 | 7.64e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 5 | 7.36e-01 | 8.70e-02 | 9.05e-01 |
| GOBP DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 40 | 3.42e-01 | 8.69e-02 | 6.78e-01 |
| GOBP PLATELET MORPHOGENESIS | 19 | 5.12e-01 | 8.69e-02 | 7.93e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 78 | 1.85e-01 | -8.69e-02 | 5.02e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 44 | 3.19e-01 | -8.69e-02 | 6.58e-01 |
| GOBP AUDITORY RECEPTOR CELL DEVELOPMENT | 19 | 5.12e-01 | 8.69e-02 | 7.93e-01 |
| GOBP ANIMAL ORGAN FORMATION | 32 | 3.95e-01 | -8.68e-02 | 7.20e-01 |
| GOBP POSITIVE REGULATION OF LIPID KINASE ACTIVITY | 13 | 5.88e-01 | -8.68e-02 | 8.36e-01 |
| GOCC EXTERNAL SIDE OF PLASMA MEMBRANE | 212 | 2.97e-02 | -8.68e-02 | 1.97e-01 |
| GOBP PROTEIN REFOLDING | 23 | 4.72e-01 | 8.67e-02 | 7.71e-01 |
| GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 11 | 6.18e-01 | 8.67e-02 | 8.49e-01 |
| GOBP 5 PHOSPHORIBOSE 1 DIPHOSPHATE METABOLIC PROCESS | 5 | 7.37e-01 | 8.67e-02 | 9.05e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT | 7 | 6.91e-01 | -8.67e-02 | 8.88e-01 |
| GOBP NEGATIVE REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 6 | 7.13e-01 | 8.67e-02 | 8.96e-01 |
| GOBP HYALURONAN METABOLIC PROCESS | 19 | 5.13e-01 | -8.67e-02 | 7.94e-01 |
| GOBP REGULATION OF GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS | 5 | 7.37e-01 | -8.66e-02 | 9.05e-01 |
| GOBP GENITALIA MORPHOGENESIS | 6 | 7.13e-01 | -8.66e-02 | 8.96e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 14 | 5.75e-01 | 8.65e-02 | 8.31e-01 |
| GOMF SINGLE STRANDED DNA 3 5 DNA EXONUCLEASE ACTIVITY | 5 | 7.38e-01 | 8.65e-02 | 9.05e-01 |
| GOBP RESPONSE TO PROTOZOAN | 20 | 5.03e-01 | -8.65e-02 | 7.88e-01 |
| GOBP POSTREPLICATION REPAIR | 34 | 3.83e-01 | -8.65e-02 | 7.10e-01 |
| GOBP MUSCLE CELL DEVELOPMENT | 120 | 1.02e-01 | 8.65e-02 | 3.74e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 16 | 5.49e-01 | 8.64e-02 | 8.19e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 29 | 4.21e-01 | -8.64e-02 | 7.39e-01 |
| GOBP TRIGLYCERIDE BIOSYNTHETIC PROCESS | 32 | 3.98e-01 | 8.64e-02 | 7.21e-01 |
| GOBP REGULATION OF AMYLOID FIBRIL FORMATION | 14 | 5.76e-01 | 8.64e-02 | 8.31e-01 |
| GOBP POST TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION | 464 | 1.49e-03 | -8.63e-02 | 2.89e-02 |
| GOBP NEGATIVE REGULATION OF HEART RATE | 7 | 6.93e-01 | -8.63e-02 | 8.88e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR | 13 | 5.90e-01 | -8.63e-02 | 8.36e-01 |
| GOBP GLAND MORPHOGENESIS | 70 | 2.12e-01 | -8.63e-02 | 5.37e-01 |
| GOCC VOLTAGE GATED CALCIUM CHANNEL COMPLEX | 26 | 4.47e-01 | 8.62e-02 | 7.57e-01 |
| GOBP SYNAPTIC VESICLE EXOCYTOSIS | 64 | 2.33e-01 | 8.62e-02 | 5.63e-01 |
| GOBP REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 137 | 8.18e-02 | -8.62e-02 | 3.37e-01 |
| GOBP CELLULAR DEFENSE RESPONSE | 31 | 4.07e-01 | 8.61e-02 | 7.27e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS | 37 | 3.65e-01 | -8.61e-02 | 6.97e-01 |
| GOBP REGULATION OF POSTSYNAPSE ORGANIZATION | 77 | 1.92e-01 | -8.61e-02 | 5.10e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 203 | 3.46e-02 | -8.61e-02 | 2.16e-01 |
| GOBP NEGATIVE REGULATION OF SECRETION | 101 | 1.35e-01 | 8.61e-02 | 4.31e-01 |
| GOBP REGULATION OF EXIT FROM MITOSIS | 16 | 5.51e-01 | -8.61e-02 | 8.19e-01 |
| GOBP MAST CELL CHEMOTAXIS | 8 | 6.73e-01 | -8.61e-02 | 8.78e-01 |
| GOBP REGULATION OF CILIUM MOVEMENT | 19 | 5.16e-01 | 8.61e-02 | 7.95e-01 |
| GOBP CELLULAR RESPONSE TO CHOLESTEROL | 14 | 5.77e-01 | -8.61e-02 | 8.32e-01 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS | 242 | 2.14e-02 | -8.60e-02 | 1.61e-01 |
| GOBP CGMP MEDIATED SIGNALING | 14 | 5.78e-01 | 8.60e-02 | 8.32e-01 |
| GOBP REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS | 7 | 6.94e-01 | -8.59e-02 | 8.88e-01 |
| GOMF LIPOPEPTIDE BINDING | 7 | 6.94e-01 | 8.58e-02 | 8.88e-01 |
| GOBP REGULATION OF ENDOCYTOSIS | 216 | 3.01e-02 | -8.58e-02 | 1.97e-01 |
| GOBP PLASMA MEMBRANE TUBULATION | 16 | 5.53e-01 | 8.57e-02 | 8.19e-01 |
| GOBP CELLULAR RESPONSE TO INTERFERON BETA | 20 | 5.07e-01 | -8.57e-02 | 7.90e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME | 8 | 6.75e-01 | 8.56e-02 | 8.79e-01 |
| GOBP CALCIUM ION IMPORT | 27 | 4.42e-01 | 8.56e-02 | 7.53e-01 |
| GOBP MEMBRANE RAFT LOCALIZATION | 6 | 7.17e-01 | 8.56e-02 | 8.97e-01 |
| GOCC CD40 RECEPTOR COMPLEX | 11 | 6.23e-01 | 8.55e-02 | 8.52e-01 |
| GOBP KILLING BY HOST OF SYMBIONT CELLS | 8 | 6.76e-01 | 8.54e-02 | 8.79e-01 |
| GOBP ICOSANOID TRANSPORT | 28 | 4.35e-01 | 8.53e-02 | 7.50e-01 |
| GOMF CTPASE ACTIVITY | 5 | 7.41e-01 | 8.53e-02 | 9.06e-01 |
| GOCC CORTICAL ACTIN CYTOSKELETON | 57 | 2.66e-01 | 8.53e-02 | 6.03e-01 |
| GOBP POSITIVE REGULATION OF CARTILAGE DEVELOPMENT | 15 | 5.68e-01 | 8.52e-02 | 8.28e-01 |
| GOBP CELLULAR RESPONSE TO FATTY ACID | 19 | 5.21e-01 | 8.52e-02 | 7.98e-01 |
| GOBP BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 79 | 1.91e-01 | -8.51e-02 | 5.10e-01 |
| GOBP FAT CELL DIFFERENTIATION | 163 | 6.14e-02 | -8.50e-02 | 2.87e-01 |
| GOBP EXECUTION PHASE OF APOPTOSIS | 56 | 2.71e-01 | -8.50e-02 | 6.08e-01 |
| GOBP LIVER REGENERATION | 21 | 5.00e-01 | 8.50e-02 | 7.88e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 42 | 3.41e-01 | -8.50e-02 | 6.77e-01 |
| GOBP GALACTOSE METABOLIC PROCESS | 8 | 6.77e-01 | -8.50e-02 | 8.79e-01 |
| GOBP PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS | 23 | 4.81e-01 | 8.50e-02 | 7.78e-01 |
| GOBP PROTEIN LOCALIZATION TO GOLGI APPARATUS | 28 | 4.37e-01 | -8.49e-02 | 7.51e-01 |
| GOBP CHOLESTEROL CATABOLIC PROCESS | 6 | 7.19e-01 | -8.48e-02 | 8.99e-01 |
| GOBP POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 102 | 1.39e-01 | -8.48e-02 | 4.37e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 112 | 1.21e-01 | 8.48e-02 | 4.08e-01 |
| GOBP POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY | 54 | 2.82e-01 | -8.47e-02 | 6.20e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 25 | 4.64e-01 | 8.47e-02 | 7.65e-01 |
| GOMF NADPLUS BINDING | 17 | 5.46e-01 | 8.46e-02 | 8.16e-01 |
| GOBP LIPOSACCHARIDE METABOLIC PROCESS | 80 | 1.91e-01 | 8.46e-02 | 5.10e-01 |
| GOBP REGULATION OF PH | 76 | 2.03e-01 | 8.46e-02 | 5.25e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 31 | 4.16e-01 | 8.45e-02 | 7.34e-01 |
| GOBP NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY | 25 | 4.65e-01 | -8.45e-02 | 7.66e-01 |
| GOMF CARBON OXYGEN LYASE ACTIVITY | 56 | 2.74e-01 | -8.45e-02 | 6.11e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS BY CYTOCHROME C | 6 | 7.20e-01 | -8.45e-02 | 8.99e-01 |
| GOBP RESPONSE TO ORGANOPHOSPHORUS | 84 | 1.82e-01 | -8.43e-02 | 4.98e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 PHOSPHATE BINDING | 26 | 4.57e-01 | -8.42e-02 | 7.63e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS | 23 | 4.85e-01 | 8.42e-02 | 7.81e-01 |
| GOBP MICROTUBULE BASED MOVEMENT | 289 | 1.41e-02 | 8.41e-02 | 1.29e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS | 32 | 4.10e-01 | -8.41e-02 | 7.29e-01 |
| GOBP RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE | 6 | 7.21e-01 | -8.41e-02 | 9.00e-01 |
| GOBP LEUKOCYTE CELL CELL ADHESION | 296 | 1.31e-02 | -8.40e-02 | 1.23e-01 |
| GOBP INTERLEUKIN 33 MEDIATED SIGNALING PATHWAY | 6 | 7.22e-01 | -8.40e-02 | 9.00e-01 |
| GOBP METANEPHRIC GLOMERULUS DEVELOPMENT | 7 | 7.01e-01 | 8.39e-02 | 8.90e-01 |
| GOBP RESPONSE TO HYPEROXIA | 15 | 5.74e-01 | 8.39e-02 | 8.31e-01 |
| GOBP ESTABLISHMENT OF SERTOLI CELL BARRIER | 5 | 7.45e-01 | 8.39e-02 | 9.08e-01 |
| GOBP REGULATION OF PLASMA MEMBRANE REPAIR | 7 | 7.01e-01 | -8.39e-02 | 8.90e-01 |
| GOBP MACROPHAGE APOPTOTIC PROCESS | 11 | 6.30e-01 | -8.39e-02 | 8.55e-01 |
| GOMF DYNEIN LIGHT INTERMEDIATE CHAIN BINDING | 24 | 4.77e-01 | 8.39e-02 | 7.75e-01 |
| GOBP T CELL HOMEOSTASIS | 38 | 3.71e-01 | -8.38e-02 | 7.00e-01 |
| GOMF DNA BINDING BENDING | 9 | 6.63e-01 | -8.38e-02 | 8.73e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 884 | 2.68e-05 | -8.38e-02 | 1.35e-03 |
| GOMF ANKYRIN BINDING | 11 | 6.31e-01 | -8.38e-02 | 8.55e-01 |
| GOCC PIGMENT GRANULE | 102 | 1.44e-01 | 8.37e-02 | 4.45e-01 |
| GOBP POSITIVE REGULATION OF HIPPO SIGNALING | 7 | 7.01e-01 | -8.37e-02 | 8.90e-01 |
| GOBP REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 92 | 1.66e-01 | -8.37e-02 | 4.77e-01 |
| GOBP PHENOL CONTAINING COMPOUND METABOLIC PROCESS | 61 | 2.59e-01 | 8.37e-02 | 5.94e-01 |
| GOBP INTRACELLULAR LIPID TRANSPORT | 45 | 3.32e-01 | 8.36e-02 | 6.67e-01 |
| GOBP GERMINAL CENTER B CELL DIFFERENTIATION | 5 | 7.46e-01 | 8.36e-02 | 9.09e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 15 | 5.75e-01 | 8.35e-02 | 8.31e-01 |
| GOBP PONS DEVELOPMENT | 7 | 7.02e-01 | 8.35e-02 | 8.91e-01 |
| GOBP UBIQUITIN DEPENDENT ERAD PATHWAY | 74 | 2.14e-01 | 8.35e-02 | 5.40e-01 |
| GOCC TRANSPORT VESICLE MEMBRANE | 168 | 6.22e-02 | 8.35e-02 | 2.88e-01 |
| GOMF RNA 2 O METHYLTRANSFERASE ACTIVITY | 9 | 6.65e-01 | 8.35e-02 | 8.73e-01 |
| GOBP RESPONSE TO ACID CHEMICAL | 98 | 1.54e-01 | -8.35e-02 | 4.58e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 14 | 5.89e-01 | 8.35e-02 | 8.36e-01 |
| GOBP RESPONSE TO ATP | 21 | 5.08e-01 | -8.34e-02 | 7.91e-01 |
| GOCC CULLIN RING UBIQUITIN LIGASE COMPLEX | 161 | 6.87e-02 | -8.32e-02 | 3.03e-01 |
| GOCC TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 260 | 2.11e-02 | -8.32e-02 | 1.60e-01 |
| GOBP REVERSE CHOLESTEROL TRANSPORT | 14 | 5.90e-01 | -8.32e-02 | 8.36e-01 |
| GOBP ADP TRANSPORT | 11 | 6.33e-01 | -8.32e-02 | 8.57e-01 |
| GOBP POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 11 | 6.33e-01 | -8.31e-02 | 8.57e-01 |
| GOCC AXON CYTOPLASM | 51 | 3.05e-01 | 8.31e-02 | 6.43e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 18 | 5.42e-01 | -8.31e-02 | 8.13e-01 |
| GOBP EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS | 39 | 3.70e-01 | 8.31e-02 | 7.00e-01 |
| GOCC SMALL RIBOSOMAL SUBUNIT | 72 | 2.23e-01 | 8.30e-02 | 5.52e-01 |
| GOMF SELENIUM BINDING | 6 | 7.25e-01 | -8.30e-02 | 9.02e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 5 | 7.48e-01 | 8.30e-02 | 9.09e-01 |
| GOBP REGULATION OF NEURON APOPTOTIC PROCESS | 158 | 7.22e-02 | -8.30e-02 | 3.13e-01 |
| GOCC TRANSPORT VESICLE | 315 | 1.15e-02 | 8.30e-02 | 1.13e-01 |
| GOMF CHLORIDE CHANNEL REGULATOR ACTIVITY | 8 | 6.85e-01 | -8.29e-02 | 8.83e-01 |
| GOBP MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 15 | 5.78e-01 | -8.29e-02 | 8.32e-01 |
| GOMF S ADENOSYL L METHIONINE BINDING | 17 | 5.54e-01 | 8.29e-02 | 8.20e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 6 | 7.25e-01 | -8.29e-02 | 9.02e-01 |
| GOBP REGULATION OF BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 42 | 3.53e-01 | -8.28e-02 | 6.87e-01 |
| GOBP PURINE CONTAINING COMPOUND METABOLIC PROCESS | 397 | 4.76e-03 | 8.28e-02 | 6.52e-02 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 7 | 7.04e-01 | -8.28e-02 | 8.92e-01 |
| GOBP RESPONSE TO OXYGEN CONTAINING COMPOUND | 1212 | 1.52e-06 | -8.28e-02 | 1.31e-04 |
| GOBP CARBOHYDRATE DERIVATIVE TRANSPORT | 73 | 2.22e-01 | 8.28e-02 | 5.50e-01 |
| GOBP GLUCOSE CATABOLIC PROCESS | 21 | 5.12e-01 | 8.28e-02 | 7.93e-01 |
| GOMF ZINC ION BINDING | 608 | 5.20e-04 | -8.28e-02 | 1.35e-02 |
| GOBP NEGATIVE CHEMOTAXIS | 27 | 4.57e-01 | 8.27e-02 | 7.63e-01 |
| GOBP REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 82 | 1.96e-01 | -8.27e-02 | 5.15e-01 |
| GOCC NEUROTRANSMITTER RECEPTOR COMPLEX | 20 | 5.22e-01 | -8.27e-02 | 7.99e-01 |
| GOMF NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY | 415 | 3.97e-03 | -8.27e-02 | 5.80e-02 |
| GOBP PROTEIN RNA COMPLEX ORGANIZATION | 200 | 4.41e-02 | -8.27e-02 | 2.44e-01 |
| GOCC ADHERENS JUNCTION | 135 | 9.76e-02 | 8.27e-02 | 3.66e-01 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL ADHESION | 40 | 3.66e-01 | -8.26e-02 | 6.98e-01 |
| GOBP REGULATION OF AMINE METABOLIC PROCESS | 20 | 5.23e-01 | -8.25e-02 | 7.99e-01 |
| GOBP REGULATION OF GLIAL CELL MIGRATION | 15 | 5.80e-01 | 8.25e-02 | 8.32e-01 |
| GOBP HETEROCYCLE CATABOLIC PROCESS | 406 | 4.46e-03 | -8.25e-02 | 6.23e-02 |
| GOCC GPI ANCHOR TRANSAMIDASE COMPLEX | 5 | 7.49e-01 | -8.25e-02 | 9.10e-01 |
| GOCC TIGHT JUNCTION | 81 | 2.00e-01 | 8.24e-02 | 5.22e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY | 43 | 3.50e-01 | 8.23e-02 | 6.86e-01 |
| GOCC INTERCELLULAR BRIDGE | 66 | 2.48e-01 | 8.23e-02 | 5.82e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL | 19 | 5.35e-01 | 8.23e-02 | 8.07e-01 |
| GOBP NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 331 | 1.03e-02 | -8.22e-02 | 1.06e-01 |
| GOBP PYRIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 22 | 5.04e-01 | -8.22e-02 | 7.89e-01 |
| GOBP HOMOLOGOUS CHROMOSOME SEGREGATION | 42 | 3.57e-01 | -8.22e-02 | 6.90e-01 |
| GOBP REGULATION OF PROTEIN DEPOLYMERIZATION | 69 | 2.38e-01 | -8.22e-02 | 5.70e-01 |
| GOBP CARDIOLIPIN METABOLIC PROCESS | 13 | 6.08e-01 | 8.22e-02 | 8.46e-01 |
| GOBP DENDRITE DEVELOPMENT | 170 | 6.49e-02 | -8.22e-02 | 2.94e-01 |
| GOBP REGULATION OF PROTEIN KINASE A SIGNALING | 13 | 6.08e-01 | -8.22e-02 | 8.46e-01 |
| GOBP ENDOMEMBRANE SYSTEM ORGANIZATION | 487 | 1.98e-03 | 8.21e-02 | 3.55e-02 |
| GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 6 | 7.28e-01 | -8.21e-02 | 9.03e-01 |
| GOBP XYLULOSE 5 PHOSPHATE METABOLIC PROCESS | 6 | 7.28e-01 | 8.21e-02 | 9.03e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDES | 12 | 6.23e-01 | -8.21e-02 | 8.51e-01 |
| GOBP CELL CHEMOTAXIS | 202 | 4.47e-02 | -8.21e-02 | 2.46e-01 |
| GOBP POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 24 | 4.87e-01 | -8.20e-02 | 7.81e-01 |
| GOBP REGULATION OF CELL CYCLE PHASE TRANSITION | 376 | 6.47e-03 | -8.20e-02 | 7.95e-02 |
| GOBP PROTEIN TARGETING TO LYSOSOME | 30 | 4.37e-01 | -8.20e-02 | 7.51e-01 |
| GOBP NEURON PROJECTION REGENERATION | 40 | 3.70e-01 | -8.20e-02 | 7.00e-01 |
| GOBP DIGESTIVE SYSTEM PROCESS | 47 | 3.31e-01 | 8.20e-02 | 6.67e-01 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME ACTIVITY | 36 | 3.95e-01 | 8.19e-02 | 7.20e-01 |
| GOCC MUSCLE MYOSIN COMPLEX | 5 | 7.51e-01 | 8.18e-02 | 9.11e-01 |
| GOCC PLATELET ALPHA GRANULE LUMEN | 45 | 3.43e-01 | -8.18e-02 | 6.79e-01 |
| GOMF PHOSPHATIDYLINOSITOL BINDING | 231 | 3.25e-02 | -8.18e-02 | 2.08e-01 |
| GOBP METHIONINE BIOSYNTHETIC PROCESS | 10 | 6.54e-01 | -8.18e-02 | 8.68e-01 |
| GOMF CYTOKINE ACTIVITY | 88 | 1.85e-01 | 8.18e-02 | 5.02e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 6 | 7.29e-01 | -8.18e-02 | 9.03e-01 |
| GOBP NUCLEOSIDE SALVAGE | 9 | 6.71e-01 | 8.17e-02 | 8.77e-01 |
| GOBP FAT PAD DEVELOPMENT | 7 | 7.08e-01 | -8.17e-02 | 8.94e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 291 | 1.67e-02 | -8.17e-02 | 1.45e-01 |
| GOBP REGULATION OF FATTY ACID TRANSPORT | 18 | 5.49e-01 | 8.16e-02 | 8.18e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 9 | 6.72e-01 | 8.16e-02 | 8.77e-01 |
| GOBP PHOSPHORYLATION | 1203 | 2.35e-06 | -8.15e-02 | 1.83e-04 |
| GOBP TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 16 | 5.72e-01 | 8.15e-02 | 8.30e-01 |
| GOBP POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 7 | 7.09e-01 | -8.15e-02 | 8.95e-01 |
| GOBP UROGENITAL SYSTEM DEVELOPMENT | 36 | 3.98e-01 | -8.15e-02 | 7.21e-01 |
| GOBP RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY | 53 | 3.05e-01 | -8.15e-02 | 6.44e-01 |
| GOCC POSTSYNAPTIC DENSITY MEMBRANE | 50 | 3.19e-01 | 8.14e-02 | 6.59e-01 |
| GOBP IMP METABOLIC PROCESS | 14 | 5.98e-01 | 8.14e-02 | 8.40e-01 |
| GOBP SPERM AXONEME ASSEMBLY | 21 | 5.19e-01 | 8.14e-02 | 7.97e-01 |
| GOCC AXONEMAL DYNEIN COMPLEX | 11 | 6.40e-01 | -8.14e-02 | 8.60e-01 |
| GOMF EXCITATORY EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 11 | 6.40e-01 | -8.13e-02 | 8.60e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 28 | 4.56e-01 | -8.13e-02 | 7.62e-01 |
| GOBP REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 23 | 5.00e-01 | -8.13e-02 | 7.87e-01 |
| GOBP NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS | 18 | 5.50e-01 | 8.13e-02 | 8.19e-01 |
| GOBP RESPONSE TO NITROGEN COMPOUND | 794 | 1.07e-04 | -8.13e-02 | 4.03e-03 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 9 | 6.73e-01 | -8.13e-02 | 8.78e-01 |
| GOCC PRERIBOSOME SMALL SUBUNIT PRECURSOR | 14 | 5.99e-01 | 8.13e-02 | 8.40e-01 |
| GOBP REGULATION OF ELECTRON TRANSFER ACTIVITY | 6 | 7.30e-01 | -8.12e-02 | 9.04e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 346 | 9.61e-03 | -8.12e-02 | 1.02e-01 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION | 712 | 2.40e-04 | -8.12e-02 | 7.44e-03 |
| GOBP REGULATION OF SMOOTH MUSCLE CONTRACTION | 31 | 4.34e-01 | -8.12e-02 | 7.50e-01 |
| GOBP LAMELLIPODIUM ORGANIZATION | 74 | 2.28e-01 | -8.11e-02 | 5.57e-01 |
| GOBP NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION | 135 | 1.04e-01 | -8.11e-02 | 3.78e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL PROLIFERATION | 15 | 5.87e-01 | -8.11e-02 | 8.35e-01 |
| GOBP MEIOTIC CYTOKINESIS | 6 | 7.31e-01 | 8.11e-02 | 9.04e-01 |
| GOBP RESPONSE TO FIBROBLAST GROWTH FACTOR | 58 | 2.86e-01 | -8.11e-02 | 6.23e-01 |
| GOBP RECEPTOR SIGNALING PATHWAY VIA STAT | 111 | 1.40e-01 | -8.11e-02 | 4.39e-01 |
| GOBP METANEPHRIC NEPHRON TUBULE MORPHOGENESIS | 5 | 7.54e-01 | 8.11e-02 | 9.12e-01 |
| GOBP TESTOSTERONE BIOSYNTHETIC PROCESS | 6 | 7.31e-01 | -8.10e-02 | 9.04e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS | 10 | 6.57e-01 | -8.10e-02 | 8.70e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 7 | 7.11e-01 | 8.10e-02 | 8.96e-01 |
| GOMF PROLINE RICH REGION BINDING | 15 | 5.87e-01 | -8.10e-02 | 8.35e-01 |
| GOBP ENTRY INTO HOST | 127 | 1.15e-01 | -8.10e-02 | 3.99e-01 |
| GOMF ENZYME ACTIVATOR ACTIVITY | 479 | 2.48e-03 | -8.10e-02 | 4.22e-02 |
| GOBP TAXIS | 292 | 1.75e-02 | -8.10e-02 | 1.48e-01 |
| GOMF U6 SNRNA BINDING | 14 | 6.00e-01 | -8.09e-02 | 8.40e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 23 | 5.02e-01 | 8.09e-02 | 7.88e-01 |
| GOBP TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 400 | 5.63e-03 | -8.09e-02 | 7.38e-02 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 27 | 4.67e-01 | 8.09e-02 | 7.67e-01 |
| GOBP REGULATION OF RESPONSE TO STRESS | 1117 | 6.13e-06 | -8.08e-02 | 4.07e-04 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 8 | 6.92e-01 | -8.08e-02 | 8.88e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE BINDING | 13 | 6.14e-01 | -8.08e-02 | 8.48e-01 |
| GOCC NUCLEAR INNER MEMBRANE | 48 | 3.33e-01 | -8.08e-02 | 6.68e-01 |
| GOBP REGULATION OF GLUCOSE IMPORT | 40 | 3.77e-01 | -8.08e-02 | 7.05e-01 |
| GOCC FIBRILLAR CENTER | 130 | 1.12e-01 | -8.08e-02 | 3.93e-01 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER | 35 | 4.09e-01 | 8.07e-02 | 7.29e-01 |
| GOBP MODULATION BY HOST OF VIRAL GENOME REPLICATION | 24 | 4.94e-01 | -8.07e-02 | 7.84e-01 |
| GOBP PHOSPHOLIPID CATABOLIC PROCESS | 43 | 3.61e-01 | 8.06e-02 | 6.93e-01 |
| GOMF PYRUVATE DEHYDROGENASE ACTIVITY | 5 | 7.55e-01 | -8.06e-02 | 9.12e-01 |
| GOBP MULTICELLULAR ORGANISM GROWTH | 108 | 1.48e-01 | -8.06e-02 | 4.50e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 26 | 4.77e-01 | -8.05e-02 | 7.75e-01 |
| GOBP HISTIDINE CATABOLIC PROCESS | 5 | 7.55e-01 | 8.05e-02 | 9.12e-01 |
| GOBP PEPTIDYL AMINO ACID MODIFICATION | 716 | 2.65e-04 | -8.04e-02 | 8.14e-03 |
| GOBP ANTIMICROBIAL HUMORAL RESPONSE | 37 | 3.98e-01 | -8.04e-02 | 7.21e-01 |
| GOBP PROTEOGLYCAN BIOSYNTHETIC PROCESS | 46 | 3.46e-01 | 8.03e-02 | 6.82e-01 |
| GOMF GTPASE ACTIVITY | 260 | 2.63e-02 | 8.02e-02 | 1.83e-01 |
| GOBP POSITIVE REGULATION OF CATABOLIC PROCESS | 460 | 3.30e-03 | -8.02e-02 | 5.10e-02 |
| GOBP PROTEIN TARGETING TO VACUOLE | 43 | 3.63e-01 | -8.02e-02 | 6.95e-01 |
| GOBP MOTOR NEURON APOPTOTIC PROCESS | 17 | 5.67e-01 | -8.02e-02 | 8.28e-01 |
| GOBP REGULATION OF CALCIUM ION IMPORT | 18 | 5.56e-01 | 8.02e-02 | 8.22e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS DISULFIDE AS ACCEPTOR | 7 | 7.14e-01 | -8.01e-02 | 8.96e-01 |
| GOBP SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY | 14 | 6.04e-01 | -8.01e-02 | 8.43e-01 |
| GOBP STRIATED MUSCLE TISSUE DEVELOPMENT | 143 | 9.84e-02 | -8.01e-02 | 3.67e-01 |
| GOBP COPII COATED VESICLE BUDDING | 41 | 3.75e-01 | 8.01e-02 | 7.03e-01 |
| GOBP OLIGOSACCHARIDE METABOLIC PROCESS | 39 | 3.87e-01 | -8.01e-02 | 7.13e-01 |
| GOBP PHOSPHOLIPID HOMEOSTASIS | 13 | 6.17e-01 | 8.01e-02 | 8.49e-01 |
| GOBP POLYOL CATABOLIC PROCESS | 7 | 7.14e-01 | -8.00e-02 | 8.96e-01 |
| GOBP NEUROTRANSMITTER CATABOLIC PROCESS | 6 | 7.34e-01 | 8.00e-02 | 9.04e-01 |
| GOCC CAMP DEPENDENT PROTEIN KINASE COMPLEX | 6 | 7.34e-01 | -8.00e-02 | 9.04e-01 |
| GOBP NEURON REMODELING | 8 | 6.95e-01 | -7.99e-02 | 8.88e-01 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION | 8 | 6.95e-01 | -7.99e-02 | 8.88e-01 |
| GOBP CELL CYCLE CHECKPOINT SIGNALING | 183 | 6.26e-02 | -7.99e-02 | 2.89e-01 |
| GOBP PROTEIN K48 LINKED UBIQUITINATION | 63 | 2.73e-01 | -7.99e-02 | 6.09e-01 |
| GOBP REGULATION OF BONE MINERALIZATION | 49 | 3.34e-01 | -7.98e-02 | 6.69e-01 |
| GOBP PROTEIN DEGLYCOSYLATION | 15 | 5.93e-01 | 7.98e-02 | 8.38e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY | 45 | 3.55e-01 | 7.97e-02 | 6.89e-01 |
| GOBP COLLAGEN CATABOLIC PROCESS | 25 | 4.91e-01 | -7.97e-02 | 7.83e-01 |
| GOCC CATENIN COMPLEX | 10 | 6.63e-01 | -7.96e-02 | 8.73e-01 |
| GOBP ORGANIC HYDROXY COMPOUND METABOLIC PROCESS | 363 | 9.34e-03 | 7.96e-02 | 1.00e-01 |
| GOMF RIBONUCLEOPROTEIN COMPLEX BINDING | 161 | 8.16e-02 | 7.96e-02 | 3.36e-01 |
| GOBP CO TRANSCRIPTIONAL MRNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 5 | 7.58e-01 | -7.96e-02 | 9.14e-01 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 104 | 1.61e-01 | -7.96e-02 | 4.69e-01 |
| GOCC ENDOSOME LUMEN | 24 | 5.00e-01 | -7.96e-02 | 7.87e-01 |
| GOBP PROTEIN LOCALIZATION TO EXTRACELLULAR REGION | 241 | 3.37e-02 | 7.95e-02 | 2.13e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION | 11 | 6.48e-01 | 7.95e-02 | 8.65e-01 |
| GOBP ORGANELLE DISASSEMBLY | 136 | 1.10e-01 | 7.95e-02 | 3.89e-01 |
| GOBP POSITIVE REGULATION OF CHEMOTAXIS | 96 | 1.79e-01 | -7.94e-02 | 4.94e-01 |
| GOBP CARDIOLIPIN BIOSYNTHETIC PROCESS | 7 | 7.16e-01 | 7.94e-02 | 8.97e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 28 | 4.67e-01 | -7.94e-02 | 7.67e-01 |
| GOCC MICROTUBULE ASSOCIATED COMPLEX | 119 | 1.35e-01 | 7.94e-02 | 4.31e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY | 580 | 1.14e-03 | -7.94e-02 | 2.41e-02 |
| GOBP REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 32 | 4.37e-01 | -7.94e-02 | 7.51e-01 |
| GOBP POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 31 | 4.44e-01 | -7.94e-02 | 7.55e-01 |
| GOBP REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 5 | 7.59e-01 | 7.94e-02 | 9.14e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 31 | 4.44e-01 | 7.94e-02 | 7.55e-01 |
| GOBP EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 461 | 3.63e-03 | -7.93e-02 | 5.45e-02 |
| GOBP PERICARDIUM DEVELOPMENT | 10 | 6.65e-01 | -7.92e-02 | 8.73e-01 |
| GOMF FLIPPASE ACTIVITY | 13 | 6.21e-01 | -7.92e-02 | 8.50e-01 |
| GOBP NEUTROPHIL HOMEOSTASIS | 17 | 5.72e-01 | -7.92e-02 | 8.30e-01 |
| GOBP MITOTIC NUCLEAR DIVISION | 247 | 3.25e-02 | -7.91e-02 | 2.08e-01 |
| GOBP NAIL DEVELOPMENT | 7 | 7.17e-01 | 7.91e-02 | 8.97e-01 |
| GOBP HYPEROSMOTIC SALINITY RESPONSE | 8 | 6.99e-01 | 7.90e-02 | 8.89e-01 |
| GOBP AXONAL TRANSPORT OF MITOCHONDRION | 13 | 6.22e-01 | -7.90e-02 | 8.51e-01 |
| GOBP THYROID HORMONE METABOLIC PROCESS | 14 | 6.09e-01 | 7.90e-02 | 8.46e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 21 | 5.31e-01 | 7.90e-02 | 8.04e-01 |
| GOBP PROTEIN CONTAINING COMPLEX REMODELING | 22 | 5.22e-01 | -7.89e-02 | 7.99e-01 |
| GOBP FOREBRAIN DEVELOPMENT | 243 | 3.45e-02 | -7.89e-02 | 2.16e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION | 20 | 5.41e-01 | -7.89e-02 | 8.13e-01 |
| GOBP TRNA WOBBLE BASE MODIFICATION | 20 | 5.42e-01 | 7.88e-02 | 8.13e-01 |
| GOMF MACROMOLECULE TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 4.55e-01 | 7.88e-02 | 7.62e-01 |
| GOBP RIBONUCLEOSIDE METABOLIC PROCESS | 27 | 4.78e-01 | 7.88e-02 | 7.75e-01 |
| GOBP TRANSMEMBRANE TRANSPORT | 976 | 3.48e-05 | 7.88e-02 | 1.69e-03 |
| GOBP RNA DECAPPING | 19 | 5.52e-01 | -7.88e-02 | 8.19e-01 |
| GOBP RNA PROCESSING | 869 | 9.04e-05 | -7.87e-02 | 3.57e-03 |
| GOBP SMALL MOLECULE METABOLIC PROCESS | 1380 | 1.21e-06 | 7.87e-02 | 1.11e-04 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 23 | 5.14e-01 | -7.87e-02 | 7.94e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS | 31 | 4.49e-01 | 7.86e-02 | 7.59e-01 |
| GOBP PURINE NUCLEOSIDE METABOLIC PROCESS | 20 | 5.43e-01 | 7.85e-02 | 8.14e-01 |
| GOMF AMYLOID BETA BINDING | 67 | 2.66e-01 | -7.85e-02 | 6.04e-01 |
| GOBP NEGATIVE REGULATION OF GLIOGENESIS | 23 | 5.15e-01 | -7.85e-02 | 7.95e-01 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE | 60 | 2.93e-01 | -7.85e-02 | 6.31e-01 |
| GOBP REGULATION OF SREBP SIGNALING PATHWAY | 6 | 7.39e-01 | 7.84e-02 | 9.06e-01 |
| GOMF KINASE ACTIVATOR ACTIVITY | 105 | 1.65e-01 | -7.84e-02 | 4.76e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS | 51 | 3.33e-01 | 7.84e-02 | 6.67e-01 |
| GOBP SPINDLE ASSEMBLY | 125 | 1.31e-01 | -7.84e-02 | 4.23e-01 |
| GOMF CHANNEL REGULATOR ACTIVITY | 88 | 2.04e-01 | 7.83e-02 | 5.27e-01 |
| GOBP MYELOID DENDRITIC CELL ACTIVATION | 20 | 5.44e-01 | -7.83e-02 | 8.15e-01 |
| GOBP POSITIVE REGULATION OF NEUROGENESIS | 159 | 8.88e-02 | -7.83e-02 | 3.48e-01 |
| GOBP MITOTIC SPINDLE ASSEMBLY | 69 | 2.61e-01 | -7.83e-02 | 5.97e-01 |
| GOBP CARBOHYDRATE TRANSPORT | 111 | 1.55e-01 | 7.83e-02 | 4.59e-01 |
| GOBP POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 101 | 1.75e-01 | -7.82e-02 | 4.90e-01 |
| GOBP PROTEIN N LINKED GLYCOSYLATION VIA ASPARAGINE | 22 | 5.25e-01 | 7.82e-02 | 8.00e-01 |
| GOCC I BAND | 97 | 1.84e-01 | 7.82e-02 | 5.01e-01 |
| GOBP NEGATIVE REGULATION OF CELL DEVELOPMENT | 175 | 7.48e-02 | -7.82e-02 | 3.20e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 116 | 1.46e-01 | -7.82e-02 | 4.47e-01 |
| GOBP ACTION POTENTIAL | 84 | 2.16e-01 | 7.81e-02 | 5.42e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA SIGNALING PATHWAY | 6 | 7.40e-01 | -7.81e-02 | 9.06e-01 |
| GOBP REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 165 | 8.39e-02 | -7.81e-02 | 3.40e-01 |
| GOCC GUANYL NUCLEOTIDE EXCHANGE FACTOR COMPLEX | 16 | 5.89e-01 | 7.81e-02 | 8.36e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 241 | 3.72e-02 | -7.81e-02 | 2.24e-01 |
| GOMF GUANYL NUCLEOTIDE BINDING | 311 | 1.82e-02 | 7.81e-02 | 1.49e-01 |
| GOMF S ACYLTRANSFERASE ACTIVITY | 28 | 4.75e-01 | 7.81e-02 | 7.74e-01 |
| GOBP CUT CATABOLIC PROCESS | 5 | 7.63e-01 | -7.80e-02 | 9.16e-01 |
| GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION | 23 | 5.17e-01 | -7.80e-02 | 7.96e-01 |
| GOMF MDM2 MDM4 FAMILY PROTEIN BINDING | 9 | 6.85e-01 | -7.80e-02 | 8.84e-01 |
| GOBP METANEPHRIC RENAL VESICLE MORPHOGENESIS | 8 | 7.03e-01 | 7.79e-02 | 8.91e-01 |
| GOBP MONOAMINE TRANSPORT | 39 | 4.00e-01 | 7.79e-02 | 7.22e-01 |
| GOCC MYOSIN FILAMENT | 12 | 6.41e-01 | 7.78e-02 | 8.60e-01 |
| GOBP NEUROEPITHELIAL CELL DIFFERENTIATION | 21 | 5.37e-01 | -7.78e-02 | 8.09e-01 |
| GOBP CARDIAC MUSCLE CELL DIFFERENTIATION | 77 | 2.38e-01 | -7.78e-02 | 5.70e-01 |
| GOBP MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 23 | 5.19e-01 | -7.77e-02 | 7.97e-01 |
| GOBP ACTIN FILAMENT BASED TRANSPORT | 18 | 5.68e-01 | -7.77e-02 | 8.28e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS | 6 | 7.42e-01 | -7.77e-02 | 9.06e-01 |
| GOBP REGULATION OF NEUROBLAST PROLIFERATION | 21 | 5.38e-01 | -7.77e-02 | 8.10e-01 |
| GOBP REGULATION OF STEROID BIOSYNTHETIC PROCESS | 51 | 3.38e-01 | -7.76e-02 | 6.72e-01 |
| GOBP MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 527 | 2.39e-03 | 7.76e-02 | 4.08e-02 |
| GOBP MONOATOMIC CATION TRANSPORT | 646 | 8.08e-04 | 7.76e-02 | 1.88e-02 |
| GOBP PROTEIN MATURATION | 424 | 6.29e-03 | 7.76e-02 | 7.83e-02 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT | 18 | 5.69e-01 | 7.76e-02 | 8.28e-01 |
| GOMF NUCLEAR IMPORT SIGNAL RECEPTOR ACTIVITY | 19 | 5.58e-01 | -7.76e-02 | 8.24e-01 |
| GOBP CELLULAR RESPONSE TO XENOBIOTIC STIMULUS | 111 | 1.58e-01 | -7.76e-02 | 4.65e-01 |
| GOBP RESPONSE TO LAMINAR FLUID SHEAR STRESS | 12 | 6.42e-01 | -7.75e-02 | 8.61e-01 |
| GOCC TRANSFERASE COMPLEX | 765 | 2.84e-04 | -7.75e-02 | 8.54e-03 |
| GOMF PYRUVATE DEHYDROGENASE ACETYL TRANSFERRING KINASE ACTIVITY | 5 | 7.64e-01 | 7.75e-02 | 9.17e-01 |
| GOBP INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 50 | 3.43e-01 | -7.75e-02 | 6.80e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 119 | 1.45e-01 | -7.75e-02 | 4.45e-01 |
| GOBP RESPONSE TO GAMMA RADIATION | 45 | 3.69e-01 | -7.75e-02 | 7.00e-01 |
| GOBP FEMALE MEIOTIC NUCLEAR DIVISION | 32 | 4.49e-01 | 7.74e-02 | 7.58e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS WITH A FLAVIN AS ACCEPTOR | 11 | 6.57e-01 | -7.74e-02 | 8.70e-01 |
| GOBP HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS | 34 | 4.35e-01 | -7.74e-02 | 7.50e-01 |
| GOBP B CELL PROLIFERATION | 61 | 2.96e-01 | -7.73e-02 | 6.34e-01 |
| GOBP DICARBOXYLIC ACID TRANSPORT | 66 | 2.78e-01 | -7.73e-02 | 6.15e-01 |
| GOCC PORE COMPLEX | 21 | 5.40e-01 | -7.73e-02 | 8.11e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON OXYGEN BONDS | 22 | 5.30e-01 | 7.73e-02 | 8.04e-01 |
| GOBP POSITIVE REGULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 10 | 6.72e-01 | 7.73e-02 | 8.78e-01 |
| GOMF PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 255 | 3.40e-02 | 7.72e-02 | 2.14e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE MIGRATION | 33 | 4.43e-01 | 7.72e-02 | 7.54e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I | 31 | 4.57e-01 | -7.72e-02 | 7.62e-01 |
| GOCC CAJAL BODY | 57 | 3.13e-01 | -7.72e-02 | 6.52e-01 |
| GOBP MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX ASSEMBLY | 8 | 7.05e-01 | 7.72e-02 | 8.93e-01 |
| GOBP EMBRYONIC MORPHOGENESIS | 362 | 1.19e-02 | -7.72e-02 | 1.16e-01 |
| GOBP T CELL MEDIATED IMMUNITY | 93 | 1.99e-01 | -7.72e-02 | 5.19e-01 |
| GOBP RESPONSE TO SALT | 243 | 3.87e-02 | -7.71e-02 | 2.28e-01 |
| GOBP EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 21 | 5.41e-01 | -7.71e-02 | 8.13e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 89 | 2.09e-01 | -7.71e-02 | 5.33e-01 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 17 | 5.82e-01 | -7.71e-02 | 8.33e-01 |
| GOBP CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY | 83 | 2.25e-01 | 7.71e-02 | 5.53e-01 |
| GOMF THREONINE TYPE ENDOPEPTIDASE ACTIVITY | 7 | 7.24e-01 | -7.70e-02 | 9.02e-01 |
| GOBP POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 21 | 5.41e-01 | 7.70e-02 | 8.13e-01 |
| GOBP SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION | 6 | 7.44e-01 | 7.70e-02 | 9.08e-01 |
| GOBP MYOBLAST FATE COMMITMENT | 5 | 7.66e-01 | -7.70e-02 | 9.17e-01 |
| GOBP NEGATIVE REGULATION OF CELL DIFFERENTIATION | 406 | 7.95e-03 | -7.70e-02 | 8.99e-02 |
| GOMF AMINO ACID SODIUM SYMPORTER ACTIVITY | 12 | 6.45e-01 | -7.69e-02 | 8.63e-01 |
| GOBP FIBROBLAST MIGRATION | 43 | 3.83e-01 | -7.69e-02 | 7.10e-01 |
| GOBP DISRUPTION OF ANATOMICAL STRUCTURE IN ANOTHER ORGANISM | 34 | 4.38e-01 | -7.69e-02 | 7.52e-01 |
| GOBP MESODERMAL CELL DIFFERENTIATION | 14 | 6.19e-01 | 7.69e-02 | 8.49e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL PROCESS | 13 | 6.32e-01 | 7.68e-02 | 8.56e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM MYELIN MAINTENANCE | 7 | 7.25e-01 | -7.68e-02 | 9.02e-01 |
| GOBP AUTOPHAGY OF MITOCHONDRION | 92 | 2.03e-01 | 7.68e-02 | 5.26e-01 |
| GOCC TORC1 COMPLEX | 6 | 7.45e-01 | -7.67e-02 | 9.08e-01 |
| GOBP CELLULAR RESPONSE TO LIPID | 416 | 7.46e-03 | -7.67e-02 | 8.58e-02 |
| GOBP RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE | 14 | 6.19e-01 | 7.67e-02 | 8.49e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO WOUNDING | 50 | 3.49e-01 | 7.66e-02 | 6.84e-01 |
| GOBP POSITIVE REGULATION OF CELL ACTIVATION | 295 | 2.40e-02 | -7.66e-02 | 1.74e-01 |
| GOBP NON MOTILE CILIUM ASSEMBLY | 58 | 3.14e-01 | -7.65e-02 | 6.52e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 31 | 4.61e-01 | 7.65e-02 | 7.64e-01 |
| GOBP REGULATION OF ENDOSOME ORGANIZATION | 5 | 7.67e-01 | 7.64e-02 | 9.18e-01 |
| GOBP GLYCOLIPID CATABOLIC PROCESS | 11 | 6.61e-01 | 7.64e-02 | 8.72e-01 |
| GOBP VASCULAR PROCESS IN CIRCULATORY SYSTEM | 155 | 1.01e-01 | -7.64e-02 | 3.73e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 13 | 6.34e-01 | 7.63e-02 | 8.57e-01 |
| GOBP REGULATION OF BASEMENT MEMBRANE ORGANIZATION | 9 | 6.92e-01 | -7.63e-02 | 8.88e-01 |
| GOBP REGULATION OF NEURON DIFFERENTIATION | 98 | 1.92e-01 | -7.63e-02 | 5.11e-01 |
| GOBP ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER | 14 | 6.21e-01 | 7.62e-02 | 8.50e-01 |
| GOCC EXTRINSIC COMPONENT OF ENDOSOME MEMBRANE | 5 | 7.68e-01 | 7.62e-02 | 9.18e-01 |
| GOBP DIACYLGLYCEROL METABOLIC PROCESS | 23 | 5.27e-01 | 7.62e-02 | 8.02e-01 |
| GOMF LIPASE ACTIVATOR ACTIVITY | 15 | 6.10e-01 | 7.62e-02 | 8.46e-01 |
| GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 8 | 7.09e-01 | 7.62e-02 | 8.95e-01 |
| GOBP SNRNA TRANSCRIPTION | 18 | 5.76e-01 | -7.61e-02 | 8.31e-01 |
| GOBP ALCOHOL METABOLIC PROCESS | 250 | 3.86e-02 | 7.61e-02 | 2.27e-01 |
| GOBP CELLULAR RESPONSE TO PH | 16 | 5.98e-01 | -7.61e-02 | 8.40e-01 |
| GOBP POSITIVE REGULATION OF TOR SIGNALING | 62 | 3.01e-01 | -7.60e-02 | 6.39e-01 |
| GOBP MITOTIC SPINDLE ELONGATION | 11 | 6.62e-01 | 7.60e-02 | 8.73e-01 |
| GOBP MORPHOGENESIS OF A POLARIZED EPITHELIUM | 71 | 2.68e-01 | 7.60e-02 | 6.05e-01 |
| GOCC WNT SIGNALOSOME | 10 | 6.77e-01 | -7.60e-02 | 8.79e-01 |
| GOBP EPIGENETIC PROGRAMMING IN THE ZYGOTIC PRONUCLEI | 8 | 7.10e-01 | -7.60e-02 | 8.95e-01 |
| GOBP SPINDLE ELONGATION | 13 | 6.35e-01 | 7.59e-02 | 8.57e-01 |
| GOBP PROTEIN DESTABILIZATION | 47 | 3.68e-01 | -7.59e-02 | 6.99e-01 |
| GOBP DETERMINATION OF ADULT LIFESPAN | 25 | 5.12e-01 | -7.59e-02 | 7.93e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 75 | 2.56e-01 | -7.58e-02 | 5.91e-01 |
| GOBP AUTONOMIC NERVOUS SYSTEM DEVELOPMENT | 20 | 5.57e-01 | 7.58e-02 | 8.23e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC | 17 | 5.88e-01 | 7.58e-02 | 8.36e-01 |
| GOMF IRON ION BINDING | 83 | 2.33e-01 | 7.58e-02 | 5.63e-01 |
| GOBP SMALL MOLECULE BIOSYNTHETIC PROCESS | 435 | 6.89e-03 | 7.58e-02 | 8.24e-02 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS | 6 | 7.48e-01 | -7.58e-02 | 9.09e-01 |
| GOBP REGULATION OF KINASE ACTIVITY | 439 | 6.67e-03 | -7.57e-02 | 8.05e-02 |
| GOBP N TERMINAL PROTEIN LIPIDATION | 5 | 7.69e-01 | -7.57e-02 | 9.18e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 103 | 1.85e-01 | -7.57e-02 | 5.02e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 31 | 4.66e-01 | -7.56e-02 | 7.67e-01 |
| GOBP POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 18 | 5.79e-01 | -7.56e-02 | 8.32e-01 |
| GOBP GLIAL CELL PROLIFERATION | 38 | 4.20e-01 | -7.56e-02 | 7.39e-01 |
| GOBP PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 177 | 8.33e-02 | -7.56e-02 | 3.40e-01 |
| GOCC LATE ENDOSOME | 259 | 3.67e-02 | 7.55e-02 | 2.22e-01 |
| GOBP TERTIARY ALCOHOL METABOLIC PROCESS | 11 | 6.65e-01 | 7.55e-02 | 8.73e-01 |
| GOMF PROTEASE BINDING | 103 | 1.86e-01 | 7.55e-02 | 5.03e-01 |
| GOBP RESPONSE TO CHEMOKINE | 54 | 3.38e-01 | 7.54e-02 | 6.72e-01 |
| GOBP MITOTIC CELL CYCLE PROCESS | 672 | 9.06e-04 | -7.54e-02 | 2.05e-02 |
| GOCC MISMATCH REPAIR COMPLEX | 7 | 7.30e-01 | 7.54e-02 | 9.04e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING | 18 | 5.80e-01 | -7.53e-02 | 8.32e-01 |
| GOMF PHOSPHATIDYLSERINE 1 ACYLHYDROLASE ACTIVITY | 8 | 7.12e-01 | -7.53e-02 | 8.96e-01 |
| GOBP RETINA DEVELOPMENT IN CAMERA TYPE EYE | 97 | 2.00e-01 | -7.53e-02 | 5.22e-01 |
| GOBP LIPID DROPLET ORGANIZATION | 26 | 5.07e-01 | 7.53e-02 | 7.90e-01 |
| GOBP CELLULAR RESPONSE TO CAMP | 33 | 4.54e-01 | -7.53e-02 | 7.62e-01 |
| GOBP REGULATION OF CHOLESTEROL EFFLUX | 29 | 4.83e-01 | -7.53e-02 | 7.80e-01 |
| GOBP ETHER BIOSYNTHETIC PROCESS | 11 | 6.66e-01 | 7.53e-02 | 8.74e-01 |
| GOCC MYELIN SHEATH ADAXONAL REGION | 5 | 7.71e-01 | 7.52e-02 | 9.19e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 51 | 3.53e-01 | -7.52e-02 | 6.87e-01 |
| GOBP MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 117 | 1.60e-01 | -7.52e-02 | 4.68e-01 |
| GOBP GLUTAMINE TRANSPORT | 7 | 7.30e-01 | -7.52e-02 | 9.04e-01 |
| GOMF L GLUTAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 7.30e-01 | -7.52e-02 | 9.04e-01 |
| GOBP AMMONIUM TRANSMEMBRANE TRANSPORT | 9 | 6.96e-01 | 7.52e-02 | 8.88e-01 |
| GOMF AMMONIUM TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 6.96e-01 | 7.52e-02 | 8.88e-01 |
| GOBP STRIATED MUSCLE CELL DEVELOPMENT | 45 | 3.83e-01 | 7.52e-02 | 7.10e-01 |
| GOBP DOPAMINE SECRETION | 18 | 5.81e-01 | 7.52e-02 | 8.32e-01 |
| GOBP REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 84 | 2.34e-01 | 7.51e-02 | 5.65e-01 |
| GOMF CARBOHYDRATE BINDING | 165 | 9.64e-02 | -7.51e-02 | 3.66e-01 |
| GOBP REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 32 | 4.62e-01 | -7.51e-02 | 7.65e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 24 | 5.25e-01 | -7.50e-02 | 8.00e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 26 | 5.08e-01 | 7.50e-02 | 7.91e-01 |
| GOBP ACTIN FILAMENT BUNDLE ORGANIZATION | 127 | 1.45e-01 | 7.50e-02 | 4.45e-01 |
| GOCC SPLICEOSOMAL TRI SNRNP COMPLEX | 36 | 4.36e-01 | 7.50e-02 | 7.51e-01 |
| GOBP RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM | 47 | 3.74e-01 | -7.50e-02 | 7.02e-01 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS | 154 | 1.09e-01 | -7.49e-02 | 3.87e-01 |
| GOBP OXIDATIVE DEMETHYLATION | 7 | 7.32e-01 | 7.49e-02 | 9.04e-01 |
| GOBP REGULATION OF SPINDLE ASSEMBLY | 31 | 4.71e-01 | -7.48e-02 | 7.71e-01 |
| GOBP REGULATION OF B CELL PROLIFERATION | 48 | 3.70e-01 | -7.48e-02 | 7.00e-01 |
| GOBP REGULATION OF DNA DEMETHYLATION | 8 | 7.14e-01 | -7.48e-02 | 8.96e-01 |
| GOBP REGULATION OF PHOSPHORYLATION | 757 | 4.98e-04 | -7.48e-02 | 1.31e-02 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ORGANIZATION | 305 | 2.51e-02 | -7.47e-02 | 1.79e-01 |
| GOBP SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 9 | 6.98e-01 | 7.47e-02 | 8.89e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 19 | 5.73e-01 | 7.47e-02 | 8.30e-01 |
| GOBP ORGANELLE TRANSPORT ALONG MICROTUBULE | 79 | 2.51e-01 | 7.47e-02 | 5.86e-01 |
| GOBP PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING | 13 | 6.41e-01 | 7.46e-02 | 8.60e-01 |
| GOBP REGULATION OF NK T CELL ACTIVATION | 8 | 7.15e-01 | 7.46e-02 | 8.97e-01 |
| GOMF PHOSPHATASE BINDING | 162 | 1.02e-01 | -7.46e-02 | 3.74e-01 |
| GOBP REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 151 | 1.14e-01 | -7.46e-02 | 3.97e-01 |
| GOCC SERINE TYPE ENDOPEPTIDASE COMPLEX | 5 | 7.73e-01 | 7.45e-02 | 9.20e-01 |
| GOBP NEGATIVE REGULATION OF MOLECULAR FUNCTION | 537 | 3.26e-03 | -7.45e-02 | 5.06e-02 |
| GOBP MAINTENANCE OF SYNAPSE STRUCTURE | 18 | 5.84e-01 | 7.45e-02 | 8.34e-01 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 30 | 4.80e-01 | -7.45e-02 | 7.77e-01 |
| GOMF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 7 | 7.33e-01 | -7.45e-02 | 9.04e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 568 | 2.53e-03 | -7.44e-02 | 4.28e-02 |
| GOCC RECYCLING ENDOSOME MEMBRANE | 90 | 2.23e-01 | 7.44e-02 | 5.51e-01 |
| GOBP POSITIVE REGULATION OF B CELL ACTIVATION | 70 | 2.82e-01 | -7.44e-02 | 6.20e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 23 | 5.37e-01 | -7.43e-02 | 8.09e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 13 | 6.43e-01 | 7.43e-02 | 8.61e-01 |
| GOBP FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 9 | 7.00e-01 | 7.43e-02 | 8.89e-01 |
| GOBP PROTEIN LIPID COMPLEX ASSEMBLY | 20 | 5.65e-01 | -7.43e-02 | 8.28e-01 |
| GOBP MICROTUBULE NUCLEATION | 44 | 3.94e-01 | -7.43e-02 | 7.19e-01 |
| GOMF ALPHA TUBULIN BINDING | 36 | 4.41e-01 | -7.42e-02 | 7.53e-01 |
| GOBP HISTONE MRNA METABOLIC PROCESS | 24 | 5.29e-01 | -7.42e-02 | 8.03e-01 |
| GOBP VESICLE LOCALIZATION | 186 | 8.13e-02 | 7.42e-02 | 3.35e-01 |
| GOMF UBIQUITIN SPECIFIC PROTEASE BINDING | 19 | 5.75e-01 | 7.42e-02 | 8.31e-01 |
| GOBP REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 10 | 6.85e-01 | 7.42e-02 | 8.83e-01 |
| GOBP CONNECTIVE TISSUE REPLACEMENT INVOLVED IN INFLAMMATORY RESPONSE WOUND HEALING | 6 | 7.53e-01 | 7.42e-02 | 9.12e-01 |
| GOBP REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION | 78 | 2.58e-01 | -7.42e-02 | 5.93e-01 |
| GOCC NEURON PROJECTION MEMBRANE | 34 | 4.54e-01 | -7.42e-02 | 7.62e-01 |
| GOMF TOLL LIKE RECEPTOR 4 BINDING | 5 | 7.74e-01 | 7.41e-02 | 9.20e-01 |
| GOBP RRNA TRANSCRIPTION | 33 | 4.61e-01 | -7.41e-02 | 7.64e-01 |
| GOBP NEGATIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 7 | 7.34e-01 | 7.41e-02 | 9.04e-01 |
| GOBP PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 55 | 3.42e-01 | 7.41e-02 | 6.78e-01 |
| GOBP REGULATION OF LIPID TRANSPORT | 87 | 2.33e-01 | 7.41e-02 | 5.63e-01 |
| GOBP GLAND DEVELOPMENT | 271 | 3.62e-02 | -7.41e-02 | 2.20e-01 |
| GOBP LEUKOCYTE AGGREGATION | 11 | 6.71e-01 | 7.40e-02 | 8.77e-01 |
| GOBP BIOGENIC AMINE METABOLIC PROCESS | 64 | 3.06e-01 | 7.40e-02 | 6.45e-01 |
| GOBP BLOOD COAGULATION FIBRIN CLOT FORMATION | 7 | 7.34e-01 | 7.40e-02 | 9.04e-01 |
| GOMF MOLECULAR TRANSDUCER ACTIVITY | 552 | 3.06e-03 | -7.40e-02 | 4.85e-02 |
| GOBP DNA DEAMINATION | 12 | 6.57e-01 | 7.40e-02 | 8.70e-01 |
| GOMF SNORNA BINDING | 32 | 4.69e-01 | 7.40e-02 | 7.68e-01 |
| GOMF MOLECULAR TAG ACTIVITY | 12 | 6.57e-01 | 7.40e-02 | 8.70e-01 |
| GOBP G PROTEIN COUPLED OPIOID RECEPTOR SIGNALING PATHWAY | 7 | 7.35e-01 | -7.40e-02 | 9.04e-01 |
| GOBP LONG CHAIN FATTY ACID TRANSPORT | 38 | 4.30e-01 | 7.39e-02 | 7.48e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 7 | 7.35e-01 | -7.39e-02 | 9.04e-01 |
| GOBP CERAMIDE CATABOLIC PROCESS | 12 | 6.58e-01 | 7.39e-02 | 8.70e-01 |
| GOBP LIPID TRANSPORT ACROSS BLOOD BRAIN BARRIER | 6 | 7.54e-01 | 7.39e-02 | 9.12e-01 |
| GOMF RETINOIC ACID BINDING | 6 | 7.54e-01 | -7.39e-02 | 9.12e-01 |
| GOBP RETINAL METABOLIC PROCESS | 11 | 6.71e-01 | -7.39e-02 | 8.77e-01 |
| GOMF THREONINE TYPE PEPTIDASE ACTIVITY | 12 | 6.58e-01 | -7.39e-02 | 8.70e-01 |
| GOCC AXONAL GROWTH CONE | 20 | 5.68e-01 | 7.38e-02 | 8.28e-01 |
| GOBP TRANSPORT ALONG MICROTUBULE | 150 | 1.19e-01 | 7.38e-02 | 4.03e-01 |
| GOMF RNA DIRECTED DNA POLYMERASE ACTIVITY | 5 | 7.76e-01 | 7.36e-02 | 9.21e-01 |
| GOMF TELOMERASE ACTIVITY | 5 | 7.76e-01 | 7.36e-02 | 9.21e-01 |
| GOMF RNA NUCLEASE ACTIVITY | 111 | 1.81e-01 | -7.36e-02 | 4.97e-01 |
| GOBP NEURON NEURON SYNAPTIC TRANSMISSION | 5 | 7.76e-01 | 7.36e-02 | 9.21e-01 |
| GOBP CHONDROCYTE DEVELOPMENT | 18 | 5.89e-01 | 7.36e-02 | 8.36e-01 |
| GOBP REGULATION OF STORE OPERATED CALCIUM ENTRY | 11 | 6.73e-01 | -7.35e-02 | 8.78e-01 |
| GOBP NEGATIVE REGULATION OF P38MAPK CASCADE | 7 | 7.37e-01 | 7.34e-02 | 9.05e-01 |
| GOBP NUCLEOBASE METABOLIC PROCESS | 34 | 4.59e-01 | 7.33e-02 | 7.64e-01 |
| GOBP POSITIVE REGULATION OF ACTIN NUCLEATION | 12 | 6.60e-01 | 7.33e-02 | 8.72e-01 |
| GOBP REGULATION OF CILIUM DEPENDENT CELL MOTILITY | 12 | 6.60e-01 | 7.33e-02 | 8.72e-01 |
| GOBP FORMATION OF PRIMARY GERM LAYER | 73 | 2.79e-01 | 7.33e-02 | 6.16e-01 |
| GOMF AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 55 | 3.47e-01 | 7.33e-02 | 6.83e-01 |
| GOBP FEEDING BEHAVIOR | 41 | 4.17e-01 | -7.33e-02 | 7.35e-01 |
| GOMF ACYL COA OXIDASE ACTIVITY | 5 | 7.77e-01 | -7.33e-02 | 9.21e-01 |
| GOBP RETROGRADE TRANS SYNAPTIC SIGNALING | 7 | 7.37e-01 | 7.33e-02 | 9.05e-01 |
| GOMF BETA TUBULIN BINDING | 36 | 4.47e-01 | -7.32e-02 | 7.57e-01 |
| GOBP NEURON PROJECTION EXTENSION | 127 | 1.55e-01 | 7.32e-02 | 4.59e-01 |
| GOBP METANEPHROS DEVELOPMENT | 45 | 3.96e-01 | 7.32e-02 | 7.20e-01 |
| GOBP CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC | 63 | 3.15e-01 | -7.32e-02 | 6.54e-01 |
| GOBP REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 152 | 1.20e-01 | -7.31e-02 | 4.05e-01 |
| GOBP REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY | 47 | 3.86e-01 | -7.31e-02 | 7.12e-01 |
| GOBP REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE | 8 | 7.20e-01 | 7.31e-02 | 8.99e-01 |
| GOMF HEXOSYLTRANSFERASE ACTIVITY | 134 | 1.44e-01 | 7.31e-02 | 4.45e-01 |
| GOBP REGULATION OF TUBE SIZE | 74 | 2.77e-01 | -7.31e-02 | 6.15e-01 |
| GOBP MICROTUBULE BASED TRANSPORT | 177 | 9.44e-02 | 7.30e-02 | 3.62e-01 |
| GOMF DNA INSERTION OR DELETION BINDING | 6 | 7.57e-01 | -7.30e-02 | 9.14e-01 |
| GOBP POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION | 13 | 6.49e-01 | -7.29e-02 | 8.65e-01 |
| GOBP REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 33 | 4.69e-01 | -7.29e-02 | 7.68e-01 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 562 | 3.25e-03 | -7.29e-02 | 5.05e-02 |
| GOBP POSITIVE REGULATION OF DNA BINDING | 29 | 4.97e-01 | 7.29e-02 | 7.86e-01 |
| GOBP AMINE METABOLIC PROCESS | 74 | 2.79e-01 | 7.29e-02 | 6.16e-01 |
| GOBP PROTEIN DEPOLYMERIZATION | 92 | 2.27e-01 | -7.29e-02 | 5.56e-01 |
| GOBP POSITIVE REGULATION OF MACROAUTOPHAGY | 65 | 3.10e-01 | -7.28e-02 | 6.50e-01 |
| GOCC KERATIN FILAMENT | 10 | 6.90e-01 | 7.28e-02 | 8.87e-01 |
| GOBP REGULATION OF BLOOD VESSEL REMODELING | 5 | 7.78e-01 | 7.28e-02 | 9.21e-01 |
| GOBP NEGATIVE REGULATION OF BONE REMODELING | 9 | 7.05e-01 | -7.28e-02 | 8.93e-01 |
| GOBP AMINO SUGAR CATABOLIC PROCESS | 13 | 6.50e-01 | 7.27e-02 | 8.66e-01 |
| GOBP RESPONSE TO XENOBIOTIC STIMULUS | 262 | 4.34e-02 | -7.26e-02 | 2.42e-01 |
| GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC STRUCTURE | 7 | 7.39e-01 | 7.26e-02 | 9.06e-01 |
| GOBP NEGATIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 6 | 7.58e-01 | 7.26e-02 | 9.14e-01 |
| GOMF MINOR GROOVE OF ADENINE THYMINE RICH DNA BINDING | 6 | 7.58e-01 | -7.26e-02 | 9.14e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO TYPE II INTERFERON | 5 | 7.79e-01 | 7.26e-02 | 9.21e-01 |
| GOBP ORGANIC ACID METABOLIC PROCESS | 690 | 1.23e-03 | 7.25e-02 | 2.53e-02 |
| GOBP FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA | 14 | 6.39e-01 | -7.24e-02 | 8.59e-01 |
| GOBP N TERMINAL PROTEIN AMINO ACID MODIFICATION | 24 | 5.41e-01 | 7.22e-02 | 8.13e-01 |
| GOBP REGULATION OF MONOOXYGENASE ACTIVITY | 28 | 5.09e-01 | 7.22e-02 | 7.91e-01 |
| GOMF TRANSLATION FACTOR ACTIVITY RNA BINDING | 81 | 2.62e-01 | 7.21e-02 | 5.98e-01 |
| GOBP POSITIVE REGULATION OF LIPID TRANSPORT | 55 | 3.55e-01 | 7.21e-02 | 6.89e-01 |
| GOCC MITOCHONDRIAL PERMEABILITY TRANSITION PORE COMPLEX | 6 | 7.60e-01 | 7.21e-02 | 9.14e-01 |
| GOCC U1 SNRNP | 19 | 5.86e-01 | -7.21e-02 | 8.35e-01 |
| GOMF MODIFIED AMINO ACID BINDING | 55 | 3.55e-01 | -7.21e-02 | 6.89e-01 |
| GOBP MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 40 | 4.30e-01 | -7.21e-02 | 7.48e-01 |
| GOBP TORC2 SIGNALING | 15 | 6.29e-01 | -7.20e-02 | 8.55e-01 |
| GOBP CELL CYCLE G2 M PHASE TRANSITION | 142 | 1.39e-01 | -7.20e-02 | 4.37e-01 |
| GOMF RNA EXONUCLEASE ACTIVITY | 43 | 4.14e-01 | -7.20e-02 | 7.32e-01 |
| GOBP NEGATIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 23 | 5.50e-01 | -7.20e-02 | 8.19e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 19 | 5.87e-01 | -7.19e-02 | 8.35e-01 |
| GOBP ALDITOL METABOLIC PROCESS | 16 | 6.19e-01 | 7.19e-02 | 8.49e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 720 | 1.09e-03 | -7.18e-02 | 2.34e-02 |
| GOBP LEUKOCYTE PROLIFERATION | 240 | 5.58e-02 | -7.18e-02 | 2.72e-01 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE | 18 | 5.98e-01 | 7.18e-02 | 8.40e-01 |
| GOBP GLUCOSE IMPORT | 51 | 3.76e-01 | -7.17e-02 | 7.04e-01 |
| GOBP RESPONSE TO PAIN | 18 | 5.98e-01 | -7.17e-02 | 8.40e-01 |
| GOCC MLL1 2 COMPLEX | 32 | 4.83e-01 | -7.17e-02 | 7.80e-01 |
| GOMF L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 44 | 4.11e-01 | 7.17e-02 | 7.30e-01 |
| GOBP TRACHEA DEVELOPMENT | 12 | 6.67e-01 | -7.17e-02 | 8.75e-01 |
| GOBP HYDROGEN PEROXIDE CATABOLIC PROCESS | 15 | 6.31e-01 | 7.17e-02 | 8.56e-01 |
| GOBP SMAD PROTEIN SIGNAL TRANSDUCTION | 56 | 3.54e-01 | -7.17e-02 | 6.87e-01 |
| GOBP STRIATED MUSCLE CELL APOPTOTIC PROCESS | 32 | 4.83e-01 | -7.16e-02 | 7.80e-01 |
| GOBP REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 13 | 6.55e-01 | 7.16e-02 | 8.69e-01 |
| GOBP FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS | 24 | 5.44e-01 | 7.16e-02 | 8.15e-01 |
| GOBP POTASSIUM ION HOMEOSTASIS | 17 | 6.10e-01 | -7.16e-02 | 8.46e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 60 | 3.38e-01 | -7.16e-02 | 6.72e-01 |
| GOBP POSITIVE REGULATION OF BLOOD PRESSURE | 13 | 6.55e-01 | 7.15e-02 | 8.69e-01 |
| GOBP TRANSPOSITION | 20 | 5.80e-01 | -7.15e-02 | 8.32e-01 |
| GOBP CENTROMERIC SISTER CHROMATID COHESION | 10 | 6.96e-01 | 7.14e-02 | 8.88e-01 |
| GOBP RESPIRATORY SYSTEM DEVELOPMENT | 129 | 1.62e-01 | -7.14e-02 | 4.70e-01 |
| GOBP RAS PROTEIN SIGNAL TRANSDUCTION | 290 | 3.70e-02 | -7.14e-02 | 2.23e-01 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION | 10 | 6.96e-01 | -7.13e-02 | 8.88e-01 |
| GOBP VIRAL PROTEIN PROCESSING | 30 | 4.99e-01 | -7.13e-02 | 7.87e-01 |
| GOMF RRNA BINDING | 64 | 3.25e-01 | -7.12e-02 | 6.63e-01 |
| GOBP STEROID METABOLIC PROCESS | 199 | 8.37e-02 | 7.12e-02 | 3.40e-01 |
| GOBP O GLYCAN PROCESSING | 32 | 4.86e-01 | 7.12e-02 | 7.81e-01 |
| GOBP POSTSYNAPSE ASSEMBLY | 22 | 5.63e-01 | 7.12e-02 | 8.26e-01 |
| GOBP HEAD DEVELOPMENT | 493 | 7.05e-03 | -7.11e-02 | 8.36e-02 |
| GOBP MEMBRANE RAFT ORGANIZATION | 22 | 5.64e-01 | -7.11e-02 | 8.26e-01 |
| GOBP ACTIN MEDIATED CELL CONTRACTION | 64 | 3.26e-01 | 7.10e-02 | 6.63e-01 |
| GOMF DOPAMINE RECEPTOR BINDING | 11 | 6.83e-01 | 7.10e-02 | 8.83e-01 |
| GOMF GLYCOLIPID MANNOSYLTRANSFERASE ACTIVITY | 5 | 7.83e-01 | 7.10e-02 | 9.22e-01 |
| GOBP REGULATION OF INTEGRIN ACTIVATION | 13 | 6.58e-01 | 7.10e-02 | 8.70e-01 |
| GOBP CARDIOBLAST DIFFERENTIATION | 10 | 6.98e-01 | -7.10e-02 | 8.89e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO STRESS | 563 | 4.16e-03 | -7.09e-02 | 5.94e-02 |
| GOBP POSITIVE REGULATION OF PROTEIN GLYCOSYLATION | 8 | 7.28e-01 | 7.09e-02 | 9.03e-01 |
| GOBP DOLICHYL DIPHOSPHATE METABOLIC PROCESS | 5 | 7.84e-01 | 7.09e-02 | 9.22e-01 |
| GOBP MITOTIC DNA INTEGRITY CHECKPOINT SIGNALING | 83 | 2.65e-01 | -7.09e-02 | 6.02e-01 |
| GOMF SPHINGOSINE 1 PHOSPHATE PHOSPHATASE ACTIVITY | 5 | 7.84e-01 | 7.09e-02 | 9.22e-01 |
| GOMF METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 241 | 5.91e-02 | 7.07e-02 | 2.80e-01 |
| GOBP LEUKOCYTE MEDIATED CYTOTOXICITY | 89 | 2.50e-01 | -7.06e-02 | 5.84e-01 |
| GOCC ORGANELLE SUBCOMPARTMENT | 1182 | 5.10e-05 | 7.06e-02 | 2.35e-03 |
| GOCC SPECIFIC GRANULE | 128 | 1.69e-01 | -7.05e-02 | 4.81e-01 |
| GOMF BRANCHED CHAIN AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 7.47e-01 | 7.05e-02 | 9.09e-01 |
| GOBP REGULATION OF T CIRCLE FORMATION | 6 | 7.65e-01 | 7.05e-02 | 9.17e-01 |
| GOBP REGULATION OF PHOSPHOLIPID TRANSPORT | 13 | 6.60e-01 | -7.05e-02 | 8.72e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 16 | 6.26e-01 | 7.05e-02 | 8.52e-01 |
| GOBP LIVER MORPHOGENESIS | 18 | 6.05e-01 | -7.05e-02 | 8.43e-01 |
| GOBP KIDNEY EPITHELIUM DEVELOPMENT | 76 | 2.89e-01 | 7.05e-02 | 6.27e-01 |
| GOBP FERTILIZATION | 96 | 2.33e-01 | 7.04e-02 | 5.64e-01 |
| GOMF CARNITINE O ACYLTRANSFERASE ACTIVITY | 5 | 7.85e-01 | 7.04e-02 | 9.22e-01 |
| GOBP RECEPTOR INTERNALIZATION | 89 | 2.52e-01 | -7.03e-02 | 5.86e-01 |
| GOBP NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY | 22 | 5.68e-01 | 7.03e-02 | 8.28e-01 |
| GOBP RESPONSE TO MUSCLE STRETCH | 19 | 5.96e-01 | -7.03e-02 | 8.39e-01 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 178 | 1.07e-01 | -7.02e-02 | 3.82e-01 |
| GOMF CHONDROITIN SULFATE BINDING | 7 | 7.48e-01 | -7.02e-02 | 9.09e-01 |
| GOBP NUCLEAR MIGRATION | 23 | 5.60e-01 | -7.02e-02 | 8.26e-01 |
| GOBP POSTSYNAPSE TO NUCLEUS SIGNALING PATHWAY | 5 | 7.86e-01 | 7.02e-02 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 22 | 5.69e-01 | -7.01e-02 | 8.28e-01 |
| GOBP PROTEIN LOCALIZATION TO PERINUCLEAR REGION OF CYTOPLASM | 5 | 7.86e-01 | 7.01e-02 | 9.23e-01 |
| GOBP LYMPHOCYTE COSTIMULATION | 32 | 4.93e-01 | -7.01e-02 | 7.84e-01 |
| GOBP POSITIVE REGULATION OF HORMONE SECRETION | 77 | 2.88e-01 | -7.00e-02 | 6.27e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE | 112 | 2.01e-01 | -7.00e-02 | 5.23e-01 |
| GOCC STEREOCILIUM TIP | 11 | 6.88e-01 | 7.00e-02 | 8.86e-01 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION | 202 | 8.68e-02 | -7.00e-02 | 3.45e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS | 26 | 5.37e-01 | -6.99e-02 | 8.09e-01 |
| GOBP LEUKOCYTE HOMEOSTASIS | 88 | 2.57e-01 | -6.99e-02 | 5.93e-01 |
| GOBP RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 50 | 3.93e-01 | 6.99e-02 | 7.18e-01 |
| GOBP INTESTINAL STEM CELL HOMEOSTASIS | 5 | 7.87e-01 | 6.99e-02 | 9.23e-01 |
| GOMF BILE ACID BINDING | 5 | 7.87e-01 | 6.98e-02 | 9.23e-01 |
| GOBP NEGATIVE REGULATION OF LIPID TRANSPORT | 18 | 6.08e-01 | 6.98e-02 | 8.46e-01 |
| GOBP SENSORY PERCEPTION OF TASTE | 14 | 6.51e-01 | -6.98e-02 | 8.66e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 15 | 6.40e-01 | -6.98e-02 | 8.60e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 8 | 7.33e-01 | 6.97e-02 | 9.04e-01 |
| GOCC SEH1 ASSOCIATED COMPLEX | 8 | 7.33e-01 | 6.97e-02 | 9.04e-01 |
| GOCC DENDRITE TERMINUS | 12 | 6.76e-01 | 6.97e-02 | 8.79e-01 |
| GOBP ACTIN FILAMENT DEPOLYMERIZATION | 47 | 4.09e-01 | 6.96e-02 | 7.29e-01 |
| GOBP BILE ACID METABOLIC PROCESS | 32 | 4.96e-01 | -6.96e-02 | 7.85e-01 |
| GOBP NEGATIVE REGULATION OF LOCOMOTION | 229 | 7.02e-02 | -6.96e-02 | 3.08e-01 |
| GOBP IMMUNE RESPONSE TO TUMOR CELL | 19 | 6.00e-01 | 6.96e-02 | 8.40e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO FOOD | 6 | 7.68e-01 | 6.95e-02 | 9.18e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 6 | 7.68e-01 | 6.95e-02 | 9.18e-01 |
| GOBP HEPATICOBILIARY SYSTEM DEVELOPMENT | 99 | 2.33e-01 | -6.95e-02 | 5.63e-01 |
| GOCC U4 SNRNP | 10 | 7.04e-01 | 6.95e-02 | 8.92e-01 |
| GOBP RESPONSE TO BACTERIUM | 410 | 1.61e-02 | -6.95e-02 | 1.41e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE METABOLIC PROCESS | 9 | 7.18e-01 | 6.94e-02 | 8.98e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATIONAL INITIATION | 24 | 5.56e-01 | 6.94e-02 | 8.22e-01 |
| GOBP REGULATION OF MUSCLE SYSTEM PROCESS | 141 | 1.55e-01 | -6.94e-02 | 4.61e-01 |
| GOMF EXTRACELLULAR MATRIX CONSTITUENT CONFERRING ELASTICITY | 6 | 7.69e-01 | 6.93e-02 | 9.18e-01 |
| GOBP MAMMARY GLAND DEVELOPMENT | 86 | 2.67e-01 | -6.93e-02 | 6.04e-01 |
| GOBP STRESS INDUCED PREMATURE SENESCENCE | 5 | 7.88e-01 | -6.93e-02 | 9.24e-01 |
| GOMF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY | 22 | 5.74e-01 | -6.92e-02 | 8.31e-01 |
| GOBP GROWTH PLATE CARTILAGE CHONDROCYTE DIFFERENTIATION | 7 | 7.51e-01 | -6.92e-02 | 9.11e-01 |
| GOBP STARTLE RESPONSE | 16 | 6.32e-01 | -6.92e-02 | 8.56e-01 |
| GOMF TRNA BINDING | 68 | 3.24e-01 | 6.91e-02 | 6.63e-01 |
| GOBP REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 34 | 4.85e-01 | -6.91e-02 | 7.81e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEAR ENVELOPE | 13 | 6.66e-01 | 6.91e-02 | 8.75e-01 |
| GOMF DNA EXONUCLEASE ACTIVITY | 23 | 5.66e-01 | -6.91e-02 | 8.28e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA BINDING | 18 | 6.12e-01 | 6.91e-02 | 8.46e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 65 | 3.36e-01 | -6.91e-02 | 6.70e-01 |
| GOBP CARDIOCYTE DIFFERENTIATION | 97 | 2.40e-01 | -6.91e-02 | 5.73e-01 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE | 207 | 8.73e-02 | -6.91e-02 | 3.45e-01 |
| GOMF SECONDARY ACTIVE SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 7.05e-01 | 6.90e-02 | 8.93e-01 |
| GOBP POSITIVE REGULATION OF MIRNA TRANSCRIPTION | 38 | 4.62e-01 | -6.90e-02 | 7.64e-01 |
| GOBP GLUTATHIONE TRANSMEMBRANE TRANSPORT | 6 | 7.70e-01 | -6.90e-02 | 9.18e-01 |
| GOBP ACTIVATION OF GTPASE ACTIVITY | 78 | 2.93e-01 | -6.90e-02 | 6.31e-01 |
| GOBP NUCLEOSIDE TRANSMEMBRANE TRANSPORT | 6 | 7.70e-01 | -6.90e-02 | 9.18e-01 |
| GOBP STORE OPERATED CALCIUM ENTRY | 16 | 6.33e-01 | 6.90e-02 | 8.57e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 12 | 6.79e-01 | -6.89e-02 | 8.80e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY INVOLVED IN VENTRAL SPINAL CORD PATTERNING | 6 | 7.70e-01 | -6.89e-02 | 9.18e-01 |
| GOBP REGULATION OF LYASE ACTIVITY | 28 | 5.28e-01 | 6.89e-02 | 8.02e-01 |
| GOBP FACIAL NERVE MORPHOGENESIS | 5 | 7.90e-01 | -6.89e-02 | 9.24e-01 |
| GOBP SENSORY SYSTEM DEVELOPMENT | 229 | 7.32e-02 | -6.88e-02 | 3.16e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST PROLIFERATION | 6 | 7.71e-01 | 6.87e-02 | 9.19e-01 |
| GOBP PROTEIN CONTAINING COMPLEX DISASSEMBLY | 218 | 8.08e-02 | -6.87e-02 | 3.35e-01 |
| GOBP LONG TERM MEMORY | 22 | 5.77e-01 | 6.87e-02 | 8.32e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 55 | 3.78e-01 | -6.87e-02 | 7.06e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE | 16 | 6.34e-01 | 6.87e-02 | 8.57e-01 |
| GOCC CYTOSOLIC REGION | 18 | 6.14e-01 | 6.87e-02 | 8.48e-01 |
| GOBP MITOTIC NUCLEAR MEMBRANE ORGANIZATION | 10 | 7.07e-01 | -6.86e-02 | 8.94e-01 |
| GOCC SYMMETRIC SYNAPSE | 5 | 7.90e-01 | 6.86e-02 | 9.24e-01 |
| GOMF DEATH DOMAIN BINDING | 10 | 7.07e-01 | 6.86e-02 | 8.94e-01 |
| GOBP REGULATION OF PROTEIN MODIFICATION PROCESS | 998 | 2.72e-04 | -6.86e-02 | 8.24e-03 |
| GOBP ENDOCRINE HORMONE SECRETION | 30 | 5.16e-01 | 6.86e-02 | 7.95e-01 |
| GOBP ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS | 435 | 1.45e-02 | -6.86e-02 | 1.32e-01 |
| GOCC CUL2 RING UBIQUITIN LIGASE COMPLEX | 20 | 5.96e-01 | -6.86e-02 | 8.39e-01 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME BINDING | 33 | 4.96e-01 | -6.86e-02 | 7.85e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINESIS | 34 | 4.89e-01 | 6.85e-02 | 7.82e-01 |
| GOMF PHOSPHOLIPASE C ACTIVITY | 18 | 6.15e-01 | -6.85e-02 | 8.48e-01 |
| GOBP ATTACHMENT OF GPI ANCHOR TO PROTEIN | 6 | 7.72e-01 | 6.85e-02 | 9.19e-01 |
| GOBP SPROUTING ANGIOGENESIS | 80 | 2.90e-01 | 6.85e-02 | 6.29e-01 |
| GOMF PYRIMIDINE NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 7.22e-01 | -6.84e-02 | 9.00e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 9 | 7.22e-01 | 6.84e-02 | 9.00e-01 |
| GOBP INTERLEUKIN 1 ALPHA PRODUCTION | 5 | 7.91e-01 | -6.84e-02 | 9.24e-01 |
| GOBP POSITIVE REGULATION OF SIGNALING | 1228 | 6.48e-05 | -6.84e-02 | 2.82e-03 |
| GOBP REGULATION OF CELL CELL ADHESION | 337 | 3.15e-02 | -6.83e-02 | 2.03e-01 |
| GOBP COLLECTING DUCT DEVELOPMENT | 7 | 7.54e-01 | -6.83e-02 | 9.12e-01 |
| GOMF DIPEPTIDASE ACTIVITY | 12 | 6.82e-01 | 6.83e-02 | 8.82e-01 |
| GOMF WIDE PORE CHANNEL ACTIVITY | 15 | 6.47e-01 | -6.83e-02 | 8.64e-01 |
| GOMF TRANSMITTER GATED CHANNEL ACTIVITY | 18 | 6.16e-01 | -6.83e-02 | 8.48e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE | 38 | 4.67e-01 | 6.83e-02 | 7.67e-01 |
| GOMF DNA DAMAGE SENSOR ACTIVITY | 19 | 6.06e-01 | -6.83e-02 | 8.45e-01 |
| GOBP REGULATION OF EXECUTION PHASE OF APOPTOSIS | 13 | 6.70e-01 | 6.83e-02 | 8.77e-01 |
| GOBP SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 154 | 1.44e-01 | -6.82e-02 | 4.45e-01 |
| GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING | 9 | 7.23e-01 | -6.82e-02 | 9.01e-01 |
| GOBP POSITIVE REGULATION OF COAGULATION | 21 | 5.89e-01 | 6.82e-02 | 8.36e-01 |
| GOCC PHOTORECEPTOR OUTER SEGMENT | 56 | 3.78e-01 | 6.81e-02 | 7.05e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOSOME | 26 | 5.48e-01 | 6.81e-02 | 8.18e-01 |
| GOBP NUCLEOLUS ORGANIZATION | 17 | 6.27e-01 | -6.81e-02 | 8.53e-01 |
| GOBP MALE MEIOTIC NUCLEAR DIVISION | 31 | 5.12e-01 | -6.81e-02 | 7.93e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE BINDING | 151 | 1.49e-01 | -6.80e-02 | 4.53e-01 |
| GOBP STEROL TRANSPORT | 95 | 2.52e-01 | 6.80e-02 | 5.87e-01 |
| GOBP RETICULOPHAGY | 17 | 6.27e-01 | 6.80e-02 | 8.53e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 311 | 3.97e-02 | -6.80e-02 | 2.30e-01 |
| GOBP CELLULAR RESPONSE TO STRESS | 1638 | 5.98e-06 | -6.80e-02 | 4.06e-04 |
| GOBP REGULATION OF ATP BIOSYNTHETIC PROCESS | 13 | 6.72e-01 | -6.79e-02 | 8.77e-01 |
| GOCC CATION CHANNEL COMPLEX | 96 | 2.51e-01 | 6.79e-02 | 5.85e-01 |
| GOBP SYNAPTIC TRANSMISSION CHOLINERGIC | 12 | 6.84e-01 | -6.78e-02 | 8.83e-01 |
| GOBP PLASMA MEMBRANE ORGANIZATION | 121 | 1.98e-01 | 6.78e-02 | 5.19e-01 |
| GOMF UBIQUITIN CONJUGATING ENZYME BINDING | 27 | 5.42e-01 | -6.78e-02 | 8.13e-01 |
| GOBP RIBOSOME ASSEMBLY | 57 | 3.76e-01 | 6.78e-02 | 7.04e-01 |
| GOBP DENDRITIC SPINE MAINTENANCE | 18 | 6.19e-01 | -6.77e-02 | 8.49e-01 |
| GOBP REGULATION OF PEPTIDASE ACTIVITY | 218 | 8.53e-02 | -6.77e-02 | 3.43e-01 |
| GOBP REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 136 | 1.73e-01 | -6.77e-02 | 4.88e-01 |
| GOBP CARDIAC VENTRICLE DEVELOPMENT | 71 | 3.25e-01 | -6.76e-02 | 6.63e-01 |
| GOMF SIGNALING RECEPTOR REGULATOR ACTIVITY | 208 | 9.33e-02 | 6.76e-02 | 3.60e-01 |
| GOBP REGULATION OF NEURONAL SYNAPTIC PLASTICITY | 35 | 4.89e-01 | -6.76e-02 | 7.82e-01 |
| GOMF 3 5 DNA HELICASE ACTIVITY | 15 | 6.51e-01 | -6.76e-02 | 8.66e-01 |
| GOBP DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 586 | 5.42e-03 | -6.75e-02 | 7.17e-02 |
| GOBP TELOMERIC D LOOP DISASSEMBLY | 8 | 7.41e-01 | 6.75e-02 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 15 | 6.51e-01 | -6.74e-02 | 8.66e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 19 | 6.11e-01 | -6.74e-02 | 8.46e-01 |
| GOBP MYELOID LEUKOCYTE MIGRATION | 168 | 1.32e-01 | -6.74e-02 | 4.26e-01 |
| GOBP VESICLE TETHERING | 32 | 5.10e-01 | -6.74e-02 | 7.92e-01 |
| GOMF POTASSIUM PROTON ANTIPORTER ACTIVITY | 9 | 7.27e-01 | -6.73e-02 | 9.03e-01 |
| GOBP POSITIVE REGULATION OF HEAT GENERATION | 6 | 7.75e-01 | -6.72e-02 | 9.21e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE B ACTIVITY | 15 | 6.52e-01 | -6.72e-02 | 8.67e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING | 12 | 6.87e-01 | -6.72e-02 | 8.85e-01 |
| GOBP ESTABLISHMENT OF BLOOD BRAIN BARRIER | 10 | 7.13e-01 | 6.71e-02 | 8.96e-01 |
| GOMF CELL CELL ADHESION MEDIATOR ACTIVITY | 29 | 5.32e-01 | 6.71e-02 | 8.05e-01 |
| GOBP HAIR FOLLICLE MATURATION | 10 | 7.14e-01 | -6.70e-02 | 8.96e-01 |
| GOMF AMINO ACID MONOATOMIC CATION SYMPORTER ACTIVITY | 16 | 6.43e-01 | -6.70e-02 | 8.61e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE | 98 | 2.52e-01 | -6.70e-02 | 5.87e-01 |
| GOBP VESICLE ORGANIZATION | 306 | 4.44e-02 | 6.70e-02 | 2.45e-01 |
| GOBP CELL KILLING | 122 | 2.02e-01 | -6.69e-02 | 5.24e-01 |
| GOCC UBIQUITIN LIGASE COMPLEX | 289 | 5.08e-02 | -6.69e-02 | 2.61e-01 |
| GOBP REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 24 | 5.71e-01 | 6.69e-02 | 8.29e-01 |
| GOBP POSTSYNAPTIC SPECIALIZATION ORGANIZATION | 29 | 5.33e-01 | 6.69e-02 | 8.06e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 30 | 5.26e-01 | -6.68e-02 | 8.01e-01 |
| GOBP BLASTOCYST FORMATION | 35 | 4.94e-01 | -6.68e-02 | 7.84e-01 |
| GOBP REGULATION OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 7 | 7.60e-01 | 6.68e-02 | 9.14e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 5 | 7.96e-01 | 6.68e-02 | 9.27e-01 |
| GOCC SPERM PRINCIPAL PIECE | 21 | 5.96e-01 | 6.68e-02 | 8.39e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 27 | 5.48e-01 | 6.67e-02 | 8.18e-01 |
| GOBP ORGANIC ACID CATABOLIC PROCESS | 193 | 1.11e-01 | 6.67e-02 | 3.90e-01 |
| GOBP POSITIVE REGULATION OF LIPID STORAGE | 19 | 6.15e-01 | 6.66e-02 | 8.48e-01 |
| GOBP REGULATION OF CATECHOLAMINE METABOLIC PROCESS | 12 | 6.90e-01 | -6.66e-02 | 8.87e-01 |
| GOBP LIPID IMPORT INTO CELL | 14 | 6.66e-01 | 6.66e-02 | 8.75e-01 |
| GOCC RECEPTOR COMPLEX | 224 | 8.68e-02 | -6.65e-02 | 3.45e-01 |
| GOBP HUMORAL IMMUNE RESPONSE | 100 | 2.51e-01 | -6.65e-02 | 5.85e-01 |
| GOBP RESPIRATORY BURST | 32 | 5.15e-01 | -6.65e-02 | 7.95e-01 |
| GOBP REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 49 | 4.21e-01 | 6.65e-02 | 7.39e-01 |
| GOBP MACROPHAGE CYTOKINE PRODUCTION | 32 | 5.15e-01 | -6.65e-02 | 7.95e-01 |
| GOMF G PROTEIN BETA SUBUNIT BINDING | 10 | 7.16e-01 | -6.65e-02 | 8.97e-01 |
| GOBP ADENINE TRANSPORT | 6 | 7.78e-01 | 6.64e-02 | 9.21e-01 |
| GOCC CONTRACTILE FIBER | 163 | 1.44e-01 | 6.64e-02 | 4.45e-01 |
| GOBP NEGATIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS | 5 | 7.97e-01 | 6.64e-02 | 9.27e-01 |
| GOBP NEURON APOPTOTIC PROCESS | 195 | 1.10e-01 | -6.64e-02 | 3.90e-01 |
| GOBP MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 621 | 4.94e-03 | 6.64e-02 | 6.72e-02 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 20 | 6.08e-01 | -6.64e-02 | 8.46e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 57 | 3.86e-01 | -6.63e-02 | 7.13e-01 |
| GOBP LYMPHANGIOGENESIS | 8 | 7.45e-01 | -6.63e-02 | 9.08e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 50 | 4.18e-01 | 6.63e-02 | 7.36e-01 |
| GOBP ADHERENS JUNCTION ORGANIZATION | 33 | 5.10e-01 | 6.63e-02 | 7.92e-01 |
| GOCC MEMBRANE PROTEIN COMPLEX | 869 | 9.95e-04 | 6.62e-02 | 2.20e-02 |
| GOCC FILOPODIUM | 83 | 2.98e-01 | 6.62e-02 | 6.36e-01 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH | 137 | 1.82e-01 | -6.61e-02 | 4.98e-01 |
| GOBP LACTATION | 31 | 5.24e-01 | 6.61e-02 | 8.00e-01 |
| GOBP REGULATION OF PROTEIN STABILITY | 282 | 5.67e-02 | -6.61e-02 | 2.74e-01 |
| GOBP SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 81 | 3.04e-01 | 6.61e-02 | 6.43e-01 |
| GOBP RESPONSE TO MISFOLDED PROTEIN | 25 | 5.67e-01 | -6.61e-02 | 8.28e-01 |
| GOMF PURINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 25 | 5.68e-01 | 6.61e-02 | 8.28e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 31 | 5.25e-01 | 6.60e-02 | 8.00e-01 |
| GOBP RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 142 | 1.75e-01 | 6.60e-02 | 4.90e-01 |
| GOMF ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 6.92e-01 | 6.60e-02 | 8.88e-01 |
| GOBP SUBSTRATE DEPENDENT CELL MIGRATION CELL EXTENSION | 9 | 7.32e-01 | -6.60e-02 | 9.04e-01 |
| GOBP MICROTUBULE BUNDLE FORMATION | 72 | 3.33e-01 | 6.60e-02 | 6.68e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION | 29 | 5.39e-01 | 6.60e-02 | 8.11e-01 |
| GOBP REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 26 | 5.61e-01 | -6.59e-02 | 8.26e-01 |
| GOMF 3 5 EXONUCLEASE ACTIVITY | 53 | 4.07e-01 | -6.58e-02 | 7.27e-01 |
| GOBP STEROID HORMONE SECRETION | 16 | 6.49e-01 | -6.58e-02 | 8.65e-01 |
| GOBP ESCRT COMPLEX DISASSEMBLY | 10 | 7.19e-01 | -6.58e-02 | 8.99e-01 |
| GOBP INTERMEMBRANE LIPID TRANSFER | 41 | 4.66e-01 | 6.58e-02 | 7.67e-01 |
| GOMF LIPID TRANSFER ACTIVITY | 41 | 4.66e-01 | 6.58e-02 | 7.67e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY | 267 | 6.48e-02 | -6.58e-02 | 2.93e-01 |
| GOMF BIOACTIVE LIPID RECEPTOR ACTIVITY | 7 | 7.63e-01 | -6.58e-02 | 9.16e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 9 | 7.33e-01 | 6.57e-02 | 9.04e-01 |
| GOBP MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION | 33 | 5.14e-01 | 6.57e-02 | 7.94e-01 |
| GOBP RESPONSE TO OSMOTIC STRESS | 67 | 3.53e-01 | -6.57e-02 | 6.87e-01 |
| GOBP CELLULAR RESPONSE TO EPINEPHRINE STIMULUS | 9 | 7.33e-01 | -6.57e-02 | 9.04e-01 |
| GOCC AXON INITIAL SEGMENT | 13 | 6.82e-01 | 6.57e-02 | 8.82e-01 |
| GOBP DORSAL VENTRAL NEURAL TUBE PATTERNING | 18 | 6.29e-01 | 6.57e-02 | 8.55e-01 |
| GOMF MANNOSIDASE ACTIVITY | 15 | 6.60e-01 | 6.57e-02 | 8.72e-01 |
| GOBP MEMBRANE ORGANIZATION | 674 | 3.82e-03 | 6.57e-02 | 5.63e-02 |
| GOBP ACUTE PHASE RESPONSE | 20 | 6.11e-01 | -6.56e-02 | 8.46e-01 |
| GOBP GOLGI ORGANIZATION | 135 | 1.89e-01 | 6.56e-02 | 5.08e-01 |
| GOBP REGULATION OF T CELL CHEMOTAXIS | 9 | 7.33e-01 | -6.56e-02 | 9.04e-01 |
| GOBP MAST CELL CYTOKINE PRODUCTION | 5 | 8.00e-01 | -6.56e-02 | 9.27e-01 |
| GOBP OSTEOBLAST DIFFERENTIATION | 145 | 1.73e-01 | -6.55e-02 | 4.88e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDASE ACTIVITY | 137 | 1.86e-01 | -6.55e-02 | 5.03e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 1201 | 1.52e-04 | -6.55e-02 | 5.27e-03 |
| GOBP MESENCHYME DEVELOPMENT | 184 | 1.26e-01 | -6.55e-02 | 4.17e-01 |
| GOBP NEGATIVE REGULATION OF LIPASE ACTIVITY | 7 | 7.64e-01 | -6.55e-02 | 9.17e-01 |
| GOCC CILIARY PLASM | 101 | 2.56e-01 | 6.54e-02 | 5.91e-01 |
| GOMF PEPTIDE HORMONE RECEPTOR BINDING | 6 | 7.81e-01 | -6.54e-02 | 9.22e-01 |
| GOBP CELLULAR METABOLIC COMPOUND SALVAGE | 27 | 5.57e-01 | 6.54e-02 | 8.22e-01 |
| GOBP CELLULAR RESPONSE TO STEROL | 17 | 6.41e-01 | 6.54e-02 | 8.60e-01 |
| GOBP MUCOPOLYSACCHARIDE METABOLIC PROCESS | 63 | 3.70e-01 | -6.54e-02 | 7.00e-01 |
| GOCC CLATHRIN ADAPTOR COMPLEX | 24 | 5.80e-01 | -6.54e-02 | 8.32e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 50 | 4.24e-01 | 6.53e-02 | 7.42e-01 |
| GOBP NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS | 8 | 7.49e-01 | 6.53e-02 | 9.10e-01 |
| GOBP ERAD PATHWAY | 100 | 2.60e-01 | 6.53e-02 | 5.94e-01 |
| GOBP ACTIN NUCLEATION | 48 | 4.34e-01 | 6.53e-02 | 7.50e-01 |
| GOBP DENDRITE ARBORIZATION | 6 | 7.82e-01 | -6.53e-02 | 9.22e-01 |
| GOCC NUCLEAR OUTER MEMBRANE | 24 | 5.80e-01 | 6.53e-02 | 8.32e-01 |
| GOBP RESPONSE TO PURINE CONTAINING COMPOUND | 95 | 2.72e-01 | -6.52e-02 | 6.09e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION | 73 | 3.36e-01 | 6.52e-02 | 6.70e-01 |
| GOCC INTEGRIN COMPLEX | 26 | 5.66e-01 | -6.51e-02 | 8.28e-01 |
| GOBP RESPONSE TO INTERLEUKIN 12 | 10 | 7.22e-01 | -6.50e-02 | 9.00e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MIGRATION | 106 | 2.48e-01 | -6.50e-02 | 5.82e-01 |
| GOCC SCF UBIQUITIN LIGASE COMPLEX | 57 | 3.96e-01 | -6.50e-02 | 7.20e-01 |
| GOBP U2 TYPE PRESPLICEOSOME ASSEMBLY | 24 | 5.82e-01 | 6.50e-02 | 8.32e-01 |
| GOMF ICOSANOID BINDING | 7 | 7.66e-01 | 6.49e-02 | 9.17e-01 |
| GOBP TYPE 2 IMMUNE RESPONSE | 30 | 5.39e-01 | -6.49e-02 | 8.11e-01 |
| GOBP REGULATION OF CELL MATRIX ADHESION | 89 | 2.91e-01 | 6.49e-02 | 6.29e-01 |
| GOBP COPPER ION TRANSMEMBRANE TRANSPORT | 7 | 7.67e-01 | -6.48e-02 | 9.17e-01 |
| GOMF COPPER ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 7.67e-01 | -6.48e-02 | 9.17e-01 |
| GOBP NUCLEOSIDE TRANSPORT | 7 | 7.67e-01 | 6.48e-02 | 9.17e-01 |
| GOBP REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 18 | 6.34e-01 | -6.48e-02 | 8.57e-01 |
| GOBP GLUCAN BIOSYNTHETIC PROCESS | 33 | 5.20e-01 | -6.47e-02 | 7.98e-01 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 1113 | 3.10e-04 | -6.46e-02 | 9.08e-03 |
| GOBP REGULATION OF CELL CYCLE | 894 | 1.13e-03 | -6.46e-02 | 2.41e-02 |
| GOMF LEUKOTRIENE C4 SYNTHASE ACTIVITY | 5 | 8.03e-01 | -6.46e-02 | 9.29e-01 |
| GOBP IN UTERO EMBRYONIC DEVELOPMENT | 298 | 5.57e-02 | -6.46e-02 | 2.72e-01 |
| GOBP LIPID LOCALIZATION | 323 | 4.67e-02 | 6.45e-02 | 2.52e-01 |
| GOBP GROWTH PLATE CARTILAGE DEVELOPMENT | 11 | 7.11e-01 | -6.45e-02 | 8.96e-01 |
| GOBP NETRIN ACTIVATED SIGNALING PATHWAY | 7 | 7.68e-01 | -6.45e-02 | 9.18e-01 |
| GOBP CARDIAC CELL DEVELOPMENT | 56 | 4.04e-01 | -6.45e-02 | 7.25e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 18 | 6.36e-01 | 6.44e-02 | 8.58e-01 |
| GOBP INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 42 | 4.70e-01 | 6.44e-02 | 7.70e-01 |
| GOBP CELLULAR RESPONSE TO UNFOLDED PROTEIN | 79 | 3.22e-01 | 6.44e-02 | 6.62e-01 |
| GOBP NEURAL PLATE PATTERN SPECIFICATION | 6 | 7.85e-01 | 6.44e-02 | 9.22e-01 |
| GOBP MONOATOMIC ANION TRANSPORT | 94 | 2.81e-01 | 6.44e-02 | 6.19e-01 |
| GOBP SPHINGOLIPID BIOSYNTHETIC PROCESS | 78 | 3.26e-01 | 6.44e-02 | 6.63e-01 |
| GOBP REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 1332 | 9.64e-05 | -6.43e-02 | 3.74e-03 |
| GOMF MONOATOMIC CATION CHANNEL ACTIVITY | 164 | 1.56e-01 | 6.43e-02 | 4.62e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY | 7 | 7.68e-01 | -6.43e-02 | 9.18e-01 |
| GOBP POST EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 6 | 7.85e-01 | -6.43e-02 | 9.22e-01 |
| GOMF ACTIN MONOMER BINDING | 21 | 6.11e-01 | 6.42e-02 | 8.46e-01 |
| GOBP REGULATION OF MULTICELLULAR ORGANISM GROWTH | 44 | 4.61e-01 | 6.42e-02 | 7.64e-01 |
| GOBP NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION | 15 | 6.67e-01 | 6.41e-02 | 8.75e-01 |
| GOCC NUCLEOLUS | 909 | 1.14e-03 | -6.41e-02 | 2.41e-02 |
| GOBP REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 67 | 3.65e-01 | -6.41e-02 | 6.97e-01 |
| GOBP GAP JUNCTION ASSEMBLY | 9 | 7.39e-01 | -6.41e-02 | 9.06e-01 |
| GOBP CELLULAR RESPONSE TO CAFFEINE | 9 | 7.40e-01 | -6.40e-02 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 18 | 6.39e-01 | -6.40e-02 | 8.59e-01 |
| GOBP OLEFINIC COMPOUND METABOLIC PROCESS | 83 | 3.15e-01 | 6.39e-02 | 6.54e-01 |
| GOCC TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX | 15 | 6.69e-01 | 6.39e-02 | 8.76e-01 |
| GOBP LIPID STORAGE | 71 | 3.52e-01 | 6.38e-02 | 6.87e-01 |
| GOBP THALAMUS DEVELOPMENT | 6 | 7.87e-01 | -6.38e-02 | 9.23e-01 |
| GOCC COATED VESICLE MEMBRANE | 166 | 1.57e-01 | 6.38e-02 | 4.62e-01 |
| GOBP REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE | 10 | 7.27e-01 | -6.37e-02 | 9.03e-01 |
| GOBP REGULATION OF AMIDE METABOLIC PROCESS | 413 | 2.69e-02 | -6.37e-02 | 1.86e-01 |
| GOBP COLLAGEN BIOSYNTHETIC PROCESS | 27 | 5.67e-01 | -6.36e-02 | 8.28e-01 |
| GOBP POLYOL METABOLIC PROCESS | 74 | 3.44e-01 | -6.36e-02 | 6.81e-01 |
| GOBP CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 43 | 4.71e-01 | 6.35e-02 | 7.71e-01 |
| GOBP POSITIVE REGULATION OF BINDING | 99 | 2.75e-01 | -6.35e-02 | 6.11e-01 |
| GOMF PROTEIN CARBOXYL O METHYLTRANSFERASE ACTIVITY | 6 | 7.88e-01 | -6.34e-02 | 9.24e-01 |
| GOBP MONOATOMIC ION TRANSPORT | 760 | 3.11e-03 | 6.34e-02 | 4.92e-02 |
| GOBP REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 15 | 6.71e-01 | -6.34e-02 | 8.77e-01 |
| GOBP POSITIVE REGULATION OF LIPID LOCALIZATION | 72 | 3.53e-01 | 6.33e-02 | 6.87e-01 |
| GOCC CLATHRIN COAT | 42 | 4.78e-01 | -6.33e-02 | 7.75e-01 |
| GOMF MONOATOMIC ANION MONOATOMIC CATION SYMPORTER ACTIVITY | 14 | 6.82e-01 | 6.33e-02 | 8.82e-01 |
| GOBP NEUTROPHIL MEDIATED CYTOTOXICITY | 6 | 7.88e-01 | -6.33e-02 | 9.24e-01 |
| GOCC ENDOCYTIC VESICLE | 273 | 7.26e-02 | -6.33e-02 | 3.15e-01 |
| GOBP PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 18 | 6.42e-01 | 6.32e-02 | 8.61e-01 |
| GOBP POST ANAL TAIL MORPHOGENESIS | 10 | 7.29e-01 | -6.32e-02 | 9.03e-01 |
| GOBP RENAL SYSTEM PROCESS | 65 | 3.79e-01 | 6.32e-02 | 7.06e-01 |
| GOBP GLYCEROLIPID CATABOLIC PROCESS | 46 | 4.59e-01 | 6.32e-02 | 7.64e-01 |
| GOBP PEROXISOMAL TRANSPORT | 23 | 6.00e-01 | 6.32e-02 | 8.40e-01 |
| GOBP MONOATOMIC ION HOMEOSTASIS | 403 | 3.01e-02 | 6.32e-02 | 1.97e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT | 14 | 6.83e-01 | -6.31e-02 | 8.82e-01 |
| GOBP NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 19 | 6.34e-01 | -6.31e-02 | 8.57e-01 |
| GOMF ADP BINDING | 33 | 5.31e-01 | -6.31e-02 | 8.04e-01 |
| GOBP LEUCINE METABOLIC PROCESS | 7 | 7.73e-01 | 6.31e-02 | 9.20e-01 |
| GOBP MAPK CASCADE | 539 | 1.26e-02 | -6.31e-02 | 1.19e-01 |
| GOCC CELL BODY MEMBRANE | 17 | 6.53e-01 | -6.30e-02 | 8.68e-01 |
| GOBP FORELIMB MORPHOGENESIS | 19 | 6.35e-01 | 6.30e-02 | 8.57e-01 |
| GOMF LIGAND GATED CALCIUM CHANNEL ACTIVITY | 23 | 6.01e-01 | 6.30e-02 | 8.41e-01 |
| GOCC MAIN AXON | 45 | 4.65e-01 | 6.30e-02 | 7.66e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS POLYSACCHARIDE CHAIN BIOSYNTHETIC PROCESS | 6 | 7.89e-01 | -6.30e-02 | 9.24e-01 |
| GOMF PROTEIN PHOSPHATASE BINDING | 121 | 2.32e-01 | -6.29e-02 | 5.63e-01 |
| GOBP NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT | 11 | 7.18e-01 | 6.29e-02 | 8.98e-01 |
| GOCC CAVEOLA | 58 | 4.08e-01 | 6.29e-02 | 7.27e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND | 9 | 7.44e-01 | -6.29e-02 | 9.08e-01 |
| GOBP SINGLE FERTILIZATION | 73 | 3.53e-01 | 6.29e-02 | 6.87e-01 |
| GOBP TRANS SYNAPTIC SIGNALING BY LIPID | 5 | 8.08e-01 | -6.29e-02 | 9.32e-01 |
| GOBP ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS | 1422 | 8.59e-05 | 6.28e-02 | 3.44e-03 |
| GOCC EXTRINSIC COMPONENT OF ORGANELLE MEMBRANE | 24 | 5.94e-01 | 6.28e-02 | 8.38e-01 |
| GOBP PRIMITIVE HEMOPOIESIS | 6 | 7.90e-01 | -6.28e-02 | 9.24e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS | 191 | 1.35e-01 | -6.28e-02 | 4.31e-01 |
| GOMF PHOSPHOPROTEIN BINDING | 81 | 3.29e-01 | -6.28e-02 | 6.66e-01 |
| GOBP NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION | 124 | 2.28e-01 | -6.27e-02 | 5.57e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 64 | 3.86e-01 | -6.27e-02 | 7.12e-01 |
| GOMF NUCLEOTIDE RECEPTOR ACTIVITY | 13 | 6.96e-01 | -6.27e-02 | 8.88e-01 |
| GOBP MEMBRANE LIPID BIOSYNTHETIC PROCESS | 111 | 2.55e-01 | 6.26e-02 | 5.90e-01 |
| GOBP ALDITOL CATABOLIC PROCESS | 6 | 7.91e-01 | 6.26e-02 | 9.24e-01 |
| GOBP REGULATION OF KERATINOCYTE DIFFERENTIATION | 25 | 5.88e-01 | -6.26e-02 | 8.36e-01 |
| GOBP DENDRITE MORPHOGENESIS | 100 | 2.80e-01 | -6.26e-02 | 6.17e-01 |
| GOBP LONG CHAIN FATTY ACID METABOLIC PROCESS | 67 | 3.76e-01 | 6.26e-02 | 7.04e-01 |
| GOBP SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING | 28 | 5.67e-01 | 6.25e-02 | 8.28e-01 |
| GOBP ORGANOPHOSPHATE METABOLIC PROCESS | 781 | 3.14e-03 | 6.25e-02 | 4.94e-02 |
| GOCC CLATHRIN VESICLE COAT | 30 | 5.54e-01 | 6.24e-02 | 8.20e-01 |
| GOBP REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 7 | 7.75e-01 | 6.24e-02 | 9.21e-01 |
| GOBP DNA CYTOSINE DEAMINATION | 8 | 7.60e-01 | 6.24e-02 | 9.14e-01 |
| GOBP SENSORY ORGAN DEVELOPMENT | 314 | 5.79e-02 | -6.24e-02 | 2.77e-01 |
| GOBP GLOMERULAR EPITHELIAL CELL DEVELOPMENT | 9 | 7.46e-01 | 6.24e-02 | 9.08e-01 |
| GOCC NEURON PROJECTION TERMINUS | 66 | 3.82e-01 | 6.23e-02 | 7.09e-01 |
| GOBP REGULATION OF CATALYTIC ACTIVITY | 1101 | 5.43e-04 | -6.23e-02 | 1.40e-02 |
| GOBP REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 6 | 7.92e-01 | -6.22e-02 | 9.25e-01 |
| GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS | 11 | 7.21e-01 | -6.22e-02 | 9.00e-01 |
| GOBP REGULATION OF REGULATED SECRETORY PATHWAY | 89 | 3.11e-01 | -6.22e-02 | 6.50e-01 |
| GOCC KINETOCHORE MICROTUBULE | 19 | 6.39e-01 | -6.21e-02 | 8.59e-01 |
| GOBP TRIGLYCERIDE CATABOLIC PROCESS | 16 | 6.67e-01 | -6.21e-02 | 8.75e-01 |
| GOBP REGULATION OF PHOSPHORUS METABOLIC PROCESS | 856 | 2.21e-03 | -6.20e-02 | 3.87e-02 |
| GOBP SALIVARY GLAND DEVELOPMENT | 20 | 6.32e-01 | -6.19e-02 | 8.56e-01 |
| GOMF ACETYLCHOLINE RECEPTOR BINDING | 10 | 7.35e-01 | -6.19e-02 | 9.04e-01 |
| GOBP REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 285 | 7.28e-02 | -6.19e-02 | 3.15e-01 |
| GOBP RESPONSE TO COPPER ION | 28 | 5.71e-01 | 6.18e-02 | 8.29e-01 |
| GOBP PROTEIN K63 LINKED UBIQUITINATION | 54 | 4.32e-01 | 6.18e-02 | 7.49e-01 |
| GOBP REGULATION OF LEUKOCYTE PROLIFERATION | 189 | 1.43e-01 | -6.18e-02 | 4.44e-01 |
| GOBP ESTABLISHMENT OF LYMPHOCYTE POLARITY | 12 | 7.11e-01 | -6.18e-02 | 8.96e-01 |
| GOBP REACTIVE NITROGEN SPECIES METABOLIC PROCESS | 54 | 4.32e-01 | 6.18e-02 | 7.49e-01 |
| GOBP MYELOID DENDRITIC CELL DIFFERENTIATION | 13 | 7.00e-01 | 6.18e-02 | 8.89e-01 |
| GOBP CELL DIFFERENTIATION IN SPINAL CORD | 20 | 6.33e-01 | 6.17e-02 | 8.57e-01 |
| GOBP POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 64 | 3.93e-01 | 6.17e-02 | 7.18e-01 |
| GOBP CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 25 | 5.93e-01 | -6.17e-02 | 8.38e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 73 | 3.62e-01 | -6.17e-02 | 6.95e-01 |
| GOBP PEPTIDYL THREONINE DEPHOSPHORYLATION | 18 | 6.50e-01 | 6.17e-02 | 8.66e-01 |
| GOBP MIDBODY ABSCISSION | 16 | 6.69e-01 | 6.17e-02 | 8.76e-01 |
| GOMF MOLECULAR CARRIER ACTIVITY | 83 | 3.32e-01 | 6.17e-02 | 6.67e-01 |
| GOBP MEMBRANE PROTEIN PROTEOLYSIS | 51 | 4.46e-01 | -6.16e-02 | 7.57e-01 |
| GOMF PENTOSYLTRANSFERASE ACTIVITY | 47 | 4.65e-01 | -6.16e-02 | 7.66e-01 |
| GOMF BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 8 | 7.63e-01 | 6.16e-02 | 9.16e-01 |
| GOBP ABSCISSION | 6 | 7.94e-01 | -6.16e-02 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 12 | 7.12e-01 | -6.16e-02 | 8.96e-01 |
| GOBP OLFACTORY BULB INTERNEURON DEVELOPMENT | 6 | 7.94e-01 | 6.16e-02 | 9.26e-01 |
| GOBP REGULATION OF CILIUM ASSEMBLY | 82 | 3.36e-01 | -6.15e-02 | 6.70e-01 |
| GOBP POSITIVE REGULATION OF T CELL TOLERANCE INDUCTION | 7 | 7.78e-01 | -6.15e-02 | 9.21e-01 |
| GOBP EXONUCLEOLYTIC CATABOLISM OF DEADENYLATED MRNA | 13 | 7.01e-01 | 6.15e-02 | 8.90e-01 |
| GOCC ENDOPLASMIC RETICULUM LUMEN | 187 | 1.48e-01 | -6.15e-02 | 4.49e-01 |
| GOMF MOLECULAR ADAPTOR ACTIVITY | 498 | 1.93e-02 | -6.15e-02 | 1.54e-01 |
| GOCC MYOSIN COMPLEX | 32 | 5.48e-01 | 6.15e-02 | 8.18e-01 |
| GOBP RESPONSE TO LIPID | 602 | 1.04e-02 | -6.14e-02 | 1.07e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 43 | 4.86e-01 | -6.14e-02 | 7.81e-01 |
| GOCC CLEAVAGE FURROW | 47 | 4.67e-01 | 6.13e-02 | 7.67e-01 |
| GOBP ARACHIDONIC ACID METABOLIC PROCESS | 28 | 5.74e-01 | 6.13e-02 | 8.31e-01 |
| GOBP REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 25 | 5.96e-01 | -6.13e-02 | 8.39e-01 |
| GOBP REPRODUCTION | 907 | 1.87e-03 | -6.13e-02 | 3.39e-02 |
| GOBP MAINTENANCE OF PROTEIN LOCATION | 78 | 3.50e-01 | -6.13e-02 | 6.85e-01 |
| GOCC MICROBODY | 125 | 2.37e-01 | 6.13e-02 | 5.69e-01 |
| GOMF HISTONE KINASE ACTIVITY | 18 | 6.53e-01 | -6.12e-02 | 8.68e-01 |
| GOBP MITOCHONDRIAL TRNA PROCESSING | 14 | 6.92e-01 | 6.12e-02 | 8.88e-01 |
| GOBP ACID SECRETION | 23 | 6.12e-01 | -6.12e-02 | 8.46e-01 |
| GOCC PRONUCLEUS | 12 | 7.14e-01 | -6.12e-02 | 8.96e-01 |
| GOBP REGULATION OF RESPONSE TO WOUNDING | 108 | 2.73e-01 | 6.12e-02 | 6.09e-01 |
| GOBP REGULATION OF PROTEIN COMPLEX STABILITY | 10 | 7.38e-01 | 6.11e-02 | 9.05e-01 |
| GOCC TORC2 COMPLEX | 9 | 7.51e-01 | 6.11e-02 | 9.11e-01 |
| GOMF GATED CHANNEL ACTIVITY | 146 | 2.03e-01 | 6.11e-02 | 5.25e-01 |
| GOMF KINASE BINDING | 626 | 9.38e-03 | -6.11e-02 | 1.00e-01 |
| GOBP PEPTIDYL LYSINE TRIMETHYLATION | 10 | 7.38e-01 | -6.11e-02 | 9.05e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS | 10 | 7.38e-01 | -6.11e-02 | 9.05e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 704 | 6.04e-03 | -6.10e-02 | 7.67e-02 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE MEMBRANE | 17 | 6.63e-01 | 6.10e-02 | 8.73e-01 |
| GOBP AMMONIUM ION METABOLIC PROCESS | 12 | 7.15e-01 | -6.10e-02 | 8.97e-01 |
| GOBP TISSUE REGENERATION | 44 | 4.84e-01 | 6.10e-02 | 7.81e-01 |
| GOBP EMBRYONIC DIGESTIVE TRACT DEVELOPMENT | 14 | 6.93e-01 | 6.10e-02 | 8.88e-01 |
| GOBP PURINE NUCLEOTIDE TRANSPORT | 33 | 5.44e-01 | -6.10e-02 | 8.15e-01 |
| GOCC EXTERNAL SIDE OF APICAL PLASMA MEMBRANE | 5 | 8.13e-01 | 6.10e-02 | 9.34e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 26 | 5.91e-01 | -6.09e-02 | 8.37e-01 |
| GOBP RETROGRADE TRANSPORT VESICLE RECYCLING WITHIN GOLGI | 9 | 7.52e-01 | 6.09e-02 | 9.11e-01 |
| GOBP NEGATIVE REGULATION OF COAGULATION | 29 | 5.71e-01 | 6.08e-02 | 8.29e-01 |
| GOBP CELL ADHESION MEDIATED BY INTEGRIN | 66 | 3.93e-01 | 6.08e-02 | 7.18e-01 |
| GOBP REGULATION OF FATTY ACID OXIDATION | 25 | 5.99e-01 | -6.08e-02 | 8.40e-01 |
| GOBP CELLULAR RESPONSE TO SODIUM ARSENITE | 5 | 8.14e-01 | 6.07e-02 | 9.34e-01 |
| GOBP RESPONSE TO SODIUM ARSENITE | 5 | 8.14e-01 | 6.07e-02 | 9.34e-01 |
| GOCC RUFFLE | 160 | 1.86e-01 | -6.06e-02 | 5.03e-01 |
| GOBP SMOOTH MUSCLE CONTRACTION | 56 | 4.33e-01 | -6.06e-02 | 7.49e-01 |
| GOBP NEURAL RETINA DEVELOPMENT | 42 | 4.97e-01 | -6.06e-02 | 7.86e-01 |
| GOBP REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 41 | 5.02e-01 | 6.06e-02 | 7.88e-01 |
| GOBP MEMBRANE DISASSEMBLY | 11 | 7.28e-01 | 6.06e-02 | 9.03e-01 |
| GOMF EXONUCLEASE ACTIVITY | 79 | 3.53e-01 | -6.05e-02 | 6.87e-01 |
| GOBP POSITIVE REGULATION OF BLOOD CIRCULATION | 17 | 6.66e-01 | 6.04e-02 | 8.75e-01 |
| GOMF APOLIPOPROTEIN A I BINDING | 5 | 8.15e-01 | 6.04e-02 | 9.34e-01 |
| GOBP FUCOSE METABOLIC PROCESS | 11 | 7.29e-01 | -6.04e-02 | 9.03e-01 |
| GOBP QUATERNARY AMMONIUM GROUP TRANSPORT | 16 | 6.76e-01 | -6.04e-02 | 8.79e-01 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE BINDING | 292 | 7.66e-02 | -6.04e-02 | 3.25e-01 |
| GOMF GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE NADPLUS NON PHOSPHORYLATING ACTIVITY | 6 | 7.98e-01 | -6.04e-02 | 9.27e-01 |
| GOMF ATP HYDROLYSIS ACTIVITY | 348 | 5.37e-02 | -6.03e-02 | 2.66e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 49 | 4.65e-01 | -6.03e-02 | 7.66e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 92 | 3.18e-01 | -6.03e-02 | 6.57e-01 |
| GOMF ATP DEPENDENT PROTEIN BINDING | 6 | 7.98e-01 | 6.03e-02 | 9.27e-01 |
| GOBP EMBRYO DEVELOPMENT | 746 | 5.29e-03 | -6.03e-02 | 7.03e-02 |
| GOMF RETINOL BINDING | 5 | 8.15e-01 | 6.03e-02 | 9.34e-01 |
| GOBP SPHINGOMYELIN BIOSYNTHETIC PROCESS | 10 | 7.41e-01 | 6.03e-02 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF CENTRIOLE REPLICATION | 9 | 7.54e-01 | 6.03e-02 | 9.12e-01 |
| GOBP LONG TERM SYNAPTIC DEPRESSION | 21 | 6.33e-01 | 6.03e-02 | 8.57e-01 |
| GOBP REGULATION OF CELL PROJECTION ORGANIZATION | 504 | 2.10e-02 | -6.03e-02 | 1.60e-01 |
| GOBP NEGATIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS | 6 | 7.98e-01 | 6.03e-02 | 9.27e-01 |
| GOBP ERYTHROCYTE DEVELOPMENT | 30 | 5.68e-01 | -6.02e-02 | 8.28e-01 |
| GOMF CULLIN FAMILY PROTEIN BINDING | 24 | 6.10e-01 | 6.02e-02 | 8.46e-01 |
| GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION | 30 | 5.68e-01 | 6.02e-02 | 8.28e-01 |
| GOBP POSITIVE REGULATION OF AMIDE METABOLIC PROCESS | 141 | 2.18e-01 | -6.01e-02 | 5.46e-01 |
| GOBP POSTSYNAPSE ORGANIZATION | 137 | 2.25e-01 | -6.01e-02 | 5.53e-01 |
| GOBP CELL CYCLE PROCESS | 1068 | 9.97e-04 | -6.01e-02 | 2.20e-02 |
| GOBP POSITIVE REGULATION OF HEART RATE | 9 | 7.55e-01 | 6.01e-02 | 9.12e-01 |
| GOBP REGULATION OF OSTEOBLAST PROLIFERATION | 16 | 6.78e-01 | -6.01e-02 | 8.79e-01 |
| GOCC DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX | 12 | 7.19e-01 | 6.00e-02 | 8.99e-01 |
| GOBP CARDIAC MYOFIBRIL ASSEMBLY | 11 | 7.31e-01 | -5.99e-02 | 9.04e-01 |
| GOBP NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION | 594 | 1.30e-02 | -5.99e-02 | 1.22e-01 |
| GOBP CIRCULATORY SYSTEM DEVELOPMENT | 738 | 5.88e-03 | -5.99e-02 | 7.58e-02 |
| GOBP CELL CELL SIGNALING | 983 | 1.61e-03 | -5.99e-02 | 3.06e-02 |
| GOBP ENDOCYTOSIS | 536 | 1.83e-02 | -5.98e-02 | 1.49e-01 |
| GOMF NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 7.84e-01 | 5.98e-02 | 9.22e-01 |
| GOCC MIDBODY | 191 | 1.55e-01 | -5.98e-02 | 4.60e-01 |
| GOBP REGULATION OF LYSOSOME ORGANIZATION | 10 | 7.44e-01 | -5.98e-02 | 9.08e-01 |
| GOMF NUCLEOTIDYLTRANSFERASE ACTIVITY | 128 | 2.44e-01 | -5.97e-02 | 5.77e-01 |
| GOBP NEGATIVE REGULATION OF MAPK CASCADE | 129 | 2.42e-01 | -5.97e-02 | 5.75e-01 |
| GOCC CELL CORTEX | 233 | 1.17e-01 | 5.97e-02 | 4.01e-01 |
| GOMF SEQUENCE SPECIFIC SINGLE STRANDED DNA BINDING | 14 | 6.99e-01 | -5.96e-02 | 8.89e-01 |
| GOBP BEHAVIORAL RESPONSE TO PAIN | 11 | 7.32e-01 | -5.96e-02 | 9.04e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE | 327 | 6.47e-02 | -5.96e-02 | 2.93e-01 |
| GOCC TRANSCRIPTION FACTOR TFIIH HOLO COMPLEX | 12 | 7.21e-01 | 5.96e-02 | 9.00e-01 |
| GOCC GAMMA TUBULIN COMPLEX | 16 | 6.80e-01 | 5.95e-02 | 8.81e-01 |
| GOBP NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 12 | 7.21e-01 | 5.95e-02 | 9.00e-01 |
| GOCC SPINDLE MICROTUBULE | 75 | 3.74e-01 | -5.95e-02 | 7.02e-01 |
| GOMF NAADP SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 5 | 8.18e-01 | 5.94e-02 | 9.34e-01 |
| GOBP LOCOMOTION | 817 | 4.11e-03 | -5.94e-02 | 5.93e-02 |
| GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 29 | 5.80e-01 | 5.94e-02 | 8.32e-01 |
| GOMF UBIQUITIN LIGASE COMPLEX SCAFFOLD ACTIVITY | 6 | 8.01e-01 | -5.94e-02 | 9.28e-01 |
| GOBP EXTRACELLULAR MATRIX ASSEMBLY | 23 | 6.22e-01 | -5.94e-02 | 8.51e-01 |
| GOBP UBIQUINONE METABOLIC PROCESS | 19 | 6.54e-01 | 5.94e-02 | 8.68e-01 |
| GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 7 | 7.86e-01 | -5.93e-02 | 9.23e-01 |
| GOCC CELL SUBSTRATE JUNCTION | 381 | 4.77e-02 | -5.92e-02 | 2.54e-01 |
| GOCC ACROSOMAL MEMBRANE | 16 | 6.82e-01 | 5.92e-02 | 8.82e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEUS | 267 | 9.65e-02 | -5.92e-02 | 3.66e-01 |
| GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE III | 8 | 7.72e-01 | 5.92e-02 | 9.19e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CONTRACTION | 6 | 8.02e-01 | -5.91e-02 | 9.29e-01 |
| GOBP SENSORY ORGAN MORPHOGENESIS | 137 | 2.33e-01 | -5.91e-02 | 5.63e-01 |
| GOBP EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 12 | 7.23e-01 | -5.91e-02 | 9.01e-01 |
| GOBP EYE PHOTORECEPTOR CELL DIFFERENTIATION | 23 | 6.24e-01 | -5.91e-02 | 8.52e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE | 422 | 3.81e-02 | -5.90e-02 | 2.26e-01 |
| GOBP REGULATION OF CATABOLIC PROCESS | 871 | 3.31e-03 | -5.90e-02 | 5.10e-02 |
| GOBP OSTEOCLAST DIFFERENTIATION | 85 | 3.47e-01 | -5.90e-02 | 6.83e-01 |
| GOBP CARDIAC RIGHT VENTRICLE MORPHOGENESIS | 10 | 7.47e-01 | 5.90e-02 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 5 | 8.19e-01 | 5.90e-02 | 9.35e-01 |
| GOCC GLIAL CELL PROJECTION | 20 | 6.48e-01 | -5.90e-02 | 8.65e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE PROCESS | 268 | 9.73e-02 | -5.89e-02 | 3.66e-01 |
| GOBP POSITIVE REGULATION OF CELL POPULATION PROLIFERATION | 812 | 4.57e-03 | -5.89e-02 | 6.34e-02 |
| GOBP MEIOTIC CELL CYCLE PROCESS | 146 | 2.20e-01 | -5.89e-02 | 5.48e-01 |
| GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY | 25 | 6.11e-01 | 5.88e-02 | 8.46e-01 |
| GOBP CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 9 | 7.60e-01 | -5.88e-02 | 9.14e-01 |
| GOCC SEPTIN CYTOSKELETON | 13 | 7.14e-01 | 5.88e-02 | 8.96e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS | 52 | 4.63e-01 | 5.88e-02 | 7.65e-01 |
| GOMF GUANINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 8.20e-01 | -5.88e-02 | 9.35e-01 |
| GOBP N ACYLPHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 5 | 8.20e-01 | -5.87e-02 | 9.35e-01 |
| GOBP REGULATION OF MITOCHONDRION ORGANIZATION | 133 | 2.43e-01 | 5.87e-02 | 5.76e-01 |
| GOBP PRESYNAPTIC MEMBRANE ORGANIZATION | 5 | 8.20e-01 | 5.87e-02 | 9.35e-01 |
| GOBP HEART FIELD SPECIFICATION | 8 | 7.74e-01 | 5.87e-02 | 9.20e-01 |
| GOBP IMMUNOGLOBULIN V D J RECOMBINATION | 8 | 7.74e-01 | -5.87e-02 | 9.20e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH HOST | 166 | 1.93e-01 | -5.87e-02 | 5.11e-01 |
| GOCC EXOCYTIC VESICLE | 159 | 2.02e-01 | 5.87e-02 | 5.24e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION | 1397 | 2.79e-04 | 5.86e-02 | 8.42e-03 |
| GOBP NEGATIVE REGULATION OF AXONOGENESIS | 43 | 5.06e-01 | 5.86e-02 | 7.90e-01 |
| GOBP CELLULAR RESPONSE TO ALDEHYDE | 12 | 7.26e-01 | -5.85e-02 | 9.02e-01 |
| GOBP MEMBRANE LIPID METABOLIC PROCESS | 153 | 2.13e-01 | 5.84e-02 | 5.38e-01 |
| GOBP CYTIDINE METABOLIC PROCESS | 10 | 7.49e-01 | -5.84e-02 | 9.10e-01 |
| GOMF CYTIDINE DEAMINASE ACTIVITY | 10 | 7.49e-01 | -5.84e-02 | 9.10e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 603 | 1.47e-02 | -5.84e-02 | 1.34e-01 |
| GOBP WOUND HEALING | 282 | 9.24e-02 | 5.84e-02 | 3.57e-01 |
| GOCC GOLGI MEMBRANE | 549 | 1.99e-02 | 5.83e-02 | 1.56e-01 |
| GOBP PROTEIN LOCALIZATION TO CYTOSKELETON | 57 | 4.47e-01 | 5.83e-02 | 7.57e-01 |
| GOMF ATP DEPENDENT ACTIVITY | 473 | 3.04e-02 | -5.83e-02 | 1.99e-01 |
| GOBP REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 79 | 3.71e-01 | -5.83e-02 | 7.00e-01 |
| GOBP CELL CYCLE | 1485 | 2.07e-04 | -5.82e-02 | 6.79e-03 |
| GOMF MANNOSYL OLIGOSACCHARIDE MANNOSIDASE ACTIVITY | 9 | 7.62e-01 | 5.82e-02 | 9.16e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 13 | 7.16e-01 | -5.82e-02 | 8.97e-01 |
| GOMF SULFUR COMPOUND BINDING | 154 | 2.13e-01 | 5.82e-02 | 5.38e-01 |
| GOBP ANTIBACTERIAL HUMORAL RESPONSE | 16 | 6.87e-01 | -5.81e-02 | 8.86e-01 |
| GOMF TRANSLATION ELONGATION FACTOR ACTIVITY | 19 | 6.61e-01 | 5.81e-02 | 8.72e-01 |
| GOBP REGULATION OF STRESS GRANULE ASSEMBLY | 7 | 7.90e-01 | -5.81e-02 | 9.24e-01 |
| GOBP NEGATIVE REGULATION OF MYELINATION | 8 | 7.76e-01 | 5.80e-02 | 9.21e-01 |
| GOBP CORPUS CALLOSUM DEVELOPMENT | 21 | 6.45e-01 | -5.80e-02 | 8.63e-01 |
| GOBP MACROMOLECULE DEPALMITOYLATION | 11 | 7.39e-01 | -5.80e-02 | 9.06e-01 |
| GOMF PALMITOYL HYDROLASE ACTIVITY | 11 | 7.39e-01 | -5.80e-02 | 9.06e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 403 | 4.63e-02 | 5.80e-02 | 2.50e-01 |
| GOCC CELL CELL JUNCTION | 339 | 6.71e-02 | 5.80e-02 | 2.99e-01 |
| GOBP CELLULAR RESPONSE TO ZINC ION | 16 | 6.88e-01 | 5.80e-02 | 8.86e-01 |
| GOCC U2 SNRNP | 25 | 6.16e-01 | 5.80e-02 | 8.48e-01 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 7 | 7.90e-01 | 5.80e-02 | 9.24e-01 |
| GOMF ADENYL NUCLEOTIDE BINDING | 1333 | 4.37e-04 | -5.80e-02 | 1.19e-02 |
| GOBP POSITIVE REGULATION OF RNA BINDING | 6 | 8.06e-01 | -5.79e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SECRETION | 97 | 3.25e-01 | 5.79e-02 | 6.63e-01 |
| GOCC VACUOLE | 704 | 9.20e-03 | 5.79e-02 | 9.90e-02 |
| GOCC AP 2 ADAPTOR COMPLEX | 8 | 7.77e-01 | 5.79e-02 | 9.21e-01 |
| GOBP PROTEOGLYCAN METABOLIC PROCESS | 61 | 4.35e-01 | 5.78e-02 | 7.50e-01 |
| GOBP CELL AGGREGATION | 7 | 7.91e-01 | 5.78e-02 | 9.24e-01 |
| GOBP ANTERIOR POSTERIOR AXIS SPECIFICATION | 27 | 6.03e-01 | 5.78e-02 | 8.42e-01 |
| GOBP REGULATION OF ATP DEPENDENT ACTIVITY | 50 | 4.80e-01 | -5.78e-02 | 7.77e-01 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT | 64 | 4.24e-01 | 5.78e-02 | 7.42e-01 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 21 | 6.47e-01 | -5.78e-02 | 8.64e-01 |
| GOBP REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 34 | 5.60e-01 | 5.77e-02 | 8.26e-01 |
| GOBP MITOTIC G2 M TRANSITION CHECKPOINT | 51 | 4.76e-01 | -5.77e-02 | 7.75e-01 |
| GOMF NUCLEAR RETINOID X RECEPTOR BINDING | 14 | 7.09e-01 | -5.77e-02 | 8.94e-01 |
| GOBP BRANCHED CHAIN AMINO ACID CATABOLIC PROCESS | 20 | 6.55e-01 | -5.77e-02 | 8.69e-01 |
| GOBP SYNAPTONEMAL COMPLEX ORGANIZATION | 18 | 6.72e-01 | -5.77e-02 | 8.77e-01 |
| GOBP REGULATION OF TRANS SYNAPTIC SIGNALING | 279 | 9.83e-02 | -5.76e-02 | 3.67e-01 |
| GOBP CELLULAR RESPONSE TO GONADOTROPIN STIMULUS | 8 | 7.78e-01 | -5.76e-02 | 9.21e-01 |
| GOBP OTOLITH DEVELOPMENT | 5 | 8.24e-01 | -5.76e-02 | 9.37e-01 |
| GOBP REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY | 9 | 7.65e-01 | 5.76e-02 | 9.17e-01 |
| GOBP NEUROTROPHIN SIGNALING PATHWAY | 26 | 6.12e-01 | -5.76e-02 | 8.46e-01 |
| GOBP UBIQUITIN RECYCLING | 13 | 7.19e-01 | -5.76e-02 | 8.99e-01 |
| GOBP LIPID MODIFICATION | 145 | 2.32e-01 | 5.75e-02 | 5.63e-01 |
| GOMF APOLIPOPROTEIN BINDING | 11 | 7.41e-01 | -5.75e-02 | 9.06e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 10 | 7.53e-01 | -5.75e-02 | 9.12e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION | 64 | 4.27e-01 | 5.75e-02 | 7.44e-01 |
| GOBP POSITIVE REGULATION OF MIRNA METABOLIC PROCESS | 47 | 4.96e-01 | -5.75e-02 | 7.85e-01 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 36 | 5.51e-01 | 5.74e-02 | 8.19e-01 |
| GOBP SENSORY PERCEPTION OF MECHANICAL STIMULUS | 111 | 2.97e-01 | -5.74e-02 | 6.34e-01 |
| GOBP REGULATION OF STEROID METABOLIC PROCESS | 65 | 4.24e-01 | -5.74e-02 | 7.42e-01 |
| GOBP MOLTING CYCLE PROCESS | 55 | 4.62e-01 | -5.74e-02 | 7.64e-01 |
| GOBP HIPPO SIGNALING | 34 | 5.63e-01 | -5.74e-02 | 8.26e-01 |
| GOBP NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING | 8 | 7.79e-01 | -5.74e-02 | 9.21e-01 |
| GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 77 | 3.85e-01 | -5.74e-02 | 7.12e-01 |
| GOBP ORGANOPHOSPHATE BIOSYNTHETIC PROCESS | 503 | 2.83e-02 | 5.73e-02 | 1.91e-01 |
| GOBP VESICLE MEDIATED CHOLESTEROL TRANSPORT | 9 | 7.66e-01 | -5.73e-02 | 9.17e-01 |
| GOMF DEATH RECEPTOR BINDING | 16 | 6.92e-01 | -5.72e-02 | 8.88e-01 |
| GOBP GLIAL CELL MIGRATION | 45 | 5.07e-01 | 5.72e-02 | 7.90e-01 |
| GOBP STEM CELL DIFFERENTIATION | 162 | 2.09e-01 | -5.72e-02 | 5.33e-01 |
| GOBP REGULATION OF LOCOMOTION | 701 | 1.03e-02 | -5.72e-02 | 1.06e-01 |
| GOBP MALE MEIOSIS I | 16 | 6.92e-01 | -5.72e-02 | 8.88e-01 |
| GOBP MEMBRANE LIPID CATABOLIC PROCESS | 25 | 6.21e-01 | 5.72e-02 | 8.50e-01 |
| GOBP REGULATION OF AUTOPHAGOSOME MATURATION | 16 | 6.92e-01 | -5.71e-02 | 8.88e-01 |
| GOBP POSITIVE REGULATION OF ORGANIC ACID TRANSPORT | 25 | 6.21e-01 | 5.71e-02 | 8.50e-01 |
| GOCC EXTRINSIC COMPONENT OF MEMBRANE | 141 | 2.42e-01 | -5.71e-02 | 5.75e-01 |
| GOMF HYDROXYMETHYL FORMYL AND RELATED TRANSFERASE ACTIVITY | 7 | 7.94e-01 | 5.71e-02 | 9.26e-01 |
| GOBP OOGENESIS | 63 | 4.34e-01 | -5.71e-02 | 7.50e-01 |
| GOBP MULTICELLULAR ORGANISM REPRODUCTION | 570 | 2.05e-02 | -5.70e-02 | 1.58e-01 |
| GOBP BLOOD VESSEL MORPHOGENESIS | 397 | 5.19e-02 | -5.70e-02 | 2.64e-01 |
| GOBP RAP PROTEIN SIGNAL TRANSDUCTION | 13 | 7.22e-01 | 5.70e-02 | 9.00e-01 |
| GOCC SARCOLEMMA | 93 | 3.43e-01 | 5.70e-02 | 6.79e-01 |
| GOBP RESPONSE TO HYDROPEROXIDE | 12 | 7.33e-01 | -5.69e-02 | 9.04e-01 |
| GOBP REGULATION OF VESICLE FUSION | 14 | 7.12e-01 | -5.69e-02 | 8.96e-01 |
| GOBP MAINTENANCE OF ORGANELLE LOCATION | 11 | 7.44e-01 | -5.69e-02 | 9.08e-01 |
| GOBP REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 49 | 4.91e-01 | -5.69e-02 | 7.83e-01 |
| GOMF PROTEIN PHOSPHATASE 2A BINDING | 27 | 6.09e-01 | -5.69e-02 | 8.46e-01 |
| GOCC AP TYPE MEMBRANE COAT ADAPTOR COMPLEX | 36 | 5.55e-01 | -5.69e-02 | 8.20e-01 |
| GOBP CATECHOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 9 | 7.68e-01 | 5.69e-02 | 9.18e-01 |
| GOBP RESPONSE TO STEROL DEPLETION | 15 | 7.03e-01 | 5.69e-02 | 8.91e-01 |
| GOBP APPENDAGE MORPHOGENESIS | 81 | 3.77e-01 | -5.68e-02 | 7.05e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE BINDING | 62 | 4.39e-01 | -5.68e-02 | 7.52e-01 |
| GOMF O ACETYLTRANSFERASE ACTIVITY | 6 | 8.10e-01 | -5.68e-02 | 9.33e-01 |
| GOMF TRNA CYTOSINE METHYLTRANSFERASE ACTIVITY | 9 | 7.68e-01 | -5.68e-02 | 9.18e-01 |
| GOBP REGULATION OF CELL CYCLE PROCESS | 595 | 1.86e-02 | -5.67e-02 | 1.51e-01 |
| GOMF L ASPARTATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 7.95e-01 | 5.66e-02 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 87 | 3.62e-01 | 5.66e-02 | 6.94e-01 |
| GOBP SMALL MOLECULE CATABOLIC PROCESS | 283 | 1.02e-01 | 5.66e-02 | 3.74e-01 |
| GOCC GOLGI CIS CISTERNA | 12 | 7.34e-01 | 5.66e-02 | 9.04e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN REGULATION OF CONTRACTION | 6 | 8.10e-01 | 5.66e-02 | 9.33e-01 |
| GOBP REGULATION OF NEUROGENESIS | 244 | 1.29e-01 | -5.66e-02 | 4.20e-01 |
| GOBP AMINO ACID BETAINE METABOLIC PROCESS | 11 | 7.45e-01 | -5.66e-02 | 9.08e-01 |
| GOBP POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE | 18 | 6.78e-01 | 5.65e-02 | 8.80e-01 |
| GOBP T CELL MIGRATION | 51 | 4.85e-01 | -5.65e-02 | 7.81e-01 |
| GOBP POSITIVE REGULATION OF MAPK CASCADE | 311 | 8.75e-02 | -5.65e-02 | 3.45e-01 |
| GOBP MUSCLE TISSUE DEVELOPMENT | 246 | 1.28e-01 | -5.65e-02 | 4.20e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPIRATION | 10 | 7.58e-01 | -5.64e-02 | 9.14e-01 |
| GOBP BEHAVIORAL RESPONSE TO COCAINE | 8 | 7.83e-01 | -5.64e-02 | 9.22e-01 |
| GOBP LYMPH VESSEL MORPHOGENESIS | 12 | 7.35e-01 | 5.63e-02 | 9.04e-01 |
| GOBP REGULATION OF HORMONE METABOLIC PROCESS | 26 | 6.20e-01 | -5.62e-02 | 8.49e-01 |
| GOMF K63 LINKED DEUBIQUITINASE ACTIVITY | 15 | 7.06e-01 | 5.62e-02 | 8.94e-01 |
| GOBP INNER EAR MORPHOGENESIS | 44 | 5.19e-01 | 5.62e-02 | 7.97e-01 |
| GOBP PROSTANOID BIOSYNTHETIC PROCESS | 21 | 6.56e-01 | 5.62e-02 | 8.70e-01 |
| GOMF PROTEIN MACROMOLECULE ADAPTOR ACTIVITY | 364 | 6.67e-02 | -5.61e-02 | 2.98e-01 |
| GOBP CELLULAR RESPONSE TO LIGHT STIMULUS | 96 | 3.43e-01 | -5.61e-02 | 6.79e-01 |
| GOMF NF KAPPAB BINDING | 28 | 6.08e-01 | 5.61e-02 | 8.46e-01 |
| GOBP REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 9 | 7.71e-01 | -5.61e-02 | 9.19e-01 |
| GOBP KETONE BIOSYNTHETIC PROCESS | 35 | 5.66e-01 | -5.60e-02 | 8.28e-01 |
| GOBP DICARBOXYLIC ACID BIOSYNTHETIC PROCESS | 10 | 7.59e-01 | -5.60e-02 | 9.14e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 15 | 7.07e-01 | -5.60e-02 | 8.94e-01 |
| GOBP ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 38 | 5.51e-01 | 5.60e-02 | 8.19e-01 |
| GOCC COPII VESICLE COAT | 15 | 7.08e-01 | 5.59e-02 | 8.94e-01 |
| GOBP CRISTAE FORMATION | 17 | 6.90e-01 | 5.59e-02 | 8.87e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 8 | 7.84e-01 | 5.59e-02 | 9.22e-01 |
| GOBP REGULATION OF PHOSPHOLIPID CATABOLIC PROCESS | 6 | 8.13e-01 | -5.59e-02 | 9.34e-01 |
| GOBP TORC1 SIGNALING | 91 | 3.57e-01 | -5.59e-02 | 6.90e-01 |
| GOBP MITOPHAGY | 36 | 5.62e-01 | -5.58e-02 | 8.26e-01 |
| GOBP PRESYNAPTIC ACTIVE ZONE ORGANIZATION | 5 | 8.29e-01 | 5.58e-02 | 9.39e-01 |
| GOBP PHOTORECEPTOR CELL MAINTENANCE | 26 | 6.22e-01 | -5.58e-02 | 8.51e-01 |
| GOBP GLUTAMATE RECEPTOR SIGNALING PATHWAY | 31 | 5.91e-01 | -5.58e-02 | 8.37e-01 |
| GOBP VESICLE BUDDING FROM MEMBRANE | 78 | 3.95e-01 | 5.58e-02 | 7.19e-01 |
| GOBP VENOUS BLOOD VESSEL DEVELOPMENT | 9 | 7.72e-01 | 5.57e-02 | 9.20e-01 |
| GOBP MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS | 6 | 8.13e-01 | -5.57e-02 | 9.34e-01 |
| GOBP SELECTIVE AUTOPHAGY | 91 | 3.59e-01 | -5.57e-02 | 6.91e-01 |
| GOBP PROSTATE GLAND GROWTH | 7 | 7.99e-01 | -5.57e-02 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 144 | 2.49e-01 | -5.57e-02 | 5.84e-01 |
| GOBP LIPID METABOLIC PROCESS | 964 | 3.68e-03 | 5.56e-02 | 5.48e-02 |
| GOMF NEUTRAL L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 31 | 5.92e-01 | -5.56e-02 | 8.38e-01 |
| GOBP LEUKOCYTE MIGRATION | 275 | 1.13e-01 | -5.56e-02 | 3.96e-01 |
| GOBP INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION | 28 | 6.11e-01 | 5.55e-02 | 8.46e-01 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 31 | 5.93e-01 | -5.55e-02 | 8.38e-01 |
| GOBP MESONEPHRIC TUBULE MORPHOGENESIS | 28 | 6.12e-01 | 5.54e-02 | 8.46e-01 |
| GOBP AV NODE CELL TO BUNDLE OF HIS CELL SIGNALING | 6 | 8.14e-01 | -5.54e-02 | 9.34e-01 |
| GOMF PYRIMIDINE NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 8.14e-01 | 5.54e-02 | 9.34e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 17 | 6.93e-01 | 5.53e-02 | 8.88e-01 |
| GOBP REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 260 | 1.25e-01 | -5.53e-02 | 4.15e-01 |
| GOCC CENTRIOLAR SUBDISTAL APPENDAGE | 9 | 7.74e-01 | -5.53e-02 | 9.20e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION | 118 | 3.01e-01 | -5.52e-02 | 6.39e-01 |
| GOBP PHOSPHOLIPID DEPHOSPHORYLATION | 32 | 5.89e-01 | -5.52e-02 | 8.36e-01 |
| GOMF SERINE HYDROLASE ACTIVITY | 95 | 3.53e-01 | -5.52e-02 | 6.87e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON SULFUR BONDS | 31 | 5.95e-01 | -5.52e-02 | 8.39e-01 |
| GOBP PLASMA CELL DIFFERENTIATION | 6 | 8.15e-01 | -5.52e-02 | 9.34e-01 |
| GOMF PORIN ACTIVITY | 6 | 8.15e-01 | -5.51e-02 | 9.34e-01 |
| GOBP AMINOGLYCAN BIOSYNTHETIC PROCESS | 55 | 4.80e-01 | 5.51e-02 | 7.77e-01 |
| GOBP VENTRAL SPINAL CORD DEVELOPMENT | 19 | 6.78e-01 | 5.51e-02 | 8.79e-01 |
| GOBP ENDOSOMAL VESICLE FUSION | 12 | 7.41e-01 | -5.51e-02 | 9.06e-01 |
| GOMF INOSITOL BISPHOSPHATE PHOSPHATASE ACTIVITY | 5 | 8.31e-01 | 5.51e-02 | 9.41e-01 |
| GOCC NUCLEAR PORE OUTER RING | 9 | 7.75e-01 | -5.51e-02 | 9.21e-01 |
| GOCC IMMUNOLOGICAL SYNAPSE | 35 | 5.73e-01 | -5.51e-02 | 8.30e-01 |
| GOBP NEURAL TUBE PATTERNING | 28 | 6.14e-01 | -5.50e-02 | 8.48e-01 |
| GOBP HETEROTYPIC CELL CELL ADHESION | 46 | 5.19e-01 | 5.50e-02 | 7.97e-01 |
| GOBP LEUKOCYTE CHEMOTAXIS | 164 | 2.25e-01 | -5.50e-02 | 5.53e-01 |
| GOBP MATURATION OF LSU RRNA | 28 | 6.15e-01 | -5.50e-02 | 8.48e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION INTRACELLULAR COMPONENT | 17 | 6.95e-01 | -5.49e-02 | 8.88e-01 |
| GOCC POTASSIUM CHANNEL COMPLEX | 45 | 5.24e-01 | 5.49e-02 | 8.00e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 154 | 2.41e-01 | -5.48e-02 | 5.75e-01 |
| GOBP EMBRYONIC PATTERN SPECIFICATION | 37 | 5.64e-01 | 5.48e-02 | 8.27e-01 |
| GOCC HRD1P UBIQUITIN LIGASE ERAD L COMPLEX | 6 | 8.16e-01 | 5.48e-02 | 9.34e-01 |
| GOBP TELOMERE LOCALIZATION | 8 | 7.89e-01 | -5.47e-02 | 9.24e-01 |
| GOMF LYASE ACTIVITY | 152 | 2.45e-01 | 5.47e-02 | 5.79e-01 |
| GOBP LATERAL MESODERM DEVELOPMENT | 7 | 8.02e-01 | 5.47e-02 | 9.29e-01 |
| GOBP SKELETAL MUSCLE CELL DIFFERENTIATION | 43 | 5.35e-01 | -5.47e-02 | 8.07e-01 |
| GOCC TERMINAL BOUTON | 21 | 6.65e-01 | -5.47e-02 | 8.73e-01 |
| GOBP REGULATION OF CHONDROCYTE DIFFERENTIATION | 25 | 6.37e-01 | 5.46e-02 | 8.58e-01 |
| GOBP NUCLEOBASE TRANSPORT | 10 | 7.65e-01 | 5.45e-02 | 9.17e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 20 | 6.74e-01 | -5.44e-02 | 8.78e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A NUCLEIC ACID | 551 | 2.97e-02 | -5.44e-02 | 1.97e-01 |
| GOBP CELLULAR RESPONSE TO STEROL DEPLETION | 13 | 7.34e-01 | 5.44e-02 | 9.04e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 49 | 5.10e-01 | -5.44e-02 | 7.92e-01 |
| GOCC PLASMA MEMBRANE PROTEIN COMPLEX | 345 | 8.35e-02 | -5.44e-02 | 3.40e-01 |
| GOBP CALCIUM ION TRANSPORT INTO CYTOSOL | 12 | 7.44e-01 | 5.43e-02 | 9.08e-01 |
| GOMF SODIUM CHANNEL INHIBITOR ACTIVITY | 5 | 8.33e-01 | 5.43e-02 | 9.41e-01 |
| GOMF METALLOAMINOPEPTIDASE ACTIVITY | 21 | 6.67e-01 | -5.43e-02 | 8.75e-01 |
| GOBP SYNAPTIC TRANSMISSION GABAERGIC | 25 | 6.38e-01 | 5.43e-02 | 8.59e-01 |
| GOBP DETECTION OF LIGHT STIMULUS | 32 | 5.95e-01 | 5.43e-02 | 8.39e-01 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 83 | 3.93e-01 | -5.43e-02 | 7.18e-01 |
| GOBP VESICLE TARGETING | 62 | 4.61e-01 | -5.42e-02 | 7.64e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING | 12 | 7.45e-01 | -5.42e-02 | 9.08e-01 |
| GOBP SYNAPTIC VESICLE RECYCLING | 64 | 4.54e-01 | -5.41e-02 | 7.62e-01 |
| GOBP ORGANELLE INHERITANCE | 15 | 7.17e-01 | -5.41e-02 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 30 | 6.08e-01 | 5.41e-02 | 8.46e-01 |
| GOBP SENSORY PERCEPTION OF SOUR TASTE | 5 | 8.34e-01 | -5.40e-02 | 9.41e-01 |
| GOBP PEPTIDYL LYSINE MONOMETHYLATION | 9 | 7.79e-01 | -5.40e-02 | 9.21e-01 |
| GOBP INORGANIC ION HOMEOSTASIS | 342 | 8.73e-02 | 5.39e-02 | 3.45e-01 |
| GOBP VASCULATURE DEVELOPMENT | 486 | 4.25e-02 | -5.39e-02 | 2.40e-01 |
| GOBP CARBOHYDRATE TRANSMEMBRANE TRANSPORT | 91 | 3.75e-01 | 5.38e-02 | 7.03e-01 |
| GOBP EMBRYONIC ORGAN DEVELOPMENT | 257 | 1.38e-01 | -5.38e-02 | 4.36e-01 |
| GOCC MONOATOMIC ION CHANNEL COMPLEX | 140 | 2.73e-01 | 5.37e-02 | 6.09e-01 |
| GOBP ANTEROGRADE AXONAL TRANSPORT | 40 | 5.57e-01 | 5.37e-02 | 8.23e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL MIGRATION | 112 | 3.27e-01 | -5.36e-02 | 6.64e-01 |
| GOMF DNA ENDONUCLEASE ACTIVITY | 38 | 5.68e-01 | -5.36e-02 | 8.28e-01 |
| GOBP MRNA CIS SPLICING VIA SPLICEOSOME | 24 | 6.50e-01 | -5.36e-02 | 8.66e-01 |
| GOMF UBIQUITINATION LIKE MODIFICATION DEPENDENT PROTEIN BINDING | 19 | 6.86e-01 | -5.36e-02 | 8.84e-01 |
| GOCC VACUOLAR MEMBRANE | 424 | 5.97e-02 | 5.35e-02 | 2.82e-01 |
| GOBP RESPONSE TO ABIOTIC STIMULUS | 819 | 9.82e-03 | -5.34e-02 | 1.03e-01 |
| GOBP REGULATION OF POLYSACCHARIDE BIOSYNTHETIC PROCESS | 25 | 6.44e-01 | -5.34e-02 | 8.63e-01 |
| GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 68 | 4.47e-01 | -5.33e-02 | 7.57e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL PIGMENTATION | 7 | 8.07e-01 | 5.33e-02 | 9.32e-01 |
| GOBP NEGATIVE REGULATION OF EXOCYTOSIS | 29 | 6.20e-01 | 5.33e-02 | 8.49e-01 |
| GOBP REGULATION OF PROTEIN TARGETING | 72 | 4.35e-01 | 5.33e-02 | 7.50e-01 |
| GOMF MYOSIN V BINDING | 10 | 7.71e-01 | 5.33e-02 | 9.19e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 9 | 7.82e-01 | -5.33e-02 | 9.22e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION | 9 | 7.82e-01 | -5.33e-02 | 9.22e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION | 18 | 6.96e-01 | 5.33e-02 | 8.88e-01 |
| GOBP PROTEIN PROCESSING | 170 | 2.32e-01 | 5.33e-02 | 5.63e-01 |
| GOMF ALCOHOL BINDING | 60 | 4.76e-01 | -5.32e-02 | 7.75e-01 |
| GOBP FIBROBLAST ACTIVATION | 11 | 7.60e-01 | -5.32e-02 | 9.14e-01 |
| GOBP PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS | 31 | 6.08e-01 | 5.32e-02 | 8.46e-01 |
| GOBP CEREBRAL CORTEX NEURON DIFFERENTIATION | 12 | 7.50e-01 | -5.32e-02 | 9.10e-01 |
| GOMF HISTONE DEUBIQUITINASE ACTIVITY | 6 | 8.22e-01 | -5.31e-02 | 9.36e-01 |
| GOCC ER UBIQUITIN LIGASE COMPLEX | 8 | 7.95e-01 | 5.31e-02 | 9.26e-01 |
| GOCC NEUROMUSCULAR JUNCTION | 50 | 5.16e-01 | -5.31e-02 | 7.95e-01 |
| GOCC 9PLUS0 NON MOTILE CILIUM | 85 | 3.98e-01 | 5.31e-02 | 7.21e-01 |
| GOMF HEAT SHOCK PROTEIN BINDING | 111 | 3.34e-01 | 5.31e-02 | 6.69e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL | 22 | 6.67e-01 | 5.31e-02 | 8.75e-01 |
| GOBP RESPONSE TO TOXIC SUBSTANCE | 168 | 2.36e-01 | 5.30e-02 | 5.68e-01 |
| GOMF HSP70 PROTEIN BINDING | 42 | 5.52e-01 | 5.30e-02 | 8.19e-01 |
| GOBP RESPONSE TO STEROL | 25 | 6.46e-01 | -5.30e-02 | 8.64e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 18 | 6.97e-01 | 5.30e-02 | 8.89e-01 |
| GOBP CELLULAR RESPONSE TO BIOTIC STIMULUS | 191 | 2.08e-01 | -5.29e-02 | 5.32e-01 |
| GOBP HOMOTYPIC CELL CELL ADHESION | 68 | 4.51e-01 | -5.29e-02 | 7.60e-01 |
| GOBP REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 30 | 6.16e-01 | -5.29e-02 | 8.49e-01 |
| GOMF TESTOSTERONE DEHYDROGENASE NADPLUS ACTIVITY | 6 | 8.23e-01 | 5.28e-02 | 9.36e-01 |
| GOBP FOREBRAIN NEURON DIFFERENTIATION | 21 | 6.75e-01 | -5.28e-02 | 8.79e-01 |
| GOBP RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS | 14 | 7.33e-01 | -5.28e-02 | 9.04e-01 |
| GOBP RESPONSE TO PLATELET DERIVED GROWTH FACTOR | 19 | 6.91e-01 | 5.28e-02 | 8.87e-01 |
| GOBP SYNAPSE ASSEMBLY | 107 | 3.47e-01 | -5.27e-02 | 6.82e-01 |
| GOBP NEUROTRANSMITTER TRANSPORT | 122 | 3.15e-01 | 5.27e-02 | 6.54e-01 |
| GOBP IMPORT INTO CELL | 655 | 2.22e-02 | -5.26e-02 | 1.66e-01 |
| GOMF PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 80 | 4.16e-01 | -5.26e-02 | 7.34e-01 |
| GOBP FREE UBIQUITIN CHAIN POLYMERIZATION | 9 | 7.85e-01 | 5.26e-02 | 9.22e-01 |
| GOBP T CELL DIFFERENTIATION IN THYMUS | 59 | 4.85e-01 | 5.26e-02 | 7.81e-01 |
| GOBP CARDIAC CONDUCTION | 53 | 5.08e-01 | -5.25e-02 | 7.91e-01 |
| GOBP REGULATION OF NEURON PROJECTION DEVELOPMENT | 313 | 1.11e-01 | -5.25e-02 | 3.90e-01 |
| GOBP MITOTIC CELL CYCLE | 787 | 1.28e-02 | -5.25e-02 | 1.21e-01 |
| GOMF CARGO RECEPTOR ACTIVITY | 44 | 5.47e-01 | -5.25e-02 | 8.17e-01 |
| GOBP MITOTIC NUCLEAR MEMBRANE DISASSEMBLY | 7 | 8.10e-01 | -5.24e-02 | 9.33e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 6 | 8.24e-01 | 5.24e-02 | 9.37e-01 |
| GOCC SCHAFFER COLLATERAL CA1 SYNAPSE | 58 | 4.90e-01 | 5.24e-02 | 7.83e-01 |
| GOBP AXON DEVELOPMENT | 310 | 1.14e-01 | -5.24e-02 | 3.96e-01 |
| GOBP CELLULAR RESPONSE TO ETHANOL | 10 | 7.74e-01 | -5.24e-02 | 9.20e-01 |
| GOMF GTPASE ACTIVATING PROTEIN BINDING | 11 | 7.64e-01 | -5.23e-02 | 9.17e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 12 | 7.54e-01 | 5.23e-02 | 9.12e-01 |
| GOMF TRANSITION METAL ION BINDING | 772 | 1.40e-02 | -5.23e-02 | 1.28e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 24 | 6.58e-01 | 5.23e-02 | 8.70e-01 |
| GOBP COPI COATED VESICLE BUDDING | 6 | 8.25e-01 | -5.23e-02 | 9.37e-01 |
| GOBP CELL JUNCTION DISASSEMBLY | 19 | 6.93e-01 | -5.23e-02 | 8.88e-01 |
| GOBP POSITIVE REGULATION OF LOCOMOTION | 401 | 7.42e-02 | -5.21e-02 | 3.19e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION | 10 | 7.75e-01 | -5.21e-02 | 9.21e-01 |
| GOBP REGULATION OF LIPOPHAGY | 5 | 8.40e-01 | -5.21e-02 | 9.43e-01 |
| GOBP PROTEIN TARGETING TO PEROXISOME | 19 | 6.95e-01 | 5.20e-02 | 8.88e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MIGRATION | 38 | 5.79e-01 | -5.20e-02 | 8.32e-01 |
| GOBP NEGATIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE | 15 | 7.27e-01 | -5.20e-02 | 9.03e-01 |
| GOBP REGULATION OF SODIUM ION TRANSPORT | 49 | 5.29e-01 | 5.20e-02 | 8.03e-01 |
| GOMF PROTEIN TYROSINE THREONINE PHOSPHATASE ACTIVITY | 8 | 7.99e-01 | 5.20e-02 | 9.27e-01 |
| GOBP PROTEOGLYCAN CATABOLIC PROCESS | 10 | 7.76e-01 | -5.19e-02 | 9.21e-01 |
| GOMF ENZYME REGULATOR ACTIVITY | 988 | 6.12e-03 | -5.19e-02 | 7.68e-02 |
| GOBP MUSCLE ATROPHY | 6 | 8.26e-01 | -5.19e-02 | 9.38e-01 |
| GOBP NOTCH RECEPTOR PROCESSING | 8 | 7.99e-01 | -5.19e-02 | 9.27e-01 |
| GOBP BLASTOCYST GROWTH | 19 | 6.95e-01 | 5.19e-02 | 8.88e-01 |
| GOBP REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 55 | 5.06e-01 | 5.19e-02 | 7.90e-01 |
| GOCC NEURON SPINE | 118 | 3.31e-01 | -5.19e-02 | 6.67e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 28 | 6.35e-01 | -5.18e-02 | 8.57e-01 |
| GOBP PROTEIN LOCALIZATION TO PRESYNAPSE | 6 | 8.26e-01 | -5.18e-02 | 9.38e-01 |
| GOBP RESPONSE TO AUDITORY STIMULUS | 20 | 6.88e-01 | 5.18e-02 | 8.86e-01 |
| GOCC SMALL SUBUNIT PROCESSOME | 70 | 4.54e-01 | -5.18e-02 | 7.62e-01 |
| GOBP SHORT CHAIN FATTY ACID CATABOLIC PROCESS | 6 | 8.26e-01 | 5.18e-02 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF MEIOTIC CELL CYCLE | 15 | 7.29e-01 | 5.17e-02 | 9.03e-01 |
| GOBP EXPORT ACROSS PLASMA MEMBRANE | 42 | 5.62e-01 | -5.17e-02 | 8.26e-01 |
| GOBP POSITIVE REGULATION OF CAMP MEDIATED SIGNALING | 5 | 8.42e-01 | -5.16e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF VESICLE TRANSPORT ALONG MICROTUBULE | 5 | 8.42e-01 | -5.16e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 26 | 6.49e-01 | -5.16e-02 | 8.65e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 64 | 4.76e-01 | -5.16e-02 | 7.75e-01 |
| GOBP REGULATION OF XENOPHAGY | 8 | 8.01e-01 | -5.16e-02 | 9.28e-01 |
| GOBP LEUKOCYTE APOPTOTIC PROCESS | 95 | 3.85e-01 | -5.16e-02 | 7.12e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL HOMEOSTASIS | 555 | 3.89e-02 | -5.15e-02 | 2.28e-01 |
| GOMF STRUCTURAL MOLECULE ACTIVITY | 427 | 6.90e-02 | 5.15e-02 | 3.04e-01 |
| GOMF ENDOPEPTIDASE REGULATOR ACTIVITY | 90 | 4.00e-01 | 5.14e-02 | 7.22e-01 |
| GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 15 | 7.31e-01 | 5.13e-02 | 9.04e-01 |
| GOBP CELLULAR RESPONSE TO ABIOTIC STIMULUS | 261 | 1.54e-01 | -5.13e-02 | 4.59e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS | 5 | 8.43e-01 | 5.13e-02 | 9.44e-01 |
| GOMF SINGLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 9 | 7.90e-01 | -5.13e-02 | 9.24e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS | 36 | 5.95e-01 | 5.12e-02 | 8.39e-01 |
| GOBP REGULATION OF SIGNALING RECEPTOR ACTIVITY | 69 | 4.63e-01 | -5.11e-02 | 7.65e-01 |
| GOBP INTERMEDIATE FILAMENT BASED PROCESS | 33 | 6.12e-01 | -5.11e-02 | 8.46e-01 |
| GOBP KIDNEY MORPHOGENESIS | 47 | 5.45e-01 | 5.11e-02 | 8.15e-01 |
| GOBP REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 9 | 7.91e-01 | -5.11e-02 | 9.24e-01 |
| GOCC SCAR COMPLEX | 11 | 7.69e-01 | 5.10e-02 | 9.18e-01 |
| GOBP NEGATIVE REGULATION OF SIGNALING | 996 | 6.84e-03 | -5.10e-02 | 8.20e-02 |
| GOBP REGULATION OF DNA REPLICATION | 111 | 3.54e-01 | -5.10e-02 | 6.87e-01 |
| GOBP GLUCOSE METABOLIC PROCESS | 149 | 2.84e-01 | -5.09e-02 | 6.22e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB | 17 | 7.16e-01 | -5.09e-02 | 8.97e-01 |
| GOBP EPITHELIAL TUBE MORPHOGENESIS | 211 | 2.03e-01 | -5.09e-02 | 5.26e-01 |
| GOMF LIGAND GATED CHANNEL ACTIVITY | 58 | 5.03e-01 | -5.09e-02 | 7.88e-01 |
| GOMF ACTIN FILAMENT BINDING | 161 | 2.66e-01 | 5.08e-02 | 6.03e-01 |
| GOCC PHOTORECEPTOR OUTER SEGMENT MEMBRANE | 12 | 7.60e-01 | -5.08e-02 | 9.15e-01 |
| GOCC TRAPPIII PROTEIN COMPLEX | 12 | 7.60e-01 | -5.08e-02 | 9.15e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 108 | 3.62e-01 | -5.08e-02 | 6.94e-01 |
| GOBP REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE | 31 | 6.25e-01 | -5.08e-02 | 8.52e-01 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING N GLYCOSYL COMPOUNDS | 34 | 6.09e-01 | -5.08e-02 | 8.46e-01 |
| GOBP REGULATION OF PEPTIDE TRANSPORT | 114 | 3.51e-01 | -5.07e-02 | 6.86e-01 |
| GOBP NEGATIVE REGULATION OF GROWTH | 175 | 2.49e-01 | -5.06e-02 | 5.84e-01 |
| GOMF EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 25 | 6.62e-01 | -5.05e-02 | 8.72e-01 |
| GOBP CELL JUNCTION MAINTENANCE | 31 | 6.26e-01 | 5.05e-02 | 8.53e-01 |
| GOBP MALE GAMETE GENERATION | 365 | 9.84e-02 | -5.05e-02 | 3.67e-01 |
| GOBP HEMOGLOBIN BIOSYNTHETIC PROCESS | 10 | 7.82e-01 | 5.04e-02 | 9.22e-01 |
| GOBP LEUKOTRIENE BIOSYNTHETIC PROCESS | 10 | 7.83e-01 | -5.04e-02 | 9.22e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 10 | 7.83e-01 | -5.04e-02 | 9.22e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS | 23 | 6.76e-01 | -5.04e-02 | 8.79e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE PERMEABILITY | 18 | 7.12e-01 | 5.03e-02 | 8.96e-01 |
| GOBP EPIDERMIS DEVELOPMENT | 192 | 2.30e-01 | 5.03e-02 | 5.60e-01 |
| GOBP SUBSTRATE DEPENDENT CELL MIGRATION | 23 | 6.76e-01 | -5.03e-02 | 8.79e-01 |
| GOBP REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 19 | 7.04e-01 | 5.03e-02 | 8.92e-01 |
| GOCC DNA RECOMBINASE MEDIATOR COMPLEX | 7 | 8.18e-01 | 5.03e-02 | 9.34e-01 |
| GOBP ACTIN POLYMERIZATION OR DEPOLYMERIZATION | 154 | 2.82e-01 | -5.03e-02 | 6.20e-01 |
| GOBP VISUAL BEHAVIOR | 34 | 6.12e-01 | 5.03e-02 | 8.46e-01 |
| GOMF ENOYL COA HYDRATASE ACTIVITY | 11 | 7.73e-01 | -5.03e-02 | 9.20e-01 |
| GOMF LIPOPOLYSACCHARIDE BINDING | 22 | 6.83e-01 | -5.02e-02 | 8.83e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 15 | 7.36e-01 | 5.02e-02 | 9.05e-01 |
| GOBP NEUTROPHIL CLEARANCE | 5 | 8.46e-01 | 5.02e-02 | 9.46e-01 |
| GOBP GLANDULAR EPITHELIAL CELL DIFFERENTIATION | 33 | 6.18e-01 | 5.02e-02 | 8.49e-01 |
| GOBP POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 121 | 3.42e-01 | 5.01e-02 | 6.78e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 10 | 7.84e-01 | -5.01e-02 | 9.22e-01 |
| GOCC CYTOPLASMIC REGION | 199 | 2.24e-01 | 5.01e-02 | 5.52e-01 |
| GOBP REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 34 | 6.13e-01 | 5.01e-02 | 8.47e-01 |
| GOBP REGULATION OF MEMBRANE POTENTIAL | 252 | 1.72e-01 | 5.01e-02 | 4.86e-01 |
| GOBP DEVELOPMENTAL PIGMENTATION | 30 | 6.35e-01 | 5.00e-02 | 8.57e-01 |
| GOBP PROTEIN LOCALIZATION TO CYTOPLASMIC STRESS GRANULE | 8 | 8.06e-01 | -5.00e-02 | 9.31e-01 |
| GOBP COPPER ION IMPORT | 5 | 8.47e-01 | 5.00e-02 | 9.46e-01 |
| GOBP REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 22 | 6.85e-01 | 5.00e-02 | 8.84e-01 |
| GOBP RESPONSE TO INORGANIC SUBSTANCE | 375 | 9.75e-02 | -5.00e-02 | 3.66e-01 |
| GOBP POSITIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 11 | 7.74e-01 | 5.00e-02 | 9.20e-01 |
| GOBP NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 7 | 8.19e-01 | 4.99e-02 | 9.35e-01 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 12 | 7.65e-01 | 4.99e-02 | 9.17e-01 |
| GOBP CAMERA TYPE EYE MORPHOGENESIS | 72 | 4.65e-01 | -4.98e-02 | 7.66e-01 |
| GOBP SKELETAL SYSTEM DEVELOPMENT | 300 | 1.39e-01 | -4.97e-02 | 4.38e-01 |
| GOBP REGULATION OF B CELL APOPTOTIC PROCESS | 18 | 7.15e-01 | -4.97e-02 | 8.97e-01 |
| GOMF STEROL TRANSFER ACTIVITY | 17 | 7.23e-01 | -4.97e-02 | 9.00e-01 |
| GOBP HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 25 | 6.67e-01 | 4.97e-02 | 8.75e-01 |
| GOCC CUL5 RING UBIQUITIN LIGASE COMPLEX | 8 | 8.08e-01 | 4.96e-02 | 9.32e-01 |
| GOBP SYNAPTIC SIGNALING | 431 | 7.85e-02 | -4.96e-02 | 3.30e-01 |
| GOBP REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS | 53 | 5.33e-01 | -4.95e-02 | 8.06e-01 |
| GOBP FEMALE MEIOSIS I | 11 | 7.76e-01 | 4.95e-02 | 9.21e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE IN 5 ETS OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 8 | 8.08e-01 | 4.95e-02 | 9.32e-01 |
| GOMF ATP TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 7.67e-01 | -4.95e-02 | 9.17e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 29 | 6.45e-01 | 4.94e-02 | 8.63e-01 |
| GOBP REGULATION OF AUTOPHAGY | 315 | 1.32e-01 | -4.94e-02 | 4.26e-01 |
| GOCC PHAGOCYTIC VESICLE | 130 | 3.31e-01 | -4.94e-02 | 6.67e-01 |
| GOMF FRIZZLED BINDING | 14 | 7.49e-01 | 4.94e-02 | 9.10e-01 |
| GOBP COCHLEA DEVELOPMENT | 18 | 7.17e-01 | 4.94e-02 | 8.97e-01 |
| GOBP EYE MORPHOGENESIS | 87 | 4.27e-01 | -4.93e-02 | 7.44e-01 |
| GOBP T HELPER 1 CELL CYTOKINE PRODUCTION | 6 | 8.34e-01 | 4.93e-02 | 9.41e-01 |
| GOMF NADPH BINDING | 15 | 7.41e-01 | -4.93e-02 | 9.06e-01 |
| GOMF SPHINGOLIPID TRANSPORTER ACTIVITY | 14 | 7.50e-01 | -4.92e-02 | 9.10e-01 |
| GOBP DETECTION OF STIMULUS | 127 | 3.39e-01 | -4.92e-02 | 6.74e-01 |
| GOBP MYELIN ASSEMBLY | 18 | 7.18e-01 | 4.92e-02 | 8.98e-01 |
| GOBP CELL VOLUME HOMEOSTASIS | 26 | 6.64e-01 | -4.92e-02 | 8.73e-01 |
| GOBP SODIUM ION IMPORT ACROSS PLASMA MEMBRANE | 12 | 7.68e-01 | -4.91e-02 | 9.18e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 12 | 7.68e-01 | 4.91e-02 | 9.18e-01 |
| GOBP ESTABLISHMENT OF TISSUE POLARITY | 54 | 5.33e-01 | 4.91e-02 | 8.05e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO WOUNDING | 55 | 5.29e-01 | 4.91e-02 | 8.03e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 58 | 5.18e-01 | -4.91e-02 | 7.97e-01 |
| GOBP POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE | 131 | 3.32e-01 | -4.91e-02 | 6.67e-01 |
| GOBP POSITIVE CHEMOTAXIS | 31 | 6.36e-01 | -4.91e-02 | 8.58e-01 |
| GOBP SEQUESTERING OF ACTIN MONOMERS | 8 | 8.10e-01 | -4.90e-02 | 9.33e-01 |
| GOMF TRANSLATION REPRESSOR ACTIVITY | 30 | 6.42e-01 | 4.90e-02 | 8.61e-01 |
| GOMF CYTOKINE BINDING | 88 | 4.27e-01 | -4.90e-02 | 7.44e-01 |
| GOBP MELANOCYTE DIFFERENTIATION | 12 | 7.69e-01 | 4.90e-02 | 9.18e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 52 | 5.42e-01 | -4.89e-02 | 8.13e-01 |
| GOBP BILE ACID SIGNALING PATHWAY | 5 | 8.50e-01 | -4.89e-02 | 9.47e-01 |
| GOBP METANEPHROS MORPHOGENESIS | 14 | 7.51e-01 | -4.89e-02 | 9.11e-01 |
| GOBP NEGATIVE REGULATION OF RESPIRATORY BURST | 5 | 8.50e-01 | 4.89e-02 | 9.47e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 29 | 6.49e-01 | 4.88e-02 | 8.65e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 841 | 1.69e-02 | -4.88e-02 | 1.45e-01 |
| GOCC SEMAPHORIN RECEPTOR COMPLEX | 8 | 8.11e-01 | 4.88e-02 | 9.33e-01 |
| GOMF SEMAPHORIN RECEPTOR ACTIVITY | 8 | 8.11e-01 | 4.88e-02 | 9.33e-01 |
| GOBP REGULATION OF EPITHELIAL CELL MIGRATION | 161 | 2.86e-01 | -4.88e-02 | 6.24e-01 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 91 | 4.22e-01 | -4.87e-02 | 7.40e-01 |
| GOBP CYTOSOLIC TRANSPORT | 169 | 2.75e-01 | 4.87e-02 | 6.11e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHORYLATION | 461 | 7.40e-02 | -4.87e-02 | 3.18e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID OXIDATION | 10 | 7.90e-01 | 4.87e-02 | 9.24e-01 |
| GOMF RETINAL BINDING | 7 | 8.24e-01 | 4.87e-02 | 9.37e-01 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 35 | 6.19e-01 | 4.86e-02 | 8.49e-01 |
| GOMF NUCLEASE ACTIVITY | 188 | 2.52e-01 | -4.85e-02 | 5.86e-01 |
| GOCC KINOCILIUM | 6 | 8.37e-01 | 4.85e-02 | 9.42e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDINES | 5 | 8.51e-01 | -4.85e-02 | 9.47e-01 |
| GOCC SARCOPLASMIC RETICULUM | 50 | 5.53e-01 | -4.85e-02 | 8.20e-01 |
| GOCC NON MOTILE CILIUM | 105 | 3.91e-01 | 4.84e-02 | 7.17e-01 |
| GOBP BROWN FAT CELL DIFFERENTIATION | 37 | 6.10e-01 | -4.84e-02 | 8.46e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE | 55 | 5.35e-01 | -4.84e-02 | 8.07e-01 |
| GOBP RESPONSE TO WOUNDING | 374 | 1.09e-01 | 4.84e-02 | 3.87e-01 |
| GOBP RESPONSE TO SELENIUM ION | 5 | 8.51e-01 | 4.84e-02 | 9.47e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN | 24 | 6.82e-01 | -4.83e-02 | 8.82e-01 |
| GOBP SPHINGOLIPID METABOLIC PROCESS | 115 | 3.71e-01 | 4.83e-02 | 7.00e-01 |
| GOMF HISTONE H3 KINASE ACTIVITY | 10 | 7.91e-01 | 4.83e-02 | 9.24e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 5 | 8.52e-01 | 4.83e-02 | 9.47e-01 |
| GOBP OSTEOBLAST PROLIFERATION | 21 | 7.02e-01 | -4.83e-02 | 8.91e-01 |
| GOBP DNA DEALKYLATION | 31 | 6.42e-01 | -4.82e-02 | 8.61e-01 |
| GOBP GLIAL CELL DEVELOPMENT | 81 | 4.54e-01 | -4.82e-02 | 7.62e-01 |
| GOBP GLYCOSYL COMPOUND METABOLIC PROCESS | 65 | 5.02e-01 | 4.82e-02 | 7.88e-01 |
| GOMF MRNA METHYLTRANSFERASE ACTIVITY | 13 | 7.64e-01 | 4.81e-02 | 9.17e-01 |
| GOBP GLUTATHIONE TRANSPORT | 7 | 8.26e-01 | -4.81e-02 | 9.38e-01 |
| GOBP SPINAL CORD DEVELOPMENT | 53 | 5.45e-01 | 4.81e-02 | 8.15e-01 |
| GOMF CYCLIC NUCLEOTIDE BINDING | 25 | 6.78e-01 | -4.80e-02 | 8.80e-01 |
| GOBP MORPHOGENESIS OF A BRANCHING STRUCTURE | 109 | 3.88e-01 | -4.79e-02 | 7.14e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE | 400 | 1.01e-01 | 4.79e-02 | 3.72e-01 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION | 10 | 7.93e-01 | 4.79e-02 | 9.25e-01 |
| GOMF COLLAGEN BINDING | 47 | 5.70e-01 | -4.79e-02 | 8.29e-01 |
| GOBP AXON EXTENSION | 90 | 4.33e-01 | 4.78e-02 | 7.49e-01 |
| GOBP CAMP MEDIATED SIGNALING | 30 | 6.50e-01 | -4.78e-02 | 8.66e-01 |
| GOMF HISTONE UBIQUITIN LIGASE ACTIVITY | 11 | 7.84e-01 | -4.78e-02 | 9.22e-01 |
| GOBP BRAIN MORPHOGENESIS | 25 | 6.79e-01 | 4.78e-02 | 8.80e-01 |
| GOBP POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 33 | 6.35e-01 | 4.78e-02 | 8.57e-01 |
| GOMF TRANSLATION INITIATION FACTOR ACTIVITY | 49 | 5.63e-01 | 4.78e-02 | 8.26e-01 |
| GOBP REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 22 | 6.98e-01 | -4.77e-02 | 8.89e-01 |
| GOBP T CELL CYTOKINE PRODUCTION | 27 | 6.68e-01 | -4.77e-02 | 8.75e-01 |
| GOMF VINCULIN BINDING | 11 | 7.84e-01 | -4.77e-02 | 9.22e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 32 | 6.41e-01 | 4.76e-02 | 8.60e-01 |
| GOMF MANNOSYLTRANSFERASE ACTIVITY | 23 | 6.93e-01 | -4.76e-02 | 8.88e-01 |
| GOBP NEUTRAL LIPID BIOSYNTHETIC PROCESS | 38 | 6.12e-01 | 4.76e-02 | 8.46e-01 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 91 | 4.33e-01 | -4.76e-02 | 7.49e-01 |
| GOBP ENDODERM FORMATION | 34 | 6.31e-01 | 4.76e-02 | 8.56e-01 |
| GOBP RESCUE OF STALLED RIBOSOME | 25 | 6.81e-01 | -4.75e-02 | 8.81e-01 |
| GOBP POLARIZED EPITHELIAL CELL DIFFERENTIATION | 20 | 7.14e-01 | 4.74e-02 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 136 | 3.40e-01 | -4.74e-02 | 6.76e-01 |
| GOBP REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 15 | 7.51e-01 | -4.74e-02 | 9.11e-01 |
| GOBP RESPONSE TO ESTROGEN | 48 | 5.71e-01 | -4.73e-02 | 8.29e-01 |
| GOMF UBIQUITIN LIKE PROTEIN PEPTIDASE ACTIVITY | 106 | 4.01e-01 | -4.72e-02 | 7.23e-01 |
| GOBP TOR SIGNALING | 142 | 3.32e-01 | -4.72e-02 | 6.67e-01 |
| GOCC NLS DEPENDENT PROTEIN NUCLEAR IMPORT COMPLEX | 9 | 8.06e-01 | -4.72e-02 | 9.31e-01 |
| GOBP MRNA METHYLATION | 18 | 7.29e-01 | -4.71e-02 | 9.03e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 12 | 7.77e-01 | -4.71e-02 | 9.21e-01 |
| GOMF CYCLASE REGULATOR ACTIVITY | 9 | 8.07e-01 | 4.71e-02 | 9.31e-01 |
| GOBP HEMIDESMOSOME ASSEMBLY | 5 | 8.55e-01 | 4.71e-02 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION | 5 | 8.55e-01 | -4.71e-02 | 9.48e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT BIOGENESIS | 74 | 4.85e-01 | -4.70e-02 | 7.81e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 16 | 7.45e-01 | 4.70e-02 | 9.08e-01 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION | 110 | 3.95e-01 | -4.70e-02 | 7.20e-01 |
| GOBP CERAMIDE BIOSYNTHETIC PROCESS | 49 | 5.70e-01 | -4.69e-02 | 8.29e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION | 12 | 7.78e-01 | -4.69e-02 | 9.21e-01 |
| GOCC LATERAL PART OF CELL | 5 | 8.56e-01 | 4.69e-02 | 9.48e-01 |
| GOBP RENAL VESICLE DEVELOPMENT | 9 | 8.08e-01 | 4.69e-02 | 9.32e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER FORMATION | 10 | 7.98e-01 | -4.69e-02 | 9.27e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT | 67 | 5.07e-01 | -4.69e-02 | 7.90e-01 |
| GOMF GLYCOLIPID BINDING | 21 | 7.10e-01 | 4.68e-02 | 8.96e-01 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS | 151 | 3.21e-01 | -4.68e-02 | 6.61e-01 |
| GOBP CELLULAR LIPID METABOLIC PROCESS | 714 | 3.40e-02 | 4.68e-02 | 2.14e-01 |
| GOBP NEGATIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 6 | 8.43e-01 | 4.68e-02 | 9.44e-01 |
| GOCC OMEGASOME | 5 | 8.56e-01 | -4.68e-02 | 9.48e-01 |
| GOMF L PROLINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 8.56e-01 | -4.68e-02 | 9.48e-01 |
| GOBP CHONDROCYTE DIFFERENTIATION | 65 | 5.15e-01 | 4.67e-02 | 7.95e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN NUCLEATION | 7 | 8.30e-01 | 4.67e-02 | 9.40e-01 |
| GOBP EXTRACELLULAR MATRIX DISASSEMBLY | 37 | 6.23e-01 | 4.67e-02 | 8.51e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 42 | 6.01e-01 | -4.67e-02 | 8.40e-01 |
| GOBP REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 159 | 3.11e-01 | -4.66e-02 | 6.50e-01 |
| GOCC PHOTORECEPTOR CONNECTING CILIUM | 32 | 6.48e-01 | 4.66e-02 | 8.65e-01 |
| GOBP REGULATION OF ACTION POTENTIAL | 39 | 6.15e-01 | 4.66e-02 | 8.48e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION | 382 | 1.19e-01 | 4.66e-02 | 4.03e-01 |
| GOBP PHOSPHATE ION HOMEOSTASIS | 6 | 8.43e-01 | 4.66e-02 | 9.45e-01 |
| GOMF CYTOKINE RECEPTOR BINDING | 149 | 3.27e-01 | 4.66e-02 | 6.64e-01 |
| GOBP NEUROGENESIS | 1105 | 9.62e-03 | -4.65e-02 | 1.02e-01 |
| GOBP PUTRESCINE BIOSYNTHETIC PROCESS | 5 | 8.57e-01 | 4.65e-02 | 9.49e-01 |
| GOBP REGULATION OF STEROID HORMONE SECRETION | 12 | 7.80e-01 | -4.65e-02 | 9.22e-01 |
| GOMF RNA 7 METHYLGUANOSINE CAP BINDING | 12 | 7.81e-01 | 4.65e-02 | 9.22e-01 |
| GOBP GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS | 182 | 2.80e-01 | -4.64e-02 | 6.18e-01 |
| GOMF CHOLESTEROL BINDING | 41 | 6.07e-01 | -4.64e-02 | 8.45e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY FOR OTHER SUBSTITUTED PHOSPHATE GROUPS | 22 | 7.06e-01 | 4.64e-02 | 8.94e-01 |
| GOBP CERAMIDE METABOLIC PROCESS | 75 | 4.87e-01 | 4.64e-02 | 7.81e-01 |
| GOBP SULFUR AMINO ACID METABOLIC PROCESS | 23 | 7.00e-01 | -4.64e-02 | 8.89e-01 |
| GOMF PHOSPHORUS OXYGEN LYASE ACTIVITY | 18 | 7.33e-01 | -4.64e-02 | 9.04e-01 |
| GOBP POSITIVE REGULATION OF CELL ADHESION | 347 | 1.39e-01 | -4.64e-02 | 4.37e-01 |
| GOBP HAIR CELL DIFFERENTIATION | 32 | 6.50e-01 | 4.64e-02 | 8.66e-01 |
| GOBP RESPONSE TO CATECHOLAMINE | 46 | 5.87e-01 | 4.64e-02 | 8.35e-01 |
| GOMF SIGNALING ADAPTOR ACTIVITY | 85 | 4.61e-01 | -4.63e-02 | 7.64e-01 |
| GOBP DEVELOPMENTAL GROWTH | 431 | 1.01e-01 | -4.63e-02 | 3.72e-01 |
| GOCC POSTSYNAPSE | 423 | 1.04e-01 | -4.62e-02 | 3.78e-01 |
| GOBP POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 36 | 6.31e-01 | -4.62e-02 | 8.56e-01 |
| GOBP GLOMERULUS MORPHOGENESIS | 6 | 8.45e-01 | -4.62e-02 | 9.45e-01 |
| GOMF SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 40 | 6.13e-01 | 4.62e-02 | 8.47e-01 |
| GOBP REGULATION OF COLLAGEN FIBRIL ORGANIZATION | 5 | 8.58e-01 | 4.62e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 107 | 4.10e-01 | -4.61e-02 | 7.29e-01 |
| GOBP POSITIVE REGULATION OF CELL MIGRATION BY VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 6 | 8.45e-01 | -4.61e-02 | 9.45e-01 |
| GOCC SUPRAMOLECULAR POLYMER | 650 | 4.59e-02 | 4.61e-02 | 2.49e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 27 | 6.79e-01 | 4.61e-02 | 8.80e-01 |
| GOMF PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 76 | 4.88e-01 | 4.60e-02 | 7.81e-01 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ASSEMBLY | 8 | 8.22e-01 | 4.60e-02 | 9.36e-01 |
| GOBP REGULATION OF SYSTEM PROCESS | 303 | 1.70e-01 | -4.60e-02 | 4.82e-01 |
| GOBP METHYLATION | 242 | 2.19e-01 | -4.59e-02 | 5.48e-01 |
| GOCC PERICILIARY MEMBRANE COMPARTMENT | 5 | 8.59e-01 | 4.59e-02 | 9.50e-01 |
| GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 50 | 5.75e-01 | 4.59e-02 | 8.31e-01 |
| GOBP REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 8.22e-01 | -4.59e-02 | 9.36e-01 |
| GOMF 5 3 DNA HELICASE ACTIVITY | 8 | 8.22e-01 | -4.59e-02 | 9.36e-01 |
| GOBP GAMETE GENERATION | 482 | 8.57e-02 | -4.59e-02 | 3.44e-01 |
| GOBP INFLAMMATORY RESPONSE TO WOUNDING | 21 | 7.16e-01 | 4.59e-02 | 8.97e-01 |
| GOBP NUCLEOPHAGY | 19 | 7.29e-01 | 4.58e-02 | 9.03e-01 |
| GOBP LOCALIZATION WITHIN MEMBRANE | 569 | 6.27e-02 | 4.58e-02 | 2.89e-01 |
| GOBP POSITIVE REGULATION OF BMP SIGNALING PATHWAY | 22 | 7.10e-01 | 4.58e-02 | 8.96e-01 |
| GOBP GLUTAMATE SECRETION | 14 | 7.67e-01 | -4.58e-02 | 9.17e-01 |
| GOBP MODIFICATION OF SYNAPTIC STRUCTURE | 19 | 7.30e-01 | 4.57e-02 | 9.04e-01 |
| GOBP CENTRAL NERVOUS SYSTEM DEVELOPMENT | 640 | 4.95e-02 | -4.57e-02 | 2.59e-01 |
| GOBP NEGATIVE REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 6 | 8.46e-01 | 4.56e-02 | 9.46e-01 |
| GOBP NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 6 | 8.46e-01 | 4.56e-02 | 9.46e-01 |
| GOBP RESPONSE TO CALCIUM ION | 99 | 4.33e-01 | -4.56e-02 | 7.49e-01 |
| GOBP BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS | 12 | 7.85e-01 | -4.56e-02 | 9.22e-01 |
| GOBP VOLUNTARY MUSCULOSKELETAL MOVEMENT | 7 | 8.35e-01 | -4.56e-02 | 9.41e-01 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 14 | 7.68e-01 | 4.56e-02 | 9.18e-01 |
| GOMF TRANSLATION REGULATOR ACTIVITY NUCLEIC ACID BINDING | 99 | 4.34e-01 | 4.55e-02 | 7.50e-01 |
| GOBP NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY | 26 | 6.88e-01 | -4.55e-02 | 8.86e-01 |
| GOBP CELLULAR RESPONSE TO INDOLE 3 METHANOL | 5 | 8.60e-01 | -4.55e-02 | 9.50e-01 |
| GOBP CELL CELL ADHESION | 581 | 6.22e-02 | -4.55e-02 | 2.88e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 27 | 6.83e-01 | 4.55e-02 | 8.82e-01 |
| GOBP RECEPTOR METABOLIC PROCESS | 63 | 5.33e-01 | 4.54e-02 | 8.06e-01 |
| GOCC COATED VESICLE | 251 | 2.16e-01 | 4.54e-02 | 5.42e-01 |
| GOMF DNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS | 10 | 8.04e-01 | 4.54e-02 | 9.30e-01 |
| GOMF CARBON NITROGEN LIGASE ACTIVITY WITH GLUTAMINE AS AMIDO N DONOR | 8 | 8.24e-01 | -4.54e-02 | 9.37e-01 |
| GOBP REGULATION OF BLOOD PRESSURE | 94 | 4.48e-01 | 4.53e-02 | 7.58e-01 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC MEMBRANE | 10 | 8.04e-01 | -4.53e-02 | 9.30e-01 |
| GOCC ENDOLYSOSOME MEMBRANE | 16 | 7.54e-01 | 4.53e-02 | 9.12e-01 |
| GOBP MULTICELLULAR ORGANISMAL RESPONSE TO STRESS | 50 | 5.81e-01 | -4.52e-02 | 8.32e-01 |
| GOBP BONE GROWTH | 17 | 7.47e-01 | -4.52e-02 | 9.09e-01 |
| GOBP BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION | 8 | 8.25e-01 | 4.52e-02 | 9.37e-01 |
| GOBP POLYADENYLATION DEPENDENT SNORNA 3 END PROCESSING | 8 | 8.25e-01 | 4.51e-02 | 9.38e-01 |
| GOBP MESENCHYMAL CELL DIFFERENTIATION | 156 | 3.32e-01 | -4.51e-02 | 6.67e-01 |
| GOCC SPECIFIC GRANULE LUMEN | 44 | 6.05e-01 | 4.50e-02 | 8.44e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE PERMEABILITY | 41 | 6.19e-01 | 4.50e-02 | 8.49e-01 |
| GOMF MAGNESIUM ION BINDING | 190 | 2.86e-01 | -4.49e-02 | 6.24e-01 |
| GOBP AXO DENDRITIC TRANSPORT | 65 | 5.32e-01 | 4.48e-02 | 8.05e-01 |
| GOBP NUCLEAR MEMBRANE REASSEMBLY | 25 | 6.98e-01 | 4.48e-02 | 8.89e-01 |
| GOBP LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 34 | 6.51e-01 | -4.48e-02 | 8.66e-01 |
| GOBP PROTEIN ACYLATION | 127 | 3.84e-01 | -4.48e-02 | 7.11e-01 |
| GOBP GENERATION OF NEURONS | 938 | 2.11e-02 | -4.47e-02 | 1.60e-01 |
| GOBP PLASMA MEMBRANE REPAIR | 28 | 6.82e-01 | 4.47e-02 | 8.82e-01 |
| GOBP ERBB SIGNALING PATHWAY | 93 | 4.57e-01 | -4.47e-02 | 7.62e-01 |
| GOCC SEC61 TRANSLOCON COMPLEX | 5 | 8.63e-01 | 4.47e-02 | 9.52e-01 |
| GOMF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 73 | 5.10e-01 | 4.46e-02 | 7.92e-01 |
| GOCC CLUSTER OF ACTIN BASED CELL PROJECTIONS | 107 | 4.26e-01 | 4.46e-02 | 7.44e-01 |
| GOBP POSITIVE REGULATION OF LIPID CATABOLIC PROCESS | 15 | 7.65e-01 | 4.45e-02 | 9.17e-01 |
| GOBP REGULATION OF APOPTOTIC SIGNALING PATHWAY | 307 | 1.81e-01 | -4.45e-02 | 4.97e-01 |
| GOBP REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION | 138 | 3.67e-01 | -4.45e-02 | 6.99e-01 |
| GOBP AMYLOID BETA CLEARANCE | 30 | 6.73e-01 | 4.45e-02 | 8.78e-01 |
| GOBP POTASSIUM ION TRANSPORT | 122 | 3.97e-01 | 4.45e-02 | 7.21e-01 |
| GOCC PRECATALYTIC SPLICEOSOME | 52 | 5.79e-01 | 4.45e-02 | 8.32e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 258 | 2.20e-01 | 4.44e-02 | 5.48e-01 |
| GOBP REGULATION OF MAST CELL CHEMOTAXIS | 7 | 8.39e-01 | 4.44e-02 | 9.43e-01 |
| GOBP INTRACELLULAR TRANSPORT | 1398 | 5.95e-03 | 4.44e-02 | 7.64e-02 |
| GOBP PROTEIN LOCALIZATION TO LYSOSOME | 50 | 5.88e-01 | -4.44e-02 | 8.35e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 8.51e-01 | 4.44e-02 | 9.47e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 91 | 4.65e-01 | 4.43e-02 | 7.66e-01 |
| GOBP T HELPER 1 CELL DIFFERENTIATION | 19 | 7.38e-01 | -4.43e-02 | 9.05e-01 |
| GOBP STRIATED MUSCLE CONTRACTION | 114 | 4.14e-01 | 4.43e-02 | 7.32e-01 |
| GOBP NUCLEUS ORGANIZATION | 127 | 3.89e-01 | -4.43e-02 | 7.15e-01 |
| GOCC MYOFILAMENT | 16 | 7.59e-01 | -4.43e-02 | 9.14e-01 |
| GOBP AMINO ACID CATABOLIC PROCESS | 82 | 4.89e-01 | 4.43e-02 | 7.82e-01 |
| GOBP POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION | 20 | 7.32e-01 | -4.42e-02 | 9.04e-01 |
| GOBP RESPONSE TO IMMOBILIZATION STRESS | 16 | 7.60e-01 | -4.42e-02 | 9.14e-01 |
| GOMF STRUCTURAL MOLECULE ACTIVITY CONFERRING ELASTICITY | 8 | 8.29e-01 | -4.42e-02 | 9.39e-01 |
| GOBP POSITIVE REGULATION OF T CELL PROLIFERATION | 73 | 5.15e-01 | -4.41e-02 | 7.95e-01 |
| GOBP TOLL LIKE RECEPTOR SIGNALING PATHWAY | 61 | 5.52e-01 | -4.40e-02 | 8.19e-01 |
| GOBP MUSCLE ORGAN DEVELOPMENT | 213 | 2.70e-01 | -4.40e-02 | 6.06e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION MEMBRANE | 58 | 5.63e-01 | 4.40e-02 | 8.26e-01 |
| GOBP PROTEIN TARGETING TO VACUOLE INVOLVED IN AUTOPHAGY | 5 | 8.65e-01 | 4.39e-02 | 9.52e-01 |
| GOBP MITOTIC INTRA S DNA DAMAGE CHECKPOINT SIGNALING | 16 | 7.62e-01 | 4.38e-02 | 9.15e-01 |
| GOBP REGULATION OF ORGANELLE ORGANIZATION | 989 | 2.07e-02 | -4.38e-02 | 1.59e-01 |
| GOBP PROTEIN POLYGLUTAMYLATION | 7 | 8.41e-01 | 4.38e-02 | 9.44e-01 |
| GOBP REGULATION OF ORGANIC ACID TRANSPORT | 44 | 6.16e-01 | -4.38e-02 | 8.48e-01 |
| GOBP REGULATION OF VESICLE MEDIATED TRANSPORT | 392 | 1.38e-01 | -4.38e-02 | 4.36e-01 |
| GOBP SPECIFICATION OF SYMMETRY | 83 | 4.91e-01 | 4.38e-02 | 7.83e-01 |
| GOMF NAD RETINOL DEHYDROGENASE ACTIVITY | 10 | 8.11e-01 | -4.37e-02 | 9.33e-01 |
| GOBP REGULATION OF TISSUE REMODELING | 51 | 5.89e-01 | -4.37e-02 | 8.36e-01 |
| GOBP REGULATION OF GROWTH RATE | 5 | 8.66e-01 | 4.37e-02 | 9.52e-01 |
| GOBP MULTI MULTICELLULAR ORGANISM PROCESS | 123 | 4.04e-01 | -4.36e-02 | 7.25e-01 |
| GOBP POSITIVE REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 5 | 8.66e-01 | -4.36e-02 | 9.52e-01 |
| GOCC SYNAPTONEMAL STRUCTURE | 26 | 7.01e-01 | -4.36e-02 | 8.90e-01 |
| GOMF NUCLEOSIDE BINDING | 8 | 8.31e-01 | -4.36e-02 | 9.41e-01 |
| GOBP GERM CELL DEVELOPMENT | 207 | 2.81e-01 | -4.35e-02 | 6.19e-01 |
| GOBP EMBRYONIC APPENDAGE MORPHOGENESIS | 66 | 5.41e-01 | -4.35e-02 | 8.13e-01 |
| GOBP NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS | 13 | 7.86e-01 | 4.35e-02 | 9.23e-01 |
| GOBP REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 31 | 6.75e-01 | -4.35e-02 | 8.79e-01 |
| GOBP REGULATION OF FATTY ACID METABOLIC PROCESS | 64 | 5.48e-01 | 4.34e-02 | 8.18e-01 |
| GOBP APICAL JUNCTION ASSEMBLY | 49 | 5.99e-01 | 4.34e-02 | 8.40e-01 |
| GOBP MRNA MODIFICATION | 31 | 6.76e-01 | 4.34e-02 | 8.79e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 10 | 8.12e-01 | -4.33e-02 | 9.34e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR PERMEABILITY | 14 | 7.79e-01 | -4.33e-02 | 9.21e-01 |
| GOBP REGULATION OF PROTEIN UBIQUITINATION | 182 | 3.14e-01 | -4.33e-02 | 6.53e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY | 127 | 4.00e-01 | -4.33e-02 | 7.22e-01 |
| GOCC DENDRITIC TREE | 407 | 1.36e-01 | -4.32e-02 | 4.33e-01 |
| GOCC CELL CORTEX REGION | 28 | 6.92e-01 | 4.32e-02 | 8.88e-01 |
| GOBP MITOTIC DNA REPLICATION CHECKPOINT SIGNALING | 9 | 8.22e-01 | 4.32e-02 | 9.36e-01 |
| GOBP ORGANELLE FISSION | 396 | 1.42e-01 | -4.32e-02 | 4.42e-01 |
| GOCC GROWTH FACTOR COMPLEX | 5 | 8.67e-01 | 4.32e-02 | 9.52e-01 |
| GOBP AMINE TRANSPORT | 49 | 6.01e-01 | -4.32e-02 | 8.41e-01 |
| GOBP ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS | 28 | 6.93e-01 | -4.32e-02 | 8.88e-01 |
| GOMF ENDOPEPTIDASE ACTIVITY | 221 | 2.70e-01 | -4.31e-02 | 6.07e-01 |
| GOBP CRANIAL NERVE DEVELOPMENT | 28 | 6.93e-01 | -4.31e-02 | 8.88e-01 |
| GOBP MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 16 | 7.66e-01 | -4.30e-02 | 9.17e-01 |
| GOBP MEIOTIC CELL CYCLE | 204 | 2.90e-01 | -4.30e-02 | 6.29e-01 |
| GOBP MACROPHAGE PROLIFERATION | 8 | 8.33e-01 | 4.30e-02 | 9.41e-01 |
| GOBP REGULATION OF LIGASE ACTIVITY | 9 | 8.23e-01 | -4.30e-02 | 9.36e-01 |
| GOCC MHC CLASS I PEPTIDE LOADING COMPLEX | 8 | 8.33e-01 | -4.30e-02 | 9.41e-01 |
| GOBP REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 24 | 7.16e-01 | -4.29e-02 | 8.97e-01 |
| GOMF SECONDARY ACTIVE MONOCARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 8.14e-01 | -4.29e-02 | 9.34e-01 |
| GOBP REGULATION OF RUFFLE ASSEMBLY | 27 | 7.00e-01 | 4.29e-02 | 8.89e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 1006 | 2.24e-02 | -4.29e-02 | 1.66e-01 |
| GOBP HEMOGLOBIN METABOLIC PROCESS | 11 | 8.06e-01 | -4.29e-02 | 9.31e-01 |
| GOBP RESPONSE TO EPINEPHRINE | 11 | 8.06e-01 | -4.29e-02 | 9.31e-01 |
| GOBP REGULATION OF POLYSACCHARIDE METABOLIC PROCESS | 31 | 6.80e-01 | 4.29e-02 | 8.81e-01 |
| GOBP UREA CYCLE | 6 | 8.56e-01 | 4.28e-02 | 9.48e-01 |
| GOBP UREA METABOLIC PROCESS | 6 | 8.56e-01 | 4.28e-02 | 9.48e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 398 | 1.44e-01 | -4.28e-02 | 4.45e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 38 | 6.48e-01 | 4.28e-02 | 8.65e-01 |
| GOBP REGULATION OF ORGANELLE ASSEMBLY | 218 | 2.77e-01 | -4.28e-02 | 6.15e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL WATER HOMEOSTASIS | 18 | 7.54e-01 | 4.27e-02 | 9.12e-01 |
| GOBP GASTRIC ACID SECRETION | 7 | 8.45e-01 | 4.26e-02 | 9.45e-01 |
| GOBP ADAPTIVE THERMOGENESIS | 121 | 4.19e-01 | -4.26e-02 | 7.37e-01 |
| GOBP AMEBOIDAL TYPE CELL MIGRATION | 296 | 2.08e-01 | -4.26e-02 | 5.32e-01 |
| GOMF ER RETENTION SEQUENCE BINDING | 5 | 8.69e-01 | 4.26e-02 | 9.53e-01 |
| GOBP BONE DEVELOPMENT | 133 | 3.97e-01 | -4.25e-02 | 7.21e-01 |
| GOCC RIBOSOMAL SUBUNIT | 180 | 3.26e-01 | 4.25e-02 | 6.63e-01 |
| GOBP XENOBIOTIC METABOLIC PROCESS | 62 | 5.63e-01 | 4.25e-02 | 8.26e-01 |
| GOBP S ADENOSYLMETHIONINE METABOLIC PROCESS | 12 | 7.99e-01 | -4.25e-02 | 9.27e-01 |
| GOBP CELLULAR RESPONSE TO HYDROGEN PEROXIDE | 56 | 5.84e-01 | -4.23e-02 | 8.34e-01 |
| GOBP NEUTRAL LIPID METABOLIC PROCESS | 92 | 4.83e-01 | 4.23e-02 | 7.80e-01 |
| GOCC CELL LEADING EDGE | 346 | 1.78e-01 | -4.23e-02 | 4.93e-01 |
| GOBP PROTEIN STABILIZATION | 181 | 3.28e-01 | -4.22e-02 | 6.64e-01 |
| GOMF OXYGEN BINDING | 13 | 7.92e-01 | -4.22e-02 | 9.25e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PROCESS | 193 | 3.13e-01 | -4.22e-02 | 6.52e-01 |
| GOBP REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 49 | 6.10e-01 | 4.22e-02 | 8.46e-01 |
| GOMF TRANSLATION INITIATION FACTOR BINDING | 30 | 6.90e-01 | 4.21e-02 | 8.87e-01 |
| GOCC PHAGOPHORE ASSEMBLY SITE | 36 | 6.63e-01 | -4.20e-02 | 8.73e-01 |
| GOBP LIPID BIOSYNTHETIC PROCESS | 543 | 9.55e-02 | 4.20e-02 | 3.65e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTRASPECIES INTERACTION BETWEEN ORGANISMS | 29 | 6.96e-01 | 4.20e-02 | 8.88e-01 |
| GOBP RESPONSE TO BILE ACID | 5 | 8.71e-01 | 4.19e-02 | 9.54e-01 |
| GOBP RESPONSE TO MOLECULE OF BACTERIAL ORIGIN | 247 | 2.58e-01 | -4.19e-02 | 5.93e-01 |
| GOBP POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 113 | 4.42e-01 | 4.19e-02 | 7.54e-01 |
| GOBP PROTEIN NITROSYLATION | 12 | 8.02e-01 | 4.19e-02 | 9.29e-01 |
| GOMF BH DOMAIN BINDING | 8 | 8.38e-01 | -4.18e-02 | 9.43e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA SINGLE STRAND ANNEALING | 7 | 8.48e-01 | 4.18e-02 | 9.46e-01 |
| GOBP REGULATION OF NOREPINEPHRINE SECRETION | 5 | 8.71e-01 | -4.18e-02 | 9.54e-01 |
| GOBP ALPHA AMINO ACID CATABOLIC PROCESS | 65 | 5.60e-01 | 4.18e-02 | 8.26e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 6 | 8.59e-01 | -4.18e-02 | 9.50e-01 |
| GOBP GLANDULAR EPITHELIAL CELL MATURATION | 5 | 8.72e-01 | 4.18e-02 | 9.54e-01 |
| GOBP REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 235 | 2.72e-01 | -4.17e-02 | 6.09e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 29 | 6.98e-01 | -4.17e-02 | 8.89e-01 |
| GOBP DNA INTEGRITY CHECKPOINT SIGNALING | 130 | 4.12e-01 | -4.17e-02 | 7.31e-01 |
| GOBP N ACETYLNEURAMINATE CATABOLIC PROCESS | 6 | 8.60e-01 | -4.17e-02 | 9.50e-01 |
| GOMF GLYCOSYLTRANSFERASE ACTIVITY | 195 | 3.17e-01 | 4.17e-02 | 6.56e-01 |
| GOBP CERAMIDE TRANSPORT | 13 | 7.95e-01 | 4.16e-02 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE | 26 | 7.14e-01 | 4.16e-02 | 8.96e-01 |
| GOBP NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS | 19 | 7.54e-01 | -4.15e-02 | 9.12e-01 |
| GOBP REGULATION OF BLOOD CIRCULATION | 136 | 4.04e-01 | -4.15e-02 | 7.25e-01 |
| GOMF QUINONE BINDING | 15 | 7.81e-01 | 4.15e-02 | 9.22e-01 |
| GOBP POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 18 | 7.60e-01 | 4.15e-02 | 9.15e-01 |
| GOBP RESPONSE TO METAL ION | 246 | 2.63e-01 | -4.15e-02 | 5.99e-01 |
| GOBP EMBRYONIC HINDLIMB MORPHOGENESIS | 11 | 8.12e-01 | 4.15e-02 | 9.33e-01 |
| GOBP IMPORT ACROSS PLASMA MEMBRANE | 115 | 4.43e-01 | -4.15e-02 | 7.54e-01 |
| GOBP TOOTH MINERALIZATION | 16 | 7.74e-01 | -4.15e-02 | 9.20e-01 |
| GOBP CELLULAR RESPONSE TO GAMMA RADIATION | 23 | 7.31e-01 | -4.14e-02 | 9.04e-01 |
| GOMF NADPLUS NUCLEOSIDASE ACTIVITY | 12 | 8.04e-01 | -4.14e-02 | 9.30e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 16 | 7.74e-01 | 4.14e-02 | 9.20e-01 |
| GOBP REGULATION OF PINOCYTOSIS | 10 | 8.21e-01 | -4.14e-02 | 9.36e-01 |
| GOBP ESTABLISHMENT OF ENDOTHELIAL BARRIER | 43 | 6.39e-01 | -4.14e-02 | 8.59e-01 |
| GOCC ZONULA ADHERENS | 8 | 8.40e-01 | 4.13e-02 | 9.43e-01 |
| GOBP NEGATIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 5 | 8.73e-01 | -4.13e-02 | 9.54e-01 |
| GOBP HORMONE BIOSYNTHETIC PROCESS | 37 | 6.64e-01 | -4.13e-02 | 8.73e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 435 | 1.41e-01 | -4.13e-02 | 4.41e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE POTENTIAL | 6 | 8.61e-01 | 4.13e-02 | 9.51e-01 |
| GOBP INTESTINAL EPITHELIAL CELL DIFFERENTIATION | 15 | 7.82e-01 | 4.13e-02 | 9.22e-01 |
| GOBP ASSOCIATIVE LEARNING | 54 | 6.00e-01 | -4.12e-02 | 8.40e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL BINDING | 13 | 7.97e-01 | -4.12e-02 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION | 5 | 8.73e-01 | -4.12e-02 | 9.54e-01 |
| GOBP INTRACELLULAR PROTEIN TRANSPORT | 769 | 5.31e-02 | 4.12e-02 | 2.66e-01 |
| GOMF GLYCOSAMINOGLYCAN BINDING | 112 | 4.52e-01 | -4.12e-02 | 7.61e-01 |
| GOBP SODIUM ION TRANSMEMBRANE TRANSPORT | 89 | 5.02e-01 | 4.12e-02 | 7.88e-01 |
| GOCC VACUOLAR LUMEN | 134 | 4.11e-01 | -4.11e-02 | 7.31e-01 |
| GOMF DOLICHYL DIPHOSPHOOLIGOSACCHARIDE PROTEIN GLYCOTRANSFERASE ACTIVITY | 5 | 8.74e-01 | 4.11e-02 | 9.55e-01 |
| GOBP APPENDAGE DEVELOPMENT | 106 | 4.65e-01 | -4.11e-02 | 7.66e-01 |
| GOBP ACUTE INFLAMMATORY RESPONSE | 63 | 5.73e-01 | 4.11e-02 | 8.30e-01 |
| GOBP ORGANIC HYDROXY COMPOUND TRANSPORT | 181 | 3.42e-01 | 4.10e-02 | 6.78e-01 |
| GOCC GOLGI CISTERNA MEMBRANE | 63 | 5.74e-01 | 4.10e-02 | 8.31e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED FLAVIN OR FLAVOPROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 11 | 8.14e-01 | 4.10e-02 | 9.34e-01 |
| GOCC RNA POLYMERASE COMPLEX | 96 | 4.88e-01 | 4.10e-02 | 7.81e-01 |
| GOMF EFFLUX TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 8.14e-01 | -4.10e-02 | 9.34e-01 |
| GOBP GLYCEROLIPID METABOLIC PROCESS | 300 | 2.23e-01 | -4.10e-02 | 5.51e-01 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 32 | 6.88e-01 | -4.10e-02 | 8.86e-01 |
| GOBP MEMBRANE FUSION INVOLVED IN VIRAL ENTRY INTO HOST CELL | 5 | 8.74e-01 | -4.09e-02 | 9.55e-01 |
| GOBP EXCITATORY CHEMICAL SYNAPTIC TRANSMISSION | 7 | 8.52e-01 | 4.09e-02 | 9.47e-01 |
| GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 6 | 8.62e-01 | 4.08e-02 | 9.52e-01 |
| GOBP NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 10 | 8.23e-01 | 4.08e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS | 19 | 7.58e-01 | -4.08e-02 | 9.14e-01 |
| GOMF O METHYLTRANSFERASE ACTIVITY | 22 | 7.41e-01 | 4.08e-02 | 9.06e-01 |
| GOBP CELLULAR RESPONSE TO MECHANICAL STIMULUS | 60 | 5.85e-01 | 4.08e-02 | 8.35e-01 |
| GOMF MOLECULAR FUNCTION ACTIVATOR ACTIVITY | 696 | 6.81e-02 | -4.08e-02 | 3.02e-01 |
| GOBP HEART VALVE MORPHOGENESIS | 36 | 6.72e-01 | -4.08e-02 | 8.78e-01 |
| GOBP INTERFERON ALPHA PRODUCTION | 25 | 7.24e-01 | 4.08e-02 | 9.02e-01 |
| GOBP REGULATION OF CELLULAR LOCALIZATION | 753 | 5.83e-02 | 4.08e-02 | 2.79e-01 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 95 | 4.93e-01 | -4.07e-02 | 7.84e-01 |
| GOBP ENDOTHELIAL CELL CHEMOTAXIS | 12 | 8.07e-01 | -4.07e-02 | 9.32e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 13 | 7.99e-01 | 4.07e-02 | 9.27e-01 |
| GOCC SERINE TYPE PEPTIDASE COMPLEX | 6 | 8.63e-01 | -4.07e-02 | 9.52e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 48 | 6.26e-01 | 4.07e-02 | 8.53e-01 |
| GOBP POSITIVE REGULATION OF T CELL MIGRATION | 26 | 7.20e-01 | -4.06e-02 | 8.99e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 97 | 4.90e-01 | -4.06e-02 | 7.82e-01 |
| GOMF INTEGRIN BINDING | 99 | 4.86e-01 | -4.05e-02 | 7.81e-01 |
| GOBP SPLICEOSOMAL CONFORMATIONAL CHANGES TO GENERATE CATALYTIC CONFORMATION | 5 | 8.75e-01 | -4.05e-02 | 9.55e-01 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 68 | 5.64e-01 | 4.05e-02 | 8.27e-01 |
| GOCC RIBONUCLEOPROTEIN COMPLEX | 676 | 7.43e-02 | -4.05e-02 | 3.19e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 18 | 7.66e-01 | -4.05e-02 | 9.17e-01 |
| GOBP POSITIVE REGULATION OF SECRETION | 196 | 3.30e-01 | 4.04e-02 | 6.66e-01 |
| GOBP NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS | 106 | 4.73e-01 | -4.04e-02 | 7.72e-01 |
| GOBP REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 19 | 7.61e-01 | -4.03e-02 | 9.15e-01 |
| GOBP SEXUAL REPRODUCTION | 661 | 7.91e-02 | -4.02e-02 | 3.31e-01 |
| GOBP LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS | 13 | 8.02e-01 | 4.01e-02 | 9.29e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 500 | 1.26e-01 | -4.01e-02 | 4.17e-01 |
| GOMF CALCIUM INDUCED CALCIUM RELEASE ACTIVITY | 6 | 8.65e-01 | 4.01e-02 | 9.52e-01 |
| GOBP PROTEIN LOCALIZATION TO VACUOLE | 75 | 5.50e-01 | -4.00e-02 | 8.19e-01 |
| GOBP CEREBRAL CORTEX CELL MIGRATION | 33 | 6.91e-01 | -4.00e-02 | 8.88e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID BETA OXIDATION | 7 | 8.55e-01 | 4.00e-02 | 9.48e-01 |
| GOBP GOLGI TO VACUOLE TRANSPORT | 19 | 7.63e-01 | 4.00e-02 | 9.16e-01 |
| GOMF DEUBIQUITINASE ACTIVITY | 94 | 5.04e-01 | -4.00e-02 | 7.88e-01 |
| GOMF PYRIMIDINE NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 8.66e-01 | -3.99e-02 | 9.52e-01 |
| GOBP NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 126 | 4.40e-01 | -3.99e-02 | 7.52e-01 |
| GOBP PEPTIDYL METHIONINE MODIFICATION | 10 | 8.27e-01 | 3.99e-02 | 9.38e-01 |
| GOBP RESPONSE TO INTERLEUKIN 17 | 14 | 7.96e-01 | -3.99e-02 | 9.27e-01 |
| GOMF MICROTUBULE MINUS END BINDING | 14 | 7.96e-01 | -3.99e-02 | 9.27e-01 |
| GOBP REGULATION OF PROTEIN TARGETING TO MEMBRANE | 29 | 7.11e-01 | 3.98e-02 | 8.96e-01 |
| GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION | 6 | 8.66e-01 | 3.98e-02 | 9.52e-01 |
| GOMF CYSTEINE TYPE PEPTIDASE ACTIVITY | 148 | 4.04e-01 | -3.98e-02 | 7.25e-01 |
| GOCC GAP JUNCTION | 10 | 8.28e-01 | -3.98e-02 | 9.39e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE REGULATOR ACTIVITY | 11 | 8.19e-01 | 3.98e-02 | 9.35e-01 |
| GOMF DICARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 22 | 7.47e-01 | 3.97e-02 | 9.09e-01 |
| GOBP ODONTOGENESIS | 63 | 5.86e-01 | 3.97e-02 | 8.35e-01 |
| GOBP SPERMATID NUCLEUS DIFFERENTIATION | 17 | 7.77e-01 | -3.97e-02 | 9.21e-01 |
| GOBP ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS | 22 | 7.47e-01 | 3.97e-02 | 9.09e-01 |
| GOBP STEROID HORMONE BIOSYNTHETIC PROCESS | 24 | 7.37e-01 | -3.97e-02 | 9.05e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL | 13 | 8.04e-01 | 3.97e-02 | 9.30e-01 |
| GOBP DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 161 | 3.87e-01 | 3.96e-02 | 7.13e-01 |
| GOBP LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE | 11 | 8.20e-01 | 3.96e-02 | 9.35e-01 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 84 | 5.31e-01 | -3.95e-02 | 8.04e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 26 | 7.27e-01 | -3.95e-02 | 9.03e-01 |
| GOMF WNT PROTEIN BINDING | 20 | 7.60e-01 | 3.95e-02 | 9.14e-01 |
| GOBP RNA 3 END PROCESSING | 89 | 5.20e-01 | -3.95e-02 | 7.98e-01 |
| GOBP REGULATION OF CYTOKINESIS | 75 | 5.55e-01 | 3.95e-02 | 8.20e-01 |
| GOBP BLOOD VESSEL MATURATION | 6 | 8.67e-01 | -3.94e-02 | 9.52e-01 |
| GOBP NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 69 | 5.72e-01 | -3.93e-02 | 8.30e-01 |
| GOCC GBAF COMPLEX | 13 | 8.06e-01 | -3.93e-02 | 9.31e-01 |
| GOBP INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE | 62 | 5.93e-01 | -3.93e-02 | 8.38e-01 |
| GOCC U2 TYPE CATALYTIC STEP 2 SPLICEOSOME | 30 | 7.10e-01 | 3.93e-02 | 8.95e-01 |
| GOBP RESPONSE TO AXON INJURY | 58 | 6.05e-01 | 3.92e-02 | 8.44e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 24 | 7.39e-01 | -3.92e-02 | 9.06e-01 |
| GOBP ENDOCRINE PROCESS | 44 | 6.53e-01 | 3.92e-02 | 8.68e-01 |
| GOCC ENDOSOME MEMBRANE | 475 | 1.45e-01 | 3.92e-02 | 4.45e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 30 | 7.11e-01 | 3.92e-02 | 8.96e-01 |
| GOBP TUBE MORPHOGENESIS | 558 | 1.15e-01 | -3.91e-02 | 3.99e-01 |
| GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE II | 15 | 7.93e-01 | 3.91e-02 | 9.25e-01 |
| GOBP SNO S RNA METABOLIC PROCESS | 15 | 7.93e-01 | 3.91e-02 | 9.25e-01 |
| GOMF TRIGLYCERIDE LIPASE ACTIVITY | 13 | 8.07e-01 | -3.91e-02 | 9.32e-01 |
| GOBP LIGAND GATED ION CHANNEL SIGNALING PATHWAY | 22 | 7.51e-01 | 3.90e-02 | 9.11e-01 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSPORT | 69 | 5.75e-01 | 3.90e-02 | 8.31e-01 |
| GOBP MACROMOLECULE METHYLATION | 186 | 3.60e-01 | -3.90e-02 | 6.92e-01 |
| GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION | 54 | 6.21e-01 | -3.89e-02 | 8.50e-01 |
| GOBP REGULATION OF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 5 | 8.80e-01 | -3.89e-02 | 9.58e-01 |
| GOBP RESPONSE TO CORTICOSTERONE | 6 | 8.69e-01 | -3.89e-02 | 9.53e-01 |
| GOBP CELLULAR KETONE METABOLIC PROCESS | 153 | 4.07e-01 | 3.89e-02 | 7.27e-01 |
| GOBP TELOMERIC LOOP DISASSEMBLY | 10 | 8.32e-01 | 3.88e-02 | 9.41e-01 |
| GOBP HYPOTHALAMUS DEVELOPMENT | 12 | 8.16e-01 | -3.88e-02 | 9.34e-01 |
| GOCC EXCITATORY SYNAPSE | 35 | 6.91e-01 | -3.88e-02 | 8.88e-01 |
| GOBP PROTEIN POLYMERIZATION | 231 | 3.11e-01 | -3.88e-02 | 6.50e-01 |
| GOBP SULFUR COMPOUND CATABOLIC PROCESS | 31 | 7.09e-01 | -3.87e-02 | 8.95e-01 |
| GOBP NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 25 | 7.38e-01 | 3.87e-02 | 9.05e-01 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS | 62 | 5.98e-01 | -3.87e-02 | 8.40e-01 |
| GOBP PLATELET ACTIVATION | 96 | 5.13e-01 | -3.87e-02 | 7.94e-01 |
| GOMF DNA POLYMERASE BINDING | 21 | 7.59e-01 | 3.86e-02 | 9.14e-01 |
| GOMF FIBRONECTIN BINDING | 19 | 7.71e-01 | 3.85e-02 | 9.19e-01 |
| GOCC PHAGOLYSOSOME | 5 | 8.81e-01 | -3.85e-02 | 9.59e-01 |
| GOBP FOREBRAIN NEURON DEVELOPMENT | 15 | 7.96e-01 | 3.85e-02 | 9.27e-01 |
| GOBP REGULATION OF LIPID LOCALIZATION | 108 | 4.90e-01 | 3.85e-02 | 7.82e-01 |
| GOBP ERROR FREE TRANSLESION SYNTHESIS | 5 | 8.82e-01 | -3.85e-02 | 9.59e-01 |
| GOBP POLYOL TRANSMEMBRANE TRANSPORT | 7 | 8.60e-01 | -3.85e-02 | 9.50e-01 |
| GOBP REGULATION OF AXON GUIDANCE | 7 | 8.60e-01 | 3.84e-02 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 305 | 2.50e-01 | -3.84e-02 | 5.84e-01 |
| GOMF CARBOHYDRATE KINASE ACTIVITY | 19 | 7.72e-01 | -3.84e-02 | 9.19e-01 |
| GOBP RESPONSE TO HEAT | 80 | 5.53e-01 | -3.84e-02 | 8.19e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 5 | 8.82e-01 | -3.84e-02 | 9.59e-01 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE I | 62 | 6.02e-01 | -3.83e-02 | 8.41e-01 |
| GOBP METHIONINE METABOLIC PROCESS | 13 | 8.11e-01 | -3.83e-02 | 9.33e-01 |
| GOBP NEURAL PRECURSOR CELL PROLIFERATION | 92 | 5.25e-01 | -3.83e-02 | 8.00e-01 |
| GOMF ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY | 26 | 7.35e-01 | 3.83e-02 | 9.04e-01 |
| GOBP POSITIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 6 | 8.71e-01 | 3.83e-02 | 9.54e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 8 | 8.51e-01 | -3.83e-02 | 9.47e-01 |
| GOBP REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 34 | 6.99e-01 | -3.83e-02 | 8.89e-01 |
| GOCC LEADING EDGE MEMBRANE | 136 | 4.41e-01 | -3.83e-02 | 7.53e-01 |
| GOBP REGULATION OF TRANSLATIONAL ELONGATION | 11 | 8.26e-01 | -3.83e-02 | 9.38e-01 |
| GOBP RESPONSE TO DOPAMINE | 35 | 6.95e-01 | 3.83e-02 | 8.88e-01 |
| GOBP TUBE DEVELOPMENT | 697 | 8.69e-02 | -3.82e-02 | 3.45e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 27 | 7.31e-01 | 3.82e-02 | 9.04e-01 |
| GOBP MITOTIC SPINDLE ORGANIZATION | 124 | 4.63e-01 | -3.82e-02 | 7.65e-01 |
| GOBP NEUROTRANSMITTER SECRETION | 94 | 5.23e-01 | 3.82e-02 | 7.99e-01 |
| GOCC U2 TYPE SPLICEOSOMAL COMPLEX | 89 | 5.34e-01 | -3.81e-02 | 8.06e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 10 | 8.35e-01 | 3.81e-02 | 9.41e-01 |
| GOBP CRANIAL SKELETAL SYSTEM DEVELOPMENT | 40 | 6.77e-01 | -3.80e-02 | 8.79e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN POLYMERIZATION | 63 | 6.02e-01 | 3.80e-02 | 8.41e-01 |
| GOBP CYTOKINETIC PROCESS | 41 | 6.74e-01 | -3.80e-02 | 8.78e-01 |
| GOMF PHOSPHOLIPID BINDING | 370 | 2.11e-01 | -3.80e-02 | 5.35e-01 |
| GOBP BILE ACID BIOSYNTHETIC PROCESS | 25 | 7.43e-01 | -3.80e-02 | 9.07e-01 |
| GOBP METANEPHRIC COLLECTING DUCT DEVELOPMENT | 6 | 8.72e-01 | 3.80e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 8 | 8.53e-01 | 3.79e-02 | 9.47e-01 |
| GOBP GLYCEROLIPID BIOSYNTHETIC PROCESS | 209 | 3.46e-01 | -3.79e-02 | 6.82e-01 |
| GOBP REGULATION OF HYDROLASE ACTIVITY | 552 | 1.29e-01 | -3.79e-02 | 4.22e-01 |
| GOBP RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE | 15 | 8.00e-01 | 3.79e-02 | 9.27e-01 |
| GOBP ORGANIC ACID TRANSMEMBRANE TRANSPORT | 105 | 5.03e-01 | 3.78e-02 | 7.88e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 8.72e-01 | -3.78e-02 | 9.54e-01 |
| GOBP OUTFLOW TRACT MORPHOGENESIS | 43 | 6.68e-01 | -3.78e-02 | 8.75e-01 |
| GOBP CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION | 32 | 7.12e-01 | 3.78e-02 | 8.96e-01 |
| GOBP GOLGI TO PLASMA MEMBRANE TRANSPORT | 53 | 6.35e-01 | 3.77e-02 | 8.57e-01 |
| GOMF ATP DEPENDENT PROTEIN DISAGGREGASE ACTIVITY | 6 | 8.73e-01 | -3.77e-02 | 9.54e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS | 77 | 5.67e-01 | 3.77e-02 | 8.28e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 12 | 8.21e-01 | 3.77e-02 | 9.36e-01 |
| GOBP INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 27 | 7.35e-01 | -3.77e-02 | 9.04e-01 |
| GOBP BILE ACID SECRETION | 8 | 8.54e-01 | 3.77e-02 | 9.48e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 7 | 8.63e-01 | 3.77e-02 | 9.52e-01 |
| GOBP NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS | 33 | 7.08e-01 | 3.76e-02 | 8.94e-01 |
| GOBP RESPONSE TO TUMOR CELL | 33 | 7.08e-01 | 3.76e-02 | 8.94e-01 |
| GOBP CELLULAR RESPONSE TO ANTIBIOTIC | 11 | 8.29e-01 | -3.76e-02 | 9.39e-01 |
| GOBP SPERM MOTILITY | 65 | 6.00e-01 | 3.76e-02 | 8.40e-01 |
| GOBP HEART MORPHOGENESIS | 156 | 4.18e-01 | -3.76e-02 | 7.37e-01 |
| GOBP DETECTION OF ABIOTIC STIMULUS | 74 | 5.77e-01 | -3.76e-02 | 8.32e-01 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 26 | 7.40e-01 | 3.75e-02 | 9.06e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 17 | 7.89e-01 | -3.75e-02 | 9.24e-01 |
| GOBP RESPONSE TO LIGHT INTENSITY | 13 | 8.15e-01 | 3.74e-02 | 9.34e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE DEPOLARIZATION | 6 | 8.74e-01 | -3.74e-02 | 9.55e-01 |
| GOBP SIGNAL PEPTIDE PROCESSING | 13 | 8.16e-01 | -3.74e-02 | 9.34e-01 |
| GOBP GLYCEROPHOSPHOLIPID METABOLIC PROCESS | 247 | 3.14e-01 | -3.73e-02 | 6.52e-01 |
| GOBP REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 35 | 7.03e-01 | -3.73e-02 | 8.91e-01 |
| GOMF ADP TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 8.38e-01 | -3.73e-02 | 9.43e-01 |
| GOBP REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS | 8 | 8.55e-01 | 3.72e-02 | 9.48e-01 |
| GOMF PROTEIN SELF ASSOCIATION | 55 | 6.34e-01 | -3.71e-02 | 8.57e-01 |
| GOBP TRANSLATIONAL INITIATION | 114 | 4.94e-01 | 3.71e-02 | 7.84e-01 |
| GOBP GROWTH | 633 | 1.13e-01 | -3.71e-02 | 3.94e-01 |
| GOBP RETINA HOMEOSTASIS | 43 | 6.74e-01 | -3.71e-02 | 8.78e-01 |
| GOBP POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 5 | 8.86e-01 | 3.70e-02 | 9.59e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE ACTIVITY | 39 | 6.89e-01 | -3.70e-02 | 8.87e-01 |
| GOBP POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 18 | 7.86e-01 | -3.70e-02 | 9.23e-01 |
| GOBP VESICLE TARGETING ROUGH ER TO CIS GOLGI | 25 | 7.49e-01 | 3.70e-02 | 9.10e-01 |
| GOBP SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE | 176 | 3.98e-01 | -3.70e-02 | 7.21e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 29 | 7.31e-01 | -3.70e-02 | 9.04e-01 |
| GOMF ENDOPEPTIDASE ACTIVATOR ACTIVITY | 14 | 8.11e-01 | 3.69e-02 | 9.33e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS | 16 | 7.98e-01 | -3.69e-02 | 9.27e-01 |
| GOCC SECRETORY GRANULE MEMBRANE | 245 | 3.21e-01 | -3.68e-02 | 6.61e-01 |
| GOBP LIPOPROTEIN BIOSYNTHETIC PROCESS | 85 | 5.57e-01 | 3.68e-02 | 8.23e-01 |
| GOBP LEUCINE IMPORT ACROSS PLASMA MEMBRANE | 5 | 8.87e-01 | 3.68e-02 | 9.59e-01 |
| GOBP MIDDLE EAR MORPHOGENESIS | 8 | 8.57e-01 | -3.68e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDE SECRETION | 26 | 7.46e-01 | 3.67e-02 | 9.08e-01 |
| GOBP VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE | 133 | 4.65e-01 | 3.67e-02 | 7.66e-01 |
| GOMF SIGNALING RECEPTOR BINDING | 845 | 7.24e-02 | -3.66e-02 | 3.14e-01 |
| GOBP HEPARIN METABOLIC PROCESS | 12 | 8.26e-01 | -3.66e-02 | 9.38e-01 |
| GOMF AMIDE BINDING | 279 | 2.94e-01 | -3.66e-02 | 6.32e-01 |
| GOBP NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 9 | 8.50e-01 | 3.65e-02 | 9.47e-01 |
| GOBP NATURAL KILLER CELL DEGRANULATION | 9 | 8.50e-01 | 3.65e-02 | 9.47e-01 |
| GOBP ERK1 AND ERK2 CASCADE | 215 | 3.58e-01 | -3.65e-02 | 6.90e-01 |
| GOMF MYOSIN PHOSPHATASE ACTIVITY | 64 | 6.15e-01 | -3.64e-02 | 8.48e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 8 | 8.59e-01 | -3.64e-02 | 9.50e-01 |
| GOCC POLYMERIC CYTOSKELETAL FIBER | 493 | 1.68e-01 | 3.64e-02 | 4.81e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 31 | 7.27e-01 | 3.63e-02 | 9.02e-01 |
| GOBP ENSHEATHMENT OF NEURONS | 104 | 5.23e-01 | 3.63e-02 | 7.99e-01 |
| GOBP PLATELET AGGREGATION | 52 | 6.51e-01 | -3.63e-02 | 8.66e-01 |
| GOBP SENSORY PERCEPTION OF CHEMICAL STIMULUS | 34 | 7.14e-01 | 3.63e-02 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 6 | 8.78e-01 | -3.63e-02 | 9.56e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 10 | 8.43e-01 | 3.63e-02 | 9.44e-01 |
| GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT | 118 | 4.97e-01 | 3.63e-02 | 7.86e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 115 | 5.03e-01 | 3.62e-02 | 7.88e-01 |
| GOBP DENTATE GYRUS DEVELOPMENT | 12 | 8.28e-01 | 3.61e-02 | 9.39e-01 |
| GOBP NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 19 | 7.85e-01 | 3.61e-02 | 9.22e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL SURFACE | 52 | 6.52e-01 | 3.61e-02 | 8.67e-01 |
| GOBP EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 54 | 6.47e-01 | -3.61e-02 | 8.64e-01 |
| GOBP CEREBRAL CORTEX DEVELOPMENT | 87 | 5.61e-01 | -3.61e-02 | 8.26e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING | 20 | 7.80e-01 | 3.61e-02 | 9.22e-01 |
| GOBP SPHINGOSINE BIOSYNTHETIC PROCESS | 10 | 8.44e-01 | -3.61e-02 | 9.45e-01 |
| GOMF NUCLEAR ANDROGEN RECEPTOR BINDING | 23 | 7.65e-01 | -3.60e-02 | 9.17e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION | 8 | 8.60e-01 | 3.60e-02 | 9.50e-01 |
| GOBP ADULT LOCOMOTORY BEHAVIOR | 47 | 6.69e-01 | -3.60e-02 | 8.76e-01 |
| GOMF DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 12 | 8.29e-01 | -3.60e-02 | 9.39e-01 |
| GOBP SEQUESTERING OF TRIGLYCERIDE | 14 | 8.16e-01 | -3.60e-02 | 9.34e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 30 | 7.33e-01 | -3.60e-02 | 9.04e-01 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION | 39 | 6.98e-01 | -3.59e-02 | 8.89e-01 |
| GOBP REGULATION OF EXCITATORY SYNAPSE ASSEMBLY | 10 | 8.44e-01 | -3.59e-02 | 9.45e-01 |
| GOMF RIBOSOMAL SMALL SUBUNIT BINDING | 17 | 7.98e-01 | 3.59e-02 | 9.27e-01 |
| GOBP REGULATION OF KERATINOCYTE PROLIFERATION | 27 | 7.47e-01 | -3.59e-02 | 9.09e-01 |
| GOCC NUCLEOTIDE ACTIVATED PROTEIN KINASE COMPLEX | 11 | 8.37e-01 | 3.59e-02 | 9.42e-01 |
| GOBP MHC CLASS I BIOSYNTHETIC PROCESS | 5 | 8.90e-01 | -3.59e-02 | 9.61e-01 |
| GOBP VALINE METABOLIC PROCESS | 7 | 8.70e-01 | -3.58e-02 | 9.53e-01 |
| GOBP GLYCINE TRANSPORT | 6 | 8.79e-01 | 3.58e-02 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 5 | 8.90e-01 | -3.58e-02 | 9.61e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS | 39 | 6.99e-01 | 3.58e-02 | 8.89e-01 |
| GOBP NEGATIVE REGULATION OF LIPID METABOLIC PROCESS | 70 | 6.05e-01 | 3.58e-02 | 8.43e-01 |
| GOMF INTERLEUKIN 1 BINDING | 7 | 8.70e-01 | -3.57e-02 | 9.53e-01 |
| GOBP REGULATION OF MEMBRANE DEPOLARIZATION | 30 | 7.35e-01 | -3.57e-02 | 9.04e-01 |
| GOBP POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS | 73 | 5.98e-01 | -3.57e-02 | 8.40e-01 |
| GOBP PURINE NUCLEOTIDE SALVAGE | 10 | 8.45e-01 | -3.57e-02 | 9.45e-01 |
| GOBP MONOSACCHARIDE CATABOLIC PROCESS | 40 | 6.97e-01 | 3.56e-02 | 8.89e-01 |
| GOBP CYTOPLASMIC MICROTUBULE ORGANIZATION | 53 | 6.54e-01 | 3.56e-02 | 8.68e-01 |
| GOBP APOPTOTIC SIGNALING PATHWAY | 488 | 1.79e-01 | -3.56e-02 | 4.94e-01 |
| GOBP PURINE CONTAINING COMPOUND CATABOLIC PROCESS | 51 | 6.60e-01 | 3.56e-02 | 8.72e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 26 | 7.53e-01 | -3.56e-02 | 9.12e-01 |
| GOCC SPINDLE | 381 | 2.35e-01 | -3.56e-02 | 5.66e-01 |
| GOBP REGULATION OF FIBROBLAST MIGRATION | 30 | 7.36e-01 | 3.55e-02 | 9.05e-01 |
| GOBP ACROSOME ASSEMBLY | 14 | 8.18e-01 | -3.55e-02 | 9.34e-01 |
| GOBP REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 41 | 6.94e-01 | -3.55e-02 | 8.88e-01 |
| GOBP GLIAL CELL DIFFERENTIATION | 152 | 4.50e-01 | -3.55e-02 | 7.60e-01 |
| GOBP REGULATION OF ANOIKIS | 17 | 8.00e-01 | 3.55e-02 | 9.27e-01 |
| GOBP GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE | 20 | 7.83e-01 | -3.55e-02 | 9.22e-01 |
| GOBP REGULATION OF PROTEIN DEPHOSPHORYLATION | 64 | 6.24e-01 | -3.55e-02 | 8.52e-01 |
| GOBP REGULATION OF PROTEIN FOLDING | 8 | 8.62e-01 | -3.54e-02 | 9.52e-01 |
| GOBP MICROTUBULE BASED PROCESS | 724 | 1.07e-01 | 3.54e-02 | 3.82e-01 |
| GOBP INTEGRATED STRESS RESPONSE SIGNALING | 40 | 6.99e-01 | -3.54e-02 | 8.89e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 95 | 5.52e-01 | 3.53e-02 | 8.19e-01 |
| GOBP REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 162 | 4.38e-01 | 3.53e-02 | 7.52e-01 |
| GOBP MOLTING CYCLE | 64 | 6.25e-01 | -3.53e-02 | 8.52e-01 |
| GOBP POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 11 | 8.39e-01 | -3.53e-02 | 9.43e-01 |
| GOBP CARDIAC VENTRICLE MORPHOGENESIS | 34 | 7.22e-01 | 3.53e-02 | 9.00e-01 |
| GOBP CENTROSOME DUPLICATION | 71 | 6.08e-01 | -3.53e-02 | 8.46e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 28 | 7.47e-01 | -3.53e-02 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION | 6 | 8.81e-01 | 3.52e-02 | 9.58e-01 |
| GOMF CALCIUM DEPENDENT CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 12 | 8.33e-01 | 3.52e-02 | 9.41e-01 |
| GOBP ESTROGEN METABOLIC PROCESS | 17 | 8.02e-01 | 3.52e-02 | 9.29e-01 |
| GOBP GLYCERALDEHYDE 3 PHOSPHATE METABOLIC PROCESS | 5 | 8.92e-01 | 3.52e-02 | 9.62e-01 |
| GOBP NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT | 67 | 6.18e-01 | -3.52e-02 | 8.49e-01 |
| GOMF PURINE NUCLEOTIDE BINDING | 1607 | 2.01e-02 | -3.52e-02 | 1.57e-01 |
| GOMF HSP90 PROTEIN BINDING | 36 | 7.15e-01 | 3.52e-02 | 8.97e-01 |
| GOMF INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 8.63e-01 | 3.52e-02 | 9.52e-01 |
| GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 19 | 7.91e-01 | -3.51e-02 | 9.24e-01 |
| GOBP PHARYNGEAL SYSTEM DEVELOPMENT | 12 | 8.33e-01 | -3.51e-02 | 9.41e-01 |
| GOBP PROTEIN DEPHOSPHORYLATION | 169 | 4.32e-01 | -3.51e-02 | 7.49e-01 |
| GOMF ENDONUCLEASE ACTIVITY | 109 | 5.28e-01 | -3.50e-02 | 8.02e-01 |
| GOCC DEUTEROSOME | 5 | 8.92e-01 | -3.50e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 35 | 7.20e-01 | -3.50e-02 | 8.99e-01 |
| GOBP GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS | 19 | 7.92e-01 | -3.50e-02 | 9.25e-01 |
| GOBP POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 86 | 5.75e-01 | -3.50e-02 | 8.31e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 19 | 7.92e-01 | -3.50e-02 | 9.25e-01 |
| GOBP SYNAPSE ORGANIZATION | 290 | 3.07e-01 | -3.50e-02 | 6.46e-01 |
| GOBP EPIDERMAL CELL DIFFERENTIATION | 116 | 5.16e-01 | 3.49e-02 | 7.95e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 8 | 8.64e-01 | -3.49e-02 | 9.52e-01 |
| GOBP VESICLE MEDIATED TRANSPORT IN SYNAPSE | 156 | 4.53e-01 | 3.49e-02 | 7.61e-01 |
| GOBP MIDBRAIN DEVELOPMENT | 58 | 6.46e-01 | 3.49e-02 | 8.64e-01 |
| GOBP POSITIVE REGULATION OF VACUOLE ORGANIZATION | 22 | 7.77e-01 | 3.49e-02 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 74 | 6.05e-01 | -3.48e-02 | 8.43e-01 |
| GOBP EXOCYTOSIS | 252 | 3.42e-01 | 3.48e-02 | 6.78e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 18 | 7.98e-01 | -3.48e-02 | 9.27e-01 |
| GOBP PROTEIN POLYUBIQUITINATION | 201 | 3.96e-01 | -3.48e-02 | 7.20e-01 |
| GOBP REGULATION OF SULFUR METABOLIC PROCESS | 12 | 8.35e-01 | -3.47e-02 | 9.41e-01 |
| GOBP VACUOLE ORGANIZATION | 206 | 3.91e-01 | 3.47e-02 | 7.17e-01 |
| GOBP CHEMICAL HOMEOSTASIS | 667 | 1.28e-01 | 3.47e-02 | 4.20e-01 |
| GOBP REGULATION OF ATP METABOLIC PROCESS | 18 | 7.99e-01 | -3.47e-02 | 9.27e-01 |
| GOCC AZUROPHIL GRANULE MEMBRANE | 53 | 6.63e-01 | -3.46e-02 | 8.73e-01 |
| GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 10 | 8.50e-01 | -3.46e-02 | 9.47e-01 |
| GOBP REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE | 17 | 8.05e-01 | 3.46e-02 | 9.31e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION INITIATION | 125 | 5.04e-01 | -3.46e-02 | 7.89e-01 |
| GOBP MONONUCLEAR CELL MIGRATION | 142 | 4.77e-01 | -3.46e-02 | 7.75e-01 |
| GOBP POSITIVE REGULATION OF AXON EXTENSION | 29 | 7.47e-01 | -3.46e-02 | 9.09e-01 |
| GOBP REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 20 | 7.89e-01 | 3.46e-02 | 9.24e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDINES | 28 | 7.52e-01 | 3.46e-02 | 9.11e-01 |
| GOBP REGULATION OF LIPID BIOSYNTHETIC PROCESS | 129 | 4.99e-01 | 3.45e-02 | 7.87e-01 |
| GOBP ESTABLISHMENT OF SPINDLE ORIENTATION | 34 | 7.28e-01 | -3.45e-02 | 9.03e-01 |
| GOBP PROTEIN ACTIVATION CASCADE | 10 | 8.50e-01 | -3.45e-02 | 9.47e-01 |
| GOBP CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT | 181 | 4.24e-01 | 3.45e-02 | 7.42e-01 |
| GOMF UBIQUITIN BINDING | 100 | 5.52e-01 | 3.44e-02 | 8.19e-01 |
| GOBP PYRUVATE TRANSPORT | 5 | 8.94e-01 | -3.44e-02 | 9.63e-01 |
| GOBP TETRAHYDROFOLATE METABOLIC PROCESS | 15 | 8.18e-01 | -3.44e-02 | 9.34e-01 |
| GOMF FOLIC ACID BINDING | 11 | 8.44e-01 | 3.44e-02 | 9.45e-01 |
| GOBP GLUTAMATE CATABOLIC PROCESS | 5 | 8.94e-01 | -3.44e-02 | 9.63e-01 |
| GOBP PROTEIN K63 LINKED DEUBIQUITINATION | 30 | 7.45e-01 | -3.43e-02 | 9.08e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 101 | 5.52e-01 | -3.43e-02 | 8.19e-01 |
| GOBP REGULATION OF T CELL MEDIATED CYTOTOXICITY | 35 | 7.26e-01 | -3.43e-02 | 9.02e-01 |
| GOBP REGULATION OF CELL ADHESION | 550 | 1.71e-01 | -3.43e-02 | 4.84e-01 |
| GOBP PROSTATE GLAND DEVELOPMENT | 29 | 7.49e-01 | -3.43e-02 | 9.10e-01 |
| GOBP CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM | 273 | 3.31e-01 | -3.43e-02 | 6.67e-01 |
| GOCC CYTOLYTIC GRANULE | 8 | 8.67e-01 | -3.43e-02 | 9.52e-01 |
| GOBP NUCLEAR RNA SURVEILLANCE | 14 | 8.24e-01 | 3.43e-02 | 9.37e-01 |
| GOBP CELLULAR RESPONSE TO COPPER ION | 19 | 7.96e-01 | 3.42e-02 | 9.27e-01 |
| GOBP CARDIAC MUSCLE CONTRACTION | 84 | 5.88e-01 | 3.42e-02 | 8.36e-01 |
| GOBP MYELIN MAINTENANCE | 15 | 8.19e-01 | 3.42e-02 | 9.35e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE | 247 | 3.56e-01 | -3.42e-02 | 6.89e-01 |
| GOBP MEIOTIC CHROMOSOME SEGREGATION | 65 | 6.34e-01 | -3.42e-02 | 8.57e-01 |
| GOCC NEURON PROJECTION CYTOPLASM | 71 | 6.19e-01 | 3.42e-02 | 8.49e-01 |
| GOCC CELL SURFACE | 515 | 1.86e-01 | -3.41e-02 | 5.04e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 11 | 8.45e-01 | -3.41e-02 | 9.45e-01 |
| GOMF PROTEIN KINASE A REGULATORY SUBUNIT BINDING | 22 | 7.82e-01 | -3.41e-02 | 9.22e-01 |
| GOBP REGULATION OF REPRODUCTIVE PROCESS | 120 | 5.19e-01 | 3.41e-02 | 7.97e-01 |
| GOMF CYCLASE ACTIVITY | 19 | 7.97e-01 | -3.41e-02 | 9.27e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 87 | 5.82e-01 | 3.41e-02 | 8.33e-01 |
| GOBP NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 119 | 5.21e-01 | -3.41e-02 | 7.98e-01 |
| GOBP NEURON DEVELOPMENT | 750 | 1.14e-01 | -3.41e-02 | 3.97e-01 |
| GOBP REGULATION OF MYELINATION | 34 | 7.31e-01 | 3.40e-02 | 9.04e-01 |
| GOBP LYMPHOID PROGENITOR CELL DIFFERENTIATION | 16 | 8.14e-01 | -3.40e-02 | 9.34e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT BIOGENESIS | 99 | 5.59e-01 | -3.40e-02 | 8.25e-01 |
| GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 32 | 7.40e-01 | -3.39e-02 | 9.06e-01 |
| GOBP INTERLEUKIN 2 PRODUCTION | 47 | 6.88e-01 | -3.39e-02 | 8.86e-01 |
| GOMF SINGLE STRANDED DNA ENDODEOXYRIBONUCLEASE ACTIVITY | 10 | 8.53e-01 | -3.39e-02 | 9.47e-01 |
| GOCC WASH COMPLEX | 10 | 8.53e-01 | -3.39e-02 | 9.47e-01 |
| GOBP DNA REPLICATION CHECKPOINT SIGNALING | 17 | 8.09e-01 | 3.39e-02 | 9.32e-01 |
| GOBP RESPONSE TO MUSCLE ACTIVITY | 17 | 8.09e-01 | 3.38e-02 | 9.32e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MONOUBIQUITINATION | 5 | 8.96e-01 | 3.38e-02 | 9.64e-01 |
| GOBP TRIGLYCERIDE METABOLIC PROCESS | 68 | 6.30e-01 | 3.38e-02 | 8.55e-01 |
| GOBP REGULATION OF PROTEOLYSIS | 477 | 2.09e-01 | -3.37e-02 | 5.33e-01 |
| GOCC MICROFIBRIL | 6 | 8.86e-01 | 3.37e-02 | 9.59e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 32 | 7.42e-01 | -3.37e-02 | 9.06e-01 |
| GOBP CELL ADHESION | 932 | 8.39e-02 | -3.36e-02 | 3.40e-01 |
| GOBP ADHERENS JUNCTION ASSEMBLY | 12 | 8.40e-01 | 3.36e-02 | 9.43e-01 |
| GOBP B CELL APOPTOTIC PROCESS | 24 | 7.76e-01 | -3.36e-02 | 9.21e-01 |
| GOBP REGULATION OF AMYLOID BETA CLEARANCE | 13 | 8.34e-01 | -3.36e-02 | 9.41e-01 |
| GOBP INTERLEUKIN 17 MEDIATED SIGNALING PATHWAY | 8 | 8.70e-01 | 3.35e-02 | 9.53e-01 |
| GOBP MUSCLE STRUCTURE DEVELOPMENT | 442 | 2.29e-01 | -3.35e-02 | 5.58e-01 |
| GOMF STRUCTURAL CONSTITUENT OF EYE LENS | 7 | 8.78e-01 | 3.35e-02 | 9.56e-01 |
| GOBP CHONDROCYTE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 5 | 8.97e-01 | 3.35e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE RECYCLING | 6 | 8.87e-01 | 3.35e-02 | 9.59e-01 |
| GOBP PHOTORECEPTOR CELL DIFFERENTIATION | 32 | 7.44e-01 | 3.34e-02 | 9.08e-01 |
| GOBP CELLULAR RESPONSE TO SALT STRESS | 11 | 8.48e-01 | -3.34e-02 | 9.46e-01 |
| GOBP MISMATCH REPAIR | 28 | 7.60e-01 | -3.34e-02 | 9.14e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE RECYCLING | 24 | 7.77e-01 | 3.34e-02 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 15 | 8.23e-01 | 3.34e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 182 | 4.38e-01 | 3.34e-02 | 7.52e-01 |
| GOMF VOLTAGE GATED CHANNEL ACTIVITY | 90 | 5.85e-01 | 3.33e-02 | 8.35e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE INHIBITOR ACTIVITY | 9 | 8.63e-01 | 3.33e-02 | 9.52e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 379 | 2.68e-01 | -3.33e-02 | 6.05e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 9 | 8.63e-01 | -3.32e-02 | 9.52e-01 |
| GOBP PLASMA LIPOPROTEIN PARTICLE CLEARANCE | 29 | 7.57e-01 | -3.32e-02 | 9.14e-01 |
| GOBP REGULATION OF GLUCOCORTICOID METABOLIC PROCESS | 8 | 8.71e-01 | -3.32e-02 | 9.54e-01 |
| GOBP REGULATION OF DEVELOPMENTAL GROWTH | 202 | 4.17e-01 | -3.32e-02 | 7.35e-01 |
| GOBP FEAR RESPONSE | 25 | 7.74e-01 | -3.32e-02 | 9.20e-01 |
| GOBP CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS | 144 | 4.92e-01 | 3.32e-02 | 7.84e-01 |
| GOBP MUSCLE ORGAN MORPHOGENESIS | 36 | 7.31e-01 | -3.32e-02 | 9.04e-01 |
| GOBP OSSIFICATION | 261 | 3.58e-01 | -3.31e-02 | 6.90e-01 |
| GOBP NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 96 | 5.75e-01 | 3.31e-02 | 8.31e-01 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE ADHESION | 86 | 5.96e-01 | 3.31e-02 | 8.39e-01 |
| GOBP FEMALE GAMETE GENERATION | 101 | 5.66e-01 | -3.31e-02 | 8.28e-01 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 35 | 7.35e-01 | -3.31e-02 | 9.04e-01 |
| GOBP CELL MOTILITY | 1112 | 6.54e-02 | -3.30e-02 | 2.95e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 37 | 7.29e-01 | 3.29e-02 | 9.03e-01 |
| GOBP NON CANONICAL WNT SIGNALING PATHWAY | 49 | 6.91e-01 | -3.29e-02 | 8.87e-01 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION | 42 | 7.13e-01 | 3.28e-02 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF ERAD PATHWAY | 14 | 8.32e-01 | -3.28e-02 | 9.41e-01 |
| GOBP REGULATION OF SNARE COMPLEX ASSEMBLY | 12 | 8.44e-01 | 3.28e-02 | 9.45e-01 |
| GOBP RESPONSE TO CAFFEINE | 12 | 8.44e-01 | -3.28e-02 | 9.45e-01 |
| GOBP REGULATION OF MEMBRANE LIPID DISTRIBUTION | 47 | 6.97e-01 | -3.28e-02 | 8.89e-01 |
| GOBP POLYSACCHARIDE BIOSYNTHETIC PROCESS | 45 | 7.04e-01 | -3.28e-02 | 8.92e-01 |
| GOBP PROTEIN K11 LINKED DEUBIQUITINATION | 9 | 8.65e-01 | -3.28e-02 | 9.52e-01 |
| GOBP POSITIVE REGULATION OF REPRODUCTIVE PROCESS | 44 | 7.07e-01 | 3.27e-02 | 8.94e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSPORT | 38 | 7.27e-01 | 3.27e-02 | 9.03e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 44 | 7.07e-01 | 3.27e-02 | 8.94e-01 |
| GOBP REGULATION OF STEROL TRANSPORT | 44 | 7.08e-01 | -3.27e-02 | 8.94e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE | 14 | 8.32e-01 | -3.27e-02 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 89 | 5.95e-01 | -3.27e-02 | 8.39e-01 |
| GOBP GOLGI DISASSEMBLY | 6 | 8.90e-01 | 3.26e-02 | 9.61e-01 |
| GOCC VESICLE MEMBRANE | 964 | 8.89e-02 | 3.26e-02 | 3.48e-01 |
| GOBP GLOMERULAR EPITHELIAL CELL DIFFERENTIATION | 13 | 8.39e-01 | 3.26e-02 | 9.43e-01 |
| GOBP DORSAL VENTRAL AXIS SPECIFICATION | 6 | 8.90e-01 | 3.26e-02 | 9.61e-01 |
| GOBP METANEPHRIC NEPHRON DEVELOPMENT | 19 | 8.06e-01 | 3.26e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF DENDRITE DEVELOPMENT | 11 | 8.52e-01 | 3.25e-02 | 9.47e-01 |
| GOBP ENDOLYSOSOMAL TOLL LIKE RECEPTOR SIGNALING PATHWAY | 38 | 7.29e-01 | -3.25e-02 | 9.03e-01 |
| GOBP DORSAL VENTRAL PATTERN FORMATION | 46 | 7.04e-01 | 3.24e-02 | 8.92e-01 |
| GOBP RESPONSE TO ACTIVITY | 48 | 6.98e-01 | -3.24e-02 | 8.89e-01 |
| GOBP DUMP CATABOLIC PROCESS | 5 | 9.00e-01 | 3.23e-02 | 9.65e-01 |
| GOBP REGULATION OF HAIR FOLLICLE DEVELOPMENT | 11 | 8.53e-01 | -3.23e-02 | 9.47e-01 |
| GOBP NEUROTRANSMITTER METABOLIC PROCESS | 13 | 8.40e-01 | -3.23e-02 | 9.43e-01 |
| GOBP BONE MINERALIZATION | 75 | 6.29e-01 | 3.23e-02 | 8.55e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 35 | 7.41e-01 | -3.23e-02 | 9.06e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 12 | 8.47e-01 | -3.22e-02 | 9.46e-01 |
| GOMF R SMAD BINDING | 21 | 7.98e-01 | -3.22e-02 | 9.27e-01 |
| GOCC MICROTUBULE | 363 | 2.93e-01 | 3.22e-02 | 6.31e-01 |
| GOBP REGULATION OF LYMPHOCYTE MIGRATION | 51 | 6.91e-01 | -3.22e-02 | 8.87e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION | 14 | 8.35e-01 | -3.22e-02 | 9.41e-01 |
| GOBP FUCOSYLATION | 11 | 8.53e-01 | -3.22e-02 | 9.48e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER TRANSPORT | 59 | 6.69e-01 | 3.22e-02 | 8.76e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN CELL | 56 | 6.78e-01 | -3.21e-02 | 8.79e-01 |
| GOBP GLYCOPROTEIN CATABOLIC PROCESS | 27 | 7.73e-01 | 3.21e-02 | 9.20e-01 |
| GOBP TIGHT JUNCTION ORGANIZATION | 52 | 6.89e-01 | 3.21e-02 | 8.87e-01 |
| GOCC SECRETORY GRANULE | 639 | 1.69e-01 | -3.21e-02 | 4.81e-01 |
| GOBP REGULATION OF CYCLASE ACTIVITY | 26 | 7.77e-01 | -3.21e-02 | 9.21e-01 |
| GOBP ENDODERMAL CELL DIFFERENTIATION | 30 | 7.61e-01 | 3.21e-02 | 9.15e-01 |
| GOCC MEIOTIC SPINDLE | 11 | 8.54e-01 | 3.20e-02 | 9.48e-01 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA | 9 | 8.68e-01 | -3.20e-02 | 9.52e-01 |
| GOBP STEROID CATABOLIC PROCESS | 16 | 8.25e-01 | 3.20e-02 | 9.37e-01 |
| GOBP INNER EAR RECEPTOR CELL DEVELOPMENT | 33 | 7.51e-01 | 3.19e-02 | 9.11e-01 |
| GOBP L AMINO ACID TRANSPORT | 59 | 6.72e-01 | -3.19e-02 | 8.77e-01 |
| GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING | 19 | 8.10e-01 | -3.19e-02 | 9.33e-01 |
| GOBP INTRACILIARY RETROGRADE TRANSPORT | 10 | 8.61e-01 | -3.19e-02 | 9.51e-01 |
| GOBP GLOMERULAR EPITHELIUM DEVELOPMENT | 14 | 8.37e-01 | -3.19e-02 | 9.42e-01 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT INTO CELL | 6 | 8.93e-01 | -3.18e-02 | 9.63e-01 |
| GOMF CALCIUM ION BINDING | 370 | 2.95e-01 | 3.18e-02 | 6.32e-01 |
| GOBP CELL MATURATION | 111 | 5.64e-01 | 3.17e-02 | 8.26e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATASE ACTIVITY | 22 | 7.97e-01 | 3.17e-02 | 9.27e-01 |
| GOBP MYOTUBE DIFFERENTIATION | 81 | 6.22e-01 | 3.17e-02 | 8.51e-01 |
| GOBP ENDOSOMAL TRANSPORT | 228 | 4.13e-01 | 3.15e-02 | 7.31e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 18 | 8.17e-01 | -3.15e-02 | 9.34e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR INTERNALIZATION | 19 | 8.12e-01 | 3.15e-02 | 9.33e-01 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL | 110 | 5.69e-01 | -3.15e-02 | 8.28e-01 |
| GOBP NEGATIVE REGULATION OF DEPHOSPHORYLATION | 30 | 7.67e-01 | 3.13e-02 | 9.17e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS | 17 | 8.23e-01 | -3.13e-02 | 9.36e-01 |
| GOBP REGULATION OF RESPONSE TO TUMOR CELL | 17 | 8.23e-01 | 3.13e-02 | 9.36e-01 |
| GOBP REGULATION OF MICROTUBULE BINDING | 7 | 8.86e-01 | -3.13e-02 | 9.59e-01 |
| GOBP TELENCEPHALON DEVELOPMENT | 174 | 4.77e-01 | -3.13e-02 | 7.75e-01 |
| GOBP RRNA 5 END PROCESSING | 5 | 9.04e-01 | -3.12e-02 | 9.66e-01 |
| GOBP TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 44 | 7.21e-01 | -3.12e-02 | 9.00e-01 |
| GOBP RESPONSE TO COLD | 35 | 7.50e-01 | -3.11e-02 | 9.10e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYMERIZATION | 69 | 6.55e-01 | -3.11e-02 | 8.69e-01 |
| GOBP SMOOTH MUSCLE CELL PROLIFERATION | 95 | 6.01e-01 | -3.11e-02 | 8.40e-01 |
| GOCC CELL TRAILING EDGE | 14 | 8.40e-01 | -3.11e-02 | 9.43e-01 |
| GOBP GOLGI LOCALIZATION | 13 | 8.46e-01 | -3.10e-02 | 9.46e-01 |
| GOBP CARDIAC MUSCLE TISSUE MORPHOGENESIS | 27 | 7.80e-01 | -3.10e-02 | 9.22e-01 |
| GOBP RESPONSE TO TUMOR NECROSIS FACTOR | 186 | 4.67e-01 | -3.10e-02 | 7.67e-01 |
| GOBP POSITIVE REGULATION OF CELL GROWTH | 108 | 5.78e-01 | 3.10e-02 | 8.32e-01 |
| GOBP PHENOTYPIC SWITCHING | 5 | 9.05e-01 | 3.09e-02 | 9.67e-01 |
| GOBP PYRUVATE METABOLIC PROCESS | 100 | 5.93e-01 | 3.09e-02 | 8.38e-01 |
| GOBP VIRAL BUDDING | 24 | 7.93e-01 | 3.09e-02 | 9.25e-01 |
| GOBP POLYOL BIOSYNTHETIC PROCESS | 43 | 7.26e-01 | -3.09e-02 | 9.02e-01 |
| GOCC PROTEIN PHOSPHATASE 4 COMPLEX | 5 | 9.05e-01 | -3.08e-02 | 9.67e-01 |
| GOBP RESPONSE TO TEMPERATURE STIMULUS | 127 | 5.49e-01 | -3.08e-02 | 8.18e-01 |
| GOMF CYTOSKELETAL PROTEIN BINDING | 763 | 1.50e-01 | 3.08e-02 | 4.53e-01 |
| GOBP SECRETION | 617 | 1.94e-01 | 3.08e-02 | 5.12e-01 |
| GOMF SULFUR COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 48 | 7.12e-01 | 3.08e-02 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF STRESS FIBER ASSEMBLY | 44 | 7.24e-01 | 3.07e-02 | 9.02e-01 |
| GOBP POSITIVE REGULATION OF PROGRAMMED CELL DEATH | 413 | 2.86e-01 | -3.07e-02 | 6.23e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERASE ACTIVITY | 10 | 8.67e-01 | -3.07e-02 | 9.52e-01 |
| GOBP CELLULAR RESPONSE TO LAMINAR FLUID SHEAR STRESS | 6 | 8.97e-01 | -3.06e-02 | 9.64e-01 |
| GOBP SPINAL CORD MOTOR NEURON DIFFERENTIATION | 15 | 8.37e-01 | -3.06e-02 | 9.43e-01 |
| GOBP NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 19 | 8.17e-01 | -3.06e-02 | 9.34e-01 |
| GOCC FICOLIN 1 RICH GRANULE MEMBRANE | 49 | 7.11e-01 | -3.06e-02 | 8.96e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION | 27 | 7.83e-01 | -3.06e-02 | 9.22e-01 |
| GOCC AUTOPHAGOSOME | 104 | 5.91e-01 | 3.05e-02 | 8.37e-01 |
| GOBP LENS MORPHOGENESIS IN CAMERA TYPE EYE | 11 | 8.61e-01 | 3.05e-02 | 9.51e-01 |
| GOBP G1 TO G0 TRANSITION | 14 | 8.44e-01 | 3.04e-02 | 9.45e-01 |
| GOBP NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I | 18 | 8.23e-01 | -3.04e-02 | 9.36e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL CHEMICAL HOMEOSTASIS | 47 | 7.18e-01 | -3.04e-02 | 8.98e-01 |
| GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 20 | 8.15e-01 | -3.03e-02 | 9.34e-01 |
| GOMF TAU PROTEIN BINDING | 41 | 7.38e-01 | 3.02e-02 | 9.05e-01 |
| GOBP RIBOSOME BIOGENESIS | 310 | 3.62e-01 | 3.02e-02 | 6.94e-01 |
| GOBP NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 5 | 9.07e-01 | 3.02e-02 | 9.67e-01 |
| GOBP BONE REMODELING | 61 | 6.84e-01 | -3.01e-02 | 8.83e-01 |
| GOBP ACTIN FILAMENT SEVERING | 16 | 8.35e-01 | -3.01e-02 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 23 | 8.03e-01 | -3.01e-02 | 9.29e-01 |
| GOBP REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 63 | 6.80e-01 | -3.01e-02 | 8.81e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 29 | 7.79e-01 | -3.01e-02 | 9.21e-01 |
| GOBP REGULATION OF CELL DIVISION | 133 | 5.50e-01 | 3.01e-02 | 8.19e-01 |
| GOBP BASE EXCISION REPAIR AP SITE FORMATION | 12 | 8.57e-01 | 3.00e-02 | 9.49e-01 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL | 47 | 7.22e-01 | 3.00e-02 | 9.00e-01 |
| GOBP PANCREAS DEVELOPMENT | 39 | 7.46e-01 | 3.00e-02 | 9.08e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MEMBRANE | 6 | 8.99e-01 | 3.00e-02 | 9.64e-01 |
| GOBP REGULATION OF GROWTH | 417 | 2.95e-01 | -3.00e-02 | 6.32e-01 |
| GOBP GENOMIC IMPRINTING | 14 | 8.46e-01 | 3.00e-02 | 9.46e-01 |
| GOBP POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 96 | 6.12e-01 | -2.99e-02 | 8.47e-01 |
| GOBP NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 112 | 5.84e-01 | -2.99e-02 | 8.34e-01 |
| GOBP POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION | 8 | 8.83e-01 | -2.99e-02 | 9.59e-01 |
| GOBP RADIAL GLIA GUIDED PYRAMIDAL NEURON MIGRATION | 5 | 9.08e-01 | -2.99e-02 | 9.68e-01 |
| GOBP SYNAPSE PRUNING | 8 | 8.84e-01 | -2.99e-02 | 9.59e-01 |
| GOBP OOCYTE DIFFERENTIATION | 38 | 7.50e-01 | -2.99e-02 | 9.10e-01 |
| GOBP ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 107 | 5.94e-01 | -2.98e-02 | 8.38e-01 |
| GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 32 | 7.70e-01 | -2.98e-02 | 9.19e-01 |
| GOCC RNA CAP BINDING COMPLEX | 20 | 8.17e-01 | -2.98e-02 | 9.34e-01 |
| GOBP GPI ANCHOR METABOLIC PROCESS | 29 | 7.81e-01 | 2.98e-02 | 9.22e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 30 | 7.78e-01 | -2.98e-02 | 9.21e-01 |
| GOBP REGULATION OF GTPASE ACTIVITY | 228 | 4.40e-01 | -2.98e-02 | 7.52e-01 |
| GOBP ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS | 25 | 7.97e-01 | 2.97e-02 | 9.27e-01 |
| GOBP ENDOTHELIAL CELL DEVELOPMENT | 51 | 7.13e-01 | -2.97e-02 | 8.96e-01 |
| GOBP REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 73 | 6.61e-01 | 2.97e-02 | 8.72e-01 |
| GOBP COENZYME A BIOSYNTHETIC PROCESS | 11 | 8.65e-01 | -2.97e-02 | 9.52e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON CARBON BONDS | 7 | 8.92e-01 | 2.97e-02 | 9.63e-01 |
| GOBP FOREBRAIN GENERATION OF NEURONS | 25 | 7.97e-01 | -2.97e-02 | 9.27e-01 |
| GOBP REGULATION OF PHOSPHOLIPID TRANSLOCATION | 5 | 9.09e-01 | -2.96e-02 | 9.68e-01 |
| GOBP REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 37 | 7.55e-01 | -2.96e-02 | 9.12e-01 |
| GOBP CELL MORPHOGENESIS | 648 | 2.01e-01 | -2.96e-02 | 5.23e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BASED MOVEMENT | 30 | 7.80e-01 | 2.95e-02 | 9.21e-01 |
| GOBP NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT | 6 | 9.01e-01 | -2.95e-02 | 9.65e-01 |
| GOCC AUTOPHAGOSOME MEMBRANE | 46 | 7.30e-01 | 2.95e-02 | 9.04e-01 |
| GOBP ORGANIC CATION TRANSPORT | 36 | 7.60e-01 | 2.95e-02 | 9.14e-01 |
| GOBP CATECHOLAMINE SECRETION | 26 | 7.95e-01 | -2.94e-02 | 9.26e-01 |
| GOBP RESPONSE TO L GLUTAMATE | 13 | 8.54e-01 | 2.94e-02 | 9.48e-01 |
| GOBP CELLULAR RESPONSE TO CHEMICAL STRESS | 252 | 4.22e-01 | -2.94e-02 | 7.41e-01 |
| GOCC COPII COATED ER TO GOLGI TRANSPORT VESICLE | 82 | 6.46e-01 | 2.94e-02 | 8.64e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS | 22 | 8.12e-01 | 2.94e-02 | 9.33e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION | 122 | 5.76e-01 | -2.93e-02 | 8.31e-01 |
| GOBP REGULATION OF MACROAUTOPHAGY | 146 | 5.41e-01 | -2.93e-02 | 8.13e-01 |
| GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 93 | 6.25e-01 | -2.93e-02 | 8.52e-01 |
| GOCC CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 126 | 5.70e-01 | 2.93e-02 | 8.29e-01 |
| GOCC RECYCLING ENDOSOME | 169 | 5.12e-01 | 2.93e-02 | 7.93e-01 |
| GOBP SYNAPTIC VESICLE MEMBRANE ORGANIZATION | 17 | 8.35e-01 | 2.93e-02 | 9.41e-01 |
| GOBP REGULATION OF CENTRIOLE REPLICATION | 22 | 8.13e-01 | 2.91e-02 | 9.34e-01 |
| GOBP LYSOSOMAL TRANSPORT | 117 | 5.87e-01 | 2.91e-02 | 8.35e-01 |
| GOBP MACROMOLECULE CATABOLIC PROCESS | 1180 | 9.62e-02 | -2.90e-02 | 3.66e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 142 | 5.52e-01 | 2.90e-02 | 8.19e-01 |
| GOBP N TERMINAL PEPTIDYL METHIONINE ACETYLATION | 6 | 9.03e-01 | -2.89e-02 | 9.66e-01 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 44 | 7.41e-01 | -2.88e-02 | 9.06e-01 |
| GOBP T CELL APOPTOTIC PROCESS | 44 | 7.41e-01 | 2.88e-02 | 9.06e-01 |
| GOBP CELLULAR RESPONSE TO FLUID SHEAR STRESS | 16 | 8.42e-01 | 2.88e-02 | 9.44e-01 |
| GOMF SNARE BINDING | 82 | 6.52e-01 | -2.88e-02 | 8.67e-01 |
| GOCC FICOLIN 1 RICH GRANULE | 170 | 5.18e-01 | -2.88e-02 | 7.96e-01 |
| GOMF TRANSLATION REGULATOR ACTIVITY | 123 | 5.82e-01 | 2.88e-02 | 8.32e-01 |
| GOBP CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS | 79 | 6.59e-01 | 2.88e-02 | 8.71e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD CIRCULATION | 17 | 8.38e-01 | -2.87e-02 | 9.43e-01 |
| GOBP REGULATION OF DNA CATABOLIC PROCESS | 8 | 8.88e-01 | -2.87e-02 | 9.60e-01 |
| GOBP PYRIMIDINE NUCLEOBASE METABOLIC PROCESS | 18 | 8.33e-01 | 2.87e-02 | 9.41e-01 |
| GOBP HEPATIC STELLATE CELL ACTIVATION | 6 | 9.03e-01 | -2.86e-02 | 9.66e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 121 | 5.87e-01 | -2.86e-02 | 8.35e-01 |
| GOBP REGULATION OF RESPONSE TO FOOD | 8 | 8.89e-01 | 2.86e-02 | 9.60e-01 |
| GOBP RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 92 | 6.37e-01 | 2.85e-02 | 8.58e-01 |
| GOBP TUBULIN COMPLEX ASSEMBLY | 9 | 8.82e-01 | 2.85e-02 | 9.59e-01 |
| GOBP RESPONSE TO NITROSATIVE STRESS | 9 | 8.82e-01 | 2.85e-02 | 9.59e-01 |
| GOMF TPR DOMAIN BINDING | 7 | 8.96e-01 | -2.85e-02 | 9.64e-01 |
| GOBP CIRCULATORY SYSTEM PROCESS | 342 | 3.67e-01 | -2.85e-02 | 6.98e-01 |
| GOBP SECRETORY GRANULE ORGANIZATION | 45 | 7.42e-01 | 2.84e-02 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY | 208 | 4.81e-01 | -2.84e-02 | 7.78e-01 |
| GOBP SPLICEOSOMAL SNRNP ASSEMBLY | 39 | 7.59e-01 | 2.84e-02 | 9.14e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 31 | 7.85e-01 | 2.83e-02 | 9.22e-01 |
| GOBP RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 233 | 4.58e-01 | 2.83e-02 | 7.63e-01 |
| GOCC STRIATED MUSCLE THIN FILAMENT | 12 | 8.65e-01 | -2.83e-02 | 9.52e-01 |
| GOCC ENDOLYSOSOME | 24 | 8.11e-01 | 2.82e-02 | 9.33e-01 |
| GOBP REGULATION OF ANGIOTENSIN LEVELS IN BLOOD | 5 | 9.13e-01 | -2.82e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 63 | 7.00e-01 | -2.81e-02 | 8.89e-01 |
| GOBP PALLIUM DEVELOPMENT | 123 | 5.91e-01 | -2.81e-02 | 8.37e-01 |
| GOBP HISTIDINE METABOLIC PROCESS | 7 | 8.98e-01 | 2.81e-02 | 9.64e-01 |
| GOMF GLYCOGEN BINDING | 6 | 9.05e-01 | 2.81e-02 | 9.67e-01 |
| GOBP REGULATION OF MICROTUBULE BASED PROCESS | 207 | 4.87e-01 | -2.81e-02 | 7.81e-01 |
| GOBP DENDRITIC CELL APOPTOTIC PROCESS | 8 | 8.91e-01 | 2.81e-02 | 9.62e-01 |
| GOBP INFLAMMASOME MEDIATED SIGNALING PATHWAY | 35 | 7.74e-01 | -2.80e-02 | 9.20e-01 |
| GOMF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 67 | 6.92e-01 | -2.80e-02 | 8.88e-01 |
| GOBP MUSCLE CELL DIFFERENTIATION | 259 | 4.39e-01 | 2.80e-02 | 7.52e-01 |
| GOBP CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 371 | 3.56e-01 | -2.80e-02 | 6.90e-01 |
| GOBP REGULATION OF HETEROTYPIC CELL CELL ADHESION | 18 | 8.37e-01 | 2.79e-02 | 9.43e-01 |
| GOBP ESTABLISHMENT OF CELL POLARITY | 125 | 5.90e-01 | -2.79e-02 | 8.36e-01 |
| GOCC FICOLIN 1 RICH GRANULE LUMEN | 121 | 5.96e-01 | -2.79e-02 | 8.39e-01 |
| GOBP MITOCHONDRIAL GENOME MAINTENANCE | 29 | 7.95e-01 | 2.79e-02 | 9.26e-01 |
| GOMF EUKARYOTIC INITIATION FACTOR 4E BINDING | 9 | 8.85e-01 | -2.78e-02 | 9.59e-01 |
| GOBP CARBOHYDRATE CATABOLIC PROCESS | 130 | 5.84e-01 | 2.78e-02 | 8.34e-01 |
| GOMF AMINOPEPTIDASE ACTIVITY | 33 | 7.82e-01 | -2.78e-02 | 9.22e-01 |
| GOCC BCL 2 FAMILY PROTEIN COMPLEX | 9 | 8.85e-01 | 2.78e-02 | 9.59e-01 |
| GOBP AMYLOID BETA CLEARANCE BY TRANSCYTOSIS | 7 | 8.99e-01 | 2.78e-02 | 9.64e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 15 | 8.52e-01 | 2.78e-02 | 9.47e-01 |
| GOBP PROTEIN LOCALIZATION TO ORGANELLE | 826 | 1.78e-01 | 2.78e-02 | 4.93e-01 |
| GOBP CELL RECOGNITION | 84 | 6.60e-01 | -2.78e-02 | 8.72e-01 |
| GOBP AUTOPHAGOSOME MATURATION | 61 | 7.08e-01 | 2.77e-02 | 8.94e-01 |
| GOCC CELL PROJECTION MEMBRANE | 252 | 4.50e-01 | 2.77e-02 | 7.59e-01 |
| GOCC SIDE OF MEMBRANE | 435 | 3.23e-01 | -2.77e-02 | 6.62e-01 |
| GOBP SNRNA METABOLIC PROCESS | 54 | 7.25e-01 | -2.77e-02 | 9.02e-01 |
| GOCC CYTOPLASMIC UBIQUITIN LIGASE COMPLEX | 12 | 8.68e-01 | -2.76e-02 | 9.52e-01 |
| GOBP MEIOTIC TELOMERE CLUSTERING | 7 | 8.99e-01 | 2.76e-02 | 9.64e-01 |
| GOBP CELLULAR RESPONSE TO RADIATION | 145 | 5.66e-01 | -2.76e-02 | 8.28e-01 |
| GOBP GLIOGENESIS | 214 | 4.87e-01 | -2.76e-02 | 7.81e-01 |
| GOBP ICOSANOID METABOLIC PROCESS | 66 | 6.99e-01 | 2.76e-02 | 8.89e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 23 | 8.19e-01 | 2.76e-02 | 9.35e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION | 17 | 8.44e-01 | 2.75e-02 | 9.45e-01 |
| GOBP NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY | 6 | 9.07e-01 | 2.75e-02 | 9.67e-01 |
| GOCC DENDRITIC GROWTH CONE | 9 | 8.86e-01 | 2.75e-02 | 9.59e-01 |
| GOMF LIGASE ACTIVITY | 125 | 5.96e-01 | 2.75e-02 | 8.39e-01 |
| GOMF S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY | 165 | 5.45e-01 | -2.74e-02 | 8.15e-01 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 13 | 8.64e-01 | 2.73e-02 | 9.52e-01 |
| GOBP REGULATION OF DEPHOSPHORYLATION | 89 | 6.56e-01 | -2.73e-02 | 8.70e-01 |
| GOBP NERVE GROWTH FACTOR SIGNALING PATHWAY | 8 | 8.94e-01 | -2.73e-02 | 9.63e-01 |
| GOBP DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 8 | 8.94e-01 | 2.73e-02 | 9.63e-01 |
| GOMF PHOSPHOLIPID TRANSPORTER ACTIVITY | 53 | 7.32e-01 | -2.72e-02 | 9.04e-01 |
| GOBP GLUTAMINE METABOLIC PROCESS | 21 | 8.29e-01 | 2.72e-02 | 9.40e-01 |
| GOBP CALCIUM ION HOMEOSTASIS | 208 | 5.00e-01 | 2.72e-02 | 7.87e-01 |
| GOMF CGMP BINDING | 7 | 9.01e-01 | 2.72e-02 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 21 | 8.29e-01 | -2.72e-02 | 9.40e-01 |
| GOBP EXTRACELLULAR TRANSPORT | 30 | 7.97e-01 | 2.71e-02 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 19 | 8.38e-01 | 2.71e-02 | 9.43e-01 |
| GOMF EXOPEPTIDASE ACTIVITY | 73 | 6.89e-01 | -2.71e-02 | 8.87e-01 |
| GOBP CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 36 | 7.79e-01 | 2.71e-02 | 9.21e-01 |
| GOBP RESPONSE TO FLUID SHEAR STRESS | 27 | 8.08e-01 | -2.71e-02 | 9.32e-01 |
| GOCC U6 SNRNP | 8 | 8.95e-01 | 2.70e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF LIPASE ACTIVITY | 36 | 7.79e-01 | 2.70e-02 | 9.21e-01 |
| GOBP VACUOLAR TRANSPORT | 150 | 5.69e-01 | 2.70e-02 | 8.28e-01 |
| GOBP MESODERM DEVELOPMENT | 73 | 6.91e-01 | -2.70e-02 | 8.87e-01 |
| GOMF S100 PROTEIN BINDING | 12 | 8.72e-01 | -2.69e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 70 | 6.97e-01 | -2.69e-02 | 8.89e-01 |
| GOMF LIPID BINDING | 603 | 2.62e-01 | -2.69e-02 | 5.98e-01 |
| GOBP BASE CONVERSION OR SUBSTITUTION EDITING | 13 | 8.67e-01 | -2.69e-02 | 9.52e-01 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION | 55 | 7.31e-01 | 2.68e-02 | 9.04e-01 |
| GOBP EPITHELIAL CELL MORPHOGENESIS | 20 | 8.35e-01 | 2.68e-02 | 9.42e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN CELL CYCLE ARREST | 16 | 8.53e-01 | -2.68e-02 | 9.47e-01 |
| GOBP NAD METABOLIC PROCESS | 33 | 7.90e-01 | 2.68e-02 | 9.24e-01 |
| GOBP NEGATIVE REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 8 | 8.96e-01 | -2.67e-02 | 9.64e-01 |
| GOMF ORGANIC HYDROXY COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 29 | 8.04e-01 | 2.67e-02 | 9.30e-01 |
| GOCC MITOCHONDRIAL PYRUVATE DEHYDROGENASE COMPLEX | 7 | 9.03e-01 | -2.67e-02 | 9.66e-01 |
| GOBP REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY | 6 | 9.10e-01 | -2.66e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF B CELL PROLIFERATION | 34 | 7.89e-01 | -2.65e-02 | 9.24e-01 |
| GOBP DEVELOPMENTAL CELL GROWTH | 160 | 5.63e-01 | 2.65e-02 | 8.26e-01 |
| GOBP MORPHOGENESIS OF AN ENDOTHELIUM | 13 | 8.69e-01 | 2.65e-02 | 9.53e-01 |
| GOCC POSTSYNAPTIC RECYCLING ENDOSOME | 8 | 8.97e-01 | -2.64e-02 | 9.64e-01 |
| GOMF UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME ACTIVITY | 10 | 8.85e-01 | 2.64e-02 | 9.59e-01 |
| GOBP REGULATION OF CELL SUBSTRATE ADHESION | 155 | 5.71e-01 | 2.64e-02 | 8.29e-01 |
| GOBP PROTEIN CONTAINING COMPLEX LOCALIZATION | 150 | 5.78e-01 | 2.64e-02 | 8.32e-01 |
| GOBP ENDOCYTIC RECYCLING | 79 | 6.86e-01 | 2.63e-02 | 8.84e-01 |
| GOBP REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 32 | 7.97e-01 | 2.63e-02 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION | 144 | 5.86e-01 | 2.63e-02 | 8.35e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 8 | 8.98e-01 | -2.63e-02 | 9.64e-01 |
| GOMF ABC TYPE TRANSPORTER ACTIVITY | 37 | 7.82e-01 | 2.63e-02 | 9.22e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 42 | 7.69e-01 | 2.62e-02 | 9.18e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE PRIMING | 7 | 9.04e-01 | 2.62e-02 | 9.67e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 21 | 8.35e-01 | -2.62e-02 | 9.42e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR RECYCLING | 11 | 8.80e-01 | -2.62e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 6 | 9.12e-01 | 2.62e-02 | 9.69e-01 |
| GOBP CARTILAGE DEVELOPMENT | 110 | 6.36e-01 | 2.62e-02 | 8.57e-01 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE III | 60 | 7.26e-01 | -2.62e-02 | 9.02e-01 |
| GOBP REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 73 | 7.00e-01 | -2.61e-02 | 8.89e-01 |
| GOCC SEX CHROMOSOME | 28 | 8.11e-01 | 2.61e-02 | 9.33e-01 |
| GOBP DENDRITIC CELL DIFFERENTIATION | 35 | 7.90e-01 | -2.61e-02 | 9.24e-01 |
| GOCC SMOOTH ENDOPLASMIC RETICULUM | 22 | 8.32e-01 | -2.61e-02 | 9.41e-01 |
| GOBP MACROPHAGE MIGRATION | 44 | 7.65e-01 | 2.61e-02 | 9.17e-01 |
| GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 40 | 7.76e-01 | -2.60e-02 | 9.21e-01 |
| GOMF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 142 | 5.93e-01 | -2.60e-02 | 8.38e-01 |
| GOBP PROTEIN CONTAINING COMPLEX ASSEMBLY | 1263 | 1.24e-01 | -2.60e-02 | 4.12e-01 |
| GOBP FIBROBLAST PROLIFERATION | 77 | 6.94e-01 | -2.60e-02 | 8.88e-01 |
| GOBP PROTEIN RNA COMPLEX DISASSEMBLY | 8 | 8.99e-01 | -2.60e-02 | 9.64e-01 |
| GOBP ORGANELLE ASSEMBLY | 825 | 2.08e-01 | 2.60e-02 | 5.32e-01 |
| GOBP ENDOTHELIAL CELL MIGRATION | 149 | 5.85e-01 | -2.59e-02 | 8.35e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 12 | 8.77e-01 | 2.59e-02 | 9.56e-01 |
| GOCC JUXTAPARANODE REGION OF AXON | 9 | 8.93e-01 | -2.59e-02 | 9.63e-01 |
| GOBP COGNITION | 190 | 5.40e-01 | -2.58e-02 | 8.11e-01 |
| GOCC ACTIN CYTOSKELETON | 374 | 3.92e-01 | 2.58e-02 | 7.18e-01 |
| GOBP HEART PROCESS | 139 | 6.00e-01 | 2.58e-02 | 8.40e-01 |
| GOMF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 93 | 6.67e-01 | 2.58e-02 | 8.75e-01 |
| GOBP NEGATIVE REGULATION OF TRANSPORTER ACTIVITY | 41 | 7.75e-01 | 2.58e-02 | 9.21e-01 |
| GOBP AUTOPHAGOSOME ORGANIZATION | 110 | 6.41e-01 | 2.58e-02 | 8.60e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 40 | 7.78e-01 | 2.57e-02 | 9.21e-01 |
| GOBP VESICLE CARGO LOADING | 27 | 8.17e-01 | 2.57e-02 | 9.34e-01 |
| GOBP ASTRAL MICROTUBULE ORGANIZATION | 9 | 8.94e-01 | 2.57e-02 | 9.63e-01 |
| GOBP NCRNA CATABOLIC PROCESS | 50 | 7.54e-01 | -2.56e-02 | 9.12e-01 |
| GOBP REGULATION OF HORMONE LEVELS | 299 | 4.47e-01 | 2.56e-02 | 7.57e-01 |
| GOMF CDP ALCOHOL PHOSPHATIDYLTRANSFERASE ACTIVITY | 8 | 9.00e-01 | 2.56e-02 | 9.65e-01 |
| GOBP DOPAMINE RECEPTOR SIGNALING PATHWAY | 21 | 8.39e-01 | 2.56e-02 | 9.43e-01 |
| GOBP PEPTIDE TRANSPORT | 156 | 5.81e-01 | -2.56e-02 | 8.32e-01 |
| GOBP REGULATION OF SYNAPTIC PLASTICITY | 116 | 6.34e-01 | -2.56e-02 | 8.57e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR TRANSPORT | 177 | 5.57e-01 | 2.56e-02 | 8.23e-01 |
| GOCC SITE OF POLARIZED GROWTH | 142 | 5.99e-01 | -2.56e-02 | 8.40e-01 |
| GOBP NEUTRAL AMINO ACID TRANSPORT | 37 | 7.88e-01 | -2.56e-02 | 9.24e-01 |
| GOMF PHOSPHATIDYLCHOLINE BINDING | 22 | 8.35e-01 | -2.56e-02 | 9.42e-01 |
| GOCC CUL4B RING E3 UBIQUITIN LIGASE COMPLEX | 6 | 9.14e-01 | -2.56e-02 | 9.70e-01 |
| GOBP REGULATION OF PROGRAMMED CELL DEATH | 1097 | 1.56e-01 | -2.56e-02 | 4.62e-01 |
| GOBP NEGATIVE REGULATION OF TRANSPORT | 287 | 4.58e-01 | 2.55e-02 | 7.63e-01 |
| GOMF NUCLEOSIDE TRIPHOSPHATE DIPHOSPHATASE ACTIVITY | 8 | 9.01e-01 | 2.55e-02 | 9.65e-01 |
| GOBP REGULATION OF BODY FLUID LEVELS | 233 | 5.04e-01 | 2.55e-02 | 7.89e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION | 16 | 8.60e-01 | -2.55e-02 | 9.50e-01 |
| GOCC VCP NPL4 UFD1 AAA ATPASE COMPLEX | 8 | 9.01e-01 | 2.54e-02 | 9.65e-01 |
| GOBP SODIUM ION TRANSPORT | 124 | 6.25e-01 | 2.54e-02 | 8.52e-01 |
| GOBP CELL PART MORPHOGENESIS | 447 | 3.58e-01 | -2.54e-02 | 6.91e-01 |
| GOBP DECIDUALIZATION | 18 | 8.52e-01 | -2.54e-02 | 9.47e-01 |
| GOBP SNO S RNA PROCESSING | 12 | 8.79e-01 | -2.53e-02 | 9.58e-01 |
| GOCC SPERM CONNECTING PIECE | 8 | 9.01e-01 | 2.53e-02 | 9.65e-01 |
| GOBP CELL MATRIX ADHESION | 163 | 5.78e-01 | 2.53e-02 | 8.32e-01 |
| GOBP HYPEROSMOTIC RESPONSE | 21 | 8.41e-01 | 2.53e-02 | 9.44e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE BINDING | 23 | 8.34e-01 | 2.53e-02 | 9.41e-01 |
| GOMF TOLL LIKE RECEPTOR BINDING | 14 | 8.70e-01 | 2.52e-02 | 9.53e-01 |
| GOBP REGULATION OF OXIDOREDUCTASE ACTIVITY | 49 | 7.61e-01 | 2.51e-02 | 9.15e-01 |
| GOBP NEGATIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 8 | 9.02e-01 | -2.51e-02 | 9.66e-01 |
| GOBP GOLGI TO ENDOSOME TRANSPORT | 17 | 8.58e-01 | -2.51e-02 | 9.49e-01 |
| GOCC LIPID DROPLET | 85 | 6.90e-01 | 2.51e-02 | 8.87e-01 |
| GOBP REGULATION OF ENDOCYTIC RECYCLING | 16 | 8.62e-01 | -2.50e-02 | 9.52e-01 |
| GOBP MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 18 | 8.54e-01 | -2.50e-02 | 9.48e-01 |
| GOBP ONE CARBON METABOLIC PROCESS | 25 | 8.29e-01 | -2.50e-02 | 9.39e-01 |
| GOBP AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION | 7 | 9.09e-01 | -2.50e-02 | 9.68e-01 |
| GOBP DNA CATABOLIC PROCESS | 24 | 8.32e-01 | 2.50e-02 | 9.41e-01 |
| GOBP TYPE B PANCREATIC CELL DIFFERENTIATION | 15 | 8.67e-01 | -2.50e-02 | 9.52e-01 |
| GOBP NEURON MATURATION | 32 | 8.07e-01 | 2.50e-02 | 9.31e-01 |
| GOBP ENDOPLASMIC RETICULUM MEMBRANE ORGANIZATION | 11 | 8.86e-01 | -2.50e-02 | 9.59e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL | 119 | 6.39e-01 | -2.49e-02 | 8.59e-01 |
| GOBP ERROR PRONE TRANSLESION SYNTHESIS | 11 | 8.86e-01 | -2.49e-02 | 9.59e-01 |
| GOCC MICROTUBULE MINUS END | 7 | 9.09e-01 | -2.49e-02 | 9.68e-01 |
| GOMF XENOBIOTIC TRANSMEMBRANE TRANSPORTER ACTIVITY | 29 | 8.17e-01 | 2.49e-02 | 9.34e-01 |
| GOBP MUSCLE SYSTEM PROCESS | 261 | 4.90e-01 | -2.49e-02 | 7.83e-01 |
| GOCC SYNAPSE | 958 | 1.96e-01 | -2.48e-02 | 5.15e-01 |
| GOBP GLANDULAR EPITHELIAL CELL DEVELOPMENT | 20 | 8.48e-01 | 2.48e-02 | 9.46e-01 |
| GOBP PINOCYTOSIS | 19 | 8.52e-01 | 2.48e-02 | 9.47e-01 |
| GOBP RENAL WATER HOMEOSTASIS | 14 | 8.72e-01 | 2.48e-02 | 9.54e-01 |
| GOBP SUBSTANTIA NIGRA DEVELOPMENT | 35 | 8.00e-01 | 2.47e-02 | 9.27e-01 |
| GOBP REGULATION OF CHOLESTEROL METABOLIC PROCESS | 26 | 8.27e-01 | -2.47e-02 | 9.38e-01 |
| GOBP REGULATION OF SECRETION | 384 | 4.07e-01 | 2.47e-02 | 7.27e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 12 | 8.82e-01 | -2.46e-02 | 9.59e-01 |
| GOBP REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 7 | 9.10e-01 | -2.46e-02 | 9.68e-01 |
| GOBP REGULATION OF ACTIN FILAMENT LENGTH | 117 | 6.46e-01 | -2.46e-02 | 8.64e-01 |
| GOMF SIGNAL SEQUENCE BINDING | 40 | 7.88e-01 | 2.46e-02 | 9.24e-01 |
| GOBP HORMONE METABOLIC PROCESS | 130 | 6.29e-01 | 2.46e-02 | 8.54e-01 |
| GOMF MAP KINASE SCAFFOLD ACTIVITY | 10 | 8.93e-01 | 2.46e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 40 | 7.88e-01 | 2.46e-02 | 9.24e-01 |
| GOBP FAS SIGNALING PATHWAY | 6 | 9.17e-01 | 2.45e-02 | 9.71e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION | 235 | 5.18e-01 | -2.45e-02 | 7.96e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 36 | 7.99e-01 | 2.45e-02 | 9.27e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 23 | 8.39e-01 | -2.45e-02 | 9.43e-01 |
| GOBP REGULATION OF GLIAL CELL DIFFERENTIATION | 44 | 7.79e-01 | 2.45e-02 | 9.21e-01 |
| GOCC PHAGOPHORE ASSEMBLY SITE MEMBRANE | 21 | 8.46e-01 | 2.45e-02 | 9.46e-01 |
| GOCC GERM CELL NUCLEUS | 48 | 7.69e-01 | -2.45e-02 | 9.18e-01 |
| GOBP HIPPOCAMPUS DEVELOPMENT | 60 | 7.44e-01 | -2.44e-02 | 9.08e-01 |
| GOBP PREPULSE INHIBITION | 8 | 9.05e-01 | -2.43e-02 | 9.67e-01 |
| GOBP CELLULAR HOMEOSTASIS | 557 | 3.28e-01 | 2.43e-02 | 6.65e-01 |
| GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 6 | 9.18e-01 | 2.43e-02 | 9.71e-01 |
| GOBP REGULATION OF CELLULAR COMPONENT BIOGENESIS | 784 | 2.51e-01 | -2.43e-02 | 5.85e-01 |
| GOBP REGULATION OF CYTOSKELETON ORGANIZATION | 406 | 4.03e-01 | -2.43e-02 | 7.24e-01 |
| GOBP REGULATION OF PROTEIN POLYMERIZATION | 160 | 5.97e-01 | -2.43e-02 | 8.39e-01 |
| GOBP AUTOPHAGIC CELL DEATH | 9 | 9.00e-01 | 2.42e-02 | 9.65e-01 |
| GOBP EAR DEVELOPMENT | 111 | 6.60e-01 | -2.42e-02 | 8.72e-01 |
| GOCC LARGE RIBOSOMAL SUBUNIT | 112 | 6.59e-01 | 2.42e-02 | 8.71e-01 |
| GOMF DIPHOSPHOTRANSFERASE ACTIVITY | 5 | 9.26e-01 | -2.41e-02 | 9.74e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 15 | 8.71e-01 | 2.41e-02 | 9.54e-01 |
| GOBP CARDIAC CHAMBER MORPHOGENESIS | 73 | 7.23e-01 | -2.40e-02 | 9.01e-01 |
| GOBP POSITIVE REGULATION OF AXONOGENESIS | 55 | 7.58e-01 | -2.40e-02 | 9.14e-01 |
| GOBP POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 7 | 9.13e-01 | -2.40e-02 | 9.69e-01 |
| GOCC TRANS GOLGI NETWORK MEMBRANE | 90 | 6.95e-01 | 2.40e-02 | 8.88e-01 |
| GOMF CALMODULIN BINDING | 143 | 6.21e-01 | -2.40e-02 | 8.50e-01 |
| GOBP NEURON PROJECTION ARBORIZATION | 24 | 8.39e-01 | 2.39e-02 | 9.43e-01 |
| GOCC METHYLOSOME | 12 | 8.86e-01 | -2.39e-02 | 9.59e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 25 | 8.36e-01 | -2.39e-02 | 9.42e-01 |
| GOCC MICROVILLUS | 62 | 7.45e-01 | 2.39e-02 | 9.08e-01 |
| GOBP POSITIVE REGULATION OF ATP METABOLIC PROCESS | 8 | 9.07e-01 | -2.39e-02 | 9.67e-01 |
| GOBP CELLULAR RESPONSE TO COLD | 10 | 8.96e-01 | -2.38e-02 | 9.64e-01 |
| GOBP REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE | 21 | 8.51e-01 | 2.37e-02 | 9.47e-01 |
| GOBP ENTEROENDOCRINE CELL DIFFERENTIATION | 17 | 8.66e-01 | -2.37e-02 | 9.52e-01 |
| GOBP SPINDLE ORGANIZATION | 187 | 5.77e-01 | -2.37e-02 | 8.32e-01 |
| GOBP NEGATIVE REGULATION OF ANOIKIS | 13 | 8.82e-01 | 2.37e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 21 | 8.51e-01 | -2.37e-02 | 9.47e-01 |
| GOCC PRESYNAPSE | 363 | 4.40e-01 | 2.37e-02 | 7.52e-01 |
| GOMF 3 5 DNA EXONUCLEASE ACTIVITY | 13 | 8.83e-01 | 2.36e-02 | 9.59e-01 |
| GOBP REGULATION OF STRIATED MUSCLE CONTRACTION | 63 | 7.46e-01 | 2.36e-02 | 9.08e-01 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 106 | 6.74e-01 | -2.36e-02 | 8.78e-01 |
| GOBP T HELPER 1 TYPE IMMUNE RESPONSE | 36 | 8.06e-01 | -2.36e-02 | 9.31e-01 |
| GOBP REGULATION OF PROTEIN CATABOLIC PROCESS | 310 | 4.76e-01 | 2.36e-02 | 7.75e-01 |
| GOCC CATALYTIC COMPLEX | 1524 | 1.28e-01 | -2.36e-02 | 4.20e-01 |
| GOBP PATTERN SPECIFICATION PROCESS | 237 | 5.32e-01 | -2.36e-02 | 8.05e-01 |
| GOMF GAMMA TUBULIN BINDING | 32 | 8.17e-01 | 2.36e-02 | 9.34e-01 |
| GOBP COMPLEMENT ACTIVATION CLASSICAL PATHWAY | 22 | 8.48e-01 | 2.36e-02 | 9.46e-01 |
| GOBP DNA LIGATION | 16 | 8.71e-01 | -2.35e-02 | 9.53e-01 |
| GOBP VASODILATION | 25 | 8.39e-01 | 2.35e-02 | 9.43e-01 |
| GOBP REGULATION OF PLATELET ACTIVATION | 33 | 8.15e-01 | 2.35e-02 | 9.34e-01 |
| GOCC NUCLEAR ENVELOPE | 421 | 4.10e-01 | -2.35e-02 | 7.29e-01 |
| GOBP SULFUR COMPOUND BIOSYNTHETIC PROCESS | 118 | 6.60e-01 | 2.34e-02 | 8.72e-01 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 55 | 7.64e-01 | 2.34e-02 | 9.17e-01 |
| GOBP ANIMAL ORGAN MORPHOGENESIS | 583 | 3.36e-01 | -2.34e-02 | 6.70e-01 |
| GOBP TISSUE MIGRATION | 217 | 5.52e-01 | -2.34e-02 | 8.19e-01 |
| GOBP SKELETAL MUSCLE CONTRACTION | 28 | 8.30e-01 | 2.34e-02 | 9.40e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 36 | 8.08e-01 | 2.34e-02 | 9.32e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY | 32 | 8.19e-01 | -2.33e-02 | 9.35e-01 |
| GOBP LIPID GLYCOSYLATION | 6 | 9.21e-01 | 2.33e-02 | 9.72e-01 |
| GOBP REGULATION OF LIPID CATABOLIC PROCESS | 41 | 7.96e-01 | -2.33e-02 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF TRANSPORTER ACTIVITY | 66 | 7.44e-01 | -2.32e-02 | 9.08e-01 |
| GOMF EXOGENOUS PROTEIN BINDING | 64 | 7.49e-01 | -2.32e-02 | 9.10e-01 |
| GOBP CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 17 | 8.69e-01 | -2.32e-02 | 9.53e-01 |
| GOBP PURINE CONTAINING COMPOUND SALVAGE | 13 | 8.85e-01 | -2.31e-02 | 9.59e-01 |
| GOCC LYSOSOMAL LUMEN | 74 | 7.31e-01 | -2.31e-02 | 9.04e-01 |
| GOMF NADPLUS PROTEIN ASPARTATE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 9.29e-01 | -2.31e-02 | 9.75e-01 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 25 | 8.42e-01 | 2.31e-02 | 9.44e-01 |
| GOMF PHOSPHOSERINE RESIDUE BINDING | 10 | 8.99e-01 | -2.31e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SUMOYLATION | 11 | 8.95e-01 | -2.31e-02 | 9.63e-01 |
| GOBP MESODERM MORPHOGENESIS | 40 | 8.01e-01 | 2.30e-02 | 9.28e-01 |
| GOBP MONOSACCHARIDE BIOSYNTHETIC PROCESS | 81 | 7.20e-01 | 2.30e-02 | 8.99e-01 |
| GOBP AMYLOID FIBRIL FORMATION | 36 | 8.11e-01 | 2.30e-02 | 9.33e-01 |
| GOBP MICROTUBULE ORGANIZING CENTER ORGANIZATION | 138 | 6.42e-01 | -2.30e-02 | 8.61e-01 |
| GOMF L LEUCINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 9.22e-01 | 2.30e-02 | 9.72e-01 |
| GOBP REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 9 | 9.05e-01 | -2.29e-02 | 9.67e-01 |
| GOCC MITOTIC SPINDLE | 159 | 6.19e-01 | -2.29e-02 | 8.49e-01 |
| GOBP VENTRICULAR COMPACT MYOCARDIUM MORPHOGENESIS | 5 | 9.29e-01 | 2.29e-02 | 9.75e-01 |
| GOBP POSITIVE REGULATION OF TORC1 SIGNALING | 50 | 7.80e-01 | 2.29e-02 | 9.21e-01 |
| GOBP STRESS FIBER ASSEMBLY | 87 | 7.13e-01 | -2.29e-02 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 19 | 8.63e-01 | -2.28e-02 | 9.52e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL PROLIFERATION | 13 | 8.87e-01 | 2.28e-02 | 9.59e-01 |
| GOCC SPERM PLASMA MEMBRANE | 5 | 9.30e-01 | 2.28e-02 | 9.75e-01 |
| GOBP CELL CELL JUNCTION ORGANIZATION | 135 | 6.47e-01 | 2.28e-02 | 8.65e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 51 | 7.79e-01 | -2.27e-02 | 9.21e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN | 19 | 8.64e-01 | -2.27e-02 | 9.52e-01 |
| GOBP RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 7 | 9.17e-01 | -2.26e-02 | 9.71e-01 |
| GOCC MANNOSYLTRANSFERASE COMPLEX | 5 | 9.30e-01 | 2.26e-02 | 9.75e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION | 272 | 5.22e-01 | -2.26e-02 | 7.99e-01 |
| GOBP NUCLEAR ENVELOPE ORGANIZATION | 53 | 7.76e-01 | -2.26e-02 | 9.21e-01 |
| GOCC LAMELLIPODIUM | 173 | 6.09e-01 | 2.26e-02 | 8.46e-01 |
| GOBP TRANS SYNAPTIC SIGNALING BY TRANS SYNAPTIC COMPLEX | 6 | 9.24e-01 | -2.26e-02 | 9.73e-01 |
| GOBP REGULATION OF PROTEIN SUMOYLATION | 20 | 8.61e-01 | 2.26e-02 | 9.51e-01 |
| GOBP LUNG MORPHOGENESIS | 31 | 8.28e-01 | -2.26e-02 | 9.39e-01 |
| GOBP REGULATION OF CELL MORPHOGENESIS | 200 | 5.83e-01 | -2.25e-02 | 8.34e-01 |
| GOBP EXOCYTIC PROCESS | 62 | 7.59e-01 | -2.25e-02 | 9.14e-01 |
| GOMF PHOSPHOLIPASE A1 ACTIVITY | 12 | 8.93e-01 | 2.25e-02 | 9.63e-01 |
| GOBP XENOBIOTIC TRANSPORT | 35 | 8.18e-01 | 2.25e-02 | 9.34e-01 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION | 30 | 8.31e-01 | 2.25e-02 | 9.41e-01 |
| GOBP CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 250 | 5.42e-01 | -2.24e-02 | 8.13e-01 |
| GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 14 | 8.85e-01 | 2.24e-02 | 9.59e-01 |
| GOBP REGULATION OF MYOFIBROBLAST DIFFERENTIATION | 6 | 9.24e-01 | -2.24e-02 | 9.73e-01 |
| GOBP REGULATION OF MICROTUBULE BASED MOVEMENT | 31 | 8.30e-01 | 2.23e-02 | 9.40e-01 |
| GOBP MITOCHONDRIAL DEPOLARIZATION | 19 | 8.67e-01 | -2.22e-02 | 9.52e-01 |
| GOBP NATURAL KILLER CELL MEDIATED IMMUNITY | 48 | 7.90e-01 | 2.22e-02 | 9.24e-01 |
| GOBP GLYCEROL 3 PHOSPHATE METABOLIC PROCESS | 8 | 9.13e-01 | 2.22e-02 | 9.70e-01 |
| GOBP EMBRYONIC HEART TUBE DEVELOPMENT | 52 | 7.82e-01 | -2.22e-02 | 9.22e-01 |
| GOBP OVULATION | 8 | 9.14e-01 | 2.21e-02 | 9.70e-01 |
| GOBP NK T CELL ACTIVATION | 10 | 9.04e-01 | 2.21e-02 | 9.66e-01 |
| GOMF PEPTIDASE ACTIVITY | 377 | 4.63e-01 | -2.21e-02 | 7.65e-01 |
| GOMF LIM DOMAIN BINDING | 5 | 9.32e-01 | -2.20e-02 | 9.77e-01 |
| GOBP REGULATION OF MRNA 3 END PROCESSING | 12 | 8.95e-01 | 2.20e-02 | 9.63e-01 |
| GOBP REGULATION OF MUSCLE TISSUE DEVELOPMENT | 22 | 8.58e-01 | -2.20e-02 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY | 20 | 8.65e-01 | 2.20e-02 | 9.52e-01 |
| GOBP COPULATION | 7 | 9.20e-01 | 2.20e-02 | 9.72e-01 |
| GOBP EXTERNAL ENCAPSULATING STRUCTURE ORGANIZATION | 173 | 6.19e-01 | 2.19e-02 | 8.49e-01 |
| GOMF GROWTH FACTOR BINDING | 81 | 7.33e-01 | -2.19e-02 | 9.04e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 102 | 7.03e-01 | -2.19e-02 | 8.91e-01 |
| GOBP CEREBELLAR CORTEX MORPHOGENESIS | 24 | 8.53e-01 | -2.19e-02 | 9.47e-01 |
| GOCC PHOSPHATASE COMPLEX | 48 | 7.94e-01 | -2.18e-02 | 9.26e-01 |
| GOMF ANDROSTAN 3 ALPHA 17 BETA DIOL DEHYDROGENASE ACTIVITY | 6 | 9.26e-01 | -2.18e-02 | 9.74e-01 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS | 291 | 5.25e-01 | -2.17e-02 | 8.00e-01 |
| GOBP PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 17 | 8.77e-01 | -2.16e-02 | 9.56e-01 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 9.33e-01 | 2.16e-02 | 9.77e-01 |
| GOMF C ACYLTRANSFERASE ACTIVITY | 14 | 8.89e-01 | 2.16e-02 | 9.60e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 32 | 8.33e-01 | 2.16e-02 | 9.41e-01 |
| GOBP OLIGODENDROCYTE DEVELOPMENT | 26 | 8.49e-01 | 2.16e-02 | 9.47e-01 |
| GOMF PHOSPHORIC ESTER HYDROLASE ACTIVITY | 275 | 5.39e-01 | -2.15e-02 | 8.11e-01 |
| GOBP PHOTOTRANSDUCTION | 20 | 8.68e-01 | 2.15e-02 | 9.52e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME | 12 | 8.97e-01 | -2.15e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF HYDROLASE ACTIVITY | 374 | 4.76e-01 | -2.15e-02 | 7.75e-01 |
| GOBP MESONEPHROS DEVELOPMENT | 49 | 7.95e-01 | -2.15e-02 | 9.26e-01 |
| GOBP CELL CELL ADHESION INVOLVED IN GASTRULATION | 10 | 9.06e-01 | 2.15e-02 | 9.67e-01 |
| GOBP INTEGRIN ACTIVATION | 18 | 8.75e-01 | 2.15e-02 | 9.55e-01 |
| GOBP NUCLEOTIDE TRANSPORT | 39 | 8.17e-01 | 2.14e-02 | 9.34e-01 |
| GOCC PLASMA MEMBRANE REGION | 828 | 2.98e-01 | 2.14e-02 | 6.36e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 7 | 9.22e-01 | -2.14e-02 | 9.72e-01 |
| GOBP REGULATION OF MACROPHAGE ACTIVATION | 42 | 8.11e-01 | -2.13e-02 | 9.33e-01 |
| GOBP MUSCLE CONTRACTION | 203 | 6.02e-01 | 2.12e-02 | 8.42e-01 |
| GOBP REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 128 | 6.79e-01 | -2.12e-02 | 8.80e-01 |
| GOCC AZUROPHIL GRANULE | 131 | 6.75e-01 | -2.12e-02 | 8.79e-01 |
| GOBP NEURON CELLULAR HOMEOSTASIS | 44 | 8.08e-01 | 2.12e-02 | 9.32e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 25 | 8.55e-01 | 2.12e-02 | 9.48e-01 |
| GOBP REGULATION OF NOTCH SIGNALING PATHWAY | 69 | 7.62e-01 | 2.11e-02 | 9.15e-01 |
| GOBP NON MEMBRANE BOUNDED ORGANELLE ASSEMBLY | 353 | 4.96e-01 | -2.11e-02 | 7.85e-01 |
| GOCC ER TO GOLGI TRANSPORT VESICLE MEMBRANE | 56 | 7.85e-01 | -2.11e-02 | 9.22e-01 |
| GOMF GTPASE BINDING | 278 | 5.46e-01 | 2.11e-02 | 8.16e-01 |
| GOBP REGULATION OF FERTILIZATION | 6 | 9.29e-01 | 2.11e-02 | 9.75e-01 |
| GOCC CHROMAFFIN GRANULE | 9 | 9.13e-01 | -2.10e-02 | 9.70e-01 |
| GOBP PROTEOLYSIS | 1237 | 2.18e-01 | -2.10e-02 | 5.45e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 31 | 8.40e-01 | -2.10e-02 | 9.43e-01 |
| GOBP OOCYTE MATURATION | 17 | 8.81e-01 | -2.10e-02 | 9.58e-01 |
| GOMF NAD DEPENDENT PROTEIN DEACETYLASE ACTIVITY | 7 | 9.24e-01 | -2.10e-02 | 9.73e-01 |
| GOBP LYMPHOCYTE APOPTOTIC PROCESS | 65 | 7.70e-01 | -2.09e-02 | 9.19e-01 |
| GOBP SYMPATHETIC GANGLION DEVELOPMENT | 6 | 9.29e-01 | 2.09e-02 | 9.75e-01 |
| GOBP ODONTOGENESIS OF DENTIN CONTAINING TOOTH | 43 | 8.12e-01 | 2.09e-02 | 9.33e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 101 | 7.17e-01 | -2.09e-02 | 8.97e-01 |
| GOBP MEMBRANE FISSION | 41 | 8.17e-01 | -2.09e-02 | 9.34e-01 |
| GOBP HEART TRABECULA MORPHOGENESIS | 22 | 8.65e-01 | 2.09e-02 | 9.52e-01 |
| GOCC PRESYNAPTIC MEMBRANE | 90 | 7.32e-01 | -2.09e-02 | 9.04e-01 |
| GOBP MEMORY | 68 | 7.66e-01 | -2.09e-02 | 9.17e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BASED PROCESS | 281 | 5.49e-01 | -2.08e-02 | 8.18e-01 |
| GOCC INNER KINETOCHORE | 17 | 8.82e-01 | 2.08e-02 | 9.59e-01 |
| GOBP NEURON MIGRATION | 109 | 7.08e-01 | -2.08e-02 | 8.94e-01 |
| GOBP OXIDATIVE RNA DEMETHYLATION | 5 | 9.36e-01 | -2.08e-02 | 9.78e-01 |
| GOMF OXIDATIVE RNA DEMETHYLASE ACTIVITY | 5 | 9.36e-01 | -2.08e-02 | 9.78e-01 |
| GOMF DEATH RECEPTOR ACTIVITY | 10 | 9.09e-01 | 2.08e-02 | 9.68e-01 |
| GOMF PHOSPHATIDYLINOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 8 | 9.19e-01 | 2.07e-02 | 9.71e-01 |
| GOBP WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE | 8 | 9.19e-01 | -2.07e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 50 | 8.00e-01 | -2.07e-02 | 9.27e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSPORT | 58 | 7.85e-01 | 2.07e-02 | 9.22e-01 |
| GOBP COLLATERAL SPROUTING | 16 | 8.86e-01 | -2.07e-02 | 9.59e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION | 47 | 8.06e-01 | 2.07e-02 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF CELL SIZE | 9 | 9.15e-01 | 2.06e-02 | 9.70e-01 |
| GOBP MEMBRANE DEPOLARIZATION | 47 | 8.07e-01 | 2.06e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF MYELINATION | 13 | 8.98e-01 | -2.06e-02 | 9.64e-01 |
| GOBP TRANSLATIONAL READTHROUGH | 8 | 9.20e-01 | -2.05e-02 | 9.72e-01 |
| GOBP PROTEIN LIPID COMPLEX ORGANIZATION | 35 | 8.34e-01 | -2.05e-02 | 9.41e-01 |
| GOBP KERATINOCYTE PROLIFERATION | 34 | 8.36e-01 | -2.05e-02 | 9.42e-01 |
| GOBP REGULATION OF VASCULAR PERMEABILITY | 33 | 8.39e-01 | -2.04e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 30 | 8.47e-01 | -2.04e-02 | 9.46e-01 |
| GOBP PROTEIN AUTOUBIQUITINATION | 60 | 7.85e-01 | 2.04e-02 | 9.22e-01 |
| GOBP ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 758 | 3.43e-01 | -2.04e-02 | 6.79e-01 |
| GOBP REGULATION OF CELL SIZE | 141 | 6.78e-01 | -2.03e-02 | 8.79e-01 |
| GOCC ANCHORING JUNCTION | 672 | 3.72e-01 | -2.03e-02 | 7.00e-01 |
| GOBP GASTRULATION | 123 | 6.98e-01 | -2.03e-02 | 8.89e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 5 | 9.37e-01 | -2.03e-02 | 9.79e-01 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL MATRIX ADHESION | 10 | 9.12e-01 | -2.03e-02 | 9.69e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY | 63 | 7.81e-01 | -2.02e-02 | 9.22e-01 |
| GOMF SPLICING FACTOR BINDING | 5 | 9.38e-01 | 2.02e-02 | 9.79e-01 |
| GOBP IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY | 17 | 8.85e-01 | -2.02e-02 | 9.59e-01 |
| GOBP CYTOSKELETON DEPENDENT CYTOKINESIS | 106 | 7.20e-01 | -2.02e-02 | 8.99e-01 |
| GOBP MITOCHONDRION DISTRIBUTION | 14 | 8.96e-01 | -2.02e-02 | 9.64e-01 |
| GOCC SAGA COMPLEX | 23 | 8.67e-01 | -2.02e-02 | 9.52e-01 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 11 | 9.08e-01 | -2.01e-02 | 9.68e-01 |
| GOBP TUBULIN DEACETYLATION | 20 | 8.76e-01 | -2.01e-02 | 9.56e-01 |
| GOBP REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 23 | 8.68e-01 | -2.00e-02 | 9.52e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 24 | 8.65e-01 | 2.00e-02 | 9.52e-01 |
| GOCC PLASMA MEMBRANE RAFT | 75 | 7.65e-01 | 2.00e-02 | 9.17e-01 |
| GOBP EXPORT FROM CELL | 586 | 4.10e-01 | 2.00e-02 | 7.29e-01 |
| GOBP PANCREATIC JUICE SECRETION | 5 | 9.38e-01 | -2.00e-02 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 6 | 9.33e-01 | -2.00e-02 | 9.77e-01 |
| GOBP ORGANELLE LOCALIZATION | 518 | 4.39e-01 | 1.99e-02 | 7.52e-01 |
| GOBP ESTABLISHMENT OF ORGANELLE LOCALIZATION | 402 | 4.95e-01 | -1.99e-02 | 7.85e-01 |
| GOMF 5S RRNA BINDING | 9 | 9.18e-01 | -1.99e-02 | 9.71e-01 |
| GOBP HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 48 | 8.12e-01 | -1.99e-02 | 9.33e-01 |
| GOMF CARBOXYPEPTIDASE ACTIVITY | 26 | 8.61e-01 | -1.99e-02 | 9.51e-01 |
| GOCC SUPRAMOLECULAR COMPLEX | 966 | 2.99e-01 | -1.99e-02 | 6.37e-01 |
| GOCC PERIKARYON | 85 | 7.52e-01 | 1.99e-02 | 9.11e-01 |
| GOMF GLUCURONOSYL N ACETYLGALACTOSAMINYL PROTEOGLYCAN 4 BETA N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 6 | 9.33e-01 | 1.98e-02 | 9.77e-01 |
| GOBP REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 75 | 7.67e-01 | -1.98e-02 | 9.17e-01 |
| GOCC PRP19 COMPLEX | 12 | 9.05e-01 | 1.98e-02 | 9.67e-01 |
| GOBP POSITIVE REGULATION OF CATALYTIC ACTIVITY | 698 | 3.75e-01 | -1.98e-02 | 7.03e-01 |
| GOCC SMN COMPLEX | 10 | 9.14e-01 | 1.98e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 5 | 9.39e-01 | -1.97e-02 | 9.79e-01 |
| GOBP CATECHOL CONTAINING COMPOUND METABOLIC PROCESS | 30 | 8.52e-01 | 1.97e-02 | 9.47e-01 |
| GOBP C21 STEROID HORMONE BIOSYNTHETIC PROCESS | 10 | 9.14e-01 | 1.97e-02 | 9.70e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING TENSILE STRENGTH | 21 | 8.76e-01 | -1.97e-02 | 9.56e-01 |
| GOMF PALMITOYLTRANSFERASE ACTIVITY | 32 | 8.48e-01 | -1.96e-02 | 9.46e-01 |
| GOBP RESPONSE TO INTERLEUKIN 7 | 14 | 8.99e-01 | 1.96e-02 | 9.64e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 PHOSPHATE BINDING | 41 | 8.28e-01 | -1.96e-02 | 9.39e-01 |
| GOBP SPHINGOMYELIN METABOLIC PROCESS | 16 | 8.93e-01 | -1.95e-02 | 9.63e-01 |
| GOBP CELLULAR RESPONSE TO HEAT | 54 | 8.05e-01 | -1.95e-02 | 9.31e-01 |
| GOBP REGULATION OF PROTEIN OLIGOMERIZATION | 5 | 9.40e-01 | -1.95e-02 | 9.79e-01 |
| GOMF PYRIMIDINE NUCLEOTIDE BINDING | 6 | 9.34e-01 | 1.94e-02 | 9.77e-01 |
| GOCC CENTRIOLE | 138 | 6.94e-01 | 1.94e-02 | 8.88e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE MIGRATION | 10 | 9.16e-01 | 1.94e-02 | 9.70e-01 |
| GOBP AMINO ACID TRANSMEMBRANE TRANSPORT | 64 | 7.89e-01 | -1.94e-02 | 9.24e-01 |
| GOBP CYCLIC NUCLEOTIDE MEDIATED SIGNALING | 43 | 8.26e-01 | -1.94e-02 | 9.38e-01 |
| GOMF HORMONE RECEPTOR BINDING | 11 | 9.12e-01 | -1.93e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF DEPHOSPHORYLATION | 43 | 8.27e-01 | -1.93e-02 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 10 | 9.16e-01 | 1.93e-02 | 9.71e-01 |
| GOCC COLLAGEN TRIMER | 40 | 8.34e-01 | -1.92e-02 | 9.41e-01 |
| GOBP NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 14 | 9.01e-01 | -1.92e-02 | 9.65e-01 |
| GOBP MESENCHYMAL TO EPITHELIAL TRANSITION | 10 | 9.17e-01 | -1.91e-02 | 9.71e-01 |
| GOBP REGULATION OF HIPPO SIGNALING | 22 | 8.77e-01 | -1.91e-02 | 9.56e-01 |
| GOCC GLYCOPROTEIN COMPLEX | 15 | 8.98e-01 | -1.91e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF LIPID LOCALIZATION | 32 | 8.52e-01 | 1.91e-02 | 9.47e-01 |
| GOBP CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 54 | 8.09e-01 | -1.91e-02 | 9.32e-01 |
| GOBP NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 182 | 6.58e-01 | -1.90e-02 | 8.71e-01 |
| GOBP TISSUE REMODELING | 111 | 7.29e-01 | 1.90e-02 | 9.03e-01 |
| GOMF ACTIN BINDING | 328 | 5.55e-01 | 1.90e-02 | 8.20e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 64 | 7.93e-01 | -1.90e-02 | 9.25e-01 |
| GOBP CORTICAL CYTOSKELETON ORGANIZATION | 47 | 8.22e-01 | 1.90e-02 | 9.36e-01 |
| GOBP REGULATION OF MITOTIC NUCLEAR DIVISION | 97 | 7.47e-01 | -1.90e-02 | 9.09e-01 |
| GOBP REGULATION OF AXON EXTENSION | 67 | 7.90e-01 | 1.89e-02 | 9.24e-01 |
| GOBP MYELOID LEUKOCYTE CYTOKINE PRODUCTION | 43 | 8.31e-01 | -1.88e-02 | 9.41e-01 |
| GOBP REGULATION OF CENTROSOME CYCLE | 50 | 8.18e-01 | 1.88e-02 | 9.34e-01 |
| GOBP REGULATION OF METALLOPEPTIDASE ACTIVITY | 12 | 9.10e-01 | -1.88e-02 | 9.68e-01 |
| GOBP REGULATION OF CELL GROWTH | 296 | 5.80e-01 | -1.87e-02 | 8.32e-01 |
| GOBP POSITIVE REGULATION OF KINASE ACTIVITY | 242 | 6.16e-01 | -1.87e-02 | 8.48e-01 |
| GOCC EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 49 | 8.21e-01 | -1.87e-02 | 9.36e-01 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 3 PHOSPHOMONOESTERS | 16 | 8.97e-01 | 1.87e-02 | 9.64e-01 |
| GOBP RENAL SYSTEM VASCULATURE DEVELOPMENT | 19 | 8.88e-01 | 1.87e-02 | 9.60e-01 |
| GOBP NEUROMUSCULAR PROCESS | 99 | 7.49e-01 | 1.87e-02 | 9.10e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY | 23 | 8.77e-01 | -1.87e-02 | 9.56e-01 |
| GOBP SPINDLE LOCALIZATION | 50 | 8.20e-01 | -1.87e-02 | 9.35e-01 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS | 10 | 9.19e-01 | -1.86e-02 | 9.71e-01 |
| GOBP RESPONSE TO INTERLEUKIN 1 | 91 | 7.59e-01 | 1.86e-02 | 9.14e-01 |
| GOCC AZUROPHIL GRANULE LUMEN | 73 | 7.84e-01 | -1.86e-02 | 9.22e-01 |
| GOBP POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY | 32 | 8.56e-01 | -1.86e-02 | 9.48e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT | 27 | 8.67e-01 | -1.86e-02 | 9.52e-01 |
| GOCC GLUTAMATERGIC SYNAPSE | 282 | 5.93e-01 | -1.85e-02 | 8.38e-01 |
| GOBP TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION | 9 | 9.23e-01 | -1.85e-02 | 9.73e-01 |
| GOMF WNT RECEPTOR ACTIVITY | 14 | 9.05e-01 | 1.85e-02 | 9.67e-01 |
| GOBP REGULATION OF LONG TERM SYNAPTIC DEPRESSION | 11 | 9.15e-01 | 1.85e-02 | 9.70e-01 |
| GOBP REGULATION OF HOMOTYPIC CELL CELL ADHESION | 23 | 8.78e-01 | 1.85e-02 | 9.56e-01 |
| GOMF POLY ADP D RIBOSE BINDING | 6 | 9.37e-01 | -1.85e-02 | 9.79e-01 |
| GOMF 4 IRON 4 SULFUR CLUSTER BINDING | 42 | 8.36e-01 | -1.85e-02 | 9.42e-01 |
| GOBP REGULATION OF TRANSMEMBRANE TRANSPORT | 335 | 5.63e-01 | -1.84e-02 | 8.26e-01 |
| GOBP ADHESION OF SYMBIONT TO HOST | 8 | 9.28e-01 | -1.84e-02 | 9.75e-01 |
| GOBP ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE | 21 | 8.84e-01 | 1.84e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 38 | 8.45e-01 | -1.83e-02 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 28 | 8.67e-01 | 1.83e-02 | 9.52e-01 |
| GOBP EARLY ENDOSOME TO GOLGI TRANSPORT | 12 | 9.13e-01 | 1.83e-02 | 9.69e-01 |
| GOMF PHOSPHOLIPASE ACTIVITY | 68 | 7.94e-01 | 1.83e-02 | 9.26e-01 |
| GOMF LEUCINE ZIPPER DOMAIN BINDING | 9 | 9.24e-01 | -1.83e-02 | 9.73e-01 |
| GOBP CELL SUBSTRATE ADHESION | 247 | 6.23e-01 | 1.82e-02 | 8.51e-01 |
| GOBP LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR | 8 | 9.29e-01 | -1.82e-02 | 9.75e-01 |
| GOBP SPHINGOLIPID CATABOLIC PROCESS | 21 | 8.86e-01 | -1.80e-02 | 9.59e-01 |
| GOCC PHAGOCYTIC VESICLE MEMBRANE | 75 | 7.87e-01 | 1.80e-02 | 9.24e-01 |
| GOBP RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM | 26 | 8.74e-01 | 1.80e-02 | 9.55e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 121 | 7.35e-01 | -1.78e-02 | 9.04e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL PERIPHERY | 279 | 6.09e-01 | 1.78e-02 | 8.46e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT | 215 | 6.55e-01 | -1.77e-02 | 8.69e-01 |
| GOCC SM LIKE PROTEIN FAMILY COMPLEX | 85 | 7.78e-01 | 1.77e-02 | 9.21e-01 |
| GOBP RUFFLE ASSEMBLY | 39 | 8.48e-01 | -1.77e-02 | 9.46e-01 |
| GOCC EXTERNAL ENCAPSULATING STRUCTURE | 237 | 6.39e-01 | -1.77e-02 | 8.59e-01 |
| GOCC EXTRINSIC COMPONENT OF PLASMA MEMBRANE | 77 | 7.88e-01 | -1.77e-02 | 9.24e-01 |
| GOBP SPERMATID DIFFERENTIATION | 119 | 7.39e-01 | -1.77e-02 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF LIPID METABOLIC PROCESS | 94 | 7.68e-01 | 1.76e-02 | 9.18e-01 |
| GOBP REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 15 | 9.06e-01 | 1.76e-02 | 9.67e-01 |
| GOBP RIBONUCLEOPROTEIN COMPLEX BIOGENESIS | 452 | 5.22e-01 | -1.76e-02 | 7.99e-01 |
| GOMF FMN BINDING | 9 | 9.27e-01 | -1.76e-02 | 9.74e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT SUCCINATE TO UBIQUINONE | 5 | 9.46e-01 | -1.76e-02 | 9.81e-01 |
| GOBP CELLULAR RESPONSE TO DECREASED OXYGEN LEVELS | 108 | 7.53e-01 | -1.75e-02 | 9.12e-01 |
| GOBP ADULT BEHAVIOR | 83 | 7.83e-01 | -1.75e-02 | 9.22e-01 |
| GOMF PROTEIN DIMERIZATION ACTIVITY | 729 | 4.23e-01 | 1.75e-02 | 7.41e-01 |
| GOBP EXTRACELLULAR EXOSOME ASSEMBLY | 6 | 9.41e-01 | -1.75e-02 | 9.79e-01 |
| GOBP ACETYL COA METABOLIC PROCESS | 29 | 8.71e-01 | -1.74e-02 | 9.54e-01 |
| GOBP SMOOTH MUSCLE CELL DIFFERENTIATION | 36 | 8.57e-01 | 1.74e-02 | 9.49e-01 |
| GOBP T CELL MEDIATED CYTOTOXICITY | 43 | 8.44e-01 | -1.73e-02 | 9.45e-01 |
| GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 8 | 9.33e-01 | -1.73e-02 | 9.77e-01 |
| GOBP NUCLEOSIDE METABOLIC PROCESS | 46 | 8.39e-01 | -1.73e-02 | 9.43e-01 |
| GOBP REGULATION OF MONOATOMIC ION TRANSPORT | 320 | 5.98e-01 | -1.72e-02 | 8.40e-01 |
| GOBP MACROAUTOPHAGY | 311 | 6.03e-01 | 1.72e-02 | 8.42e-01 |
| GOBP N TERMINAL PROTEIN AMINO ACID ACETYLATION | 15 | 9.08e-01 | -1.72e-02 | 9.68e-01 |
| GOBP PHARYNGEAL ARCH ARTERY MORPHOGENESIS | 5 | 9.47e-01 | 1.72e-02 | 9.82e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PLANAR POLARITY | 39 | 8.53e-01 | 1.71e-02 | 9.47e-01 |
| GOBP ACTIVATION INDUCED CELL DEATH OF T CELLS | 8 | 9.33e-01 | 1.71e-02 | 9.77e-01 |
| GOBP ENDOCHONDRAL BONE MORPHOGENESIS | 33 | 8.65e-01 | -1.71e-02 | 9.52e-01 |
| GOCC ROUGH ENDOPLASMIC RETICULUM | 48 | 8.38e-01 | -1.71e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 17 | 9.03e-01 | -1.71e-02 | 9.66e-01 |
| GOBP ORGANOPHOSPHATE ESTER TRANSPORT | 121 | 7.46e-01 | 1.71e-02 | 9.08e-01 |
| GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 12 | 9.19e-01 | 1.71e-02 | 9.71e-01 |
| GOBP MAINTENANCE OF LOCATION IN CELL | 174 | 6.99e-01 | -1.70e-02 | 8.89e-01 |
| GOCC G PROTEIN COUPLED RECEPTOR DIMERIC COMPLEX | 6 | 9.43e-01 | -1.70e-02 | 9.80e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES | 656 | 4.60e-01 | 1.70e-02 | 7.64e-01 |
| GOCC MEMBRANE MICRODOMAIN | 208 | 6.74e-01 | -1.70e-02 | 8.78e-01 |
| GOBP APOPTOTIC PROCESS | 1420 | 2.90e-01 | -1.69e-02 | 6.29e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEOLUS | 17 | 9.04e-01 | 1.69e-02 | 9.66e-01 |
| GOBP NEGATIVE REGULATION OF CELL MATRIX ADHESION | 26 | 8.82e-01 | 1.68e-02 | 9.59e-01 |
| GOCC POSTSYNAPTIC ENDOSOME | 11 | 9.23e-01 | -1.68e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 18 PRODUCTION | 6 | 9.43e-01 | 1.68e-02 | 9.80e-01 |
| GOCC GOLGI APPARATUS | 1247 | 3.24e-01 | 1.68e-02 | 6.62e-01 |
| GOCC VESICLE LUMEN | 258 | 6.44e-01 | -1.68e-02 | 8.62e-01 |
| GOBP MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION | 14 | 9.14e-01 | 1.67e-02 | 9.70e-01 |
| GOBP CELLULAR RESPONSE TO IONIZING RADIATION | 60 | 8.23e-01 | -1.67e-02 | 9.36e-01 |
| GOBP INDUCTION OF POSITIVE CHEMOTAXIS | 8 | 9.35e-01 | -1.67e-02 | 9.77e-01 |
| GOBP CELL DIVISION | 543 | 5.06e-01 | -1.67e-02 | 7.90e-01 |
| GOBP ENERGY RESERVE METABOLIC PROCESS | 62 | 8.20e-01 | -1.67e-02 | 9.35e-01 |
| GOCC SECRETORY VESICLE | 751 | 4.41e-01 | -1.66e-02 | 7.52e-01 |
| GOBP REGULATION OF NMDA RECEPTOR ACTIVITY | 10 | 9.28e-01 | 1.66e-02 | 9.75e-01 |
| GOBP CELL CELL JUNCTION MAINTENANCE | 12 | 9.21e-01 | -1.66e-02 | 9.72e-01 |
| GOMF QUATERNARY AMMONIUM GROUP BINDING | 28 | 8.80e-01 | 1.65e-02 | 9.58e-01 |
| GOBP SULFUR COMPOUND TRANSPORT | 43 | 8.52e-01 | 1.65e-02 | 9.47e-01 |
| GOCC COLLAGEN CONTAINING EXTRACELLULAR MATRIX | 193 | 6.93e-01 | -1.65e-02 | 8.88e-01 |
| GOBP NEURAL CREST CELL DIFFERENTIATION | 56 | 8.31e-01 | 1.65e-02 | 9.41e-01 |
| GOBP CONNECTIVE TISSUE DEVELOPMENT | 168 | 7.13e-01 | -1.65e-02 | 8.96e-01 |
| GOBP CARBOHYDRATE METABOLIC PROCESS | 426 | 5.62e-01 | 1.64e-02 | 8.26e-01 |
| GOBP BEHAVIOR | 373 | 5.87e-01 | -1.64e-02 | 8.35e-01 |
| GOCC DISTAL AXON | 188 | 6.98e-01 | 1.64e-02 | 8.89e-01 |
| GOBP GLYCOLYTIC PROCESS THROUGH GLUCOSE 6 PHOSPHATE | 17 | 9.07e-01 | -1.64e-02 | 9.67e-01 |
| GOBP RESPONSE TO AMINO ACID STARVATION | 50 | 8.41e-01 | -1.64e-02 | 9.44e-01 |
| GOMF DIACYLGLYCEROL BINDING | 10 | 9.29e-01 | 1.64e-02 | 9.75e-01 |
| GOBP RESPONSE TO ISOQUINOLINE ALKALOID | 8 | 9.36e-01 | 1.64e-02 | 9.78e-01 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED CELL DEATH | 634 | 4.85e-01 | -1.63e-02 | 7.81e-01 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 124 | 7.54e-01 | -1.63e-02 | 9.12e-01 |
| GOCC PROTEASOME CORE COMPLEX BETA SUBUNIT COMPLEX | 10 | 9.30e-01 | 1.61e-02 | 9.75e-01 |
| GOMF PHOSPHOFRUCTOKINASE ACTIVITY | 7 | 9.41e-01 | 1.61e-02 | 9.79e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN CATABOLIC PROCESS | 9 | 9.33e-01 | 1.61e-02 | 9.77e-01 |
| GOBP PRIMARY ALCOHOL METABOLIC PROCESS | 56 | 8.35e-01 | -1.61e-02 | 9.41e-01 |
| GOCC CILIARY BASAL BODY | 141 | 7.41e-01 | 1.61e-02 | 9.06e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION | 9 | 9.33e-01 | -1.61e-02 | 9.77e-01 |
| GOCC MICROTUBULE CYTOSKELETON | 1141 | 3.64e-01 | 1.61e-02 | 6.97e-01 |
| GOBP POSITIVE REGULATION OF CENTRIOLE ELONGATION | 5 | 9.50e-01 | -1.61e-02 | 9.83e-01 |
| GOBP ICOSANOID BIOSYNTHETIC PROCESS | 35 | 8.70e-01 | -1.60e-02 | 9.53e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 48 | 8.48e-01 | 1.60e-02 | 9.46e-01 |
| GOCC FILOPODIUM MEMBRANE | 15 | 9.14e-01 | 1.60e-02 | 9.70e-01 |
| GOBP REGULATION OF LIPID METABOLIC PROCESS | 228 | 6.77e-01 | 1.60e-02 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 168 | 7.22e-01 | 1.59e-02 | 9.00e-01 |
| GOBP WYBUTOSINE METABOLIC PROCESS | 6 | 9.46e-01 | -1.59e-02 | 9.81e-01 |
| GOBP NEUROBLAST PROLIFERATION | 39 | 8.64e-01 | 1.58e-02 | 9.52e-01 |
| GOCC CELL DIVISION SITE | 64 | 8.27e-01 | 1.58e-02 | 9.38e-01 |
| GOCC NUCLEAR PORE | 86 | 8.01e-01 | -1.57e-02 | 9.28e-01 |
| GOBP MESENCHYMAL CELL PROLIFERATION | 23 | 8.96e-01 | -1.57e-02 | 9.64e-01 |
| GOMF POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 54 | 8.42e-01 | 1.56e-02 | 9.44e-01 |
| GOBP MATING BEHAVIOR | 15 | 9.16e-01 | -1.56e-02 | 9.71e-01 |
| GOBP PLASMA MEMBRANE RAFT ASSEMBLY | 5 | 9.52e-01 | 1.56e-02 | 9.84e-01 |
| GOBP HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION | 6 | 9.47e-01 | -1.56e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF CATION CHANNEL ACTIVITY | 34 | 8.75e-01 | 1.56e-02 | 9.55e-01 |
| GOBP ACTIN FILAMENT BASED PROCESS | 589 | 5.20e-01 | -1.56e-02 | 7.98e-01 |
| GOCC MITOTIC SPINDLE MIDZONE | 11 | 9.29e-01 | 1.55e-02 | 9.75e-01 |
| GOBP DEVELOPMENTAL MATURATION | 202 | 7.06e-01 | 1.54e-02 | 8.93e-01 |
| GOBP REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 22 | 9.00e-01 | 1.54e-02 | 9.65e-01 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS | 63 | 8.33e-01 | -1.54e-02 | 9.41e-01 |
| GOMF SMALL MOLECULE SENSOR ACTIVITY | 32 | 8.80e-01 | 1.54e-02 | 9.58e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON SINGLE DONORS WITH INCORPORATION OF MOLECULAR OXYGEN | 15 | 9.18e-01 | -1.54e-02 | 9.71e-01 |
| GOBP CELLULAR COMPONENT MORPHOGENESIS | 513 | 5.53e-01 | -1.54e-02 | 8.19e-01 |
| GOMF CLATHRIN BINDING | 52 | 8.48e-01 | 1.54e-02 | 9.46e-01 |
| GOBP EPITHELIAL CELL DEVELOPMENT | 142 | 7.52e-01 | 1.54e-02 | 9.11e-01 |
| GOBP REGULATION OF COAGULATION | 44 | 8.60e-01 | -1.53e-02 | 9.50e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 35 | 8.75e-01 | -1.53e-02 | 9.55e-01 |
| GOBP HYDROGEN PEROXIDE METABOLIC PROCESS | 31 | 8.83e-01 | 1.53e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF NEUROBLAST PROLIFERATION | 14 | 9.21e-01 | 1.53e-02 | 9.72e-01 |
| GOBP REGULATION OF MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 191 | 7.16e-01 | -1.53e-02 | 8.97e-01 |
| GOMF POTASSIUM CHANNEL ACTIVITY | 47 | 8.56e-01 | 1.53e-02 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION | 14 | 9.21e-01 | 1.52e-02 | 9.72e-01 |
| GOMF LIPASE ACTIVITY | 81 | 8.13e-01 | 1.52e-02 | 9.34e-01 |
| GOBP REGULATION OF COLLATERAL SPROUTING | 10 | 9.34e-01 | 1.52e-02 | 9.77e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 15 | 9.19e-01 | 1.52e-02 | 9.71e-01 |
| GOBP CELLULAR CATABOLIC PROCESS | 1270 | 3.67e-01 | -1.52e-02 | 6.98e-01 |
| GOMF GAP JUNCTION CHANNEL ACTIVITY | 6 | 9.49e-01 | 1.52e-02 | 9.83e-01 |
| GOBP REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 206 | 7.07e-01 | -1.52e-02 | 8.94e-01 |
| GOMF GLUTAMATE RECEPTOR ACTIVITY | 14 | 9.22e-01 | -1.52e-02 | 9.72e-01 |
| GOBP TEMPERATURE HOMEOSTASIS | 129 | 7.66e-01 | -1.52e-02 | 9.17e-01 |
| GOBP CHOLESTEROL EFFLUX | 40 | 8.68e-01 | -1.52e-02 | 9.52e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDES | 54 | 8.47e-01 | -1.52e-02 | 9.46e-01 |
| GOBP MATERNAL PLACENTA DEVELOPMENT | 25 | 8.96e-01 | -1.51e-02 | 9.64e-01 |
| GOBP VESICLE COATING | 38 | 8.72e-01 | -1.51e-02 | 9.54e-01 |
| GOMF PHOSPHATIDYLINOSITOL BISPHOSPHATE BINDING | 83 | 8.12e-01 | -1.51e-02 | 9.33e-01 |
| GOBP NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT | 11 | 9.31e-01 | -1.51e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY | 49 | 8.55e-01 | -1.50e-02 | 9.48e-01 |
| GOBP REGULATED EXOCYTOSIS | 156 | 7.47e-01 | -1.50e-02 | 9.09e-01 |
| GOBP REGULATION OF BONE REMODELING | 34 | 8.80e-01 | -1.50e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 21 | 9.05e-01 | 1.50e-02 | 9.67e-01 |
| GOBP PHOSPHOLIPID TRANSPORT | 79 | 8.19e-01 | -1.49e-02 | 9.35e-01 |
| GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 6 | 9.50e-01 | -1.49e-02 | 9.83e-01 |
| GOBP REGULATION OF PROTEIN K48 LINKED UBIQUITINATION | 6 | 9.50e-01 | 1.49e-02 | 9.83e-01 |
| GOBP SKELETAL MUSCLE ORGAN DEVELOPMENT | 110 | 7.88e-01 | -1.49e-02 | 9.24e-01 |
| GOCC MICROTUBULE ORGANIZING CENTER | 733 | 4.96e-01 | -1.49e-02 | 7.85e-01 |
| GOBP HEMOSTASIS | 152 | 7.53e-01 | -1.48e-02 | 9.12e-01 |
| GOCC ESCRT COMPLEX | 26 | 8.96e-01 | 1.48e-02 | 9.64e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 20 | 9.09e-01 | -1.48e-02 | 9.68e-01 |
| GOBP TROPHOBLAST CELL MIGRATION | 11 | 9.32e-01 | -1.48e-02 | 9.77e-01 |
| GOCC MEMBRANE COAT | 87 | 8.12e-01 | 1.48e-02 | 9.33e-01 |
| GOBP OLFACTORY LOBE DEVELOPMENT | 24 | 9.01e-01 | 1.47e-02 | 9.65e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS | 88 | 8.11e-01 | 1.47e-02 | 9.33e-01 |
| GOBP DENDRITIC CELL MIGRATION | 26 | 8.97e-01 | 1.47e-02 | 9.64e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 33 | 8.84e-01 | -1.47e-02 | 9.59e-01 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS | 39 | 8.74e-01 | 1.47e-02 | 9.55e-01 |
| GOMF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 9 | 9.39e-01 | -1.46e-02 | 9.79e-01 |
| GOBP AORTIC VALVE MORPHOGENESIS | 18 | 9.15e-01 | -1.46e-02 | 9.70e-01 |
| GOBP LENS FIBER CELL DEVELOPMENT | 8 | 9.43e-01 | 1.46e-02 | 9.80e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 180 | 7.36e-01 | 1.46e-02 | 9.05e-01 |
| GOMF NMDA GLUTAMATE RECEPTOR ACTIVITY | 6 | 9.51e-01 | -1.45e-02 | 9.84e-01 |
| GOBP ACTIN FILAMENT BASED MOVEMENT | 89 | 8.13e-01 | 1.45e-02 | 9.34e-01 |
| GOBP REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 24 | 9.02e-01 | -1.45e-02 | 9.66e-01 |
| GOBP NEGATIVE REGULATION OF HYDROLASE ACTIVITY | 132 | 7.75e-01 | -1.44e-02 | 9.21e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 6 | 9.51e-01 | -1.44e-02 | 9.84e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 52 | 8.58e-01 | -1.44e-02 | 9.49e-01 |
| GOBP PROTEIN EXPORT FROM NUCLEUS | 57 | 8.51e-01 | -1.44e-02 | 9.47e-01 |
| GOBP COBALAMIN METABOLIC PROCESS | 8 | 9.44e-01 | 1.43e-02 | 9.80e-01 |
| GOBP SURFACTANT HOMEOSTASIS | 10 | 9.37e-01 | 1.43e-02 | 9.79e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 16 | 9.21e-01 | -1.43e-02 | 9.72e-01 |
| GOBP CARBOHYDRATE PHOSPHORYLATION | 21 | 9.10e-01 | 1.43e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS | 44 | 8.70e-01 | -1.43e-02 | 9.53e-01 |
| GOBP FERROPTOSIS | 5 | 9.56e-01 | 1.43e-02 | 9.85e-01 |
| GOMF PEPTIDE RECEPTOR ACTIVITY | 35 | 8.84e-01 | -1.43e-02 | 9.59e-01 |
| GOBP REGULATION OF HORMONE SECRETION | 143 | 7.68e-01 | 1.43e-02 | 9.18e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 23 | 9.06e-01 | 1.42e-02 | 9.67e-01 |
| GOBP CENTRIOLE ELONGATION | 8 | 9.44e-01 | 1.42e-02 | 9.80e-01 |
| GOBP INTERLEUKIN 18 PRODUCTION | 10 | 9.38e-01 | -1.42e-02 | 9.79e-01 |
| GOBP REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY | 112 | 7.95e-01 | 1.42e-02 | 9.26e-01 |
| GOBP EXOCRINE SYSTEM DEVELOPMENT | 25 | 9.02e-01 | 1.42e-02 | 9.66e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX SUBSTRATE RELEASE | 5 | 9.57e-01 | -1.41e-02 | 9.85e-01 |
| GOBP CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS | 11 | 9.36e-01 | 1.41e-02 | 9.78e-01 |
| GOBP GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS | 21 | 9.11e-01 | -1.41e-02 | 9.69e-01 |
| GOBP HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS | 10 | 9.39e-01 | 1.41e-02 | 9.79e-01 |
| GOBP EAR MORPHOGENESIS | 54 | 8.58e-01 | -1.40e-02 | 9.50e-01 |
| GOBP CALCITONIN FAMILY RECEPTOR SIGNALING PATHWAY | 6 | 9.53e-01 | -1.40e-02 | 9.84e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS | 71 | 8.38e-01 | 1.40e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF VESICLE FUSION | 6 | 9.53e-01 | 1.40e-02 | 9.84e-01 |
| GOBP STEM CELL DIVISION | 22 | 9.10e-01 | -1.40e-02 | 9.68e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 37 | 8.84e-01 | 1.39e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 416 | 6.28e-01 | -1.39e-02 | 8.53e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS | 97 | 8.13e-01 | -1.39e-02 | 9.34e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATIONAL INITIATION | 22 | 9.10e-01 | 1.39e-02 | 9.68e-01 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE MEMBRANE | 50 | 8.65e-01 | -1.39e-02 | 9.52e-01 |
| GOBP TRANSLATIONAL ELONGATION | 61 | 8.51e-01 | -1.39e-02 | 9.47e-01 |
| GOBP NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION | 31 | 8.94e-01 | 1.39e-02 | 9.63e-01 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH | 73 | 8.38e-01 | 1.38e-02 | 9.43e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS OXYGEN AS ACCEPTOR | 9 | 9.43e-01 | 1.38e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF CYCLASE ACTIVITY | 21 | 9.13e-01 | 1.38e-02 | 9.70e-01 |
| GOBP TETRAPYRROLE CATABOLIC PROCESS | 9 | 9.43e-01 | -1.38e-02 | 9.80e-01 |
| GOBP VESICLE TARGETING TO FROM OR WITHIN GOLGI | 32 | 8.93e-01 | 1.37e-02 | 9.63e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 16 | 9.24e-01 | -1.37e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE APOPTOTIC PROCESS | 5 | 9.58e-01 | 1.37e-02 | 9.85e-01 |
| GOBP POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT | 18 | 9.20e-01 | 1.37e-02 | 9.72e-01 |
| GOBP REGULATION OF INTRACELLULAR TRANSPORT | 289 | 6.91e-01 | 1.36e-02 | 8.87e-01 |
| GOBP REGULATION OF GLYCOGEN METABOLIC PROCESS | 26 | 9.04e-01 | 1.36e-02 | 9.67e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 33 | 8.92e-01 | 1.36e-02 | 9.63e-01 |
| GOCC TRANS GOLGI NETWORK | 225 | 7.26e-01 | -1.36e-02 | 9.02e-01 |
| GOBP REGULATION OF HEART RATE | 51 | 8.67e-01 | 1.36e-02 | 9.52e-01 |
| GOCC GOLGI STACK | 110 | 8.06e-01 | 1.35e-02 | 9.31e-01 |
| GOBP LIMBIC SYSTEM DEVELOPMENT | 70 | 8.45e-01 | -1.35e-02 | 9.45e-01 |
| GOMF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 10 | 9.41e-01 | 1.35e-02 | 9.79e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 22 | 9.13e-01 | 1.35e-02 | 9.69e-01 |
| GOBP RECEPTOR CLUSTERING | 41 | 8.81e-01 | -1.35e-02 | 9.58e-01 |
| GOCC SYNAPTIC MEMBRANE | 213 | 7.34e-01 | -1.35e-02 | 9.04e-01 |
| GOBP PHOSPHOLIPID BIOSYNTHETIC PROCESS | 219 | 7.33e-01 | -1.34e-02 | 9.04e-01 |
| GOBP OSTEOCLAST FUSION | 6 | 9.55e-01 | 1.34e-02 | 9.85e-01 |
| GOBP AMIDE METABOLIC PROCESS | 962 | 4.85e-01 | 1.34e-02 | 7.81e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CONTRACTION | 24 | 9.10e-01 | 1.34e-02 | 9.68e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS | 15 | 9.29e-01 | -1.33e-02 | 9.75e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 38 | 8.87e-01 | -1.33e-02 | 9.59e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS | 20 | 9.18e-01 | -1.32e-02 | 9.71e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE | 50 | 8.72e-01 | 1.32e-02 | 9.54e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE ACTIVATOR ACTIVITY | 11 | 9.40e-01 | -1.31e-02 | 9.79e-01 |
| GOBP SKIN DEVELOPMENT | 157 | 7.77e-01 | -1.31e-02 | 9.21e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE MEMBRANE | 19 | 9.21e-01 | 1.31e-02 | 9.72e-01 |
| GOBP REGULATION OF LIPASE ACTIVITY | 46 | 8.78e-01 | 1.31e-02 | 9.56e-01 |
| GOBP MULTICELLULAR ORGANISMAL MOVEMENT | 38 | 8.89e-01 | -1.31e-02 | 9.61e-01 |
| GOBP ENAMEL MINERALIZATION | 10 | 9.43e-01 | 1.31e-02 | 9.80e-01 |
| GOBP REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 48 | 8.76e-01 | 1.30e-02 | 9.56e-01 |
| GOCC PROTEIN LIPID COMPLEX | 25 | 9.11e-01 | 1.30e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 7 | 9.53e-01 | -1.30e-02 | 9.84e-01 |
| GOBP REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 250 | 7.26e-01 | -1.29e-02 | 9.02e-01 |
| GOBP TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 89 | 8.34e-01 | 1.29e-02 | 9.41e-01 |
| GOBP INTERLEUKIN 17A MEDIATED SIGNALING PATHWAY | 5 | 9.60e-01 | 1.29e-02 | 9.86e-01 |
| GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM | 21 | 9.19e-01 | -1.29e-02 | 9.71e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMATIN | 5 | 9.60e-01 | -1.29e-02 | 9.86e-01 |
| GOBP NERVOUS SYSTEM PROCESS | 589 | 5.96e-01 | -1.28e-02 | 8.39e-01 |
| GOCC SOMATODENDRITIC COMPARTMENT | 544 | 6.11e-01 | -1.28e-02 | 8.46e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 29 | 9.06e-01 | -1.27e-02 | 9.67e-01 |
| GOCC SNO S RNA CONTAINING RIBONUCLEOPROTEIN COMPLEX | 23 | 9.16e-01 | 1.27e-02 | 9.71e-01 |
| GOBP ANTEROGRADE DENDRITIC TRANSPORT | 7 | 9.54e-01 | 1.26e-02 | 9.85e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 41 | 8.89e-01 | 1.26e-02 | 9.60e-01 |
| GOCC EARLY ENDOSOME | 349 | 6.86e-01 | -1.26e-02 | 8.84e-01 |
| GOCC ACTIN BASED CELL PROJECTION | 159 | 7.84e-01 | -1.26e-02 | 9.22e-01 |
| GOBP ANATOMICAL STRUCTURE MATURATION | 150 | 7.90e-01 | 1.26e-02 | 9.24e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 182 | 7.71e-01 | -1.25e-02 | 9.19e-01 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 8 | 9.51e-01 | 1.25e-02 | 9.84e-01 |
| GOBP SNARE COMPLEX ASSEMBLY | 19 | 9.25e-01 | -1.25e-02 | 9.73e-01 |
| GOBP SYNAPTIC VESICLE PRIMING | 12 | 9.40e-01 | 1.25e-02 | 9.79e-01 |
| GOBP TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 46 | 8.84e-01 | -1.25e-02 | 9.59e-01 |
| GOCC TRANSCRIPTION ELONGATION FACTOR COMPLEX | 45 | 8.86e-01 | -1.24e-02 | 9.59e-01 |
| GOBP CELLULAR COMPONENT DISASSEMBLY | 422 | 6.64e-01 | -1.24e-02 | 8.73e-01 |
| GOMF PROTEIN HOMODIMERIZATION ACTIVITY | 544 | 6.26e-01 | 1.23e-02 | 8.52e-01 |
| GOBP L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT | 47 | 8.84e-01 | -1.23e-02 | 9.59e-01 |
| GOBP CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 99 | 8.34e-01 | 1.22e-02 | 9.41e-01 |
| GOBP AMIDE TRANSPORT | 217 | 7.57e-01 | -1.22e-02 | 9.14e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 6 | 9.59e-01 | 1.21e-02 | 9.86e-01 |
| GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY | 14 | 9.37e-01 | -1.21e-02 | 9.79e-01 |
| GOMF MICROTUBULE BINDING | 225 | 7.55e-01 | 1.21e-02 | 9.12e-01 |
| GOBP RESPONSE TO REACTIVE OXYGEN SPECIES | 162 | 7.91e-01 | 1.21e-02 | 9.24e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 12 | 9.42e-01 | -1.21e-02 | 9.80e-01 |
| GOMF CARD DOMAIN BINDING | 13 | 9.40e-01 | 1.21e-02 | 9.79e-01 |
| GOBP SKIN EPIDERMIS DEVELOPMENT | 68 | 8.64e-01 | 1.21e-02 | 9.52e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 86 | 8.47e-01 | 1.21e-02 | 9.46e-01 |
| GOBP CELLULAR RESPONSE TO INTERLEUKIN 1 | 72 | 8.60e-01 | 1.21e-02 | 9.50e-01 |
| GOBP SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 48 | 8.85e-01 | 1.20e-02 | 9.59e-01 |
| GOBP NEGATIVE REGULATION OF OSSIFICATION | 23 | 9.21e-01 | 1.20e-02 | 9.72e-01 |
| GOBP GLUCOSYLCERAMIDE METABOLIC PROCESS | 5 | 9.63e-01 | 1.20e-02 | 9.87e-01 |
| GOCC ENDOPLASMIC RETICULUM PALMITOYLTRANSFERASE COMPLEX | 7 | 9.57e-01 | 1.19e-02 | 9.85e-01 |
| GOMF IONOTROPIC GLUTAMATE RECEPTOR ACTIVITY | 13 | 9.41e-01 | -1.19e-02 | 9.79e-01 |
| GOCC TRAPP COMPLEX | 15 | 9.37e-01 | -1.19e-02 | 9.78e-01 |
| GOCC CYTOPLASMIC SIDE OF MEMBRANE | 157 | 7.98e-01 | 1.18e-02 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION | 12 | 9.44e-01 | 1.18e-02 | 9.80e-01 |
| GOBP PHAGOCYTOSIS ENGULFMENT | 40 | 8.97e-01 | 1.18e-02 | 9.64e-01 |
| GOBP TYPE B PANCREATIC CELL DEVELOPMENT | 14 | 9.39e-01 | -1.18e-02 | 9.79e-01 |
| GOBP GLUCAN METABOLIC PROCESS | 60 | 8.75e-01 | -1.17e-02 | 9.55e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 11 | 9.46e-01 | 1.17e-02 | 9.81e-01 |
| GOCC STEREOCILIUM BASE | 5 | 9.64e-01 | 1.17e-02 | 9.87e-01 |
| GOBP MUCOCILIARY CLEARANCE | 6 | 9.61e-01 | 1.17e-02 | 9.86e-01 |
| GOBP DENDRITIC CELL CHEMOTAXIS | 19 | 9.30e-01 | -1.17e-02 | 9.75e-01 |
| GOMF ATP DEPENDENT DNA DAMAGE SENSOR ACTIVITY | 15 | 9.38e-01 | -1.17e-02 | 9.79e-01 |
| GOBP LNCRNA MEDIATED POST TRANSCRIPTIONAL GENE SILENCING | 7 | 9.57e-01 | -1.16e-02 | 9.85e-01 |
| GOBP POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 53 | 8.84e-01 | -1.16e-02 | 9.59e-01 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE SIZE | 345 | 7.12e-01 | -1.16e-02 | 8.96e-01 |
| GOBP RESPONSE TO INDOLE 3 METHANOL | 6 | 9.61e-01 | -1.16e-02 | 9.86e-01 |
| GOBP SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 41 | 8.99e-01 | -1.15e-02 | 9.64e-01 |
| GOBP REGULATION OF HEART CONTRACTION | 108 | 8.37e-01 | 1.15e-02 | 9.42e-01 |
| GOMF SODIUM CHANNEL REGULATOR ACTIVITY | 27 | 9.19e-01 | -1.14e-02 | 9.71e-01 |
| GOBP BONE RESORPTION | 48 | 8.92e-01 | 1.14e-02 | 9.62e-01 |
| GOBP REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 198 | 7.84e-01 | 1.13e-02 | 9.22e-01 |
| GOCC TRANSCRIPTION FACTOR TFTC COMPLEX | 18 | 9.34e-01 | 1.13e-02 | 9.77e-01 |
| GOCC POSTSYNAPTIC MEMBRANE | 135 | 8.20e-01 | -1.13e-02 | 9.35e-01 |
| GOBP PHAGOSOME MATURATION | 28 | 9.18e-01 | 1.13e-02 | 9.71e-01 |
| GOBP LYMPH VESSEL DEVELOPMENT | 15 | 9.40e-01 | -1.13e-02 | 9.79e-01 |
| GOBP SECOND MESSENGER MEDIATED SIGNALING | 183 | 7.95e-01 | -1.11e-02 | 9.26e-01 |
| GOBP NEGATIVE REGULATION OF TISSUE REMODELING | 12 | 9.47e-01 | -1.11e-02 | 9.82e-01 |
| GOMF LYSOPHOSPHOLIPID ACYLTRANSFERASE ACTIVITY | 21 | 9.31e-01 | 1.10e-02 | 9.76e-01 |
| GOBP REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 7 | 9.60e-01 | 1.09e-02 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF MOLECULAR FUNCTION | 953 | 5.72e-01 | -1.09e-02 | 8.29e-01 |
| GOBP INSULIN SECRETION | 120 | 8.37e-01 | 1.09e-02 | 9.42e-01 |
| GOMF POTASSIUM CHANNEL REGULATOR ACTIVITY | 34 | 9.13e-01 | -1.08e-02 | 9.70e-01 |
| GOBP SEQUESTERING OF CALCIUM ION | 95 | 8.55e-01 | -1.08e-02 | 9.48e-01 |
| GOCC GOLGI CISTERNA | 83 | 8.65e-01 | 1.08e-02 | 9.52e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS | 13 | 9.46e-01 | -1.08e-02 | 9.81e-01 |
| GOMF STRUCTURAL CONSTITUENT OF RIBOSOME | 156 | 8.17e-01 | -1.07e-02 | 9.34e-01 |
| GOBP REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 301 | 7.50e-01 | -1.07e-02 | 9.10e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION | 86 | 8.64e-01 | 1.07e-02 | 9.52e-01 |
| GOBP REGULATION OF NERVOUS SYSTEM PROCESS | 74 | 8.74e-01 | 1.06e-02 | 9.55e-01 |
| GOCC ATPASE COMPLEX | 134 | 8.33e-01 | 1.06e-02 | 9.41e-01 |
| GOBP NEGATIVE REGULATION OF NEUTROPHIL ACTIVATION | 5 | 9.67e-01 | 1.05e-02 | 9.89e-01 |
| GOMF ENZYME INHIBITOR ACTIVITY | 244 | 7.77e-01 | -1.05e-02 | 9.21e-01 |
| GOBP SIGNAL RELEASE | 288 | 7.59e-01 | 1.05e-02 | 9.14e-01 |
| GOBP REGULATION OF CYTOCHROME C OXIDASE ACTIVITY | 5 | 9.68e-01 | 1.05e-02 | 9.89e-01 |
| GOCC NUCLEOCYTOPLASMIC TRANSPORT COMPLEX | 11 | 9.52e-01 | 1.05e-02 | 9.84e-01 |
| GOBP C21 STEROID HORMONE METABOLIC PROCESS | 17 | 9.41e-01 | -1.05e-02 | 9.79e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 25 | 9.28e-01 | -1.04e-02 | 9.75e-01 |
| GOBP LIPOPROTEIN METABOLIC PROCESS | 112 | 8.49e-01 | 1.04e-02 | 9.47e-01 |
| GOBP LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 19 | 9.38e-01 | 1.04e-02 | 9.79e-01 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 334 | 7.45e-01 | -1.04e-02 | 9.08e-01 |
| GOMF STEROL ESTERASE ACTIVITY | 6 | 9.65e-01 | -1.04e-02 | 9.88e-01 |
| GOBP MEMBRANE INVAGINATION | 56 | 8.93e-01 | -1.04e-02 | 9.63e-01 |
| GOBP REGULATION OF EXTENT OF CELL GROWTH | 75 | 8.77e-01 | -1.03e-02 | 9.56e-01 |
| GOBP SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT | 29 | 9.24e-01 | -1.03e-02 | 9.73e-01 |
| GOBP REGULATION OF EXOCYTOSIS | 136 | 8.37e-01 | 1.02e-02 | 9.42e-01 |
| GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 13 | 9.49e-01 | 1.02e-02 | 9.83e-01 |
| GOBP TISSUE HOMEOSTASIS | 174 | 8.17e-01 | -1.02e-02 | 9.34e-01 |
| GOCC CLATHRIN COATED VESICLE MEMBRANE | 104 | 8.58e-01 | 1.02e-02 | 9.49e-01 |
| GOCC SARCOPLASM | 64 | 8.88e-01 | 1.02e-02 | 9.60e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND SALVAGE | 7 | 9.63e-01 | -1.01e-02 | 9.87e-01 |
| GOBP AMINO SUGAR METABOLIC PROCESS | 34 | 9.19e-01 | 1.01e-02 | 9.71e-01 |
| GOMF PROTEIN TRANSPORTER ACTIVITY | 35 | 9.18e-01 | 1.01e-02 | 9.71e-01 |
| GOBP CENTRIOLE ASSEMBLY | 45 | 9.07e-01 | 1.01e-02 | 9.67e-01 |
| GOMF ORGANIC ACID SODIUM SYMPORTER ACTIVITY | 17 | 9.43e-01 | 1.01e-02 | 9.80e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHATASE ACTIVITY | 21 | 9.36e-01 | 1.00e-02 | 9.78e-01 |
| GOCC HIPPOCAMPAL MOSSY FIBER TO CA3 SYNAPSE | 30 | 9.24e-01 | -1.00e-02 | 9.73e-01 |
| GOBP REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY | 17 | 9.43e-01 | -1.00e-02 | 9.80e-01 |
| GOBP EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS | 15 | 9.47e-01 | -9.98e-03 | 9.81e-01 |
| GOBP CHROMOSOME ATTACHMENT TO THE NUCLEAR ENVELOPE | 5 | 9.69e-01 | -9.92e-03 | 9.91e-01 |
| GOBP NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 17 | 9.44e-01 | 9.89e-03 | 9.80e-01 |
| GOBP MITOTIC CYTOKINESIS | 83 | 8.77e-01 | -9.83e-03 | 9.56e-01 |
| GOBP VESICLE DOCKING INVOLVED IN EXOCYTOSIS | 35 | 9.20e-01 | -9.81e-03 | 9.72e-01 |
| GOBP TRABECULA FORMATION | 17 | 9.44e-01 | -9.80e-03 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSPORT | 128 | 8.49e-01 | -9.78e-03 | 9.46e-01 |
| GOBP STRIATED MUSCLE CELL DIFFERENTIATION | 189 | 8.17e-01 | 9.76e-03 | 9.34e-01 |
| GOBP REGULATION OF PIGMENTATION | 10 | 9.57e-01 | -9.75e-03 | 9.85e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSLATION | 29 | 9.28e-01 | -9.69e-03 | 9.75e-01 |
| GOCC RUFFLE MEMBRANE | 86 | 8.77e-01 | 9.69e-03 | 9.56e-01 |
| GOCC POSTSYNAPTIC DENSITY INTRACELLULAR COMPONENT | 13 | 9.52e-01 | 9.64e-03 | 9.84e-01 |
| GOBP THYROID HORMONE GENERATION | 12 | 9.54e-01 | 9.64e-03 | 9.85e-01 |
| GOBP CELL JUNCTION ORGANIZATION | 476 | 7.20e-01 | -9.62e-03 | 8.99e-01 |
| GOBP NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 21 | 9.39e-01 | 9.62e-03 | 9.79e-01 |
| GOCC MALE GERM CELL NUCLEUS | 39 | 9.17e-01 | 9.61e-03 | 9.71e-01 |
| GOBP RENAL VESICLE FORMATION | 5 | 9.70e-01 | 9.61e-03 | 9.91e-01 |
| GOBP SENSORY PERCEPTION OF LIGHT STIMULUS | 107 | 8.64e-01 | 9.59e-03 | 9.52e-01 |
| GOBP TRANSCYTOSIS | 17 | 9.46e-01 | 9.58e-03 | 9.81e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS | 83 | 8.81e-01 | 9.53e-03 | 9.58e-01 |
| GOBP NEURONAL ION CHANNEL CLUSTERING | 10 | 9.58e-01 | -9.51e-03 | 9.86e-01 |
| GOMF PDZ DOMAIN BINDING | 62 | 8.97e-01 | -9.49e-03 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 17 | 9.46e-01 | -9.49e-03 | 9.81e-01 |
| GOMF CALCITONIN FAMILY RECEPTOR ACTIVITY | 5 | 9.71e-01 | -9.44e-03 | 9.91e-01 |
| GOBP CARDIAC MUSCLE CELL CONTRACTION | 46 | 9.12e-01 | -9.42e-03 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE | 66 | 8.95e-01 | -9.41e-03 | 9.63e-01 |
| GOBP REGULATION OF METAL ION TRANSPORT | 242 | 8.02e-01 | -9.38e-03 | 9.29e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE POTENTIAL | 11 | 9.57e-01 | 9.37e-03 | 9.85e-01 |
| GOBP EMBRYONIC HEART TUBE MORPHOGENESIS | 47 | 9.12e-01 | -9.36e-03 | 9.69e-01 |
| GOBP RESPONSE TO MECHANICAL STIMULUS | 153 | 8.42e-01 | -9.34e-03 | 9.44e-01 |
| GOBP REGULATION OF EPIDERMIS DEVELOPMENT | 40 | 9.19e-01 | -9.33e-03 | 9.71e-01 |
| GOCC BRCA1 A COMPLEX | 8 | 9.64e-01 | -9.28e-03 | 9.87e-01 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE | 23 | 9.39e-01 | 9.28e-03 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 14 | 9.52e-01 | 9.24e-03 | 9.84e-01 |
| GOBP RESPONSE TO OXIDATIVE STRESS | 318 | 7.78e-01 | 9.22e-03 | 9.21e-01 |
| GOCC CENTRIOLAR SATELLITE | 95 | 8.77e-01 | -9.21e-03 | 9.56e-01 |
| GOBP NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY | 27 | 9.34e-01 | -9.19e-03 | 9.77e-01 |
| GOBP METANEPHRIC NEPHRON MORPHOGENESIS | 13 | 9.55e-01 | 9.13e-03 | 9.85e-01 |
| GOBP SUPRAMOLECULAR FIBER ORGANIZATION | 592 | 7.06e-01 | -9.10e-03 | 8.94e-01 |
| GOBP MONOSACCHARIDE METABOLIC PROCESS | 207 | 8.22e-01 | -9.06e-03 | 9.36e-01 |
| GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION | 223 | 8.16e-01 | -9.06e-03 | 9.34e-01 |
| GOCC ATAC COMPLEX | 13 | 9.55e-01 | 9.02e-03 | 9.85e-01 |
| GOBP HEART FORMATION | 18 | 9.47e-01 | 9.01e-03 | 9.82e-01 |
| GOBP DIGESTIVE SYSTEM DEVELOPMENT | 67 | 8.99e-01 | 9.00e-03 | 9.64e-01 |
| GOBP REGULATION OF CELL JUNCTION ASSEMBLY | 137 | 8.56e-01 | -8.99e-03 | 9.48e-01 |
| GOBP REGULATION OF CATION CHANNEL ACTIVITY | 68 | 8.98e-01 | 8.99e-03 | 9.64e-01 |
| GOCC RIBOSOME | 224 | 8.17e-01 | 8.98e-03 | 9.34e-01 |
| GOBP REGULATION OF PROTEIN KINASE C SIGNALING | 12 | 9.57e-01 | -8.96e-03 | 9.85e-01 |
| GOBP FATTY ACID TRANSMEMBRANE TRANSPORT | 17 | 9.49e-01 | 8.96e-03 | 9.83e-01 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE | 10 | 9.61e-01 | 8.93e-03 | 9.86e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIUM | 325 | 7.84e-01 | -8.86e-03 | 9.22e-01 |
| GOBP ORGANONITROGEN COMPOUND CATABOLIC PROCESS | 1125 | 6.20e-01 | 8.84e-03 | 8.49e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE III PROMOTER | 8 | 9.65e-01 | 8.83e-03 | 9.88e-01 |
| GOBP MANNOSE METABOLIC PROCESS | 9 | 9.64e-01 | 8.77e-03 | 9.87e-01 |
| GOCC PLATELET ALPHA GRANULE | 63 | 9.04e-01 | 8.75e-03 | 9.67e-01 |
| GOMF SIALYLTRANSFERASE ACTIVITY | 13 | 9.57e-01 | -8.73e-03 | 9.85e-01 |
| GOCC BRCA1 C COMPLEX | 6 | 9.70e-01 | 8.73e-03 | 9.91e-01 |
| GOMF CELL ADHESION MOLECULE BINDING | 413 | 7.62e-01 | -8.71e-03 | 9.16e-01 |
| GOBP G PROTEIN COUPLED SEROTONIN RECEPTOR SIGNALING PATHWAY | 6 | 9.71e-01 | -8.65e-03 | 9.91e-01 |
| GOBP SEROTONIN RECEPTOR SIGNALING PATHWAY | 6 | 9.71e-01 | -8.65e-03 | 9.91e-01 |
| GOMF G PROTEIN COUPLED SEROTONIN RECEPTOR ACTIVITY | 6 | 9.71e-01 | -8.65e-03 | 9.91e-01 |
| GOMF SEROTONIN RECEPTOR ACTIVITY | 6 | 9.71e-01 | -8.65e-03 | 9.91e-01 |
| GOBP PROCESS UTILIZING AUTOPHAGIC MECHANISM | 524 | 7.39e-01 | -8.54e-03 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF GROWTH | 158 | 8.54e-01 | 8.50e-03 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL | 120 | 8.73e-01 | -8.46e-03 | 9.54e-01 |
| GOBP CORTICAL ACTIN CYTOSKELETON ORGANIZATION | 40 | 9.27e-01 | 8.41e-03 | 9.74e-01 |
| GOBP CELL PROJECTION ORGANIZATION | 1143 | 6.38e-01 | -8.31e-03 | 8.59e-01 |
| GOCC GOLGI LUMEN | 43 | 9.25e-01 | 8.31e-03 | 9.73e-01 |
| GOBP REGULATION OF MACROPHAGE MIGRATION | 33 | 9.34e-01 | -8.31e-03 | 9.77e-01 |
| GOBP NLS BEARING PROTEIN IMPORT INTO NUCLEUS | 14 | 9.57e-01 | 8.28e-03 | 9.85e-01 |
| GOBP BARBED END ACTIN FILAMENT CAPPING | 22 | 9.46e-01 | 8.27e-03 | 9.81e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 44 | 9.24e-01 | 8.27e-03 | 9.73e-01 |
| GOBP CELLULAR LIPID BIOSYNTHETIC PROCESS | 11 | 9.62e-01 | -8.24e-03 | 9.87e-01 |
| GOBP ENDODERM DEVELOPMENT | 49 | 9.21e-01 | -8.23e-03 | 9.72e-01 |
| GOBP ER NUCLEUS SIGNALING PATHWAY | 43 | 9.26e-01 | -8.21e-03 | 9.74e-01 |
| GOBP POSITIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE | 12 | 9.61e-01 | -8.20e-03 | 9.86e-01 |
| GOBP STEM CELL DEVELOPMENT | 53 | 9.18e-01 | 8.20e-03 | 9.71e-01 |
| GOBP REGULATION OF ACTIN FILAMENT ORGANIZATION | 204 | 8.41e-01 | -8.18e-03 | 9.43e-01 |
| GOBP SYNAPTIC VESICLE MATURATION | 23 | 9.46e-01 | -8.18e-03 | 9.81e-01 |
| GOBP RESPONSE TO HYDROGEN PEROXIDE | 86 | 8.96e-01 | -8.18e-03 | 9.64e-01 |
| GOBP LUNG ALVEOLUS DEVELOPMENT | 29 | 9.40e-01 | -8.08e-03 | 9.79e-01 |
| GOBP NOTCH SIGNALING PATHWAY | 118 | 8.80e-01 | -8.05e-03 | 9.58e-01 |
| GOBP RUFFLE ORGANIZATION | 49 | 9.22e-01 | 8.04e-03 | 9.72e-01 |
| GOBP DE NOVO AMP BIOSYNTHETIC PROCESS | 6 | 9.73e-01 | 7.91e-03 | 9.92e-01 |
| GOCC PERINUCLEAR REGION OF CYTOPLASM | 574 | 7.47e-01 | 7.91e-03 | 9.09e-01 |
| GOBP MODULATION BY HOST OF VIRAL PROCESS | 44 | 9.28e-01 | -7.91e-03 | 9.75e-01 |
| GOBP REGULATION OF GLIOGENESIS | 64 | 9.14e-01 | -7.83e-03 | 9.70e-01 |
| GOBP REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 53 | 9.22e-01 | -7.82e-03 | 9.72e-01 |
| GOBP AMIDE BIOSYNTHETIC PROCESS | 745 | 7.18e-01 | 7.81e-03 | 8.98e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 159 | 8.65e-01 | -7.80e-03 | 9.52e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING | 39 | 9.33e-01 | -7.78e-03 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST PROLIFERATION | 37 | 9.35e-01 | -7.76e-03 | 9.77e-01 |
| GOBP NCRNA PROCESSING | 400 | 7.91e-01 | 7.75e-03 | 9.24e-01 |
| GOCC CENTROSOME | 568 | 7.54e-01 | -7.72e-03 | 9.12e-01 |
| GOBP CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE | 6 | 9.74e-01 | 7.71e-03 | 9.92e-01 |
| GOMF ORGANIC ACID BINDING | 124 | 8.82e-01 | -7.70e-03 | 9.59e-01 |
| GOBP BENZENE CONTAINING COMPOUND METABOLIC PROCESS | 17 | 9.57e-01 | -7.58e-03 | 9.85e-01 |
| GOBP REGULATION OF MEIOTIC CELL CYCLE | 45 | 9.30e-01 | 7.58e-03 | 9.75e-01 |
| GOBP MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 31 | 9.42e-01 | 7.56e-03 | 9.80e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN | 106 | 8.93e-01 | 7.54e-03 | 9.63e-01 |
| GOBP REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 32 | 9.41e-01 | -7.54e-03 | 9.79e-01 |
| GOBP POSITIVE REGULATION OF P38MAPK CASCADE | 23 | 9.50e-01 | -7.53e-03 | 9.83e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS | 102 | 8.96e-01 | 7.52e-03 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 8 | 9.71e-01 | -7.47e-03 | 9.91e-01 |
| GOMF U3 SNORNA BINDING | 10 | 9.67e-01 | 7.45e-03 | 9.89e-01 |
| GOCC MICROBODY LUMEN | 42 | 9.34e-01 | -7.44e-03 | 9.77e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 79 | 9.09e-01 | -7.43e-03 | 9.68e-01 |
| GOBP ENDOTHELIAL CELL PROLIFERATION | 100 | 8.98e-01 | 7.41e-03 | 9.64e-01 |
| GOBP RESPONSE TO OXYGEN LEVELS | 243 | 8.43e-01 | 7.41e-03 | 9.44e-01 |
| GOBP REGULATION OF CALCIUM MEDIATED SIGNALING | 62 | 9.20e-01 | -7.40e-03 | 9.72e-01 |
| GOMF TETRAPYRROLE BINDING | 80 | 9.09e-01 | -7.40e-03 | 9.68e-01 |
| GOCC PODOSOME | 30 | 9.44e-01 | -7.40e-03 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 6 | 9.75e-01 | 7.39e-03 | 9.92e-01 |
| GOBP SNRNA TRANSPORT | 6 | 9.75e-01 | 7.39e-03 | 9.92e-01 |
| GOBP MICROTUBULE POLYMERIZATION | 85 | 9.07e-01 | -7.37e-03 | 9.67e-01 |
| GOMF MOLECULAR FUNCTION INHIBITOR ACTIVITY | 316 | 8.23e-01 | 7.35e-03 | 9.36e-01 |
| GOBP REPLACEMENT OSSIFICATION | 17 | 9.58e-01 | 7.33e-03 | 9.86e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN LEVELS | 120 | 8.90e-01 | -7.32e-03 | 9.61e-01 |
| GOBP ANIMAL ORGAN REGENERATION | 43 | 9.35e-01 | 7.24e-03 | 9.77e-01 |
| GOBP REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 25 | 9.50e-01 | 7.21e-03 | 9.83e-01 |
| GOBP REGULATION OF FIBROBLAST PROLIFERATION | 65 | 9.20e-01 | 7.19e-03 | 9.72e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 24 | 9.52e-01 | 7.13e-03 | 9.84e-01 |
| GOBP PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 19 | 9.57e-01 | 7.13e-03 | 9.85e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 140 | 8.84e-01 | -7.13e-03 | 9.59e-01 |
| GOBP REGULATION OF VASCULATURE DEVELOPMENT | 191 | 8.65e-01 | -7.12e-03 | 9.52e-01 |
| GOBP PEPTIDE BIOSYNTHETIC PROCESS | 643 | 7.61e-01 | 7.08e-03 | 9.15e-01 |
| GOBP LEARNING | 92 | 9.07e-01 | 7.06e-03 | 9.67e-01 |
| GOMF PROTEIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 25 | 9.51e-01 | -7.04e-03 | 9.84e-01 |
| GOBP CYTOKINESIS | 161 | 8.78e-01 | -7.03e-03 | 9.56e-01 |
| GOMF WW DOMAIN BINDING | 17 | 9.60e-01 | 7.01e-03 | 9.86e-01 |
| GOMF SIGNALING RECEPTOR COMPLEX ADAPTOR ACTIVITY | 43 | 9.37e-01 | -7.00e-03 | 9.78e-01 |
| GOBP FEMALE MEIOSIS CHROMOSOME SEGREGATION | 6 | 9.76e-01 | -6.97e-03 | 9.93e-01 |
| GOBP PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 676 | 7.61e-01 | -6.91e-03 | 9.15e-01 |
| GOBP ACTIN FILAMENT ORGANIZATION | 350 | 8.26e-01 | 6.86e-03 | 9.38e-01 |
| GOCC CLATHRIN SCULPTED VESICLE | 6 | 9.77e-01 | -6.85e-03 | 9.93e-01 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE | 31 | 9.47e-01 | 6.85e-03 | 9.82e-01 |
| GOBP NUCLEAR MEMBRANE ORGANIZATION | 43 | 9.38e-01 | -6.84e-03 | 9.79e-01 |
| GOMF STEROL BINDING | 50 | 9.33e-01 | 6.83e-03 | 9.77e-01 |
| GOBP REGULATION OF ERAD PATHWAY | 20 | 9.58e-01 | -6.80e-03 | 9.85e-01 |
| GOBP CAVEOLIN MEDIATED ENDOCYTOSIS | 8 | 9.73e-01 | 6.80e-03 | 9.92e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT | 154 | 8.85e-01 | -6.79e-03 | 9.59e-01 |
| GOBP GLYCOSPHINGOLIPID CATABOLIC PROCESS | 9 | 9.72e-01 | -6.76e-03 | 9.91e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING SULPHUR CONTAINING GROUPS | 41 | 9.40e-01 | 6.76e-03 | 9.79e-01 |
| GOBP VACUOLAR LOCALIZATION | 72 | 9.21e-01 | 6.72e-03 | 9.72e-01 |
| GOBP REGULATION OF CELLULAR COMPONENT SIZE | 278 | 8.47e-01 | -6.72e-03 | 9.46e-01 |
| GOBP CHONDROITIN SULFATE METABOLIC PROCESS | 22 | 9.57e-01 | -6.72e-03 | 9.85e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 15 | 9.64e-01 | 6.71e-03 | 9.87e-01 |
| GOBP VESICLE MEDIATED TRANSPORT | 1218 | 6.96e-01 | 6.71e-03 | 8.88e-01 |
| GOMF METALLOEXOPEPTIDASE ACTIVITY | 42 | 9.40e-01 | -6.70e-03 | 9.79e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 43 | 9.40e-01 | 6.67e-03 | 9.79e-01 |
| GOBP BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS | 9 | 9.73e-01 | -6.63e-03 | 9.91e-01 |
| GOBP EPIDERMIS MORPHOGENESIS | 19 | 9.61e-01 | 6.55e-03 | 9.86e-01 |
| GOBP NUCLEOTIDE TRANSMEMBRANE TRANSPORT | 25 | 9.55e-01 | -6.54e-03 | 9.85e-01 |
| GOBP ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 67 | 9.27e-01 | 6.49e-03 | 9.74e-01 |
| GOMF PURINE RIBONUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 20 | 9.61e-01 | 6.39e-03 | 9.86e-01 |
| GOBP CARBOHYDRATE BIOSYNTHETIC PROCESS | 151 | 8.93e-01 | 6.36e-03 | 9.63e-01 |
| GOCC ENDOSOME | 844 | 7.55e-01 | 6.36e-03 | 9.12e-01 |
| GOCC PRERIBOSOME | 103 | 9.11e-01 | 6.35e-03 | 9.69e-01 |
| GOBP RESPONSE TO INTERLEUKIN 18 | 7 | 9.77e-01 | 6.34e-03 | 9.93e-01 |
| GOBP SKELETAL SYSTEM MORPHOGENESIS | 121 | 9.05e-01 | -6.30e-03 | 9.67e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS | 182 | 8.84e-01 | -6.28e-03 | 9.59e-01 |
| GOCC CDC73 PAF1 COMPLEX | 6 | 9.79e-01 | -6.20e-03 | 9.94e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION | 53 | 9.38e-01 | 6.16e-03 | 9.79e-01 |
| GOBP THYMOCYTE APOPTOTIC PROCESS | 15 | 9.67e-01 | 6.13e-03 | 9.89e-01 |
| GOBP WALKING BEHAVIOR | 21 | 9.61e-01 | 6.13e-03 | 9.87e-01 |
| GOBP GLUTAMATE METABOLIC PROCESS | 20 | 9.62e-01 | -6.13e-03 | 9.87e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION | 77 | 9.27e-01 | 6.07e-03 | 9.74e-01 |
| GOCC CLATHRIN COATED VESICLE | 163 | 8.94e-01 | 6.06e-03 | 9.63e-01 |
| GOBP PHOSPHOLIPID METABOLIC PROCESS | 301 | 8.57e-01 | 6.04e-03 | 9.49e-01 |
| GOBP FOREBRAIN CELL MIGRATION | 42 | 9.46e-01 | 6.03e-03 | 9.81e-01 |
| GOBP CELLULAR COMPONENT MAINTENANCE | 52 | 9.41e-01 | 5.93e-03 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 27 | 9.58e-01 | 5.92e-03 | 9.85e-01 |
| GOBP POSITIVE REGULATION OF SPINDLE ASSEMBLY | 7 | 9.78e-01 | -5.91e-03 | 9.94e-01 |
| GOBP GLYCOLYTIC PROCESS | 74 | 9.30e-01 | 5.90e-03 | 9.75e-01 |
| GOMF HEPARIN BINDING | 80 | 9.27e-01 | 5.90e-03 | 9.74e-01 |
| GOMF LIPID TRANSPORTER ACTIVITY | 120 | 9.11e-01 | 5.90e-03 | 9.69e-01 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVITY | 22 | 9.62e-01 | 5.88e-03 | 9.87e-01 |
| GOMF UBIQUITIN LIKE PROTEIN BINDING | 119 | 9.12e-01 | 5.87e-03 | 9.69e-01 |
| GOBP COLLAGEN FIBRIL ORGANIZATION | 31 | 9.55e-01 | 5.82e-03 | 9.85e-01 |
| GOCC BASEMENT MEMBRANE | 42 | 9.48e-01 | 5.81e-03 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE | 98 | 9.21e-01 | 5.79e-03 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN UBIQUITINATION | 99 | 9.22e-01 | 5.70e-03 | 9.72e-01 |
| GOBP REGULATION OF TRANSPORT | 1173 | 7.45e-01 | -5.69e-03 | 9.08e-01 |
| GOMF GTP DEPENDENT PROTEIN BINDING | 19 | 9.66e-01 | -5.68e-03 | 9.89e-01 |
| GOBP ENDOTHELIUM DEVELOPMENT | 94 | 9.25e-01 | 5.63e-03 | 9.73e-01 |
| GOMF CADHERIN BINDING | 277 | 8.73e-01 | -5.60e-03 | 9.54e-01 |
| GOBP DETECTION OF CALCIUM ION | 10 | 9.76e-01 | 5.50e-03 | 9.93e-01 |
| GOBP BASEMENT MEMBRANE ASSEMBLY | 6 | 9.81e-01 | -5.50e-03 | 9.95e-01 |
| GOBP REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 174 | 9.02e-01 | 5.42e-03 | 9.66e-01 |
| GOBP POST GOLGI VESICLE MEDIATED TRANSPORT | 97 | 9.27e-01 | 5.37e-03 | 9.74e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS | 13 | 9.73e-01 | 5.36e-03 | 9.92e-01 |
| GOBP NEURAL FOLD FORMATION | 5 | 9.84e-01 | -5.28e-03 | 9.96e-01 |
| GOBP DEPHOSPHORYLATION | 246 | 8.87e-01 | 5.28e-03 | 9.59e-01 |
| GOMF CALCIUM DEPENDENT PHOSPHOLIPID BINDING | 34 | 9.58e-01 | -5.26e-03 | 9.85e-01 |
| GOBP CENTRIOLE CENTRIOLE COHESION | 14 | 9.73e-01 | 5.24e-03 | 9.92e-01 |
| GOBP PURINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 31 | 9.60e-01 | 5.23e-03 | 9.86e-01 |
| GOBP RESPONSE TO FATTY ACID | 35 | 9.58e-01 | 5.15e-03 | 9.85e-01 |
| GOBP THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY | 9 | 9.79e-01 | -5.13e-03 | 9.94e-01 |
| GOBP SULFUR AMINO ACID BIOSYNTHETIC PROCESS | 11 | 9.77e-01 | -5.06e-03 | 9.93e-01 |
| GOBP LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 48 | 9.52e-01 | -5.04e-03 | 9.84e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 5 KINASE ACTIVITY | 8 | 9.80e-01 | -5.02e-03 | 9.95e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT | 50 | 9.51e-01 | -4.99e-03 | 9.84e-01 |
| GOBP PROTEIN HISTIDYL MODIFICATION TO DIPHTHAMIDE | 6 | 9.83e-01 | 4.96e-03 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE | 52 | 9.51e-01 | -4.92e-03 | 9.84e-01 |
| GOBP IMMUNOLOGICAL SYNAPSE FORMATION | 12 | 9.76e-01 | 4.91e-03 | 9.93e-01 |
| GOBP ALDEHYDE CATABOLIC PROCESS | 10 | 9.79e-01 | -4.90e-03 | 9.94e-01 |
| GOBP NEGATIVE REGULATION OF COLLATERAL SPROUTING | 7 | 9.82e-01 | 4.90e-03 | 9.95e-01 |
| GOCC XY BODY | 12 | 9.77e-01 | -4.88e-03 | 9.93e-01 |
| GOBP TRANSMISSION OF NERVE IMPULSE | 35 | 9.60e-01 | -4.88e-03 | 9.86e-01 |
| GOCC EXTRINSIC COMPONENT OF MITOCHONDRIAL INNER MEMBRANE | 7 | 9.82e-01 | 4.83e-03 | 9.95e-01 |
| GOCC NEURON PROJECTION | 852 | 8.14e-01 | -4.78e-03 | 9.34e-01 |
| GOMF CORECEPTOR ACTIVITY | 30 | 9.64e-01 | 4.77e-03 | 9.87e-01 |
| GOBP MAINTENANCE OF LOCATION | 259 | 8.95e-01 | -4.76e-03 | 9.64e-01 |
| GOBP EXCRETION | 10 | 9.79e-01 | -4.72e-03 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION | 8 | 9.82e-01 | -4.69e-03 | 9.95e-01 |
| GOBP EMBRYONIC ORGAN MORPHOGENESIS | 147 | 9.22e-01 | -4.68e-03 | 9.72e-01 |
| GOMF INTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 19 | 9.72e-01 | -4.67e-03 | 9.91e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS | 14 | 9.76e-01 | -4.64e-03 | 9.93e-01 |
| GOBP HEXOSE CATABOLIC PROCESS | 32 | 9.64e-01 | -4.62e-03 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 5 | 9.86e-01 | -4.59e-03 | 9.96e-01 |
| GOBP NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE | 23 | 9.70e-01 | 4.57e-03 | 9.91e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 86 | 9.43e-01 | 4.45e-03 | 9.80e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER SECRETION | 53 | 9.56e-01 | 4.42e-03 | 9.85e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 58 | 9.54e-01 | -4.38e-03 | 9.85e-01 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 604 | 8.55e-01 | 4.37e-03 | 9.48e-01 |
| GOMF PEPTIDASE REGULATOR ACTIVITY | 124 | 9.33e-01 | -4.36e-03 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 6 | 9.85e-01 | 4.34e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF DNA REPLICATION | 32 | 9.66e-01 | -4.33e-03 | 9.89e-01 |
| GOBP SNRNA PROCESSING | 26 | 9.70e-01 | 4.31e-03 | 9.91e-01 |
| GOBP RECEPTOR CATABOLIC PROCESS | 25 | 9.70e-01 | 4.28e-03 | 9.91e-01 |
| GOBP RESPONSE TO SALT STRESS | 18 | 9.75e-01 | 4.27e-03 | 9.92e-01 |
| GOBP RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES | 15 | 9.77e-01 | -4.27e-03 | 9.93e-01 |
| GOBP ARF PROTEIN SIGNAL TRANSDUCTION | 20 | 9.74e-01 | -4.23e-03 | 9.92e-01 |
| GOCC GOLGI ASSOCIATED VESICLE | 76 | 9.50e-01 | 4.18e-03 | 9.83e-01 |
| GOBP RENAL SYSTEM DEVELOPMENT | 190 | 9.21e-01 | 4.17e-03 | 9.72e-01 |
| GOBP IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 18 | 9.76e-01 | 4.15e-03 | 9.93e-01 |
| GOCC CORVET COMPLEX | 7 | 9.85e-01 | -4.10e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE MIGRATION | 19 | 9.75e-01 | -4.09e-03 | 9.93e-01 |
| GOBP N ACETYLNEURAMINATE METABOLIC PROCESS | 11 | 9.81e-01 | 4.07e-03 | 9.95e-01 |
| GOBP GOLGI TO LYSOSOME TRANSPORT | 11 | 9.82e-01 | 4.03e-03 | 9.95e-01 |
| GOCC SAGA TYPE COMPLEX | 36 | 9.67e-01 | 3.99e-03 | 9.89e-01 |
| GOBP NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 8 | 9.85e-01 | -3.92e-03 | 9.96e-01 |
| GOBP RRNA METABOLIC PROCESS | 247 | 9.16e-01 | 3.89e-03 | 9.71e-01 |
| GOBP PEPTIDE METABOLIC PROCESS | 740 | 8.59e-01 | -3.86e-03 | 9.50e-01 |
| GOBP BONE MORPHOGENESIS | 53 | 9.62e-01 | -3.81e-03 | 9.87e-01 |
| GOMF PROTEIN DISULFIDE ISOMERASE ACTIVITY | 18 | 9.78e-01 | -3.81e-03 | 9.94e-01 |
| GOCC NUCLEAR MEMBRANE | 271 | 9.14e-01 | -3.80e-03 | 9.70e-01 |
| GOBP LYMPHOCYTE MIGRATION | 82 | 9.53e-01 | -3.80e-03 | 9.84e-01 |
| GOMF STEROID BINDING | 71 | 9.56e-01 | 3.78e-03 | 9.85e-01 |
| GOMF DNA DEMETHYLASE ACTIVITY | 5 | 9.88e-01 | -3.78e-03 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT | 71 | 9.56e-01 | 3.75e-03 | 9.85e-01 |
| GOBP CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND | 11 | 9.83e-01 | 3.73e-03 | 9.95e-01 |
| GOBP CELL PROJECTION ASSEMBLY | 489 | 8.89e-01 | 3.71e-03 | 9.60e-01 |
| GOBP NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 35 | 9.70e-01 | -3.71e-03 | 9.91e-01 |
| GOBP CELLULAR RESPONSE TO NITROSATIVE STRESS | 5 | 9.89e-01 | 3.68e-03 | 9.97e-01 |
| GOCC NEURON TO NEURON SYNAPSE | 249 | 9.21e-01 | -3.66e-03 | 9.72e-01 |
| GOBP CEREBELLAR CORTEX FORMATION | 17 | 9.79e-01 | 3.66e-03 | 9.94e-01 |
| GOMF PHOSPHATASE ACTIVITY | 212 | 9.27e-01 | 3.65e-03 | 9.74e-01 |
| GOCC GOLGI TRANSPORT COMPLEX | 9 | 9.85e-01 | 3.65e-03 | 9.96e-01 |
| GOCC PRESYNAPTIC CYTOSOL | 12 | 9.83e-01 | 3.65e-03 | 9.95e-01 |
| GOCC T TUBULE | 33 | 9.71e-01 | -3.62e-03 | 9.91e-01 |
| GOBP CELLULAR ALDEHYDE METABOLIC PROCESS | 48 | 9.65e-01 | -3.62e-03 | 9.88e-01 |
| GOBP REGULATION OF AXONOGENESIS | 105 | 9.50e-01 | 3.56e-03 | 9.83e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE II PROMOTER | 91 | 9.53e-01 | 3.55e-03 | 9.84e-01 |
| GOBP ACTOMYOSIN STRUCTURE ORGANIZATION | 153 | 9.40e-01 | 3.55e-03 | 9.79e-01 |
| GOMF JUN KINASE KINASE KINASE ACTIVITY | 11 | 9.84e-01 | 3.50e-03 | 9.96e-01 |
| GOBP PROTEIN CATABOLIC PROCESS | 861 | 8.63e-01 | 3.49e-03 | 9.52e-01 |
| GOBP CELL SUBSTRATE JUNCTION DISASSEMBLY | 8 | 9.86e-01 | -3.48e-03 | 9.96e-01 |
| GOBP DNA STRAND ELONGATION | 36 | 9.71e-01 | 3.47e-03 | 9.91e-01 |
| GOBP REGULATION OF NUCLEAR DIVISION | 110 | 9.50e-01 | -3.45e-03 | 9.83e-01 |
| GOMF CALCIUM RELEASE CHANNEL ACTIVITY | 17 | 9.80e-01 | -3.45e-03 | 9.95e-01 |
| GOBP REGULATION OF PROTEIN MONOUBIQUITINATION | 6 | 9.88e-01 | 3.41e-03 | 9.97e-01 |
| GOBP MESENCHYMAL CELL MIGRATION | 33 | 9.73e-01 | 3.38e-03 | 9.92e-01 |
| GOMF MICROFILAMENT MOTOR ACTIVITY | 22 | 9.78e-01 | -3.33e-03 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF ATP DEPENDENT ACTIVITY | 33 | 9.74e-01 | 3.31e-03 | 9.92e-01 |
| GOBP CARDIAC CONDUCTION SYSTEM DEVELOPMENT | 16 | 9.82e-01 | 3.23e-03 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF TROPHOBLAST CELL MIGRATION | 5 | 9.90e-01 | 3.23e-03 | 9.97e-01 |
| GOBP REGULATION OF MEIOTIC NUCLEAR DIVISION | 16 | 9.82e-01 | -3.18e-03 | 9.95e-01 |
| GOBP REGULATION OF EMBRYONIC DEVELOPMENT | 70 | 9.63e-01 | 3.16e-03 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS | 13 | 9.84e-01 | -3.16e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY | 30 | 9.76e-01 | -3.16e-03 | 9.93e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS | 195 | 9.40e-01 | -3.12e-03 | 9.79e-01 |
| GOBP POLYSACCHARIDE METABOLIC PROCESS | 74 | 9.63e-01 | 3.09e-03 | 9.87e-01 |
| GOBP OLIGODENDROCYTE DIFFERENTIATION | 60 | 9.67e-01 | 3.08e-03 | 9.89e-01 |
| GOBP REGULATION OF GLUTAMATE SECRETION | 10 | 9.87e-01 | -3.07e-03 | 9.96e-01 |
| GOMF SCAFFOLD PROTEIN BINDING | 52 | 9.70e-01 | -3.03e-03 | 9.91e-01 |
| GOBP MITOCHONDRION LOCALIZATION | 39 | 9.74e-01 | 3.02e-03 | 9.92e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS IB | 12 | 9.86e-01 | -2.96e-03 | 9.96e-01 |
| GOBP CELL JUNCTION ASSEMBLY | 271 | 9.35e-01 | 2.90e-03 | 9.77e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE | 7 | 9.89e-01 | -2.89e-03 | 9.97e-01 |
| GOBP REGULATION OF CELLULAR KETONE METABOLIC PROCESS | 95 | 9.61e-01 | 2.88e-03 | 9.87e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 10 | 9.88e-01 | -2.83e-03 | 9.97e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ESTER BONDS | 579 | 9.08e-01 | 2.82e-03 | 9.68e-01 |
| GOBP PYRIMIDINE DIMER REPAIR | 9 | 9.88e-01 | -2.80e-03 | 9.97e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR ACTIVITY | 151 | 9.53e-01 | -2.79e-03 | 9.84e-01 |
| GOBP AMINO ACID TRANSPORT | 93 | 9.63e-01 | 2.79e-03 | 9.87e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR BINDING | 26 | 9.80e-01 | -2.78e-03 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES | 119 | 9.59e-01 | -2.76e-03 | 9.86e-01 |
| GOBP AMINOGLYCAN METABOLIC PROCESS | 81 | 9.66e-01 | 2.74e-03 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF MAP KINASE ACTIVITY | 60 | 9.71e-01 | -2.71e-03 | 9.91e-01 |
| GOBP PYRAMIDAL NEURON DEVELOPMENT | 8 | 9.90e-01 | -2.68e-03 | 9.97e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 15 | 9.86e-01 | 2.66e-03 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 12 | 9.87e-01 | 2.65e-03 | 9.97e-01 |
| GOBP MYELOID DENDRITIC CELL CYTOKINE PRODUCTION | 6 | 9.91e-01 | -2.65e-03 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 26 | 9.82e-01 | 2.60e-03 | 9.95e-01 |
| GOBP FIBRINOLYSIS | 14 | 9.87e-01 | 2.59e-03 | 9.96e-01 |
| GOBP RETINAL ROD CELL DEVELOPMENT | 5 | 9.92e-01 | 2.58e-03 | 9.97e-01 |
| GOBP AMELOGENESIS | 14 | 9.87e-01 | 2.54e-03 | 9.97e-01 |
| GOBP REGULATION OF MICROVILLUS LENGTH | 5 | 9.92e-01 | 2.53e-03 | 9.97e-01 |
| GOBP PROTEASOMAL PROTEIN CATABOLIC PROCESS | 483 | 9.24e-01 | -2.53e-03 | 9.73e-01 |
| GOBP PROXIMAL DISTAL PATTERN FORMATION | 8 | 9.90e-01 | -2.51e-03 | 9.97e-01 |
| GOMF RETINAL DEHYDROGENASE ACTIVITY | 5 | 9.92e-01 | 2.51e-03 | 9.97e-01 |
| GOBP SPHINGOID METABOLIC PROCESS | 16 | 9.86e-01 | 2.50e-03 | 9.96e-01 |
| GOCC INTRACELLULAR PROTEIN CONTAINING COMPLEX | 814 | 9.05e-01 | -2.47e-03 | 9.67e-01 |
| GOBP B CELL CHEMOTAXIS | 6 | 9.92e-01 | -2.45e-03 | 9.97e-01 |
| GOBP BIOMINERAL TISSUE DEVELOPMENT | 100 | 9.67e-01 | -2.42e-03 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF GTPASE ACTIVITY | 177 | 9.56e-01 | 2.42e-03 | 9.85e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR BINDING | 141 | 9.61e-01 | -2.41e-03 | 9.86e-01 |
| GOMF VOLUME SENSITIVE ANION CHANNEL ACTIVITY | 8 | 9.91e-01 | 2.41e-03 | 9.97e-01 |
| GOBP REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES | 9 | 9.90e-01 | 2.36e-03 | 9.97e-01 |
| GOBP LOCOMOTORY BEHAVIOR | 116 | 9.65e-01 | -2.36e-03 | 9.88e-01 |
| GOBP EPITHELIUM DEVELOPMENT | 729 | 9.15e-01 | 2.33e-03 | 9.70e-01 |
| GOBP REGULATION OF MICROTUBULE NUCLEATION | 19 | 9.86e-01 | 2.31e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 13 | 9.88e-01 | 2.31e-03 | 9.97e-01 |
| GOMF MRNA REGULATORY ELEMENT BINDING TRANSLATION REPRESSOR ACTIVITY | 15 | 9.88e-01 | -2.30e-03 | 9.97e-01 |
| GOBP REGULATION OF TRANSPORTER ACTIVITY | 146 | 9.62e-01 | -2.29e-03 | 9.87e-01 |
| GOBP CELLULAR RESPONSE TO OXIDATIVE STRESS | 203 | 9.55e-01 | 2.29e-03 | 9.85e-01 |
| GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 233 | 9.53e-01 | -2.24e-03 | 9.84e-01 |
| GOBP TISSUE MORPHOGENESIS | 387 | 9.40e-01 | 2.23e-03 | 9.79e-01 |
| GOBP REGULATION OF SPINDLE ORGANIZATION | 43 | 9.80e-01 | 2.20e-03 | 9.95e-01 |
| GOBP DUMP METABOLIC PROCESS | 6 | 9.93e-01 | -2.09e-03 | 9.97e-01 |
| GOMF P TYPE TRANSMEMBRANE TRANSPORTER ACTIVITY | 15 | 9.89e-01 | 2.07e-03 | 9.97e-01 |
| GOBP LOW DENSITY LIPOPROTEIN PARTICLE REMODELING | 7 | 9.92e-01 | -2.07e-03 | 9.97e-01 |
| GOBP PROTEIN TRANSPORT TO VACUOLE INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 14 | 9.89e-01 | 2.05e-03 | 9.97e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 14 | 9.90e-01 | 1.97e-03 | 9.97e-01 |
| GOBP REGULATION OF LIPID STORAGE | 42 | 9.82e-01 | -1.96e-03 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION | 18 | 9.89e-01 | -1.93e-03 | 9.97e-01 |
| GOBP REGULATION OF CELL SHAPE | 115 | 9.72e-01 | 1.91e-03 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 14 | 9.90e-01 | 1.91e-03 | 9.97e-01 |
| GOBP CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 111 | 9.73e-01 | -1.89e-03 | 9.91e-01 |
| GOBP COMPLEMENT ACTIVATION | 31 | 9.86e-01 | 1.84e-03 | 9.96e-01 |
| GOBP REGULATION OF PLATELET AGGREGATION | 17 | 9.90e-01 | -1.82e-03 | 9.97e-01 |
| GOBP PROGESTERONE METABOLIC PROCESS | 9 | 9.92e-01 | -1.82e-03 | 9.97e-01 |
| GOCC ACROSOMAL VESICLE | 78 | 9.78e-01 | -1.78e-03 | 9.94e-01 |
| GOBP REGENERATION | 122 | 9.73e-01 | -1.77e-03 | 9.92e-01 |
| GOCC ENDOCYTIC VESICLE MEMBRANE | 155 | 9.70e-01 | 1.77e-03 | 9.91e-01 |
| GOBP REGULATION OF CARTILAGE DEVELOPMENT | 34 | 9.86e-01 | 1.76e-03 | 9.96e-01 |
| GOBP PEPTIDYL HISTIDINE MODIFICATION | 8 | 9.93e-01 | 1.73e-03 | 9.97e-01 |
| GOBP CELL GROWTH | 352 | 9.56e-01 | 1.73e-03 | 9.85e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 40 | 9.85e-01 | 1.73e-03 | 9.96e-01 |
| GOBP SYNAPTIC TRANSMISSION GLUTAMATERGIC | 62 | 9.81e-01 | -1.72e-03 | 9.95e-01 |
| GOMF BETA 2 MICROGLOBULIN BINDING | 8 | 9.93e-01 | -1.70e-03 | 9.97e-01 |
| GOBP NUCLEOTIDE SALVAGE | 17 | 9.90e-01 | -1.68e-03 | 9.97e-01 |
| GOCC EARLY ENDOSOME MEMBRANE | 154 | 9.71e-01 | 1.68e-03 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION | 12 | 9.92e-01 | 1.67e-03 | 9.97e-01 |
| GOBP RESPONSE TO NITRIC OXIDE | 14 | 9.91e-01 | -1.66e-03 | 9.97e-01 |
| GOBP NEURAL NUCLEUS DEVELOPMENT | 45 | 9.85e-01 | 1.66e-03 | 9.96e-01 |
| GOBP MITOCHONDRION ENDOPLASMIC RETICULUM MEMBRANE TETHERING | 7 | 9.94e-01 | 1.64e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 22 | 9.90e-01 | 1.60e-03 | 9.97e-01 |
| GOBP ALANINE TRANSPORT | 12 | 9.92e-01 | 1.58e-03 | 9.97e-01 |
| GOBP DICARBOXYLIC ACID METABOLIC PROCESS | 70 | 9.82e-01 | -1.56e-03 | 9.95e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON RNA | 348 | 9.60e-01 | 1.55e-03 | 9.86e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION | 404 | 9.58e-01 | -1.54e-03 | 9.85e-01 |
| GOBP TYPE B PANCREATIC CELL APOPTOTIC PROCESS | 7 | 9.95e-01 | 1.50e-03 | 9.98e-01 |
| GOBP HOMEOSTATIC PROCESS | 1156 | 9.33e-01 | -1.49e-03 | 9.77e-01 |
| GOBP REGULATION OF NEURON PROJECTION ARBORIZATION | 13 | 9.93e-01 | -1.48e-03 | 9.97e-01 |
| GOBP KERATINOCYTE DIFFERENTIATION | 74 | 9.82e-01 | -1.48e-03 | 9.95e-01 |
| GOBP TRNA TRANSPORT | 5 | 9.95e-01 | -1.46e-03 | 9.98e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 8 | 9.95e-01 | -1.35e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 6 | 9.95e-01 | 1.34e-03 | 9.98e-01 |
| GOCC AXON | 438 | 9.62e-01 | 1.32e-03 | 9.87e-01 |
| GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE | 10 | 9.94e-01 | -1.30e-03 | 9.98e-01 |
| GOMF DNA NUCLEASE ACTIVITY | 58 | 9.86e-01 | -1.29e-03 | 9.96e-01 |
| GOBP MICROTUBULE ORGANIZING CENTER LOCALIZATION | 29 | 9.90e-01 | -1.28e-03 | 9.97e-01 |
| GOBP CYTOSKELETON ORGANIZATION | 1122 | 9.43e-01 | -1.27e-03 | 9.80e-01 |
| GOMF DNA N GLYCOSYLASE ACTIVITY | 14 | 9.94e-01 | 1.26e-03 | 9.97e-01 |
| GOBP EMBRYONIC DIGIT MORPHOGENESIS | 31 | 9.91e-01 | 1.21e-03 | 9.97e-01 |
| GOBP CALCIUM MEDIATED SIGNALING | 134 | 9.81e-01 | -1.18e-03 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 21 | 9.93e-01 | -1.17e-03 | 9.97e-01 |
| GOBP HORMONE TRANSPORT | 184 | 9.79e-01 | -1.14e-03 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF ORGANELLE ASSEMBLY | 76 | 9.87e-01 | 1.09e-03 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 26 | 9.93e-01 | -1.05e-03 | 9.97e-01 |
| GOCC GOLGI APPARATUS SUBCOMPARTMENT | 312 | 9.75e-01 | -1.04e-03 | 9.92e-01 |
| GOBP SENSORY PERCEPTION OF PAIN | 42 | 9.91e-01 | 9.90e-04 | 9.97e-01 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION | 517 | 9.70e-01 | 9.81e-04 | 9.91e-01 |
| GOMF U2 SNRNA BINDING | 6 | 9.97e-01 | -9.76e-04 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF TRANSPORT | 627 | 9.68e-01 | 9.35e-04 | 9.90e-01 |
| GOBP MECHANORECEPTOR DIFFERENTIATION | 41 | 9.92e-01 | 9.20e-04 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 28 | 9.93e-01 | 8.98e-04 | 9.97e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION | 63 | 9.90e-01 | 8.97e-04 | 9.97e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 81 | 9.89e-01 | 8.67e-04 | 9.97e-01 |
| GOBP PROTEIN LOCALIZATION TO EARLY ENDOSOME | 11 | 9.96e-01 | 8.48e-04 | 9.99e-01 |
| GOBP REGULATION OF MUSCLE CONTRACTION | 99 | 9.88e-01 | 8.42e-04 | 9.97e-01 |
| GOCC ENDONUCLEASE COMPLEX | 38 | 9.93e-01 | -8.07e-04 | 9.97e-01 |
| GOBP CALCIUM ION TRANSPORT | 277 | 9.82e-01 | -8.02e-04 | 9.95e-01 |
| GOBP SELF PROTEOLYSIS | 8 | 9.97e-01 | -7.92e-04 | 9.99e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE ACTIVITY | 66 | 9.91e-01 | 7.87e-04 | 9.97e-01 |
| GOCC CHROMOSOME TELOMERIC REPEAT REGION | 12 | 9.96e-01 | 7.77e-04 | 9.99e-01 |
| GOBP AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS | 14 | 9.96e-01 | -7.52e-04 | 9.99e-01 |
| GOBP REGULATION OF PHOSPHATASE ACTIVITY | 49 | 9.93e-01 | 7.12e-04 | 9.97e-01 |
| GOBP NCRNA METABOLIC PROCESS | 545 | 9.79e-01 | 6.77e-04 | 9.94e-01 |
| GOMF VOLTAGE GATED MONOATOMIC CATION CHANNEL ACTIVITY | 58 | 9.93e-01 | 6.60e-04 | 9.97e-01 |
| GOBP REGULATION OF CAMP MEDIATED SIGNALING | 14 | 9.97e-01 | 6.41e-04 | 9.99e-01 |
| GOBP SENSORY PERCEPTION | 275 | 9.86e-01 | 6.28e-04 | 9.96e-01 |
| GOMF TUBULIN BINDING | 308 | 9.85e-01 | 6.20e-04 | 9.96e-01 |
| GOBP LOCOMOTORY EXPLORATION BEHAVIOR | 6 | 9.98e-01 | 5.78e-04 | 9.99e-01 |
| GOBP RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 28 | 9.96e-01 | 5.64e-04 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 14 | 9.97e-01 | -5.64e-04 | 9.99e-01 |
| GOBP REGULATION OF MITOTIC CENTROSOME SEPARATION | 7 | 9.98e-01 | 5.47e-04 | 9.99e-01 |
| GOBP RESPONSE TO ISCHEMIA | 45 | 9.95e-01 | 5.33e-04 | 9.98e-01 |
| GOCC CELL BODY | 356 | 9.86e-01 | 5.30e-04 | 9.96e-01 |
| GOBP NEUTRAL LIPID CATABOLIC PROCESS | 24 | 9.97e-01 | -4.99e-04 | 9.99e-01 |
| GOBP CELL CELL JUNCTION ASSEMBLY | 91 | 9.94e-01 | -4.89e-04 | 9.97e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 15 | 9.98e-01 | 4.63e-04 | 9.99e-01 |
| GOBP RESPONSE TO ACIDIC PH | 16 | 9.98e-01 | 4.49e-04 | 9.99e-01 |
| GOCC VARICOSITY | 6 | 9.99e-01 | -4.38e-04 | 9.99e-01 |
| GOMF LIGAND GATED MONOATOMIC CATION CHANNEL ACTIVITY | 46 | 9.96e-01 | 4.22e-04 | 9.99e-01 |
| GOBP REGULATION OF INSULIN SECRETION | 98 | 9.94e-01 | 4.06e-04 | 9.98e-01 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT | 34 | 9.97e-01 | -3.80e-04 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF GLIOGENESIS | 45 | 9.97e-01 | 3.33e-04 | 9.99e-01 |
| GOCC CLATHRIN COAT OF COATED PIT | 15 | 9.98e-01 | -2.87e-04 | 9.99e-01 |
| GOCC TOR COMPLEX | 11 | 9.99e-01 | -2.50e-04 | 9.99e-01 |
| GOCC SPLICEOSOMAL SNRNP COMPLEX | 65 | 9.98e-01 | -2.09e-04 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF DNA DEMETHYLATION | 7 | 9.99e-01 | 1.54e-04 | 1.00e+00 |
| GOBP REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 293 | 9.97e-01 | -1.17e-04 | 9.99e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 18 | 9.99e-01 | -1.13e-04 | 1.00e+00 |
| GOBP PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 38 | 1.00e+00 | 1.89e-05 | 1.00e+00 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION | 7 | 1.00e+00 | -1.71e-05 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 17 | 1.00e+00 | 7.04e-06 | 1.00e+00 |
Detailed Gene set reports
GOBP THREONINE METABOLIC PROCESS
| set | GOBP THREONINE METABOLIC PROCESS |
| setSize | 5 |
| pANOVA | 0.000713 |
| s.dist | 0.874 |
| p.adjustANOVA | 0.0172 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SDS | 8233 |
| SDSL | 8110 |
| GCAT | 8022 |
| PHGDH | 7196 |
| RIDA | 4365 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SDS | 8233 |
| SDSL | 8110 |
| GCAT | 8022 |
| PHGDH | 7196 |
| RIDA | 4365 |
GOBP RESPONSE TO MOLECULE OF FUNGAL ORIGIN
| set | GOBP RESPONSE TO MOLECULE OF FUNGAL ORIGIN |
| setSize | 5 |
| pANOVA | 0.00115 |
| s.dist | -0.839 |
| p.adjustANOVA | 0.0243 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MYD88 | -8201 |
| SCIMP | -7981 |
| SYK | -7110 |
| CLEC7A | -6755 |
| BTK | -5680 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| MYD88 | -8201 |
| SCIMP | -7981 |
| SYK | -7110 |
| CLEC7A | -6755 |
| BTK | -5680 |
GOBP REGULATION OF CDC42 PROTEIN SIGNAL TRANSDUCTION
| set | GOBP REGULATION OF CDC42 PROTEIN SIGNAL TRANSDUCTION |
| setSize | 6 |
| pANOVA | 0.000383 |
| s.dist | -0.837 |
| p.adjustANOVA | 0.0107 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| APOA1 | -8479 |
| NRP1 | -7438 |
| ABL1 | -7339 |
| APOE | -7244 |
| RALBP1 | -6189 |
| ABCA1 | -6076 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| APOA1 | -8479 |
| NRP1 | -7438 |
| ABL1 | -7339 |
| APOE | -7244 |
| RALBP1 | -6189 |
| ABCA1 | -6076 |
GOCC MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TRANSPORTER COMPLEX
| set | GOCC MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TRANSPORTER COMPLEX |
| setSize | 6 |
| pANOVA | 0.000499 |
| s.dist | 0.821 |
| p.adjustANOVA | 0.0131 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TIMM8A | 7993 |
| TIMM10B | 7749 |
| TIMM9 | 7274 |
| TIMM10 | 6984 |
| TIMM8B | 6042 |
| TIMM13 | 4394 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TIMM8A | 7993 |
| TIMM10B | 7749 |
| TIMM9 | 7274 |
| TIMM10 | 6984 |
| TIMM8B | 6042 |
| TIMM13 | 4394 |
GOBP INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY
| set | GOBP INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY |
| setSize | 6 |
| pANOVA | 0.000515 |
| s.dist | -0.819 |
| p.adjustANOVA | 0.0134 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| JAK2 | -8251 |
| CSF2RB | -7937 |
| STAT5A | -7796 |
| IL3RA | -7447 |
| SYK | -7110 |
| FCER1G | -3295 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| JAK2 | -8251 |
| CSF2RB | -7937 |
| STAT5A | -7796 |
| IL3RA | -7447 |
| SYK | -7110 |
| FCER1G | -3295 |
GOMF ANGIOTENSIN RECEPTOR BINDING
| set | GOMF ANGIOTENSIN RECEPTOR BINDING |
| setSize | 5 |
| pANOVA | 0.00155 |
| s.dist | -0.817 |
| p.adjustANOVA | 0.0298 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| JAK2 | -8251 |
| ARAP1 | -7213 |
| ARRB1 | -7121 |
| ARRB2 | -6656 |
| TYK2 | -5568 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| JAK2 | -8251 |
| ARAP1 | -7213 |
| ARRB1 | -7121 |
| ARRB2 | -6656 |
| TYK2 | -5568 |
GOBP NEGATIVE REGULATION OF MONOCYTE DIFFERENTIATION
| set | GOBP NEGATIVE REGULATION OF MONOCYTE DIFFERENTIATION |
| setSize | 5 |
| pANOVA | 0.00171 |
| s.dist | -0.81 |
| p.adjustANOVA | 0.0318 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| GPR68 | -8469 |
| INPP5D | -8450 |
| MYC | -8381 |
| ZBTB46 | -8361 |
| CDK6 | -836 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| GPR68 | -8469 |
| INPP5D | -8450 |
| MYC | -8381 |
| ZBTB46 | -8361 |
| CDK6 | -836 |
GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS
| set | GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS |
| setSize | 5 |
| pANOVA | 0.00204 |
| s.dist | 0.797 |
| p.adjustANOVA | 0.0363 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CCL7 | 8214 |
| CCL3 | 8049 |
| CCL2 | 7734 |
| CCL4 | 6428 |
| CCL5 | 2264 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CCL7 | 8214 |
| CCL3 | 8049 |
| CCL2 | 7734 |
| CCL4 | 6428 |
| CCL5 | 2264 |
GOBP POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING
| set | GOBP POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING |
| setSize | 8 |
| pANOVA | 0.000107 |
| s.dist | -0.791 |
| p.adjustANOVA | 0.00403 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| GCNT1 | -8451 |
| PTAFR | -8391 |
| CHST2 | -8155 |
| ITGA4 | -8025 |
| GP1BA | -6244 |
| FUT7 | -5816 |
| ST3GAL4 | -5479 |
| FUT4 | -3345 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| GCNT1 | -8451 |
| PTAFR | -8391 |
| CHST2 | -8155 |
| ITGA4 | -8025 |
| GP1BA | -6244 |
| FUT7 | -5816 |
| ST3GAL4 | -5479 |
| FUT4 | -3345 |
GOBP REGULATION OF ADIPONECTIN SECRETION
| set | GOBP REGULATION OF ADIPONECTIN SECRETION |
| setSize | 7 |
| pANOVA | 0.000328 |
| s.dist | 0.784 |
| p.adjustANOVA | 0.00951 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RAB11FIP5 | 7835 |
| IL1B | 7754 |
| PPARG | 7041 |
| RAB11FIP1 | 6739 |
| HCAR2 | 6410 |
| RAB11FIP3 | 5457 |
| C1QTNF3 | 3784 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| RAB11FIP5 | 7835 |
| IL1B | 7754 |
| PPARG | 7041 |
| RAB11FIP1 | 6739 |
| HCAR2 | 6410 |
| RAB11FIP3 | 5457 |
| C1QTNF3 | 3784 |
GOBP BRANCHED CHAIN AMINO ACID BIOSYNTHETIC PROCESS
| set | GOBP BRANCHED CHAIN AMINO ACID BIOSYNTHETIC PROCESS |
| setSize | 5 |
| pANOVA | 0.00247 |
| s.dist | 0.782 |
| p.adjustANOVA | 0.0422 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SDS | 8233 |
| SDSL | 8110 |
| BCAT1 | 7974 |
| ILVBL | 6189 |
| BCAT2 | 1556 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SDS | 8233 |
| SDSL | 8110 |
| BCAT1 | 7974 |
| ILVBL | 6189 |
| BCAT2 | 1556 |
GOBP REGULATION OF DNA TOPOISOMERASE ATP HYDROLYZING ACTIVITY
| set | GOBP REGULATION OF DNA TOPOISOMERASE ATP HYDROLYZING ACTIVITY |
| setSize | 5 |
| pANOVA | 0.00274 |
| s.dist | -0.774 |
| p.adjustANOVA | 0.0451 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HNRNPU | -7650 |
| UHRF1 | -7472 |
| PLSCR1 | -7433 |
| DHX9 | -5880 |
| SETMAR | -4545 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HNRNPU | -7650 |
| UHRF1 | -7472 |
| PLSCR1 | -7433 |
| DHX9 | -5880 |
| SETMAR | -4545 |
GOMF HISTONE DEACETYLASE REGULATOR ACTIVITY
| set | GOMF HISTONE DEACETYLASE REGULATOR ACTIVITY |
| setSize | 6 |
| pANOVA | 0.00133 |
| s.dist | -0.756 |
| p.adjustANOVA | 0.0266 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SKI | -8079 |
| TP53 | -7109 |
| MAPK8 | -7024 |
| UCN | -6335 |
| ING2 | -5425 |
| HOPX | -4741 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SKI | -8079 |
| TP53 | -7109 |
| MAPK8 | -7024 |
| UCN | -6335 |
| ING2 | -5425 |
| HOPX | -4741 |
GOCC PROTEASE INHIBITOR COMPLEX
| set | GOCC PROTEASE INHIBITOR COMPLEX |
| setSize | 5 |
| pANOVA | 0.00395 |
| s.dist | 0.744 |
| p.adjustANOVA | 0.0578 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CASP1 | 7682 |
| SERPINB6 | 7280 |
| CARD16 | 6850 |
| PLAU | 5357 |
| SERPINE1 | 3338 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CASP1 | 7682 |
| SERPINB6 | 7280 |
| CARD16 | 6850 |
| PLAU | 5357 |
| SERPINE1 | 3338 |
GOBP RESOLUTION OF RECOMBINATION INTERMEDIATES
| set | GOBP RESOLUTION OF RECOMBINATION INTERMEDIATES |
| setSize | 6 |
| pANOVA | 0.00174 |
| s.dist | -0.738 |
| p.adjustANOVA | 0.0322 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TOP3A | -7543 |
| RMI1 | -6850 |
| BLM | -6452 |
| RMI2 | -5799 |
| GEN1 | -5714 |
| XRCC3 | -5430 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TOP3A | -7543 |
| RMI1 | -6850 |
| BLM | -6452 |
| RMI2 | -5799 |
| GEN1 | -5714 |
| XRCC3 | -5430 |
GOBP MIRNA MEDIATED GENE SILENCING BY MRNA DESTABILIZATION
| set | GOBP MIRNA MEDIATED GENE SILENCING BY MRNA DESTABILIZATION |
| setSize | 5 |
| pANOVA | 0.00452 |
| s.dist | -0.733 |
| p.adjustANOVA | 0.0629 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| AGO3 | -8126 |
| AGO4 | -6577 |
| AGO1 | -6064 |
| MOV10 | -5769 |
| AGO2 | -4758 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| AGO3 | -8126 |
| AGO4 | -6577 |
| AGO1 | -6064 |
| MOV10 | -5769 |
| AGO2 | -4758 |
GOBP HISTONE H3 K9 METHYLATION
| set | GOBP HISTONE H3 K9 METHYLATION |
| setSize | 5 |
| pANOVA | 0.00463 |
| s.dist | -0.731 |
| p.adjustANOVA | 0.0641 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SETDB1 | -7291 |
| EHMT1 | -6691 |
| EHMT2 | -6187 |
| SETDB2 | -5550 |
| MECP2 | -5492 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SETDB1 | -7291 |
| EHMT1 | -6691 |
| EHMT2 | -6187 |
| SETDB2 | -5550 |
| MECP2 | -5492 |
GOBP ADP METABOLIC PROCESS
| set | GOBP ADP METABOLIC PROCESS |
| setSize | 7 |
| pANOVA | 0.00081 |
| s.dist | 0.731 |
| p.adjustANOVA | 0.0188 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| AK3 | 8059 |
| BAD | 7651 |
| NUDT9 | 7227 |
| AK5 | 6355 |
| AK4 | 5892 |
| AK2 | 5581 |
| AK1 | 1159 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| AK3 | 8059 |
| BAD | 7651 |
| NUDT9 | 7227 |
| AK5 | 6355 |
| AK4 | 5892 |
| AK2 | 5581 |
| AK1 | 1159 |
GOBP ASTROCYTE CELL MIGRATION
| set | GOBP ASTROCYTE CELL MIGRATION |
| setSize | 6 |
| pANOVA | 0.00214 |
| s.dist | 0.724 |
| p.adjustANOVA | 0.0376 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| GPR183 | 8240 |
| CCL3 | 8049 |
| CCL2 | 7734 |
| HEXB | 6007 |
| SCRIB | 4785 |
| MMP14 | 763 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| GPR183 | 8240 |
| CCL3 | 8049 |
| CCL2 | 7734 |
| HEXB | 6007 |
| SCRIB | 4785 |
| MMP14 | 763 |
GOMF CD4 RECEPTOR BINDING
| set | GOMF CD4 RECEPTOR BINDING |
| setSize | 6 |
| pANOVA | 0.00222 |
| s.dist | -0.721 |
| p.adjustANOVA | 0.0388 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CD74 | -7873 |
| HLA-DRB1 | -7475 |
| PLSCR1 | -7433 |
| IL16 | -7070 |
| CD22 | -3766 |
| SPG21 | -3319 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CD74 | -7873 |
| HLA-DRB1 | -7475 |
| PLSCR1 | -7433 |
| IL16 | -7070 |
| CD22 | -3766 |
| SPG21 | -3319 |
GOBP VITAMIN B6 METABOLIC PROCESS
| set | GOBP VITAMIN B6 METABOLIC PROCESS |
| setSize | 5 |
| pANOVA | 0.00526 |
| s.dist | 0.721 |
| p.adjustANOVA | 0.07 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSAT1 | 8062 |
| PDXK | 6960 |
| ALPL | 5282 |
| PDXP | 5072 |
| PNPO | 4137 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PSAT1 | 8062 |
| PDXK | 6960 |
| ALPL | 5282 |
| PDXP | 5072 |
| PNPO | 4137 |
GOMF SUPERCOILED DNA BINDING
| set | GOMF SUPERCOILED DNA BINDING |
| setSize | 6 |
| pANOVA | 0.00238 |
| s.dist | -0.716 |
| p.adjustANOVA | 0.0408 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HMGB2 | -7972 |
| ABL1 | -7339 |
| RPS3 | -6676 |
| PSIP1 | -6220 |
| HMGB1 | -4930 |
| TOP1 | -3557 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HMGB2 | -7972 |
| ABL1 | -7339 |
| RPS3 | -6676 |
| PSIP1 | -6220 |
| HMGB1 | -4930 |
| TOP1 | -3557 |
GOMF HISTONE H3K9ME2 METHYLTRANSFERASE ACTIVITY
| set | GOMF HISTONE H3K9ME2 METHYLTRANSFERASE ACTIVITY |
| setSize | 6 |
| pANOVA | 0.0025 |
| s.dist | -0.713 |
| p.adjustANOVA | 0.0423 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SETDB1 | -7291 |
| EHMT1 | -6691 |
| ASH1L | -6633 |
| EHMT2 | -6187 |
| SETD5 | -5692 |
| MECOM | -4030 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SETDB1 | -7291 |
| EHMT1 | -6691 |
| ASH1L | -6633 |
| EHMT2 | -6187 |
| SETD5 | -5692 |
| MECOM | -4030 |
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY
| set | GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY |
| setSize | 5 |
| pANOVA | 0.00585 |
| s.dist | -0.712 |
| p.adjustANOVA | 0.0758 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CASP3 | -8233 |
| CASP10 | -8215 |
| CASP2 | -7578 |
| CASP8 | -5015 |
| CASP9 | -1349 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CASP3 | -8233 |
| CASP10 | -8215 |
| CASP2 | -7578 |
| CASP8 | -5015 |
| CASP9 | -1349 |
GOBP RESPONSE TO FUNGICIDE
| set | GOBP RESPONSE TO FUNGICIDE |
| setSize | 6 |
| pANOVA | 0.00271 |
| s.dist | -0.707 |
| p.adjustANOVA | 0.0449 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| KDM5B | -8322 |
| KDM6B | -7774 |
| EHMT1 | -6691 |
| EHMT2 | -6187 |
| KDM1A | -4929 |
| SRD5A1 | -2325 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| KDM5B | -8322 |
| KDM6B | -7774 |
| EHMT1 | -6691 |
| EHMT2 | -6187 |
| KDM1A | -4929 |
| SRD5A1 | -2325 |
GOBP PURINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS
| set | GOBP PURINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS |
| setSize | 6 |
| pANOVA | 0.00272 |
| s.dist | 0.707 |
| p.adjustANOVA | 0.0451 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| AK3 | 8059 |
| GUK1 | 7665 |
| AK5 | 6355 |
| AK4 | 5892 |
| AK2 | 5581 |
| AK1 | 1159 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| AK3 | 8059 |
| GUK1 | 7665 |
| AK5 | 6355 |
| AK4 | 5892 |
| AK2 | 5581 |
| AK1 | 1159 |
GOBP CATECHOLAMINE UPTAKE
| set | GOBP CATECHOLAMINE UPTAKE |
| setSize | 6 |
| pANOVA | 0.00278 |
| s.dist | 0.705 |
| p.adjustANOVA | 0.0455 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SNCA | 7953 |
| SLC22A1 | 6836 |
| PRKN | 6434 |
| PARK7 | 5661 |
| ACTB | 4609 |
| TOR1A | 3149 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SNCA | 7953 |
| SLC22A1 | 6836 |
| PRKN | 6434 |
| PARK7 | 5661 |
| ACTB | 4609 |
| TOR1A | 3149 |
GOMF PROTEIN SERINE THREONINE KINASE BINDING
| set | GOMF PROTEIN SERINE THREONINE KINASE BINDING |
| setSize | 7 |
| pANOVA | 0.00136 |
| s.dist | -0.699 |
| p.adjustANOVA | 0.027 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NAIP | -8297 |
| CCDC102B | -7377 |
| MAPK8 | -7024 |
| MAP3K7 | -6138 |
| DNM3 | -6061 |
| DAZAP2 | -3989 |
| XIAP | -2919 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| NAIP | -8297 |
| CCDC102B | -7377 |
| MAPK8 | -7024 |
| MAP3K7 | -6138 |
| DNM3 | -6061 |
| DAZAP2 | -3989 |
| XIAP | -2919 |
GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
| set | GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY |
| setSize | 6 |
| pANOVA | 0.00307 |
| s.dist | -0.698 |
| p.adjustANOVA | 0.0487 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PDE4B | -8453 |
| ARRDC3 | -8344 |
| OPRL1 | -8298 |
| GNAI2 | -7569 |
| ATP2B4 | -2931 |
| CRTC3 | -178 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PDE4B | -8453 |
| ARRDC3 | -8344 |
| OPRL1 | -8298 |
| GNAI2 | -7569 |
| ATP2B4 | -2931 |
| CRTC3 | -178 |
GOCC EKC KEOPS COMPLEX
| set | GOCC EKC KEOPS COMPLEX |
| setSize | 5 |
| pANOVA | 0.00747 |
| s.dist | 0.691 |
| p.adjustANOVA | 0.0859 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TPRKB | 7594 |
| GON7 | 6583 |
| LAGE3 | 6006 |
| TP53RK | 5071 |
| OSGEP | 3012 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TPRKB | 7594 |
| GON7 | 6583 |
| LAGE3 | 6006 |
| TP53RK | 5071 |
| OSGEP | 3012 |
GOCC RISC LOADING COMPLEX
| set | GOCC RISC LOADING COMPLEX |
| setSize | 8 |
| pANOVA | 0.000786 |
| s.dist | -0.686 |
| p.adjustANOVA | 0.0184 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| AGO3 | -8126 |
| DICER1 | -7996 |
| AGO4 | -6577 |
| AGO1 | -6064 |
| DHX9 | -5880 |
| PRKRA | -4973 |
| AGO2 | -4758 |
| TARBP2 | -2492 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| AGO3 | -8126 |
| DICER1 | -7996 |
| AGO4 | -6577 |
| AGO1 | -6064 |
| DHX9 | -5880 |
| PRKRA | -4973 |
| AGO2 | -4758 |
| TARBP2 | -2492 |
GOMF HISTONE H3K9 MONOMETHYLTRANSFERASE ACTIVITY
| set | GOMF HISTONE H3K9 MONOMETHYLTRANSFERASE ACTIVITY |
| setSize | 5 |
| pANOVA | 0.00816 |
| s.dist | -0.683 |
| p.adjustANOVA | 0.0913 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SETDB1 | -7291 |
| ASH1L | -6633 |
| SETD5 | -5692 |
| SETDB2 | -5550 |
| MECOM | -4030 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SETDB1 | -7291 |
| ASH1L | -6633 |
| SETD5 | -5692 |
| SETDB2 | -5550 |
| MECOM | -4030 |
GOMF AMINOACYL TRNA HYDROLASE ACTIVITY
| set | GOMF AMINOACYL TRNA HYDROLASE ACTIVITY |
| setSize | 5 |
| pANOVA | 0.00926 |
| s.dist | 0.672 |
| p.adjustANOVA | 0.0995 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ETF1 | 7133 |
| PTRH1 | 6480 |
| PTRHD1 | 6237 |
| MRPL58 | 4620 |
| PTRH2 | 3011 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ETF1 | 7133 |
| PTRH1 | 6480 |
| PTRHD1 | 6237 |
| MRPL58 | 4620 |
| PTRH2 | 3011 |
GOBP MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION
| set | GOBP MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION |
| setSize | 5 |
| pANOVA | 0.00944 |
| s.dist | -0.67 |
| p.adjustANOVA | 0.1 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SUN2 | -8240 |
| SRGAP2 | -8040 |
| SRGAP2C | -7512 |
| SYNE2 | -6530 |
| SUN1 | 1663 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SUN2 | -8240 |
| SRGAP2 | -8040 |
| SRGAP2C | -7512 |
| SYNE2 | -6530 |
| SUN1 | 1663 |
GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING
| set | GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING |
| setSize | 7 |
| pANOVA | 0.0022 |
| s.dist | -0.668 |
| p.adjustANOVA | 0.0386 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| APOA1 | -8479 |
| LPL | -8130 |
| APOE | -7244 |
| LIPC | -5348 |
| LCAT | -4328 |
| APOC2 | -3465 |
| CETP | -3011 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| APOA1 | -8479 |
| LPL | -8130 |
| APOE | -7244 |
| LIPC | -5348 |
| LCAT | -4328 |
| APOC2 | -3465 |
| CETP | -3011 |
GOBP FATTY ACID ELONGATION SATURATED FATTY ACID
| set | GOBP FATTY ACID ELONGATION SATURATED FATTY ACID |
| setSize | 5 |
| pANOVA | 0.00992 |
| s.dist | 0.666 |
| p.adjustANOVA | 0.104 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ELOVL6 | 6114 |
| ELOVL7 | 5831 |
| ELOVL1 | 5562 |
| ELOVL5 | 4977 |
| ELOVL3 | 4743 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ELOVL6 | 6114 |
| ELOVL7 | 5831 |
| ELOVL1 | 5562 |
| ELOVL5 | 4977 |
| ELOVL3 | 4743 |
GOMF FATTY ACID ELONGASE ACTIVITY
| set | GOMF FATTY ACID ELONGASE ACTIVITY |
| setSize | 5 |
| pANOVA | 0.00992 |
| s.dist | 0.666 |
| p.adjustANOVA | 0.104 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ELOVL6 | 6114 |
| ELOVL7 | 5831 |
| ELOVL1 | 5562 |
| ELOVL5 | 4977 |
| ELOVL3 | 4743 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ELOVL6 | 6114 |
| ELOVL7 | 5831 |
| ELOVL1 | 5562 |
| ELOVL5 | 4977 |
| ELOVL3 | 4743 |
GOBP CORTICOSPINAL TRACT MORPHOGENESIS
| set | GOBP CORTICOSPINAL TRACT MORPHOGENESIS |
| setSize | 5 |
| pANOVA | 0.00995 |
| s.dist | -0.666 |
| p.adjustANOVA | 0.104 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NIN | -7707 |
| SPG11 | -7390 |
| FBXO45 | -7286 |
| SCN1B | -6423 |
| SLIT2 | 341 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| NIN | -7707 |
| SPG11 | -7390 |
| FBXO45 | -7286 |
| SCN1B | -6423 |
| SLIT2 | 341 |
GOMF IGG BINDING
| set | GOMF IGG BINDING |
| setSize | 6 |
| pANOVA | 0.00476 |
| s.dist | -0.665 |
| p.adjustANOVA | 0.0652 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| FCGRT | -8168 |
| FCGR3A | -6564 |
| FCGR1A | -5997 |
| FCGR2A | -5688 |
| FCGR2B | -4433 |
| FCER1G | -3295 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| FCGRT | -8168 |
| FCGR3A | -6564 |
| FCGR1A | -5997 |
| FCGR2A | -5688 |
| FCGR2B | -4433 |
| FCER1G | -3295 |
GOBP NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS
| set | GOBP NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS |
| setSize | 5 |
| pANOVA | 0.01 |
| s.dist | 0.665 |
| p.adjustANOVA | 0.104 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SPHK1 | 8217 |
| ORMDL2 | 7768 |
| PRKAA1 | 4561 |
| ORMDL3 | 3721 |
| ORMDL1 | 2926 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SPHK1 | 8217 |
| ORMDL2 | 7768 |
| PRKAA1 | 4561 |
| ORMDL3 | 3721 |
| ORMDL1 | 2926 |
GOCC ACTIVIN RECEPTOR COMPLEX
| set | GOCC ACTIVIN RECEPTOR COMPLEX |
| setSize | 5 |
| pANOVA | 0.0103 |
| s.dist | -0.663 |
| p.adjustANOVA | 0.106 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TGFBR1 | -8116 |
| ACVR1 | -7602 |
| ACVR2B | -6082 |
| ACVR1B | -4611 |
| ACVR2A | -1927 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TGFBR1 | -8116 |
| ACVR1 | -7602 |
| ACVR2B | -6082 |
| ACVR1B | -4611 |
| ACVR2A | -1927 |
GOBP NEGATIVE REGULATION OF CATECHOLAMINE SECRETION
| set | GOBP NEGATIVE REGULATION OF CATECHOLAMINE SECRETION |
| setSize | 5 |
| pANOVA | 0.0104 |
| s.dist | -0.662 |
| p.adjustANOVA | 0.106 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ABAT | -8141 |
| SYT11 | -7187 |
| ADRA2B | -5839 |
| GABBR1 | -5247 |
| P2RY1 | -1883 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ABAT | -8141 |
| SYT11 | -7187 |
| ADRA2B | -5839 |
| GABBR1 | -5247 |
| P2RY1 | -1883 |
GOBP ADP BIOSYNTHETIC PROCESS
| set | GOBP ADP BIOSYNTHETIC PROCESS |
| setSize | 5 |
| pANOVA | 0.0104 |
| s.dist | 0.662 |
| p.adjustANOVA | 0.106 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| AK3 | 8059 |
| AK5 | 6355 |
| AK4 | 5892 |
| AK2 | 5581 |
| AK1 | 1159 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| AK3 | 8059 |
| AK5 | 6355 |
| AK4 | 5892 |
| AK2 | 5581 |
| AK1 | 1159 |
GOMF HISTONE H3K9 METHYLTRANSFERASE ACTIVITY
| set | GOMF HISTONE H3K9 METHYLTRANSFERASE ACTIVITY |
| setSize | 10 |
| pANOVA | 0.000294 |
| s.dist | -0.661 |
| p.adjustANOVA | 0.00874 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SETDB1 | -7291 |
| SUV39H1 | -6842 |
| PRDM2 | -6802 |
| EHMT1 | -6691 |
| ASH1L | -6633 |
| EHMT2 | -6187 |
| SETD5 | -5692 |
| SETDB2 | -5550 |
| MECOM | -4030 |
| SUV39H2 | -821 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SETDB1 | -7291 |
| SUV39H1 | -6842 |
| PRDM2 | -6802 |
| EHMT1 | -6691 |
| ASH1L | -6633 |
| EHMT2 | -6187 |
| SETD5 | -5692 |
| SETDB2 | -5550 |
| MECOM | -4030 |
| SUV39H2 | -821 |
GOBP NEGATIVE REGULATION OF T CELL MIGRATION
| set | GOBP NEGATIVE REGULATION OF T CELL MIGRATION |
| setSize | 5 |
| pANOVA | 0.0108 |
| s.dist | -0.658 |
| p.adjustANOVA | 0.109 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| APOD | -8432 |
| IL27RA | -7909 |
| RIPOR2 | -6641 |
| CD200R1 | -3805 |
| LRCH1 | -1378 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| APOD | -8432 |
| IL27RA | -7909 |
| RIPOR2 | -6641 |
| CD200R1 | -3805 |
| LRCH1 | -1378 |
GOMF TRANSLATION TERMINATION FACTOR ACTIVITY
| set | GOMF TRANSLATION TERMINATION FACTOR ACTIVITY |
| setSize | 6 |
| pANOVA | 0.00524 |
| s.dist | 0.658 |
| p.adjustANOVA | 0.07 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ETF1 | 7133 |
| GSPT2 | 6677 |
| MTRF1L | 6643 |
| GSPT1 | 5643 |
| MRPL58 | 4620 |
| MTRF1 | 1563 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ETF1 | 7133 |
| GSPT2 | 6677 |
| MTRF1L | 6643 |
| GSPT1 | 5643 |
| MRPL58 | 4620 |
| MTRF1 | 1563 |
GOMF HISTONE H4K16 ACETYLTRANSFERASE ACTIVITY
| set | GOMF HISTONE H4K16 ACETYLTRANSFERASE ACTIVITY |
| setSize | 9 |
| pANOVA | 0.000638 |
| s.dist | -0.657 |
| p.adjustANOVA | 0.0158 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| JADE1 | -8076 |
| KAT8 | -7572 |
| ING4 | -7198 |
| MSL3 | -6935 |
| KAT7 | -6927 |
| KAT6A | -6758 |
| ING3 | -4553 |
| JADE2 | -3423 |
| KAT5 | 840 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| JADE1 | -8076 |
| KAT8 | -7572 |
| ING4 | -7198 |
| MSL3 | -6935 |
| KAT7 | -6927 |
| KAT6A | -6758 |
| ING3 | -4553 |
| JADE2 | -3423 |
| KAT5 | 840 |
GOBP REGULATION OF FC GAMMA RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS
| set | GOBP REGULATION OF FC GAMMA RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS |
| setSize | 5 |
| pANOVA | 0.011 |
| s.dist | -0.657 |
| p.adjustANOVA | 0.11 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PTPRC | -8261 |
| APPL2 | -7161 |
| PTPRJ | -7064 |
| CD47 | -4788 |
| APPL1 | -824 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PTPRC | -8261 |
| APPL2 | -7161 |
| PTPRJ | -7064 |
| CD47 | -4788 |
| APPL1 | -824 |
GOBP REGULATION OF ISOMERASE ACTIVITY
| set | GOBP REGULATION OF ISOMERASE ACTIVITY |
| setSize | 8 |
| pANOVA | 0.00129 |
| s.dist | -0.657 |
| p.adjustANOVA | 0.0263 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HNRNPU | -7650 |
| UHRF1 | -7472 |
| PLSCR1 | -7433 |
| ITGB2 | -6448 |
| DHX9 | -5880 |
| ITGAM | -5571 |
| SETMAR | -4545 |
| NOD2 | 54 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HNRNPU | -7650 |
| UHRF1 | -7472 |
| PLSCR1 | -7433 |
| ITGB2 | -6448 |
| DHX9 | -5880 |
| ITGAM | -5571 |
| SETMAR | -4545 |
| NOD2 | 54 |
GOBP PROTEIN TRANSPORT WITHIN LIPID BILAYER
| set | GOBP PROTEIN TRANSPORT WITHIN LIPID BILAYER |
| setSize | 5 |
| pANOVA | 0.0113 |
| s.dist | 0.654 |
| p.adjustANOVA | 0.112 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RILPL2 | 7615 |
| RFTN1 | 7439 |
| ATP1B1 | 6400 |
| RILPL1 | 4225 |
| CD24 | 1062 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| RILPL2 | 7615 |
| RFTN1 | 7439 |
| ATP1B1 | 6400 |
| RILPL1 | 4225 |
| CD24 | 1062 |
Here is the session info with all the versions of packages used.
sessionInfo()## R version 4.4.1 (2024-06-14)
## Platform: x86_64-pc-linux-gnu
## Running under: Ubuntu 22.04.4 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## time zone: Australia/Melbourne
## tzcode source: system (glibc)
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.4.0 GGally_2.2.1
## [3] reshape2_1.4.4 gplots_3.1.3.1
## [5] gtools_3.9.5 tibble_3.2.1
## [7] dplyr_1.1.4 echarts4r_0.4.5
## [9] limma_3.60.0 SingleR_2.6.0
## [11] celldex_1.14.0 harmony_1.2.0
## [13] Rcpp_1.0.12 mitch_1.16.0
## [15] DESeq2_1.44.0 muscat_1.18.0
## [17] beeswarm_0.4.0 stringi_1.8.4
## [19] SingleCellExperiment_1.26.0 SummarizedExperiment_1.34.0
## [21] Biobase_2.64.0 GenomicRanges_1.56.0
## [23] GenomeInfoDb_1.40.0 IRanges_2.38.0
## [25] S4Vectors_0.42.0 BiocGenerics_0.50.0
## [27] MatrixGenerics_1.16.0 matrixStats_1.3.0
## [29] hdf5r_1.3.11 Seurat_5.1.0
## [31] SeuratObject_5.0.2 sp_2.1-4
## [33] plyr_1.8.9 ggplot2_3.5.1
## [35] kableExtra_1.4.0
##
## loaded via a namespace (and not attached):
## [1] progress_1.2.3 goftest_1.2-3
## [3] Biostrings_2.72.0 HDF5Array_1.32.0
## [5] vctrs_0.6.5 spatstat.random_3.2-3
## [7] digest_0.6.36 png_0.1-8
## [9] corpcor_1.6.10 shape_1.4.6.1
## [11] gypsum_1.0.1 ggrepel_0.9.5
## [13] deldir_2.0-4 parallelly_1.37.1
## [15] MASS_7.3-61 httpuv_1.6.15
## [17] foreach_1.5.2 withr_3.0.0
## [19] xfun_0.45 survival_3.7-0
## [21] memoise_2.0.1.9000 ggbeeswarm_0.7.2
## [23] systemfonts_1.1.0 zoo_1.8-12
## [25] GlobalOptions_0.1.2 pbapply_1.7-2
## [27] prettyunits_1.2.0 KEGGREST_1.44.0
## [29] promises_1.3.0 httr_1.4.7
## [31] globals_0.16.3 fitdistrplus_1.1-11
## [33] rhdf5filters_1.16.0 rhdf5_2.48.0
## [35] rstudioapi_0.16.0 UCSC.utils_1.0.0
## [37] miniUI_0.1.1.1 generics_0.1.3
## [39] curl_5.2.1 zlibbioc_1.50.0
## [41] ScaledMatrix_1.12.0 polyclip_1.10-6
## [43] GenomeInfoDbData_1.2.12 ExperimentHub_2.12.0
## [45] SparseArray_1.4.3 xtable_1.8-4
## [47] stringr_1.5.1 doParallel_1.0.17
## [49] evaluate_0.24.0 S4Arrays_1.4.0
## [51] BiocFileCache_2.12.0 hms_1.1.3
## [53] irlba_2.3.5.1 colorspace_2.1-0
## [55] filelock_1.0.3 ROCR_1.0-11
## [57] reticulate_1.38.0 spatstat.data_3.1-2
## [59] magrittr_2.0.3 lmtest_0.9-40
## [61] later_1.3.2 viridis_0.6.5
## [63] lattice_0.22-6 spatstat.geom_3.2-9
## [65] future.apply_1.11.2 scattermore_1.2
## [67] scuttle_1.14.0 cowplot_1.1.3
## [69] RcppAnnoy_0.0.22 pillar_1.9.0
## [71] nlme_3.1-165 iterators_1.0.14
## [73] caTools_1.18.2 compiler_4.4.1
## [75] beachmat_2.20.0 RSpectra_0.16-1
## [77] tensor_1.5 minqa_1.2.7
## [79] crayon_1.5.3 abind_1.4-5
## [81] scater_1.32.0 blme_1.0-5
## [83] locfit_1.5-9.10 bit_4.0.5
## [85] codetools_0.2-20 BiocSingular_1.20.0
## [87] bslib_0.7.0 alabaster.ranges_1.4.0
## [89] GetoptLong_1.0.5 plotly_4.10.4
## [91] remaCor_0.0.18 mime_0.12
## [93] splines_4.4.1 circlize_0.4.16
## [95] fastDummies_1.7.3 dbplyr_2.5.0
## [97] sparseMatrixStats_1.16.0 knitr_1.48
## [99] blob_1.2.4 utf8_1.2.4
## [101] clue_0.3-65 BiocVersion_3.19.1
## [103] lme4_1.1-35.3 listenv_0.9.1
## [105] DelayedMatrixStats_1.26.0 Rdpack_2.6
## [107] Matrix_1.7-0 statmod_1.5.0
## [109] svglite_2.1.3 fANCOVA_0.6-1
## [111] pkgconfig_2.0.3 tools_4.4.1
## [113] cachem_1.1.0 RhpcBLASctl_0.23-42
## [115] rbibutils_2.2.16 RSQLite_2.3.7
## [117] viridisLite_0.4.2 DBI_1.2.3
## [119] numDeriv_2016.8-1.1 fastmap_1.2.0
## [121] rmarkdown_2.27 scales_1.3.0
## [123] grid_4.4.1 ica_1.0-3
## [125] broom_1.0.6 AnnotationHub_3.12.0
## [127] sass_0.4.9 patchwork_1.2.0
## [129] BiocManager_1.30.23 ggstats_0.6.0
## [131] dotCall64_1.1-1 RANN_2.6.1
## [133] alabaster.schemas_1.4.0 farver_2.1.2
## [135] aod_1.3.3 mgcv_1.9-1
## [137] yaml_2.3.9 cli_3.6.3
## [139] purrr_1.0.2 leiden_0.4.3.1
## [141] lifecycle_1.0.4 uwot_0.2.2
## [143] glmmTMB_1.1.9 mvtnorm_1.2-5
## [145] backports_1.5.0 BiocParallel_1.38.0
## [147] gtable_0.3.5 rjson_0.2.21
## [149] ggridges_0.5.6 progressr_0.14.0
## [151] jsonlite_1.8.8 edgeR_4.2.0
## [153] RcppHNSW_0.6.0 bitops_1.0-7
## [155] bit64_4.0.5 Rtsne_0.17
## [157] alabaster.matrix_1.4.0 spatstat.utils_3.0-5
## [159] BiocNeighbors_1.22.0 highr_0.11
## [161] jquerylib_0.1.4 alabaster.se_1.4.0
## [163] pbkrtest_0.5.3 lazyeval_0.2.2
## [165] alabaster.base_1.4.1 shiny_1.8.1.1
## [167] htmltools_0.5.8.1 sctransform_0.4.1
## [169] rappdirs_0.3.3 glue_1.7.0
## [171] spam_2.10-0 httr2_1.0.1
## [173] XVector_0.44.0 gridExtra_2.3
## [175] EnvStats_2.8.1 boot_1.3-30
## [177] igraph_2.0.3 variancePartition_1.34.0
## [179] TMB_1.9.11 R6_2.5.1
## [181] tidyr_1.3.1 labeling_0.4.3
## [183] cluster_2.1.6 Rhdf5lib_1.26.0
## [185] nloptr_2.1.1 DelayedArray_0.30.1
## [187] tidyselect_1.2.1 vipor_0.4.7
## [189] xml2_1.3.6 AnnotationDbi_1.66.0
## [191] future_1.33.2 rsvd_1.0.5
## [193] munsell_0.5.1 KernSmooth_2.23-24
## [195] data.table_1.15.4 htmlwidgets_1.6.4
## [197] ComplexHeatmap_2.20.0 RColorBrewer_1.1-3
## [199] rlang_1.1.4 spatstat.sparse_3.1-0
## [201] spatstat.explore_3.2-7 lmerTest_3.1-3
## [203] fansi_1.0.6END of report